Citrus Sinensis ID: 020078
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LSV3 | 433 | Putative wall-associated | no | no | 0.933 | 0.713 | 0.345 | 8e-48 | |
| Q9LMN6 | 738 | Wall-associated receptor | no | no | 0.945 | 0.424 | 0.330 | 2e-46 | |
| Q9LMN7 | 733 | Wall-associated receptor | no | no | 0.936 | 0.422 | 0.339 | 5e-46 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.888 | 0.393 | 0.363 | 2e-45 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.921 | 0.423 | 0.361 | 3e-45 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.942 | 0.421 | 0.329 | 2e-44 | |
| Q39191 | 735 | Wall-associated receptor | no | no | 0.915 | 0.412 | 0.341 | 3e-44 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.966 | 0.438 | 0.333 | 3e-44 | |
| Q9LMP1 | 732 | Wall-associated receptor | no | no | 0.942 | 0.426 | 0.329 | 4e-44 | |
| O64798 | 389 | Inactive serine/threonine | no | no | 0.936 | 0.796 | 0.355 | 6e-44 |
| >sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 191 bits (484), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 117/339 (34%), Positives = 191/339 (56%), Gaps = 30/339 (8%)
Query: 5 LRKTKNQEKVDKKTFLR--NGKILLEKLIISCDGKRN-PIRSFSAGELKIATNNYNGHQV 61
+RK + K+ ++ F G +L+E+L S G N + F+ ++K ATN Y+ ++
Sbjct: 56 IRKHQKDTKIQRQLFFEKNGGGMLIERL--SGAGSSNIDFKIFTEEDMKEATNGYDVSRI 113
Query: 62 IA-SEHYKLYKGFLENRPISVMK---FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC 117
+ + +YKG L + I +K GDN E F N ++ +Q+NHRN++KL+GC
Sbjct: 114 LGQGGQWTVYKGILPDNSIVAIKKTRLGDN--NQVEQF-INEVLVLSQINHRNVVKLLGC 170
Query: 118 CIETEIPILVFEFVEYGTLADRICSPHGP-HLEPLLWRHRLKIAMEIGNAMAYIHIGFRR 176
C+ETE+P+LV+EF+ G+L D + HG + L W HRL+IA+E+ A+AY+H G
Sbjct: 171 CLETEVPLLVYEFITGGSLFDHL---HGSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASI 227
Query: 177 PIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC 236
PI+ +DIK IL DE AK++DF S+ P + +T+ M+ T YL PEY T L
Sbjct: 228 PIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTT-MVQGTLGYLDPEYYTTWLL 286
Query: 237 NEKTDVFCFGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKS 287
NEK+DV+ FG++L+EL++G++ L+ + + NRL EI+D V+ +
Sbjct: 287 NEKSDVYSFGVVLMELISGQKALCFERPETSKHLVSYFVLATKENRLHEIIDDQVLNE-- 344
Query: 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
E ++++ ++ EC +RP M+ A +L +
Sbjct: 345 --ENQREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (472), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 112/339 (33%), Positives = 191/339 (56%), Gaps = 26/339 (7%)
Query: 5 LRKTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIA- 63
++ TK+ E + ++ F +NG +L + + ++ F+ +K AT+ Y+ ++++
Sbjct: 360 MKNTKDTE-LRQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILGQ 418
Query: 64 SEHYKLYKGFLENRPISVMK---FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE 120
+YKG L + I +K GDN E F N ++ +Q+NHRN++KL+GCC+E
Sbjct: 419 GGQGTVYKGILPDNSIVAIKKARLGDN--SQVEQF-INEVLVLSQINHRNVVKLLGCCLE 475
Query: 121 TEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179
TE+P+LV+EF+ GTL D + HG + L W HRL++A+EI +AY+H PI+
Sbjct: 476 TEVPLLVYEFISSGTLFDHL---HGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPII 532
Query: 180 FKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEK 239
+DIK + IL DE AK++DF S IP + + + M+ T YL PEY TGL NEK
Sbjct: 533 HRDIKTANILLDENLTAKVADFGASRLIPMDKEDLAT-MVQGTLGYLDPEYYNTGLLNEK 591
Query: 240 TDVFCFGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290
+DV+ FG++L+ELL+G++ ++ + + NRL EI+D V+ + +
Sbjct: 592 SDVYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKENRLHEIIDGQVMNENN--- 648
Query: 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
++++Q ++ EC + +RP M A +L + ++
Sbjct: 649 -QREIQKAARIAVECTRLTGEERPGMKEVAAELEALRVT 686
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 185 bits (469), Expect = 5e-46, Method: Compositional matrix adjust.
Identities = 114/336 (33%), Positives = 188/336 (55%), Gaps = 26/336 (7%)
Query: 5 LRKTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIA- 63
+R KN E + ++ F +NG +L + + ++ F+ +K AT+ YN +++
Sbjct: 358 MRHRKNTE-LRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGMKEATDGYNESRILGQ 416
Query: 64 SEHYKLYKGFLENRPISVMK---FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE 120
+YKG L++ I +K GD E F N ++ +Q+NHRN++KL+GCC+E
Sbjct: 417 GGQGTVYKGILQDNSIVAIKKARLGDR--SQVEQF-INEVLVLSQINHRNVVKLLGCCLE 473
Query: 121 TEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179
TE+P+LV+EF+ GTL D + HG + L W HRL+IA+E+ +AY+H PI+
Sbjct: 474 TEVPLLVYEFISSGTLFDHL---HGSMFDSSLTWEHRLRIAIEVAGTLAYLHSYASIPII 530
Query: 180 FKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEK 239
+D+K + IL DE AK++DF S IP + +T+ M+ T YL PEY TGL NEK
Sbjct: 531 HRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTT-MVQGTLGYLDPEYYNTGLLNEK 589
Query: 240 TDVFCFGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290
+DV+ FG++L+ELL+G + L+ + ++ NRL EI+D V+ + +
Sbjct: 590 SDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMNEYN--- 646
Query: 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
++++Q ++ EC +RP+M A +L +
Sbjct: 647 -QREIQESARIAVECTRIMGEERPSMKEVAAELEAL 681
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (464), Expect = 2e-45, Method: Compositional matrix adjust.
Identities = 113/311 (36%), Positives = 173/311 (55%), Gaps = 17/311 (5%)
Query: 16 KKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIA-SEHYKLYKGFL 74
+K F RNG +LL++ + +G R FS+ EL+ AT+N+N ++V+ +YKG L
Sbjct: 376 RKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGML 435
Query: 75 ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134
+ I +K E+ N +V AQ+NHRNI+KL+GCC+ETE+P+LV+EFV G
Sbjct: 436 VDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNG 495
Query: 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194
L R+ + + W RL IA+EI A++Y+H PI +DIK + IL DE N
Sbjct: 496 DLCKRLHDESDDYT--MTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERN 553
Query: 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
AK+SDF S + +TH+T+ + T Y+ PEY + EK+DV+ FG++L+ELLT
Sbjct: 554 RAKVSDFGTSRSVTIDQTHLTTQ-VAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLT 612
Query: 255 GRRDNI---------LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFEC 305
G + + L H + V+ NR+ +IVD + ++ C Q+ ++ L C
Sbjct: 613 GEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDE--C--NMDQVMSVANLARRC 668
Query: 306 VNESAGDRPTM 316
+N RP M
Sbjct: 669 LNRKGKKRPNM 679
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 3e-45, Method: Compositional matrix adjust.
Identities = 119/329 (36%), Positives = 188/329 (57%), Gaps = 24/329 (7%)
Query: 3 WFLRKTKNQEKVDK---KTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGH 59
W L K + KV K K F RNG +LL++ G N + FS+ +L+ AT+ +N
Sbjct: 334 WLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNAS 393
Query: 60 QVIA-SEHYKLYKGFLENRPI-SVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC 117
+++ +YKG LE+ I +V K EN E F N I+ +Q+NHRN++K++GC
Sbjct: 394 RILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEF-INEIILLSQINHRNVVKILGC 452
Query: 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIGNAMAYIHIGFRR 176
C+ETE+PILV+EF+ L D + H P + P+ W RL IA E+ +A++Y+H
Sbjct: 453 CLETEVPILVYEFIPNRNLFDHL---HNPSEDFPMSWEVRLCIACEVADALSYLHSAVSI 509
Query: 177 PIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC 236
PI +D+K + IL DE + AK+SDF S + +TH+T+ ++ T Y+ PEY+ +
Sbjct: 510 PIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTT-IVQGTIGYVDPEYLQSNHF 568
Query: 237 NEKTDVFCFGMLLLELLTGRRDNILLEHVK---------KHVENNRLGEIVDPIVVEDKS 287
K+DV+ FG+LL+ELLTG + LL + + + N+RL EI+D + E+
Sbjct: 569 TGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEE-- 626
Query: 288 CPEKEQQLQALLQLIFECVNESAGDRPTM 316
C +E + A+ +L C++ ++ RPTM
Sbjct: 627 CDREE--VLAVAKLARRCLSLNSEHRPTM 653
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 109/331 (32%), Positives = 179/331 (54%), Gaps = 19/331 (5%)
Query: 7 KTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIA-SE 65
K + K+ ++ F +NG +L + + + F+ +K ATN Y+ +++
Sbjct: 366 KQRKYTKLRRQFFEQNGGGMLIQRLSGAGLSNIDFKIFTEEGMKEATNGYDESRILGQGG 425
Query: 66 HYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125
+YKG L + I +K + + ++ +Q+NHRN++K++GCC+ETE+P+
Sbjct: 426 QGTVYKGILPDNTIVAIKKARLADSRQVDQFIHEVLVLSQINHRNVVKILGCCLETEVPL 485
Query: 126 LVFEFVEYGTLADRICSPHGPHLEP-LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIK 184
LV+EF+ GTL D + HG + L W HRL+IA+E+ +AY+H PI+ +DIK
Sbjct: 486 LVYEFITNGTLFDHL---HGSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIHRDIK 542
Query: 185 LSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244
+ IL DE AK++DF S+ IP + +T+ M+ T YL PEY TGL NEK+DV+
Sbjct: 543 TANILLDENLTAKVADFGASKLIPMDKEQLTT-MVQGTLGYLDPEYYTTGLLNEKSDVYS 601
Query: 245 FGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295
FG++L+ELL+G++ L+ + E NRL EI+D V+ + + E +
Sbjct: 602 FGVVLMELLSGQKALCFERPQASKHLVSYFVSATEENRLHEIIDDQVLNEDNLKE----I 657
Query: 296 QALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
Q ++ EC +RP M A +L +
Sbjct: 658 QEAARIAAECTRLMGEERPRMKEVAAKLEAL 688
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q39191|WAK1_ARATH Wall-associated receptor kinase 1 OS=Arabidopsis thaliana GN=WAK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 112/328 (34%), Positives = 178/328 (54%), Gaps = 25/328 (7%)
Query: 13 KVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIA-SEHYKLYK 71
K+ ++ F +NG +L + + ++ F+ +K ATN Y +++ +YK
Sbjct: 366 KLREQFFEQNGGGMLTQRLSGAGPSNVDVKIFTEDGMKKATNGYAESRILGQGGQGTVYK 425
Query: 72 GFLENRPISVMK---FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128
G L + I +K GD S E F N ++ +Q+NHRN++KL+GCC+ETE+P+LV+
Sbjct: 426 GILPDNSIVAIKKARLGD--SSQVEQF-INEVLVLSQINHRNVVKLLGCCLETEVPLLVY 482
Query: 129 EFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQ 187
EF+ GTL D + HG ++ L W HRLKIA+E+ +AY+H PI+ +DIK +
Sbjct: 483 EFITNGTLFDHL---HGSMIDSSLTWEHRLKIAIEVAGTLAYLHSSASIPIIHRDIKTAN 539
Query: 188 ILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGM 247
IL D AK++DF S IP + + + M+ T YL PEY TGL NEK+DV+ FG+
Sbjct: 540 ILLDVNLTAKVADFGASRLIPMDKEELET-MVQGTLGYLDPEYYNTGLLNEKSDVYSFGV 598
Query: 248 LLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQAL 298
+L+ELL+G++ L+ + + NRL EI+ V+ + + E +Q
Sbjct: 599 VLMELLSGQKALCFKRPQSSKHLVSYFATATKENRLDEIIGGEVMNEDNLKE----IQEA 654
Query: 299 LQLIFECVNESAGDRPTMVYAAKQLRQM 326
++ EC +RP M A +L +
Sbjct: 655 ARIAAECTRLMGEERPRMKEVAAKLEAL 682
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Required during plant's response to pathogen infection and in plant defense against heavy metal toxicity. Phosphorylates the oxygen-evolving enhancer protein 2 (OEE2) in an GRP-3-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 113/339 (33%), Positives = 188/339 (55%), Gaps = 19/339 (5%)
Query: 3 WFLRKTKNQEKVD--KKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQ 60
W + K + ++ KK F RNG +LL++ + + DG + FS+ EL+ AT+N++ +
Sbjct: 374 WLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDR 433
Query: 61 VIA-SEHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCI 119
V+ +YKG L + I +K E+ N IV +Q+NHRNI+KL+GCC+
Sbjct: 434 VLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCL 493
Query: 120 ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179
ETE+PILV+E++ G L R+ + + W RL+IA+EI A+ Y+H PI
Sbjct: 494 ETEVPILVYEYIPNGDLFKRLHDESDDYT--MTWEVRLRIAIEIAGALTYMHSAASFPIF 551
Query: 180 FKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEK 239
+DIK + IL DE AK+SDF S + +TH+T+ ++ T Y+ PEY L+ K
Sbjct: 552 HRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTT-LVAGTFGYMDPEYFLSSQYTHK 610
Query: 240 TDVFCFGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290
+DV+ FG++L+EL+TG + L H + ++ NR+ +I+D + ++
Sbjct: 611 SDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDES---- 666
Query: 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
K +Q+ A+ +L +C+N +RP M + +L ++ S
Sbjct: 667 KLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 179 bits (453), Expect = 4e-44, Method: Compositional matrix adjust.
Identities = 110/334 (32%), Positives = 185/334 (55%), Gaps = 22/334 (6%)
Query: 5 LRKTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIA- 63
++ KN E + +K F +NG +L + + ++ F+ +K ATN Y+ +++
Sbjct: 354 IKHRKNTE-LRQKFFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHESRILGQ 412
Query: 64 SEHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122
+YKG L +N +++ K E F N ++ +Q+NHRN++K++GCC+ETE
Sbjct: 413 GGQGTVYKGILPDNSIVAIKKARLGNRSQVEQF-INEVLVLSQINHRNVVKVLGCCLETE 471
Query: 123 IPILVFEFVEYGTLADRICSPHGP-HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181
+P+LV+EF+ GTL D + HG + L W HRL+IA E+ ++AY+H PI+ +
Sbjct: 472 VPLLVYEFINSGTLFDHL---HGSLYDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIHR 528
Query: 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTD 241
DIK + IL D+ AK++DF S IP + +T+ ++ T YL PEY TGL NEK+D
Sbjct: 529 DIKTANILLDKNLTAKVADFGASRLIPMDKEQLTT-IVQGTLGYLDPEYYNTGLLNEKSD 587
Query: 242 VFCFGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292
V+ FG++L+ELL+G++ L+ +NNR EI+D V+ + + +
Sbjct: 588 VYSFGVVLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIIDGQVMNE----DNQ 643
Query: 293 QQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+++Q ++ EC +RP M A +L +
Sbjct: 644 REIQEAARIAAECTRLMGEERPRMKEVAAELEAL 677
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O64798|Y1747_ARATH Inactive serine/threonine-protein kinase At1g67470 OS=Arabidopsis thaliana GN=At1g67470 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 178 bits (451), Expect = 6e-44, Method: Compositional matrix adjust.
Identities = 119/335 (35%), Positives = 180/335 (53%), Gaps = 25/335 (7%)
Query: 1 MNWFLRKTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQ 60
M W+ +K K + ++ + G LL+ LI CDGK NPI+ FSA E++ ATNN+
Sbjct: 1 MGWWRKKKKPKSEIASE----RGAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFGVSN 56
Query: 61 VIAS-EH---YKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLI 115
+++ H YK Y G EN + +++ + S ++ F +I ++ ++ H+N LKLI
Sbjct: 57 LVSELSHDFDYKWYSGKNENHDMILVRKAFSQSVYYKDTFFRDIAVSSMVSGHKNFLKLI 116
Query: 116 GCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR 175
G C+E E P++V+ V+ + P W+ R+KIA +I A+AY+H F
Sbjct: 117 GYCLEFEEPVMVYHGVKKHYHLESSEQP---------WKRRMKIAEDIATALAYLHTAFP 167
Query: 176 RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL 235
RP V++ + L+ IL DE VAKL DFS IPEGET V + T YL P Y+ G+
Sbjct: 168 RPFVYRCLSLTNILLDEDGVAKLMDFSFCVSIPEGETFVQVDYIAGTVDYLKPNYLKHGV 227
Query: 236 CNEKTDVFCFGMLLLELLTGRR--DNILLE--HVKKHVENNRLGEIVDPIVVEDKSCPEK 291
+E+TDVF G + LL G + D I+ K +E ++ EI DP + E E+
Sbjct: 228 VSEETDVFAVGHSMQMLLMGEKIFDRIMRRPFPTSKFMEEPKMDEIADPEMGEISE--EE 285
Query: 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
Q++A L L C G+ PTMV AK+L+ +
Sbjct: 286 LCQMKAFLLLSLRCTGH-VGEVPTMVEVAKELKSI 319
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| 255582635 | 331 | receptor protein kinase, putative [Ricin | 0.918 | 0.918 | 0.512 | 2e-82 | |
| 224123144 | 344 | predicted protein [Populus trichocarpa] | 0.972 | 0.936 | 0.477 | 1e-81 | |
| 255542662 | 330 | serine-threonine protein kinase, plant-t | 0.939 | 0.942 | 0.466 | 7e-72 | |
| 255542658 | 356 | serine-threonine protein kinase, plant-t | 0.939 | 0.873 | 0.446 | 2e-68 | |
| 255542656 | 331 | serine-threonine protein kinase, plant-t | 0.918 | 0.918 | 0.432 | 3e-66 | |
| 359495254 | 331 | PREDICTED: wall-associated receptor kina | 0.927 | 0.927 | 0.426 | 4e-55 | |
| 297740943 | 321 | unnamed protein product [Vitis vinifera] | 0.912 | 0.940 | 0.433 | 6e-55 | |
| 15230374 | 340 | putative protein kinase [Arabidopsis tha | 0.915 | 0.891 | 0.382 | 3e-54 | |
| 359493231 | 497 | PREDICTED: inactive serine/threonine-pro | 0.927 | 0.617 | 0.401 | 7e-54 | |
| 297740944 | 375 | unnamed protein product [Vitis vinifera] | 0.906 | 0.8 | 0.420 | 2e-53 |
| >gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 311 bits (798), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 164/320 (51%), Positives = 219/320 (68%), Gaps = 16/320 (5%)
Query: 20 LRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEH-YKLYKGFLENRP 78
L NG++LLEKLI SCDG+ NPIR FSA EL AT++Y+ ++I + YKLY G L R
Sbjct: 13 LMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKLYNGLLHERT 72
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYGTLA 137
ISV KF D + +C+N+I+FA QM+ H+N LKL+GCC+ET+IP+LVFE +EYGTLA
Sbjct: 73 ISVKKFKDKSEQY--KYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVFEPIEYGTLA 130
Query: 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197
R+ P+ +PLLWRHRLKIA+EI NA++Y+H F RPIVF++IK I DE +VAK
Sbjct: 131 GRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAK 190
Query: 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
LSDFS + IPEGE+HV ML +APEY T NE DV+ FG+ LL LLTG++
Sbjct: 191 LSDFSLAVSIPEGESHVKD-MLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQK 249
Query: 258 --DNI---------LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECV 306
D+ L++HVKK + ++R E VD I++ + S PEK+QQLQA L F C+
Sbjct: 250 VVDSYRPQAGEELGLVDHVKKFIADDRFYETVDSIILGEGSLPEKDQQLQAFTLLSFRCI 309
Query: 307 NESAGDRPTMVYAAKQLRQM 326
+E+ DRP M+ AK+LR++
Sbjct: 310 SEADEDRPMMIDVAKELRKI 329
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 309 bits (791), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 161/337 (47%), Positives = 232/337 (68%), Gaps = 15/337 (4%)
Query: 7 KTKNQEKVDKKT-FLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASE 65
+TK +KV+K+T F++NG LLEKL+ CDGK N IRSFSA ELK ATNNY+ +++ +
Sbjct: 6 ETKKDKKVNKETAFIKNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQKILTGD 65
Query: 66 H-YKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEI 123
YKLYKGFL+ RP+SV KF D+ + +CFN+IV+A++M+ H++ +KL+GCC+E I
Sbjct: 66 SGYKLYKGFLQGRPVSVKKFKDD--DEQYEYCFNDIVYASKMSVHKSFMKLLGCCLEARI 123
Query: 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI 183
PILVFE+V TL+D + +PLLW R KIAM++ NA+A++H F +PIVF++I
Sbjct: 124 PILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNI 183
Query: 184 KLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVF 243
K IL D+ + AKLSDFS S IP+GE+HV + T +APEY+ TG NEK DVF
Sbjct: 184 KPLNILLDDNHEAKLSDFSISISIPKGESHVRDSVAGATG-LIAPEYLTTGNFNEKQDVF 242
Query: 244 CFGMLLLELLTGR---------RDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294
FG+ LL LL+G+ ++ +L +HVKK +E++R +++D ++ + + P KEQQ
Sbjct: 243 NFGVFLLVLLSGQMVVDFSRPEKEILLQDHVKKCIEDDRFNKVIDSTIIAEGTWPGKEQQ 302
Query: 295 LQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSAV 331
LQA L C++E A DRPTM+ +K+LR++Y SA+
Sbjct: 303 LQAYTALSLRCISELAEDRPTMIDVSKELRKIYWSAI 339
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 276 bits (707), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 153/328 (46%), Positives = 209/328 (63%), Gaps = 17/328 (5%)
Query: 16 KKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEHY-KLYKGFL 74
K+ FL NG LLEK + C+G+ NPIR+FS+ EL+ AT NYN QV+ + Y +LYKGFL
Sbjct: 4 KEAFLINGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELYKGFL 63
Query: 75 ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEY 133
++RP+ V KF E N IV+A+ M+ H N +KL+GCC+ET PILVFE +
Sbjct: 64 QDRPVIVKKF---LEVGVEQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAKE 120
Query: 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193
TLADRI + H EP+ W+ RLKI +I N + YIH F RPIV ++IK S IL DE
Sbjct: 121 KTLADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDED 180
Query: 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
VAKLSDFS IPEG++ V ++ T +A E + TG NEK+DV+ FG++LL +L
Sbjct: 181 YVAKLSDFSLCVSIPEGKSRVRD-IMAGTMGLIASESLATGYFNEKSDVYSFGVVLLVVL 239
Query: 254 TGRRD-----------NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302
TG+R +L+ HVKKH+E E+VDPI+V +++ K Q+L+ L
Sbjct: 240 TGQRSFDFSRTETGEQFLLVNHVKKHIETGGFKEMVDPIIVAEEAGNRKGQELEDFRDLA 299
Query: 303 FECVNESAGDRPTMVYAAKQLRQMYLSA 330
C+++SA +RPTM+ AKQLR +YLS+
Sbjct: 300 LRCIHDSAEERPTMIEVAKQLRHIYLSS 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 265 bits (678), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 155/347 (44%), Positives = 209/347 (60%), Gaps = 36/347 (10%)
Query: 15 DKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEHY-KLYKGF 73
++ +RNG ILLEK I +G+ NPIR FS EL+ ATN+Y+ + VI + LYKGF
Sbjct: 12 NETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNVIYEGGWHTLYKGF 71
Query: 74 LENRPISVMKFGDNYSENGENFC-FNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFV 131
L +RP+ V ++ +N E C N+IVFA++M+ H+N+LKL+GCC+E+EIPILVFE+
Sbjct: 72 LRDRPVIVKRYRNNIHER---VCPINDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYA 128
Query: 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191
E G L D I PLLW+ RLKIA++ N +AY+H RP+V +DI LS I D
Sbjct: 129 EKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWLD 188
Query: 192 EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLE 251
E VAK++DF+ S I EGETH+ +L T Y APEY+ +G+ NEK DVF FG+LLL
Sbjct: 189 EDYVAKVTDFTVSMSILEGETHIEDFVLG-TCGYAAPEYVRSGIFNEKIDVFSFGVLLLV 247
Query: 252 LLT------GRRDNIL-----------------LEHVKKHVEN------NRLGEIVDPIV 282
LLT G +NIL L K+ +E +L +DPI+
Sbjct: 248 LLTDQKPFQGNWENILKDARFDEIIGSLIVEKGLWSEKEQLETFLTRTRQKLDLTIDPII 307
Query: 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
VE+ PEKEQQL+A L L +C++ +RP + AKQLR YLS
Sbjct: 308 VEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFYLS 354
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 258 bits (658), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 141/326 (43%), Positives = 204/326 (62%), Gaps = 22/326 (6%)
Query: 16 KKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEHY-KLYKGFL 74
+K +RNG+ LLEK + +G+ NP+R FS EL+ ATN+Y+ H V + +LYKG +
Sbjct: 11 EKALMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFYIDGTCRLYKGLI 70
Query: 75 ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEY 133
+RP+ V K+ +Y E+ ++IV A++M+ HRN+LKL+GCC+E+EIPI VFE+ E
Sbjct: 71 RDRPVIVKKY--DYKHPSED-PVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAEK 127
Query: 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193
GTL D + LLW+ RLKIA+++ + +AY+H F RPIV +DI L+ IL DE
Sbjct: 128 GTLEDYV------QKTALLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDED 181
Query: 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
AK++ FS S IPEGETH+ + T Y+APEY + + NEK DV+ FG++LL LL
Sbjct: 182 CAAKVTGFSLSISIPEGETHIEDE-VAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLL 240
Query: 254 TGR----------RDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIF 303
TG + L+ V+ ++N R EI+DP ++E+ PEKEQQL++ L L
Sbjct: 241 TGHGPILRSPTTNESHALVVFVEAKIKNERFNEIIDPAILEEGPWPEKEQQLKSFLTLAM 300
Query: 304 ECVNESAGDRPTMVYAAKQLRQMYLS 329
+C + DRP + AKQLR +Y S
Sbjct: 301 QCTRKDEEDRPEITDVAKQLRHIYHS 326
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359495254|ref|XP_002271826.2| PREDICTED: wall-associated receptor kinase-like 8-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 221 bits (563), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 140/328 (42%), Positives = 198/328 (60%), Gaps = 21/328 (6%)
Query: 11 QEKVDKKTFLRNGKILLEKLIISCDGKR-NPIRSFSAGELKIATNNYNGHQVIASE--HY 67
++++ K++ L+NG +LL++ I +GK NPIRSF EL+ AT++YN + + +
Sbjct: 6 RKEMKKESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNC 65
Query: 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPIL 126
YKG LE R ISV N+ E G N IV A+QM+ H+N LKL+GCC+ET IPIL
Sbjct: 66 IWYKGSLEGRTISVRT---NFYE-GVEMAINEIVIASQMSAHKNALKLLGCCLETRIPIL 121
Query: 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
V+EF G+L DRI SP P L W+ RL+IA +I N +AY+HI F R I+ DIK S
Sbjct: 122 VYEFPSGGSLIDRIFSPPNP----LSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPS 177
Query: 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFG 246
D+ AKLSDFS S +PEGE HV + T YLAPE +++G+ EK DVF FG
Sbjct: 178 SFFLDQDCAAKLSDFSLSITLPEGEMHVEDE-IRGTFGYLAPETLISGVYTEKNDVFSFG 236
Query: 247 MLLLELLTGRRDNILL--------EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQAL 298
+LLLELL G+R + ++ ++ + V + IVDPI++ +E Q QA+
Sbjct: 237 ILLLELLIGKRAHSIMHEERASIQDYAQSFVNTYDINGIVDPIILAQPRGIHEELQFQAI 296
Query: 299 LQLIFECVNESAGDRPTMVYAAKQLRQM 326
L C + +RPT+V AAK++R++
Sbjct: 297 FDLAMRCSMKDMDERPTIVNAAKEVRRI 324
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740943|emb|CBI31255.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 220 bits (561), Expect = 6e-55, Method: Compositional matrix adjust.
Identities = 140/323 (43%), Positives = 194/323 (60%), Gaps = 21/323 (6%)
Query: 16 KKTFLRNGKILLEKLIISCDGKR-NPIRSFSAGELKIATNNYNGHQVIASE--HYKLYKG 72
K++ L+NG +LL++ I +GK NPIRSF EL+ AT++YN + + + YKG
Sbjct: 3 KESMLKNGSLLLKERISYFNGKYFNPIRSFCMKELQNATDDYNTGLIFDHDVGNCIWYKG 62
Query: 73 FLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFV 131
LE R ISV N+ E G N IV A+QM+ H+N LKL+GCC+ET IPILV+EF
Sbjct: 63 SLEGRTISVRT---NFYE-GVEMAINEIVIASQMSAHKNALKLLGCCLETRIPILVYEFP 118
Query: 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191
G+L DRI SP P L W+ RL+IA +I N +AY+HI F R I+ DIK S D
Sbjct: 119 SGGSLIDRIFSPPNP----LSWKSRLRIAYDIANVIAYLHIAFPRSIIHTDIKPSSFFLD 174
Query: 192 EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLE 251
+ AKLSDFS S +PEGE HV + T YLAPE +++G+ EK DVF FG+LLLE
Sbjct: 175 QDCAAKLSDFSLSITLPEGEMHVEDE-IRGTFGYLAPETLISGVYTEKNDVFSFGILLLE 233
Query: 252 LLTGRRDNILL--------EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIF 303
LL G+R + ++ ++ + V + IVDPI++ +E Q QA+ L
Sbjct: 234 LLIGKRAHSIMHEERASIQDYAQSFVNTYDINGIVDPIILAQPRGIHEELQFQAIFDLAM 293
Query: 304 ECVNESAGDRPTMVYAAKQLRQM 326
C + +RPT+V AAK++R++
Sbjct: 294 RCSMKDMDERPTIVNAAKEVRRI 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15230374|ref|NP_191329.1| putative protein kinase [Arabidopsis thaliana] gi|4678277|emb|CAB41185.1| protein kinase-like protein [Arabidopsis thaliana] gi|332646168|gb|AEE79689.1| putative protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 218 bits (555), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 122/319 (38%), Positives = 193/319 (60%), Gaps = 16/319 (5%)
Query: 21 RNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEHYKLYKGFLENRPIS 80
+NG +LLE+LI + G NPIR+FS+ ++ ATN+++ + VI+ + + YKG +ENRP+
Sbjct: 21 KNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYVISEDRFVWYKGMIENRPVL 80
Query: 81 VMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRI 140
+ KF D + +NF + V + +H+N+LKL+GCC+E P+LV E+ E+G L
Sbjct: 81 IKKFQDCSVFDADNFYRDIAVSSLMSSHKNVLKLLGCCLEFPRPVLVCEYPEHGALNCIR 140
Query: 141 CSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200
C G P W RL+IA EI +A+AY+H F R I+ +D+KL+ I DE AKLS
Sbjct: 141 CGKEGVRSFP--WNVRLRIAKEIADAVAYLHTEFPRTIIHRDLKLANIFLDENWSAKLSS 198
Query: 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRD-- 258
FS S +PEGET V + M+ RT Y+ P+Y TGL E D++ G+++L +LTG+ +
Sbjct: 199 FSLSIVLPEGETGV-NDMVCRTSSYIEPDYFNTGLVTENVDIYSLGIIMLIILTGKSEYN 257
Query: 259 -------NILLEHVKKHVENNRLGEIVDPIVVEDKS--CPEKEQ-QLQALLQLIFECVNE 308
+L +V K +E L E++DP +++ S P+ + Q++A ++L F CV
Sbjct: 258 SEVAVYLPVLPVYVGKFLERGLLTELIDPSILDSTSDDIPKHSRLQMEAFIELAFRCVRF 317
Query: 309 SAGDR-PTMVYAAKQLRQM 326
G+ P M+ AK+L+++
Sbjct: 318 RPGENVPRMIDVAKELKKI 336
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493231|ref|XP_002265528.2| PREDICTED: inactive serine/threonine-protein kinase At1g67470-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 217 bits (552), Expect = 7e-54, Method: Compositional matrix adjust.
Identities = 130/324 (40%), Positives = 190/324 (58%), Gaps = 17/324 (5%)
Query: 19 FLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEHY-KLYKGFLENR 77
FL+NG +LLEKL+ S +G+ NPIR+FS EL+ ATN YN + Y + YKG LE R
Sbjct: 9 FLKNGSLLLEKLVSSLNGRSNPIRNFSIKELEQATNKYNSSLIFDRWTYSEWYKGSLEGR 68
Query: 78 PISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYGT- 135
+SV KF + I FA Q++ H+N+LKL GCC+ET+ P+LV+E+ G
Sbjct: 69 FVSVRKFHPVIDDAFLERVIKEITFATQLSAHKNVLKLFGCCLETQTPVLVYEYPVNGVV 128
Query: 136 -LADRI-CSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193
L D I S G + L W+ RL+I+ +I + +AY+H F R I+ +++ LS DE
Sbjct: 129 PLYDVIHPSTDGKSRQRLPWKSRLRISGDIAHVIAYLHTAFPRAIIHREVTLSFFFLDED 188
Query: 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
V KLS+F + +PEG +V ++ + ++APEY +TG+ EK DVF FG LLLELL
Sbjct: 189 CVPKLSNFFFAIALPEGRKYVVDGVMG-IEGFIAPEYEMTGMVTEKVDVFSFGKLLLELL 247
Query: 254 TGRR-----------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302
TGRR + +L + +K +VE++ L VD ++ +E QL A+ +L
Sbjct: 248 TGRRTIDFGPLGNDGELLLQDCIKTYVEDHELDGFVDASILPRGGEIHEELQLLAVTKLA 307
Query: 303 FECVNESAGDRPTMVYAAKQLRQM 326
C+ +A RPTMV AK+LR++
Sbjct: 308 LRCIMTAAEQRPTMVEIAKELRRI 331
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740944|emb|CBI31256.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 216 bits (549), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 135/321 (42%), Positives = 191/321 (59%), Gaps = 21/321 (6%)
Query: 20 LRNGKILLEKLIISCDGK-RNPIRSFSAGELKIATNNYNGHQVI---ASEHYKLYKGFLE 75
L+NG +LLEK I G+ NPI +FS E++ AT+N+NG+ + S YK YKG LE
Sbjct: 17 LKNGSLLLEKRISYFGGRYSNPIHNFSIQEIQRATDNFNGNLIFNDDVSSFYKWYKGSLE 76
Query: 76 NRPISVMK-FGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEY 133
R I + K F +++EN + N I A QM+ H+N LKL+GCC+ET +PILV+EF
Sbjct: 77 GRVICIRKIFRSSFAENPQ-IVTNEIAVATQMSSHKNALKLLGCCLETRVPILVYEFSSC 135
Query: 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193
LA++I + EP + RLKIA EI + +AY+H F RPI+ +DIK D
Sbjct: 136 EPLAEKIFDCN----EPFPLKGRLKIAYEIASVIAYLHTAFPRPIIHRDIKPHHFFLDNG 191
Query: 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
+ KLS+F S +PEGET V + T YLAPE + + EKTDVF FG L+LELL
Sbjct: 192 STPKLSNFELSIALPEGETRVKD-VPRGTLGYLAPE-LFSWEYTEKTDVFSFGTLILELL 249
Query: 254 TGRRDNILL--------EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFEC 305
T RR + L +H + H+E + +I+DP + + ++QQ +A+ QL +C
Sbjct: 250 TRRRASFLAKRKGVSMRKHGEDHIETYGIHDILDPSSLVEGGGVLEQQQFEAVCQLALKC 309
Query: 306 VNESAGDRPTMVYAAKQLRQM 326
E A DRPT+V AAK++R++
Sbjct: 310 TEEFAEDRPTIVDAAKEIRRI 330
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| TAIR|locus:2076596 | 340 | AT3G57700 [Arabidopsis thalian | 0.957 | 0.932 | 0.376 | 8.9e-54 | |
| TAIR|locus:2076586 | 351 | AT3G57710 [Arabidopsis thalian | 0.963 | 0.908 | 0.352 | 6e-48 | |
| TAIR|locus:2076671 | 355 | AT3G57730 [Arabidopsis thalian | 0.951 | 0.887 | 0.356 | 1.2e-47 | |
| TAIR|locus:2094468 | 433 | AT3G25490 [Arabidopsis thalian | 0.930 | 0.711 | 0.352 | 8.8e-47 | |
| TAIR|locus:2076656 | 357 | AT3G57740 [Arabidopsis thalian | 0.818 | 0.759 | 0.392 | 3.7e-46 | |
| TAIR|locus:2076681 | 359 | AT3G57720 [Arabidopsis thalian | 0.960 | 0.885 | 0.351 | 1e-45 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.921 | 0.423 | 0.358 | 1e-44 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.930 | 0.420 | 0.349 | 1.5e-44 | |
| TAIR|locus:2014952 | 738 | WAK4 "wall associated kinase 4 | 0.927 | 0.415 | 0.351 | 2.1e-44 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.930 | 0.415 | 0.346 | 6e-44 |
| TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 556 (200.8 bits), Expect = 8.9e-54, P = 8.9e-54
Identities = 126/335 (37%), Positives = 197/335 (58%)
Query: 6 RKTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASE 65
RK K Q+K ++ +NG +LLE+LI + G NPIR+FS+ ++ ATN+++ + VI+ +
Sbjct: 6 RKKKKQKKEEEINLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYVISED 65
Query: 66 HYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIP 124
+ YKG +ENRP+ + KF D + +NF + +I ++ M+ H+N+LKL+GCC+E P
Sbjct: 66 RFVWYKGMIENRPVLIKKFQDCSVFDADNF-YRDIAVSSLMSSHKNVLKLLGCCLEFPRP 124
Query: 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIK 184
+LV E+ E+G L C G P W RL+IA EI +A+AY+H F R I+ +D+K
Sbjct: 125 VLVCEYPEHGALNCIRCGKEGVRSFP--WNVRLRIAKEIADAVAYLHTEFPRTIIHRDLK 182
Query: 185 LSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244
L+ I DE AKLS FS S +PEGET V M+ RT Y+ P+Y TGL E D++
Sbjct: 183 LANIFLDENWSAKLSSFSLSIVLPEGETGVND-MVCRTSSYIEPDYFNTGLVTENVDIYS 241
Query: 245 FGMLLLELLTGRRD-N--------ILLEHVKKHVENNRLGEIVDPIVVEDKS--CPEKEX 293
G+++L +LTG+ + N +L +V K +E L E++DP +++ S P+
Sbjct: 242 LGIIMLIILTGKSEYNSEVAVYLPVLPVYVGKFLERGLLTELIDPSILDSTSDDIPKHSR 301
Query: 294 XXXXXXXXI-FECVNESAGDR-PTMVYAAKQLRQM 326
+ F CV G+ P M+ AK+L+++
Sbjct: 302 LQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKI 336
|
|
| TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 6.0e-48, P = 6.0e-48
Identities = 119/338 (35%), Positives = 189/338 (55%)
Query: 8 TKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASE-H 66
T+ ++ K+ FL NG I L +L+ C+GK PIRSFS ++ ATNN++ ++ + +
Sbjct: 12 TRKEKDKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDVY 71
Query: 67 YKLYKGFLENRPISVMKFGDNY---SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETE 122
YK Y+G +E+R + +F ++ + +N+IV +A+M NH N L+L+GCC+E
Sbjct: 72 YKWYRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFP 131
Query: 123 IPILVFEFVEYGTLADRI-CSPHGPHLEPLL-WRHRLKIAMEIGNAMAYIHIGFRRPIVF 180
P+LVFEF E+G + R +G E LL W RLKI EI NA+ Y+H F + I+
Sbjct: 132 FPVLVFEFAEHGAMNQRGGVIVNGE--ESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIH 189
Query: 181 KDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKT 240
+D+K + D+ AKLSD S S +PEG++ + + + T Y+ P Y T E T
Sbjct: 190 RDVKPMHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYT 249
Query: 241 DVFCFGMLLLELLTGR------RDNIL---LEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291
DV+ FG+ LL ++TG+ D L L V++ EN +L E++DP +++D + ++
Sbjct: 250 DVYSFGICLLVIITGKPAIMTISDGDLQGILSLVRELCENGKLDEVIDPRLMKDITSGQR 309
Query: 292 EXXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQMYLS 329
+ C E DRP M+ AK+L+Q+ S
Sbjct: 310 LQVEACVVLAL-RCCKERDEDRPKMIQVAKELKQIEAS 346
|
|
| TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 119/334 (35%), Positives = 191/334 (57%)
Query: 9 KNQEKVDKKT--FLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEH 66
K +EK KK FL NG I L++LI+ C+GK PIRSF++ +++ AT N++ +A E
Sbjct: 18 KKKEKSMKKERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEG 77
Query: 67 YKL-YKGFLENRPISVMKFGD-NYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEI 123
+ + YKG +E+R + +F + ++ + + +IV +A+M NH N LKL+GCC+E
Sbjct: 78 FYIWYKGVIEDRSYMIKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPF 137
Query: 124 PILVFEFVEYGTLADRI-CSPHGPH-LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181
P+LVFEF E+G L R + +G L PL R LKI EI NA+AY+H+ F + I+++
Sbjct: 138 PVLVFEFAEHGVLNYRGGITVNGEESLLPLSLR--LKIGKEIANALAYLHMAFPKIIIYR 195
Query: 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTD 241
D+K + D AKLSD S S + EG++ + + + T YL P Y T + E TD
Sbjct: 196 DVKPLHVFLDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTD 255
Query: 242 VFCFGMLLLELLTG------RRDNI---LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292
V+ FG+ L+ ++TG D +L ++K EN +L EIV P+++++ + ++
Sbjct: 256 VYSFGVFLMVVITGISVYFTGSDGYPVGILGYMKGLAENGKLNEIVYPMIMKEMTSAQRL 315
Query: 293 XXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQM 326
+ C E DRP M+ AK+L+++
Sbjct: 316 QVEACVLLAL-RCCEERVEDRPKMIQVAKELKRI 348
|
|
| TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 490 (177.5 bits), Expect = 8.8e-47, P = 8.8e-47
Identities = 120/340 (35%), Positives = 195/340 (57%)
Query: 5 LRKTKNQEKVDKKTFL-RNGK-ILLEKLIISCDGKRN-PIRSFSAGELKIATNNYNGHQV 61
+RK + K+ ++ F +NG +L+E+L S G N + F+ ++K ATN Y+ ++
Sbjct: 56 IRKHQKDTKIQRQLFFEKNGGGMLIERL--SGAGSSNIDFKIFTEEDMKEATNGYDVSRI 113
Query: 62 IASE-HYKLYKGFL-ENRPISVMK--FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC 117
+ + +YKG L +N +++ K GDN E F N ++ +Q+NHRN++KL+GC
Sbjct: 114 LGQGGQWTVYKGILPDNSIVAIKKTRLGDN--NQVEQF-INEVLVLSQINHRNVVKLLGC 170
Query: 118 CIETEIPILVFEFVEYGTLADRICSPHGP-HLEPLLWRHRLKIAMEIGNAMAYIHIGFRR 176
C+ETE+P+LV+EF+ G+L D + HG + L W HRL+IA+E+ A+AY+H G
Sbjct: 171 CLETEVPLLVYEFITGGSLFDHL---HGSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASI 227
Query: 177 PIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC 236
PI+ +DIK IL DE AK++DF S+ P + +T+ M+ T YL PEY T L
Sbjct: 228 PIIHRDIKTENILLDENLTAKVADFGASKLKPMDKEQLTT-MVQGTLGYLDPEYYTTWLL 286
Query: 237 NEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHV--------ENNRLGEIVDPIVVEDK 286
NEK+DV+ FG++L+EL++G++ + E KH+ + NRL EI+D V+ ++
Sbjct: 287 NEKSDVYSFGVVLMELISGQKA-LCFERPETSKHLVSYFVLATKENRLHEIIDDQVLNEE 345
Query: 287 SCPEKEXXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQM 326
+ ++E EC +RP M+ A +L +
Sbjct: 346 N--QREIHEAARVAV--ECTRLKGEERPRMIEVAAELETL 381
|
|
| TAIR|locus:2076656 AT3G57740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 3.7e-46, Sum P(2) = 3.7e-46
Identities = 117/298 (39%), Positives = 162/298 (54%)
Query: 7 KTKNQEKVDKKT-FLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASE 65
K KN E ++ F NGK+LLE LI C+GK NPI++FSA E+ AT+N++ ++
Sbjct: 9 KKKNSEANQRQRWFQENGKVLLEDLIELCNGKSNPIKTFSAEEILQATDNFSESNLVIRF 68
Query: 66 HYKLYKGFLENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123
++ +Y+G L+NRP+ + + NY S+ E C + V + H+N LKL+GCC+E E
Sbjct: 69 NF-MYRGILQNRPVLIKRATWNYYKSDTLEKICRDIAVSSMVSGHKNFLKLLGCCLEFEH 127
Query: 124 PILVFEFVEYGTLADRICSPHG-PHLEPLL-WRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181
P+LV E+ A+RI P P+ E LL WR R+KIA EI A++Y+H R ++
Sbjct: 128 PVLVCEY------AERI--PFNTPNPEMLLPWRMRIKIAKEIAIAVSYLHTALSRTMIHT 179
Query: 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM--LTRTKRYLAPEYILTGLCNEK 239
DI+ I D AKLSDF IPEGET V H + T YL Y TGL E
Sbjct: 180 DIQPFNIFVDSNGTAKLSDFCLCIAIPEGETFVKVHADRVEGTLDYLEYNYAATGLITEY 239
Query: 240 TDVFCFGMLLLELLT---G------RRDNILLEHV--KKHVENNRLGEIVDPIVVEDK 286
TDVF FG+LL T G D L E K++V N R+ + + V E +
Sbjct: 240 TDVFSFGVLLQNFFTRTYGVVDCCCSEDESLFEEFEDKQNVMNLRISDRISKFVEEGR 297
|
|
| TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.0e-45, P = 1.0e-45
Identities = 118/336 (35%), Positives = 185/336 (55%)
Query: 6 RKTKNQEKVDKKTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASE 65
RK K ++ ++K FL NG I L++LI C+GK PIR+FS+ ++ AT+N+ + +E
Sbjct: 20 RKEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSCFVTAE 79
Query: 66 -HYKLYKGFLENRPISVMKFGD-NYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETE 122
Y YKG +E+R + +F + ++ +N IV +A+M NH N LKLIG C+E
Sbjct: 80 GFYVWYKGIIEDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFCLEFS 139
Query: 123 IPILVFEFVEYGTLADRI-CSPHGPH-LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVF 180
+P+LVFE+ E+G L R +G + PL R LKI EI NA+ Y+H+ F + ++
Sbjct: 140 LPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSLR--LKIGKEIANAVTYLHMAFPKILIH 197
Query: 181 KDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKT 240
+ IK + DE KLSDFS S +PEG++ + + T YL P Y T + E T
Sbjct: 198 RHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMVTEYT 257
Query: 241 DVFCFGMLLLELLTGR------RDNILLEHVKKHV----ENNRLGEIVDPIVVEDKSCPE 290
DV+ FG+ L+ +LTG+ + +H+ +V EN +L ++DP V+ED + +
Sbjct: 258 DVYSFGVFLMVILTGKPALASTSSDGDYKHIASYVKGFHENGQLDGVIDPKVMEDITSAQ 317
Query: 291 KEXXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQM 326
K + C +RP M+ AK+L+Q+
Sbjct: 318 KVHVEACVVLAL-RCCELRDENRPKMIQIAKELKQI 352
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 1.0e-44, P = 1.0e-44
Identities = 118/329 (35%), Positives = 185/329 (56%)
Query: 3 WFLRKTKNQEKVDK---KTFLRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGH 59
W L K + KV K K F RNG +LL++ G N + FS+ +L+ AT+ +N
Sbjct: 334 WLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNAS 393
Query: 60 QVIASEHY-KLYKGFLENRPI-SVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC 117
+++ +YKG LE+ I +V K EN E F N I+ +Q+NHRN++K++GC
Sbjct: 394 RILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEF-INEIILLSQINHRNVVKILGC 452
Query: 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIGNAMAYIHIGFRR 176
C+ETE+PILV+EF+ L D + H P + P+ W RL IA E+ +A++Y+H
Sbjct: 453 CLETEVPILVYEFIPNRNLFDHL---HNPSEDFPMSWEVRLCIACEVADALSYLHSAVSI 509
Query: 177 PIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC 236
PI +D+K + IL DE + AK+SDF S + +TH+T+ ++ T Y+ PEY+ +
Sbjct: 510 PIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTT-IVQGTIGYVDPEYLQSNHF 568
Query: 237 NEKTDVFCFGMLLLELLTGRRDNILL--EHVK-------KHVENNRLGEIVDPIVVEDKS 287
K+DV+ FG+LL+ELLTG + LL + V+ + + N+RL EI+D + E+
Sbjct: 569 TGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEE-- 626
Query: 288 CPEKEXXXXXXXXXIFECVNESAGDRPTM 316
C +E C++ ++ RPTM
Sbjct: 627 CDREEVLAVAKLAR--RCLSLNSEHRPTM 653
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 1.5e-44, P = 1.5e-44
Identities = 118/338 (34%), Positives = 189/338 (55%)
Query: 5 LRKTKNQEKVDKKTFLRNGK-ILLEKLIISCDGKRN-PIRSFSAGELKIATNNYNGHQVI 62
+R KN E + ++ F +NG +L+++L S G N ++ F+ +K AT+ YN +++
Sbjct: 358 MRHRKNTE-LRQQFFEQNGGGMLIQRL--SGAGPSNVDVKIFTEEGMKEATDGYNESRIL 414
Query: 63 ASEHY-KLYKGFLENRPISVMK---FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCC 118
+YKG L++ I +K GD E F N ++ +Q+NHRN++KL+GCC
Sbjct: 415 GQGGQGTVYKGILQDNSIVAIKKARLGDR--SQVEQF-INEVLVLSQINHRNVVKLLGCC 471
Query: 119 IETEIPILVFEFVEYGTLADRICSPHGPHLEP-LLWRHRLKIAMEIGNAMAYIHIGFRRP 177
+ETE+P+LV+EF+ GTL D + HG + L W HRL+IA+E+ +AY+H P
Sbjct: 472 LETEVPLLVYEFISSGTLFDHL---HGSMFDSSLTWEHRLRIAIEVAGTLAYLHSYASIP 528
Query: 178 IVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCN 237
I+ +D+K + IL DE AK++DF S IP + +T+ M+ T YL PEY TGL N
Sbjct: 529 IIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTT-MVQGTLGYLDPEYYNTGLLN 587
Query: 238 EKTDVFCFGMLLLELLTGRR---------DNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288
EK+DV+ FG++L+ELL+G + L+ + ++ NRL EI+D V+ + +
Sbjct: 588 EKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMNEYN- 646
Query: 289 PEKEXXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQM 326
++E EC +RP+M A +L +
Sbjct: 647 -QREIQESARIAV--ECTRIMGEERPSMKEVAAELEAL 681
|
|
| TAIR|locus:2014952 WAK4 "wall associated kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 2.1e-44, P = 2.1e-44
Identities = 119/339 (35%), Positives = 194/339 (57%)
Query: 5 LRKTKNQEKVDKKTFLRNGK-ILLEKLIISCDGKRN-PIRSFSAGELKIATNNYNGHQVI 62
++ TK+ E + ++ F +NG +L+++L S G N ++ F+ +K AT+ Y+ ++++
Sbjct: 360 MKNTKDTE-LRQQFFEQNGGGMLMQRL--SGAGPSNVDVKIFTEEGMKEATDGYDENRIL 416
Query: 63 ASEHY-KLYKGFL-ENRPISVMK--FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCC 118
+YKG L +N +++ K GDN E F N ++ +Q+NHRN++KL+GCC
Sbjct: 417 GQGGQGTVYKGILPDNSIVAIKKARLGDN--SQVEQF-INEVLVLSQINHRNVVKLLGCC 473
Query: 119 IETEIPILVFEFVEYGTLADRICSPHGPHLEP-LLWRHRLKIAMEIGNAMAYIHIGFRRP 177
+ETE+P+LV+EF+ GTL D + HG + L W HRL++A+EI +AY+H P
Sbjct: 474 LETEVPLLVYEFISSGTLFDHL---HGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIP 530
Query: 178 IVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCN 237
I+ +DIK + IL DE AK++DF S IP + + + M+ T YL PEY TGL N
Sbjct: 531 IIHRDIKTANILLDENLTAKVADFGASRLIPMDKEDLAT-MVQGTLGYLDPEYYNTGLLN 589
Query: 238 EKTDVFCFGMLLLELLTGRRDNILLEH--VKKHV--------ENNRLGEIVDPIVVEDKS 287
EK+DV+ FG++L+ELL+G++ + E KH+ + NRL EI+D V+ + +
Sbjct: 590 EKSDVYSFGVVLMELLSGQKA-LCFERPQTSKHIVSYFASATKENRLHEIIDGQVMNENN 648
Query: 288 CPEKEXXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQM 326
++E EC + +RP M A +L +
Sbjct: 649 --QREIQKAARIAV--ECTRLTGEERPGMKEVAAELEAL 683
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 6.0e-44, P = 6.0e-44
Identities = 116/335 (34%), Positives = 187/335 (55%)
Query: 7 KTKNQEKVDKKTFLRNGK-ILLEKLIISCDGKRN-PIRSFSAGELKIATNNYNGHQVIAS 64
K + K+ ++ F +NG +L+++L S G N + F+ +K ATN Y+ +++
Sbjct: 366 KQRKYTKLRRQFFEQNGGGMLIQRL--SGAGLSNIDFKIFTEEGMKEATNGYDESRILGQ 423
Query: 65 EHY-KLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122
+YKG L +N +++ K S + F + ++ +Q+NHRN++K++GCC+ETE
Sbjct: 424 GGQGTVYKGILPDNTIVAIKKARLADSRQVDQF-IHEVLVLSQINHRNVVKILGCCLETE 482
Query: 123 IPILVFEFVEYGTLADRICSPHGPHLEP-LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181
+P+LV+EF+ GTL D + HG + L W HRL+IA+E+ +AY+H PI+ +
Sbjct: 483 VPLLVYEFITNGTLFDHL---HGSIFDSSLTWEHRLRIAIEVAGTLAYLHSSASIPIIHR 539
Query: 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTD 241
DIK + IL DE AK++DF S+ IP + +T+ M+ T YL PEY TGL NEK+D
Sbjct: 540 DIKTANILLDENLTAKVADFGASKLIPMDKEQLTT-MVQGTLGYLDPEYYTTGLLNEKSD 598
Query: 242 VFCFGMLLLELLTGRRDNILLEH--VKKHV--------ENNRLGEIVDPIVVEDKSCPEK 291
V+ FG++L+ELL+G++ + E KH+ E NRL EI+D V+ + + E
Sbjct: 599 VYSFGVVLMELLSGQKA-LCFERPQASKHLVSYFVSATEENRLHEIIDDQVLNEDNLKEI 657
Query: 292 EXXXXXXXXXIFECVNESAGDRPTMVYAAKQLRQM 326
+ EC +RP M A +L +
Sbjct: 658 QEAARIAA----ECTRLMGEERPRMKEVAAKLEAL 688
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XIII000087 | hypothetical protein (344 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 331 | |||
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-31 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-30 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-18 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-16 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-15 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-13 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-08 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-08 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-08 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-07 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-06 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-04 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| TIGR01989 | 437 | TIGR01989, COQ6, ubiquinone biosynthesis monooxyge | 3e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 0.001 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.002 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.002 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.002 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.002 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 0.002 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.002 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.002 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 0.002 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.003 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 31/231 (13%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEP--LLWRHRLKIA 160
++ H N+++L+G C E E LV E++E G L D R P P E L + L A
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
++I M Y+ + V +D+ L E V K+SDF S + + + + T
Sbjct: 112 IQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR---KKT 165
Query: 221 RTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NR 273
K R++APE + G+ K+DV+ FG+LL E+ T G + E V +++ R
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR 225
Query: 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324
L P + CP++ L +L+ C DRPT ++L
Sbjct: 226 L---PKP-----EYCPDE------LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+++H N++KL+G C E E +V E++E G L + L L A++I
Sbjct: 56 RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR----PKLSLSDLLSFALQI 111
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
M Y+ + + +D+ L E V K+SDF S + + + + K
Sbjct: 112 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG----GK 164
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NRLGE 276
R++APE + G K+DV+ FG+LL E+ T G + + E V ++++N RL
Sbjct: 165 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRL-- 222
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
P +CP + L L+ +C E DRPT + L
Sbjct: 223 ---PQP---PNCPPE------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 60/227 (26%), Positives = 101/227 (44%), Gaps = 31/227 (13%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+++H NI+KL+G C E E ++V E++ G L D + + L L A++I
Sbjct: 56 RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQI 112
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
M Y+ + + +D+ L E V K+SDF S + + + + K
Sbjct: 113 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG----GK 165
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NRLGE 276
R++APE + G K+DV+ FG+LL E+ T G + V ++++ RL
Sbjct: 166 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRL-- 223
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
P +CP + L +L+ +C E DRPT + L
Sbjct: 224 ---PKP---PNCPPE------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 3e-28
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H NI++L+G C + E +V E++ G L D + H E L + L++A++I
Sbjct: 57 KLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK----HGEKLTLKDLLQMALQIA 112
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
M Y+ + V +D+ L E V K+SDF S I E + + +
Sbjct: 113 KGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENNRLGEIVDPI 281
++APE + G K+DV+ FG+LL E+ T G + + E V + +E+ P
Sbjct: 170 WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR--P- 226
Query: 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
++CP++ L +L+ +C DRPT
Sbjct: 227 ----ENCPDE------LYELMLQCWAYDPEDRPTF 251
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 13/187 (6%)
Query: 70 YKGF--LENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127
Y + +++ S + I ++NH NI+KL G + LV
Sbjct: 10 YLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLV 69
Query: 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQ 187
E+ E G+L D + G L L+I ++I + Y+H I+ +D+K
Sbjct: 70 MEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPEN 122
Query: 188 ILFDE-YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCF 245
IL D KL+DF S+ + ++ + + + T Y+APE +L G +EK+D++
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSEKSDIWSL 180
Query: 246 GMLLLEL 252
G++L EL
Sbjct: 181 GVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+++H NI++LI + + LV E+ E G L D + S G PL KIA++I
Sbjct: 53 RRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGG----PLSEDEAKKIALQI 107
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--SESEYIPEGETHVTSHMLTR 221
+ Y+H I+ +D+K IL DE V K++DF ++
Sbjct: 108 LRGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT----FVG 160
Query: 222 TKRYLAPEYILTGLCNE---KTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV 278
T Y+APE +L G N K DV+ G++L ELLTG+ + + I+
Sbjct: 161 TPWYMAPEVLLGG--NGYGPKVDVWSLGVILYELLTGK---PPFSGENILDQLQLIRRIL 215
Query: 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325
P + + P+ + LI +C+N+ RPT A+++ Q
Sbjct: 216 GPPL--EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPT----AEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 11/152 (7%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H NI++L + + LV E+ E G L D + L +I
Sbjct: 53 KLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSE---DEARFYLRQIL 107
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
+A+ Y+H + IV +D+K IL DE KL+DF + + GE T T
Sbjct: 108 SALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPE 161
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y+APE +L + D++ G++L ELLTG+
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 4e-16
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 105 QMNHRNILKLIGCCIETEIP-ILVF-EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
+ H NI++ G + E + +F E+V G+L+ + L + R + +
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTR---Q 109
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I +AY+H IV +DIK + IL D V KL+DF ++ + + ET + + T
Sbjct: 110 ILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
++APE I D++ G ++E+ TG+
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 74.4 bits (181), Expect = 6e-15
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 24/230 (10%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
+ NI+KL + LV E+V+ G+L D + PL L I +I +A
Sbjct: 56 HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSA 113
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESEYIPEGETHVTSHMLTR---- 221
+ Y+H + I+ +DIK IL D V KL DF ++ +P+ + + L
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 222 TKRYLAPEYILTGLCNE---KTDVFCFGMLLLELLTGRR------DNILLEHVKKHVENN 272
T Y+APE +L +D++ G+ L ELLTG ++ K +
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230
Query: 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322
P + S E +A L+ + + + +R +
Sbjct: 231 -----PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 50/221 (22%), Positives = 93/221 (42%), Gaps = 33/221 (14%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIG 164
++H N+++L G + + ++V E G+L DR+ H L + A++I
Sbjct: 53 LDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDY----AVQIA 107
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
N M Y+ + + +D+ IL + K+ DF +P+ E H +
Sbjct: 108 NGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF 164
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVENNRLGE 276
+ APE + T + +DV+ FG+ L E+ T G + +L+ + K E RL
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE--RL-- 220
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMV 317
++CP+ + ++ +C + DRPT
Sbjct: 221 ------ERPEACPQD------IYNVMLQCWAHNPADRPTFA 249
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H N+++L+G ++ +V E++ G+L D + S + +L A+++
Sbjct: 56 TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVIT---LAQQLGFALDVC 112
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
M Y+ + V +D+ +L E VAK+SDF G S K
Sbjct: 113 EGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDF--------GLAKEASQGQDSGKL 161
Query: 224 --RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GR--RDNILLEHVKKHVENNRLGEIV 278
++ APE + + K+DV+ FG+LL E+ + GR I L+ V HVE E
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAP 221
Query: 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
+ CP + +++ +C RPT +QL
Sbjct: 222 E-------GCPP------EVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 38/233 (16%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPH---------------GP 146
A+ +H NI+KL+G C + L+FE++ YG L + R SP G
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 147 HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206
+ PL +L IA ++ MAY+ R V +D+ L E V K++DF S
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH- 264
I + + S R++ PE I ++DV+ +G++L E+ + G + + H
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 265 -VKKHVENNRLGEIVDPIVVEDKSCPEK-EQQLQALLQLIFECVNESAGDRPT 315
V +V R G ++ SCP+ +L L++L C ++ DRP+
Sbjct: 240 EVIYYV---RDGNVL--------SCPDNCPLELYNLMRL---CWSKLPSDRPS 278
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 106 MNHRNILKLIGCCIETEIPILVF-EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H NI+K IG IET + + E+ E G+L +I GP E L+ + + ++
Sbjct: 56 LKHPNIVKYIGS-IETSDSLYIILEYAENGSLR-QIIKKFGPFPESLVAVY---VY-QVL 109
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
+AY+H + ++ +DIK + IL + V KL+DF + + + + T
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPY 164
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
++APE I + +D++ G ++ELLTG
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 53/224 (23%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H +++L G C E LVFEF+E+G L+D + + G + L L + +++
Sbjct: 55 KLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL----LGMCLDVC 110
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
MAY+ ++ +D+ L E V K+SDF + ++ + + + +S +
Sbjct: 111 EGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD-DQYTSSTGTKFPVK 166
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPI--- 281
+ +PE + K+DV+ FG+L+ E+ + K EN E+V+ I
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFS---------EGKTPYENRSNSEVVETINAG 217
Query: 282 --VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
+ + + Q++ +L+ C E DRP+ QL
Sbjct: 218 FRLYKPRLAS------QSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 23/229 (10%)
Query: 89 SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL 148
SE N IV + + H NI+ ++ ++ E+ GTL D+I G
Sbjct: 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF 98
Query: 149 --EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206
E +LW +I +A++YIH + I+ +DIK I + + KL DF S+
Sbjct: 99 EEEMVLW-----YLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150
Query: 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK 266
+ + + + T Y++PE N K+D++ G +L ELLT +K
Sbjct: 151 LGSEYSMAET--VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT----------LK 198
Query: 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
+ + +V IV + + P L+ L+ + + RPT
Sbjct: 199 RTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 28/168 (16%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL----------EPLLW 153
H NI+K G C E + PI+VFE++E+G L + S HGP L
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS-HGPDAAFLKSPDSPMGELTL 121
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE-------Y 206
L+IA++I + M Y+ + V +D+ L V K+ DF S Y
Sbjct: 122 SQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
G T ML R++ PE I+ ++DV+ FG++L E+ T
Sbjct: 179 RVGGHT-----ML--PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 22/169 (13%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTL-----ADRICSPHG-------------- 145
Q+NH +++KL G C + +L+ E+ +YG+L R P
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 146 PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205
P L + A +I M Y+ +V +D+ +L E K+SDF S
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ E +++V +++A E + + ++DV+ FG+LL E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 52/231 (22%), Positives = 98/231 (42%), Gaps = 24/231 (10%)
Query: 96 CFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG-PHLEPLLWR 154
+ A+++ I++ ++ +V E+ E G L + G P E +WR
Sbjct: 46 AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR 105
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
++I + +A++H + I+ +DIK + D Y+ K+ D ++ + +
Sbjct: 106 FFIQILL----GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTN 156
Query: 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRL 274
++ + T YL+PE NEK+DV+ G++L E TG+ + N
Sbjct: 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP----------FDANNQ 206
Query: 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325
G ++ I + P + Q L QLI +C+ + RP + LR
Sbjct: 207 GALILKI-IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 4e-13
Identities = 50/197 (25%), Positives = 78/197 (39%), Gaps = 44/197 (22%)
Query: 81 VMKFGD--NYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
V+K D N SE N + ++NH NI+K E +V E+ + G L+
Sbjct: 29 VLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQ 88
Query: 139 RI---CSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195
+I P E + +++ + A+ Y+H R I+ +DIK I +
Sbjct: 89 KIKKQKKEGKPFPEEQILDWFVQLCL----ALKYLH---SRKILHRDIKPQNIFLTSNGL 141
Query: 196 AKLSDFSESEYIPEGETHVTSHMLTRTKR----------YLAPEYILTGLC-----NEKT 240
KL DF S +L+ T YL+PE LC N K+
Sbjct: 142 VKLGDFG------------ISKVLSSTVDLAKTVVGTPYYLSPE-----LCQNKPYNYKS 184
Query: 241 DVFCFGMLLLELLTGRR 257
D++ G +L EL T +
Sbjct: 185 DIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 62/225 (27%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGP--HLEPLLWRHRLKIAM 161
++ H +++L C E E PI +V E++ G+L D + S G L L+ +A
Sbjct: 57 KLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV-----DMAA 110
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I MAY+ R + +D+ IL E V K++DF + I + E T+ +
Sbjct: 111 QIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAK 165
Query: 222 TK-RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVENNR 273
++ APE G K+DV+ FG+LL E++T G + +LE V++ R
Sbjct: 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER---GYR 222
Query: 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
+ P CPE+ L L+ +C ++ +RPT Y
Sbjct: 223 M-----PRPPN---CPEE------LYDLMLQCWDKDPEERPTFEY 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 56/245 (22%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTL-----ADRICSPHGPHLEPLLWRHRLK 158
+ NH NI+KL+G C+ E ++ E +E G L R+ P L + L
Sbjct: 54 SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT---LKELLD 110
Query: 159 IAMEIGNA------MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-------SESE 205
I +++ M +IH R + ++ +S+ +D V K+ DF
Sbjct: 111 ICLDVAKGCVYLEQMHFIH----RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRD 258
Y EGE + R++APE +L G ++DV+ FG+L+ E+LT +
Sbjct: 167 YRKEGEGLLPV-------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
Query: 259 NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
+L+HV G + P ++CP+K + QL+ C + +RPT
Sbjct: 220 QEVLQHVTAG------GRLQKP-----ENCPDK------IYQLMTNCWAQDPSERPTFDR 262
Query: 319 AAKQL 323
+ L
Sbjct: 263 IQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 35/171 (20%), Positives = 84/171 (49%), Gaps = 11/171 (6%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
A ++H ++++L+G C+ +++ L+ + + G L D + + H + + ++ L ++I
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRN----HKDNIGSQYLLNWCVQI 118
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
M+Y+ + +V +D+ +L K++DF ++ + E +
Sbjct: 119 AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN 271
+++A E IL + K+DV+ +G+ + EL+T G + + I + +E
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H N+++L+G C ++ EF+ YG L D + + + ++ L +A +I
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQIS 114
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
+AM Y+ ++ + +D+ L E ++ K++DF S + G+T+ T+H +
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTY-TAHAGAKFPI 169
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT---GRRDNILLEHVKKHVENNRLGEIVDP 280
++ APE + + K+DV+ FG+LL E+ T I L V + +E E
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---- 225
Query: 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ CP K + +L+ C + DRP+ + M+
Sbjct: 226 ---RPEGCPPK------VYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 10/160 (6%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
N I + H NI+K G ++ + +V EF G+L D + S + E +
Sbjct: 45 INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI---- 100
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ E+ + Y+H I+ +DIK + IL KL DF S +
Sbjct: 101 AYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKAR 154
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+ + T ++APE I + K D++ G+ +EL G+
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 7/151 (4%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q +H NI+KLIG C++ + +V E V G+L + L + L+++++
Sbjct: 48 QYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAA 103
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
M Y+ + + +D+ L E NV K+SDF S G V+ + +
Sbjct: 104 AGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK 160
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+ APE + G ++DV+ +G+LL E +
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 42/161 (26%), Positives = 72/161 (44%), Gaps = 17/161 (10%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPH-----------LEPLLWR 154
+ H++I++ G C E ++VFE++ +G L +R HGP L
Sbjct: 64 LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLG 122
Query: 155 HRLKIAMEIGNAMAYI-HIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
L IA +I + M Y+ + F V +D+ L + V K+ DF S I + +
Sbjct: 123 QMLAIASQIASGMVYLASLHF----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 178
Query: 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
R++ PE IL ++D++ FG++L E+ T
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 52/238 (21%), Positives = 94/238 (39%), Gaps = 40/238 (16%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP------ 150
+ + H NI+ L+G C + + ++FE++ +G L + + + PH +
Sbjct: 56 RQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVR-NSPHSDVGAESGD 114
Query: 151 -----LLWRHR-LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204
L L IA++I M Y+ V +D+ L E K+SDF S
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
Query: 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRR 257
I + + R++ PE IL G ++D++ FG++L E+ + G
Sbjct: 172 RDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231
Query: 258 DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
+ ++E ++ + P + CP + L+ EC NE RP
Sbjct: 232 NQEVIEMIRS--------RQLLPCPED---CP------ARVYALMIECWNEIPARRPR 272
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 106 MNHRNILKLIGCCIET--EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRL-KIAME 162
++H NI+K G C + L+ E++ G+L D + + RL + +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-----QRHRDQINLKRLLLFSSQ 117
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I M Y+ + + +D+ IL + ++ K+SDF ++ +PE + + +
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 223 K-RYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ APE + T + +DV+ FG+ L EL T
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 51/155 (32%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q+ H NI+ L LVFE+VE L SP G L P R ++
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVR---SYIWQLL 110
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG-ETHVTSHMLTRTK 223
A+AY H I+ +DIK IL E V KL DF + + + +T ++ TR
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRW- 166
Query: 224 RYLAPEYILTGLCN--EKTDVFCFGMLLLELLTGR 256
Y APE +L G N + DV+ G ++ ELL G
Sbjct: 167 -YRAPE-LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 33/224 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLE--PLLWRHRLKI 159
+++H+N+++L+G C E E ++ E+ + G L R L+ PL + ++ +
Sbjct: 63 RKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS------DFSESEYIPEGETH 213
+I M ++ V +D+ L K+S D SEY
Sbjct: 123 CTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179
Query: 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVEN-- 271
+ R+LAPE + + K+DV+ FG+L+ E+ T L E
Sbjct: 180 IPL-------RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE----LPFYGLSDEEVL 228
Query: 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
NRL + V + CP + +L C + DRP+
Sbjct: 229 NRLQAGKLELPVPE-GCPSRLYKLMT------RCWAVNPKDRPS 265
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 6e-11
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 13/158 (8%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H N++K G + E + E+ GTL + + HG L+ + R +++
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEE-LLE-HGRILDEHVIR---VYTLQLL 109
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM--LTRT 222
+AY+H IV +DIK + I D V KL DF + + T + + L T
Sbjct: 110 EGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 223 KRYLAPEYILTGLCNEK---TDVFCFGMLLLELLTGRR 257
Y+APE I G D++ G ++LE+ TG+R
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 26/218 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEI 163
++ H ++ L E I I V EF+ G+L D + G +L+ P L + +A +I
Sbjct: 57 KLRHDKLVPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYLKLPQL----VDMAAQI 111
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ MAYI R + +D++ + IL + V K++DF + I + E +
Sbjct: 112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPI 167
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDP 280
++ APE L G K+DV+ FG+LL EL+T R ++ V + VE R + P
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE--RGYRMPCP 225
Query: 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
+ CPE +L +L+ C + +RPT Y
Sbjct: 226 -----QGCPE------SLHELMKLCWKKDPDERPTFEY 252
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I + + HRNI++ +G E + E V G+L+ + S GP L + I
Sbjct: 56 IALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGP-----LKDNEQTI 110
Query: 160 AM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYI----PEGE 211
+I + Y+H IV +DIK +L + Y+ V K+SDF S+ + P E
Sbjct: 111 IFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167
Query: 212 THVTSHMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGR 256
T T T +Y+APE I G D++ G ++E+ TG+
Sbjct: 168 T------FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 63/219 (28%), Positives = 100/219 (45%), Gaps = 28/219 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEI 163
++ H +++L E I I V E++ G+L D + G +L P L + +A +I
Sbjct: 57 KLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGEMGKYLRLPQL----VDMAAQI 111
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ MAY+ R V +D++ + IL E V K++DF + I + E +
Sbjct: 112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPI 167
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENN-RLGEIVD 279
++ APE L G K+DV+ FG+LL EL T R ++ V VE R+
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----- 222
Query: 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
P E CPE +L L+ +C + +RPT Y
Sbjct: 223 PCPPE---CPE------SLHDLMCQCWRKEPEERPTFEY 252
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 32/226 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
++ NH+NI++LIG E ++ E + G L R P L + L A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLSDFSESEYIPEGETHVTSHM 218
++ Y+ + +DI L VAK++DF + I +
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL-------TGRRDNILLEHVKKHVEN 271
+++ PE L G+ KTDV+ FG+LL E+ GR + ++E V
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV---TGG 237
Query: 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMV 317
RL DP K CP + +++ +C + DRP
Sbjct: 238 GRL----DP----PKGCPG------PVYRIMTDCWQHTPEDRPNFA 269
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 53/233 (22%), Positives = 91/233 (39%), Gaps = 36/233 (15%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS-PHGPHLEPLLWRHRLKIAME 162
AQ++H I++LIG C + +LV E G L + P + H ++AM
Sbjct: 51 AQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAH--QVAM- 106
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
MAY+ + V +D+ +L + AK+SDF S + G + + R
Sbjct: 107 ---GMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRW 160
Query: 223 K-RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVENNRL 274
++ APE I G + K+DV+ +G+ L E + + ++ ++ RL
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES---GERL 217
Query: 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
PE+ Q + ++ C DRPT R+
Sbjct: 218 P------------RPEECP--QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHR------- 156
Q+ H N+++L+G +E + + +V E++ G+L D + S R R
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-----------RGRSVLGGDC 103
Query: 157 -LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
LK ++++ AM Y+ V +D+ +L E NVAK+SDF ++ E T
Sbjct: 104 LLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASST 155
Query: 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENN 272
++ APE + + K+DV+ FG+LL E+ + R I L+ V VE
Sbjct: 156 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 215
Query: 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ D CP + ++ +C + A RP+ + +QL +
Sbjct: 216 YKMDAPD-------GCPP------VVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 30/217 (13%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H N+++L G C + +V E++ G L + + G L L + ++
Sbjct: 55 KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL----LDMCSDVC 110
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
AM Y+ + +D+ L E NV K+SDF + Y+ + + TS T+
Sbjct: 111 EAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPV 165
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPI-- 281
++ PE + K+DV+ FG+L+ E+ + K E E+V+ +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEG---------KMPYERFSNSEVVESVSA 216
Query: 282 ---VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
+ K P + + +++ C +E DRP
Sbjct: 217 GYRLYRPKLAPTE------VYTIMYSCWHEKPEDRPA 247
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI- 163
Q +H NI++LIG C + + +V E V+ G + + GP L ++K +++
Sbjct: 49 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT-EGPRL-------KVKELIQMV 100
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
NA A + + + +D+ L E NV K+SDF S +G T M
Sbjct: 101 ENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLE 251
++ APE + G + ++DV+ FG+LL E
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 24/158 (15%)
Query: 106 MNHRNILKLIGCCIET--EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H NI+K GCC E + L+ E+V G+L D + H +L LL A +I
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLL-----FAQQI 116
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MAY+H + + +D+ +L D + K+ DF ++ +PEG H R +
Sbjct: 117 CEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG------HEYYRVR 167
Query: 224 R-------YLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ A E + + +DV+ FG+ L ELLT
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
+ H NI++ +G C++ + EFV G+++ I + GP EP+ ++ +I +
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSIS-SILNRFGPLPEPVFCKY----TKQILD 113
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT-SHMLTR--- 221
+AY+H +V +DIK + ++ + KL DF + + H T S+ML
Sbjct: 114 GVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T ++APE I K+D++ G + E+ TG+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 5e-10
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
+++NH I+KL +TE + LV E+ G L + S G E R R A E
Sbjct: 48 SRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEE---RARFYAA-E 101
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I A+ Y+H I+++D+K IL D KL+DF ++ + + + T
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
YLAPE +L + D + G+LL E+LTG+
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 106 MNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEI 163
+ H ++KL + T+ PI ++ EF+ G+L D + S G P L + + +I
Sbjct: 58 LQHDKLVKLHA--VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL----IDFSAQI 111
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MA+I +R + +D++ + IL V K++DF + I + E +
Sbjct: 112 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPI 167
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDP 280
++ APE I G K+DV+ FG+LL+E++T R + V + +E +
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE- 226
Query: 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
+CPE+ L ++ C +RPT Y
Sbjct: 227 ------NCPEE------LYNIMMRCWKNRPEERPTFEY 252
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 25/218 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H NI+KLIG C + L+ E++E L++ L L W R KIA+ I
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV--------LRNLSWERRRKIAIGIA 790
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
A+ ++H +V ++ +I+ D + L + + ++S
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS-------A 843
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR--------DNILLEHVKKHVENNRLGE 276
Y+APE T EK+D++ FG++L+ELLTG+ ++E + + L
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP 314
+DP + D S + E + ++ L C RP
Sbjct: 904 WIDPSIRGDVSVNQNE--IVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 20/165 (12%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I ++ H NI++ +G ++ + + E+V G++A + + +G E L+ R+ ++
Sbjct: 57 IALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA-LLNNYGAFEETLV-RNFVR- 113
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+I + Y+H R I+ +DIK + IL D K+SDF S+ + E + S
Sbjct: 114 --QILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLS-TK 164
Query: 220 TRTKR--------YLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T R ++APE + K D++ G L++E+LTG+
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 36/223 (16%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAME 162
Q+ H +++L + T+ PI ++ E++E G+L D + +P G L L + +A +
Sbjct: 57 QLQHPRLVRLYA--VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKL----IDMAAQ 110
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I MA+I R+ + +D++ + IL E K++DF + I + E +
Sbjct: 111 IAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFP 166
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVENNRLG 275
++ APE I G K+DV+ FG+LL E++T G + ++++++ R
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE------RGY 220
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
+ P +CPE L +L+ C E +RPT Y
Sbjct: 221 RMPRP-----DNCPE------ELYELMRLCWKEKPEERPTFEY 252
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 9/154 (5%)
Query: 106 MNHRNILKLIGCCIE-TEIPILVFEFVEYGTLAD--RICSPHGPHLEP--LLWRHRLKIA 160
++H+NIL ++ CIE E P +++ ++ +G L + C G P L + + +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCR-LGEANNPQALSTQQLVHMA 123
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
++I M+Y+H +R ++ KDI + DE K++D + S + + H
Sbjct: 124 IQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN 180
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
R +++A E ++ + +DV+ FG+LL EL+T
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 20/200 (10%)
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
+V E+++ G+LAD + G EP+L IA +I + Y+H +R I+ +DIK
Sbjct: 76 IVLEYMDGGSLADLL-KKVGKIPEPVL----AYIARQILKGLDYLH--TKRHIIHRDIKP 128
Query: 186 SQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCF 245
S +L + K++DF S+ + + + T T Y++PE I + D++
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVT--YMSPERIQGESYSYAADIWSL 186
Query: 246 GMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFEC 305
G+ LLE G+ E++ I E+ I C
Sbjct: 187 GLTLLECALGK-------FPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239
Query: 306 VNESAGDRPTMVYAAKQLRQ 325
+ + RP+ A +L Q
Sbjct: 240 LQKDPKKRPS----AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 33/221 (14%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEIG 164
+ H +++L + E ++ E++ G+L D + S G + P L + + +I
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKL----IDFSAQIA 113
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
MAYI R+ + +D++ + +L E + K++DF + I + E + +
Sbjct: 114 EGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIK 169
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVENNRLGEI 277
+ APE I G K+DV+ FG+LL E++T G ++ ++ +++ R+
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM--- 226
Query: 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
++CP++ L ++ C E A +RPT Y
Sbjct: 227 --------ENCPDE------LYDIMKTCWKEKAEERPTFDY 253
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 20/198 (10%)
Query: 69 LYKGFLENRPISVMKFG-DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127
L K N ++V K D+ S+ I+ + Q+ H NIL + I +V
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77
Query: 128 FEFVEYGTLADRICS--PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
+ YG+ D + + P G L L LK ++ NA+ YIH + + + +K
Sbjct: 78 SPLMAYGSCEDLLKTHFPEG--LPELAIAFILK---DVLNALDYIH---SKGFIHRSVKA 129
Query: 186 SQILFDEYNVAKLSDFSES-EYIPEGETHVTSHMLTRTK----RYLAPEYI---LTGLCN 237
S IL LS S I G+ H ++ +L+PE + L G N
Sbjct: 130 SHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-N 188
Query: 238 EKTDVFCFGMLLLELLTG 255
EK+D++ G+ EL G
Sbjct: 189 EKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-09
Identities = 52/213 (24%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+++H +++L G C + PI +V E++ G L + + HG +P L++ ++
Sbjct: 55 KLSHEKLVQLYGVC-TKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQP---SQLLEMCKDV 109
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MAY+ + + +D+ L D+ K+SDF S Y+ + E TS + ++
Sbjct: 110 CEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFP 164
Query: 224 -RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIV 282
R+ PE +L + K+DV+ FG+L+ E+ + L + NN E V+ V
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS-------LGKMPYERFNNS--ETVEK-V 214
Query: 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
+ + + +++ C +E A +RPT
Sbjct: 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPT 247
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 56/237 (23%), Positives = 97/237 (40%), Gaps = 24/237 (10%)
Query: 96 CFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLL-WR 154
C I Q+NH N++K IE +V E + G L+ I H + L+ +
Sbjct: 49 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEK 106
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
K +++ +A+ ++H R ++ +DIK + + V KL D + T
Sbjct: 107 TVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-- 161
Query: 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR----DNILLEHVKKHVE 270
+H L T Y++PE I N K+D++ G LL E+ + D + L + K +E
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE 221
Query: 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
D + + L QL+ C+N RP + Y ++M+
Sbjct: 222 QC------------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 13/158 (8%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL---------EPLLWRHR 156
+ H +I+K G C+E + I+VFE++++G L ++ HGP L
Sbjct: 64 LQHEHIVKFYGVCVEGDPLIMVFEYMKHGDL-NKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
L IA +I M Y+ + V +D+ L E + K+ DF S + + +
Sbjct: 123 LHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
R++ PE I+ ++DV+ G++L E+ T
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 46/188 (24%), Positives = 90/188 (47%), Gaps = 9/188 (4%)
Query: 68 KLYKGFLENR-PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126
+++KG L+++ P++V ++ + + + Q +H NI+KLIG C + + +
Sbjct: 10 EVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYI 69
Query: 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
V E V G + + L + +K A++ MAY+ + + +D+
Sbjct: 70 VMELVPGGDFLSFLRKKK----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAAR 122
Query: 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFG 246
L E NV K+SDF S +G + +S + ++ APE + G + ++DV+ +G
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDG-IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 247 MLLLELLT 254
+LL E +
Sbjct: 182 ILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 25/198 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H+N+++L+G + + I V E + G L + + + G L ++ L+ ++++
Sbjct: 55 KLHHKNLVRLLGVILHNGLYI-VMELMSKGNLVNFLRT-RGRALVSVI--QLLQFSLDVA 110
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
M Y+ + +V +D+ IL E VAK+SDF G V S + +K
Sbjct: 111 EGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDF--------GLARVGSMGVDNSKL 159
Query: 224 --RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENNRLGEIV 278
++ APE + + K+DV+ +G+LL E+ + GR + L+ VK+ VE E
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219
Query: 279 D----PIVVEDKSCPEKE 292
+ + V SC E E
Sbjct: 220 EGCPADVYVLMTSCWETE 237
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 51/215 (23%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
+ H++++ L C E ++ E +E G+L + SP G L + +A ++
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV---ASLIDMACQVAE 115
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRY 225
MAY+ + + +D+ IL E V K++DF + I E + + ++
Sbjct: 116 GMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP--YKW 170
Query: 226 LAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285
APE G + K+DV+ FG+LL E+ T + + H E+ D I
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT--YGQVPYPGMNNH-------EVYDQITAGY 221
Query: 286 K-----SCPEKEQQLQALLQLIFECVNESAGDRPT 315
+ CP Q + +++ EC DRP+
Sbjct: 222 RMPCPAKCP------QEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 42/152 (27%), Positives = 80/152 (52%), Gaps = 12/152 (7%)
Query: 107 NHRNILKLIGCCIETE-IPILVFEFVEYGTLADRICSP-HGPHLEPLLWRHRLKIAMEIG 164
+H N+L L+G C+ +E P++V ++++G L + I S H P ++ L+ +++
Sbjct: 54 SHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-----GFGLQVA 108
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH-VTSHMLTRTK 223
M Y+ + V +D+ + DE K++DF + I + E + V +H +
Sbjct: 109 KGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
Query: 224 -RYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+++A E + T K+DV+ FG+LL EL+T
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-PLLWRHRLKIAMEI 163
++ H +++L E I I V E++ G+L D + G L+ P L + +A ++
Sbjct: 57 KLRHDKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDGEGRALKLPNL----VDMAAQV 111
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MAYI R + +D++ + IL + V K++DF + I + E +
Sbjct: 112 AAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPI 167
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283
++ APE L G K+DV+ FG+LL EL+T R V NNR E+++ +
Sbjct: 168 KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR-------VPYPGMNNR--EVLEQVER 218
Query: 284 EDK-SCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318
+ CP+ +L +L+ +C + +RPT Y
Sbjct: 219 GYRMPCPQDCP--ISLHELMLQCWKKDPEERPTFEY 252
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 33/219 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H +++L C E +V E ++YG+L + + G L+ + +A ++
Sbjct: 57 KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK---LPQLIDMAAQVA 113
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
+ MAY+ + + +D+ +L E N+ K++DF + I E + +
Sbjct: 114 SGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI--YEAREGAKFPI 168
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVENNRLGE 276
++ APE L + K+DV+ FG+LL E++T G + +L+ V + R+
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ---GYRM-- 223
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
P CP + L ++ +C E DRPT
Sbjct: 224 ---P---CPPGCP------KELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGP---------HLEPLLWRHR 156
H+NI+ L+G C + ++ E+ G L + R P GP E L ++
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ A ++ M Y+ R + +D+ +L E NV K++DF + G +
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFG----LARGVHDIDY 189
Query: 217 HMLTRTKR----YLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ T R ++APE + + ++DV+ FG+L+ E+ T
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 16/234 (6%)
Query: 96 CFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLL-WR 154
C I Q+NH N++K + IE +V E + G L+ I + + L+ R
Sbjct: 49 CVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMI--KYFKKQKRLIPER 106
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
K +++ +A+ ++H R ++ +DIK + + V KL D + T
Sbjct: 107 TVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-- 161
Query: 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRL 274
+H L T Y++PE I N K+D++ G LL E+ + + L
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA--------LQSPFYGDKMNL 213
Query: 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328
+ I D E + L +L+ C+ RP + Y + +QM++
Sbjct: 214 FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 39/230 (16%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRIC--SPH----------GPHLEPL 151
A+++H NI+ L+G + + ++FE++ G L + + SPH G L
Sbjct: 62 AELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121
Query: 152 LWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211
L IA++I M Y+ F V KD+ IL E K+SD S I +
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEH 264
+ R++ PE I+ G + +D++ FG++L E+ + G + ++E
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP 314
V+K ++ + CP + + L+ EC E RP
Sbjct: 239 VRKR-----------QLLPCSEDCPPR------MYSLMTECWQEGPSRRP 271
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 39/161 (24%), Positives = 73/161 (45%), Gaps = 16/161 (9%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL------EPLLWR----- 154
+ H +I+K G C + + I+VFE++++G L ++ HGP +P +
Sbjct: 64 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 155 -HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
L IA +I + M Y+ + V +D+ L + K+ DF S + + +
Sbjct: 123 SQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179
Query: 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
R++ PE I+ ++DV+ FG++L E+ T
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-08
Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 28/239 (11%)
Query: 96 CFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRI---CSPHGPHLEPLL 152
C I Q++H N++K + IE +V E + G L+ I E +
Sbjct: 49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI 108
Query: 153 WRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212
W K +++ +A+ ++H + I+ +DIK + + V KL D + T
Sbjct: 109 W----KYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR----DNILLEHVKKH 268
+H L T Y++PE I N K+D++ G LL E+ + D + L + K
Sbjct: 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219
Query: 269 VENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+E + P + + L L+ C+N RP + Y + ++M+
Sbjct: 220 IEKC-----------DYPPLP-ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 11/143 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A +I + ++H +R IV++D+K +L D++ ++SD + + G+
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV- 278
T Y+APE + + + D F G L E++ GR K+ VE L
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP---FRQRKEKVEKEELKRRTL 211
Query: 279 -DPIVVEDKSCPEKEQQLQALLQ 300
+ DK PE + +ALLQ
Sbjct: 212 EMAVEYPDKFSPEAKDLCEALLQ 234
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
I Q+ H N++ LI + LVFEFV++ L D P+G L+ R
Sbjct: 48 MREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVR-- 103
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
K +I + + H I+ +DIK IL + V KL DF + + T
Sbjct: 104 -KYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159
Query: 217 HMLTRTKRYLAPEYILTGLCNEK-TDVFCFGMLLLELLTG 255
++ TR Y APE ++ + D++ G L+ E+LTG
Sbjct: 160 YVATRW--YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 56/240 (23%), Positives = 91/240 (37%), Gaps = 40/240 (16%)
Query: 98 NNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY---GTLADRICSPHGPHLEPLLWR 154
I + H I++ GC + F+EY G++ D++ +G E +
Sbjct: 53 CEIQLLKNLQHERIVQYYGC---LRDDETLSIFMEYMPGGSVKDQL-KAYGALTETV--- 105
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
K +I + Y+H IV +DIK + IL D KL DF S+ + +
Sbjct: 106 -TRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 215 TSHM-LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE------HVKK 267
T +T T +++PE I K DV+ G ++E+LT + E +
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 221
Query: 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
N +L V P L+ F E+A RP+ A + LR +
Sbjct: 222 QPTNPQLPSHVSPDARN-------------FLRRTFV---ENAKKRPS---AEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 42/133 (31%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIK 184
+ EF++ G+L DRI GP +L KIA+ + + Y++ R I+ +DIK
Sbjct: 79 CMCMEFMDCGSL-DRIYKKGGPIPVEILG----KIAVAVVEGLTYLYNVHR--IMHRDIK 131
Query: 185 LSQILFDEYNVAKLSDFSESEYIPEGE-THVTSHMLTRTKRYLAPEYILTGLCNEKTDVF 243
S IL + KL DF S GE + + T Y++PE I G K+DV+
Sbjct: 132 PSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 244 CFGMLLLELLTGR 256
G+ ++EL G+
Sbjct: 187 SLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 32/226 (14%)
Query: 98 NNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP---LLWR 154
++ A+M H NI+ E +V E+ + G L RI G L W
Sbjct: 48 KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW- 106
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN--VAKLSDFSESEYIPEGET 212
++I + +IH R I+ +DIK SQ +F N VAKL DF + + ++
Sbjct: 107 -----FVQISLGLKHIH---DRKILHRDIK-SQNIFLSKNGMVAKLGDFGIARQL--NDS 155
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN 272
++ T YL+PE N KTD++ G +L EL T +K E N
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT----------LKHPFEGN 205
Query: 273 RLGEIVDPIVVEDKS--CPEKEQQLQALLQLIFECVNESAGDRPTM 316
L ++V I + P + L++L+ +F+ S DRP++
Sbjct: 206 NLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV---SPRDRPSI 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 48/157 (30%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 108 HRNILKLIGCCI---ETEIPILVFEFVEYGTL---ADRICSPHGPHLEPLLWRHRLKIAM 161
I+K G + + I I + E+ E G+L ++ G E +L KIA
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVL----GKIAE 112
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS--HML 219
+ ++Y+H R I+ +DIK S IL KL DF S GE V S
Sbjct: 113 SVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GEL-VNSLAGTF 163
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T T Y+APE I + +DV+ G+ LLE+ R
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 69/281 (24%), Positives = 119/281 (42%), Gaps = 42/281 (14%)
Query: 50 KIATNNYNGHQVI-ASEHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFA 103
+I ++ +VI A E ++++G L+ +++ Y+E +
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLK-IA-- 160
Q +H NI++L G + + +++ E++E G L D+ H L+ IA
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES---EYIPEGETHVTSH 217
M+ + M Y+H +D+ IL + K+SDF S E PEG T+ TS
Sbjct: 120 MKYLSDMNYVH---------RDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSG 169
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR---DNILLEHVKKHVENNR 273
R+ APE I +DV+ FG+++ E+++ G R D E +K + R
Sbjct: 170 GKIPI-RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR 228
Query: 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP 314
L +D CP A+ QL+ +C + RP
Sbjct: 229 LPAPMD--------CP------SAVYQLMLQCWQQDRARRP 255
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 5e-08
Identities = 40/168 (23%), Positives = 65/168 (38%), Gaps = 26/168 (15%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
H I+KL + E V E+ G L I +G E R A EI A
Sbjct: 60 GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCT-RF---YAAEILLA 114
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-----------SESEYIPEGETHVT 215
+ Y+H + I+ +D+K IL D+ K++DF ES
Sbjct: 115 LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 216 SHMLTR-------TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
R T Y++PE + + +D++ G ++ ++LTG+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 42/163 (25%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS--PHGPHLEPLLWRHRL 157
+ +Q NH N++K + + LV ++ G+L D + S P G E ++
Sbjct: 50 VQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAII----A 105
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG--ETHVT 215
+ E+ + Y+H + +DIK IL E K++DF S + +G T
Sbjct: 106 TVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162
Query: 216 SHMLTRTKRYLAPEYI--LTGLCNEKTDVFCFGMLLLELLTGR 256
T ++APE + + G + K D++ FG+ +EL TG
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGY-DFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-08
Identities = 38/156 (24%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++H NI++ +G E + E+V G++ +G E L+ R + +E
Sbjct: 63 KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIG-SCLRTYGRFEEQLV-RFFTEQVLE- 119
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+AY+H + I+ +D+K +L D + K+SDF S+ + + + + +
Sbjct: 120 --GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
Query: 224 RYLAPEYILTGLC--NEKTDVFCFGMLLLELLTGRR 257
++APE I + + K D++ G ++LE+ GRR
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 38/182 (20%), Positives = 70/182 (38%), Gaps = 23/182 (12%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
I M+ E N I+ H NI+ + + +V E+++ G+L D
Sbjct: 49 IKKMRLRKQNKEL----IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
I + + + E+ + Y+H + ++ +DIK IL + KL
Sbjct: 105 II----TQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKL 157
Query: 199 SDFSESEYIPEGETHVTSHMLTR-----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
+DF + +T R T ++APE I K D++ G++ +E+
Sbjct: 158 ADFGFA-------AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
Query: 254 TG 255
G
Sbjct: 211 EG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 9e-08
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 32/165 (19%)
Query: 105 QMNHRNILKLIGCCIETEIP--ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM- 161
++ H NI++L +VFE++++ D L LL +K
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH----D---------LTGLLDSPEVKFTES 100
Query: 162 -------EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI-PEGETH 213
++ + Y+H I+ +DIK S IL + V KL+DF +
Sbjct: 101 QIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157
Query: 214 VTSHMLTRTKRYLAPEYILTGLCN--EKTDVFCFGMLLLELLTGR 256
T+ ++T Y PE +L G + D++ G +L EL G+
Sbjct: 158 YTNRVITLW--YRPPE-LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 33/155 (21%), Positives = 69/155 (44%), Gaps = 20/155 (12%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
NH NI+ L+G C +++ E+ YG L + + L L + ++
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLT---LEDLLSFSYQVAKG 153
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-------SESEYIPEGETHVTSHML 219
MA++ + + +D+ +L + K+ DF ++S Y+ +G +
Sbjct: 154 MAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+++APE I + ++DV+ +G+LL E+ +
Sbjct: 208 ----KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP-----------LLWRH 155
+H NI+ L+G C + E+ YG L D + +P L +
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
L+ A ++ M Y+ + + +D+ +L E +K++DF S E +V
Sbjct: 121 LLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK 174
Query: 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
M R++A E + + K+DV+ FG+LL E+++
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 42/133 (31%), Positives = 64/133 (48%), Gaps = 13/133 (9%)
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
L+ ++V G L + H R+ IA EI A+ ++H + I+++DIKL
Sbjct: 82 LILDYVNGGELFTHLY--QREHFT--ESEVRVYIA-EIVLALDHLH---QLGIIYRDIKL 133
Query: 186 SQILFDEYNVAKLSDFSES-EYIPEGETHVTSHMLTRTKRYLAPEYILTGLC--NEKTDV 242
IL D L+DF S E++ E E ++ T Y+APE I G ++ D
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191
Query: 243 FCFGMLLLELLTG 255
+ G+L ELLTG
Sbjct: 192 WSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 33/230 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q +H NI++L G ++ +++ E++E G+L D+ + + + I
Sbjct: 61 QFDHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVG---QLVGMLRGIA 116
Query: 165 NAMAYI-HIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ M Y+ + + V +D+ IL + V K+SDF S + + E T+
Sbjct: 117 SGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR-----DNILLEHVKKHVENN-RLGE 276
R+ APE I +DV+ FG+++ E+++ G R N + V K VE+ RL
Sbjct: 173 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRLPP 229
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+D CP AL QL+ +C + +RPT L +M
Sbjct: 230 PMD--------CPS------ALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 40/184 (21%), Positives = 83/184 (45%), Gaps = 12/184 (6%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
++V + ++ N I +++ + NI++L+G C+ + ++ E++E G L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 139 RICS-------PHGPHLEPLLWRHRLKIAMEIGNAMAYI-HIGFRRPIVFKDIKLSQILF 190
+ H ++ + + L +A++I + M Y+ + F V +D+ L
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF----VHRDLATRNCLV 162
Query: 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLL 250
+ K++DF S + G+ + R++A E IL G +DV+ FG+ L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 251 ELLT 254
E+ T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 24/163 (14%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRI---------CSPHGPHL--EPLLWRHR 156
H+NI+ L+G C + +V E+ +G L D + SP P E L +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ A ++ M ++ + + +D+ +L E +V K++DF + I H
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHID 186
Query: 217 HMLTRTK-----RYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ T +++APE + + ++DV+ FG+LL E+ T
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 13/142 (9%)
Query: 117 CCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR 175
C +T + V E+V G L I G EP H + A EI + ++H
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEP----HAVFYAAEIAIGLFFLH---S 119
Query: 176 RPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLTRTKRYLAPEYILTG 234
+ I+++D+KL ++ D K++DF E I G+T T T Y+APE I
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT---FCGTPDYIAPEIIAYQ 176
Query: 235 LCNEKTDVFCFGMLLLELLTGR 256
+ D + FG+LL E+L G+
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 38/162 (23%), Positives = 74/162 (45%), Gaps = 22/162 (13%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-----------PLLWRHR 156
H+NI+ L+G C + ++ E+ G L + + + P +E L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ A ++ M Y+ + + +D+ +L E NV K++DF + I H+
Sbjct: 143 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 195
Query: 217 HMLTRTKR----YLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ T R ++APE + + ++DV+ FG+LL E+ T
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 6/99 (6%)
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218
EI A+ Y+H + I+ +DIK IL DE ++DF+ + + ++
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-- 159
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+ T Y+APE + + D + G+ E L G+R
Sbjct: 160 -SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 31/158 (19%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-----------PLLWRHR 156
H+NI+ L+G C + ++ E+ G L + + + P +E + ++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ ++ M Y+ + + +D+ +L E NV K++DF + + + + +
Sbjct: 140 VSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+++APE + + ++DV+ FG+L+ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 23/166 (13%)
Query: 104 AQMNHRNILKLI--GCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
A++ H NI+ L+ G + VFE+V TL + + + G L + +
Sbjct: 33 ARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAA-DGA-LPAGETGR---LML 86
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV---AKLSDFSESEYIPE-GETHVTSH 217
++ +A+A H + IV +D+K I+ + V AK+ DF +P + V +
Sbjct: 87 QVLDALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVAT- 142
Query: 218 MLTRTKRYL------APEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
LTRT L APE + +D++ +G++ LE LTG+R
Sbjct: 143 -LTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 4e-07
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 17/159 (10%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP-----------LLWRH 155
+H NI+ L+G C L E+ +G L D + +P L +
Sbjct: 54 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
L A ++ M Y+ ++ + +D+ IL E VAK++DF S E +V
Sbjct: 114 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 167
Query: 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
M R++A E + + +DV+ +G+LL E+++
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H +++L G C + + +V EF+E G L + + G + +L L + ++
Sbjct: 55 KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML----LSMCQDVC 110
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
M Y+ R + +D+ L V K+SDF + Y+ + E + +S +
Sbjct: 111 EGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVK 166
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ PE + K+DV+ FG+L+ E+ T
Sbjct: 167 WSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 22/162 (13%)
Query: 106 MNHRNILKLIG---------CCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRH 155
M + +L L G C +T+ + V E+V G L I G EP
Sbjct: 43 MTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEP----R 97
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHV 214
A EI + ++H R I+++D+KL +L D K++DF E I G V
Sbjct: 98 ARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---V 151
Query: 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T+ T Y+APE + D + G+LL E+L G+
Sbjct: 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 5e-07
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A ++ A+ Y+H IV++D+K +L D K++DF ++ + ++ L
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTL 158
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T YLAPE IL+ + D + G+L+ E+L G
Sbjct: 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 33/162 (20%)
Query: 107 NHRNILKLIGCCIET-----EIPILVFEFVEYGTLADRICSPHGPHL--EPLLWRHRLKI 159
NH N++K C + EI +L+ EF++ G+L G H+ E L +
Sbjct: 130 NHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSL-------EGTHIADEQFL----ADV 173
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A +I + +AY+H RR IV +DIK S +L + K++DF S + + S +
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 220 TRTKRYLAPEYILTGLCNEK-----TDVFCFGMLLLELLTGR 256
T Y++PE I T L + D++ G+ +LE GR
Sbjct: 230 -GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 39/163 (23%), Positives = 75/163 (46%), Gaps = 19/163 (11%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
FN +V H NI+++ + + +V EF+E G L D + H E +
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQI---- 117
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF----SESEYIPEGET 212
+ + + A++++H + ++ +DIK IL KLSDF S+ +P ++
Sbjct: 118 ATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
L T ++APE I + D++ G++++E++ G
Sbjct: 175 ------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 34/158 (21%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL-----------EPLLWRHR 156
H+NI+ L+G C + ++ E+ G L + + + P + E L ++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ A ++ M Y+ + + +D+ +L E NV K++DF + + + + +
Sbjct: 137 VSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+++APE + + ++DV+ FG+LL E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 9e-07
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + ++H ++ I+++D+KL +L D+ K++DF + GE +
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTF 156
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE + NE D + FG+LL E+L G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 46/150 (30%), Positives = 66/150 (44%), Gaps = 12/150 (8%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
NH + +L C + V EFV G L I E R R A EI +A
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEA---RARF-YAAEITSA 108
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLTRTKRY 225
+ ++H + I+++D+KL +L D KL+DF E I G T+ T Y
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG---KTTSTFCGTPDY 162
Query: 226 LAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+APE + L D + G+LL E+L G
Sbjct: 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 20/157 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPILVF-EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM-- 161
++ H NI++ +G E + + +F E V G+LA ++ +G EP+ I +
Sbjct: 58 KLQHPNIVQYLGTEREED-NLYIFLELVPGGSLA-KLLKKYGSFPEPV-------IRLYT 108
Query: 162 -EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+I + Y+H R V +DIK + IL D V KL+DF ++ + +
Sbjct: 109 RQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFK 162
Query: 221 RTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGR 256
+ ++APE I G D++ G +LE+ TG+
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHM 218
A EI + ++H RR I+++D+KL ++ D K++DF E++ +G VT+
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRT 160
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE I + D + +G+LL E+L G+
Sbjct: 161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 17/153 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q +H +I+KLIG TE P+ +V E G L + + L + + ++
Sbjct: 63 QFDHPHIVKLIGVI--TENPVWIVMELAPLGELRSYLQV----NKYSLDLASLILYSYQL 116
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
A+AY+ + V +DI +L + KL DF S Y+ + + S + K
Sbjct: 117 STALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS----KGK 169
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
+++APE I +DV+ FG+ + E+L
Sbjct: 170 LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 12/132 (9%)
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
V E+V G L +I G EP H + A EI + ++H + I+++D+KL
Sbjct: 78 FVMEYVNGGDLMYQI-QQVGRFKEP----HAVFYAAEIAIGLFFLH---SKGIIYRDLKL 129
Query: 186 SQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244
++ D K++DF E + +G VT+ T Y+APE I + D +
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 245 FGMLLLELLTGR 256
FG+LL E+L G+
Sbjct: 187 FGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 47/225 (20%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 105 QMNHRNILKLIGCCIETE------IPILVFEFVEYGTLADRIC-SPHGPHLEPLLWRHRL 157
+ +H N+++LIG C++T P+++ F+++G L + S G + L + +
Sbjct: 56 EFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLV 115
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
K +I + M Y+ + + +D+ + +E ++DF S+ I G+ +
Sbjct: 116 KFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHVE 270
+ +++A E + + K+DV+ FG+ + E+ T G ++ + ++++ +
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR---Q 229
Query: 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
NRL + D C L L L+ C + DRP+
Sbjct: 230 GNRLKQPPD--------C------LDGLYSLMSSCWLLNPKDRPS 260
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (116), Expect = 2e-06
Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 31/163 (19%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLK-IAM 161
++ H NI+KL+ LVFE+ + D + L P + +K I
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYCDM----DLKKYLDKRPGPLSP----NLIKSIMY 105
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
++ +AY H I+ +D+K IL + V KL+DF + + T
Sbjct: 106 QLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAF-------GIPLRTY 155
Query: 222 TKR-----YLAPEYILTGLCNEKT---DVFCFGMLLLELLTGR 256
T Y APE IL G + D++ G + E++TG+
Sbjct: 156 THEVVTLWYRAPE-ILLG-SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 43/157 (27%), Positives = 66/157 (42%), Gaps = 12/157 (7%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIA 160
VF NH ++ L C V E+V G L H L H +
Sbjct: 48 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMF-----HMQRQRKLPEEHARFYS 102
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHML 219
EI A+ Y+H R I+++D+KL +L D KL+D+ E + G+ T+
Sbjct: 103 AEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTF 156
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE + D + G+L+ E++ GR
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 9/100 (9%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
EI A+ Y+H I+ +D+K IL D KL+DF S+ +
Sbjct: 101 EIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157
Query: 222 TKR------YLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
KR Y+APE IL ++ D + G +L E L G
Sbjct: 158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 40/164 (24%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 103 AAQM---NHRNILKLIGCCIETE------IPILVFEFVEYGTLADRICSPH---GPHLEP 150
AA M +H N++KLIG C E P+++ F+++G L + P P
Sbjct: 52 AACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP 111
Query: 151 LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210
L + LK ++I M Y+ R + +D+ + E ++DF S+ I G
Sbjct: 112 L--QTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSG 166
Query: 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ + + +++A E + + K+DV+ FG+ + E+ T
Sbjct: 167 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 107 NHRNILKLIGCCI-ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
N I+ G +I I + E+++ G+L + G E +L KIA+ +
Sbjct: 57 NSPYIVGFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG----KIAVAVLK 111
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TK 223
+ Y+H + I+ +D+K S IL + KL DF S + V S T T
Sbjct: 112 GLTYLH--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTS 163
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y+APE I + K+D++ G+ L+EL TGR
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 17/158 (10%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP-----------LLWRHR 156
H NI+ L+G C L E+ +G L D + +P L +
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
L A ++ M Y+ ++ + +D+ IL E VAK++DF S E +V
Sbjct: 127 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 180
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
M R++A E + + +DV+ +G+LL E+++
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 31/247 (12%)
Query: 89 SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS------ 142
++N N + +++ NI++L+G C++ + ++ E++E G L + S
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118
Query: 143 -----PHGPHLEPLL---WRHRLKIAMEIGNAMAYIH-IGFRRPIVFKDIKLSQILFDEY 193
P L + L +A++I + M Y+ + F V +D+ L E
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF----VHRDLATRNCLVGEN 174
Query: 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
K++DF S + G+ + R++A E IL G +DV+ FG+ L E+L
Sbjct: 175 LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 254 TGRRDNILLEHVKKHVENNRLGEIV-----DPIVVEDKSCPEKEQQLQALLQLIFECVNE 308
++ E + V N GE + CP Q L +L+ +C +
Sbjct: 235 MLCKEQPYGELTDEQVIENA-GEFFRDQGRQVYLFRPPPCP------QGLYELMLQCWSR 287
Query: 309 SAGDRPT 315
+RP+
Sbjct: 288 DCRERPS 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 10/170 (5%)
Query: 89 SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL 148
+++ N ++H NI++ +E + ++V E+ GTLA+ I L
Sbjct: 39 TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLL 98
Query: 149 EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESEYI 207
+ L ++I A+ ++H + I+ +D+K IL D++ V K+ DF S+ +
Sbjct: 99 DE---DTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
Query: 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+ ++ + T Y++PE N+K+D++ G +L EL + +R
Sbjct: 153 ---SSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 38/158 (24%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
+NH N+L+ +G CIE+ +LV EF G L + + S G + ++A E+ +
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--SESEYIPEGETHVTSHMLTRTK 223
+ ++H + + D+ L K+ D+ + +Y PE + ++T
Sbjct: 112 GLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY-PE-DYYITKDCHAVPL 166
Query: 224 RYLAPEY-------ILTGLCNEKTDVFCFGMLLLELLT 254
R+LAPE +L +K++++ G+ + EL T
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 54/237 (22%), Positives = 99/237 (41%), Gaps = 44/237 (18%)
Query: 29 KLIISCDGKRNPIRSF------SAGELKIATNNYNGHQVIASEHYKLYKGFLENRPISVM 82
+L++S R + SF S G + IAT + G QV +
Sbjct: 12 QLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQV-------------------AV 52
Query: 83 KFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS 142
K D + FN +V +H N++ + + + +V EF+E G L D +
Sbjct: 53 KKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT- 111
Query: 143 PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF- 201
H E + + + + A++Y+H + ++ +DIK IL KLSDF
Sbjct: 112 -HTRMNEEQI----ATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFG 163
Query: 202 ---SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
S+ +P+ ++ L T ++APE I + D++ G++++E++ G
Sbjct: 164 FCAQVSKEVPKRKS------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 12/157 (7%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIA 160
VF NH ++ L C V EFV G L H L H +
Sbjct: 48 VFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMF-----HMQRQRKLPEEHARFYS 102
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHML 219
EI A+ ++H R I+++D+KL +L D KL+D+ E I G+T T
Sbjct: 103 AEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST---F 156
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE + D + G+L+ E++ GR
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 41/162 (25%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSP---HGPHLEPLLWRHRLKI 159
+ N ++++L+G + ++V E + G L R P + P L P + +++
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS------ESEYI-PEGET 212
A EI + MAY+ + V +D+ + E K+ DF E++Y G+
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+L R++APE + G+ K+DV+ FG++L E+ T
Sbjct: 182 -----LLP--VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
A Y+H R I+++D+K +L D KL DF ++ + G+ + T
Sbjct: 104 LAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y+APE IL + D + G+LL ELLTGR
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 47/220 (21%), Positives = 97/220 (44%), Gaps = 22/220 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS-----PHGPHLEPLLWRHRLKI 159
+ N ++++L+G + + +++ E + G L + S + P P + +++
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + MAY++ V +D+ + E K+ DF + I E + +
Sbjct: 125 AGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 181
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVD 279
R+++PE + G+ +DV+ FG++L E+ T L E + + N ++ V
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQGMSNEQVLRFVM 235
Query: 280 PIVVEDK--SCPEKEQQLQALLQLIFECVNESAGDRPTMV 317
+ DK +CP+ L +L+ C + RP+ +
Sbjct: 236 EGGLLDKPDNCPD------MLFELMRMCWQYNPKMRPSFL 269
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 49/176 (27%), Positives = 78/176 (44%), Gaps = 27/176 (15%)
Query: 87 NYSENGENFCFNNIV----FAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS 142
+YS N + +I+ F Q+ H N ++ GC + LV E+ G+ +D +
Sbjct: 49 SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDIL-- 105
Query: 143 PHGPHLEPLLWRHRLKIAMEIGNAM---AYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199
H +PL ++IA A+ AY+H R + +DIK IL E KL+
Sbjct: 106 --EVHKKPL---QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLA 157
Query: 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLEL 252
DF + + + V T ++APE IL G + K DV+ G+ +EL
Sbjct: 158 DFGSASLVSPANSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 36/103 (34%), Positives = 49/103 (47%), Gaps = 8/103 (7%)
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGET 212
R R A EI +A+ Y+H IV++D+K IL D L+DF E I + +T
Sbjct: 97 RARFYAA-EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T T YLAPE I + D +C G +L E+L G
Sbjct: 153 TTT---FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 17/156 (10%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
+ F Q+ H N ++ GC ++ LV E+ G+ +D + H +PL I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAI 126
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+AY+H ++ +DIK IL E KL+DF + + V
Sbjct: 127 THGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVG---- 179
Query: 220 TRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLEL 252
T ++APE IL G + K DV+ G+ +EL
Sbjct: 180 --TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 9e-06
Identities = 41/141 (29%), Positives = 63/141 (44%), Gaps = 13/141 (9%)
Query: 118 CIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR 176
C +T + LV E+V G L H L H A EI A+ ++H R
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMF-----HMQRQRKLPEEHARFYAAEICIALNFLH---ER 115
Query: 177 PIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLTRTKRYLAPEYILTGL 235
I+++D+KL +L D KL+D+ E + G+T T T Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST---FCGTPNYIAPEILRGEE 172
Query: 236 CNEKTDVFCFGMLLLELLTGR 256
D + G+L+ E++ GR
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 28/217 (12%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q +H NI+ L G +++ ++V E++E G+L D H + + + I
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVI---QLVGMLRGI 115
Query: 164 GNAMAYIH-IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG-ETHVTSHMLTR 221
+ M Y+ +G+ V +D+ IL + V K+SDF S + + E T+
Sbjct: 116 ASGMKYLSDMGY----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRD--NILLEHVKKHVENN-RLGEI 277
R+ APE I +DV+ +G+++ E+++ G R + + V K +E RL
Sbjct: 172 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAP 231
Query: 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP 314
+D CP AL QL+ +C + +RP
Sbjct: 232 MD--------CP------AALHQLMLDCWQKDRNERP 254
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 44/206 (21%), Positives = 76/206 (36%), Gaps = 61/206 (29%)
Query: 107 NHRNILKLIGCCIETEIPILVF-EFVEYGTL----------------------------- 136
NH N++ L+G C + P++V EF +YG L
Sbjct: 69 NHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMV 128
Query: 137 -------------ADRICSPHGPH----LEPL-----LWRHRLKI------AMEIGNAMA 168
A + S P P LW+ L + + ++ M
Sbjct: 129 EQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGME 188
Query: 169 YIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAP 228
++ R + +D+ IL E NV K+ DF + I + +V +++AP
Sbjct: 189 FLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245
Query: 229 EYILTGLCNEKTDVFCFGMLLLELLT 254
E I + ++DV+ FG+LL E+ +
Sbjct: 246 ESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 10/142 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + ++H R +V++D+K + IL DE+ ++SD + + + H +
Sbjct: 103 ATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 220 TRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV 278
T Y+APE + G + D F G +L +LL G + KH E +R+ V
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTV 214
Query: 279 DPIVVEDKSCPEKEQQLQALLQ 300
+ + + D PE + L+ LLQ
Sbjct: 215 N-VELPDSFSPELKSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 13/159 (8%)
Query: 105 QMNHRNILKLIGCCI--ETEIPILVFEFVEYGTLADRI--CSPHGPHL-EPLLWRHRLKI 159
++ H NI++ I + +V E+ E G LA I C ++ E +WR I
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----I 110
Query: 160 AMEIGNAMAYIHIGF--RRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
++ A+ H ++ +D+K + I D N KL DF ++ + + ++
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+ T Y++PE + +EK+D++ G L+ EL
Sbjct: 171 V--GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 10/142 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + ++H F +V++D+K + IL DE+ ++SD + + + H +
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---- 155
Query: 220 TRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV 278
T Y+APE + G+ + D F G +L +LL G + KH E +R+ +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTM 214
Query: 279 DPIVVEDKSCPEKEQQLQALLQ 300
+ + S PE L+ LLQ
Sbjct: 215 AVELPDSFS-PELRSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + ++H + IV++D+KL IL D K++DF + G+ +
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT--F 156
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE +L N D + FG+LL E+L G+
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 27/106 (25%), Positives = 50/106 (47%), Gaps = 3/106 (2%)
Query: 149 EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208
EPL + + ++ M ++ R + +D+ IL E NV K+ DF + I
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ +V +++APE I + ++DV+ FG+LL E+ +
Sbjct: 225 KDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 9/100 (9%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
+ E+ + +H +R I+ +DIK +L D+ KL+DF S E + V
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG-- 155
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T YLAPE IL ++ +D + G ++ E L G
Sbjct: 156 ----TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 5/96 (5%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI +A+ Y+H I+++D+K IL D L+DF + E T+
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTF 156
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T YLAPE + + D +C G +L E+L G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 31/151 (20%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
A +++ ++ +L+G C+ + + L+ + + +G L D + H + + ++ L ++I
Sbjct: 64 ASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQI 118
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
M Y+ R +V +D+ +L K++DF ++ + E +
Sbjct: 119 AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+++A E IL + ++DV+ +G+ + EL+T
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 8/94 (8%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
E+ A Y+H + I+++D+K +L D K++DF ++ +P+ + L
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-----RTFTLCG 177
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T YLAPE I + + D + G+LL E + G
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 43/190 (22%), Positives = 85/190 (44%), Gaps = 15/190 (7%)
Query: 75 ENRP--ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132
N+P ++V ++ ++N N I +++ NI++L+ CI ++ ++ E++E
Sbjct: 43 GNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYME 102
Query: 133 YGTLADRICSPHGPHLEPLL-------WRHRLKIAMEIGNAMAYI-HIGFRRPIVFKDIK 184
G L + H P + + +A +I + M Y+ + F V +D+
Sbjct: 103 NGDLNQFLSR-HEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF----VHRDLA 157
Query: 185 LSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244
L + K++DF S + G+ + R+++ E IL G +DV+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217
Query: 245 FGMLLLELLT 254
FG+ L E+LT
Sbjct: 218 FGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 15/160 (9%)
Query: 100 IVFAAQMNH---RNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
+ +Q+ NI K G ++ ++ E+ E G++ R GP E ++
Sbjct: 50 VALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAE----KYI 103
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
I E+ A+ YIH + ++ +DIK + IL KL DF + + + + ++
Sbjct: 104 SVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST 160
Query: 217 HMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG 255
T ++APE I G + K D++ G+ + E+ TG
Sbjct: 161 --FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 23/184 (12%)
Query: 76 NRPISVMKFGDNYSENGENFCFNNIV----FAAQMNHRNILKLIGCCIETEIPILVFEFV 131
+ +++ K +YS N + +I+ F ++ H N ++ GC + LV E+
Sbjct: 40 SEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97
Query: 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191
G+ +D + H +PL + +AY+H ++ +D+K IL
Sbjct: 98 -LGSASDLL----EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLS 149
Query: 192 EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGML 248
E + KL DF + + V T ++APE IL G + K DV+ G+
Sbjct: 150 EPGLVKLGDFGSASIMAPANXFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGIT 203
Query: 249 LLEL 252
+EL
Sbjct: 204 CIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 45/223 (20%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 110 NILKLIGCCIETEIPILVFEFVEYGTLAD-----RICSPHGPHLEPLLWRHRLKIAMEIG 164
++++L+G + + ++V E + +G L R + + P P + +++A EI
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
+ MAY++ + V +D+ + K+ DF + I E + + R
Sbjct: 130 DGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV--DPIV 282
++APE + G+ +D++ FG++L E+ + L E + + N ++ + V +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMDGGYL 240
Query: 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325
+ +CPE+ + L+++ C + RPT + L+
Sbjct: 241 DQPDNCPER---VTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHMLT 220
EI A+ ++H + IV++DIKL IL D L+DF S E++ E + S
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FC 167
Query: 221 RTKRYLAPEYILTGLCNEK-TDVFCFGMLLLELLTG 255
T Y+APE I + K D + G+L+ ELLTG
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 38/109 (34%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 148 LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEY 206
LEP R R A EI +A+ Y+H IV++D+K IL D L+DF E
Sbjct: 94 LEP---RARF-YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146
Query: 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
I E + T+ T YLAPE + + D +C G +L E+L G
Sbjct: 147 I---EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLT 220
EI A+ ++H ++ I+++D+K IL D KL+DF E I EG +H
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---VTHTFC 161
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T Y+APE ++ + D + G L+ ++LTG
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 8/96 (8%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI A+ Y+H + IV++D+K IL D+ KL+DF ++ + + L
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTL 158
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T YLAPE I + N+ D + G+L+ E+L G
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 31/97 (31%), Positives = 47/97 (48%), Gaps = 7/97 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG-ETHVTSHM 218
A E+ +A+ Y+H I+++D+K IL D L+DF + EG E T+
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTST 155
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T YLAPE + + D +C G +L E+L G
Sbjct: 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 12/159 (7%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I H ++KL+ +LV E++ L++ + P E +
Sbjct: 50 IKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKS----Y 104
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+ +AY+H I+ +D+K + +L V K++DF + E E + SH +
Sbjct: 105 MRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV 161
Query: 220 TRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGR 256
T+ Y APE +L G + D++ G + ELL G
Sbjct: 162 A-TRWYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 18/117 (15%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLT 220
EI +A+ Y+H +V++D+KL ++ D+ K++DF E I +G T T
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FC 156
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-----RDN------ILLEHVK 266
T YLAPE + D + G+++ E++ GR +D+ IL+E ++
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 15/106 (14%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
K+ + I A+ Y+ + ++ +D+K S IL D KL DF S + + +
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---- 171
Query: 218 MLTRTK---RYLAPEYILTGLCNEK----TDVFCFGMLLLELLTGR 256
TR+ Y+APE I N K DV+ G+ L+EL TG+
Sbjct: 172 --TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 17/156 (10%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
+ F ++ H N ++ GC + LV E+ G+ +D + H +PL I
Sbjct: 76 VKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL----EVHKKPLQEVEIAAI 130
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+AY+H ++ +DIK IL E KL+DF + + V
Sbjct: 131 THGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVG---- 183
Query: 220 TRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLEL 252
T ++APE IL G + K DV+ G+ +EL
Sbjct: 184 --TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 15/187 (8%)
Query: 92 GENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPL 151
GE+ N ++N + ++ L + LV + G L I + P E
Sbjct: 43 GESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE- 101
Query: 152 LWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211
L A EI + +H R V++D+K IL D+Y ++SD + IPEGE
Sbjct: 102 --ERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156
Query: 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG------RRDNILLEHV 265
+ T Y+APE + D + G L+ E++ G R++ + E V
Sbjct: 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
Query: 266 KKHVENN 272
+ V
Sbjct: 214 DRRVLET 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 14/154 (9%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM- 161
A++NH I+KL +TE + L+ +F+ G L R+ E + +K +
Sbjct: 53 AEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSK------EVMFTEEDVKFYLA 105
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
E+ A+ ++H I+++D+K IL DE KL+DF S+ + E S
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCG 160
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T Y+APE + + D + FG+L+ E+LTG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 14/105 (13%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
KIA+ A+ Y+ + I+ +D+K S IL D KL DF S + V S
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL------VDSI 162
Query: 218 MLTR---TKRYLAPEYILTGLCNE---KTDVFCFGMLLLELLTGR 256
TR + Y+APE I + ++DV+ G+ L E+ TG+
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 38/133 (28%), Positives = 59/133 (44%), Gaps = 8/133 (6%)
Query: 170 IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPE 229
+H + ++ +DIK + IL + KL DF S+ + T Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 230 YILTGLCNEKTDVFCFGMLLLELLTGRR--DNILLEHVKKHVENNRLGEIVDPIVVEDKS 287
++K D+F G+LL ELLT +R D +E V + L DP+
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM----HKTLAGRYDPL--PPSI 269
Query: 288 CPEKEQQLQALLQ 300
PE ++ + ALL
Sbjct: 270 SPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 42/180 (23%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 77 RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136
R ++V K D + FN +V H+N++++ + E ++ EF++ G L
Sbjct: 47 RQVAV-KMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 137 ADRICSPHGPHLEPLLWRHRLKIAME-IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195
D + + L ++ E + A+ Y+H + ++ +DIK IL
Sbjct: 106 TDIVS-------QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGR 155
Query: 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
KLSDF I + S L T ++APE I + D++ G++++E++ G
Sbjct: 156 VKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLT 220
EI +A+ Y+H + +V++D+KL ++ D+ K++DF E I +G T T
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT---FC 157
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T YLAPE + D + G+++ E++ GR
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 7/96 (7%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLT 220
EI +A+ Y+H R +V++DIKL ++ D+ K++DF E I +G T T
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT---FC 156
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T YLAPE + D + G+++ E++ GR
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 6/96 (6%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
EI A+ ++H + I+++DIKL IL D L+DF S+ E E ++
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCG 168
Query: 222 TKRYLAPEYILTGLC--NEKTDVFCFGMLLLELLTG 255
T Y+AP+ + G ++ D + G+L+ ELLTG
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 106 MNHRNILKLIGCCIE-TEIPILVF-EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H I++ GC + E + +F E++ G++ D++ +G E + K +I
Sbjct: 61 LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESV----TRKYTRQI 115
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES---EYIPEGETHVTSHMLT 220
M+Y+H IV +DIK + IL D KL DF S + I T + S +T
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VT 170
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T +++PE I K DV+ G ++E+LT +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 7/96 (7%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH-VTSHMLT 220
EI +A+ Y+H G IV++D+KL ++ D+ K++DF + EG T T
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFC 156
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T YLAPE + D + G+++ E++ GR
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 52/241 (21%), Positives = 87/241 (36%), Gaps = 49/241 (20%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD-----RICSPHGPHLEPLLWR 154
+ ++++ NI +L+G C ++ E++E G L + L
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSF 129
Query: 155 HRLK-IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE-------Y 206
L +A +I + M Y+ V +D+ L + K++DF S Y
Sbjct: 130 STLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186
Query: 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV 265
+G L R++A E +L G K+DV+ FG+ L E+LT R
Sbjct: 187 RVQGRA-----PL--PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-------- 231
Query: 266 KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQ-----------LIFECVNESAGDRP 314
+ D V+E+ ++ Q L L+ EC DRP
Sbjct: 232 ------QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP 285
Query: 315 T 315
T
Sbjct: 286 T 286
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 33/118 (27%), Positives = 56/118 (47%), Gaps = 12/118 (10%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + +H + IV++D+K IL D++ ++SD + ++PEG+T
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--- 161
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG------RRDNILLEHVKKHVEN 271
T Y+APE + D + G LL E++ G R+ I E V++ V+
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 9e-05
Identities = 35/151 (23%), Positives = 71/151 (47%), Gaps = 8/151 (5%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
A M+H ++++L+G C+ I LV + + +G L D + H + + + L ++I
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHE----HKDNIGSQLLLNWCVQI 118
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
M Y+ R +V +D+ +L N K++DF + + E +
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+++A E I ++DV+ +G+ + EL+T
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 38/163 (23%), Positives = 74/163 (45%), Gaps = 19/163 (11%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
FN +V H N++++ + + +V EF+E G L D + H E +
Sbjct: 65 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQI---- 118
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF----SESEYIPEGET 212
+ + + A++ +H + ++ +DIK IL KLSDF S+ +P ++
Sbjct: 119 AAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 175
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
L T ++APE I + D++ G++++E++ G
Sbjct: 176 ------LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 9/103 (8%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
KIA+ I A+ Y+H + ++ +D+K S +L + KL DF S Y+ + V
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 218 MLTRTKRYLAPEYILTGL----CNEKTDVFCFGMLLLELLTGR 256
+ K Y+APE I L + K+DV+ G+ ++EL TGR
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 36/246 (14%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
I +K G Y+E + Q +H NI+ L G ++ +++ EF+E G L D
Sbjct: 37 IKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGAL-D 93
Query: 139 RICSPHGPHLEPLLWRHRLK-IA--MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195
+ + L+ IA M+ + M Y+H +D+ IL + V
Sbjct: 94 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH---------RDLAARNILVNSNLV 144
Query: 196 AKLSDFSESEYIPEGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLEL 252
K+SDF S ++ + + T K R+ APE I +DV+ +G+++ E+
Sbjct: 145 CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204
Query: 253 LT-GRRD--NILLEHVKKHVENN-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNE 308
++ G R ++ + V +E + RL +D CP AL QL+ +C +
Sbjct: 205 MSYGERPYWDMSNQDVINAIEQDYRLPPPMD--------CP------TALHQLMLDCWQK 250
Query: 309 SAGDRP 314
RP
Sbjct: 251 DRNARP 256
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218
I EI + Y+H + +DIK + +L E+ KL+DF + + + T + +
Sbjct: 106 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNT 160
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV---ENNRLG 275
T ++APE I + K D++ G+ +EL G + L +K +NN
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--- 217
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
P + + S P KE + C+N+ RPT AK+L
Sbjct: 218 ---PPTLEGNYSKPLKE--------FVEACLNKEPSFRPT----AKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 17/155 (10%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEY---GTLADRICSPHGPHLEPLLWRHRLKIAME 162
+ H I++ GC + E L FVEY G++ D++ +G E + R+ +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSI-FVEYMPGGSIKDQL-KAYGALTENVTRRY----TRQ 114
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE---GETHVTSHML 219
I ++Y+H IV +DIK + IL D KL DF S+ I T + S +
Sbjct: 115 ILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--V 169
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
T T +++PE I K DV+ ++E+LT
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 5/98 (5%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
EI + Y+H + +DIK + +L E KL+DF + + + T + +
Sbjct: 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVG 163
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN 259
T ++APE I + K D++ G+ +EL G N
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 37/166 (22%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRIC--SPHG------------PHLE 149
+++ H NI+ L+G + + ++F + + L + + SPH LE
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 150 PLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL-FDEYNVAKLSDFSESEYIP 208
P + H I +I M ++ +V KD+ +L FD+ NV K+SD +
Sbjct: 123 PADFVH---IVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV-KISDLGLFREVY 175
Query: 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ + R+++PE I+ G + +D++ +G++L E+ +
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 3e-04
Identities = 26/90 (28%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYL 226
+ Y+H + +DIK IL +E AKL+DF S + +T + + T ++
Sbjct: 112 LEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWM 166
Query: 227 APEYILTGLCNEKTDVFCFGMLLLELLTGR 256
APE I N K D++ G+ +E+ G+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHM 218
A E+ A+ ++H R ++++D+KL IL D KL+DF E I G T T
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT--- 155
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE + D + G+L+ E++ G+
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 40/154 (25%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG---PHLEPLLWRHRLKIA 160
+ M H NI++ E +V ++ E G L +I + G P + L W
Sbjct: 54 SNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------F 107
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
++I A+ ++H R I+ +DIK I + KL DF + + T +
Sbjct: 108 VQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCI 162
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
T YL+PE N K+D++ G +L E+ T
Sbjct: 163 GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 7/98 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + ++H + I+++D+KL ++ D K++DF + G+ ++
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--F 156
Query: 220 TRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGR 256
T Y+APE IL GL D + FG+LL E+L G+
Sbjct: 157 CGTPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|233672 TIGR01989, COQ6, ubiquinone biosynthesis monooxygenase COQ6 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 3e-04
Identities = 22/77 (28%), Positives = 36/77 (46%), Gaps = 9/77 (11%)
Query: 20 LRNGKILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQVIASEHYKLYKG------- 72
L +G++L KL+I DG + +R + + NYN H V+A+ +
Sbjct: 164 LSDGQVLYTKLLIGADGSNSNVRKAA--NIDTTGWNYNQHAVVATLKLEEATENDVAWQR 221
Query: 73 FLENRPISVMKFGDNYS 89
FL PI+++ DN S
Sbjct: 222 FLPTGPIALLPLPDNNS 238
|
This model represents the monooxygenase responsible for the 4-hydroxylateion of the phenol ring in the aerobic biosynthesis of ubiquinone. Length = 437 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 35/150 (23%), Positives = 74/150 (49%), Gaps = 10/150 (6%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
++H I++L+G C + LV + G+L D + H L+P L ++I
Sbjct: 66 LDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHV-RQHRDSLDPQRL---LNWCVQIAK 120
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI-PEGETHVTSHMLTRTKR 224
M Y+ +V +++ IL ++ +++DF ++ + P+ + + S T K
Sbjct: 121 GMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK- 176
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
++A E IL G ++DV+ +G+ + E+++
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 15/172 (8%)
Query: 90 ENGENFCFN---NIVFAAQMNHRNILKLIGCCIE---TEIPILVFEFVEYGTLADRICSP 143
E+G N + I + H NI+K G C E I L+ EF+ G+L + + P
Sbjct: 44 ESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYL--P 100
Query: 144 HGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203
+ L + +LK A++I M Y+ R V +D+ +L + + K+ DF
Sbjct: 101 RNKNKINL--KQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 155
Query: 204 SEYIPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
++ I + + T L + APE ++ +DV+ FG+ L ELLT
Sbjct: 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 3/106 (2%)
Query: 149 EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208
+ L + + ++ M ++ R + +D+ IL E NV K+ DF + I
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 230
Query: 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ +V +++APE I + ++DV+ FG+LL E+ +
Sbjct: 231 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 12/153 (7%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS---PHGPHLEPLLWRHRLKIAM 161
Q+ H NI++ +E + +V + +E L + S E +W I +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFV 120
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
++ A+ Y+H + IV +D+ + I+ E + ++DF ++ E+ +TS +
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTS--VVG 175
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
T Y PE + EK DV+ FG +L ++ T
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 40/132 (30%), Positives = 60/132 (45%), Gaps = 11/132 (8%)
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
LVFE+VE L P+G E K+ I + IH + IV +DIK
Sbjct: 77 LVFEYVEKNMLELLEEMPNGVPPE--------KVRSYIYQLIKAIHWCHKNDIVHRDIKP 128
Query: 186 SQILFDEYNVAKLSDFSESEYIPEG-ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244
+L +V KL DF + + EG + T ++ TR Y +PE +L + D++
Sbjct: 129 ENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRW--YRSPELLLGAPYGKAVDMWS 186
Query: 245 FGMLLLELLTGR 256
G +L EL G+
Sbjct: 187 VGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 39/194 (20%), Positives = 85/194 (43%), Gaps = 11/194 (5%)
Query: 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE----- 122
K G + + ++K S + E F + +H N++KLIG + +
Sbjct: 21 KSEDGSFQKVAVKMLKADIFSSSDIEEF-LREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79
Query: 123 -IPILVFEFVEYGTL-ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVF 180
IP+++ F+++G L + S G L + ++ ++I + M Y+ + +
Sbjct: 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIH 136
Query: 181 KDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKT 240
+D+ + +E ++DF S+ I G+ + ++LA E + + +
Sbjct: 137 RDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHS 196
Query: 241 DVFCFGMLLLELLT 254
DV+ FG+ + E++T
Sbjct: 197 DVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H NI+ L ++ L+FEF+ P G +++ L + L +I
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY---QIL 111
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--SESEYIPEGETHVTSHMLTRT 222
+ + H R ++ +D+K +L D V KL+DF + + IP V +H + T
Sbjct: 112 QGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---VRVYTHEVV-T 164
Query: 223 KRYLAPEYILTGLCNEKT--DVFCFGMLLLELLTGR 256
Y APE +L G T D++ G + E+ T +
Sbjct: 165 LWYRAPE-VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 23/159 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVE---YGTLADRICSPHGPHLEPLLWRHRLKIAM 161
++NH NI+KL+ LVFEF++ Y + DR ++ L+
Sbjct: 54 ELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY-------- 105
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--SESEYIPEGE-THVTSHM 218
++ +A+ H I+ +D+K +L + V KL+DF + S P TH
Sbjct: 106 QLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-- 160
Query: 219 LTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGR 256
T+ Y APE +L + D++ G + ELL+ R
Sbjct: 161 ---TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 36/121 (29%), Positives = 59/121 (48%), Gaps = 16/121 (13%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + +H R IV++D+K IL D+Y ++SD + IPEGET +
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-----IR 159
Query: 220 TR--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG------RRDNILLEHVKKHVEN 271
R T Y+APE + D + G L+ E++ G R++ + E V++ V+
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE 219
Query: 272 N 272
+
Sbjct: 220 D 220
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 36/177 (20%), Positives = 78/177 (44%), Gaps = 8/177 (4%)
Query: 78 PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLA 137
P+++ +N S + A + + +L+G C+ + + LV + + YG L
Sbjct: 38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLL 96
Query: 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197
D + + + + + L ++I M+Y+ +V +D+ +L N K
Sbjct: 97 DYV----RENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVK 149
Query: 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
++DF + + ET + +++A E IL ++DV+ +G+ + EL+T
Sbjct: 150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 108 HRNILKLIGCCIET-EIPILVF-EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
H I++ GC + E + +F E + G++ D++ S +G E + ++ +I
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS-YGALTENVTRKY----TRQILE 117
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM-LTRTKR 224
++Y+H IV +DIK + IL D KL DF S+ + T +T T
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+++PE I K D++ G ++E+LT +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 31/105 (29%), Positives = 50/105 (47%), Gaps = 9/105 (8%)
Query: 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG 234
R IV++D+K IL D+ ++SD + IPEGE T T Y+APE I
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNE 176
Query: 235 LCNEKTDVFCFGMLLLELLTG------RRDNILLEHVKKHVENNR 273
D + G L+ E++ G R++ + E V + V+ ++
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 8e-04
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 25/163 (15%)
Query: 107 NHRNILKLIGCCIETEIP------ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIA 160
+HRNI G I+ P LV EF G++ D I + G L+ + I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY---IC 117
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
EI ++++H + ++ +DIK +L E KL DF S + T +
Sbjct: 118 REILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFI 172
Query: 221 RTKRYLAPEYILTGLCNE--------KTDVFCFGMLLLELLTG 255
T ++APE I C+E K+D++ G+ +E+ G
Sbjct: 173 GTPYWMAPEVI---ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 106 MNHRNILKLIGCCIETEIP--ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H NI+K G C LV E++ YG+L D + H E L R L A +I
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK----HRERLDHRKLLLYASQI 117
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG-ETHVTSHMLTRT 222
M Y+ G +R V +D+ IL + N K+ DF ++ +P+ E +
Sbjct: 118 CKGMEYL--GSKR-YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP 174
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ APE + + +DV+ FG++L EL T
Sbjct: 175 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 42/154 (27%), Positives = 67/154 (43%), Gaps = 15/154 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLK-IAMEI 163
Q+ H N++ LI LVFE+ ++ L + +P G + H +K I +
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG------VPEHLIKKIIWQT 109
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
A+ + H + + +D+K IL + KL DF + + T ++ TR
Sbjct: 110 LQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW- 165
Query: 224 RYLAPEYILTG--LCNEKTDVFCFGMLLLELLTG 255
Y APE +L G DV+ G + ELLTG
Sbjct: 166 -YRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 41/159 (25%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 106 MNHRNILKLIGCCIETEIPIL-VFEFVEYGTLADRICSP--HGPHLEPLLWRHRLKIAME 162
+ H NIL+ +G C+E IP L VFE+ E G L + H + + LL + ++A E
Sbjct: 52 LQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQ-ILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
I + ++H + + D+ L L + V K+ D+ + + T
Sbjct: 108 IAAGVTHMH---KHNFLHSDLALRNCFLTSDLTV-KVGDYGIGPSRYKEDYIETEDDKCV 163
Query: 222 TKRYLAPEYI-------LTGLCNEKTDVFCFGMLLLELL 253
R+LAPE + +T + ++V+ G+ L EL
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.001
Identities = 31/102 (30%), Positives = 46/102 (45%), Gaps = 15/102 (14%)
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218
I E+ + Y+H + +DIK + IL E KL+DF S +TS M
Sbjct: 103 ILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTM 152
Query: 219 LTR-----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
R T ++APE I +EK D++ G+ +EL G
Sbjct: 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.002
Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 21/156 (13%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
H NI+KL E + VFE++E G L + G + R I +I
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRS---IIYQILQG 111
Query: 167 MAYIH-IGFRRPIVF-KDIKLSQILFDEYNVAKLSDFS---ESEYIPEGETHVTSHMLTR 221
+A+IH GF F +D+K +L V K++DF E P +V+
Sbjct: 112 LAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS------ 160
Query: 222 TKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGR 256
T+ Y APE +L + + D++ G ++ EL T R
Sbjct: 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 25/99 (25%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
K+++ + +AY+ + I+ +D+K S IL + KL DF S + + ++
Sbjct: 107 KVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T+ Y++PE + + ++D++ G+ L+EL GR
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 9/141 (6%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I + YIH I+ +D+K S + +E K+ DF + + + +T ++ TR
Sbjct: 128 QILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATR 181
Query: 222 TKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280
Y APE +L + N+ D++ G ++ ELLTGR +H+ + RL
Sbjct: 182 W--YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 281 IVVEDKSCPEKEQQLQALLQL 301
+++ S +Q+L Q+
Sbjct: 240 ELLKKISSESARNYIQSLTQM 260
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 46/235 (19%), Positives = 97/235 (41%), Gaps = 35/235 (14%)
Query: 102 FAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
Q+++ I+++IG C E E +LV E + GP L L + +I +
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEM-----------ASGGP-LNKFLSGKKDEITV 94
Query: 162 E-IGNAMAYIHIGFR----RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ M + +G + + V +D+ +L + AK+SDF S+ + +++ +
Sbjct: 95 SNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154
Query: 217 HMLTRTK-RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENN 272
+ ++ APE I + ++DV+ +G+ + E + G++ ++ V +E
Sbjct: 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214
Query: 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ + CP + L+ +C DRP +++R Y
Sbjct: 215 KRLDC-------PAECPP------EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 53 TNNYNG-HQVIASEHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI 111
TN Y G +V + + V+K + + F F +Q++H+++
Sbjct: 9 TNIYKGVLRVQSDLDIVGPGQEVSV----VLKVLGSDHRDSLAF-FETASLMSQLSHKHL 63
Query: 112 LKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIH 171
+KL G C+ E I+V E+V++G L D ++ L W +L +A ++ +A+ Y+
Sbjct: 64 VKLYGVCVRDE-NIMVEEYVKFGPL-DVFLHREKNNV-SLHW--KLDVAKQLASALHYLE 118
Query: 172 IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE-SEYIPEGETHVTSHMLTRTKR-----Y 225
+ +V ++ IL VA+ +I + + +L+R +R +
Sbjct: 119 ---DKKLVHGNVCGKNIL-----VARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPW 170
Query: 226 LAPEYILTGLCN--EKTDVFCFGMLLLEL 252
+APE I G + D + FG LLE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 40/171 (23%), Positives = 58/171 (33%), Gaps = 35/171 (20%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG--TLADRICSPHGPHLEPLLWRHRL 157
I ++HR I+ LI +V + T DR PL +
Sbjct: 137 IDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS--------GPLPLEQAI 188
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF------SESEYIPE-- 209
I + A+AY+H R I+ +D+K I DE A L DF P+
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245
Query: 210 ---GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
G S L Y A KTD++ G++L E+
Sbjct: 246 GWSGTLETNSPELLALDPYCA-----------KTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 27/105 (25%), Positives = 49/105 (46%), Gaps = 17/105 (16%)
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS-------ESEYIPE 209
+ + ++ N M ++ + V +D+ +L E + K+ DF +S YI +
Sbjct: 242 VGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK 298
Query: 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
G T + +++APE I L +DV+ FG+LL E+ T
Sbjct: 299 GSTFLPL-------KWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.002
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 5/110 (4%)
Query: 150 PLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209
PL + I EI + Y+H + + +DIK + +L E KL+DF + + +
Sbjct: 97 PLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153
Query: 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN 259
T + + T ++APE I + K D++ G+ +EL G N
Sbjct: 154 --TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
+V F E G L ++ G + L ++ ++I A+ Y+H + I+ +D+K
Sbjct: 77 IVMGFCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKT 130
Query: 186 SQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCF 245
+ N+ K+ D + + E + + S L T Y++PE N K+DV+
Sbjct: 131 QNVFLTRTNIIKVGDLGIARVL-ENQCDMAS-TLIGTPYYMSPELFSNKPYNYKSDVWAL 188
Query: 246 GMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFEC 305
G + E+ T KH N + + ++E K P + L +LI
Sbjct: 189 GCCVYEMAT-----------LKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATM 237
Query: 306 VNESAGDRPTMVYAAKQLRQMYL 328
+++ RP++ LRQ Y+
Sbjct: 238 LSKRPEKRPSV---KSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 23/79 (29%), Positives = 40/79 (50%), Gaps = 3/79 (3%)
Query: 178 IVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCN 237
IV++D+K +L D+ +LSD + + +G+T +T T Y+APE + +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQR--AGTNGYMAPEILKEEPYS 172
Query: 238 EKTDVFCFGMLLLELLTGR 256
D F G + E++ GR
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.002
Identities = 33/161 (20%), Positives = 75/161 (46%), Gaps = 13/161 (8%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I A++NH +I++++G E L E++ G+++ + S +G E ++ + ++
Sbjct: 54 IRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVS-HLLSKYGAFKEAVIINYTEQL 112
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESEYIPE---GETHVT 215
++Y+H I+ +D+K + +L D +++DF + + G
Sbjct: 113 LR----GLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+L T ++APE + DV+ G +++E+ T +
Sbjct: 166 GQLLG-TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 36/173 (20%)
Query: 98 NNIVFAAQMNHRNILK-----LIGC--CIETEIPILVFEFVEYGTLADRICSPHG---PH 147
N I A +NH NI+ L G CI V E+ +G L+ I
Sbjct: 48 NEIRILASVNHPNIISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLI 100
Query: 148 LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207
E +WR +++ + +H + I+ +D+K + IL ++ K+ D
Sbjct: 101 PEQEIWRIFIQLLR----GLQALH---EQKILHRDLKSANILLVANDLVKIGDL------ 147
Query: 208 PEGETHVTSHMLTRTK----RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
G + V + +T+ Y+APE + K+D++ G LL E+ T
Sbjct: 148 --GISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.57 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.5 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.29 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.13 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.98 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.96 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.82 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.74 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.71 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.48 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.41 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.19 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.16 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.07 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.06 | |
| PLN02236 | 344 | choline kinase | 96.79 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.77 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.72 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.41 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.33 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.31 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.28 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.27 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.75 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.6 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.55 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.54 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.52 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 94.71 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.67 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.18 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.17 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=416.02 Aligned_cols=279 Identities=39% Similarity=0.649 Sum_probs=243.7
Q ss_pred CccccCHHHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeE
Q 020078 40 PIRSFSAGELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC 117 (331)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 117 (331)
+.+.|++.++..+|++|+..++||+ |||.||+|.. ++..||||++.....+. ..+|.+|+.++.+++|||+|+|+||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence 6778999999999999999999999 9999999999 55899999887765432 5669999999999999999999999
Q ss_pred EeeCC-ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 118 CIETE-IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 118 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
|.+.+ ..+|||||+++|+|.++++..... +++|.+|++||.++|+||+|||+.+..+||||||||+|||+|+++++
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 99998 499999999999999999876432 78999999999999999999998888899999999999999999999
Q ss_pred EEccCCCccccCC-CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCC---------hhHHHHH
Q 020078 197 KLSDFSESEYIPE-GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN---------ILLEHVK 266 (331)
Q Consensus 197 kl~Dfg~a~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~---------~~~~~~~ 266 (331)
||+|||+|+..+. ........ .||.+|+|||++..+..+.|+|||||||+|.|+++|+.+. ....|..
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~--~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTV--MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EccCccCcccCCccccceeeec--CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 9999999977654 22211110 5999999999999999999999999999999999999754 2577888
Q ss_pred HHhhcccccccccccccc-CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 267 KHVENNRLGEIVDPIVVE-DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.........+++|+.+.. .... . .....+..++.+|++.+|++||+|.||++.|+.+.
T Consensus 295 ~~~~~~~~~eiiD~~l~~~~~~~-~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLEEGKLREIVDPRLKEGEYPD-E--KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHHCcchhheeCCCccCCCCCh-H--HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 888888999999999874 3221 1 45667999999999999999999999999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=378.70 Aligned_cols=251 Identities=25% Similarity=0.361 Sum_probs=205.9
Q ss_pred ccCceee-cCcEEEEEEeCCce-EEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-ccEEEEEecCC
Q 020078 58 GHQVIAS-EHYKLYKGFLENRP-ISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETE-IPILVFEFVEY 133 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~~~~~-vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~ 133 (331)
....+|. +||+||+|.+.|.. ||||++...... ...+.|.+|+.+|.+++|||||+++|+|.++. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3445999 99999999998888 999999865332 22669999999999999999999999999987 78999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeeCCCCCCceEEcCCC-ceEEccCCCccccCCCC
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP-IVFKDIKLSQILFDEYN-VAKLSDFSESEYIPEGE 211 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~~ 211 (331)
|+|.+++.... ...+++..++.++.|||+|+.||| +.+ ||||||||+|+|++.++ ++||+|||+++......
T Consensus 125 GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 125 GSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 99999998741 157999999999999999999999 777 99999999999999997 99999999998765432
Q ss_pred ccccccccCCCCcccchhhhc--cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccccccccccccccCC
Q 020078 212 THVTSHMLTRTKRYLAPEYIL--TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 286 (331)
... ....||+.|||||++. ...|+.|+||||||+++|||+||+.||....... ..........+ +
T Consensus 199 ~~~--~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~-------p- 268 (362)
T KOG0192|consen 199 TSM--TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI-------P- 268 (362)
T ss_pred ccc--cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC-------C-
Confidence 111 1134999999999999 5589999999999999999999999985443322 11112111111 1
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..+++.+..|++.||..||+.||++.+++..|+.+...
T Consensus 269 -----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 269 -----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred -----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 12345799999999999999999999999999988653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-52 Score=363.13 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=209.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc-cEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI-PILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~ 130 (331)
+.+..+.||+ ..|+||+++. ++..+|+|.+..+......+++.+|+++++..+||+||.+||+|..+.. ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 3444567999 6669999999 7899999999776666678899999999999999999999999999984 9999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|.+|||.+++... ..+++...-+++.++++||.|||. ..+||||||||+|+|+...|.+||+|||.++.+.+.
T Consensus 160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999988765 348899999999999999999994 389999999999999999999999999999887655
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC-CCCc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED-KSCP 289 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 289 (331)
.+.+.+||..|||||-+.+..|+.++||||||++++|+.+|+.|+.... -......++++.+..++ +..|
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~-----~~~~~~~~Ll~~Iv~~ppP~lP 303 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN-----PPYLDIFELLCAIVDEPPPRLP 303 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC-----CCCCCHHHHHHHHhcCCCCCCC
Confidence 3334679999999999999999999999999999999999999975530 00111122333333322 2333
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. .+++++++++..||++||.+|||+.|++..
T Consensus 304 ~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 304 EG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 32 478899999999999999999999999763
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-51 Score=369.29 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=211.1
Q ss_pred ccCceee-cCcEEEEEEeCCc-eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 58 GHQVIAS-EHYKLYKGFLENR-PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
-.+.||+ -||+||.|.+++. .||+|.+..... ..+.|.+|+.+|++|+|+|||+++|+|..+..++||||||+.|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3456999 8999999999766 999999987532 35789999999999999999999999999889999999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 215 (331)
|.++|...++ ..+...+.+.++.|||+|++||+ ++++|||||.+.|||++++..+||+|||+|+...++.....
T Consensus 288 Ll~yLr~~~~---~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 288 LLDYLRTREG---GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred HHHHhhhcCC---CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 9999987433 45788899999999999999999 99999999999999999999999999999996665554433
Q ss_pred ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCC--hhHHHHHHHhhccccccccccccccCCCCchHH
Q 020078 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDN--ILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
.. ..-+..|.|||.+..+.++.|||||||||+|||++| |+.|+ .....+.+.+..+.. +..+..||.
T Consensus 362 ~~-~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR-------lp~P~~CP~-- 431 (468)
T KOG0197|consen 362 EG-GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR-------LPRPEGCPD-- 431 (468)
T ss_pred CC-CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc-------CCCCCCCCH--
Confidence 32 225788999999999999999999999999999999 67665 333444444443332 344555554
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 293 QQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
++.++|..||+.+|++||||..+...|+.+..+
T Consensus 432 ----~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 432 ----EVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ----HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 799999999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-51 Score=374.04 Aligned_cols=247 Identities=18% Similarity=0.279 Sum_probs=212.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..|...++||+ ||..||.++. .|+.||+|.+.+. .+....+...+||+|.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45889999999 9999999998 8999999999874 33345788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|+|++|+|..++..+ +++++.++..++.||+.||.||| +.+|+|||||..|++++++.++||+|||+|..+.
T Consensus 98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999988743 67999999999999999999999 9999999999999999999999999999999886
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
....- ..+.+|||.|.|||++....++..+||||+||++|-|+.|++||....... ..+.+...++..
T Consensus 170 ~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke----------ty~~Ik~~~Y~~ 237 (592)
T KOG0575|consen 170 YDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE----------TYNKIKLNEYSM 237 (592)
T ss_pred Ccccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH----------HHHHHHhcCccc
Confidence 54322 223679999999999998899999999999999999999999985432211 112222334444
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
|. ..+.++.+||.++|+.||.+|||+++|+..
T Consensus 238 P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 PS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 44 677789999999999999999999999863
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=354.04 Aligned_cols=250 Identities=20% Similarity=0.234 Sum_probs=203.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcc------hhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSEN------GENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
..+.|...+.+|+ +||.|-+|.. +++.||||++.+..... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4566778889999 8999999987 89999999998653321 2234579999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEc
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLS 199 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~ 199 (331)
..|+||||+.+|+|.+++-.. ..+.+..-..++.|++.|+.||| +.+|+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999765 34666667889999999999999 9999999999999999765 789999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCC---CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL---CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE 276 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 276 (331)
|||+|+....... ..+++||+.|.|||++.... +..++|+||+||+||-+++|.+||........
T Consensus 322 DFGlAK~~g~~sf---m~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--------- 389 (475)
T KOG0615|consen 322 DFGLAKVSGEGSF---MKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--------- 389 (475)
T ss_pred ccchhhcccccee---hhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---------
Confidence 9999998864433 23377999999999998664 34588999999999999999999743221110
Q ss_pred ccccccccC--CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 IVDPIVVED--KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+++..+. +..+.+...+++..+||.+||..||++|||+.|+++
T Consensus 390 l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 390 LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 111222222 223455688899999999999999999999999976
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=346.12 Aligned_cols=246 Identities=21% Similarity=0.358 Sum_probs=200.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
-.+|.....||. .|++||+|+. ++..||||.+.... ..+..+.+..|+.+|+.++|||||.|++++.+++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356888888999 9999999998 78999999998663 4556778889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC------CceEEccCC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY------NVAKLSDFS 202 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~------~~~kl~Dfg 202 (331)
|||.+|+|.++++..+ .+++..+..++.|+|.||.+|| +++||||||||+|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 9999999999998763 5889999999999999999999 9999999999999999865 568999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhcccccccccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDP 280 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 280 (331)
+|+.+...... .+.+|++.|||||++....|+.|+|+||+|++||++++|+.||...... ...++.+.. ++ +
T Consensus 161 fAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~--~~-~ 234 (429)
T KOG0595|consen 161 FARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNE--IV-P 234 (429)
T ss_pred hhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccc--cc-C
Confidence 99998754332 2367999999999999999999999999999999999999998533322 222221111 10 0
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl 320 (331)
.. +...++.+.+|+...++.+|.+|.++.+-.
T Consensus 235 ~~--------~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 235 VL--------PAELSNPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred ch--------hhhccCchhhhhhHHHhcCccccCchHHhh
Confidence 00 113333466777777778877777765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=339.31 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=206.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEe-EEeeCCc-cEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIG-CCIETEI-PILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~-~~~~~~~-~~lv 127 (331)
.+|.+.++||. +||+||++.. ++..+|.|.++-. -..+..+....|+.+|++|+|||||++++ .+.+++. .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 34777788999 9999999988 8999999998854 33345778889999999999999999998 5555555 8999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-CCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG-FRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||..|+|...+....... +.+++..+++++.|+++||.++|.. ....|.||||||.||+++.+|.+||+|||++++
T Consensus 99 mE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999887432222 5689999999999999999999931 123499999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
+....+. ..+.+|||.||+||.+...+|+.+|||||+||++|||+....||...+... ... .+-.+++
T Consensus 178 l~s~~tf--A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~-L~~---------KI~qgd~ 245 (375)
T KOG0591|consen 178 LSSKTTF--AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS-LCK---------KIEQGDY 245 (375)
T ss_pred hcchhHH--HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH-HHH---------HHHcCCC
Confidence 8665443 334679999999999999999999999999999999999999986543221 111 1112232
Q ss_pred C-CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 287 S-CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 287 ~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
+ +|.. ..+.++..||..|+..||+.||+...++..+.
T Consensus 246 ~~~p~~-~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 PPLPDE-HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCcHH-HhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 2 4432 77888999999999999999999655555443
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.00 Aligned_cols=246 Identities=16% Similarity=0.224 Sum_probs=198.6
Q ss_pred ccCceee-cCcEEEEEEeCCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEee----CCccEEEEEe
Q 020078 58 GHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEIPILVFEF 130 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~ 130 (331)
....+|+ +++.||+|.++++.||+|.+...... ...+.+.+|+.+|.+++|||||+++|++.+ ....++||||
T Consensus 24 ~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 24 TSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 3467888 99999999999999999998764332 124678899999999999999999999977 3467899999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
+++|+|.+++... ..+++.....++.+++.||.||| . .+++||||||+||+++.++.+||+|||+++....
T Consensus 104 ~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 104 CTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred CCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 9999999999754 35788999999999999999999 6 4888999999999999999999999999886543
Q ss_pred CCccccccccCCCCcccchhhhcc--CCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT--GLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 285 (331)
.... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........
T Consensus 176 ~~~~-----~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~----------- 239 (283)
T PHA02988 176 PPFK-----NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN----------- 239 (283)
T ss_pred cccc-----ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 3221 237899999999975 6899999999999999999999999853321 1111111110
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+.+...+.++.+|+.+||+.||++|||+.|++..|+.++.
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 000111234579999999999999999999999999998763
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=362.73 Aligned_cols=259 Identities=23% Similarity=0.365 Sum_probs=215.3
Q ss_pred cCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+..-...||+ .||+||+|... ...||||.++........++|.+|+++++.|+|||||+|+|+|.++++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 34444567999 99999999982 35699999998877668899999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 126 LVFEFVEYGTLADRICSPHGPH---------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
+|+|||..|||.++|....... ..+++..+.+.||.|||.|+.||- +.+.|||||..+|+||.++..+
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEE
Confidence 9999999999999998643211 234888999999999999999999 9999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh--HHHHHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL--LEHVKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~--~~~~~~~~~~~~ 273 (331)
||+|||+++.+=..+.+.....-.-++.|||||.+.+++||++||||||||+|||+++ |+.|+.. .+.+-+.+.+++
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 9999999986533333322211124778999999999999999999999999999998 8889843 445555555544
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
. +..+..|| .++.+||..||+.+|++|||++||-..|++.-+
T Consensus 723 l-------L~~Pe~CP------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 723 L-------LSCPENCP------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred c-------ccCCCCCC------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 3 23344444 479999999999999999999999999988654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=344.57 Aligned_cols=262 Identities=18% Similarity=0.349 Sum_probs=206.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETE 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 122 (331)
..++|...+.||+ +||.||+|.. .+..||+|.+...........+.+|+.++..+ +||||++++++|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888899999 9999999974 34679999987654444567899999999999 8999999999987644
Q ss_pred -ccEEEEEecCCCChhhhhcCCCCC-------------------------------------------------------
Q 020078 123 -IPILVFEFVEYGTLADRICSPHGP------------------------------------------------------- 146 (331)
Q Consensus 123 -~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 146 (331)
..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999988653210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCc
Q 020078 147 --HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224 (331)
Q Consensus 147 --~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 224 (331)
...++++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++...............+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0134778889999999999999999 89999999999999999999999999999986644333222222336788
Q ss_pred ccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH---HHHHhhccccccccccccccCCCCchHHHHHHHHHH
Q 020078 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH---VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQ 300 (331)
Q Consensus 225 y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (331)
|+|||++....++.++||||||+++|||++ |..||..... .......... ...+ ...++++.+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~------~~~~~~l~~ 308 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-------MRAP------ENATPEIYR 308 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-------CCCC------CCCCHHHHH
Confidence 999999998899999999999999999997 9988743221 1111111110 0001 123457999
Q ss_pred HHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 301 LIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 301 li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
|+.+||+.||++|||+.|+++.|+.+..+
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=330.08 Aligned_cols=241 Identities=20% Similarity=0.252 Sum_probs=201.6
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|+..++||+ +||+||.++. +++.+|+|.+.+..- .+..+....|..+|..++||.||++.-.|.+.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 567999999999 9999999988 788999999886522 23567888999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
+||+.||.|..+|... ..+++..+..++..|+.||.||| +++||||||||+|||+|.+|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999865 35888889999999999999999 999999999999999999999999999999865
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... .+.+++||+.|||||++....|+..+|.||+|+++|||++|.+||.......-. +.+..+...
T Consensus 176 ~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~----------~~I~~~k~~ 243 (357)
T KOG0598|consen 176 LKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY----------DKILKGKLP 243 (357)
T ss_pred ccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH----------HHHhcCcCC
Confidence 33322 333478999999999999999999999999999999999999998544432211 111211111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCC
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRP 314 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rp 314 (331)
.+. .-.+.++++++.++|+.||++|.
T Consensus 244 ~~p-~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 LPP-GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCC-ccCCHHHHHHHHHHhccCHHHhc
Confidence 111 12456899999999999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=328.98 Aligned_cols=262 Identities=20% Similarity=0.261 Sum_probs=211.6
Q ss_pred HHhcCccccCceeecCc-EEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 51 IATNNYNGHQVIASEHY-KLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 51 ~~~~~~~~~~~ig~~~g-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
...+.|+...+||.|+. +||+|+. .++.||||++.-.......+.+.+|+..|..++||||++++.+|..++..|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 34567888999999655 9999998 78999999998776665689999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|.||.+||+.+++...-. ..+.+..+..|.+++++||.||| ..+.||||||+.||||+++|.+||+|||.+..+
T Consensus 103 mpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 999999999999976432 45888999999999999999999 999999999999999999999999999998766
Q ss_pred CCCCcc-ccc-cccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh--ccccccccccc
Q 020078 208 PEGETH-VTS-HMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE--NNRLGEIVDPI 281 (331)
Q Consensus 208 ~~~~~~-~~~-~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~ 281 (331)
.+.... ... .+.+||+.|||||++... .|+.|+||||||++..||.+|..||.-...+.-... ++......
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--- 253 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--- 253 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc---
Confidence 554322 122 456799999999996543 699999999999999999999999843222222111 11111111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...........++.++.+++..||.+||++||||.++++.
T Consensus 254 -t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 -TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred -cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111222233566789999999999999999999999763
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=328.90 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=201.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC--ccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE--IPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv 127 (331)
..++...+.||+ .||.||++.. +++..|||........ ..+.+.+|+.+|.+++|||||+.+|.....+ .+++.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 345677889999 9999999999 4799999998766433 2677899999999999999999999855554 58899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCCCccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFSESEY 206 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~ 206 (331)
|||+++|+|.+++...++ .+++..+..+..||++||.||| +++|+||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999999987542 4899999999999999999999 999999999999999999 79999999999987
Q ss_pred cCCC-CccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChh-HHHHHHHhhccccccccccccc
Q 020078 207 IPEG-ETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNIL-LEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
.... ..........||+.|||||++.++.. ..++|||||||++.||+||+.||.. .......+...... ..|.+
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~i- 244 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEI- 244 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCC-
Confidence 6531 11112223569999999999986543 3599999999999999999999765 22222222211111 01111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
| ...+.++.+++.+|++.||++||||.+++..-
T Consensus 245 -----p--~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 245 -----P--DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred -----C--cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1 14556899999999999999999999998753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=343.25 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=203.8
Q ss_pred HHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++.-+..+...-+|. .-|.||.|+..++.||||++.. .-..+|+-|++|+||||+.+.|+|....-+||||
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e--------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE--------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh--------hhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 333344455678999 7889999999999999999642 2346889999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||+.|.|.+.|... .+++......|..+||.|+.||| ...|||||||.-||||..+..+||+|||.++.+.
T Consensus 192 EfCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999876 46888888999999999999999 9999999999999999999999999999999876
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
+..+. -.+.||..|||||++.+.+.++|+||||||||||||+||..|+.......-.+..+ .+....
T Consensus 264 ~~STk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG----------sNsL~L 330 (904)
T KOG4721|consen 264 DKSTK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG----------SNSLHL 330 (904)
T ss_pred hhhhh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc----------CCcccc
Confidence 54222 12569999999999999999999999999999999999999975443332222211 112222
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
|.+..++.-+.-|+++||+..|..||||.+++..|+
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 233345556999999999999999999999998875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=340.74 Aligned_cols=248 Identities=18% Similarity=0.295 Sum_probs=210.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..|..-..||+ ..|.||.+.. +++.||||++...... ..+-.++|+.+|+..+|+|||.+++.|.-.+..|.||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 45666778999 8889999988 7889999999865444 567888999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+.+... .+++.++..|+++++.||+||| ..+|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 352 m~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred cCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999998653 4889999999999999999999 999999999999999999999999999998877655
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.. ...+.+||+.|||||+.....|.++.||||||++.+||+-|.+||.........+. -...+.+....
T Consensus 423 ~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL---------Ia~ng~P~lk~ 491 (550)
T KOG0578|consen 423 QS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---------IATNGTPKLKN 491 (550)
T ss_pred cC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH---------HhhcCCCCcCC
Confidence 43 44456799999999999999999999999999999999999999854333332221 01112222233
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+...+.++.+++.+||..||.+|+||.|+|..
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33677899999999999999999999999863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=332.69 Aligned_cols=260 Identities=20% Similarity=0.237 Sum_probs=203.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 126 (331)
.+.|+....||+ .||.||+|+. +|+.||+|++.-... ........+||.||++|+||||++|.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456788889999 8999999999 889999999876543 33455667999999999999999999999886 57999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
|+|||+. +|.-++.... -.|+..++..++.|++.||+|+| ..+|+|||||.+|||||.+|.+||+|||+|++
T Consensus 196 VFeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 9999987 9988886543 46899999999999999999999 99999999999999999999999999999998
Q ss_pred cCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHh---hc---cccc-
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHV---EN---NRLG- 275 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~---~~---~~~~- 275 (331)
+........+. ++-|..|.|||.+++. .|+...|+||.||||.||+.|++.+.....+. ..+ .. ..+.
T Consensus 268 y~~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 268 YTPSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred ccCCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc
Confidence 86655433332 4479999999999875 69999999999999999999999773222111 111 10 0011
Q ss_pred ------cccccccccCCCC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 ------EIVDPIVVEDKSC-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ------~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.+...-.... .....++.+..+|+..+|..||++|.||.+++.
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111111000000 001144677999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=337.72 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=210.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCcc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIP 124 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 124 (331)
....+|.-++.||+ +|++|++|+. +++.+|||++.+.. .++..+-..+|-..|.+| .||.||+|+--|.|...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 34567888999999 8889999988 88999999988752 223345677899999999 799999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
|+|+||+++|+|.++|...+ .|++.....++.+|+.||.||| +.+||||||||+|||+|.+++++|.|||.|
T Consensus 150 YFvLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999998763 5888889999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCcc-----------ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccc
Q 020078 205 EYIPEGETH-----------VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNR 273 (331)
Q Consensus 205 ~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~ 273 (331)
+.+...... ..+..++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||...+...
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl------- 294 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL------- 294 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-------
Confidence 988643221 11245789999999999999999999999999999999999999984433221
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
++..++..++.+|. ++++.+.+|+++.|..||++|+|+.+|.+
T Consensus 295 ---iFqkI~~l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 295 ---IFQKIQALDYEFPE--GFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred ---HHHHHHHhcccCCC--CCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11222333444443 56678999999999999999999988765
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.69 Aligned_cols=247 Identities=22% Similarity=0.242 Sum_probs=205.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC----CCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN----YSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETE 122 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 122 (331)
...+.|...+.||+ +||+|+.|.. +++.||+|.+.+. ......+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44678999999999 8999999988 7899999977654 11123556778999999999 999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDF 201 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Df 201 (331)
..++||||+.+|+|.+++... ..+.+..+..++.|+++|++||| +.+|+||||||+|+|+|.+ +++||+||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999999873 35778999999999999999999 9999999999999999999 99999999
Q ss_pred CCccccC-CCCccccccccCCCCcccchhhhccCC-CC-CcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccc
Q 020078 202 SESEYIP-EGETHVTSHMLTRTKRYLAPEYILTGL-CN-EKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV 278 (331)
Q Consensus 202 g~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 278 (331)
|++.... ... ...+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.......-.
T Consensus 166 G~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~---------- 232 (370)
T KOG0583|consen 166 GLSAISPGEDG---LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY---------- 232 (370)
T ss_pred ccccccCCCCC---cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH----------
Confidence 9998774 222 223366999999999999877 86 7899999999999999999998542221111
Q ss_pred ccccccCCCCchHHHH-HHHHHHHHHHhccCCCCCCCCHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQ-LQALLQLIFECVNESAGDRPTMVYAA 320 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~Rps~~evl 320 (331)
..+..+.+.+|. .+ +.++.+|+.+||..||.+|+|+.+++
T Consensus 233 ~ki~~~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 233 RKIRKGEFKIPS--YLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHhcCCccCCC--CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 112233344443 23 67899999999999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=313.59 Aligned_cols=257 Identities=19% Similarity=0.255 Sum_probs=200.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.|+...++|+ ++|.|||++. +|+.||||++.....+ .-.+..++|+++|++|+|+|+|.|+.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4777788999 9999999998 8999999999876543 3356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|+. ++.+.+... +..++...+.+++.|++.|+.|+| +.++|||||||+|||++.++.+||||||+|+.+...
T Consensus 83 ~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 83 CDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred cch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 987 444444332 245888999999999999999999 999999999999999999999999999999988643
Q ss_pred CccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChh-----------------HHHHHHHhhcc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNIL-----------------LEHVKKHVENN 272 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~-----------------~~~~~~~~~~~ 272 (331)
....+. .+.|..|+|||.+.+ -.|..++||||+||++.||++|.+-|.. .....+.+...
T Consensus 155 gd~YTD--YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 155 GDNYTD--YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred cchhhh--hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 322221 347899999999987 5899999999999999999999986522 22233333222
Q ss_pred cc-ccccccccccCCCCchH-HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 273 RL-GEIVDPIVVEDKSCPEK-EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 273 ~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ..+.-|......+.... ...+.-+.+|++.||+.||++|++-++++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 22 11111111111111000 144567899999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.33 Aligned_cols=259 Identities=19% Similarity=0.244 Sum_probs=204.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCC-ccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETE-IPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv 127 (331)
.+.|...+.+|. .||.||+|+. +++.||||++++....-..-.-++|+.-|++|+ |||||+|..++.+++ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 456777788999 9999999998 889999999987755423334568999999999 999999999999988 89999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||||.. +|.+++..++ ..+++..+..|+.||++||+|+| ..++.|||+||+|||+..+..+||+|||+|+.+
T Consensus 89 fE~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred HHhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccc
Confidence 999986 9999998774 67999999999999999999999 999999999999999999999999999999987
Q ss_pred CCCCccccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc----ccc--cc---
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN----RLG--EI--- 277 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~----~~~--~~--- 277 (331)
....... ..+.|..|+|||+++ .+.|+.+.||||+||+++|+.+-++-|.....+.+.++-. .+. .+
T Consensus 161 ~SkpPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKPPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCCCcc---hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 6554322 245899999999987 4679999999999999999999988663333222222110 000 00
Q ss_pred ------cccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 278 ------VDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 278 ------~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+.-..+.-...+.. ...+.++.+++.+|+.+||++||||.|+++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00000000011110 1356789999999999999999999999863
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=331.79 Aligned_cols=248 Identities=19% Similarity=0.239 Sum_probs=209.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..|.....||. .||.||+|.. .++.||+|.+.-.......+...+|+.+|.+++++||.++||.+..+...|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45677788999 9999999999 78999999999887777889999999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|.+|++.+.+.... .+.+..+..++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+..+...
T Consensus 93 ~~gGsv~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-----ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccCC-----CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 99999999997642 3466777788999999999999 999999999999999999999999999999887655
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.. ...+++||+.|||||++....|+.|+||||||++.+||.+|.+|+.-. .+...+-.+....++...
T Consensus 165 ~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~----------hPmrvlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 165 VK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL----------HPMRVLFLIPKSAPPRLD 232 (467)
T ss_pred hh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc----------CcceEEEeccCCCCCccc
Confidence 43 224577999999999999889999999999999999999999995322 222222222222222222
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
. .+++.+++++..||++||+.||||.++++.
T Consensus 233 ~-~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 G-DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c-ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2 666789999999999999999999999864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=338.64 Aligned_cols=266 Identities=19% Similarity=0.278 Sum_probs=213.3
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++.+..+.+.....||+ .||+||+|.|.| .||||.+.-. ......+.|.+|+.++++-+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 556666666777888999 999999999977 5899998754 444568899999999999999999999999998877
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
.+|+.+|++.+|+.+++... ..|...+.+.|+.||++|+.||| .++|||||||..||++.+++++||+|||++
T Consensus 463 AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccce
Confidence 89999999999999998764 57889999999999999999999 999999999999999999999999999997
Q ss_pred cccCCCCccccccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 281 (331)
..-...........-.|...|||||++.. ++|+..+||||||+++|||++|..|+.......-.+..++.....|..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s 615 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS 615 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence 64322211111111237888999999974 579999999999999999999999976332222233333322222222
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
... ..++.++.+|+..||+.+|++||.+.+++..|+.+.-
T Consensus 616 ~~~-------s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 KIR-------SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhh-------ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 211 1455689999999999999999999999999887754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=322.53 Aligned_cols=262 Identities=20% Similarity=0.305 Sum_probs=200.1
Q ss_pred cCccccCceee-cCcEEEEEEeC------------------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeee
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE------------------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKL 114 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 114 (331)
+.|...+.||+ +||.||++.+. +..||+|.+...........+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46777889999 99999999752 236999998766544456789999999999999999999
Q ss_pred EeEEeeCCccEEEEEecCCCChhhhhcCCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 020078 115 IGCCIETEIPILVFEFVEYGTLADRICSPHG--------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVF 180 (331)
Q Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 180 (331)
++++.+.+..++||||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 9999999999999999999999998864321 01134678899999999999999999 899999
Q ss_pred CCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhC--CCC
Q 020078 181 KDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG--RRD 258 (331)
Q Consensus 181 rdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g--~~p 258 (331)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|+|+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999866443322222223357889999999988999999999999999999874 456
Q ss_pred ChhHHHH--HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 259 NILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 259 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
+...... ...................+..+| ..+.+|+.+||..||++|||+.++.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCP------QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccCCCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 5322111 111100000000000011122233 46999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=356.78 Aligned_cols=260 Identities=23% Similarity=0.395 Sum_probs=214.3
Q ss_pred cCccccCceee-cCcEEEEEEe---CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL---ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~---~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+......||+ .||.||.|.. ++. .||+|.+....+.....+|++|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44556788999 9999999998 333 499999998877778899999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 126 LVFEFVEYGTLADRICSPHG--PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
+++|||++|+|..+|.+... .....+.....+.++.|||+|+.||+ +++.|||||.++|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987522 11356889999999999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhcccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNRLGEIVDP 280 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~~~~~~~~ 280 (331)
|+.+-............-+..|||||.+..+.++.|+|||||||+|||++| |..||....... ..+.. ..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~-------gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE-------GG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-------CC
Confidence 995544433322221124678999999999999999999999999999999 666763322221 11111 11
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
++..+..||+ .+.++|.+||+.+|++||++..+++.+.++...
T Consensus 922 RL~~P~~CP~------~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 922 RLDPPSYCPE------KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ccCCCCCCCh------HHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 3455667776 599999999999999999999999999887653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=334.97 Aligned_cols=258 Identities=16% Similarity=0.273 Sum_probs=203.5
Q ss_pred hcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 123 (331)
.++|...+.||+ +||.||+|++ .+..||+|.+.........+.+.+|+.++..+ +||||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 456888899999 9999999974 34579999987554444567788999999999 89999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCC---------------------------------------------------------
Q 020078 124 PILVFEFVEYGTLADRICSPHGP--------------------------------------------------------- 146 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------- 146 (331)
.++||||+++|+|.+++......
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999999999998643210
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 147 -------------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 147 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
....+++..+..++.||++||.||| +.+|+||||||+|||++.++.++|+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0124788899999999999999999 899999999999999999999999999999876543322
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH---HHHHHhhccccccccccccccCCCCc
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE---HVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
.......++..|+|||++....++.++||||||+++|+|++ |..||.... ............. .+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~--- 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-------SPE--- 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-------CCC---
Confidence 22222235678999999999999999999999999999998 788874321 1112222111000 011
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+.++.+|+.+||+.||++|||+.|+++.|++.
T Consensus 341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1234799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=348.70 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=215.4
Q ss_pred ccccCceee-cCcEEEEEEe--C---CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--E---NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..++++||. .||+||+|++ . ...||||.++....++.+.+|+.|+.||.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 356799999 9999999998 3 457999999999998889999999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
||++|+|..+|....+ ++++-+...++++|+.|+.||. +.++|||||.+.|||++.+..+|++|||+++.+.+
T Consensus 711 yMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 9999999999987763 5888899999999999999999 99999999999999999999999999999998866
Q ss_pred CCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh--HHHHHHHhhccccccccccccccC
Q 020078 210 GETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL--LEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 210 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
+... ..+..-.-+..|.|||.+...+++.+|||||||+++||.++ |.+|+.. .+.+-+.+. ..
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-------------~g 850 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-------------QG 850 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-------------hc
Confidence 6522 22222223678999999999999999999999999999766 8899743 233333332 23
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
+..|.+.+++..+.+||..||++|-.+||++.+++..|.++.
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 333333355668999999999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=337.77 Aligned_cols=264 Identities=22% Similarity=0.347 Sum_probs=213.5
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe--C-C--ce-EEEEEeCC--CCCcchhHHHHHHHHHHHhcCCCceeee
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--E-N--RP-ISVMKFGD--NYSENGENFCFNNIVFAAQMNHRNILKL 114 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~-~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l 114 (331)
...+.++...++....++||+ .||.||+|++ . + .. ||+|.... .........|++|+++|++++|||||++
T Consensus 147 I~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~ 226 (474)
T KOG0194|consen 147 IPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRF 226 (474)
T ss_pred ccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 444556666777777799999 9999999998 2 2 23 89998874 2444568899999999999999999999
Q ss_pred EeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 115 IGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
||++.+..++++|||+|+||+|.++|.... ..++..+++.++.+.|+||+||| .+++|||||-++|+|++.++
T Consensus 227 yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~ 299 (474)
T KOG0194|consen 227 YGVAVLEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKG 299 (474)
T ss_pred EEEEcCCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCC
Confidence 999999999999999999999999998764 35899999999999999999999 99999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVEN 271 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~ 271 (331)
.+||+|||+++.-..-.. ......-+..|+|||.+..+.|+.++|||||||++||+++ |..|+...+.. ...+.
T Consensus 300 ~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~- 376 (474)
T KOG0194|consen 300 VVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV- 376 (474)
T ss_pred eEEeCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-
Confidence 999999999876541111 1101124678999999999999999999999999999999 78787543332 22221
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+.++.+.+...+.++..++.+||..||++||||.++.+.|+.+..
T Consensus 377 -----------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 377 -----------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred -----------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 1111112222344579999999999999999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=333.75 Aligned_cols=245 Identities=18% Similarity=0.252 Sum_probs=207.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|-....||+ +||.||||+. +.+.||+|.+.+. ..++..+.+.+|+++++.|+|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 35666678999 9999999988 6789999998865 444567889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
||.+ +|..++... ..+++..+..++.++++||.||| +.+|+|||+||.|||++..+.+|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9975 999999765 46999999999999999999999 99999999999999999999999999999998765
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
+.. .. ....|||.|||||+..+.+|+..+|+||+||++||+++|++||....-. .. +..+..++..+|
T Consensus 153 ~t~-vl-tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-~L---------v~~I~~d~v~~p 220 (808)
T KOG0597|consen 153 NTS-VL-TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-QL---------VKSILKDPVKPP 220 (808)
T ss_pred Cce-ee-eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-HH---------HHHHhcCCCCCc
Confidence 432 22 2356999999999999999999999999999999999999998543322 11 112223333344
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ..+..+.++++..|.+||.+|.|..+++.
T Consensus 221 ~--~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 221 S--TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred c--cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 3 66778999999999999999999988764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=333.86 Aligned_cols=264 Identities=17% Similarity=0.313 Sum_probs=205.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
...++|...+.||+ +||.||+|+. ++..||+|.+...........+.+|+.+++.+ +|+|||+++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 34457888999999 9999999985 22479999997654444566788999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCC--------------------------------------------------------
Q 020078 122 EIPILVFEFVEYGTLADRICSPHG-------------------------------------------------------- 145 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 145 (331)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998853210
Q ss_pred ---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 146 ---------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 146 ---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
....++++..+..++.|++.||.||| +.+|+||||||+|||+++++.++|+|||+++...........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 01124788899999999999999999 899999999999999999999999999998866443322222
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
....++..|+|||++....++.++||||||+++|+|++ |+.||................ ... ..+. ..+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~--~~~------~~~~--~~~ 341 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG--YQM------SRPD--FAP 341 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcc--cCc------cCCC--CCC
Confidence 22235678999999998899999999999999999997 999975432211111100000 000 0000 123
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 296 QALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 296 ~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 47999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=315.52 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=202.7
Q ss_pred hcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
..+|...+.||+ +||.||+|.+ .+..||+|.+...........+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788889999 9999999976 3468999998876554456689999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.+++||||||+||+++.++.++++|||.+..
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 999999999999986532 35889999999999999999999 99999999999999999999999999998765
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
....... ......++..|+|||++..+.++.++||||||+++||+++ |..||..... .......... ..
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------~~ 228 (266)
T cd05064 157 DKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-------LP 228 (266)
T ss_pred ccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------CC
Confidence 4222111 1111225678999999999999999999999999999775 9999743221 1111111110 01
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
.+. ..+..+.+++.+||+.+|++|||+.++.+.|+++
T Consensus 229 ~~~------~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 APR------NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC------CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111 2344699999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.02 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=203.3
Q ss_pred CccccCceee-cCcEEEEEEeCC-------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFLEN-------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
+|...+.||+ ++|.||+|...+ ..||+|.+...........+.+|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 5667788999 899999998722 46999998765544456778999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 127 VFEFVEYGTLADRICSPHGPH-----------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
+|||+++|+|.+++....... ...+++..++.++.|++.||.||| +.+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCc
Confidence 999999999999987542211 145788999999999999999999 899999999999999999999
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENN 272 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~ 272 (331)
++|+|||++................+++.|+|||++..+.++.++||||||+++|||++ |..||.... .........
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~ 242 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR 242 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999876543322222222346788999999998899999999999999999998 998874322 111111111
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
.... .+ ...+.++.+|+.+||+.||++|||+.|+++.|++
T Consensus 243 ~~~~-------~~------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 243 QLLP-------CP------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred CcCC-------Cc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1100 01 1344679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=315.12 Aligned_cols=248 Identities=18% Similarity=0.237 Sum_probs=197.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+|...+.||+ +||.||++.. +++.||+|.+..... ......+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3667788999 9999999987 789999999875422 1234567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 9999999888754321 35889999999999999999999 99999999999999999999999999999987643
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... ....||..|+|||++.+..++.++|||||||++|+|++|+.||...... ....... +... ...
T Consensus 155 ~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~----~~~ 223 (285)
T cd05631 155 GETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR----VKED----QEE 223 (285)
T ss_pred CCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH----hhcc----ccc
Confidence 3221 1235899999999999989999999999999999999999998532110 0000000 0000 001
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
.+ ...+.++.+|+.+||+.||++||+ +.++++
T Consensus 224 ~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11 134457999999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=297.99 Aligned_cols=259 Identities=19% Similarity=0.212 Sum_probs=202.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcch-hHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENG-ENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..|...+++|+ .||.||+|+. +|+.||||++......++ .....+||+.|+.++|+||+.|+++|.+.+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999 8999999999 899999999987644433 4578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++. +|...+.... ..+...++..++.++++|++||| .+-|+||||||.|+|++++|.+|++|||+|+.+..
T Consensus 82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 9985 9999997654 56888999999999999999999 99999999999999999999999999999998865
Q ss_pred CCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH---HHHHHhh---cccccccc----
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE---HVKKHVE---NNRLGEIV---- 278 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~---~~~~~~~---~~~~~~~~---- 278 (331)
....... .+-|..|.|||.+.+. .|+..+||||.||++.||+-|.+-+...+ .....+. -....++.
T Consensus 154 p~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 154 PNRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 5432222 1468899999998865 69999999999999999999987542221 1111111 11111111
Q ss_pred --ccccccCCCCc----hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 279 --DPIVVEDKSCP----EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 279 --~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
|-......+.+ .....+.++.||+.+||..||.+|+|+.|+++.
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11000000000 011345678999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=321.59 Aligned_cols=257 Identities=16% Similarity=0.219 Sum_probs=201.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ ++|.||++.. ++..+|+|.+.........+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888899999 9999999998 6788999998765444456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|+++|+|.+++... ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.++|+|||++..+.
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999998654 35888999999999999999999 65 69999999999999999999999999987654
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccc-------cccc--
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNR-------LGEI-- 277 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~-------~~~~-- 277 (331)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+.... ....
T Consensus 156 ~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 156 DSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred cccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 3221 123489999999999988899999999999999999999999843221 111111000 0000
Q ss_pred -------------------------cccccccC-CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 278 -------------------------VDPIVVED-KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 278 -------------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+...... ...+. ...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN-GVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCC-ccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000 00000 1245679999999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=321.61 Aligned_cols=242 Identities=19% Similarity=0.202 Sum_probs=197.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+|.. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788889999 9999999998 58899999986432 1224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 999999999998654 35888999999999999999999 9999999999999999999999999999988664
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ..
T Consensus 153 ~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~------------~~ 215 (291)
T cd05612 153 DRTW-----TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG------------KL 215 (291)
T ss_pred CCcc-----cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------Cc
Confidence 3221 1348999999999998889999999999999999999999984332211 111111 11
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAKQ 322 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~~ 322 (331)
..+. ..+..+.+|+.+||+.||.+||+ +.++++.
T Consensus 216 ~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1111 23457999999999999999995 8777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=329.80 Aligned_cols=261 Identities=16% Similarity=0.310 Sum_probs=206.1
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETE 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~ 122 (331)
..+.|...+.||+ +||.||+|... ...||+|++.........+.+.+|+.++.++. ||||++++++|.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888899999 99999999862 23699999976554445678999999999996 999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCC--------------------------------------------------------
Q 020078 123 IPILVFEFVEYGTLADRICSPHGP-------------------------------------------------------- 146 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 146 (331)
..++|||||++|+|.+++......
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999888642110
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc
Q 020078 147 -----------------------------------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191 (331)
Q Consensus 147 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~ 191 (331)
....+++..+..++.|+++||.||| +.+|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence 0124778888999999999999999 89999999999999999
Q ss_pred CCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH---HHH
Q 020078 192 EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH---VKK 267 (331)
Q Consensus 192 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~---~~~ 267 (331)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..|+..... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999986644332222222346788999999998899999999999999999997 8888743211 111
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
....... ...+ ...+.++.+++.+||+.||++|||+.++.+.|+++..
T Consensus 352 ~~~~~~~-------~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKSGYR-------MAKP------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhcCCC-------CCCC------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1111100 0011 1334579999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=331.61 Aligned_cols=244 Identities=20% Similarity=0.227 Sum_probs=206.4
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+..++-||. +.|.|-.|+. +|+.+|||.+.+. ..+.....+.+|+.+|+-+.|||+++||++++....+|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 455667888 8889999998 9999999999765 2233356688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|.|++++... .+++..++.+++.||+.|+.|+| ..+|+||||||+|+|+|.++++||+|||.|.....+
T Consensus 94 v~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred cCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999876 46899999999999999999999 999999999999999999999999999999876554
Q ss_pred CccccccccCCCCcccchhhhccCCCC-CcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
....+ -||+++|.|||++.+.+|. .++||||+||+||.|++|+.||. +.+...++..+..+.+..|
T Consensus 166 klLeT---SCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----------DdNir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 166 KLLET---SCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----------DDNIRVLLLKVQRGVFEMP 232 (786)
T ss_pred ccccc---cCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----------CccHHHHHHHHHcCcccCC
Confidence 33222 4599999999999998885 78999999999999999999974 2222233333334444444
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
. ..+.++.+|+.+||..||+.|.|+.||++.
T Consensus 233 s--~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 233 S--NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred C--cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3 567789999999999999999999999864
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=317.77 Aligned_cols=246 Identities=33% Similarity=0.507 Sum_probs=192.7
Q ss_pred cCceee-cCcEEEEEEeC------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 59 HQVIAS-EHYKLYKGFLE------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.+.||. .||.||+|.+. +..|+||.+.........+.+.+|+..+++++||||++++|+|...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999 99999999996 67899999976555545789999999999999999999999999888899999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++..... ..+++.+++.++.|++.||.||| +.+++|+||+++||+++.++.+||+|||++.......
T Consensus 84 ~~g~L~~~L~~~~~---~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 84 PGGSLDDYLKSKNK---EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TTEBHHHHHHHTCT---TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc---ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 99999999987521 46899999999999999999999 8899999999999999999999999999998763333
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.............|+|||.+....++.++||||||+++||+++ |+.|+... ............ ...+..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~ 230 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR-------LPIPDNC 230 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE-------TTSBTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------ceeccch
Confidence 2222222336778999999999999999999999999999999 67776322 111122222111 1112223
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
+ ..+.+++.+||..||++|||+.++++.|
T Consensus 231 ~------~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 P------KDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp B------HHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred h------HHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3 3699999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.20 Aligned_cols=258 Identities=16% Similarity=0.168 Sum_probs=196.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||. +||.||+|.. ++..||+|.+...........+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45888899999 9999999988 67899999987554433456788999999999999999999999999899999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 97 58988886542 34788899999999999999999 999999999999999999999999999998765432
Q ss_pred CccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhc-c-----cccc----
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVEN-N-----RLGE---- 276 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~-~-----~~~~---- 276 (331)
.... ....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||..... ....... . ....
T Consensus 157 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 157 TKTY--SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred Cccc--cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 2211 12347899999999875 4689999999999999999999999832211 1111000 0 0000
Q ss_pred -----ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 -----IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 -----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+..............+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=318.29 Aligned_cols=254 Identities=18% Similarity=0.361 Sum_probs=203.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.+|...+.||+ +||.||+|.+ ++. .||+|.+.........+.+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999 9999999987 343 38999987654444567899999999999999999999999865 5679
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence 999999999999997642 35788999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
..............++..|+|||++....++.++||||||+++|||++ |..|+..... ......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------~~~ 231 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------RLP 231 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-------CCC
Confidence 654433222222224678999999999999999999999999999998 9998743221 111111111 111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+..+ +.++.+++.+||..+|++|||+.+++..|..+..
T Consensus 232 ~~~~~------~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 232 QPPIC------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CCCCC------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11222 2368999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=303.58 Aligned_cols=235 Identities=19% Similarity=0.237 Sum_probs=204.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|+....+|. +||.|-+++. ++.-+|+|.+.+.. ..+..+...+|..+|+.+.||+++++++.|.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 45777888999 9999999988 78899999997652 2234667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|.|..+++.. ..++...+..++.+|+.||.||| +..|++|||||+|||+|.+|.+||.|||+|+.+.
T Consensus 124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999876 45889999999999999999999 9999999999999999999999999999999875
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.. +.+.+|||.|+|||.+....|+.++|-|||||++|||+.|.+||...+. ..+...++.++..+
T Consensus 196 ~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----------~~iY~KI~~~~v~f 260 (355)
T KOG0616|consen 196 GR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----------IQIYEKILEGKVKF 260 (355)
T ss_pred Cc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----------HHHHHHHHhCcccC
Confidence 44 2235699999999999999999999999999999999999999753333 33444555555555
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCC
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDR 313 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~R 313 (331)
|. .++.++.+|+.+.|+.|-.+|
T Consensus 261 P~--~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PS--YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Cc--ccCHHHHHHHHHHHhhhhHhh
Confidence 54 677789999999999999999
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=324.70 Aligned_cols=241 Identities=16% Similarity=0.210 Sum_probs=197.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ ++|.||+|+. +++.||+|.+.... .....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999 9999999998 67899999986532 1224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999998754 35788889999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ...||+.|+|||++....++.++|||||||++|+|++|..||....... ....... .
T Consensus 170 ~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~------------~ 232 (329)
T PTZ00263 170 DRTF-----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR------------L 232 (329)
T ss_pred CCcc-----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------c
Confidence 4322 1348999999999998889999999999999999999999984332211 1111111 1
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
..|. ..+..+.+|+.+||+.||++||+ +.+++.
T Consensus 233 ~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 233 KFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1111 12346899999999999999997 566653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=323.08 Aligned_cols=238 Identities=16% Similarity=0.190 Sum_probs=193.6
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
++||+ +||.||++.. +++.+|+|.+.... .......+.+|+.++.+++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36899 9999999987 78899999987532 2224567789999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 214 (331)
+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-- 150 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-- 150 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--
Confidence 999988654 45889999999999999999999 99999999999999999999999999999875422211
Q ss_pred cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchHH
Q 020078 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... .....|.
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------------~~~~~p~-- 216 (323)
T cd05571 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------------EEIRFPR-- 216 (323)
T ss_pred cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc------------CCCCCCC--
Confidence 1122458999999999998899999999999999999999999984322211 11111 1111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..+.++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 3445799999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=307.59 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=204.7
Q ss_pred cCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|...+.||+ +||.||+|.+. ...||+|.+...........|.+|+.++.+++||||+++++++.+.+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888899999 99999999882 3479999887655544567889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 99999999999986543 35889999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 284 (331)
.............++..|+|||.+.+..++.++||||||+++|++++ |..|+.... ............ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~ 229 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-------PP 229 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------CC
Confidence 53222222222235678999999998899999999999999999998 988873221 111111111000 00
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
+. ..+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 230 ~~------~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 PM------DCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 2334699999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=294.16 Aligned_cols=248 Identities=17% Similarity=0.211 Sum_probs=210.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|+.++.+|+ .||.||.|+. +...||+|.+-+..- ....+++.+|+++.+.|+||||+++|+++-+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 367899999999 9999999998 677899999876522 22457899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
+||.++|+|...+.+... ..++......++.|+|.||.|+| .+++|||||||+|+|++..+..|++|||.+...
T Consensus 101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999975432 56888888999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
+.+ ...+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.... ..+.+......+..+|
T Consensus 175 p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~~~p------- 242 (281)
T KOG0580|consen 175 PSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDLKFP------- 242 (281)
T ss_pred CCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccccCC-------
Confidence 533 3344679999999999999999999999999999999999999986555 3334433333333222
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+.++.|+|.+|+..+|.+|.+..|+++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1455679999999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=321.33 Aligned_cols=250 Identities=16% Similarity=0.163 Sum_probs=200.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|.....||+ ++|.||+|+. +++.||+|.+.... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 35788899999 9999999998 67899999987542 1224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 999999999999654 35888999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 286 (331)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||....... ...... ............
T Consensus 153 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~ 225 (333)
T cd05600 153 TY-----ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYDDP 225 (333)
T ss_pred cc-----cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCCcc
Confidence 31 122458999999999998899999999999999999999999984322211 111110 011110000000
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+.++.+++.+||..+|++|||+.++++.
T Consensus 226 ----~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 ----RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.14 Aligned_cols=236 Identities=20% Similarity=0.200 Sum_probs=189.0
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||+ +||.||+++. +++.||+|.+.... .......+.+|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 577 8999999998 67889999986432 222456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++....... ..
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~ 150 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KT 150 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cc
Confidence 9998654 35888999999999999999999 99999999999999999999999999999875432221 12
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ 296 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (331)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... ....+...+. ..+.
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~-~~~---------~~~~~~~~~~--~~~~ 218 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM-YRK---------ILQEPLRFPD--GFDR 218 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH-HHH---------HHcCCCCCCC--cCCH
Confidence 224589999999999998999999999999999999999999843221110 100 0111111111 3445
Q ss_pred HHHHHHHHhccCCCCCCCCHHHH
Q 020078 297 ALLQLIFECVNESAGDRPTMVYA 319 (331)
Q Consensus 297 ~~~~li~~cl~~dP~~Rps~~ev 319 (331)
++.+++.+||+.||++||++..+
T Consensus 219 ~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCH
Confidence 79999999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=311.19 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=204.6
Q ss_pred CccccCceee-cCcEEEEEEeCC-------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFLEN-------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
+|...+.||+ +||.||+|.... ..+++|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667788999 999999998722 46888888765544456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCc
Q 020078 127 VFEFVEYGTLADRICSPHG-------------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQ 187 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~N 187 (331)
++||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence 9999999999998864211 11135789999999999999999999 8999999999999
Q ss_pred eEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HH
Q 020078 188 ILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EH 264 (331)
Q Consensus 188 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~ 264 (331)
|++++++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..|+... ..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999876543332222222335678999999988889999999999999999998 88887432 12
Q ss_pred HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.......... ...+. ..+.++.+++..||+.+|++|||+.|+++.|+++..+
T Consensus 238 ~~~~~~~~~~-------~~~~~------~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 238 LFNLLKTGYR-------MERPE------NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHhCCCC-------CCCCC------CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 2222211100 00011 2334799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=298.20 Aligned_cols=250 Identities=21% Similarity=0.253 Sum_probs=208.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-------chhHHHHHHHHHHHhcC-CCceeeeEeEEee
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-------NGENFCFNNIVFAAQMN-HRNILKLIGCCIE 120 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~ 120 (331)
.-++|...+++|. +.+.|-.+.. ++..+|+|++...... ...+.-.+|+.||+++. ||||+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3456788889999 5556666655 7889999998643221 12456678999999995 9999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
+.+.++|+|.|+.|.|.|++.+. -.+++.....|++|+..|+.||| ..+||||||||+|||+|++.+++|+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence 99999999999999999999765 35888899999999999999999 99999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhc------cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYIL------TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENN 272 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~ 272 (331)
||+|..+..+.... ..+|||+|+|||.+. ...|+..+|+||+||++|-|+.|.+||+-...+. ..+.++
T Consensus 167 FGFa~~l~~GekLr---elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeG 243 (411)
T KOG0599|consen 167 FGFACQLEPGEKLR---ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEG 243 (411)
T ss_pred cceeeccCCchhHH---HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhc
Confidence 99999987776433 267999999999986 2358889999999999999999999986555432 222222
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. .+..|++.+.+..+.+||.+||+.||.+|.|++|++..
T Consensus 244 ky----------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 244 KY----------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc----------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 21 34567778889999999999999999999999999864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=312.17 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=203.1
Q ss_pred cCccccCceee-cCcEEEEEEe-C------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-E------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++|...+.||+ ++|.||+|.. . +..||+|.+.........+.+.+|+.++..++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777788999 9999999986 2 36899999876554445678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 126 LVFEFVEYGTLADRICSPHG---------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
+||||+++|+|.+++...+. .....+++..+..++.|++.||.||| +.+++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeE
Confidence 99999999999999975421 11245788999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~ 273 (331)
+|+|||++................+++.|+|||++..+.++.++||||||+++|+|++ |..||..... .........
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~ 241 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR 241 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876533322111112235778999999999999999999999999999998 9999742221 111111111
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
... .+. ..+..+.+++.+||..||++|||+.|+++.|+
T Consensus 242 ~~~-------~~~------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 242 LLQ-------RPR------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCC-------CCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 100 011 23357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=310.93 Aligned_cols=259 Identities=21% Similarity=0.225 Sum_probs=197.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|...+.||+ ++|.||+++. +++.+|+|++..... ....+.+.+|+.++..++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 35888889999 9999999998 678899999875422 2245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++++.+..+.... ..+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 99987775544322 35888999999999999999999 99999999999999999999999999999987644
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh------------------c
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE------------------N 271 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~------------------~ 271 (331)
..... .....|++.|+|||++.+..++.++|||||||++|+|++|+.||........... .
T Consensus 153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 153 GSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred ccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 32211 1123489999999999988899999999999999999999999843221111100 0
Q ss_pred cccccccccccccCCCC--chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSC--PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........+........ ......+.++.+|+.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000 000124567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.70 Aligned_cols=251 Identities=19% Similarity=0.320 Sum_probs=202.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+|...+.||+ ++|.||+|.. .+..+|+|.+.... .....+.+|+.++..++||||+++++++...+..+++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 34777788999 8999999988 57889999986542 2456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 84 MTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999865432 45889999999999999999999 899999999999999999999999999998876543
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... ....++..|+|||++.+..++.++||||||+++|+|++ |..|+.... .......... . ...+.
T Consensus 158 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-----~--~~~~~- 228 (263)
T cd05052 158 TYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-----R--MERPE- 228 (263)
T ss_pred eeecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-----C--CCCCC-
Confidence 32211 11224668999999988899999999999999999998 888873321 1111111110 0 01111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+.++.+++.+||+.||++|||+.++++.|+.+
T Consensus 229 -----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 -----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=320.96 Aligned_cols=261 Identities=18% Similarity=0.358 Sum_probs=205.2
Q ss_pred hcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC-C
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET-E 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~ 122 (331)
.+.|...+.||+ +||.||+|.. +++.||+|++.........+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888899999 9999999975 23689999987654444456788999999999 799999999988754 5
Q ss_pred ccEEEEEecCCCChhhhhcCCCCC--------------------------------------------------------
Q 020078 123 IPILVFEFVEYGTLADRICSPHGP-------------------------------------------------------- 146 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 146 (331)
..+++|||+++|+|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999988643210
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCccc
Q 020078 147 HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYL 226 (331)
Q Consensus 147 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~ 226 (331)
....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++..+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0125789999999999999999999 8999999999999999999999999999998765443333333344677899
Q ss_pred chhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH---HHHHHhhccccccccccccccCCCCchHHHHHHHHHHHH
Q 020078 227 APEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE---HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302 (331)
Q Consensus 227 aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (331)
|||++.+..++.++|||||||++|+|++ |..||.... ............ ..+ ...++++.+++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~--~~~~~~~~~l~ 309 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-----------RAP--EYATPEIYSIM 309 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-----------CCC--ccCCHHHHHHH
Confidence 9999999999999999999999999998 988874311 111111111100 001 12335799999
Q ss_pred HHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 303 FECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 303 ~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+||+.+|++|||+.|+++.|+.+...
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=311.82 Aligned_cols=260 Identities=19% Similarity=0.304 Sum_probs=205.9
Q ss_pred hcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++|...+.+|+ ++|.||++.. ++..+|+|.+.... ......+.+|+.++.+++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 357888899999 9999999975 23458888876543 22566799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC--------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 125 ILVFEFVEYGTLADRICSPHG--------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
++||||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence 999999999999999864321 11235899999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~ 273 (331)
+|+|||++................++..|+|||++....++.++||||||+++|+|++ |..||..... .........
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999876543332222222235778999999988889999999999999999998 8888743221 111222111
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
... .+. ..+.++.+|+.+||+.||.+|||+.++++.|+++..+
T Consensus 240 ~~~-------~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 240 VLQ-------RPR------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred cCC-------CCC------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 100 011 2234699999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.82 Aligned_cols=244 Identities=24% Similarity=0.396 Sum_probs=195.2
Q ss_pred ceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChh
Q 020078 61 VIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLA 137 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 137 (331)
.||+ ++|.||+|.. +++.+|+|.+...........+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5788 9999999988 788899998876544445678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccccc
Q 020078 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217 (331)
Q Consensus 138 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 217 (331)
+++.... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.............
T Consensus 82 ~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 82 TFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9986532 35789999999999999999999 9999999999999999999999999999987654322111111
Q ss_pred ccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCchHHHH
Q 020078 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 218 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
....+..|+|||.+..+.++.++||||||+++|++++ |..|+..... .......... ...+ ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~-----------~~~~--~~~ 221 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR-----------LPCP--ELC 221 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-----------CCCc--ccC
Confidence 1123557999999998889999999999999999998 8888742221 1111111100 0111 123
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 457999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=312.18 Aligned_cols=257 Identities=18% Similarity=0.292 Sum_probs=202.0
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
.+++|+..+.||+ ++|.||+|... +..||+|.+...........+.+|+.+++.++||||+++++++.+++.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677899999999 99999999763 357999998654433345678899999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 124 PILVFEFVEYGTLADRICSPHGP-----HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
.++||||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 1134678889999999999999999 899999999999999999999999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLG 275 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~ 275 (331)
+|||+++...............+++.|+|||++..+.++.++||||||+++|||++ |..|+.... ............
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99999876544332222112235778999999998889999999999999999999 677763322 111111111110
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
. .+. ..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 241 ~-------~~~------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 241 D-------KPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred C-------CCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 011 22346999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=322.54 Aligned_cols=243 Identities=18% Similarity=0.233 Sum_probs=198.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--C-CceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--E-NRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.++|...+.||+ +||.||+|.. . +..||+|.+.... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 356888899999 9999999986 2 3579999986432 22245678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.
T Consensus 109 v~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999754 35888999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 284 (331)
...... ...||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .
T Consensus 181 ~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~------------~ 243 (340)
T PTZ00426 181 VDTRTY-----TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE------------G 243 (340)
T ss_pred cCCCcc-----eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc------------C
Confidence 643221 2358999999999998889999999999999999999999985433221 11111 0
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAKQ 322 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~~ 322 (331)
....|. ..+.++.+++.+||+.||++|+ |+.++++.
T Consensus 244 ~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 111111 2334689999999999999995 88887653
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=306.34 Aligned_cols=252 Identities=20% Similarity=0.349 Sum_probs=202.6
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.++|...+.||+ ++|.||+|.. ++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 356777889999 9999999988 667899998765322 357889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++....+ ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 83 MAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999865322 35788899999999999999999 899999999999999999999999999999876543
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ...++..|+|||++..+.++.++||||||+++|+|++ |..||.... ........... .....
T Consensus 157 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~- 227 (261)
T cd05072 157 EYTARE-GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-------MPRME- 227 (261)
T ss_pred ceeccC-CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-------CCCCC-
Confidence 322111 1235678999999988889999999999999999998 888874321 11222211110 00011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+.++.+++.+||+.+|++|||++++.+.|+++
T Consensus 228 -----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 -----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 2334699999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=303.78 Aligned_cols=247 Identities=18% Similarity=0.303 Sum_probs=197.5
Q ss_pred CccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
.|...+.||+ +||.||++.+ ++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4666778999 9999999988 556899998764432 35678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.++.......
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999986532 34788999999999999999999 89999999999999999999999999999876543322
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCCCc
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
... ....++..|+|||++....++.++||||||+++|+|++ |+.|+...... ......... ...+.
T Consensus 156 ~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-------~~~~~--- 224 (256)
T cd05114 156 TSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR-------LYRPK--- 224 (256)
T ss_pred ecc-CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC-------CCCCC---
Confidence 211 11225668999999988889999999999999999999 88887433221 111111110 00011
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..+.++.+++.+||+.+|++|||+.+++..|+
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=314.72 Aligned_cols=251 Identities=22% Similarity=0.243 Sum_probs=203.9
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-------------chhHHHHHHHHHHHhcCCCceeee
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-------------NGENFCFNNIVFAAQMNHRNILKL 114 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~nIv~l 114 (331)
..-+.|.....||. .||.|-+|+. +++.||+|++.+.... ...+...+||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34578999999999 9999999998 8899999998753211 123578899999999999999999
Q ss_pred EeEEeeC--CccEEEEEecCCCChhhhhcCCCCCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc
Q 020078 115 IGCCIET--EIPILVFEFVEYGTLADRICSPHGPHLEP-LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191 (331)
Q Consensus 115 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~ 191 (331)
+.+..+. +..|+|+|||..|.+...=.. .+ +...++.+++.++..||.||| ..+||||||||+|+|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d------~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD------KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS 244 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC------cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence 9999874 468999999999988553321 33 889999999999999999999 99999999999999999
Q ss_pred CCCceEEccCCCccccCCCCcc----ccccccCCCCcccchhhhccCC----CCCcccchhhHHHHHHHHhCCCCChhHH
Q 020078 192 EYNVAKLSDFSESEYIPEGETH----VTSHMLTRTKRYLAPEYILTGL----CNEKTDVFCFGMLLLELLTGRRDNILLE 263 (331)
Q Consensus 192 ~~~~~kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~~l~el~~g~~p~~~~~ 263 (331)
++|++||+|||.+..+..+... .... ..|||.|+|||.+..+. .+.+.||||+||+||.|+.|+.||....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~-tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSR-TVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhh-cCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9999999999998876333111 1122 45999999999998743 3468999999999999999999974333
Q ss_pred HHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 264 HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. .+.++.+...+..+|...+..+.+.+||+++|.+||++|.+..+|..
T Consensus 324 ~----------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 E----------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred H----------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 2 23345555566666666567788999999999999999999998854
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=305.70 Aligned_cols=254 Identities=18% Similarity=0.323 Sum_probs=200.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
+.|...+.||+ ++|.||+|.+ ++. .+++|.+...........+..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35666788999 9999999998 444 4777887654433345678888889999999999999999864 45778
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
++||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||+++.
T Consensus 86 i~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 999999999999997543 45889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
..............++..|+|||++..+.++.++||||||+++||+++ |..|+.... ............ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-------~ 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL-------A 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------C
Confidence 644332222222346778999999998899999999999999999998 998874322 112222211110 1
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+..++ .++.+++.+||..||++|||+.|+++.|..+..
T Consensus 232 ~~~~~~------~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 QPQICT------IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111122 358899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=334.05 Aligned_cols=249 Identities=19% Similarity=0.191 Sum_probs=199.1
Q ss_pred CccccCceee-cCcEEEEEEe--C-CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--E-NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.|...+.||. ++|.||+|.. + +..||+|.+.... ......+.+|+.+|+.++|||||++++++...+..++||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 3888899999 9999999987 3 5778888765433 22455778899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++...... ..++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 147 ~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999887642211 145888999999999999999999 899999999999999999999999999999876544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
..........||+.|+|||++....++.++|||||||++|+|++|+.||....... ........ +
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----~--------- 289 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----D--------- 289 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----C---------
Confidence 32222333558999999999998899999999999999999999999985332211 11111110 0
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.+...+.++.+++.+||..||++|||+.+++.
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 001123457999999999999999999999875
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.60 Aligned_cols=263 Identities=19% Similarity=0.328 Sum_probs=207.4
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
+....++|...+.||+ ++|.||++... ...+|+|.+...........+.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3344567888889999 99999999872 2579999987654444556788999999999 7999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
.++..+++|||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeE
Confidence 99999999999999999999864310 11246889999999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HH
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HV 265 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~ 265 (331)
+++.++.++|+|||+++...............++..|+|||++....++.++|||||||++|++++ |..|+.... ..
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999987654332222222235678999999988889999999999999999998 888863322 12
Q ss_pred HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 266 KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
......... ...+. ..+.++.+|+.+||..||++|||+.|+++.|+++.
T Consensus 244 ~~~~~~~~~-------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGYR-------MEKPQ------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCCc-------CCCCC------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 222111110 01111 22346999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=318.28 Aligned_cols=241 Identities=18% Similarity=0.211 Sum_probs=194.1
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
+.||+ +||.||++.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899 9999999987 78899999987542 2234567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 214 (331)
+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 150 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-- 150 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--
Confidence 999888653 35889999999999999999999 99999999999999999999999999999875432211
Q ss_pred cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHH
Q 020078 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ... ........|. ..
T Consensus 151 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-~~~---------~~~~~~~~p~--~~ 218 (328)
T cd05593 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-FEL---------ILMEDIKFPR--TL 218 (328)
T ss_pred ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-HHH---------hccCCccCCC--CC
Confidence 11224589999999999988999999999999999999999999843322111 110 0011111111 34
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRP-----TMVYAAKQ 322 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rp-----s~~evl~~ 322 (331)
+.++.+++.+||..||++|| ++.++++.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 45799999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=301.61 Aligned_cols=255 Identities=17% Similarity=0.212 Sum_probs=199.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcch-hHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENG-ENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 127 (331)
++|+..+.|++ .||.||+|++ +++.||+|+++-.....+ --..++||.+|.+++|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45777888999 9999999999 889999999986543333 34678999999999999999999888754 468999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||||+. +|..++.... +++...++..++.|+++|+.||| +.-|+|||||++|+|+...|.+|++|||+|+.+
T Consensus 156 Me~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred HHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence 999986 9999997654 67899999999999999999999 999999999999999999999999999999988
Q ss_pred CCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH---HHHHHhhc-ccccccc----
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE---HVKKHVEN-NRLGEIV---- 278 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~---~~~~~~~~-~~~~~~~---- 278 (331)
.......+. .+-|..|.|||.+++. .|+++.|+||+||++.|++++++-|.... .....+.. +.+.+.+
T Consensus 228 gsp~k~~T~--lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPLKPYTP--LVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCcccCcc--eEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 766443322 3358999999999976 59999999999999999999998662211 11111111 1111100
Q ss_pred ---------------ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 ---------------DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ---------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+...+.+. ..++.-.+|+..+|..||.+|.||.|.++
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~---~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGAL---SLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cccchhhccccCCCCchhhhhhcccc---ccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00111111111 13467889999999999999999999875
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.42 Aligned_cols=257 Identities=15% Similarity=0.215 Sum_probs=199.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|+..+.||+ +||.||++.. ++..+|+|.+...........+.+|+.++..++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999 9999999998 6778899988765444456778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|+++|+|.+++... ..+++..+..++.+++.||.||| +. +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999998653 35788899999999999999999 64 79999999999999999999999999987653
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhh---ccccccc------
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVE---NNRLGEI------ 277 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~---~~~~~~~------ 277 (331)
.... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ...... .......
T Consensus 156 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 156 DSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred hhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 3211 123489999999999888899999999999999999999999743221 111100 0000000
Q ss_pred -----------------------cccccccC-CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 278 -----------------------VDPIVVED-KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 278 -----------------------~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+...... ...+. ...+.++.+|+.+||+.||++|||+.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPS-GVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccCCC-CCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000 00000 0234578999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=299.77 Aligned_cols=249 Identities=21% Similarity=0.255 Sum_probs=205.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+++|+.-.+||+ .|+.||++.. +|+.+|+|.++.+ ....+.+.+.+|+.|...|+|||||+|.+.+.+....|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3566777788999 8889998877 8899999988743 4445788999999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a 204 (331)
+|++.+|+|..-|..+ ..+++..+-.++.||+.+|.|+| .++|||||+||+|+|+.+. --+||+|||+|
T Consensus 89 Fe~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999998777654 34667778889999999999999 9999999999999999644 35899999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhcccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIV 282 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 282 (331)
..+..+. ....+.|||+|||||++...+|+.++|||+.||+||-|+.|..||+..... .+.+..+..
T Consensus 161 i~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~y-------- 229 (355)
T KOG0033|consen 161 IEVNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAY-------- 229 (355)
T ss_pred EEeCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcccc--------
Confidence 9887332 223366999999999999999999999999999999999999998763322 222222211
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.+.|.+...++++++|+.+||..||++|+|+.|+++
T Consensus 230 --d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 --DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1223344467789999999999999999999999875
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=324.82 Aligned_cols=263 Identities=17% Similarity=0.309 Sum_probs=205.7
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEe
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCI 119 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 119 (331)
+....++|...+.||+ +||.||+|++. +..||+|++.........+.+.+|+.+|.++. |||||+++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344556777889999 99999999863 35799999976544434567889999999997 999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCC------------------------------------------------------
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHG------------------------------------------------------ 145 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 145 (331)
..+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999864321
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCC
Q 020078 146 ---------------------------------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186 (331)
Q Consensus 146 ---------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~ 186 (331)
.....+++..++.++.|++.||.||| +.+++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence 01124677888999999999999999 899999999999
Q ss_pred ceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH-
Q 020078 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH- 264 (331)
Q Consensus 187 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~- 264 (331)
|||++.++.++|+|||+++...............++..|+|||++....++.++||||||+++|||++ |..|+.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999986543322111122336788999999998889999999999999999998 8888743221
Q ss_pred --HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 265 --VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 265 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.......... ...+. ..+.++.+|+.+||..+|++|||++|++..|+++.
T Consensus 349 ~~~~~~~~~~~~-------~~~p~------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQFYNAIKRGYR-------MAKPA------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHcCCC-------CCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111110 00111 23357999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.42 Aligned_cols=246 Identities=18% Similarity=0.186 Sum_probs=202.2
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
...++|+...+||+ +||.||.++- +|+.+|+|++.+..- .......+.|-.+|...++|+||+||-.|.+.+.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34678999999999 9999999987 899999999987632 234677889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
|||||+|||++..+|... ..|++.++..++.+++.|+.-|| ..++|||||||+|+|||..|++||+|||++.
T Consensus 218 LiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccc
Confidence 999999999999999765 46999999999999999999999 9999999999999999999999999999986
Q ss_pred ccCCC----------------------Ccc-------c----------------cccccCCCCcccchhhhccCCCCCcc
Q 020078 206 YIPEG----------------------ETH-------V----------------TSHMLTRTKRYLAPEYILTGLCNEKT 240 (331)
Q Consensus 206 ~~~~~----------------------~~~-------~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 240 (331)
.+... ... . .....+|||.|+|||++.+..|+..+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 43210 000 0 01124799999999999999999999
Q ss_pred cchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 020078 241 DVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315 (331)
Q Consensus 241 Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 315 (331)
|.|||||++|||+.|.+||..... .+..+.+.+ .....|.....+.++.|||.+|+. ||++|..
T Consensus 370 DwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr----------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR----------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh----------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999999954332 222222111 112223333455789999999999 9999986
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=307.93 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=202.1
Q ss_pred cCccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
..|...+.||+ +||.||+|.. .+..+++|.+...........+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 34666788999 9999999985 4468999998765444455788899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 127 VFEFVEYGTLADRICSPHG------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
||||+++|+|.+++..... .....+++.++..++.|++.||.||| +.+++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence 9999999999999853211 11134788899999999999999999 89999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVEN 271 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~ 271 (331)
.++|+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..||.... ........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 241 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK 241 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999986644332222222335778999999988889999999999999999998 888874322 11222221
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
... ...+. ..+.++.+++.+||+.||++||++.++++.|.+
T Consensus 242 ~~~-------~~~~~------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 RQL-------LPCSE------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCc-------CCCCC------CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 11111 233469999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=302.57 Aligned_cols=252 Identities=19% Similarity=0.206 Sum_probs=191.3
Q ss_pred ceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 61 VIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
.||+ +||.||+|.+ .+..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5788 9999999986 2356999988765544345678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 215 (331)
|.+++...........++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999997543222234667788899999999999999 89999999999999999999999999999875443332222
Q ss_pred ccccCCCCcccchhhhccC-------CCCCcccchhhHHHHHHHHh-CCCCChhHHHHHHHh--hccccccccccccccC
Q 020078 216 SHMLTRTKRYLAPEYILTG-------LCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHV--ENNRLGEIVDPIVVED 285 (331)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 285 (331)
.....++..|+|||++... .++.++||||||+++|||++ |..||.......... .........++....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL- 237 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC-
Confidence 2223467889999998632 35789999999999999996 998974322221111 111111111111110
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..+..+.+++.+|| .+|++|||+.||+..|+
T Consensus 238 -------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 238 -------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred -------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 12346889999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=309.13 Aligned_cols=259 Identities=17% Similarity=0.184 Sum_probs=195.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ ++|.||+|.. +++.||+|.+...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999 9999999998 6889999998755433344567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++ ++|.+++.... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 996 68888876532 35788899999999999999999 99999999999999999999999999999875433
Q ss_pred CCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH----HHhhc-cccc--------
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK----KHVEN-NRLG-------- 275 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~----~~~~~-~~~~-------- 275 (331)
.... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..... ....
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 156 PSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred CCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 2211 112347899999999865 457889999999999999999999984322111 11100 0000
Q ss_pred --cccccccc---cCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 --EIVDPIVV---EDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 --~~~~~~~~---~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+... .+..... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 0000000 0012356889999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=318.31 Aligned_cols=238 Identities=16% Similarity=0.200 Sum_probs=192.3
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
+.||+ +||.||++.. ++..||+|.+.... .......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36899 9999999987 78899999987542 2224567788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 214 (331)
+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~- 151 (323)
T cd05595 81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT- 151 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-
Confidence 998888653 35889999999999999999999 899999999999999999999999999998753222211
Q ss_pred cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchHH
Q 020078 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
.....||+.|+|||++.++.++.++|||||||++|+|++|+.||....... ..... .....|.
T Consensus 152 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~------------~~~~~p~-- 216 (323)
T cd05595 152 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM------------EEIRFPR-- 216 (323)
T ss_pred -cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------CCCCCCC--
Confidence 122458999999999998899999999999999999999999984332211 11110 0111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..++++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 3345799999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=311.03 Aligned_cols=257 Identities=16% Similarity=0.296 Sum_probs=205.2
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
...++|...+.||+ ++|.||++.. .+..+|+|.+.........+.+.+|+.+++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34467888999999 9999999975 34579999887654444567789999999999 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..++||||+++|+|.+++..... ..+++.++..++.+++.||.||| +.+|+|+||||+||+++.++.++++||
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~df 185 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDF 185 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCC
Confidence 999999999999999999865322 23789999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH---HHHhhccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV---KKHVENNRLGEI 277 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~---~~~~~~~~~~~~ 277 (331)
|+++...............++..|+|||++..+.++.++||||||+++|++++ |..|+...... .........
T Consensus 186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 262 (302)
T cd05055 186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--- 262 (302)
T ss_pred cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc---
Confidence 99986654332222222335778999999998899999999999999999998 88887432211 111111100
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
...+. ..+.++.+++.+||+.+|++|||+.|++..|+++
T Consensus 263 ----~~~~~------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 ----MAQPE------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CCCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011 2234799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=302.40 Aligned_cols=251 Identities=20% Similarity=0.354 Sum_probs=202.1
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.++|...+.||. ++|.||+|.. .+..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456888899999 9999999998 667899999865432 356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++....+ ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 83 MKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999975431 35889999999999999999999 899999999999999999999999999999876533
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ....+..|+|||++....++.++||||||+++|+|++ |+.|+...... ......... .....
T Consensus 157 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~- 227 (261)
T cd05068 157 IYEARE-GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-------MPCPP- 227 (261)
T ss_pred cccccC-CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-------CCCCC-
Confidence 221111 1113457999999988889999999999999999999 88887432221 111111100 00011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
..+..+.+++.+||+.+|++||++.+++..|+.
T Consensus 228 -----~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 -----GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred -----cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 233579999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=324.09 Aligned_cols=261 Identities=21% Similarity=0.351 Sum_probs=214.1
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
++++.-..+..-.++||. -+|.||.|.| ..-.||||.++.... ..++|+.|+.+|+.++|||+|+|+|+|.....
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 444443334444567888 8999999999 567899999875543 47899999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
+|||+|||++|+|.++|..+++ .-++.-..+.++.||++|+.||. .++.|||||.+.|+|+.++..+|++|||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL 411 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL 411 (1157)
T ss_pred eEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence 9999999999999999998765 34556667889999999999999 99999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh--HHHHHHHhhcccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL--LEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~--~~~~~~~~~~~~~~~~~~~ 280 (331)
++++..+....... ..-++.|.|||.+..+.++.|+|||+|||+|||+.| |..|+.. ...+......+.
T Consensus 412 sRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------- 483 (1157)
T KOG4278|consen 412 SRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------- 483 (1157)
T ss_pred hhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc-------
Confidence 99987654433222 224778999999999999999999999999999988 6666533 334444443322
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+.++..||. .+.+||..||+++|++||++.|+-..++.|..+
T Consensus 484 RM~~PeGCPp------kVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 484 RMDGPEGCPP------KVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cccCCCCCCH------HHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 2344555554 699999999999999999999999999998754
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=305.41 Aligned_cols=261 Identities=20% Similarity=0.337 Sum_probs=207.3
Q ss_pred HhcCccccCceee-cCcEEEEEEe-C-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee-CCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-E-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-TEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~ 123 (331)
..++|...++||+ +||.||+|.. . +..|++|.+...........+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3567888899999 9999999998 3 578999988765555557788999999999999999999999876 567
Q ss_pred cEEEEEecCCCChhhhhcCCCCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 124 PILVFEFVEYGTLADRICSPHGP---HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
.++++||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998653211 1145889999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEI 277 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~ 277 (331)
||+++.+.............++..|+|||++....++.++||||||+++|++++ |+.|+...... ........
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---- 236 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---- 236 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC----
Confidence 999986644332222122235778999999988889999999999999999999 99997432211 11111110
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...... ..+.++.+++.+||..||++|||+.+++..|+.+..
T Consensus 237 ---~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 ---RLAQPI------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---CCCCCC------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 001111 223479999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=308.10 Aligned_cols=259 Identities=19% Similarity=0.280 Sum_probs=203.8
Q ss_pred cCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+|.....||+ ++|.||+|.. ++..+++|.+..... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 34667788999 9999999985 234588888754432 24567899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 126 LVFEFVEYGTLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
+||||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence 99999999999999965321 01134789999999999999999999 99999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVEN 271 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~ 271 (331)
.++|+|||++................++..|+|||++....++.++||||||+++|+|++ |+.|+.... ........
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999999999876544332222222336788999999998899999999999999999998 999973221 11122221
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..... ... ..+..+.+++.+||+.||++|||+.++++.|+++...
T Consensus 241 ~~~~~-------~~~------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 241 GRVLE-------RPR------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCC-------CCc------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111 011 2234699999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=308.80 Aligned_cols=263 Identities=17% Similarity=0.303 Sum_probs=207.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe---------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL---------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
...++|.....||+ +||.||++.. ++..||+|.+...........+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33567788899999 9999999974 23469999887654444567899999999999 7999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
..+..+++|||+++|+|.+++...... ....+++.++..++.|++.||.||| +.+++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence 999999999999999999999754221 1135788899999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh--HHHH
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL--LEHV 265 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~--~~~~ 265 (331)
+++.++.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|++++ |..|+.. ....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999987654333222222335678999999988889999999999999999998 6777632 2222
Q ss_pred HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 266 KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.......... ..+. ..+.++.+++.+||..+|++|||+.|+++.|+++...
T Consensus 249 ~~~~~~~~~~-------~~~~------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 FKLLKEGHRM-------DKPA------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHcCCcC-------CCCC------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 2222211110 0111 2335799999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=307.28 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=203.7
Q ss_pred hcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++|...+.||+ ++|.||+|... +..+|+|.+...........+.+|+.++..++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 456778889999 99999999873 2579999987665444566788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEc
Q 020078 125 ILVFEFVEYGTLADRICSPHGP-----HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 199 (331)
++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence 9999999999999998753321 1134788899999999999999999 9999999999999999999999999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGE 276 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~ 276 (331)
|||+++.+.............++..|+|||.+..+.++.++||||||+++|++++ |..|+.... ...........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-- 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH-- 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC--
Confidence 9999876644332222222336788999999988889999999999999999998 888873221 22222221111
Q ss_pred ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
...+. ..+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 240 -----~~~~~------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 -----LDLPE------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----CCCCC------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 01111 22357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=331.00 Aligned_cols=259 Identities=19% Similarity=0.210 Sum_probs=205.6
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
.+.....+.|...+.||+ +||+||+|+. +++.||+|.+.... .......+.+|+.++..++|+||+++...+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 445566789999999999 9999999987 78999999986543 3334567889999999999999999988775432
Q ss_pred --------ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 123 --------IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 123 --------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+|+||||||+|||++.++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNG 180 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCC
Confidence 257999999999999998753321 246889999999999999999999 99999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENN 272 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~ 272 (331)
.+||+|||+++...............||+.|+|||++....++.++||||||+++|||++|+.||....... ......
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~ 260 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG 260 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 999999999987654332222233558999999999999899999999999999999999999984322211 111111
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. ++ .+...++++.+++.+||+.||++|||+.++++.
T Consensus 261 ~~----~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RY----DP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC----CC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 00 011334579999999999999999999999764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=309.27 Aligned_cols=261 Identities=17% Similarity=0.296 Sum_probs=206.1
Q ss_pred hcCccccCceee-cCcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
.+.|...+.||+ +||.||++... ...+|+|.+...........+.+|+.++..+ +||||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467888899999 99999999862 2469999987654444567788999999999 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+..++||||+++|+|.+++...... ....+++.+++.++.|++.||.||| +.+++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence 9999999999999999999754221 1135889999999999999999999 8999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKK 267 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~ 267 (331)
+.++.++|+|||.+................++..|+|||++.+..++.++||||||+++|+|++ |..|+.... ....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 9999999999999876643222111111224568999999988889999999999999999998 777763222 1111
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
....... ...+. ..+.++.+|+.+||..+|++|||+.++++.|+.+...
T Consensus 254 ~~~~~~~-------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 LLKEGHR-------MDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHcCCC-------CCCCC------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111110 01111 2345799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=303.23 Aligned_cols=262 Identities=19% Similarity=0.260 Sum_probs=202.4
Q ss_pred cCccccCceee-cCcEEEEEEeCC------------------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeee
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLEN------------------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKL 114 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 114 (331)
+.|...+.||+ +||.||++...+ ..||+|.+.........+.+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 56788889999 999999988722 45899998866554457789999999999999999999
Q ss_pred EeEEeeCCccEEEEEecCCCChhhhhcCCCCC------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 115 IGCCIETEIPILVFEFVEYGTLADRICSPHGP------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
++++..++..+++|||+++++|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhce
Confidence 99999999999999999999999998754311 1136889999999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh--CCCCChhHH--H
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT--GRRDNILLE--H 264 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~--g~~p~~~~~--~ 264 (331)
+++.++.++|+|||+++...............++..|+|||++..+.++.++||||||+++|+|++ +..|+.... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999876544332222222346778999999988889999999999999999998 566763221 1
Q ss_pred HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
....................+. ..+.++.+++.+||+.||++|||+.|++..|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGRQIYLPRPP------NCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccccccCCCcc------CCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111000000000011111 23357999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=307.75 Aligned_cols=259 Identities=19% Similarity=0.281 Sum_probs=200.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCc--eEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENR--PISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 126 (331)
.++|+..+.||+ +||.||+|.+ ++. .+++|.+...........+.+|+.++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356788889999 9999999987 443 46777776544444567888999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 127 VFEFVEYGTLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
||||+++|+|.+++..... .....+++.+++.++.|++.||.||| +.+++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence 9999999999999875321 11135789999999999999999999 999999999999999999999
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHHHhhcccc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRL 274 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~~~~~~~~ 274 (331)
++|+|||++........ .....++..|+|||++....++.++||||||+++|+|++ |..||....... ......
T Consensus 163 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~- 237 (303)
T cd05088 163 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYEKLP- 237 (303)
T ss_pred EEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-HHHHHh-
Confidence 99999999864321111 111124667999999988889999999999999999998 998874322111 111000
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
... ....+. ..+.++.+|+.+||+.+|++|||+.+++..|+.+..
T Consensus 238 -~~~--~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 238 -QGY--RLEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred -cCC--cCCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 000111 233468999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=302.71 Aligned_cols=252 Identities=20% Similarity=0.338 Sum_probs=204.2
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..+|...+.||. ++|.||+|.. .+..+++|.+...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 345777888999 9999999998 6788999998765432 456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++....+ ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 84 MEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred cccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 999999999976432 45789999999999999999999 899999999999999999999999999998776443
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... ...++..|+|||++....++.++||||||+++|+|++ |+.|+..... ......... . ...+.
T Consensus 158 ~~~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~--~~~~~- 227 (261)
T cd05148 158 VYLSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY-----R--MPCPA- 227 (261)
T ss_pred ccccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-----c--CCCCC-
Confidence 22211 2235778999999988899999999999999999998 7888743221 111111100 0 01111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..++++.+++.+||+.||++|||+.++++.|+.+
T Consensus 228 -----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 228 -----KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 3335799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=302.21 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=205.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||. ++|.||+|+. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999 9999999988 78999999876422 2234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++...... ...++...+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999888542211 135788899999999999999999 9999999999999999999999999999988764
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH-HHHhhccccccccccccccCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV-KKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ........ ....+ .
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~------~ 227 (267)
T cd08228 158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE--QCDYP------P 227 (267)
T ss_pred chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHh--cCCCC------C
Confidence 43221 11234788999999998888999999999999999999999997432211 11111000 00000 0
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.+ ....+..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 228 ~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LP-TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC-hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01 1134467999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=301.56 Aligned_cols=254 Identities=19% Similarity=0.333 Sum_probs=196.6
Q ss_pred cccCceee-cCcEEEEEEeC--Cc--eEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC------Ccc
Q 020078 57 NGHQVIAS-EHYKLYKGFLE--NR--PISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET------EIP 124 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~~--~~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~ 124 (331)
...+.||+ ++|.||+|.+. +. .+|+|.+.... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999 99999999983 22 58999876542 233467889999999999999999999988542 246
Q ss_pred EEEEEecCCCChhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 125 ILVFEFVEYGTLADRICSPH-GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
+++|||+++|+|.+++.... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874321 112245889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDP 280 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~ 280 (331)
++...............+++.|+|||+.....++.++||||||+++|+|++ |..||.... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~------ 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR------ 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 987654432222222335778999999998899999999999999999999 788874322 11122221111
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
...+. ..+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 233 -~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 -LKQPP------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred -CCCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111 2334699999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=300.52 Aligned_cols=255 Identities=20% Similarity=0.363 Sum_probs=199.3
Q ss_pred ccccCceee-cCcEEEEEEe--C---CceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc-----
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--E---NRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI----- 123 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~---~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 123 (331)
|...+.||+ +||.||+|.. + +..+|+|++.... .......+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456678999 9999999987 2 2679999987543 23345688999999999999999999999876554
Q ss_pred -cEEEEEecCCCChhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 124 -PILVFEFVEYGTLADRICSPH-GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 124 -~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
.++++||+++|+|..++.... ......+++..+..++.|++.||.||| +.+++||||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence 789999999999998885432 122246889999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhcccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNRLGEIV 278 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~~~~~~ 278 (331)
|+++...............++..|+|||++....++.++||||||+++|||++ |..|+....... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR---- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99987654432222222235678999999988889999999999999999999 778874322211 11111110
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
...+. ..+.++.+++.+||+.||++|||+.|+++.|+++
T Consensus 234 ---~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---LKQPE------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CCCCc------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111 3345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=301.39 Aligned_cols=254 Identities=21% Similarity=0.360 Sum_probs=203.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCc---eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENR---PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
+++|...+.||+ ++|.||+|+. ++. .+|+|.+.........+.+.+|+.++..++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999 9999999988 333 6999988766544456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999986532 35889999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCcccc-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccccccccccc
Q 020078 207 IPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 207 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
......... ......+..|+|||++....++.++||||||+++|++++ |..|+..... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~--------- 227 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF--------- 227 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC---------
Confidence 644322111 111123457999999988889999999999999999997 9999743221 111111110
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+.....+.++.+++.+||+.+|++||++.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000112345799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=313.53 Aligned_cols=257 Identities=19% Similarity=0.236 Sum_probs=192.3
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----ccEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-----IPIL 126 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~l 126 (331)
|...+.||+ ++|.||+|+. ++..||+|++.... .......+.+|+.+++.++||||+++++++...+ ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 677789999 9999999998 68899999987532 2224557889999999999999999999986543 3689
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||++ ++|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 82 v~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 82 VFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999996 6898888654 35889999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCcc-ccccccCCCCcccchhhhcc--CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH------H---------
Q 020078 207 IPEGETH-VTSHMLTRTKRYLAPEYILT--GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK------H--------- 268 (331)
Q Consensus 207 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~------~--------- 268 (331)
....... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||........ .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 5332211 11222458999999999865 6789999999999999999999999833211100 0
Q ss_pred --hhccccccccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 269 --VENNRLGEIVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 269 --~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
............ +......+.. ...++++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 0000000000 0223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.96 Aligned_cols=242 Identities=19% Similarity=0.259 Sum_probs=209.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPI 125 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 125 (331)
.-++|...++||+ +||+|+++.. +++.+|||.+++. ...++.+..+.|.+|+...+ ||.++.|+.++...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 4578888999999 9999999998 7889999999876 33346788889999998885 999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+.||++..+.+. ..++...+..++..|+.||.||| +++|||||||.+|||+|.+|.+||+|||+++
T Consensus 446 fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccc
Confidence 99999999996555543 46899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
..-.. ...+++++|||.|+|||++.+..|+..+|-|||||+||||+.|..||.. ..-.+++|.++..+
T Consensus 517 e~m~~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g----------ddEee~FdsI~~d~ 584 (694)
T KOG0694|consen 517 EGMGQ--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG----------DDEEEVFDSIVNDE 584 (694)
T ss_pred ccCCC--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC----------CCHHHHHHHHhcCC
Confidence 64322 2355668899999999999999999999999999999999999999643 22234556666666
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
...|. .++.++.+|+.++|+.||++|..+
T Consensus 585 ~~yP~--~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPR--FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCC--cccHHHHHHHHHHhccCcccccCC
Confidence 66665 678899999999999999999976
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.08 Aligned_cols=247 Identities=17% Similarity=0.308 Sum_probs=197.1
Q ss_pred CccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
+|...+.||+ ++|.||.|.+ .+..+|+|.+..... ..+.+.+|+.++.+++||||+++++++.+.+..+++|||++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4666678999 8999999988 445699998865432 35678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999986532 35889999999999999999999 99999999999999999999999999999876644332
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCc
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
.... ...++..|+|||++....++.++||||||+++|+|++ |..|+..... ............ . +.
T Consensus 156 ~~~~-~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~--~~--- 224 (256)
T cd05113 156 TSSV-GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY-----R--PH--- 224 (256)
T ss_pred eecC-CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-----C--CC---
Confidence 1111 1225678999999988889999999999999999998 8888743221 111111111100 0 00
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..+..+.+++.+||+.||++|||+.++++.|+
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12347999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=318.57 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=208.5
Q ss_pred ccCceee-cCcEEEEEEeC----Cc--eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 58 GHQVIAS-EHYKLYKGFLE----NR--PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~~----~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
...+||+ -||.||+|.+. |+ .||||..+.+...+..+.|+.|..+|++++|||||+|+|+|.+. +.|+|||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEec
Confidence 3578999 88999999993 22 48889988876666789999999999999999999999999865 57899999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++.|.|..++.... ..++......++.||+.||+||| +++.|||||..+|||+.+.-++||+|||+++.+.+.
T Consensus 472 ~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 472 APLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred ccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 99999999998654 46888899999999999999999 999999999999999999999999999999999776
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
.....+ ...-+..|||||.+....++++||||-|||.+||++. |..||...+. .+++-. +.+....|
T Consensus 545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------sDVI~~-iEnGeRlP 612 (974)
T KOG4257|consen 545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------SDVIGH-IENGERLP 612 (974)
T ss_pred chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------cceEEE-ecCCCCCC
Confidence 654433 2335788999999999999999999999999999876 8889643222 111111 11122222
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+..+++.+..|+.+||.++|.+||++.|+...|+.+++
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 223556679999999999999999999999999999885
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=302.63 Aligned_cols=255 Identities=18% Similarity=0.312 Sum_probs=202.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
...|...+.||+ ++|.||+|.+ ++. .||+|.+...........+.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 346777889999 9999999987 444 48999987655554567888999999999999999999999754 567
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+++||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||++++++.+||+|||+++
T Consensus 85 l~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 9999999999999987542 35889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 282 (331)
...............+++.|+|||...+..++.++||||||+++|||++ |..|+.... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL------- 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------
Confidence 7654332221111224678999999988889999999999999999998 888874321 111112111100
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..+.++.+++.+||..||++|||+.++++.|+.+..
T Consensus 231 ~~~~------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 PQPP------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCCc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0011 233478999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=319.61 Aligned_cols=251 Identities=16% Similarity=0.147 Sum_probs=197.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+++. +++.||+|.+.... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888899999 9999999998 68899999987532 1223556788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++..+.
T Consensus 81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 999999999998754 35889999999999999999999 9999999999999999999999999999987653
Q ss_pred CCCccc------------------------------------cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHH
Q 020078 209 EGETHV------------------------------------TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLEL 252 (331)
Q Consensus 209 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el 252 (331)
...... .....+||+.|+|||++....++.++|||||||++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 221100 00123589999999999988999999999999999999
Q ss_pred HhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 020078 253 LTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT---MVYAAK 321 (331)
Q Consensus 253 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~evl~ 321 (331)
++|..||................. ....+.....++++.+|+.+|+. +|.+|++ +.+++.
T Consensus 233 ~~G~~Pf~~~~~~~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQETYRKIINWKE--------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCC--------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999854332211111000000 00111111234578999999997 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=323.86 Aligned_cols=245 Identities=20% Similarity=0.323 Sum_probs=203.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.-|++..-||. +||.||-++. +.+.||||+..-. .+...++++..|+..|.+++|||+|.+.|+|......||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 44677778999 9999999998 8899999998754 33345788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||- ||-.|++..-. +++-.-.+..|+.+.+.||+||| +.+.||||||+.|||+++.|.+||+|||.|....
T Consensus 106 EYCl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 106 EYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred HHHh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 9995 68888886432 67888899999999999999999 9999999999999999999999999999987664
Q ss_pred CCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
...+ ++|||.|||||+++ .|.|+.++||||||++..||.-.++|....+-+-..+.-... -.|.+.
T Consensus 178 PAns------FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---esPtLq-- 246 (948)
T KOG0577|consen 178 PANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---ESPTLQ-- 246 (948)
T ss_pred chhc------ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---CCCCCC--
Confidence 4333 56999999999997 678999999999999999999999996443333322211000 011111
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
. .+++..+..++..||++-|.+|||..++++.
T Consensus 247 ----s-~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 ----S-NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----C-chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 1 2778889999999999999999999998753
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.90 Aligned_cols=239 Identities=15% Similarity=0.184 Sum_probs=192.5
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
+.||+ +||.||++.. ++..||+|.+.... .......+.+|+.++..++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36899 9999999987 78899999987542 2223567788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
+|.+++... ..+++..+..++.||+.||.||| + .+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 999888653 35889999999999999999999 6 79999999999999999999999999998754322211
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... .....|.
T Consensus 153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~------------~~~~~p~- 217 (325)
T cd05594 153 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------------EEIRFPR- 217 (325)
T ss_pred --cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc------------CCCCCCC-
Confidence 11245899999999999889999999999999999999999998432221 111111 0111111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRP-----TMVYAAKQ 322 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~~ 322 (331)
..++++.+++.+||+.||++|+ ++.++++.
T Consensus 218 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 -TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2345799999999999999997 89888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=298.66 Aligned_cols=245 Identities=18% Similarity=0.313 Sum_probs=194.2
Q ss_pred eee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||+ +||.||+|.+ .+..||+|.+.........+.+.+|+.++++++||||+++++++.. +..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 788 9999999976 2446999998766544456779999999999999999999999864 567899999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++.... ..+++..++.++.|++.||.||| ..+++||||||+||+++.++.++|+|||++............
T Consensus 82 ~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 82 NKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99986532 45889999999999999999999 899999999999999999999999999998865443322111
Q ss_pred -cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCchHH
Q 020078 217 -HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 217 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
....++..|+|||++....++.++||||||+++|++++ |..||..... ........... ..+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~------ 221 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL-------DCPA------ 221 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------CCCC------
Confidence 11123578999999988889999999999999999996 9999743221 11222211110 0111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
..++++.+++.+||..+|++||++.++.+.|+.++
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 23357999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=318.30 Aligned_cols=252 Identities=16% Similarity=0.172 Sum_probs=195.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.|...+.||+ +||+||+|+. ++..+|+|++.... .......+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4777889999 9999999988 77899999987542 22245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++... ..+++..+..++.|++.||.||| ..+|+||||||+|||++.++.++|+|||+++.+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 99999999998654 35788889999999999999999 89999999999999999999999999999764321
Q ss_pred CCc---------------------------------------------cccccccCCCCcccchhhhccCCCCCcccchh
Q 020078 210 GET---------------------------------------------HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244 (331)
Q Consensus 210 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 244 (331)
... ........||+.|+|||++....++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 000 00011245999999999999888999999999
Q ss_pred hHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHH--hccCCCCCCCCHHHHHHH
Q 020078 245 FGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFE--CVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 245 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~Rps~~evl~~ 322 (331)
|||++|||++|..||................. ....+.....++++.+|+.+ |+..+|..||++.++++.
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQLKVINWEN--------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc--------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999999854322111111000000 00111111234578999988 556667779999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=317.64 Aligned_cols=244 Identities=20% Similarity=0.235 Sum_probs=189.8
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|...+.||+ +||.||+|+. +++.||+|.+...........+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4555678999 9999999998 688999999876544445678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+.. ......+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+....
T Consensus 155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999986532 2456778889999999999999 8999999999999999999999999999988764332
Q ss_pred ccccccccCCCCcccchhhhccC-----CCCCcccchhhHHHHHHHHhCCCCChhHH--HHHHHhhcccccccccccccc
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG-----LCNEKTDVFCFGMLLLELLTGRRDNILLE--HVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 284 (331)
.. .....||..|+|||++... ..+.++|||||||++|||++|+.||.... ........... ..
T Consensus 223 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--------~~ 292 (353)
T PLN00034 223 DP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM--------SQ 292 (353)
T ss_pred cc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc--------cC
Confidence 11 1223589999999987532 23468999999999999999999984211 00000000000 00
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+ ...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 293 ~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAP--ATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCC--CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1334579999999999999999999999864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.38 Aligned_cols=259 Identities=21% Similarity=0.315 Sum_probs=206.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ ++|.||+|.. ++..+|+|.+... ......+.+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999 9999999998 6889999988632 22223668889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++...... ...+++.++..++.+++.||.||| +.+|+||||+|+||+++.++.++++|||++..+.
T Consensus 82 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999988643211 145789999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH-HHhhccccccccccccccCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK-KHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... ....... .... ..
T Consensus 158 ~~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~-------~~ 227 (267)
T cd08224 158 SKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDY-------PP 227 (267)
T ss_pred CCCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCC-------CC
Confidence 432211 11347889999999988889999999999999999999999974322110 0100000 0000 00
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.+. ...+.++.+++.+||..+|++|||+.++++.|+++.
T Consensus 228 ~~~-~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPA-DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCh-hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111 134457999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.89 Aligned_cols=248 Identities=21% Similarity=0.343 Sum_probs=203.9
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.++|...+.||. ++|.||+|...++.||+|.+..... ..+.+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 346777889999 9999999999999999999976543 4678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++++|.+++..... ..+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999875432 35889999999999999999999 9999999999999999999999999999988763322
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
. ...++..|+|||++..+.++.++||||||+++|++++ |..|+.... ........... ...+.
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~-- 222 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-------MEAPE-- 222 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC-------CCCcc--
Confidence 2 1225678999999988889999999999999999997 888873322 11111111100 00011
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..++++.+++.+||..+|++|||+.++++.|+++
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 223 ----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 2335799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.12 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=199.1
Q ss_pred ccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPIL 126 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 126 (331)
|...+.||+ +||.||.+.. ++..||+|.+...........+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 367788999 9999988653 56789999987654433567788999999999999999999998764 35789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
+|||+++|+|.+++.. ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999999864 34899999999999999999999 89999999999999999999999999999887
Q ss_pred cCCCCcccc-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc----c
Q 020078 207 IPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP----I 281 (331)
Q Consensus 207 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~ 281 (331)
......... .....++..|+|||.+..+.++.++||||||+++|+|++|..|+..................... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 654332111 11123566799999998888999999999999999999999886332211100000000000000 0
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.......+.+...+.++.+++.+||+.+|++|||+++++..|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000111134457999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=316.50 Aligned_cols=250 Identities=19% Similarity=0.233 Sum_probs=209.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc-cEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI-PILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~ 128 (331)
++|.....+|+ .||.++..+. ++..+++|++.-. ..+..++...+|+.++++++|||||.+++.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778889999 9997766655 7889999988743 445567788999999999999999999999999988 89999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
+||+||+|.+.+....+ ..++..++..|+.|++.|+.||| .++|+|||||+.||++..+..++|+|||+|+.+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999987653 45889999999999999999999 9999999999999999999999999999999886
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.... ...+..||+.|+.||.+.+-+|+.|+|||||||++|||++-+.+|...+...-... +.... ..
T Consensus 158 ~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k----------i~~~~-~~ 224 (426)
T KOG0589|consen 158 PEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK----------INRGL-YS 224 (426)
T ss_pred Cchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH----------Hhhcc-CC
Confidence 6542 22336699999999999999999999999999999999999999754433322211 11111 12
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
|.+...+.++..|+..||..+|..||++.+++..
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3333667789999999999999999999999976
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=304.84 Aligned_cols=257 Identities=19% Similarity=0.312 Sum_probs=200.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CC--ceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--EN--RPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|....+||+ ++|.||+|.. ++ ..+++|.+.........+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788889999 9999999988 33 246888776433333566789999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 128 FEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
+||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence 9999999999999653211 1135788999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~ 273 (331)
||+|||++........ ......+..|+|||++....++.++||||||+++|+|++ |..||..... .........
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999864322111 111123557999999988889999999999999999997 9888743221 111111100
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. ...+. ..+.++.+|+.+||..+|.+|||+.+++..|+.+..+
T Consensus 236 -----~--~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 236 -----R--MEKPR------NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred -----C--CCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00011 2335799999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=303.98 Aligned_cols=258 Identities=20% Similarity=0.257 Sum_probs=194.3
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC---c--
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE---I-- 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---~-- 123 (331)
.+-.|...+++|. +||.||+|+. +++.||||+...+.. ---+|+.+|+.+.|||||+|.-+|.... .
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 4456788899999 9999999999 778999999875432 2337999999999999999988887532 2
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFS 202 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg 202 (331)
..+||||+|. +|...+....... ..++.-.+.-+..||.+||.||| ..+|+||||||+|+|+|.+ |.+||+|||
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 3489999997 9999997532211 45777778889999999999999 8999999999999999966 999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh--------
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE-------- 270 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~-------- 270 (331)
.|+.+..+..... ..+|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|....... ..+.
T Consensus 172 SAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 172 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9998876654322 3478899999999875 69999999999999999999998662211111 1100
Q ss_pred -----ccccccccccccccCCCCc-hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 271 -----NNRLGEIVDPIVVEDKSCP-EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 271 -----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+....+...+.+...+... .....++++.+|+.++|+++|.+|.++.|++..
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0000011112222111100 112445689999999999999999999998753
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=298.93 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=189.1
Q ss_pred ceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 61 VIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
.||+ +||.||+|.. ....+++|.+...........+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 4788 9999999976 2346888887655444455678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 215 (331)
|.+++...........++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999997643322233567788899999999999999 89999999999999999999999999999865433222111
Q ss_pred ccccCCCCcccchhhhcc-------CCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccC
Q 020078 216 SHMLTRTKRYLAPEYILT-------GLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 285 (331)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..|+...... ..............+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD-- 236 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc--
Confidence 222335678999999753 356789999999999999999 67776432211 111111111111111111
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
...+..+.+++..|| .||++|||+++|++.|.
T Consensus 237 ------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 ------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 123356888999999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=305.60 Aligned_cols=254 Identities=18% Similarity=0.251 Sum_probs=198.8
Q ss_pred ccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
|...+.||+ ++|.||+|... +..||+|.+.........+.+.+|+.++..++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 445567899 89999999872 3679999987654443456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 128 FEFVEYGTLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
+||+++++|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCce
Confidence 999999999999853210 11134788889999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~ 273 (331)
||+|||+++...............+++.|+|||++..+.++.++||||||+++|||++ |..|+.... ..........
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~ 243 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999886644332222222335778999999998899999999999999999998 777763321 1111111111
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
.. ..+. +.+..+.+|+.+||+.+|++||++++++..|+.
T Consensus 244 ~~-------~~~~------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 244 VL-------PCPD------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cC-------CCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 10 0011 334569999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=319.14 Aligned_cols=251 Identities=15% Similarity=0.193 Sum_probs=198.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
..++|...+.||+ +||.||+++. ++..+|+|.+.... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999 9999999988 67899999986431 12234567889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.. ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..
T Consensus 121 v~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 121 VMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 9999999999998854 24778888999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCcccchhhhccC----CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhhcccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTG----LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEIVDP 280 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~ 280 (331)
....... ......||+.|+|||++... .++.++|||||||++|||++|+.||........ .......
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~------ 264 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN------ 264 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC------
Confidence 6433221 12234589999999998643 478999999999999999999999854332211 1111000
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAKQ 322 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~~ 322 (331)
....|.....+.++.+|+.+||+.+|++ |||+.++++.
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111111133457999999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=328.83 Aligned_cols=260 Identities=20% Similarity=0.239 Sum_probs=211.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-CC-ceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEe-e---C-
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-EN-RPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCI-E---T- 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~-~---~- 121 (331)
.....+.+.++|.+ ||+.||.+.. .+ ..+|+|++... .+...+...+||.+|+.|+ |+|||.+++... . +
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 44567788899999 9999999999 44 89999998877 4447889999999999997 999999999432 1 1
Q ss_pred --CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEc
Q 020078 122 --EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199 (331)
Q Consensus 122 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 199 (331)
-+.+|.||||++|+|.|+|..+.. ..|++.++++|+.|+++|+.+|| ++..+|||||||.|||||+.++..|||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeC
Confidence 246799999999999999986543 34899999999999999999999 346679999999999999999999999
Q ss_pred cCCCccccCCCCccc------c-ccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh
Q 020078 200 DFSESEYIPEGETHV------T-SHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV 269 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~------~-~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~ 269 (331)
|||.+.......... . .-....|+-|+|||++. +..+++|+|||+|||+||.|+....||....
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------ 262 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------ 262 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------
Confidence 999986543222100 0 00123589999999986 4578999999999999999999999963221
Q ss_pred hccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 270 ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. -.++..++..|.....+..+.+||..||+.||.+||++-+++..+-.+...
T Consensus 263 ----~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ----K----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----c----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1 124556666666668888999999999999999999999999999887643
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=296.26 Aligned_cols=243 Identities=22% Similarity=0.370 Sum_probs=195.3
Q ss_pred ceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhh
Q 020078 61 VIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 138 (331)
+||+ ++|.||+|.. ++..+|+|.+...........+.+|+.+++.++||||+++++++...+..++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6888 9999999987 6788999998766544445678899999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccc
Q 020078 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218 (331)
Q Consensus 139 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 218 (331)
++.... ..+++..+..++.+++.||.||| ..+++||||||+||+++.++.++|+|||++........... ..
T Consensus 82 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~~ 153 (250)
T cd05085 82 FLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS-GL 153 (250)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC-CC
Confidence 886532 35789999999999999999999 89999999999999999999999999999875543322111 11
Q ss_pred cCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCchHHHHH
Q 020078 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295 (331)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
..++..|+|||++..+.++.++||||||+++|++++ |..||..... .......... ...+. ..+
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~------~~~ 220 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-------MSCPQ------KCP 220 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC-------CCCCC------CCC
Confidence 224677999999998889999999999999999998 8888743221 1111111100 01111 233
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 296 QALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 296 ~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
.++.+++.+||+.+|++|||+.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 47999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=316.84 Aligned_cols=251 Identities=15% Similarity=0.142 Sum_probs=193.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..|...+.||+ +||.||++.. +++.||+|... ...+.+|+.++++++|||||++++++..+...++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 57999999999 9999999988 78899999743 33577999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+. ++|..++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++......
T Consensus 165 ~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 96 6898888654 35789999999999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH----------HHHHHhhcc-ccc-c--
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE----------HVKKHVENN-RLG-E-- 276 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----------~~~~~~~~~-~~~-~-- 276 (331)
... ......||+.|+|||++....++.++|||||||++|+|++|..|+.... ......... ... .
T Consensus 236 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 111 1122458999999999998899999999999999999999998753210 010000000 000 0
Q ss_pred ---------cc----ccccccCC---CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 ---------IV----DPIVVEDK---SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 ---------~~----~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ......+. .+......+.++.+|+.+||+.||++|||+.|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 00000000 01111134568999999999999999999999985
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=315.92 Aligned_cols=251 Identities=16% Similarity=0.153 Sum_probs=199.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||++.. +++.+|+|.+..... ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888899999 9999999988 788999999875422 224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+.
T Consensus 81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999997642 35889999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCcccchhhhc------cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYIL------TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||...........-......
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~----- 227 (330)
T cd05601 154 ANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF----- 227 (330)
T ss_pred CCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCc-----
Confidence 44322 222235899999999987 456789999999999999999999998433222111110000000
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...|.....+.++.+|+..||+ +|++|||+.+++.
T Consensus 228 ---~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 ---LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0011111234579999999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=318.97 Aligned_cols=252 Identities=17% Similarity=0.162 Sum_probs=201.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ ++|.||+|.. +++.||+|.+.... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888899999 9999999998 58999999987532 1224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..++...+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999764 35888999999999999999999 8999999999999999999999999999988664
Q ss_pred CCC---------------------------ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh
Q 020078 209 EGE---------------------------THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL 261 (331)
Q Consensus 209 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~ 261 (331)
... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 433 00112224589999999999999999999999999999999999999854
Q ss_pred HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 020078 262 LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-MVYAAKQ 322 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~evl~~ 322 (331)
.........-..... ....|.....++++.+|+.+||. ||.+||+ +.++++.
T Consensus 233 ~~~~~~~~~i~~~~~--------~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DTLQETYNKIINWKE--------SLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCHHHHHHHHhccCC--------cccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 332211111000000 00111111134579999999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=312.52 Aligned_cols=240 Identities=18% Similarity=0.229 Sum_probs=190.7
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
++||+ +||.||+|.. +++.||+|.+.... .....+.+..|..++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899 9999999988 57899999987542 223456677899998866 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|...+... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 9999888654 35888999999999999999999 899999999999999999999999999998754322221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQ 293 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
.....||+.|+|||++....++.++||||||+++|+|++|+.||........... ........|. .
T Consensus 153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~----------i~~~~~~~p~--~ 218 (321)
T cd05591 153 --TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES----------ILHDDVLYPV--W 218 (321)
T ss_pred --ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH----------HHcCCCCCCC--C
Confidence 1224589999999999988999999999999999999999999854322111110 0001111111 2
Q ss_pred HHHHHHHHHHHhccCCCCCCC-------CHHHHHH
Q 020078 294 QLQALLQLIFECVNESAGDRP-------TMVYAAK 321 (331)
Q Consensus 294 ~~~~~~~li~~cl~~dP~~Rp-------s~~evl~ 321 (331)
.+.++.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 335799999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=299.49 Aligned_cols=253 Identities=21% Similarity=0.334 Sum_probs=202.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CC---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--EN---RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+|...+.||+ +||.||+|.. ++ ..+|+|.+...........+.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777889999 9999999987 22 369999887655444567899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||++...
T Consensus 84 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 84 TEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 99999999999996543 35788999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccc-cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccc
Q 020078 208 PEGETHVTS-HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 208 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
......... ....++..|+|||++.++.++.++|+||||+++|++++ |..|+..... .......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------~~ 229 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-------LP 229 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-------CC
Confidence 544322211 11223567999999998889999999999999999886 9999743221 1111111100 00
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
... ..+.++.+++.+||+.+|++|||+.++++.|+++
T Consensus 230 ~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 APM------DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCC------CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111 2345789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.86 Aligned_cols=257 Identities=20% Similarity=0.326 Sum_probs=200.5
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
.+++|...+.||+ ++|.||+|.+. +..|++|.+...........+.+|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567888899999 99999999883 357888887655444345679999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC---ceEE
Q 020078 124 PILVFEFVEYGTLADRICSPHG--PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKL 198 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl 198 (331)
.++||||+++|+|.+++..... .....+++..+..++.||+.||.||| +.+++||||||+||+++.++ .++|
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999875431 11235889999999999999999999 89999999999999998654 6999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLG 275 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~ 275 (331)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|+|++ |..||.... ...........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~- 239 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGR- 239 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-
Confidence 99999987633322111111223567999999998899999999999999999997 888874321 11111111100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
...+. ..+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ------~~~~~------~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 ------LDPPK------GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------CCCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00011 23357999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=312.48 Aligned_cols=241 Identities=16% Similarity=0.207 Sum_probs=189.7
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHH---HhcCCCceeeeEeEEeeCCccEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFA---AQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
|...+.||+ ++|.||+|.. +++.||+|.+.... .....+.+.+|+.++ ..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456778999 9999999988 68899999987542 122345666776665 466799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|...+.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999888754 35889999999999999999999 899999999999999999999999999998754
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 285 (331)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... .
T Consensus 152 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------~ 217 (324)
T cd05589 152 MGFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------E 217 (324)
T ss_pred CCCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------C
Confidence 22221 112245899999999999889999999999999999999999998432211 1111111 1
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
...|. ..+.++.+++.+||+.||++||+ +.++++
T Consensus 218 ~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111 23456899999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=296.45 Aligned_cols=246 Identities=19% Similarity=0.311 Sum_probs=196.2
Q ss_pred CccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
+|...+.||+ ++|.||+|.+ .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4667778999 8999999988 556899998865432 34578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||+++.......
T Consensus 83 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 83 NGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999986532 35789999999999999999999 89999999999999999999999999999876643322
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCCCc
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
..... ..++..|+|||.+....++.++||||||+++|++++ |..|+...... ........ . ...+.
T Consensus 156 ~~~~~-~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~--~~~~~--- 224 (256)
T cd05059 156 TSSQG-TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-----R--LYRPK--- 224 (256)
T ss_pred cccCC-CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----c--CCCCC---
Confidence 11111 113457999999998899999999999999999999 78887432221 11111110 0 01111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
..+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 ---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2334799999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=297.11 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=198.6
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+.|...+.||+ ++|.||+|.. .+..+|+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 346777888999 9999999988 667899999875433 3467899999999999999999999885 4567899999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++..... ..+++..+..++.+++.||.||| +.+++||||||+||++++++.++|+|||++..+...
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 82 MSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999875321 35789999999999999999999 899999999999999999999999999999876443
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ...++..|+|||++....++.++||||||+++|+|++ |..||...... ........ ...
T Consensus 156 ~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-----------~~~ 223 (260)
T cd05070 156 EYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY-----------RMP 223 (260)
T ss_pred cccccc-CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------CCC
Confidence 322111 1225667999999988889999999999999999999 88887432211 11111100 001
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
.+ ...+.++.+|+.+||..+|++|||+.++.+.|+.
T Consensus 224 ~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CP--QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CC--CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 1334579999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=318.17 Aligned_cols=252 Identities=16% Similarity=0.128 Sum_probs=195.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||. +||.||++.. +++.||+|.+.... .....+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36788899999 9999999988 78899999986432 2224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 999999999998654 45788899999999999999999 9999999999999999999999999999986432
Q ss_pred CCCc------------cc---------------------------------cccccCCCCcccchhhhccCCCCCcccch
Q 020078 209 EGET------------HV---------------------------------TSHMLTRTKRYLAPEYILTGLCNEKTDVF 243 (331)
Q Consensus 209 ~~~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 243 (331)
.... .. ......||+.|+|||++....++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 00 00013589999999999988999999999
Q ss_pred hhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCC---CCHHHHH
Q 020078 244 CFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDR---PTMVYAA 320 (331)
Q Consensus 244 SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~evl 320 (331)
||||++|||++|..||................ .....|.....+.++.+|+.+||. +|.+| +|+.|++
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHETYRKIINWR--------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHHHHHHHccC--------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 99999999999999984322211111000000 001111111234579999999998 77765 5998887
Q ss_pred HH
Q 020078 321 KQ 322 (331)
Q Consensus 321 ~~ 322 (331)
..
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=306.37 Aligned_cols=260 Identities=18% Similarity=0.322 Sum_probs=204.4
Q ss_pred hcCccccCceee-cCcEEEEEEe---------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL---------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
.++|...+.||+ ++|.||++.. ....+|+|.+...........+.+|+.++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 456778899999 9999999975 23468999887655444567788999999999 699999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+..+++|||+++|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence 9999999999999999999753211 1135889999999999999999999 8999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHVKK 267 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~~~ 267 (331)
+.++.++|+|||+++...............++..|+|||++....++.++||||||+++|++++ |..||... .....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999986643322111111224567999999988889999999999999999999 78886332 12222
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
....... ...+. ..+.++.+++.+||+.||++|||+.++++.|.++..
T Consensus 248 ~~~~~~~-------~~~~~------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LLREGHR-------MDKPS------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHcCCC-------CCCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 2221111 01111 223468899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=312.26 Aligned_cols=233 Identities=21% Similarity=0.271 Sum_probs=188.0
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||+|+. +++.||+|.+.... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899 9999999998 67899999987532 223456777888888876 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 9999988654 35888999999999999999999 99999999999999999999999999999875432221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ....|.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~------------~~~~~~- 217 (320)
T cd05590 152 -TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND------------EVVYPT- 217 (320)
T ss_pred -cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------------CCCCCC-
Confidence 112245899999999999888999999999999999999999998443221 1111111 111111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
..+.++.+++.+||+.||++||++
T Consensus 218 -~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 -WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCC
Confidence 234579999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.43 Aligned_cols=253 Identities=19% Similarity=0.238 Sum_probs=199.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..+|...+.||+ ++|.||+|+. ++..+|+|.+...... ....+.+|+.++.+++||||+++++++..++..++|||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 356888899999 9999999997 7788999998654332 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++... .++++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 87 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 99999999988643 35788999999999999999999 89999999999999999999999999999886643
Q ss_pred CCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... .....++..|+|||.+. ...++.++||||||+++|+|++|..|+............ .......+..
T Consensus 159 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~---- 231 (267)
T cd06646 159 TIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-SKSNFQPPKL---- 231 (267)
T ss_pred cccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-ecCCCCCCCC----
Confidence 2211 11234788999999884 345788999999999999999999997433221111100 0000000111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
.....++.++.+++.+||+.+|++|||+.++++.|
T Consensus 232 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 --KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11113446799999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.35 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=202.2
Q ss_pred hcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++|.....||+ ++|.||++.. ++..+|+|.+...........+.+|+.+++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888889999 9999999986 35789999987655444567799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHG-----------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQ 187 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~N 187 (331)
+++|||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence 999999999999999964221 11134788899999999999999999 8999999999999
Q ss_pred eEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--H
Q 020078 188 ILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--H 264 (331)
Q Consensus 188 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~ 264 (331)
|+++.++.++|+|||++.................+..|+|||++....++.++||||||+++|+|++ |..|+.... .
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875533322111111225677999999998899999999999999999997 777863221 1
Q ss_pred HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
........... .++. ..+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ~~~~~~~~~~~-----------~~~~--~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVRDGNVL-----------SCPD--NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHhcCCCC-----------CCCC--CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111110 0111 233579999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=311.73 Aligned_cols=240 Identities=17% Similarity=0.198 Sum_probs=190.9
Q ss_pred Cceee-cCcEEEEEEe-----CCceEEEEEeCCCC---CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 60 QVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY---SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.||+ +||.||+++. .++.||+|.+.... .......+.+|+.++..++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 46899 9999999976 46789999986531 122345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++... ..+.+..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999998654 35778888899999999999999 999999999999999999999999999998754322
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
... .....||+.|+|||++....++.++||||||+++|||++|+.||...........- .......|.
T Consensus 154 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~----------~~~~~~~~~ 221 (323)
T cd05584 154 GTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI----------LKGKLNLPP 221 (323)
T ss_pred CCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH----------HcCCCCCCC
Confidence 221 12245899999999999888999999999999999999999998543322111100 000111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..+.++.+++.+||+.||++|| ++.++++
T Consensus 222 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 --YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2335799999999999999999 7877765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=299.25 Aligned_cols=256 Identities=20% Similarity=0.259 Sum_probs=202.7
Q ss_pred cCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|.....||+ ++|.||+|... ...|++|...........+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 45777889999 99999999872 236899988765544456789999999999999999999999875 457899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.++++|||+++..
T Consensus 85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999999999996542 35889999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
......... ...++..|+|||.+....++.++||||||+++|++++ |..||...........-.... ....+.
T Consensus 158 ~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~ 231 (270)
T cd05056 158 EDESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-----RLPMPP 231 (270)
T ss_pred ccccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-----cCCCCC
Confidence 544322221 1224568999999988889999999999999999986 999974332221111100000 001111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..+.++.+++.+||..+|++|||+.++++.|+++..+
T Consensus 232 ------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 232 ------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2335799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=310.07 Aligned_cols=237 Identities=20% Similarity=0.250 Sum_probs=187.7
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
++||+ +||.||+|.. +++.||+|.+.... .....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899 9999999998 67789999987532 122345566777777654 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..++...+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~- 151 (316)
T cd05592 81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-
Confidence 9999988654 35888999999999999999999 89999999999999999999999999999876533221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ....|.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------~~~~~~- 217 (316)
T cd05592 152 -KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND------------RPHFPR- 217 (316)
T ss_pred -ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------CCCCCC-
Confidence 1122458999999999998889999999999999999999999985332211 111110 001111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMV-YAA 320 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~-evl 320 (331)
..+.++.+++.+||..||++||++. +++
T Consensus 218 -~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 -WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2345789999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=302.55 Aligned_cols=262 Identities=19% Similarity=0.281 Sum_probs=198.8
Q ss_pred cCccccCceee-cCcEEEEEEeCC----------------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLEN----------------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIG 116 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~ 116 (331)
+.|...+.||+ +||.||++...+ ..||+|.+...........+.+|+.++.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 46778889999 999999987622 2489999876544445678999999999999999999999
Q ss_pred EEeeCCccEEEEEecCCCChhhhhcCCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceE
Q 020078 117 CCIETEIPILVFEFVEYGTLADRICSPHG-------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL 189 (331)
Q Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nil 189 (331)
++...+..++||||+++++|.+++..... .....+++..++.++.|++.||.||| +.+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence 99999999999999999999998864321 01124688899999999999999999 899999999999999
Q ss_pred EcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh--CCCCChhHHHHHH
Q 020078 190 FDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT--GRRDNILLEHVKK 267 (331)
Q Consensus 190 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~--g~~p~~~~~~~~~ 267 (331)
++.++.+||+|||++................++..|+|||++..+.++.++||||||+++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999876543322222222335678999999998899999999999999999998 4556643221110
Q ss_pred Hhhcccccccccc--ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 268 HVENNRLGEIVDP--IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 268 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
............. ....+.. .++.+.+|+.+||..||++|||+.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPL------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCCCCCC------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 0000000000000 0011111 2346999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.26 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=201.1
Q ss_pred CccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~ 125 (331)
.|...+.||+ ++|.||.+.+ ++..||+|.+...........+.+|+.+++.++||||+++++++.+. +..+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4667788999 9999999974 46789999987654444567899999999999999999999999875 5678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.
T Consensus 85 lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999986532 35889999999999999999999 9999999999999999999999999999988
Q ss_pred ccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc-ccc---c
Q 020078 206 YIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE-IVD---P 280 (331)
Q Consensus 206 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~---~ 280 (331)
.+....... ......++..|+|||++.+..++.++||||||+++|+|++++.|.................+ ... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 765433211 11223467789999999888899999999999999999998766422111100000000000 000 0
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
.+......+.+...+.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000001111113445799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=296.36 Aligned_cols=246 Identities=23% Similarity=0.326 Sum_probs=198.1
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEe-eCCccEEEEEec
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCI-ETEIPILVFEFV 131 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~ 131 (331)
.+|...+.||+ ++|.||++...+..+++|.+.... ..+.+.+|+.++++++|+||+++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35777889999 999999999999999999986432 3567899999999999999999999865 456789999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++..... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999875432 34788999999999999999999 8999999999999999999999999999987553322
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.. ..++..|+|||++....++.++||||||+++|+|++ |+.|+.... ............. . ..
T Consensus 157 ~~-----~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~--~~-- 222 (256)
T cd05082 157 DT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-----A--PD-- 222 (256)
T ss_pred CC-----CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-----C--CC--
Confidence 21 225678999999988889999999999999999997 888874221 1111111111100 0 11
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 223 ----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 ----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 2345799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=297.73 Aligned_cols=248 Identities=19% Similarity=0.305 Sum_probs=193.5
Q ss_pred ceee-cCcEEEEEEe--CCc--eEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 61 VIAS-EHYKLYKGFL--ENR--PISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
+||+ ++|.||+|.+ ++. .+++|.+.........+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5888 9999999998 333 46888876544444567888999999999 7999999999999999999999999999
Q ss_pred ChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 135 TLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 135 ~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
+|.+++..... .....+++.++..++.|++.||.||| +.+++||||||+||+++.++.++++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 99999865321 11134789999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhcccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDP 280 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~ 280 (331)
+....... .......+..|+|||++....++.++||||||+++|+|++ |..||...... ........
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~------- 228 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY------- 228 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC-------
Confidence 86332111 1111123567999999988889999999999999999997 88887432211 11111100
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
....+. ..+.++.+++.+||..||.+|||+.+++..|+.+.
T Consensus 229 ~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCCCC------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000111 22346899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=300.18 Aligned_cols=262 Identities=18% Similarity=0.274 Sum_probs=199.1
Q ss_pred cCccccCceee-cCcEEEEEEeC------------------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeee
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE------------------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKL 114 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l 114 (331)
++|...+.||+ +||.||++... ...+|+|.+...........+.+|+.++..++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888889999 99999998542 346899998765444456789999999999999999999
Q ss_pred EeEEeeCCccEEEEEecCCCChhhhhcCCCCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 115 IGCCIETEIPILVFEFVEYGTLADRICSPHGPH------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
++++...+..++||||+++|+|.+++....... ...+++.++..++.|++.||.||| +.+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence 999999999999999999999999987532111 124778899999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh--CCCCChhHHHHH
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT--GRRDNILLEHVK 266 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~--g~~p~~~~~~~~ 266 (331)
+++.++.++|+|||++..+.............++..|+|||+...+.++.++||||||+++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999876543322111111224678999999988899999999999999999998 666763221111
Q ss_pred HHhhcccc-cc-ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 267 KHVENNRL-GE-IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 267 ~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
........ .. ........+.. ++..+.+|+.+||+.||++|||+.++++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPAL------CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCC------CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00000000 00 00000111112 2346999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=298.85 Aligned_cols=252 Identities=22% Similarity=0.347 Sum_probs=200.6
Q ss_pred CccccCceee-cCcEEEEEEe--CC---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--EN---RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.|...+.||+ ++|.||+|.. ++ ..||+|.+...........|..|+.+++.++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667888999 9999999988 33 3599999876544445678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+++|+||||+||+++.++.++++|||++....
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999986543 35889999999999999999999 8999999999999999999999999999987664
Q ss_pred CCCcccc-ccccC--CCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccccccccccc
Q 020078 209 EGETHVT-SHMLT--RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 209 ~~~~~~~-~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
....... ..... .+..|+|||++....++.++||||||+++||+++ |..||..... ......... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-------~~ 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-------RL 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-------cC
Confidence 4322111 11111 2457999999998899999999999999999886 9998743221 111111100 01
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+. +.+.++.+++.+||..+|++||++.+++..|+++
T Consensus 231 ~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 PPPM------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCcc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 2344689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=301.29 Aligned_cols=257 Identities=16% Similarity=0.198 Sum_probs=191.1
Q ss_pred CccccCceee-cCcEEEEEEe---CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhc---CCCceeeeEeEEee-----C
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQM---NHRNILKLIGCCIE-----T 121 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~-----~ 121 (331)
.|...+.||+ +||.||+|+. .+..||+|.+...... .....+.+|+.++..+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5778889999 9999999987 3578999988654322 2234566788877766 69999999999863 3
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
...++||||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 45789999997 689898865322 35889999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhccc---cc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVENNR---LG 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~~~---~~ 275 (331)
|++........ .....||+.|+|||++....++.++|||||||++|+|++|++||..... ......... ..
T Consensus 155 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 99976543321 1223489999999999888999999999999999999999999843221 111111000 00
Q ss_pred c------ccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 E------IVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~------~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ............+.. ...++.+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000000000000000 123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=302.10 Aligned_cols=243 Identities=16% Similarity=0.214 Sum_probs=190.4
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||+ +||.||++.. +++.+|+|.+..... ......+..|+.++.+++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 577 9999999987 689999999865321 11234566799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..........
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~-- 152 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT-- 152 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceee--
Confidence 988854321 45888999999999999999999 9999999999999999999999999999987765432211
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccCCCCchHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
...|+..|+|||++....++.++||||+||++|+|++|+.||..... .......... . .....+. ...
T Consensus 153 -~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~----~~~~~~~-~~~ 222 (277)
T cd05607 153 -QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL----E----DEVKFEH-QNF 222 (277)
T ss_pred -ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh----c----ccccccc-ccC
Confidence 13489999999999988899999999999999999999999743211 0111111000 0 0000010 133
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+.++.+|+.+||+.||++||++.|+++.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 4579999999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=312.34 Aligned_cols=244 Identities=20% Similarity=0.255 Sum_probs=187.7
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
++||+ +||.||++.. +++.||+|.+.... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899 9999999988 67899999987542 222456688999999998 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~- 151 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-
Confidence 9999888653 35899999999999999999999 99999999999999999999999999999875322111
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQ 293 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..................|. .
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~p~--~ 227 (329)
T cd05588 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD-QNTEDYLFQVILEKQIRIPR--S 227 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc-ccchHHHHHHHHcCCCCCCC--C
Confidence 1122458999999999999899999999999999999999999984211100000 00000000000111111111 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCH
Q 020078 294 QLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 294 ~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.+.++.+++.+||+.||++|||+
T Consensus 228 ~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 228 LSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCHHHHHHHHHHhccCHHHcCCC
Confidence 34579999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=313.66 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=209.2
Q ss_pred CccccCceee-cCcEEEEEEeCC-ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 55 NYNGHQVIAS-EHYKLYKGFLEN-RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
.....+.||+ .||.|..+..++ ..||||.+........+.+|..|+++|.+|+|||||.|+|+|..++.+++++||++
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 3445678999 999999999966 99999999988777678999999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++..... +.+.-..-..||.||++|++||. +.++||||+.+.|+|+|.++++||+|||.++-+-.+..
T Consensus 619 nGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred cCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999976432 11334455679999999999999 99999999999999999999999999999986655555
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh--CCCCChhHHHHH--HHhhccccccccccccccCCCC
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT--GRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~--g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
+......+-++.|||||.+..+++++++|||+||+++||+++ ...|+....... +....--...-....+..+.-|
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 544433456789999999999999999999999999999876 445763322211 1111000111111233455556
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
|. ++.+++.+||..|.++|||+.++...|++.
T Consensus 773 p~------~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 773 PQ------GLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cH------HHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 65 699999999999999999999999988764
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=295.26 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=201.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||+ ++|.||+|.. ++..+++|.+... ........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677788999 8999999988 7889999998643 2334567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++....+ ..+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 999999999876422 45889999999999999999999 899999999999999999999999999998876544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.... ....+++.|+|||++.+..++.++|+||||+++|+|++|+.|+.............. .... ..+
T Consensus 155 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-------~~~- 222 (256)
T cd08529 155 TNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--GVFP-------PVS- 222 (256)
T ss_pred cchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCC-------CCc-
Confidence 3222 123478899999999998899999999999999999999999854332211111000 0000 001
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.++.+++.+||+.+|++||++.+++.
T Consensus 223 -~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 -QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 123457999999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.74 Aligned_cols=261 Identities=17% Similarity=0.336 Sum_probs=202.4
Q ss_pred hcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC-C
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET-E 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~-~ 122 (331)
.++|...+.||+ +||.||+|.+ .++.||+|.+...........+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 356888899999 9999999974 45789999997654444566788999999999 689999999988754 4
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCC-------------------------------------------------------
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPH------------------------------------------------------- 147 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------------- 147 (331)
..+++|||+++|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 5789999999999999986532100
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccC
Q 020078 148 -------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220 (331)
Q Consensus 148 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 220 (331)
...+++..+..++.|+++||.||| +.+|+||||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 023678888999999999999999 9999999999999999999999999999987654333222222233
Q ss_pred CCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH---HHHHhhccccccccccccccCCCCchHHHHHH
Q 020078 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH---VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ 296 (331)
Q Consensus 221 gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (331)
++..|+|||++....++.++||||||+++|++++ |..|+..... .......... ...+. ..++
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~~------~~~~ 309 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-------MRAPD------YTTP 309 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC-------CCCCC------CCCH
Confidence 5678999999988889999999999999999997 8888743211 1111111110 00011 1224
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 297 ALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 297 ~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 689999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=302.21 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=197.5
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+|...++||+ ++|.||++.. +++.||+|.+...... .....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677889999 9999999988 6889999998754221 124567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999988864321 35889999999999999999999 89999999999999999999999999999887643
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... ....|++.|+|||++....++.++||||+|+++|++++|..||....... ...... + ......
T Consensus 155 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-----~---~~~~~~ 223 (285)
T cd05605 155 GETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-----V---KEDQEE 223 (285)
T ss_pred CCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-----h---hhcccc
Confidence 3221 12348999999999998889999999999999999999999985322110 001000 0 000011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
.+ ...+..+.+|+.+||+.||++|| ++.+++.
T Consensus 224 ~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 224 YS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11 13455799999999999999999 8888855
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=296.02 Aligned_cols=247 Identities=18% Similarity=0.210 Sum_probs=200.5
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|...+.||. ++|.||++.. ++..+|+|.+.........+.+.+|+.+++.++||||+++++++.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667788999 8999999988 788999999865443445678889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++....+ ..++......++.|++.||.||| +.+|+|+||||+||+++.++.++++|||.+.......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999998864322 35788999999999999999999 9999999999999999999999999999987664332
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh--hccccccccccccccCCCCc
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV--ENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 289 (331)
... ....+++.|+|||++....++.++|+||||+++|+|++|..||.......... ...... +
T Consensus 155 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------------~ 219 (255)
T cd08219 155 AYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-------------P 219 (255)
T ss_pred ccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-------------C
Confidence 211 12348889999999988889999999999999999999999985433222111 111110 0
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+...+..+.+++.+||+.||++|||+.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011334568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.33 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=199.3
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+.|...+.||+ ++|.||+|.+ .+..||+|.+..... ..+.+.+|+.++..++||||+++++++.+ +..++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 356888889999 9999999988 445799999875332 34578999999999999999999998754 567899999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++....+ ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 82 MSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred CCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 999999999975321 34788999999999999999999 899999999999999999999999999999766443
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... ....++..|+|||+.....++.++||||||+++|++++ |..||.... .......... ...
T Consensus 156 ~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~-----------~~~ 223 (262)
T cd05071 156 EYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-----------RMP 223 (262)
T ss_pred ccccc-cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC-----------CCC
Confidence 32111 11235678999999988889999999999999999999 777763221 1111111100 001
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
. ....+.++.+++.+||+.||++|||+.++++.|+..+
T Consensus 224 ~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 224 C--PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred C--ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 1 1134557999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=303.36 Aligned_cols=260 Identities=18% Similarity=0.268 Sum_probs=202.7
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
..+.|...+.||+ ++|.||+|... +..||+|.+...........+.+|+.+++.++||||+++++++.+++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999 99999999752 347999988755443345578899999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 124 PILVFEFVEYGTLADRICSPHG-----PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
.++||||+++|+|.+++..... ......++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 11234567788999999999999999 999999999999999999999999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLG 275 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~ 275 (331)
+|||+++...............++..|+|||.+..+.++.++||||||+++|||++ |..|+...... .........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~- 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY- 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-
Confidence 99999876543332222122235678999999998899999999999999999998 67776432211 111111100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
...+. ..++.+.+++.+||+.||++|||+.++++.|++..
T Consensus 240 ------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 ------LDQPD------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred ------CCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 00011 22347999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=309.93 Aligned_cols=238 Identities=18% Similarity=0.235 Sum_probs=191.5
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||++.. ++..+|+|.+.... .......+.+|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899 9999999988 67899999987542 222456678899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 9999888654 35889999999999999999999 999999999999999999999999999998753222211
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... ....+.
T Consensus 153 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~------------~~~~~~- 217 (318)
T cd05570 153 --TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED------------EVRYPR- 217 (318)
T ss_pred --ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC------------CCCCCC-
Confidence 122348999999999999999999999999999999999999985332211 111111 011111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTM-----VYAAK 321 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~-----~evl~ 321 (331)
..+.++.+|+.+||..||++|||+ .++++
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 -WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 234579999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.19 Aligned_cols=245 Identities=20% Similarity=0.323 Sum_probs=194.2
Q ss_pred ceee-cCcEEEEEEe----CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 61 VIAS-EHYKLYKGFL----ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
.||+ ++|.||+|.+ ++..+|+|.+..... ....+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4788 9999999975 568899998865432 224668899999999999999999999986 45678999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 214 (331)
+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||.||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 999998653 35889999999999999999999 8999999999999999999999999999998765443221
Q ss_pred c-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCCch
Q 020078 215 T-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 215 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
. .....++..|+|||.+....++.++||||||+++|||++ |..||.... ............. .+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-------~~~---- 221 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME-------CPQ---- 221 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-------CCC----
Confidence 1 111224578999999988889999999999999999998 999984322 1112222111100 011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
..++++.+++.+||+.||++|||+.+|...|++.+
T Consensus 222 --~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 222 --RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred --CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 23457999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=297.68 Aligned_cols=262 Identities=18% Similarity=0.186 Sum_probs=198.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCc-eeeeEeEEeeCC------
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRN-ILKLIGCCIETE------ 122 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~------ 122 (331)
..|.....+|+ .+|+||+|+. +|+.||+|++.-... +.......+|+.+|+.|+|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555567999 8999999998 889999999986644 223566789999999999999 999999999877
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++|+||+.. +|.+++....... ..++...+..++.||++||+||| +.+|+||||||+|||+++.|.+||+|||
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence 78899999975 9999998764321 34677889999999999999999 9999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhc---c---
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVEN---N--- 272 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~---~--- 272 (331)
+|+...-...... + .++|..|.|||++.+. .|++..||||+||++.||++++.-|..... ....+.- .
T Consensus 166 lAra~~ip~~~yt-~-evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPMRTYT-P-EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCccccc-c-cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 9986653332222 2 3378899999999877 699999999999999999999886622221 1111111 1
Q ss_pred cccccc-ccccccCC-CCc----hH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 273 RLGEIV-DPIVVEDK-SCP----EK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 273 ~~~~~~-~~~~~~~~-~~~----~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+.... -+.....+ .++ .. .....+..+++.+||+.+|++|.|++.++..
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111100 00000000 000 00 0112478999999999999999999999875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=301.32 Aligned_cols=244 Identities=15% Similarity=0.183 Sum_probs=191.6
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||+ +||+||++.. +++.+|+|.+...... ...+.+..|+.+++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 577 8999999987 7889999998754221 2345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+.+...... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..+...... .
T Consensus 81 ~~~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~ 154 (280)
T cd05608 81 RYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T 154 (280)
T ss_pred HHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence 8887542211 145889999999999999999999 899999999999999999999999999998766443322 1
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...... .+ .......+ ...
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~----~~----~~~~~~~~--~~~ 224 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ----RI----LNDSVTYP--DKF 224 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH----hh----cccCCCCc--ccC
Confidence 1235899999999999999999999999999999999999998432110 000000 00 11111111 134
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
+.++.+++.+||+.||++|| |+.++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 45799999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=295.08 Aligned_cols=246 Identities=22% Similarity=0.338 Sum_probs=196.2
Q ss_pred Cceee-cCcEEEEEEe--CC---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--EN---RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ ++|.||+|.+ .+ ..+|+|.+.........+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36888 9999999987 22 6799999876654445678999999999999999999999886 4567899999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.|++.||.||| ..+++|+||||+||+++.++.++|+|||+++........
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999754 35889999999999999999999 899999999999999999999999999998876444322
Q ss_pred cc-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCc
Q 020078 214 VT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 214 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
.. .....++..|+|||.+....++.++||||||+++|++++ |..||..... .......... ...+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~--- 221 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER-------LPRPE--- 221 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc-------CCCCC---
Confidence 21 111123567999999988889999999999999999998 8998743221 1122211111 01111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
..+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 222 ---~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 222 ---ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 23347999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=311.77 Aligned_cols=233 Identities=20% Similarity=0.269 Sum_probs=187.2
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||++.. +++.+|+|.+.... .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36899 9999999998 67889999987642 222455678899988877 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 9998888653 45889999999999999999999 89999999999999999999999999999875422211
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH-----------HHHHHhhcccccccccccc
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE-----------HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~-----------~~~~~~~~~~~~~~~~~~~ 282 (331)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~------------ 218 (329)
T cd05618 152 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL------------ 218 (329)
T ss_pred -ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHh------------
Confidence 1122458999999999999999999999999999999999999973211 1111111
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
......|. ..+.++.+++.+||+.||++|||+
T Consensus 219 ~~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 219 EKQIRIPR--SLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cCCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11111111 334578999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=294.95 Aligned_cols=249 Identities=23% Similarity=0.346 Sum_probs=197.4
Q ss_pred cCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+.|.....||+ ++|.||+|.. .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 45777888999 9999999988 445799998765432 3567889999999999999999999885 45678999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++..... ..+++..+..++.+++.||.||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 83 GKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999975321 35789999999999999999999 8999999999999999999999999999997664432
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.... ....++..|+|||+...+.++.++||||||+++|+|++ |..|+...... ........ . ...
T Consensus 157 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----~------~~~ 224 (260)
T cd05069 157 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-----R------MPC 224 (260)
T ss_pred cccc-CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----C------CCC
Confidence 2111 11225678999999988889999999999999999999 88887432211 11111110 0 011
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
+ ...+..+.+++.+||+.||++|||+.++++.|++
T Consensus 225 ~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 P--QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred C--cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 1344579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.65 Aligned_cols=237 Identities=19% Similarity=0.182 Sum_probs=189.8
Q ss_pred Cceee-cCcEEEEEEe-----CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 60 QVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
+.||+ +||.||+++. ++..+|+|.+.... .......+.+|+.++.+++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 46899 9999999875 56889999987532 12234567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 99999998653 45889999999999999999999 89999999999999999999999999999876543322
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHH
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
. .....||+.|+|||++....++.++||||||+++|+|++|+.||...........- .......|.
T Consensus 154 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i----------~~~~~~~p~-- 219 (318)
T cd05582 154 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI----------LKAKLGMPQ-- 219 (318)
T ss_pred c--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH----------HcCCCCCCC--
Confidence 1 12245899999999998888999999999999999999999998543222111100 000011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRPTMVY 318 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rps~~e 318 (331)
..+.++.+|+.+||+.||++|||+.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23457899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=313.75 Aligned_cols=254 Identities=17% Similarity=0.219 Sum_probs=198.2
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
...++|...+.||+ +||.||++.. +++.+|+|.+.+. ........+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999 9999999998 6788999998642 12223456789999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++.. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 120 lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccce
Confidence 99999999999999854 24788899999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccC----CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTG----LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 281 (331)
....... .......||+.|+|||++... .++.++||||+||++|+|++|+.||........... +.+..
T Consensus 191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~------i~~~~ 263 (370)
T cd05621 191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK------IMDHK 263 (370)
T ss_pred ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC
Confidence 7643322 122234599999999998753 378899999999999999999999854332111110 00000
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAKQ 322 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~~ 322 (331)
.....|.....+..+.+++..||..+|.+ |||+.|+++.
T Consensus 264 --~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 264 --NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred --cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00111211234567999999999866544 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=296.05 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=200.3
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+.|...+.||+ ++|.||+|.. ++..+|+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 456778889999 9999999998 778999999875433 3567899999999999999999999874 4568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++....+ ..+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 82 MENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999865432 45888999999999999999999 899999999999999999999999999998766533
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... ....++..|+|||++....++.++||||||+++|++++ |+.||...... ......... ...+.
T Consensus 156 ~~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~- 226 (260)
T cd05067 156 EYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR-------MPRPD- 226 (260)
T ss_pred Ccccc-cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC-------CCCCC-
Confidence 22111 11235678999999988889999999999999999999 99997432211 111111100 00011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
..+.++.+++.+||+.+|++|||+.+++..|+.
T Consensus 227 -----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 233479999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=302.10 Aligned_cols=265 Identities=21% Similarity=0.299 Sum_probs=199.1
Q ss_pred cCccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCcc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIP 124 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~ 124 (331)
+.|...+.||+ +||.||++.. ++..||+|.+..... ...+.+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 45777788999 9999999974 467899999865432 246788999999999999999999998754 3467
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence 89999999999999986532 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCcccc-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH-HHHhhccccccccc---
Q 020078 205 EYIPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV-KKHVENNRLGEIVD--- 279 (331)
Q Consensus 205 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~--- 279 (331)
........... .....++..|+|||++.++.++.++||||||+++|||++|..|+...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 87654332211 11112345699999998888999999999999999999987654221111 11111100000000
Q ss_pred -cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 280 -PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 280 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..+......+.....+.++.+|+.+||..+|++|||+.|+++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00011111111113445799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=310.01 Aligned_cols=240 Identities=18% Similarity=0.235 Sum_probs=190.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCC-ceeeeEeEEeeCCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHR-NILKLIGCCIETEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~ 128 (331)
+|...+.||+ +||.||+|.. +++.||+|.+.... .....+.+..|+.++..++|+ +|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777889999 9999999988 56789999987542 223456788899999999764 6888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| ..+|+||||||+|||++.++.++|+|||++....
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 999999999988654 35788999999999999999999 8999999999999999999999999999987532
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........- .......
T Consensus 153 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i----------~~~~~~~ 220 (324)
T cd05587 153 FGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI----------MEHNVSY 220 (324)
T ss_pred CCCCc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH----------HcCCCCC
Confidence 22211 12245899999999999889999999999999999999999998433221111100 0001111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
|. ..+.++.+++.+||..||++||++
T Consensus 221 ~~--~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 221 PK--SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC--CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11 234579999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.62 Aligned_cols=250 Identities=15% Similarity=0.154 Sum_probs=194.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.|...+.||+ +||.||+|+. +++.+|+|.+.... .......+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4778889999 9999999998 77899999987532 12245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 99999999998654 35788888999999999999999 89999999999999999999999999999753311
Q ss_pred CCc---------------------------------------------cccccccCCCCcccchhhhccCCCCCcccchh
Q 020078 210 GET---------------------------------------------HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFC 244 (331)
Q Consensus 210 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 244 (331)
... ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 000 00011245899999999999889999999999
Q ss_pred hHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 020078 245 FGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT---MVYAAK 321 (331)
Q Consensus 245 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~evl~ 321 (331)
|||++|||++|+.||................ .....|.....++++.+++.+|+ .+|++|++ +.+++.
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQ--------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHccC--------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999985432221111110000 00111111134457889998876 59999997 777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=305.37 Aligned_cols=258 Identities=16% Similarity=0.187 Sum_probs=195.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||+ +||.||+|+. +++.||+|.+...........+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888889999 9999999988 67889999987554443455678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 975 8888876543 34788899999999999999999 899999999999999999999999999998765333
Q ss_pred CccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhc--cc----cccccc-
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVEN--NR----LGEIVD- 279 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~--~~----~~~~~~- 279 (331)
.... ....+++.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ....... .. ...+..
T Consensus 158 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 TKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred cccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 2211 11347889999999865 4688999999999999999999999832211 1111000 00 000000
Q ss_pred --------cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 --------PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 --------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+..............+.++.+|+.+||+.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000000124557899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.02 Aligned_cols=238 Identities=18% Similarity=0.247 Sum_probs=191.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+|...+.||+ +||.||+|.. ++..+|+|.+..... ......+..|..++..+ +|++|+.+++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4777889999 9999999988 567999999875421 22345677788888877 5899999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 999999999988654 35888999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ......||+.|+|||++....++.++|||||||++|+|++|+.||...... ...... ...
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~------------~~~ 218 (323)
T cd05616 153 WDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------------HNV 218 (323)
T ss_pred CCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh------------CCC
Confidence 2221 112245899999999999999999999999999999999999998533221 111111 111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
..|. ..+.++.+++.+||+.||++|+++
T Consensus 219 ~~p~--~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AYPK--SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCC--cCCHHHHHHHHHHcccCHHhcCCC
Confidence 1111 334579999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=297.79 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=205.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||. ++|.||+|.. ++..+++|.+.... .......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777888999 9999999997 78999999876432 2224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++...... ...+++..++.++.+++.||.||| +.+++|+||||+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999988642211 145889999999999999999999 9999999999999999999999999999987664
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
...... ....++..|+|||++....++.++|+||||+++|+|++|..|+............ .......+..
T Consensus 158 ~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~------ 228 (267)
T cd08229 158 SKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-KIEQCDYPPL------ 228 (267)
T ss_pred cCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh-hhhcCCCCCC------
Confidence 432211 1234888999999998888999999999999999999999997432211100000 0000000000
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
+ ....+.++.+++.+||+.||++|||+.+|.+.++++.
T Consensus 229 ~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 P-SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred C-cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1 1135567999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=295.03 Aligned_cols=249 Identities=20% Similarity=0.328 Sum_probs=191.1
Q ss_pred Cceee-cCcEEEEEEe-----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee-CCccEEEEEecC
Q 020078 60 QVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-TEIPILVFEFVE 132 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~ 132 (331)
+.||+ +||.||+|.+ ....+|+|.+.........+.+.+|+.+++.++||||+++++++.. ++..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35888 9999999986 2346999988654433356788899999999999999999998764 556889999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++.... ....+..+..++.|+++||.||| +.+++||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999986532 23567788899999999999999 89999999999999999999999999999876543221
Q ss_pred c--ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCC-CCChhHHH--HHHHhhccccccccccccccCCC
Q 020078 213 H--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-RDNILLEH--VKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 213 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~-~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
. .......++..|+|||++....++.++||||||+++|||++|. +|+..... .......... ...+.
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~- 225 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-------LLQPE- 225 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-------CCCCC-
Confidence 1 1111123567899999998888999999999999999999965 45422111 1111111000 00011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+..+.+++.+||..+|++||++.++++.|+++..
T Consensus 226 -----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 226 -----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 223469999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.67 Aligned_cols=237 Identities=19% Similarity=0.253 Sum_probs=188.5
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHh-cCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQ-MNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||+|.. +++.||+|.+.... .......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36899 9999999998 57889999987542 12234566778888876 4899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++.........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 9999998654 35888999999999999999999 899999999999999999999999999998754222211
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....|.
T Consensus 153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------~~~~~~- 217 (316)
T cd05619 153 --TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD------------NPCYPR- 217 (316)
T ss_pred --eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CCCCCc-
Confidence 12245899999999999889999999999999999999999998432211 1111110 001111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMV-YAA 320 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~-evl 320 (331)
..+.++.+++.+||+.||++||++. +++
T Consensus 218 -~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 218 -WLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 2335689999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=298.08 Aligned_cols=254 Identities=19% Similarity=0.272 Sum_probs=199.0
Q ss_pred cCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+|.....||+ +||.||++.. ++..+++|.+.... ......+.+|+.++..++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 35666788999 9999999964 34578888876443 335678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 126 LVFEFVEYGTLADRICSPHG----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
++|||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence 99999999999999865321 01134788999999999999999999 999999999999999999999
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHH--Hhhcc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKK--HVENN 272 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~--~~~~~ 272 (331)
++|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||........ .....
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99999999876543322222222235678999999998899999999999999999998 8888743222111 11111
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
.. ...+. ..++.+.+++.+||+.||++||++.|+++.|+
T Consensus 241 ~~-------~~~~~------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 RE-------LERPR------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred cc-------CCCCC------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 10 00111 22346999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=293.58 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=200.8
Q ss_pred Cceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ ++|.||+|... +..+++|.+.........+.+.+|+.++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36888 99999999993 7889999988765443477899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 134 GTLADRICSPHGP----HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 134 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+|.+++...... ....+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764211 0146899999999999999999999 99999999999999999999999999999987755
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
...........++..|+|||.+....++.++||||||+++|+|++ |..|+..... ......... ....+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 230 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY-------RLPKPE 230 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------CCCCCc
Confidence 432222222347889999999988889999999999999999999 5888743322 111111100 011111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 231 ------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 ------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 23457999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.04 Aligned_cols=251 Identities=16% Similarity=0.158 Sum_probs=194.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||+||++.. +++.+|+|.+.... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36888899999 9999999988 67899999986532 1223457888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 999999999999754 45889999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcc---------------------------------ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhC
Q 020078 209 EGETH---------------------------------VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255 (331)
Q Consensus 209 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g 255 (331)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 21100 001124699999999999988999999999999999999999
Q ss_pred CCCChhHHHHH--HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 020078 256 RRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVN--ESAGDRPTMVYAAKQ 322 (331)
Q Consensus 256 ~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dP~~Rps~~evl~~ 322 (331)
+.||....... ........ .. ...... ..++++.+++.+++. .++..||++.|+++.
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~-~~---~~p~~~------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 233 YPPFCSETPQETYKKVMNWKE-TL---IFPPEV------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCHHHHHHHHHcCcC-cc---cCCCcC------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99985432221 11111000 00 011111 233468888888554 233456899999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=297.43 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=200.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
++|...+.||+ ++|.||++.. +++++|+|.+...... .....+.+|+.++.+++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999 8999999987 6899999988643221 124578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
|+||+++++|.+.+... ..++...+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999988654 35788899999999999999999 99999999999999999999999999999876
Q ss_pred cCCCCcccc-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC
Q 020078 207 IPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 207 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
......... .....++..|+|||++.+..++.++||||||+++|++++|+.||................. ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~--- 228 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT--NPQL--- 228 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCC--CCCC---
Confidence 543221111 0123477899999999988899999999999999999999999854332222111110000 0001
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+ ...+..+.+++.+||..+|++|||+.++++.
T Consensus 229 ---~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 229 ---P--SHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---C--ccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 1234569999999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=295.31 Aligned_cols=254 Identities=19% Similarity=0.341 Sum_probs=202.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
..|...+.||+ +||.||+|.. ++. .+|+|.+...........+.+|+.++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45667788999 9999999987 333 5889988766544456788999999999999999999999987 77899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||.++.
T Consensus 86 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999987543 35889999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
..............++..|+|||.+....++.++|+||||+++||+++ |+.|+.... ........... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~~ 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER-------LP 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCC-------CC
Confidence 654433222211224568999999988889999999999999999998 999974322 11222211110 11
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+. ..+..+.+++.+||..||++|||+.++++.|+++..
T Consensus 232 ~~~------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 QPP------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111 122368999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=306.87 Aligned_cols=261 Identities=17% Similarity=0.303 Sum_probs=204.9
Q ss_pred HhcCccccCceee-cCcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE 120 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 120 (331)
....|...+.||+ +||.||++... +..+|+|.+.........+.+.+|+.++.++ +||||++++++|.+
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456788899999 99999999751 2368999887654444567899999999999 79999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceE
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL 189 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nil 189 (331)
.+..++++||+++|+|.+++...... ....+++.++..++.|++.||.||| +.+++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence 99999999999999999998753211 1235788999999999999999999 899999999999999
Q ss_pred EcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHH
Q 020078 190 FDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVK 266 (331)
Q Consensus 190 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~ 266 (331)
++.++.++|+|||+++...............++..|+|||++....++.++||||||+++|+|++ |..|+.... ...
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999886644322211111224567999999998899999999999999999998 777763322 111
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.......... .+. ..+.++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 247 ~~~~~~~~~~-------~~~------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 KLLKEGHRMD-------KPA------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHcCCCCC-------CCC------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1221111100 111 223469999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=310.27 Aligned_cols=234 Identities=18% Similarity=0.218 Sum_probs=185.2
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHH-HHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIV-FAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||+||+|+. +++.||+|.+..... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899 9999999998 788999999875321 112344555555 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK- 151 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-
Confidence 9999988653 45888999999999999999999 89999999999999999999999999999875432221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........ .....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------~~~~~----- 217 (323)
T cd05575 152 -TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP--------LRLKP----- 217 (323)
T ss_pred -ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC--------CCCCC-----
Confidence 112245899999999999889999999999999999999999998432211 11111110 00011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMV 317 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~ 317 (331)
..+.++.+++.+||+.||++||++.
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2245799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=308.85 Aligned_cols=244 Identities=18% Similarity=0.190 Sum_probs=193.0
Q ss_pred CccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCC---CcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCcc
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY---SENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIP 124 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 124 (331)
+|...+.||+ +||.||+++. ++..+|+|.+.... .....+.+..|+.++..++ ||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4777889999 9999999876 56889999986431 1223456788999999995 99999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 9999999999999998654 45889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH------HHHHHhhccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE------HVKKHVENNRLGEI 277 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~ 277 (331)
+......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... .......
T Consensus 153 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------- 224 (332)
T cd05614 153 KEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL------- 224 (332)
T ss_pred ccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-------
Confidence 7654332221 1224589999999999764 47889999999999999999999984211 1111110
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
......+. ..+..+.+++.+||+.||++|| ++.++++
T Consensus 225 -----~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 -----KCDPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred -----cCCCCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00111111 2345789999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=307.41 Aligned_cols=237 Identities=18% Similarity=0.216 Sum_probs=188.5
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||+|.. ++..||+|.+..... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899 9999999998 678999999875421 22455677788888754 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 9999988653 35788999999999999999999 99999999999999999999999999999875322221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....+.
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~------------~~~~~~- 217 (316)
T cd05620 152 -RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD------------TPHYPR- 217 (316)
T ss_pred -ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CCCCCC-
Confidence 112245899999999999889999999999999999999999998433221 1111110 001111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMV-YAA 320 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~-evl 320 (331)
..+.++.+++.+||..||++||++. +++
T Consensus 218 -~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 -WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2334799999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=294.99 Aligned_cols=252 Identities=22% Similarity=0.356 Sum_probs=202.5
Q ss_pred HhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..++|...+.||+ ++|.||+|.. ++..+|+|.+..... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3467888899999 9999999988 567899999875433 35678999999999999999999999998889999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++....+ ..+++..+..++.+++.|+.||| +.+++|+||||+||+++.++.++++|||.+..+..
T Consensus 82 ~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999976432 35889999999999999999999 89999999999999999999999999999887654
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 286 (331)
....... ...++..|+|||.+.+..++.++||||||+++|++++ |+.||...... ........ ....+.
T Consensus 156 ~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~ 227 (261)
T cd05034 156 DEYTARE-GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-------RMPRPP 227 (261)
T ss_pred hhhhhhh-ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------CCCCCC
Confidence 2221111 1224668999999998889999999999999999998 89887432211 11111100 001111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
..+.++.+++.+||+.+|++||+++++...|+.
T Consensus 228 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 ------NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 223479999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=299.49 Aligned_cols=247 Identities=17% Similarity=0.247 Sum_probs=210.2
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
-|....++|+ ++|.||++.. .|+.+|+|++.-. .+.++...|+.++.++..|++|++||.|.....+|+|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 4566678999 9999999988 8899999997533 36889999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
.-|++.+.+..++ +++.+.++..++.+-++||.||| ...-||||||+.|||+..+|.+||+|||.|-.+.+..
T Consensus 111 GAGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 9999999998765 68999999999999999999999 9999999999999999999999999999998775433
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchH
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
....++.||+.|||||++..-.|+.++||||||++..||..|++|+.....+.. ++.-....++.+..+
T Consensus 184 --AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------IFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------IFMIPTKPPPTFKKP 252 (502)
T ss_pred --HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------eEeccCCCCCCCCCh
Confidence 344457799999999999999999999999999999999999999643333222 222112223333334
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..++.++.+++++||.+.|++|-||.++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4788999999999999999999999888753
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=306.64 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=210.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPI 125 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~ 125 (331)
....|.....||. .||.||+++. +|+.+|+|.+.+.... .....+.+|+.+|.++. |||||.+++++++.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4456788889999 9999999998 6899999999765332 24578999999999998 999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC----CceEEccC
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY----NVAKLSDF 201 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Df 201 (331)
+|||+|.+|.|.+.+... .+++..+..++.|++.++.||| +.+|+||||||+|+|+... +.++++||
T Consensus 113 lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 999999999999999764 2889999999999999999999 9999999999999999643 47999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh--hccccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV--ENNRLGEIVD 279 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~ 279 (331)
|++....... .....+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .....
T Consensus 184 Gla~~~~~~~---~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~----- 255 (382)
T KOG0032|consen 184 GLAKFIKPGE---RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF----- 255 (382)
T ss_pred CCceEccCCc---eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-----
Confidence 9999887622 2223569999999999999999999999999999999999999996655443333 11111
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+..+.+...+..+.+++..|+..||..|+|+.++++.
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22333344667889999999999999999999999873
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=296.57 Aligned_cols=248 Identities=22% Similarity=0.387 Sum_probs=195.3
Q ss_pred ceee-cCcEEEEEEeCC--------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 61 VIAS-EHYKLYKGFLEN--------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.||+ ++|.||+|+..+ ..+++|.+...........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5888 999999998732 5689998766544445678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-----ceEEccCCCc
Q 020078 132 EYGTLADRICSPHGP--HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-----VAKLSDFSES 204 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Dfg~a 204 (331)
++|+|.+++...... ....+++..++.++.|++.||.||| +.+++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999753211 1134788999999999999999999 89999999999999999877 8999999998
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 281 (331)
................++..|+|||++.++.++.++||||||+++|+|++ |..|+....... ....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------~ 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-------R 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-------c
Confidence 76543322222222235778999999999999999999999999999998 998874322111 1111100 0
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
. ..+...+.++.+++.+||..+|++|||+.++++.|+
T Consensus 232 ~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 001134457999999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=320.20 Aligned_cols=258 Identities=18% Similarity=0.229 Sum_probs=188.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC-------
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET------- 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 121 (331)
....|...+.||+ +||.||+|.. +++.||+|++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 3467999999999 9999999988 67899999886432 2345799999999999999999887532
Q ss_pred -CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEc
Q 020078 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLS 199 (331)
Q Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~ 199 (331)
...++||||+++ +|.+++...... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~-~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence 235689999985 777766532111 146889999999999999999999 99999999999999999664 79999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-c-
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-R- 273 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~- 273 (331)
|||+++.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|.+||....... ...... .
T Consensus 214 DFGla~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p 290 (440)
T PTZ00036 214 DFGSAKNLLAGQRSV---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTP 290 (440)
T ss_pred ccccchhccCCCCcc---cCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999998765433221 13489999999998754 68999999999999999999999984322111 111000 0
Q ss_pred -----------ccccccccc-ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 274 -----------LGEIVDPIV-VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 274 -----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+.-+.. ..+.....+...+.++.+|+.+||+.||.+|||+.|++..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000000 0000000001234579999999999999999999999843
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=300.59 Aligned_cols=256 Identities=15% Similarity=0.203 Sum_probs=199.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ ++|.||++.. ++..+|+|.+...........+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999 9999999988 67888988887554443456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
+++|+|.+++... ..+++..+..++.|+++||.||| + .+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999654 45888999999999999999999 6 5899999999999999999999999999875533
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH-hhcccccccccc--------
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH-VENNRLGEIVDP-------- 280 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~-------- 280 (331)
... ....++..|+|||++.+..++.++|+||||+++|+|++|+.|+......... ...........+
T Consensus 153 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 153 SMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccC
Confidence 221 1235889999999998888999999999999999999999997432211100 000000000000
Q ss_pred -----------------ccc-cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 281 -----------------IVV-EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 281 -----------------~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
... ..+..|.. ..+.++.+++.+||..||++|||+.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSG-AFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCc-ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00011111 245579999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.66 Aligned_cols=251 Identities=16% Similarity=0.160 Sum_probs=195.0
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+|...+.||+ +||.||+++. +++.||+|.+.... .......+.+|+.++..++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999 9999999988 68899999986432 12235668899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++..+..
T Consensus 82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999654 35788888999999999999999 89999999999999999999999999999753310
Q ss_pred CC-----------------------------------------ccccccccCCCCcccchhhhccCCCCCcccchhhHHH
Q 020078 210 GE-----------------------------------------THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGML 248 (331)
Q Consensus 210 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~ 248 (331)
.. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000112458999999999998899999999999999
Q ss_pred HHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 020078 249 LLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP---TMVYAAKQ 322 (331)
Q Consensus 249 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp---s~~evl~~ 322 (331)
+|+|++|+.||.................. . ..+.....+.++.+++.+|+ .+|.+|+ |+.++++.
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~~----~----~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWETT----L----HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCcc----c----cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999998543322111110000000 0 00111123456889999977 5999999 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=290.37 Aligned_cols=244 Identities=23% Similarity=0.390 Sum_probs=195.9
Q ss_pred ceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhh
Q 020078 61 VIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 138 (331)
+||. ++|.||++.. .++.|++|.+...........+.+|+.++++++||||+++++++.+.+..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 5888 8999999998 5899999988765443356789999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccc
Q 020078 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218 (331)
Q Consensus 139 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 218 (331)
++.... ..+++..+..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++..............
T Consensus 82 ~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 82 FLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 986543 35788899999999999999999 89999999999999999999999999999876543222211111
Q ss_pred cCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCchHHHHH
Q 020078 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295 (331)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
..++..|+|||.+.++.++.++|+||||+++|+|++ |..|+..... ......... ....+ ...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-----------~~~~~--~~~~ 221 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-----------RMPAP--QLCP 221 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-----------CCCCC--ccCC
Confidence 224567999999988899999999999999999999 7777643221 111111100 00011 1334
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 296 QALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 296 ~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
.++.+++.+||..+|++|||+.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 57999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=293.11 Aligned_cols=235 Identities=20% Similarity=0.305 Sum_probs=183.7
Q ss_pred ceee-cCcEEEEEEeC--------------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 61 VIAS-EHYKLYKGFLE--------------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.||+ ++|.||+|++. ...|++|.+..... .....+.+|+.++..++||||+++++++.++...+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 5788 99999999862 12488888765432 24567888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc-------eEE
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV-------AKL 198 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-------~kl 198 (331)
+||||+++|+|..++.... ..+++..++.++.||++||.||| +.+|+||||||+|||++.++. +++
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999988876432 45889999999999999999999 999999999999999987664 899
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHH-hCCCCChhHHHHHH-Hhhccccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELL-TGRRDNILLEHVKK-HVENNRLG 275 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~-~g~~p~~~~~~~~~-~~~~~~~~ 275 (331)
+|||++....... ...++..|+|||++. ...++.++||||||+++|+|+ .|..|+........ .+.....
T Consensus 154 ~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~- 226 (262)
T cd05077 154 SDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC- 226 (262)
T ss_pred CCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc-
Confidence 9999986553221 133788899999987 456899999999999999998 57777643221111 0111000
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
. ... ..+.++.+|+.+||+.||++||++.+++..|
T Consensus 227 -------~--~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 -------M--LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -------c--CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 001 1224689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=298.14 Aligned_cols=248 Identities=19% Similarity=0.261 Sum_probs=193.8
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|...++||. ++|.||+|.. ++..+|+|.+...........+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 4666788999 8999999987 788999999876544434567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|..+. .+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++..+....
T Consensus 82 ~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 82 DGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 999985432 3678888999999999999999 9999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccc-cccccccccccCCCCch
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNR-LGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 290 (331)
. ....++..|+|||++....++.++||||||+++|+|++|+.||.............. ...+.+.. ....+.
T Consensus 150 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 222 (279)
T cd06619 150 A----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---PPVLPV 222 (279)
T ss_pred c----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---CCCCCC
Confidence 1 123489999999999988899999999999999999999999743211000000000 00000000 000000
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...++++.+++.+||..||++||++.|+++.
T Consensus 223 -~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 -GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1234579999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=295.67 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=196.9
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC-----
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET----- 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----- 121 (331)
.+++.|...+.||+ ++|.||+|.. +++.+|+|.+..... ....+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35677888889999 9999999988 678899999865432 356788999999998 699999999998763
Q ss_pred -CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
+..+++|||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence 357899999999999999875321 35789999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLG 275 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 275 (331)
||++........ ......|+..|+|||++. ...++.++|||||||++|+|++|..|+...............
T Consensus 155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~- 231 (272)
T cd06637 155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN- 231 (272)
T ss_pred CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC-
Confidence 999876543221 112244889999999986 335888999999999999999999998533322222211100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... .. ..+.++.+|+.+||..||.+|||+.++++
T Consensus 232 --~~~~~~-~~------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 232 --PAPRLK-SK------KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --CCCCCC-CC------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000010 11 23347999999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=294.72 Aligned_cols=254 Identities=21% Similarity=0.277 Sum_probs=198.7
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++..++++.....||+ ++|.||+|.. ++..|++|.+...... ..+.+.+|+.+++.++|+||+++++++..++..+
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 4456777878889999 9999999987 5678999988755433 5668899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCC
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPL--LWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFS 202 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg 202 (331)
+|+||+++++|.+++.... .++ +...+..++.|++.||.||| +.+|+||||||+||+++. ++.++|+|||
T Consensus 82 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg 154 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154 (268)
T ss_pred EEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecch
Confidence 9999999999999987532 234 77888899999999999999 899999999999999986 6799999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCC--CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
++.......... ....+++.|+|||++..+. ++.++||||||+++|+|++|..|+...............
T Consensus 155 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~------ 226 (268)
T cd06624 155 TSKRLAGINPCT--ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM------ 226 (268)
T ss_pred hheecccCCCcc--ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh------
Confidence 987654322211 1134788999999987654 789999999999999999999997432211111100000
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.......+ ...+.++.+++.+||+.+|++|||+.|++.
T Consensus 227 -~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 -FKIHPEIP--ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred -hccCCCCC--cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00001111 134457999999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.50 Aligned_cols=251 Identities=21% Similarity=0.198 Sum_probs=206.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+.|...+.||. ..|+||++.. .+..+|+|.+.+..- .+.......|-+||+.++||.++.||+.++.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 34555677999 8899999999 448999999987632 234566778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||+||+|..+.+.+.+ ..++.+.+..++..++.||.||| -.+||+|||||+||||-++|++.|+||.++....
T Consensus 157 eyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999988877654 56889999999999999999999 9999999999999999999999999998765331
Q ss_pred C---------------------------------CCc---------------------cccccccCCCCcccchhhhccC
Q 020078 209 E---------------------------------GET---------------------HVTSHMLTRTKRYLAPEYILTG 234 (331)
Q Consensus 209 ~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~ 234 (331)
- ... ......++||-.|.|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 000 0112345789999999999999
Q ss_pred CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCC
Q 020078 235 LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP 314 (331)
Q Consensus 235 ~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp 314 (331)
..+.++|.|+||+++|||+.|..||.. ....+-+..++..+..+|.....+..+.|||.+.|.+||++|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG----------~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKG----------SNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCC----------CCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999999999632 2233333444555666666556778899999999999999999
Q ss_pred C----HHHHH
Q 020078 315 T----MVYAA 320 (331)
Q Consensus 315 s----~~evl 320 (331)
. |.||-
T Consensus 381 g~~rGA~eIK 390 (459)
T KOG0610|consen 381 GSKRGAAEIK 390 (459)
T ss_pred ccccchHHhh
Confidence 8 66664
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=308.36 Aligned_cols=237 Identities=19% Similarity=0.227 Sum_probs=185.4
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHH-HHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIV-FAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||+++. +++.+|+|.+..... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36899 9999999998 667899999875321 112334444444 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+....+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 9999988654 34778888889999999999999 99999999999999999999999999999875432221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... .....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~--------~~~~~----- 217 (325)
T cd05602 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP--------LQLKP----- 217 (325)
T ss_pred -CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------cCCCC-----
Confidence 1222458999999999998899999999999999999999999984322211 1111100 00011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAA 320 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl 320 (331)
..+.++.+++.+||+.||.+||++.+.+
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 218 -NITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -CCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 2335799999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=295.29 Aligned_cols=250 Identities=19% Similarity=0.241 Sum_probs=196.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ ++|.||+|.. ++..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46777788999 9999999988 6789999988654332 456688999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++... ..+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 88 CGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 9999999988654 35889999999999999999999 899999999999999999999999999998765432
Q ss_pred CccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.. ......|+..|+|||++. ...++.++|+|||||++|+|++|..|+.............. .....+......
T Consensus 160 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~- 235 (267)
T cd06645 160 IA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-SNFQPPKLKDKM- 235 (267)
T ss_pred cc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-cCCCCCcccccC-
Confidence 21 112234899999999975 45688999999999999999999999743222111111000 000011111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.++..+.+++.+||+.+|++|||+.++++
T Consensus 236 -----~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 236 -----KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -----CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 23346899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=292.59 Aligned_cols=262 Identities=18% Similarity=0.198 Sum_probs=198.1
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee-----C
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE-----T 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-----~ 121 (331)
.+...|...+.||. .+|.|..+.. +++.||+|++.+.. ..-..+...+|+.+|+.++|+||+.+.+.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 45566666788999 8999999988 88999999998542 22356778899999999999999999999876 2
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..|+|+|+|+ .+|...+.+. +.++...+..++.|+++||.|+| +.+|+||||||.|++++.+..+|++||
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccc
Confidence 34799999995 5999999775 45999999999999999999999 999999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHH----------------
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEH---------------- 264 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---------------- 264 (331)
|+|+...........+..+-|..|.|||.+.. ..|+...||||.||++.||++|++-|.....
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 99998864311111122446899999999875 4799999999999999999999986611111
Q ss_pred -HHHHhhccccccccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 265 -VKKHVENNRLGEIVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 265 -~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
......+......+.. +...+.-|.. .+..+.+.+|+++||..||.+|+|+.|++..
T Consensus 250 e~l~~i~s~~ar~yi~s-lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKS-LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHHh-CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111110000000000 0001111111 1345679999999999999999999999864
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.27 Aligned_cols=248 Identities=15% Similarity=0.270 Sum_probs=200.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..|...+.||+ ++|.||+|.. ++..+++|.+...... ..+.+.+|+.++..++||||+++++.+..++..++||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 57888888999 8999999987 7789999998765443 457788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++.. ..+++.++..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 99 ~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred cCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 999999998854 34788999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.... ....+++.|+|||.+....++.++|||||||++|+|++|+.||............... . .+... .
T Consensus 170 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~--~~~~~------~ 238 (296)
T cd06654 170 QSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-G--TPELQ------N 238 (296)
T ss_pred cccc--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-C--CCCCC------C
Confidence 2111 1134888999999998888999999999999999999999998543322111110000 0 00011 1
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+...+..+.+++.+||..+|++|||+.+++..
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11344579999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=317.32 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=203.0
Q ss_pred cCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 59 HQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
.-++|+ .+|+||-|++ +...+|||.+....+. ..+.+..||.+.++|+|.|||+++|+|.++.+.-+.||-+|||+
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 457899 8999999999 6678999998766554 67788899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-CCCceEEccCCCccccCCCCccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGETHV 214 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~ 214 (331)
|.+++.+..|+. .-.+++.-.+.+||++||.||| +..|||||||.+|+|+. -.|.+||+|||.++.+..-..
T Consensus 659 LSsLLrskWGPl--KDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPL--KDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred HHHHHHhccCCC--ccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 999998876532 1267888889999999999999 99999999999999996 568999999999987754332
Q ss_pred cccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHH-HHhhccccccccccccccCCCCchH
Q 020078 215 TSHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK-KHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
.+.++.||..|||||++..| .|..++|||||||++.||.||++||....... ..++.+.. .-.++.|
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy--------KvHP~iP-- 801 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY--------KVHPPIP-- 801 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce--------ecCCCCc--
Confidence 23346699999999999977 48999999999999999999999985433322 22332221 1122333
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.++..+|.+|+.+||.+||||.+++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 378899999999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=297.73 Aligned_cols=255 Identities=20% Similarity=0.287 Sum_probs=200.1
Q ss_pred cCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+|.....||. +||.||+|+. ....+++|.+.........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56778888999 9999999986 245789998865544334678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 126 LVFEFVEYGTLADRICSPHGPH----LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+||||+++|+|.+++....... ...+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987543211 125899999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhcccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIV 278 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~ 278 (331)
|++........... ....++..|+|||.+....++.++||||||+++|++++ |..||...... ..........
T Consensus 162 ~~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~--- 237 (275)
T cd05046 162 SLSKDVYNSEYYKL-RNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE--- 237 (275)
T ss_pred ccccccCccccccc-CCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC---
Confidence 99875533222111 11235778999999988888999999999999999998 77787432211 1111111110
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..... ..+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 238 ---~~~~~------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 ---LPVPE------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---CCCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00011 23347999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.42 Aligned_cols=243 Identities=19% Similarity=0.223 Sum_probs=195.9
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
|...+.||+ +||.||++.. +++.+|+|.+...... .....+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666788999 9999999988 7889999998754222 1245678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++..... ..++...+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999998854321 35888999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH------HHHHhhcccccccccccccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH------VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~ 284 (331)
.... ...|+..|+|||++.+..++.++||||||+++|+|++|+.||..... ........ .....
T Consensus 156 ~~~~---~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~------~~~~~- 225 (285)
T cd05630 156 QTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------QEEYS- 225 (285)
T ss_pred cccc---CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh------hhhcC-
Confidence 3211 23489999999999988999999999999999999999999853211 11110000 00000
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
...+.++.+|+.+||+.||++||| +.|+++
T Consensus 226 -------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 226 -------EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -------ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 123456899999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.73 Aligned_cols=250 Identities=21% Similarity=0.337 Sum_probs=200.1
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+.|...+.||+ ++|.||++.. .+..+++|.+.... ...+.+.+|+.++++++|+||+++++++.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 457888899999 9999999987 56779999876532 235678999999999999999999999887 778999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++.+..+ ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+..+...
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 82 MAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred CCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999976422 35788899999999999999999 899999999999999999999999999998766543
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ...++..|+|||++..+.++.++|+||||+++|++++ |..|+..... .......... ....
T Consensus 156 ~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------~~~~-- 225 (260)
T cd05073 156 EYTARE-GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-------MPRP-- 225 (260)
T ss_pred Cccccc-CCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-------CCCc--
Confidence 322111 1235677999999998889999999999999999998 8888743222 1111111110 0001
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
...+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1334579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.58 Aligned_cols=256 Identities=16% Similarity=0.215 Sum_probs=199.4
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
.++....++|...+.||+ +||.||++.. +++.+|+|.+.... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455688999999999 9999999998 67899999986421 222345678899999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..++||||+++|+|.+++.. ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 999999999999999998854 24778888999999999999999 999999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccC----CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhhccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTG----LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLG 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~ 275 (331)
|++......... ......||+.|+|||++... .++.++|||||||++|+|++|..||........ ......
T Consensus 187 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-- 263 (371)
T cd05622 187 GTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK-- 263 (371)
T ss_pred CceeEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--
Confidence 999876433221 22234599999999998753 378999999999999999999999854332211 111000
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAKQ 322 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~~ 322 (331)
.....|.....+.++.+++..||..+|.+ ||++.++++.
T Consensus 264 --------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 --------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred --------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00111111234567999999999844433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=290.42 Aligned_cols=251 Identities=19% Similarity=0.221 Sum_probs=187.3
Q ss_pred ceee-cCcEEEEEEe-CC---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 61 VIAS-EHYKLYKGFL-EN---RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
.||+ +||.||+|.. ++ ..+++|.+.........+.+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5888 9999999976 33 34667776655444456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 215 (331)
|.+++...... ...++...+..++.|++.||.||| +.+++||||||+|||++.++.++|+|||++...........
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99998753221 134667778899999999999999 89999999999999999999999999999764322211111
Q ss_pred ccccCCCCcccchhhhcc-------CCCCCcccchhhHHHHHHHHhC-CCCChhHHHH--HHHhhccccccccccccccC
Q 020078 216 SHMLTRTKRYLAPEYILT-------GLCNEKTDVFCFGMLLLELLTG-RRDNILLEHV--KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~el~~g-~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 285 (331)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... .............++.+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL- 236 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC-
Confidence 122347889999998753 2357899999999999999974 5676322211 1111112222222322221
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..++.+.+++..|| .+|++|||+.++++.|.
T Consensus 237 -------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 -------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 12346888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.12 Aligned_cols=236 Identities=21% Similarity=0.253 Sum_probs=184.5
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHH-HHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIV-FAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
++||+ +||.||+|+. +++.+|+|.+..... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899 9999999998 678999999865321 122344555554 67889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|...+... ..++...+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~- 151 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE- 151 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-
Confidence 9998888643 35788888999999999999999 89999999999999999999999999999875322221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQ 293 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
......||+.|+|||++....++.++|||||||++|+|++|..||....... .... ....+...+. .
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~---------i~~~~~~~~~--~ 218 (321)
T cd05603 152 -TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-MYDN---------ILHKPLQLPG--G 218 (321)
T ss_pred -ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-HHHH---------HhcCCCCCCC--C
Confidence 1122458999999999998889999999999999999999999985432111 1100 0001111111 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHH
Q 020078 294 QLQALLQLIFECVNESAGDRPTMV 317 (331)
Q Consensus 294 ~~~~~~~li~~cl~~dP~~Rps~~ 317 (331)
.+.++.+++.+||+.||++||++.
T Consensus 219 ~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHHHHHHHHHccCCHhhcCCCC
Confidence 334689999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.35 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=204.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
...|...++||+ +||.||+|.. ++..||+|++..... ....|+.++++++|||||+++|+|.+.+..++|||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 356778889999 9999999997 788999999864332 12356889999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++. .++|..+..++.|+++||+|||+.+..+|+|||+||+||+++.++.+++. ||.+.....
T Consensus 764 y~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 764 YIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred CCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999993 37899999999999999999997667799999999999999998888875 665443221
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCCh--------hHHHHHHHhhccccccccccc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI--------LLEHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~--------~~~~~~~~~~~~~~~~~~~~~ 281 (331)
.. ...+|+.|+|||++.+..++.++|||||||++|||++|+.|+. ...+.............+|+.
T Consensus 835 ~~------~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 DT------KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred CC------CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 11 1247899999999998999999999999999999999999973 222333333333333445555
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
+......+ .....++.+++.+||+.||++||||.|+++.|+++..
T Consensus 909 ~~~~~~~~--~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVN--QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCcc--HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 54332222 2556678999999999999999999999999999865
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.47 Aligned_cols=254 Identities=19% Similarity=0.336 Sum_probs=200.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
++|...+.||+ ++|.||+|.+ ++. .+|+|.+...........+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677788999 9999999987 444 47888877554443455788999999999999999999999764 4678
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
++||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++.
T Consensus 86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence 999999999999986542 35788999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~ 283 (331)
..............++..|+|||++.+..++.++||||||+++||+++ |..|+... ............ ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------~~ 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER-------LP 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-------CC
Confidence 654333222222335678999999988889999999999999999997 88887432 222222221111 11
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+.. .+..+.+++.+||..+|++||++.+++..|+.+..
T Consensus 232 ~~~~------~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 232 QPPI------CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 22368999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.39 Aligned_cols=258 Identities=17% Similarity=0.209 Sum_probs=193.6
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----ccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-----IPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 125 (331)
+|+..+.||+ +||.||++.. +++.||+|++..... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778889999 9999999997 789999999865422 224567889999999999999999999998776 689
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+|+||+. ++|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.
T Consensus 81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999997 5888877543 45889999999999999999999 8999999999999999999999999999988
Q ss_pred ccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhhc----cccc---
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVEN----NRLG--- 275 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~----~~~~--- 275 (331)
.......... ....+++.|+|||++.+. .++.++|||||||++|||++|+.||........ .... ....
T Consensus 152 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 152 VEEPDESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ecccCccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 6543322211 123478899999998764 478999999999999999999999832211100 0000 0000
Q ss_pred -------cccccccccCCC----CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 276 -------EIVDPIVVEDKS----CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 276 -------~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+......... .......++++.+|+.+||+.||++|||+.|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000 00001224578999999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=298.19 Aligned_cols=265 Identities=18% Similarity=0.254 Sum_probs=201.1
Q ss_pred CccccCceee-cCcEEEEEEeC------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFLE------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 125 (331)
.|...+.||+ ++|.||+|+++ +..+|+|.+...........+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 3555678999 99999999873 578999998765443346789999999999999999999999987 55789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
++|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||.+.
T Consensus 85 lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999997542 35889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh-hccc---ccccccc
Q 020078 206 YIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV-ENNR---LGEIVDP 280 (331)
Q Consensus 206 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~-~~~~---~~~~~~~ 280 (331)
......... ......++..|+|||.+....++.++||||||+++|+|++|..|+.......... .... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 775332211 1111224567999999988899999999999999999999998863321110000 0000 0000000
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
.+......+.+...+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000111111113345799999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=280.96 Aligned_cols=268 Identities=19% Similarity=0.198 Sum_probs=208.7
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC---
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE--- 122 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--- 122 (331)
+.+-.+.|.+.+.+|+ ||..||.+.. +++.+|+|++.-.. .++.+..++|++..++++|||++++++++..+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 3345678999999999 9999999986 88999999998665 337889999999999999999999998887544
Q ss_pred --ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 123 --IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 123 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
..||+++|...|+|.+.+......+ .-+++.+.+.|+.++++||.+||.. ..++.||||||.|||+.+.+.+++.|
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence 4899999999999999997543222 3588999999999999999999932 23499999999999999999999999
Q ss_pred CCCccccCCCC---cc----ccccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh
Q 020078 201 FSESEYIPEGE---TH----VTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE 270 (331)
Q Consensus 201 fg~a~~~~~~~---~~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~ 270 (331)
||.+...+-.. .. .......+|..|+|||.+.- ...++++|||||||+||.|+.|..||...-. .
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~ 247 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----Q 247 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----c
Confidence 99987653211 10 01112237899999999863 3568999999999999999999999743222 1
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.+.. --.....+...|.....++.+.++++.|++.||.+||++.+++..+..+.
T Consensus 248 GgSl---aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 248 GGSL---ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CCeE---EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111 11111223333333345678999999999999999999999999998753
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=312.93 Aligned_cols=255 Identities=13% Similarity=0.132 Sum_probs=194.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..+|.....||+ ++|.||++.. .++.||+|... ...+.+|+.+|++++|+|||++++++..++..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 447888999999 9999999999 56889999632 2346789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
++. |+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++....
T Consensus 241 ~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 241 KYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred ccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 995 68988886532 35899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh----------HHHHHHHhhcccccc-cc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL----------LEHVKKHVENNRLGE-IV 278 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~----------~~~~~~~~~~~~~~~-~~ 278 (331)
...........||+.|+|||++.+..++.++|||||||++|||++|..|+.. .......+....... .+
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 3222222234589999999999988999999999999999999998754311 111122221111100 00
Q ss_pred ccc----------------cccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 279 DPI----------------VVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 279 ~~~----------------~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
... .......+.+ .....++.+|+.+||+.||++|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0000000000 0223478999999999999999999999864
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=294.74 Aligned_cols=247 Identities=18% Similarity=0.233 Sum_probs=195.3
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
|...+.||+ +||+||+|.. +++.+|+|.+...... .....+.+|+.++.+++|+||+.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566678999 9999999998 6889999998654221 2345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 82 MNGGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred ccCccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 999999988864321 35899999999999999999999 999999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||....... ..... ..... .. ..
T Consensus 156 ~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~-~~~~~-~~------~~ 224 (285)
T cd05632 156 ESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR-RVLET-EE------VY 224 (285)
T ss_pred Ccc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-hhhcc-cc------cc
Confidence 221 12348999999999998889999999999999999999999985322111 11100 00000 00 00
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
+ ...+.++.+|+..||+.||++||+ +.+++.
T Consensus 225 ~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 225 S--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred C--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0 123456899999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.19 Aligned_cols=245 Identities=20% Similarity=0.333 Sum_probs=195.8
Q ss_pred ceee-cCcEEEEEEeC---C--ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 61 VIAS-EHYKLYKGFLE---N--RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
.||+ ++|.||+|.+. + ..+|+|.+.........+.+.+|+.++++++||||+++++++.+ ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 5788 99999999872 2 25899998876553467789999999999999999999999988 8889999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 214 (331)
+|.+.+..... ..+++..++.++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..+.......
T Consensus 81 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 81 SLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred cHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99999976432 35889999999999999999999 9999999999999999999999999999998765432211
Q ss_pred -cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhccccccccccccccCCCCch
Q 020078 215 -TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 215 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
......++..|+|||++....++.++||||||+++|+|++ |..|+....... ..... .. .....+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~-----~~~~~~~---- 224 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-EG-----ERLERPE---- 224 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cC-----CcCCCCc----
Confidence 1112346788999999988889999999999999999998 999973222111 11110 00 0011111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
..+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 225 --~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 --ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 23347999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=300.88 Aligned_cols=257 Identities=18% Similarity=0.214 Sum_probs=190.0
Q ss_pred cCceeec---CcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 59 HQVIASE---HYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 59 ~~~ig~~---~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
..+||+| +++||++.. +++.||+|++...... .....+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3467774 568999988 7899999998765332 234567789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999864321 35889999999999999999999 89999999999999999999999999986543321111
Q ss_pred cc-----cccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh--hcccccccccc---
Q 020078 213 HV-----TSHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV--ENNRLGEIVDP--- 280 (331)
Q Consensus 213 ~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~--- 280 (331)
.. ......++..|+|||++..+ .++.++|||||||++|+|++|+.||.......... .........+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 00 01112367789999999763 58899999999999999999999984322111100 01110000000
Q ss_pred ----------------cc-------------ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 ----------------IV-------------VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ----------------~~-------------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ......+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000001111234568999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=289.31 Aligned_cols=247 Identities=17% Similarity=0.251 Sum_probs=201.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||. ++|.||+|.. ++..+++|.+.... ..+.+.+|+.++++++||||+++++++.+....++++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 57888889999 9999999998 47899999986542 267899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999986533 46889999999999999999999 899999999999999999999999999998876543
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
... .....++..|+|||++.+..++.++||||||+++|+|++|+.|+.............. ... .....
T Consensus 153 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~-------~~~--~~~~~ 221 (256)
T cd06612 153 MAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------KPP--PTLSD 221 (256)
T ss_pred ccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc-------CCC--CCCCc
Confidence 321 1123478899999999888899999999999999999999999754322221111000 000 01111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+...+.++.+++.+||+.||++|||+.|++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1234467999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=293.89 Aligned_cols=246 Identities=20% Similarity=0.243 Sum_probs=199.9
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|...+.||. ++|.||+|+. ++..+|+|.+...........+.+|+.+++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777788999 9999999998 678999999876544445677889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++++|.+++... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++++|||+++......
T Consensus 82 ~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 82 GGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999998642 5889999999999999999999 8999999999999999999999999999998775432
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchH
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
.. .....+++.|+|||++.+..++.++||||||+++|+|++|..|+............ . ....+.....
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-~--~~~~~~~~~~------ 221 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-P--KNNPPSLEGN------ 221 (274)
T ss_pred cc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-h--hcCCCCCccc------
Confidence 21 11234788999999999888999999999999999999999998543221111000 0 0000111100
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.++.+++.+||..+|++|||+.+++.
T Consensus 222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 -KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 13457999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=290.14 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=201.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|.....+|. ++|.||+|.. ++..+++|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 56888889999 9999999998 6788999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++.... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999886542 35889999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccC---CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG---LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
... .....++..|+|||.+... .++.++|+||||+++|+|++|+.|+.............. .....+..
T Consensus 155 ~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~----- 226 (262)
T cd06613 155 IAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SNFPPPKL----- 226 (262)
T ss_pred hhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-ccCCCccc-----
Confidence 211 1123478899999998776 789999999999999999999999854332222111100 00000011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
......+.++.+++.+||..+|++|||+.+++.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111245668999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.75 Aligned_cols=256 Identities=18% Similarity=0.185 Sum_probs=196.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
....|.....||. ++|.||++.. .+..||+|.+... ....+|+.++++++|||||++++++...+..++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 3457999999999 9999999976 3467899987543 235689999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
|||++. ++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++..
T Consensus 164 v~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999996 6888888432 46899999999999999999999 89999999999999999999999999999976
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH------HHHHHhhccccc--cc-
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE------HVKKHVENNRLG--EI- 277 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~--~~- 277 (331)
..............||+.|+|||++....++.++|||||||++|+|++|+.||.... ............ ..
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 654433333333558999999999998899999999999999999999999983211 111111100000 00
Q ss_pred -------------cccccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 278 -------------VDPIVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 278 -------------~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.......+...+. ......++.+++.+||..||++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000011110 01234578899999999999999999999864
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.00 Aligned_cols=258 Identities=16% Similarity=0.187 Sum_probs=195.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||. ++|.||+|.. ++..||+|.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45788889999 9999999988 67899999987554433455678999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ ++|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++......
T Consensus 86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 97 58988886543 35788999999999999999999 999999999999999999999999999998764332
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh------cccccccccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE------NNRLGEIVDP 280 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~------~~~~~~~~~~ 280 (331)
.... ....+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... .... ...+......
T Consensus 158 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 158 TKTY--SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred CCcc--cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcc
Confidence 2211 112368899999998754 57889999999999999999999984322110 0000 0000000000
Q ss_pred ccccCCCCc---------hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSCP---------EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........+ .....+..+.+|+.+||+.||.+|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000 00123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=307.02 Aligned_cols=236 Identities=20% Similarity=0.232 Sum_probs=186.3
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHH-HHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIV-FAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||+|+. +++.+|+|.+.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899 9999999988 78899999986542 1123445566655 46779999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|...+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 151 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD- 151 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-
Confidence 9999888653 45889999999999999999999 89999999999999999999999999999875422211
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....... ....+
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~--------~~~~~----- 217 (325)
T cd05604 152 -TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP--------LVLRP----- 217 (325)
T ss_pred -CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC--------ccCCC-----
Confidence 1122458999999999999999999999999999999999999985332211 1111100 00011
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYA 319 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~ev 319 (331)
..+.++.+++.+||..+|.+||++.+.
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 223468899999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=327.85 Aligned_cols=263 Identities=19% Similarity=0.244 Sum_probs=203.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+.|...+.||+ ++|.||+|.. +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 46888899999 9999999988 6889999998754322 23567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 129 EFVEYGTLADRICSPHG------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
||+++|+|.+++..... .....+++..++.++.||++||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 01134567788999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCc----------------cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH
Q 020078 203 ESEYIPEGET----------------HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK 266 (331)
Q Consensus 203 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~ 266 (331)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 001122458999999999998899999999999999999999999975422111
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP-TMVYAAKQLRQMYL 328 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~ 328 (331)
.... ....++.. .......++.+.+++.+||..||++|| ++.++++.|+....
T Consensus 239 i~~~----~~i~~P~~-----~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR----DVILSPIE-----VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh----hhccChhh-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1110 00011100 000113445799999999999999996 66777777877653
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.56 Aligned_cols=245 Identities=20% Similarity=0.283 Sum_probs=197.2
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
|...+.||+ ++|.||+|.. ++..||+|.+.........+.+.+|+.++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 455567898 8999999987 6788999998765544456788999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+++|.+++.. ..+++..+..++.|++.|+.||| ..+++|+||+|+||+++.++.++++|||++..+.....
T Consensus 86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 86 GGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 9999998853 35788999999999999999999 89999999999999999999999999999876644322
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHH
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
. .....++..|+|||++....++.++||||||+++|+|++|..|+............ .....+.. + .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~---~~~~~~~~------~--~ 223 (277)
T cd06642 157 K--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI---PKNSPPTL------E--G 223 (277)
T ss_pred h--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh---hcCCCCCC------C--c
Confidence 1 11234788999999999888999999999999999999999997432211111000 00000001 0 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.++.+++.+||+.+|++|||+.+++..
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 334579999999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.56 Aligned_cols=234 Identities=20% Similarity=0.251 Sum_probs=188.0
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||++.. +++.+|+|.+..... ....+.+.+|+.++.++ +||||+.+++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36899 9999999988 678899999876422 22456788999999888 599999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|..++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 9999888653 35899999999999999999999 89999999999999999999999999999875322211
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH---------HHHHHHhhcccccccccccccc
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL---------EHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||... ........ ..
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------~~ 218 (327)
T cd05617 152 -TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL------------EK 218 (327)
T ss_pred -ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH------------hC
Confidence 112245899999999999999999999999999999999999998421 11111111 11
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMV 317 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 317 (331)
+...|. ..+..+.+++.+||+.||++||++.
T Consensus 219 ~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 219 PIRIPR--FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 111111 2345689999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=292.50 Aligned_cols=248 Identities=18% Similarity=0.228 Sum_probs=194.4
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
|...+.||. ++|.||+|.. ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 445567999 9999999998 567888888865432 256778899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|..++.... .++++..+..++.|++.||.||| +.+++||||||+||+++.++.++++|||++........
T Consensus 86 ~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 86 GGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 999988876432 46889999999999999999999 89999999999999999999999999999876543221
Q ss_pred cccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 213 HVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
......++..|+|||++. ...++.++|||||||++|+|++|..|+............... ..+....+.
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~- 232 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTLAQPS- 232 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhc---CCCCCCCcc-
Confidence 112234889999999984 345778999999999999999999998543322211111000 001111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.++.+++.+||+.||++|||+.+++..
T Consensus 233 -----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 233 -----RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234579999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=304.01 Aligned_cols=239 Identities=18% Similarity=0.241 Sum_probs=191.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+|+..+.||+ +||.||++.. +++.||+|.+.... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999 9999999988 68899999987532 2224566788999998886 577888999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 999999999988654 35889999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ...... ...
T Consensus 153 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~------------~~~ 218 (323)
T cd05615 153 VDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME------------HNV 218 (323)
T ss_pred CCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------CCC
Confidence 2221 122245899999999999888999999999999999999999998543221 111111 111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMV 317 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ 317 (331)
..|. ..+.++.+++.+||+.||++|++..
T Consensus 219 ~~p~--~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 SYPK--SLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCc--cCCHHHHHHHHHHcccCHhhCCCCC
Confidence 1111 2345789999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.26 Aligned_cols=244 Identities=20% Similarity=0.340 Sum_probs=196.6
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
++|...+.||+ ++|.||+|...++.+|+|...... ..+.+.+|+.++..++||||+++++++..+ ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 45778889999 999999999999999999986432 346789999999999999999999998765 4789999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++..... ..+++..++.++.|++.||.||| +.+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~ 155 (254)
T cd05083 82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD 155 (254)
T ss_pred CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence 9999999975432 35788999999999999999999 89999999999999999999999999999875433211
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCCCc
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
. ...+..|+|||.+..+.++.++|+||||+++|+|++ |+.||..... .......... .+ ...
T Consensus 156 ~-----~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~----~~~--- 220 (254)
T cd05083 156 N-----SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR---ME----PPE--- 220 (254)
T ss_pred C-----CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC---CC----CCC---
Confidence 1 124567999999988899999999999999999998 8888743221 1111111110 00 011
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
..+.++.+++.+||+.+|++|||+++++..|++
T Consensus 221 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 233578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=291.78 Aligned_cols=246 Identities=18% Similarity=0.261 Sum_probs=200.0
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.|+..+.||. ++|.||+|.. ++..+|+|.+...........+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666778999 9999999988 678999999876544445678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++.. .++++.++..++.+++.||.||| +.+++|+||+|+||+++.++.++++|||++.......
T Consensus 85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999998854 34788899999999999999999 8999999999999999999999999999987664433
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchH
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
... ....++..|+|||++....++.++|+||||+++|+|++|..|+............ ... .... ..
T Consensus 156 ~~~--~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~--~~~~--~~ 222 (277)
T cd06640 156 IKR--NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKN--NPPT--LT 222 (277)
T ss_pred ccc--ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcC--CCCC--Cc
Confidence 211 1234788899999998888999999999999999999999997533221111100 000 0011 11
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+..+.+++.+||+.+|++||++.+++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2456679999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=289.27 Aligned_cols=247 Identities=19% Similarity=0.283 Sum_probs=197.5
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--------chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--------NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
|.....||+ ++|.||+|.. ++..+|+|.+...... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556678999 8999999987 6789999988654221 1235688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
+++|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999654 35788899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCccc----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc
Q 020078 205 EYIPEGETHV----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 205 ~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
+......... ......++..|+|||.+..+.++.++|+||||+++|+|++|+.||.............. ...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~ 230 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE---NASP 230 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc---cCCC
Confidence 8765321111 11123478899999999988899999999999999999999999865433332221111 0011
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. + ...+.++.+++.+||+.||++||++.++++
T Consensus 231 ~~------~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 231 EI------P--SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cC------C--cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11 1 123457999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=287.58 Aligned_cols=246 Identities=22% Similarity=0.395 Sum_probs=196.4
Q ss_pred CccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
.|...+.||+ ++|.||+|.+ .+..+|+|.+..... ....+.+|+.++.+++||||+++++++......++||||++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 5666788999 9999999988 578899998865432 34578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++.... ..+++..+..++.+++.||.||| +.+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999986532 35788999999999999999999 89999999999999999999999999999876543321
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCCc
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
... ....++..|+|||++..+.++.++||||||+++|+|++ |..|+.... .......... ....+ .
T Consensus 156 ~~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~~-----~--- 224 (256)
T cd05112 156 TSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYKP-----R--- 224 (256)
T ss_pred ccc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCCC-----C---
Confidence 111 11224678999999998889999999999999999998 888874322 1111111110 00001 0
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
..+.++.+|+.+||+.+|++|||+.++++.|
T Consensus 225 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 ---LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1234799999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=304.48 Aligned_cols=257 Identities=19% Similarity=0.224 Sum_probs=193.8
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC----
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE---- 122 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 122 (331)
...+.|...+.||+ +||.||++.. ++..||+|.+..... ......+.+|+.++..++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999 9999999988 688999999875432 234567889999999999999999999987543
Q ss_pred --ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 123 --IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 123 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
..++||||+++ +|.+.+. ..++...+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D 166 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 166 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence 46899999975 6766663 24778889999999999999999 99999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH-------------
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK------------- 267 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~------------- 267 (331)
||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........
T Consensus 167 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 167 FGLARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred CCCccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 999875433221 1123489999999999988999999999999999999999999843221100
Q ss_pred ------------Hhhccc-cc-----cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 268 ------------HVENNR-LG-----EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 268 ------------~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...... .. +....... +.........+.++.+|+.+||..||++|||+.|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIF-PSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhcccccc-ccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00 00000000 00000000124568999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=310.50 Aligned_cols=248 Identities=16% Similarity=0.156 Sum_probs=193.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||++.. +++.||+|.+.... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36778889999 9999999988 67899999986432 2224567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++..+.
T Consensus 81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 999999999998654 35888999999999999999999 9999999999999999999999999999987543
Q ss_pred CCCcc---------------------------------ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhC
Q 020078 209 EGETH---------------------------------VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255 (331)
Q Consensus 209 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g 255 (331)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 21100 001124589999999999999999999999999999999999
Q ss_pred CCCChhHHHHHH--HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 020078 256 RRDNILLEHVKK--HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT---MVYAA 320 (331)
Q Consensus 256 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~evl 320 (331)
+.||........ ....... . . ..|.....++++.+|+.+|+. ||.+|++ +.|++
T Consensus 233 ~~Pf~~~~~~~~~~~i~~~~~-~-----~----~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~ 291 (360)
T cd05627 233 YPPFCSETPQETYRKVMNWKE-T-----L----VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK 291 (360)
T ss_pred CCCCCCCCHHHHHHHHHcCCC-c-----e----ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence 999843322211 1111000 0 0 001000233578899999774 9999996 45554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=295.06 Aligned_cols=247 Identities=20% Similarity=0.255 Sum_probs=205.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
....|+..+.+|+ .+|.|-++.. .|+.||||.+.+..- +.+.-.+.+||+||..|+||||+.+|.+|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3456777888999 8999999977 899999999876522 2356678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||..+|.|.+++..+ ..+++.+...+++||.+|+.|+| .++++|||||.+|||+|.|+++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999876 46999999999999999999999 99999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCC-CcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
+...... .+++|++-|.+||.+.+.+|. +.+|.||||++||-|+.|..||....+- ..+.+........ +
T Consensus 203 y~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-~lvrQIs~GaYrE-----P 273 (668)
T KOG0611|consen 203 YADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-RLVRQISRGAYRE-----P 273 (668)
T ss_pred hccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-HHHHHhhcccccC-----C
Confidence 7554432 337799999999999888875 7899999999999999999998654432 2222211111111 1
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
. .+..+.-||..||..||++|-|..+|...
T Consensus 274 -~------~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 -E------TPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -C------CCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1 12257789999999999999999998653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.38 Aligned_cols=257 Identities=18% Similarity=0.226 Sum_probs=199.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ ++|+||++.. ++..+|+|.+...........+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666788999 9999999998 58889999887654444567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++... ..+++..+..++.+++.||.|||+ ..+++||||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999988653 358899999999999999999993 257999999999999999999999999998654322
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH-hhccccccccccccccC-CCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH-VENNRLGEIVDPIVVED-KSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~ 288 (331)
.. ....|+..|+|||++..+.++.++|+|||||++|++++|..||......... .............+... ...
T Consensus 158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd06620 158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL 233 (284)
T ss_pred cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC
Confidence 11 1234899999999998888999999999999999999999998532211000 00000000000011110 111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+. ...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~-~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 234 PS-SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred Cc-hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11 1245679999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.43 Aligned_cols=237 Identities=19% Similarity=0.312 Sum_probs=185.3
Q ss_pred ceee-cCcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 61 VIAS-EHYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.||. +||.||+|... ...+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR-NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhH-HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 5888 99999999872 23488888754332 2456788999999999999999999999998999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc--------eEEccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV--------AKLSDFS 202 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--------~kl~Dfg 202 (331)
+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++. ++++|||
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999997643 35789999999999999999999 999999999999999987765 6999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCC-CCChhHHHHHHHhhcccccccccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGR-RDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
++....... ...+++.|+|||++.+. .++.++||||||+++|+|++|. .|+...............
T Consensus 154 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~------ 221 (258)
T cd05078 154 ISITVLPKE------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR------ 221 (258)
T ss_pred cccccCCch------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc------
Confidence 886543221 13478899999999864 5789999999999999999995 454332222111100000
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
...|. ..+.++.+|+.+||+.||++|||+.++++.|+
T Consensus 222 -----~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 -----HQLPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -----ccCCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00111 12246899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=288.75 Aligned_cols=251 Identities=18% Similarity=0.247 Sum_probs=196.4
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc---------chhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE---------NGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~---------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
+|...+.||. ++|.||+|.. +++.+|+|.+...... ...+.+..|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 3566788999 9999999987 6889999987532111 11346788999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999998654 35888999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCC--CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc--cccccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN--RLGEIV 278 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~--~~~~~~ 278 (331)
++................++..|+|||++.... ++.++|+||||+++|++++|..|+............. .....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPI 233 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcC
Confidence 987654332222222234788999999987654 8899999999999999999999985433322222110 000111
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ...+.++.+++.+||+.+|++|||+.++++
T Consensus 234 ~~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 234 PPDVS--------MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred Ccccc--------ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11000 123457999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=295.36 Aligned_cols=248 Identities=15% Similarity=0.257 Sum_probs=200.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
...|...+.||. ++|.||+|.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 367888899999 8999999987 7899999998754433 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++.. ..+++.++..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 9999999998854 34788899999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
..... ....+++.|+|||.+.+..++.++|+||||+++|++++|..||............ .........
T Consensus 168 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---------~~~~~~~~~ 236 (297)
T cd06656 168 EQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---------ATNGTPELQ 236 (297)
T ss_pred CccCc--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee---------ccCCCCCCC
Confidence 32211 1234788999999999888999999999999999999999997433221111100 000000101
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+...+..+.+++.+||..+|++|||+.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11134457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=293.38 Aligned_cols=262 Identities=17% Similarity=0.180 Sum_probs=201.9
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
+.++.+..+.++|.....||+ ++|.||++.. ++..+|+|.+..... ....+.+|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 445666778899999999999 9999999988 678899998764322 345688899999999 6999999999985
Q ss_pred e-----CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 120 E-----TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 120 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
. ++..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +.+++||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG 161 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence 3 45689999999999999887532111 145788899999999999999999 89999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhcc-----CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-----GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV 269 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~ 269 (331)
.++|+|||++......... .....|++.|+|||++.. ..++.++|||||||++|+|++|+.|+..........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred CEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 9999999998766433211 112348999999999853 447889999999999999999999975433222221
Q ss_pred hccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 270 ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..... ..+....+. ..+.++.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~---~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 KIPRN---PPPTLHQPE------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hcccc---CCCcccCCC------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11000 001111111 123469999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=300.28 Aligned_cols=252 Identities=16% Similarity=0.161 Sum_probs=193.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+++. +++.||+|.+... ......+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999 9999999998 6789999998642 12223556889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.++|+|||++..+.
T Consensus 81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999986532 35888999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCcccchhhhcc-----CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhhccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILT-----GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEIVDPI 281 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~ 281 (331)
...... .....||+.|+|||++.. ..++.++|||||||++|+|++|+.||........ ...... ....
T Consensus 154 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~~-- 228 (331)
T cd05597 154 ADGTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--EHFQ-- 228 (331)
T ss_pred CCCCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCC--Cccc--
Confidence 432211 112348999999999873 4578899999999999999999999854322111 111100 0000
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAG--DRPTMVYAAKQ 322 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~--~Rps~~evl~~ 322 (331)
.... ....+.++.+++.+||..+++ .||++.+++..
T Consensus 229 ~~~~-----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPD-----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCc-----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 002345789999998865443 37898888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=292.68 Aligned_cols=250 Identities=16% Similarity=0.201 Sum_probs=197.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||. ++|.||+|.. ++..+++|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 356778888999 9999999998 578899999875432 256778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|..++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 90 FCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 999999988875432 35889999999999999999999 89999999999999999999999999999865433
Q ss_pred CCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccccc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
.... .....+++.|+|||++. ...++.++||||||+++|+|++|..|+.............. ...+....
T Consensus 163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~ 237 (292)
T cd06644 163 TLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLSQ 237 (292)
T ss_pred cccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCccCCC
Confidence 2211 11234788999999985 34578899999999999999999999744322111111000 00111111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+ ...+.++.+++.+||..||++||++.++++
T Consensus 238 ~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 P------SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred C------cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1 133457999999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=293.73 Aligned_cols=258 Identities=17% Similarity=0.147 Sum_probs=193.4
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||. ++|.||+|.. ++..||+|++..... ......+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4667788999 9999999988 688999999865422 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ ++|.+++..... ...+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 689888865322 135889999999999999999999 999999999999999999999999999998765332
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-cc-----------
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-RL----------- 274 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~~----------- 274 (331)
.... ....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+....... ...... ..
T Consensus 155 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 155 VRVY--THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred cccc--cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 2111 112368899999988654 47889999999999999999999884321111 110000 00
Q ss_pred ---ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 275 ---GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 275 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+...... ........++++.+++.+||..||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 00000123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=292.22 Aligned_cols=235 Identities=20% Similarity=0.295 Sum_probs=182.9
Q ss_pred ceee-cCcEEEEEEe--C------------------------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceee
Q 020078 61 VIAS-EHYKLYKGFL--E------------------------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILK 113 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~--~------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~ 113 (331)
.||+ +||.||+|.+ + ...|++|.+...... ....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRD-IALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHH-HHHHHHHHHHHHhcCCCCCeee
Confidence 5899 9999999975 1 134888887654322 4567888999999999999999
Q ss_pred eEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC
Q 020078 114 LIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193 (331)
Q Consensus 114 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 193 (331)
++++|.+++..++||||+++|+|..++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+++..
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence 9999999999999999999999998886532 35788999999999999999999 8999999999999999764
Q ss_pred C-------ceEEccCCCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHH-hCCCCChhHHH
Q 020078 194 N-------VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELL-TGRRDNILLEH 264 (331)
Q Consensus 194 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~-~g~~p~~~~~~ 264 (331)
+ .++++|||++........ ..++..|+|||.+.. ..++.++||||||+++||++ +|..|+.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~------~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREE------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccccc------cccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3 479999998764422211 236788999998875 46889999999999999985 68888743221
Q ss_pred HH--HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 265 VK--KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 265 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
.. ..... ...... ....++.+++.+||+.+|++|||+.++++.|+
T Consensus 228 ~~~~~~~~~-------~~~~~~--------~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 SEKERFYEK-------KHRLPE--------PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHHh-------ccCCCC--------CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 11110 000111 11236899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=292.96 Aligned_cols=257 Identities=18% Similarity=0.177 Sum_probs=189.8
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcc-hhHHHHHHHHHHHhc---CCCceeeeEeEEeeC-----C
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSEN-GENFCFNNIVFAAQM---NHRNILKLIGCCIET-----E 122 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~-----~ 122 (331)
.|...+.||+ ++|.||+|.. +++.||+|.+....... ....+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3677788999 9999999988 67899999887543221 234566788777766 699999999998753 3
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..+++|||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence 4789999998 489888865422 34889999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhh---ccc---
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVE---NNR--- 273 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~---~~~--- 273 (331)
++......... ....+|..|+|||++.+..++.++|||||||++|+|++|++||...... ..... ...
T Consensus 154 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 154 LARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 98866433221 1134789999999999889999999999999999999999987322111 11110 000
Q ss_pred ccccc---ccccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 LGEIV---DPIVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~~~~~---~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ..........+. ....+.++.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 000000000000 0123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=303.31 Aligned_cols=258 Identities=17% Similarity=0.220 Sum_probs=194.5
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC----
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE---- 122 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 122 (331)
...+.|...+.||+ +||.||++.. .++.+|+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999 9999999987 688999999876432 234567889999999999999999999986543
Q ss_pred --ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 123 --IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 123 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence 46899999975 6777663 24778889999999999999999 99999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhh-------
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVE------- 270 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~------- 270 (331)
||+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...
T Consensus 163 fg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 163 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred CcccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 999976543321 1123489999999999888899999999999999999999999832211110 000
Q ss_pred ---------------cc-ccccccccccccCCCC----chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 271 ---------------NN-RLGEIVDPIVVEDKSC----PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 271 ---------------~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. .......+....+... ........++.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 0000000000000000 0001224578999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.30 Aligned_cols=257 Identities=20% Similarity=0.267 Sum_probs=203.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|+..+.||. ++|.||+|.. ++..+++|.+...........+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788889999 9999999987 67889999987654443667899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++..... ...+++..+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999965321 135789999999999999999999 999999999999999999999999999998776544
Q ss_pred Cccc--cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 211 ETHV--TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... ......++..|+|||++... .++.++|+||||+++|+|++|+.|+............... ..+......
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~- 231 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGA- 231 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCcc-
Confidence 3221 12223478899999999877 7899999999999999999999998543322211111110 001111110
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.....+.++.+++.+||..||++|||+.+++.
T Consensus 232 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 232 --DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred --ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00134567999999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=288.96 Aligned_cols=249 Identities=18% Similarity=0.293 Sum_probs=197.0
Q ss_pred ccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
|.....||. +||.||+|.. +++.+|+|.+...... .....+.+|+.+++.++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 566788999 9999999988 7788999988643221 22456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... .++++..+..++.|++.||.||| +.+|+|+||+|+||++++++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 82 EFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred ecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999998653 35788999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCc----cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccccc
Q 020078 209 EGET----HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 209 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
.... ........++..|+|||++.+..++.++||||||+++|+|++|..||.................. .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~- 231 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-MPRLP- 231 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-CCCCC-
Confidence 2111 11112234788999999998888999999999999999999999998543322221111110000 01111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.++.+++.+||..+|++|||+.+++.
T Consensus 232 -------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 232 -------DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 123457999999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=293.10 Aligned_cols=247 Identities=14% Similarity=0.269 Sum_probs=199.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+|.....||. ++|.||+|.. +++.|++|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 46888889999 8999999987 7899999998754333 467788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|..++.. ..+++.++..++.+++.||.||| +.+++||||||+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 98 LAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred cCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 999999998854 34789999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
... .....++..|+|||.+....++.++|||||||++|++++|+.||............... . .+....+.
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~--~~~~~~~~---- 239 (296)
T cd06655 169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G--TPELQNPE---- 239 (296)
T ss_pred ccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C--CcccCCcc----
Confidence 221 11234788999999998888999999999999999999999998543322211110000 0 00011111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+..+.+++.+||..||++|||+.+++.
T Consensus 240 --~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 --KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 33457999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=287.36 Aligned_cols=247 Identities=21% Similarity=0.276 Sum_probs=199.5
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|+..++||. ++|.||.++. +++.+++|.+... ........+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4777889999 8998888777 7889999988654 2334567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++..... ..+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 999999999875421 35789999999999999999999 899999999999999999999999999998866443
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--HhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... .....+++.|+|||++.+..++.++||||||+++|+|++|..|+........ .........
T Consensus 155 ~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------------ 220 (256)
T cd08221 155 YSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP------------ 220 (256)
T ss_pred ccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC------------
Confidence 321 1224488999999999888889999999999999999999999743221111 111111100
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.....+.++.+++.+||..+|++|||+.++++.
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 -VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 001334579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.41 Aligned_cols=255 Identities=18% Similarity=0.326 Sum_probs=196.8
Q ss_pred ccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------
Q 020078 56 YNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------ 122 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 122 (331)
|...+.||+ ++|.||+|.+ ++..+|+|.+.... .....+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999 9999999986 35789999987543 2334667889999999999999999999987542
Q ss_pred ccEEEEEecCCCChhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 123 IPILVFEFVEYGTLADRICSPH-GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
..++++||+++|+|.+++.... ......+++.....++.|++.||.||| +.+|+||||||+||+++.++.++++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 112235788999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhcccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIV 278 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~ 278 (331)
|+++...............+++.|++||.+....++.++||||||+++|+|++ |..|+...... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR---- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc----
Confidence 99886644332222122235678999999998889999999999999999999 78886432221 111111110
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
...+. ..+..+.+++.+||+.+|++|||+.+++..|+++
T Consensus 234 ---~~~~~------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ---LKQPP------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01111 2334799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=299.43 Aligned_cols=254 Identities=16% Similarity=0.115 Sum_probs=194.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+++. .++.+|+|.+.+.. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36788899999 9999999998 56789999986421 1223445788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999997532 35788899999999999999999 9999999999999999999999999999987653
Q ss_pred CCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
..... ......||+.|+|||++. .+.++.++|||||||++|||++|+.||...........-..... .....
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~~p 230 (332)
T cd05623 154 EDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFP 230 (332)
T ss_pred cCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc--cccCC
Confidence 33221 122245899999999986 34688999999999999999999999854332221111000000 00000
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAKQ 322 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~~ 322 (331)
.. ....+.++.+|+.+|+..+|++ |+++.++++.
T Consensus 231 ~~-----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 231 AQ-----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred Cc-----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 0134567999999998665544 6889888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=287.43 Aligned_cols=233 Identities=22% Similarity=0.388 Sum_probs=184.5
Q ss_pred ceee-cCcEEEEEEeCCc------------eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 61 VIAS-EHYKLYKGFLENR------------PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.||+ +||.||+|...+. .+++|.+..... ....+.+|+.+++.++||||+++++++.. +..++|
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 5888 9999999999322 377777654432 26788999999999999999999999988 778999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-------ceEEcc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-------VAKLSD 200 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-------~~kl~D 200 (331)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .++|+|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999997642 25889999999999999999999 99999999999999999887 799999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhC-CCCChhHHHHH--HHhhccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTG-RRDNILLEHVK--KHVENNRLG 275 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g-~~p~~~~~~~~--~~~~~~~~~ 275 (331)
||++....... ...++..|+|||++... .++.++||||||+++|++++| ..|+....... ..+....
T Consensus 152 fg~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 223 (259)
T cd05037 152 PGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-- 223 (259)
T ss_pred CCccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--
Confidence 99988654311 12367789999999876 789999999999999999995 66653321111 1111000
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
.. ..+ ...++.+++.+||..+|++|||+.++++.|+
T Consensus 224 -----~~----~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 -----RL----PMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -----CC----CCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 001 0147899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=299.61 Aligned_cols=253 Identities=16% Similarity=0.114 Sum_probs=194.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+++. +++.+|+|.+.... .......+.+|+.++..++|+||+.+++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999 9999999998 67889999986531 1223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999997532 35788899999999999999999 9999999999999999999999999999987664
Q ss_pred CCCccccccccCCCCcccchhhhcc-----CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILT-----GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
..... ......||+.|+|||++.. +.++.++||||||+++|+|++|+.||...........-..... ...
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~----~~~ 228 (331)
T cd05624 154 QDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE----RFQ 228 (331)
T ss_pred CCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC----ccc
Confidence 43321 1122458999999999875 5688999999999999999999999854322211110000000 000
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~ 321 (331)
-+... .+.+.++.+++.+||..+|++ |+++.++++
T Consensus 229 ~p~~~---~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 FPSHI---TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CCCcc---ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 00000 123457999999999876644 467877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=301.00 Aligned_cols=257 Identities=18% Similarity=0.238 Sum_probs=192.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET----- 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 121 (331)
...+.|...+.||. +||.||+|.. ++..||+|++...... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678989999999 9999999987 6788999998754322 2345677999999999999999999988643
Q ss_pred -CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence 3468999988 6799887753 35889999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc--ccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN--NRL 274 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~--~~~ 274 (331)
||+++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...... ...
T Consensus 162 fg~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 162 FGLARQADDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CccceecCCCcC-----CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999986543321 2348999999999876 46889999999999999999999988432111 111000 000
Q ss_pred ccccccc--------cccCCCCchH------HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 275 GEIVDPI--------VVEDKSCPEK------EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 275 ~~~~~~~--------~~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....... +..-...+.. ....+.+.+|+.+||..||++|||+.|++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 0000000000 0123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=286.16 Aligned_cols=246 Identities=18% Similarity=0.257 Sum_probs=196.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee-CCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE-TEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e 129 (331)
+|...+.||. ++|.||++.. +++.+|+|++.... .....+.+.+|+.++++++|+|++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777889999 9999999988 67889999986542 23345678899999999999999999998764 445789999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++....+ ..+++.++..++.+++.|+.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999875321 45889999999999999999999 99999999999999999999999999999887643
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... .....+++.|+|||++.+..++.++||||||++++++++|+.|+....... ........ + .
T Consensus 155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-----~------~ 221 (257)
T cd08223 155 QCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-----P------P 221 (257)
T ss_pred cCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----C------C
Confidence 3221 122347889999999998889999999999999999999999974322111 11111111 0 0
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+ ...++++.+++.+||+.||++|||+.++++
T Consensus 222 ~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 MP--KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred Cc--cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01 134457999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=304.83 Aligned_cols=237 Identities=17% Similarity=0.175 Sum_probs=183.6
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc---CCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM---NHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
||+ +||.||+|+. +++.||+|.+..... ......+..|..++..+ +||||+.+++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 578 8999999988 688999999864321 11234455677777665 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.||++||.||| +.+|+||||||+|||++.++.++|+|||++.........
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 9999888653 35889999999999999999999 899999999999999999999999999998754332221
Q ss_pred ccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCch
Q 020078 214 VTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ....... ...+.
T Consensus 153 --~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~------------~~~~~ 218 (330)
T cd05586 153 --TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK------------VRFPK 218 (330)
T ss_pred --ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC------------CCCCC
Confidence 1224589999999998754 47899999999999999999999985432211 1111111 01111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPT----MVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps----~~evl~ 321 (331)
. ..+.++.+++.+||+.||++||+ +.++++
T Consensus 219 ~-~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 N-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred c-cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 23357899999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.97 Aligned_cols=251 Identities=17% Similarity=0.207 Sum_probs=198.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||. ++|.||+|.. ++..+|+|.+..... ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 356777888999 9999999998 678899999865432 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~ 155 (280)
T cd06611 83 FCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS 155 (280)
T ss_pred ccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence 999999999886543 45889999999999999999999 89999999999999999999999999999876533
Q ss_pred CCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccccc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
.... .....+++.|+|||++. ...++.++|+||||+++|+|++|+.|+...........-.. ...+....
T Consensus 156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~ 230 (280)
T cd06611 156 TLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK---SEPPTLDQ 230 (280)
T ss_pred cccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc---CCCCCcCC
Confidence 2221 11234788999999985 33567899999999999999999999854332221111000 00011111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+ ...+.++.+++.+||+.+|++|||+.++++.
T Consensus 231 ~------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 P------SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred c------ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 1334579999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=301.54 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=193.5
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC------
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET------ 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 121 (331)
..+.|...+.||+ +||.||++.. .++.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999 9999999987 67899999987542 223456788999999999999999999987643
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
...++||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence 346899999975 7777763 24778889999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh--------
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE-------- 270 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~-------- 270 (331)
|+++....... .....+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....
T Consensus 171 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 171 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred CCccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 99986543221 112348999999999998899999999999999999999999983221111 0000
Q ss_pred --------------cccc-ccc-cc---cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 271 --------------NNRL-GEI-VD---PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 271 --------------~~~~-~~~-~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+... ... .. +....+...........++.+|+.+||+.||++|||+.+++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000 00 0000000000000123468999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=286.99 Aligned_cols=248 Identities=19% Similarity=0.216 Sum_probs=198.4
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.|...+.||+ ++|.||++.. +++.+|+|.+... ........+.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 3677889999 9999999988 7789999998643 2233456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++..... ..+++.+++.++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998865321 34788999999999999999999 899999999999999999999999999998766443
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.... ....+++.|+|||++....++.++|+||||++++++++|+.|+......... +....+... +.
T Consensus 155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----------~~~~~~~~~-~~ 221 (256)
T cd08218 155 VELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV----------LKIIRGSYP-PV 221 (256)
T ss_pred hhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH----------HHHhcCCCC-CC
Confidence 2211 1234788999999998888999999999999999999999997432211110 000000000 00
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+...+.++.+++.+||+.+|++||++.+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1133457999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.61 Aligned_cols=189 Identities=17% Similarity=0.295 Sum_probs=162.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
...+|...+.||+ +||.||+|+. .+..||+|..... ....|+.++.+++||||+++++++.+.+..++|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 4568999999999 9999999999 5678999875332 2357999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+. |+|.+++.... ..+++..+..++.||+.||.||| ..+|+||||||+|||++.++.++|+|||+++...
T Consensus 137 e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 9995 68888886543 46899999999999999999999 8999999999999999999999999999987543
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRD 258 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p 258 (331)
..... ....||+.|+|||++.+..++.++|||||||++|||+++..|
T Consensus 209 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~ 255 (357)
T PHA03209 209 VAPAF---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPST 255 (357)
T ss_pred cCccc---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCc
Confidence 22211 123489999999999988999999999999999999986554
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=288.29 Aligned_cols=253 Identities=19% Similarity=0.201 Sum_probs=197.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 128 (331)
++|...+.||. ++|.||++.. ++..+|+|.+...........+.+|+.++++++||||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 35777888999 8999999998 67899999987654444567899999999999999999999998654 3678999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++..... ....++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999999887653211 1145788899999999999999999 8999999999999999999999999999987553
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH-------HHHHHhhccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE-------HVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~~ 281 (331)
..... ...++..|+|||.+....++.++||||||+++|+|++|..|+.... ........... +.
T Consensus 157 ~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~ 227 (287)
T cd06621 157 NSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-----PE 227 (287)
T ss_pred ccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-----hh
Confidence 32211 1336888999999988899999999999999999999999975331 11111111011 11
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.... +.....++++.+++.+||..+|++|||+.|++.
T Consensus 228 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11110 100134567999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=284.45 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=198.3
Q ss_pred cccCceee-cCcEEEEEEeCC------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 57 NGHQVIAS-EHYKLYKGFLEN------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
...+.||. ++|.||++...+ ..+|+|.+...........+..|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 45577898 999999999943 78999999766544457789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 82 YMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred ccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999875421 12899999999999999999999 99999999999999999999999999999887655
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
....... ...+++.|+|||.+....++.++||||+|+++++|++ |..|+.... ........... .....
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 227 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR-------LPKPE 227 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------CCCCC
Confidence 4332221 1226788999999988889999999999999999998 777764211 11112211111 00011
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
..+.++.+++.+||+.||++|||+.++++.|
T Consensus 228 ------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 ------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 2345799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=289.94 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=195.1
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcch-hHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENG-ENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|...+.||+ ++|+||+++. +++.+|+|.+........ .....+|+.++..++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 455678999 9999999999 566899999987644322 223456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++++|.+++... ..+++..+..++.|+++||.+|| +.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccccc-----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999722 46899999999999999999999 8999999999999999999999999999987642221
Q ss_pred ccccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHHhCCCCChhH--HHHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRRDNILL--EHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
. ......++..|+|||++. ...++.++||||+|+++|+|++|..|+... ..................... ..
T Consensus 153 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-- 227 (260)
T PF00069_consen 153 E--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ-SR-- 227 (260)
T ss_dssp S--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS-HT--
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc-cc--
Confidence 1 222244899999999998 778999999999999999999999998544 111111111110000000000 00
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....++.+++.+||+.||++|||+.++++
T Consensus 228 ----~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 ----EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11257999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=288.97 Aligned_cols=258 Identities=19% Similarity=0.242 Sum_probs=195.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|+....||+ ++|.||+|.. +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 35778889999 8999999998 688999998865422 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|..++... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 99998887776443 35889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhc-ccccc-----------
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVEN-NRLGE----------- 276 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~----------- 276 (331)
..... ....++..|+|||++.+ ..++.++||||||+++|+|++|..||............ .....
T Consensus 153 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 153 PGDDY--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred Ccccc--cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 43211 11337888999999875 45789999999999999999999998432221111100 00000
Q ss_pred --ccccc-cccCC-CCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 --IVDPI-VVEDK-SCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 --~~~~~-~~~~~-~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ..... ..+. ....+..+.+|+.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 00000 0000 0123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=292.77 Aligned_cols=195 Identities=18% Similarity=0.216 Sum_probs=157.0
Q ss_pred cCceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccEEEEEec
Q 020078 59 HQVIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPILVFEFV 131 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~ 131 (331)
...||+ +||.||+|+. ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 457999 9999999986 45789999986542 23457889999999999999999999865 34578999998
Q ss_pred CCCChhhhhcCCCC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE----cCCCceEEccCCC
Q 020078 132 EYGTLADRICSPHG----PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSE 203 (331)
Q Consensus 132 ~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfg~ 203 (331)
. ++|.+++..... .....++...+..++.|++.||.||| +.+|+||||||+|||+ +..+.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 588887753211 11235888999999999999999999 8999999999999999 4567899999999
Q ss_pred ccccCCCCcc-ccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCCh
Q 020078 204 SEYIPEGETH-VTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 204 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
++........ .......+|+.|+|||++.+. .++.++||||+||++|+|++|++||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9876443221 112224589999999999764 58899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=290.33 Aligned_cols=248 Identities=18% Similarity=0.238 Sum_probs=199.9
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|+..+.||. ++|.||++.. +++.+++|.+...........+.+|+.++++++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5666778999 8999999998 588999999877654445678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++++|.+++.... ..++...+..++.|++.||.||| + .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 82 DGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred CCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999986542 46888999999999999999999 7 89999999999999999999999999998765322
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH----HHHHHhhccccccccccccccCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE----HVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ..++..|+|||++.+..++.++||||||+++|++++|..|+.... .......... .. ...
T Consensus 155 ~~~~----~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~---~~~ 222 (265)
T cd06605 155 LAKT----FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-----NE---PPP 222 (265)
T ss_pred Hhhc----ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-----cC---CCC
Confidence 1111 347889999999988899999999999999999999999974331 1111111000 00 001
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.. ..+.++.+++.+||..||++|||+.+++..
T Consensus 223 ~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 RLPSG-KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCChh-hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 145679999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.46 Aligned_cols=247 Identities=19% Similarity=0.306 Sum_probs=198.5
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC---CCceeeeEeEEeeCCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN---HRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.|+..+.||. ++|.||+|.. ++..+|+|.+...........+.+|+.++++++ |||++++++++.+++..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4667788999 9999999998 788999999876544445677889999999997 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++.. ..+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.++++|||++....
T Consensus 82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999998854 25889999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ....|+..|+|||.+..+ .++.++|+||||+++|+|++|..|+............ .....+ .
T Consensus 153 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---~~~~~~------~ 221 (277)
T cd06917 153 QNSSKR--STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---PKSKPP------R 221 (277)
T ss_pred CCcccc--ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc---ccCCCC------C
Confidence 443211 123488899999998754 4688999999999999999999998543322211100 000001 1
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+.. ..+.++.+++.+||+.||++|||+.+++..
T Consensus 222 ~~~~-~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN-GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc-cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1110 134579999999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=291.54 Aligned_cols=257 Identities=15% Similarity=0.166 Sum_probs=192.4
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||. ++|.||+|.. ++..+|+|.+..... ......+.+|+.++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667788999 9999999998 788999999865422 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ ++|.+++.... ..+++..+..++.||++||.||| ..+|+||||||+||+++.++.++|+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 97 58888776532 35889999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH----HHHHHhhccc---------ccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE----HVKKHVENNR---------LGE 276 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----~~~~~~~~~~---------~~~ 276 (331)
.... ....++..|+|||++.+. .++.++||||||+++|+|++|..|+.... .......... ...
T Consensus 153 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 153 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCc--CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 2211 112368899999998764 47899999999999999999998852211 1111000000 000
Q ss_pred ccccc----cccCCC-CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 IVDPI----VVEDKS-CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 ~~~~~----~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.. ...... .......++++.+++.+||+.||++|||+.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00000 000000 0000134567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=327.15 Aligned_cols=256 Identities=20% Similarity=0.270 Sum_probs=196.0
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--Ccc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIP 124 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 124 (331)
...+.|.....||. +||+||+++. .+..+|+|.+.... .......+..|+.++.+|+|||||++++++.+. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 44578999999999 9999999998 67789999886542 333466789999999999999999999988653 468
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeeeCCCCCCceEEcC--------
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF----RRPIVFKDIKLSQILFDE-------- 192 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivHrdlk~~Nill~~-------- 192 (331)
|+||||+++|+|.++|...... ...+++..++.|+.||+.||.|||... ..+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 8999999999999998653211 135899999999999999999999321 146999999999999964
Q ss_pred ---------CCceEEccCCCccccCCCCccccccccCCCCcccchhhhcc--CCCCCcccchhhHHHHHHHHhCCCCChh
Q 020078 193 ---------YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT--GLCNEKTDVFCFGMLLLELLTGRRDNIL 261 (331)
Q Consensus 193 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~el~~g~~p~~~ 261 (331)
...+||+|||++..+...... ....||+.|+|||++.. ..++.++|||||||+||+|++|..||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 245899999999866433221 12358999999999864 4588999999999999999999999853
Q ss_pred HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 262 LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.............. + ..+.. ..+.++.+||..||..+|.+|||+.+++.
T Consensus 246 ~~~~~qli~~lk~~----p------~lpi~-~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQLISELKRG----P------DLPIK-GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHHHHHHHhcC----C------CCCcC-CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 32222111110000 0 00100 23357999999999999999999999984
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.52 Aligned_cols=250 Identities=17% Similarity=0.251 Sum_probs=196.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|+..+.||+ ++|.||++.. .+..+|+|.+...........+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667788999 9999999998 689999998875544435678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++++|..++..... ...+++..+..++.+++.||.|||+ ..+|+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 82 DAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999888865311 1368999999999999999999993 2589999999999999999999999999987653322
Q ss_pred ccccccccCCCCcccchhhhccC------CCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccc
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG------LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVV 283 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 283 (331)
.. ...+++.|+|||++... .++.++|+|||||++|+|++|+.||....... ..... +.+.
T Consensus 158 ~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-----~~~~--- 225 (286)
T cd06622 158 AK----TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-----IVDG--- 225 (286)
T ss_pred cc----cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH-----Hhhc---
Confidence 21 12378899999998644 35789999999999999999999974322111 11100 0000
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.....+ ...+.++.+++.+||..+|++||++.+++..
T Consensus 226 ~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 DPPTLP--SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCC--cccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 001111 1355679999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=292.75 Aligned_cols=243 Identities=18% Similarity=0.267 Sum_probs=194.1
Q ss_pred cCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 59 HQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
...||+ ++|.||++.. ++..||+|.+...... ..+.+.+|+.++..++||||+++++.+...+..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ-RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH-HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 356899 9999999988 6789999998654322 46678899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 215 (331)
|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.++|+|||++..........
T Consensus 106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~- 175 (292)
T cd06658 106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR- 175 (292)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC-
Confidence 9998743 34788999999999999999999 8999999999999999999999999999987653322211
Q ss_pred ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHH
Q 020078 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295 (331)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
....++..|+|||++....++.++||||||+++|||++|+.|+............ .....+...... ..+
T Consensus 176 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~------~~~ 245 (292)
T cd06658 176 -KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RDNLPPRVKDSH------KVS 245 (292)
T ss_pred -ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhcCCCcccccc------ccC
Confidence 1234789999999998888999999999999999999999998543222111110 001111111111 233
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 296 QALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 296 ~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.+++.+||..||++|||+.++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 468899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=290.67 Aligned_cols=257 Identities=20% Similarity=0.268 Sum_probs=199.5
Q ss_pred CHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee
Q 020078 45 SAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE 120 (331)
Q Consensus 45 ~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 120 (331)
+..++....+.|.....+|. ++|.||+|.. +++.+|+|.+..... ....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 44555566788888899999 9999999998 678899998754322 346788899999998 69999999999863
Q ss_pred ------CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 121 ------TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 121 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
.+..+++|||+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+|+||+|+||+++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCC
Confidence 4567899999999999998865322 34778889999999999999999 89999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV 269 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~ 269 (331)
.++|+|||++......... .....|+..|+|||.+. ...++.++||||||+++|+|++|..||..........
T Consensus 159 ~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 9999999998765432211 12234889999999986 3457889999999999999999999985433222221
Q ss_pred hccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 270 ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ..+... ....+.++.+++.+||..||.+|||+.|+++
T Consensus 237 ~~~~~---~~~~~~-------~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 LIPRN---PPPKLK-------SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hHhhC---CCCCCc-------ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11000 000000 0134457999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.45 Aligned_cols=249 Identities=19% Similarity=0.260 Sum_probs=193.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC----cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--Ccc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS----ENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIP 124 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 124 (331)
.+|...+.||+ ++|.||+|.. ++..+++|++..... ......+.+|+.++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999 9999999987 678999998764321 12345688999999999999999999998763 567
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++++||+++++|.+.+... ..+++.....++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 8999999999999998654 34788899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 205 EYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 205 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
......... .......++..|+|||++.+..++.++||||||+++|++++|+.||............... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~--~~~---- 227 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTN---- 227 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC--CCC----
Confidence 765432111 1111234788999999998888999999999999999999999998543322222111000 000
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+..+ ....+.+.+++ +||..+|++|||+.|+++
T Consensus 228 --~~~~--~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 --PQLP--SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCc--hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 13345677887 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=290.15 Aligned_cols=261 Identities=19% Similarity=0.204 Sum_probs=201.4
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
+...++..++++|.....||+ ++|.||++.. +++.+|+|.+..... ....+.+|+.++.++ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 344566667899999999999 9999999998 678899999865322 345678899999999 7999999999987
Q ss_pred eCC-----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 120 ETE-----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 120 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
..+ ..++||||+++|+|.+++...... ...+++..+..++.|++.||.||| ..+++||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCC
Confidence 643 578999999999999988632111 145889999999999999999999 89999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccC-----CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-----LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV 269 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~ 269 (331)
.++|+|||++.......... ....++..|+|||++... .++.++||||||+++|+|++|+.|+..........
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~ 243 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF 243 (291)
T ss_pred CEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH
Confidence 99999999987654332211 113478899999998643 36889999999999999999999985443322222
Q ss_pred hccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 270 ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ..+.+.. + ...+.++.+++.+||+.+|++|||+.|++.
T Consensus 244 ~~~~~---~~~~~~~----~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPRN---PPPTLLH----P--EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhcC---CCCCCCc----c--cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11000 0000100 1 133457999999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=311.15 Aligned_cols=257 Identities=17% Similarity=0.199 Sum_probs=187.4
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC------CceeeeEeEEe
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH------RNILKLIGCCI 119 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h------~nIv~l~~~~~ 119 (331)
+...++.|...+.||+ +||.||+|.. .++.||||++..... ....+..|+.++..++| .+++.+++++.
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3445678999999999 9999999988 678899999864321 24456678888777754 45888998887
Q ss_pred eC-CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCC---
Q 020078 120 ET-EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYN--- 194 (331)
Q Consensus 120 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~--- 194 (331)
.. ...++|||++ +++|.+++... ..+++..+..++.||+.||.||| . .+||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCccc
Confidence 64 4678999988 67898888653 35889999999999999999999 7 5999999999999998765
Q ss_pred -------------ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh
Q 020078 195 -------------VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL 261 (331)
Q Consensus 195 -------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~ 261 (331)
.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcccc-----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999875432221 124589999999999999999999999999999999999999843
Q ss_pred HHHHHH--Hhhc--ccc-------------ccccccccc-cCCC-----------Cch-HHHHHHHHHHHHHHhccCCCC
Q 020078 262 LEHVKK--HVEN--NRL-------------GEIVDPIVV-EDKS-----------CPE-KEQQLQALLQLIFECVNESAG 311 (331)
Q Consensus 262 ~~~~~~--~~~~--~~~-------------~~~~~~~~~-~~~~-----------~~~-~~~~~~~~~~li~~cl~~dP~ 311 (331)
...... .... +.. ....+.... .+.. .+. ..-..+.+.+|+.+||++||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 221100 0000 000 000000000 0000 000 001134688999999999999
Q ss_pred CCCCHHHHHH
Q 020078 312 DRPTMVYAAK 321 (331)
Q Consensus 312 ~Rps~~evl~ 321 (331)
+|||+.|+++
T Consensus 428 ~R~ta~e~L~ 437 (467)
T PTZ00284 428 KRLNARQMTT 437 (467)
T ss_pred hCCCHHHHhc
Confidence 9999999986
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=294.62 Aligned_cols=251 Identities=19% Similarity=0.192 Sum_probs=199.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+|...+.||+ ++|.||++.. +++.+|+|.+...... ...+.+.+|+.++..++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5778889999 9999999998 5799999998765333 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+.+++|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 82 YCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred ecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999998864322 45889999999999999999999 89999999999999999999999999999875532
Q ss_pred CCccc---------------------------cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 210 GETHV---------------------------TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 210 ~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 21100 111235788999999999888999999999999999999999998543
Q ss_pred HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 020078 263 EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT----MVYAAK 321 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps----~~evl~ 321 (331)
.......... ..+...+.....+.++.+++.+||..||++||| +.|++.
T Consensus 236 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDETFSNIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHHHHHHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 3222111100 011111111124467999999999999999999 777665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=285.30 Aligned_cols=246 Identities=20% Similarity=0.289 Sum_probs=198.2
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
-|...+.||. ++|.||+|.. ++..+|+|.+...........+.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3566778999 9999999987 678999998865544445677889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++.. ..+++..+..++.+++.|+.||| ..+++|+||+|+||+++.++.++++|||++..+....
T Consensus 85 ~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 85 GGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999998854 35789999999999999999999 9999999999999999999999999999987664332
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchH
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
. ......++..|+|||.+....++.++|+||||+++|+|++|..|+.............. ...+.. +
T Consensus 156 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~------~-- 222 (277)
T cd06641 156 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPK---NNPPTL------E-- 222 (277)
T ss_pred h--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhc---CCCCCC------C--
Confidence 1 11223478899999999888889999999999999999999999753322111110000 000000 0
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+.++.+++.+||..+|++||++.+++..
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1234579999999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=288.52 Aligned_cols=255 Identities=18% Similarity=0.194 Sum_probs=192.8
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|.....||+ ++|.||++.. ++..+|+|.+...........+.+|+.++.++. ||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 444567999 8999999998 678999999876544445678889999999996 999999999999999999999998
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
+. ++.++...........+++..+..++.+++.||+|||+ ..+++||||||+||+++.++.++|+|||++..+....
T Consensus 86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 64 55544321110111468899999999999999999993 3489999999999999999999999999987654332
Q ss_pred ccccccccCCCCcccchhhhccC---CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG---LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... ...++..|+|||++... .++.++||||||+++|+|++|+.||............... ...+.+....
T Consensus 163 ~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~-- 235 (288)
T cd06616 163 AKT---RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPILSNSE-- 235 (288)
T ss_pred ccc---cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcC--CCCCcCCCcC--
Confidence 211 12378899999999866 6899999999999999999999998543322111111100 0011111111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+.++.+|+.+||+.||++|||+.++++.
T Consensus 236 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 236 --EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01345679999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=287.94 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=191.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHH-HHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVF-AAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|.....||+ +||.||++.. +++.||+|++...........+..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36788889999 9999999998 6899999998765433344556667665 566789999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|++ |+|.+++....... ..+++..++.++.|++.||.||| +. +++||||||+||+++.++.+||+|||++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 997 68888776432221 46899999999999999999999 76 89999999999999999999999999987654
Q ss_pred CCCccccccccCCCCcccchhhhcc----CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILT----GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
..... ....++..|+|||++.. ..++.++|+||||+++|+|++|..|+.............. ....+
T Consensus 156 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~---- 226 (283)
T cd06617 156 DSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--EEPSP---- 226 (283)
T ss_pred ccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH--hcCCC----
Confidence 32211 11347889999998864 3468899999999999999999999742111111110000 00000
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+. ...+.++.+++.+||..+|++|||+.+++.
T Consensus 227 --~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 --QLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCc-cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 123457999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=284.74 Aligned_cols=250 Identities=18% Similarity=0.226 Sum_probs=203.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||. ++|.||++.. +++.+++|++...........+.+|+.++..++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999 9999999998 58999999987665433567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
+++++|.+++... .+++...++.++.|++.|+.||| + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999754 45889999999999999999999 8 9999999999999999999999999999887654
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH--HHHHHhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... ....++..|+|||.+....++.++|+||||+++|+|++|..|+.... ........... ...+.... .
T Consensus 153 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~--~ 226 (264)
T cd06623 153 TLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD--GPPPSLPA--E 226 (264)
T ss_pred CCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc--CCCCCCCc--c
Confidence 33322 12347889999999998889999999999999999999999985443 11111111000 00000100 0
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+..+.+++.+||..+|++|||+.++++.
T Consensus 227 -----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 -----EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -----cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 134579999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=287.41 Aligned_cols=259 Identities=17% Similarity=0.179 Sum_probs=194.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+.+|...+.||+ ++|.||+|.. ++..+|+|.+...........+.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 567888999999 9999999987 6889999998765444334567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++ ++|.+.+.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||+++....
T Consensus 84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 84 YMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred ccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 996 67777765432 34678888999999999999999 89999999999999999999999999999875433
Q ss_pred CCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc----------------
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN---------------- 272 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~---------------- 272 (331)
.... .....+++.|+|||++.+. .++.++||||||+++|+|++|..||.............
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 2211 1123368899999998754 57889999999999999999999984332211111100
Q ss_pred ccccccccccccCCCCch-----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPE-----KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.................. ....+.++.+++.+|+..||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000000 0011357889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=295.67 Aligned_cols=247 Identities=19% Similarity=0.228 Sum_probs=206.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.+-|..++-||. -|..|-.++. +|+.||||++.+..- .-....+++|++.|+-++|||||+||.+......+|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 456778888999 5667777776 999999999987532 234567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-CCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~a~~~ 207 (331)
|.=.+|+|.++|.+-. +.+.+.-..+++.||+.|+.|+| ..++|||||||+|+.+- .-|-+||.|||++-.+
T Consensus 97 ELGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 9999999999998643 56888999999999999999999 99999999999999885 5589999999998777
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCC-CcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
..+....+ .+|+..|.|||.+++..|+ +++|||||||+||.|++|+.||... .-.+-+.-++...+
T Consensus 170 ~PG~kL~T---sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA----------NDSETLTmImDCKY 236 (864)
T KOG4717|consen 170 QPGKKLTT---SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA----------NDSETLTMIMDCKY 236 (864)
T ss_pred CCcchhhc---ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc----------cchhhhhhhhcccc
Confidence 66554333 5699999999999998886 6799999999999999999996322 22222233344455
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..|. ..+.++.+||..||..||++|.|..||..
T Consensus 237 tvPs--hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPS--HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCch--hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 5554 88999999999999999999999999865
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=290.90 Aligned_cols=195 Identities=17% Similarity=0.213 Sum_probs=156.5
Q ss_pred cCceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccEEEEEec
Q 020078 59 HQVIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPILVFEFV 131 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~ 131 (331)
...||+ +||.||+|+. ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 357999 9999999986 34689999886542 23467899999999999999999999864 45678999998
Q ss_pred CCCChhhhhcCCCC----CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE----cCCCceEEccCCC
Q 020078 132 EYGTLADRICSPHG----PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSE 203 (331)
Q Consensus 132 ~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfg~ 203 (331)
++ +|.+++..... .....+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 74 78777753211 11235788999999999999999999 8999999999999999 5667999999999
Q ss_pred ccccCCCCccc-cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCCh
Q 020078 204 SEYIPEGETHV-TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 204 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
++......... ......+|+.|+|||++.+. .++.++|||||||++|||++|++||.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 98764432211 11223478999999998764 58899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=289.23 Aligned_cols=258 Identities=17% Similarity=0.182 Sum_probs=193.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||. ++|.||+|.. +++.||+|.+...........+.+|+.++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888889999 9999999988 67899999987544332345677899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ ++|.+++.... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~-~~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LD-TDLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CC-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 98 49998886543 35788999999999999999999 899999999999999999999999999998754322
Q ss_pred CccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH----Hhhcc-cc-cc----ccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK----HVENN-RL-GE----IVD 279 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~----~~~~~-~~-~~----~~~ 279 (331)
.... ....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||........ ..... .. .. ...
T Consensus 157 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 SKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred Cccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 1111 11236788999999875 4578999999999999999999999843221111 11000 00 00 000
Q ss_pred c--cc--ccCC--CCchH---HHH--HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 P--IV--VEDK--SCPEK---EQQ--LQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ~--~~--~~~~--~~~~~---~~~--~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. .. .... ..+.. ... ..++.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00 0000 00000 011 157889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=286.79 Aligned_cols=251 Identities=17% Similarity=0.273 Sum_probs=196.4
Q ss_pred CccccCceee-cCcEEEEEEe---CCceEEEEEeCCCC---------CcchhHHHHHHHHHHHh-cCCCceeeeEeEEee
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNY---------SENGENFCFNNIVFAAQ-MNHRNILKLIGCCIE 120 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~ 120 (331)
+|...+.||+ ++|.||+|.. .+..+|+|.+.... .......+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4677788999 9999999998 35789999875321 11234567788888865 799999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEc
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLS 199 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~ 199 (331)
++..+++|||+++++|.+++...... ...+++..++.++.|++.||.||| + .+++|+||+|+||+++.++.++|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEe
Confidence 99999999999999999887532111 145888999999999999999999 5 679999999999999999999999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhhccccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEI 277 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~ 277 (331)
|||.+....... ......++..|+|||++.++.++.++||||||+++|+|++|+.|+........ .......
T Consensus 157 dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 230 (269)
T cd08528 157 DFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY--- 230 (269)
T ss_pred cccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccC---
Confidence 999988765433 11223488899999999988899999999999999999999999743322111 1111110
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~ 324 (331)
.+. .. ...+.++.+++.+||+.||++|||+.|+...++
T Consensus 231 -~~~-~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 -EPL-PE-------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -CcC-Cc-------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 00 023357999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=283.83 Aligned_cols=247 Identities=20% Similarity=0.235 Sum_probs=197.2
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||+ ++|.||++.. ++..+|+|.+.... .......+.+|+.++++++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999 8999999988 77889999987542 233467888999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~a~~~~~ 209 (331)
+++++|.+++....+ ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.+ +.++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 999999999976432 45789999999999999999999 8999999999999999854 5689999999987654
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
..... ...++..|+|||.+....++.++||||||+++|+|++|..|+.............. .. ....+
T Consensus 155 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~--~~-------~~~~~ 222 (256)
T cd08220 155 KSKAY---TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GT-------FAPIS 222 (256)
T ss_pred Ccccc---ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--cC-------CCCCC
Confidence 33211 13478899999999888889999999999999999999999743221111111000 00 00001
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.++.+++.+||..+|++|||+.|++.
T Consensus 223 --~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 --DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 123457999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=290.65 Aligned_cols=245 Identities=18% Similarity=0.257 Sum_probs=194.5
Q ss_pred cccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 57 NGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
.....||+ +||.||++.. ++..||+|.+...... ....+.+|+.++..++||||+++++++..++..++|+||+++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 33446898 9999999988 6889999998654333 456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
++|..++.. ..+++..++.++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.........
T Consensus 103 ~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 103 GALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred CCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 999987743 34789999999999999999999 899999999999999999999999999998765433221
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQ 293 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
.....++..|+|||++....++.++||||||+++|+|++|+.||............... ......... .
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~------~ 242 (297)
T cd06659 174 --RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPPKLKNAH------K 242 (297)
T ss_pred --ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCCCccccC------C
Confidence 11234889999999998888999999999999999999999997432221111110000 000011111 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 294 QLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 294 ~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+.++.+++.+||+.+|++|||+.++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 23468999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=307.26 Aligned_cols=242 Identities=17% Similarity=0.231 Sum_probs=197.7
Q ss_pred ceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChh
Q 020078 61 VIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLA 137 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 137 (331)
-+|. .||.||++.. ++-..|.|.+..... ...++|+-||.||+.+.||+||+|++.|...+.+|+..|||+||-..
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkse-EELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVD 117 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSE-EELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVD 117 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccch-hHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHh
Confidence 3777 8999999988 334455566655433 37889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccccc
Q 020078 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217 (331)
Q Consensus 138 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 217 (331)
..+...+ ..++..++..+|.+++.||.||| +.+|||||||+.|||+.-+|.++|+|||.+..... ......
T Consensus 118 aimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRD 188 (1187)
T KOG0579|consen 118 AIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRD 188 (1187)
T ss_pred HHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchh--HHhhhc
Confidence 8888765 57999999999999999999999 99999999999999999999999999999754322 222344
Q ss_pred ccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHH
Q 020078 218 MLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 218 ~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
++.|||+|||||+.. ..+|+.++||||||++|.||..+.+|......+.-.+.-.. ..++....+.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---------SePPTLlqPS 259 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---------SEPPTLLQPS 259 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---------cCCCcccCcc
Confidence 577999999999864 45799999999999999999999999755444443332111 1122222223
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.++..+.|++.+||..||..||++.++++
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 77788999999999999999999999875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.91 Aligned_cols=255 Identities=18% Similarity=0.154 Sum_probs=197.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ ++|.||++.. .++.|++|.+..... ......+.+|+.++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36788889999 9999999988 678899999875432 223567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.+++.||.||| +.+++||||||+||+++.++.++++|||+++...
T Consensus 81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 999999999999654 35888999999999999999999 8999999999999999999999999999886421
Q ss_pred CCCc-------------cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccc
Q 020078 209 EGET-------------HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLG 275 (331)
Q Consensus 209 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 275 (331)
.... ........++..|+|||.+....++.++|+||||+++|++++|..||....... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~ 231 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISD 231 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhc
Confidence 1100 001111347888999999988889999999999999999999999974322111 11110000
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
....+. ... ..+.++.+++.+||+.||++||++.++.+.|+.
T Consensus 232 ~~~~~~--~~~------~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIEWPE--GDE------ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccCCCC--ccc------cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000010 001 233468999999999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=289.76 Aligned_cols=258 Identities=22% Similarity=0.249 Sum_probs=196.4
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|+..+.||+ ++|.||+|.. +++.||+|.+..... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5778889999 9999999988 578999998875432 22457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++++.+..+.... ..+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9987776555432 35889999999999999999999 899999999999999999999999999998876544
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccc----cc------cccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNR----LG------EIVD 279 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~----~~------~~~~ 279 (331)
..... ....++..|+|||++... .++.++||||||+++|+|++|+.|+.............. .. ...+
T Consensus 154 ~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PASPL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccccc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 32111 123478889999999888 789999999999999999999988743221111100000 00 0000
Q ss_pred ccccc----CCCCch------HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 PIVVE----DKSCPE------KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ~~~~~----~~~~~~------~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.... +...+. +...+.++.+++.+||..+|++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000 0012567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=288.40 Aligned_cols=248 Identities=15% Similarity=0.265 Sum_probs=200.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ ++|.||+|.. ++..+++|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 67888889999 9999999987 6788999998644332 457788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++.. ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 98 ~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 98 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred CCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999998864 24778899999999999999999 999999999999999999999999999988765433
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.... ....+++.|+|||++..+.++.++|+||||+++|++++|+.||............. .......+.
T Consensus 169 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---------~~~~~~~~~ 237 (293)
T cd06647 169 QSKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------TNGTPELQN 237 (293)
T ss_pred cccc--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---------cCCCCCCCC
Confidence 3211 12347889999999988889999999999999999999999975432211111000 001111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+..+.+++.+||..+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22345679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.22 Aligned_cols=246 Identities=20% Similarity=0.315 Sum_probs=195.6
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
...|...+.||. ++|.||+|.. +++.||+|.+.... .......+.+|+.+++.++||||+++.++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 345778889999 8999999988 68899999886432 222346788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
+||++ |+|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 94 MEYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred HHhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99997 57777775332 35889999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
..... ..+++.|+|||++. .+.++.++||||||+++|+|++|..|+............... .
T Consensus 166 ~~~~~------~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~---------~ 230 (307)
T cd06607 166 SPANS------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---------D 230 (307)
T ss_pred CCCCC------ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC---------C
Confidence 43321 34788999999874 456889999999999999999999997543322221110000 0
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+..+ ...++.++.+++.+||..||++|||+.+++..
T Consensus 231 ~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCC-chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01111 11355679999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=283.53 Aligned_cols=249 Identities=19% Similarity=0.226 Sum_probs=194.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC----cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--Ccc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS----ENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIP 124 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 124 (331)
.+|...+.||+ ++|.||+|.. ++..||+|.+..... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888899999 8999999988 678999998753321 12346788899999999999999999998764 457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
+++|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 7999999999999998653 34778889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 205 EYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 205 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
......... .......++..|+|||++.+..++.++||||||+++|+|++|+.|+............ .... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~-~----- 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-ATQP-T----- 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-hcCC-C-----
Confidence 765322111 1111234788999999998888999999999999999999999998543222221111 0000 0
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....| ...+..+.+++.+||. +|++|||+.+++.
T Consensus 227 -~~~~~--~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 -NPVLP--PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCc--hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01111 1445678899999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=286.73 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=199.4
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHH--hcCCCceeeeEeEEeeCC----ccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAA--QMNHRNILKLIGCCIETE----IPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~nIv~l~~~~~~~~----~~~l 126 (331)
......+.||+ .||+||+|.|.|+.||||++... +.+.+.+|.+|.. .|+|+||+.+++.-..++ +.||
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34556678999 99999999999999999999765 4556777777776 469999999998876544 4789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----CCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI-----GFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
|++|.+.|||.|+|.. ..++....++++..+|+||+|||. +....|.|||||+.|||+..++.+-|+|+
T Consensus 287 vTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred eeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 9999999999999976 358889999999999999999995 45678999999999999999999999999
Q ss_pred CCccccCCCCcc--ccccccCCCCcccchhhhccCC----CC--CcccchhhHHHHHHHHhCC----------CCCh---
Q 020078 202 SESEYIPEGETH--VTSHMLTRTKRYLAPEYILTGL----CN--EKTDVFCFGMLLLELLTGR----------RDNI--- 260 (331)
Q Consensus 202 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~~--~~~Dv~SlG~~l~el~~g~----------~p~~--- 260 (331)
|+|......... .....++||..|||||++.... +. ..+||||||.++||+.... .||+
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999766544222 2344577999999999997542 21 3699999999999998743 2442
Q ss_pred ----hHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 261 ----LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 261 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
....+.+.+-..+....+++.. .. ......+.+||+.||..||+.|.||--+-+.|.++.+
T Consensus 441 p~DPs~eeMrkVVCv~~~RP~ipnrW------~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCVQKLRPNIPNRW------KS-DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHHHhcceeecccCCCCCccc------cc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1222222222222222222111 11 1566789999999999999999999999999998874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=290.59 Aligned_cols=252 Identities=20% Similarity=0.218 Sum_probs=191.0
Q ss_pred cCcEEEEEEeCCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCC
Q 020078 65 EHYKLYKGFLENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSP 143 (331)
Q Consensus 65 ~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 143 (331)
+++.||++..++..||+|++... ......+.+.+|+.+++.++||||+++++++.+.+..+++|||+++|+|.+++...
T Consensus 14 ~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~ 93 (314)
T cd08216 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH 93 (314)
T ss_pred ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh
Confidence 44566666668999999998765 33345678999999999999999999999999999999999999999999998753
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc-----ccccc
Q 020078 144 HGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH-----VTSHM 218 (331)
Q Consensus 144 ~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~ 218 (331)
.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++|||.+......... .....
T Consensus 94 ~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 94 FP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred cc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccc
Confidence 22 34788899999999999999999 899999999999999999999999999988655322110 11122
Q ss_pred cCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhc--ccccc------------------
Q 020078 219 LTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVEN--NRLGE------------------ 276 (331)
Q Consensus 219 ~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~--~~~~~------------------ 276 (331)
..++..|+|||++... .++.++||||||+++|+|++|+.||............ .....
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 3467789999998753 5889999999999999999999998533222211110 00000
Q ss_pred --ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 277 --IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 277 --~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..++........+....++.++.+++.+||+.||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0011111111222223556789999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=280.31 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=196.9
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC----cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS----ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
|...+.||. ++|.||+|.. ++..|++|.+..... ....+.+.+|+.+++.++|+||+++++++.+.+..++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999 9999999998 688999998764321 224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 82 ELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999998653 35788999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... .....++..|+|||.+.... ++.++|+||||+++|++++|..||.................. +..
T Consensus 154 ~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~----- 223 (258)
T cd06632 154 EFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL--PPI----- 223 (258)
T ss_pred cccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC--CCc-----
Confidence 4331 11234788999999998776 899999999999999999999998443322222111110000 000
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+ ...+.++.+++.+||+.+|++|||+.+++.
T Consensus 224 -~--~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 -P--DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -C--CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 123457899999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=294.89 Aligned_cols=251 Identities=18% Similarity=0.184 Sum_probs=202.0
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 128 (331)
...|++.+.||. |.+.||++.. +...+|+|++... ......+-|.+|+..|.+|+ |.+||+|++|-..++.+|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 457888999999 8889999999 6678888887643 33345788999999999996 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||=+ -+|...|.+..+ ..+...+..+..|++.++.++| ..+|||.||||.|+|+-. |.+||+|||.|..+.
T Consensus 440 E~Gd-~DL~kiL~k~~~----~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECGD-IDLNKILKKKKS----IDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eccc-ccHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9865 499999987653 2332377889999999999999 999999999999999976 899999999999998
Q ss_pred CCCccccccccCCCCcccchhhhccC-----------CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTG-----------LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEI 277 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 277 (331)
.+.+.......+||+.||+||.+... +.++++|||||||+||+|+.|+.||.........+ ..+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl-----~aI 585 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKL-----HAI 585 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHH-----Hhh
Confidence 87777666667899999999998633 25689999999999999999999985544333322 233
Q ss_pred cccccccCCCC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSC-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+|.....++. +. ..++.++++.||..||++|||..|+|.
T Consensus 586 ~~P~~~Iefp~~~~----~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIPE----NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCCC----chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 34422211111 11 124999999999999999999999975
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=289.58 Aligned_cols=241 Identities=17% Similarity=0.221 Sum_probs=197.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|.....||+ ++|.||++.. +++.+|+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36778889999 9999999998 67899999986532 2224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 999999999998654 45889999999999999999999 8999999999999999999999999999988765
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 286 (331)
... ....+++.|+|||.+....++.++||||||+++|+|++|..|+....... ....... .
T Consensus 153 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~ 215 (290)
T cd05580 153 GRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK------------V 215 (290)
T ss_pred CCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------c
Confidence 442 12348899999999988888999999999999999999999975433211 1111110 0
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..|. ..+..+.+++.+||..||++|| ++.|+++
T Consensus 216 ~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111 2235799999999999999999 6777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.51 Aligned_cols=258 Identities=21% Similarity=0.258 Sum_probs=195.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|+..+.||+ ++|.||+|.. +++.+|+|.+...... ...+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 35778889999 9999999998 5789999987654332 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|..+.... ..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++..+..
T Consensus 81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 99998888766443 34889999999999999999999 89999999999999999999999999999886644
Q ss_pred CCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhhc-cccc---------
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVEN-NRLG--------- 275 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~-~~~~--------- 275 (331)
..... ....++..|+|||++.. ..++.++||||||+++|+|++|++|+........ .... ....
T Consensus 153 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 153 PGEVY--TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred Ccccc--CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 33221 12347889999999875 3478899999999999999999988742221110 0000 0000
Q ss_pred -cccccccccCCCCc--h---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 -EIVDPIVVEDKSCP--E---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 -~~~~~~~~~~~~~~--~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+.+.......... . ....+..+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000000000 0 0123467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=283.57 Aligned_cols=254 Identities=21% Similarity=0.244 Sum_probs=198.4
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCc---
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEI--- 123 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~--- 123 (331)
..+++|...+.||. ++|.||+|.. +++.+++|.+..... ..+.+.+|+.++.++ +|+||+++++++.+...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35688999999999 9999999998 668899998865433 356789999999999 69999999999977553
Q ss_pred ---cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 124 ---PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 124 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
.++||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence 79999999999999988643211 145889999999999999999999 99999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhcc-----CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-----GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLG 275 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~ 275 (331)
||++......... .....++..|+|||++.. ..++.++||||||+++|++++|..||..............
T Consensus 157 ~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-- 232 (275)
T cd06608 157 FGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR-- 232 (275)
T ss_pred Cccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc--
Confidence 9998765433221 122347889999998753 2467899999999999999999999853322221111000
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+ ........+.++.+++.+||..||++|||+.+++.
T Consensus 233 -~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 -NPPP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -cCCC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 11111135567999999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=283.88 Aligned_cols=250 Identities=17% Similarity=0.243 Sum_probs=197.2
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
+|.....||+ ++|.||+|.. ++..+|+|.+...... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999 9999999987 7889999998643221 135678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCcc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESE 205 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~ 205 (331)
|+||+++++|.+++... .++++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 99999999999998653 35888999999999999999999 89999999999999998775 69999999987
Q ss_pred ccCCCCcc--ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccc
Q 020078 206 YIPEGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPI 281 (331)
Q Consensus 206 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 281 (331)
........ .......++..|+|||++....++.++||||+|++++++++|..|+...... ....... . .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~----~-- 225 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI-A----S-- 225 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH-h----c--
Confidence 76543211 1112234788999999998888999999999999999999999997321110 0000000 0 0
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.......+ ...++++.+++.+||..+|++|||+.++++
T Consensus 226 ~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ATTAPSIP--EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred cCCCCCCc--hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011111 245568999999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.41 Aligned_cols=245 Identities=20% Similarity=0.243 Sum_probs=205.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+.|..-.+||+ |||.||-+.. +|+.+|.|++.+..- ..+....++|-.||.+++.+.||.+--+|+..+..|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 56788899999 9999998877 899999998875422 234667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
..|.||+|.-+|..-+. ..++++.+..++.+|+.||.+|| ...||+|||||+|||+|++|+++|+|+|+|..++
T Consensus 265 tlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999976543 56899999999999999999999 9999999999999999999999999999999988
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc-cCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV-EDKS 287 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 287 (331)
.+..... ++||.+|||||++.++.|+..+|.||+||+||||+.|+.||.-... ....+-+|..+. .+..
T Consensus 339 ~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-------Kvk~eEvdrr~~~~~~e 408 (591)
T KOG0986|consen 339 EGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-------KVKREEVDRRTLEDPEE 408 (591)
T ss_pred CCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-------hhhHHHHHHHHhcchhh
Confidence 7765433 4699999999999999999999999999999999999999732221 111111222222 2223
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.+ ..+++++.+|....|+.||++|..-
T Consensus 409 y~--~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 409 YS--DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cc--cccCHHHHHHHHHHHccCHHHhccC
Confidence 33 2788899999999999999999743
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=287.91 Aligned_cols=257 Identities=18% Similarity=0.187 Sum_probs=193.6
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|+..+.||. ++|.||+|+. ++..+|+|++..... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778888999 9999999988 688999998865432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ ++|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 96 689888865332 45889999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-cccccc-------
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-RLGEIV------- 278 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~~~~~~------- 278 (331)
..... ...+++.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...... ......
T Consensus 154 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 154 VRTYT--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ccccc--cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 22111 123678899999887644 5889999999999999999999874322111 111100 000000
Q ss_pred -------ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 -------DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 -------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
......... ......+.++.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000 000023457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.42 Aligned_cols=191 Identities=21% Similarity=0.254 Sum_probs=166.6
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-C-----CceeeeEeEEeeCCccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-H-----RNILKLIGCCIETEIPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~~~~~~~~~~~ 125 (331)
.|.+.++||+ .||.|.+|.+ +++.||||++++... -..+...|+.+|..|+ | -|+|++++++...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 5678899999 9999999998 789999999986543 3667788999999997 3 37999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC--CceEEccCCC
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY--NVAKLSDFSE 203 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfg~ 203 (331)
||+|.+.. +|.+++..... ..++...+..++.||+.||.+|| ..+|||+||||+||||.+. ..+||+|||.
T Consensus 265 iVfELL~~-NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred eeehhhhh-hHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 99999965 99999986543 56899999999999999999999 9999999999999999744 4799999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCC
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
|.+...... +.+-+..|+|||++++.+|+.+.||||||||+.||++|.+-|
T Consensus 338 Sc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf 388 (586)
T KOG0667|consen 338 SCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF 388 (586)
T ss_pred ccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence 987654433 133578899999999999999999999999999999998644
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.51 Aligned_cols=254 Identities=20% Similarity=0.223 Sum_probs=189.6
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeC--CccEEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIET--EIPILVFE 129 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e 129 (331)
|...+.+|+ ++|.||+|.. ++..+|+|++.............+|+.++.++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 445677899 8999999988 788999999876543323345568999999985 99999999999987 88999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++ |+|.+.+.... ..+++..+..++.|++.||.||| +.+++||||+|+||+++. +.++|+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 58888886532 35889999999999999999999 899999999999999999 9999999999886643
Q ss_pred CCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh--------------c
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE--------------N 271 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~--------------~ 271 (331)
..... ...++..|+|||++.. +.++.++|||||||++|+|++|..||....... .... .
T Consensus 152 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 152 KPPYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred CCCcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 32211 1337889999998754 457889999999999999999999884322111 0000 0
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........+........+.....+.++.+++.+||+.+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000000001134578999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=282.09 Aligned_cols=243 Identities=18% Similarity=0.288 Sum_probs=194.8
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
|..-+.||+ ++|.||++.. ++..+++|++...... ..+.+.+|+.++..++||||+++++++...+..++++||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 444568999 8999999987 6788999988644322 45678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+++|.+++.. ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++++|||.+........
T Consensus 100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 9999998865 24788999999999999999999 89999999999999999999999999998775543221
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--HhhccccccccccccccCCCCch
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
. .....|+..|+|||++....++.++||||||+++|+|++|..|+........ ..... ..+......
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~---- 239 (285)
T cd06648 171 R--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-----LPPKLKNLH---- 239 (285)
T ss_pred c--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-----CCCCCcccc----
Confidence 1 1223488999999999888899999999999999999999999743222111 11111 011111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+..+.+++.+||+.+|++|||+.++++
T Consensus 240 --~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 --KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 13347999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=280.70 Aligned_cols=248 Identities=23% Similarity=0.278 Sum_probs=197.1
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||. ++|.||+|.. ++..+|+|.+.... .....+.+.+|+.+++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4677788999 8999999998 67889999986532 222456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 209 (331)
+++++|.+++....+ ..+++..+..++.+++.||.||| +.+++|+||+|+||++++++ .++++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999865432 34789999999999999999999 89999999999999999875 569999999876644
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
..... ....|++.|+|||++....++.++|+||||+++|++++|..|+............. .....+. ..
T Consensus 155 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~---~~--- 224 (257)
T cd08225 155 SMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--QGYFAPI---SP--- 224 (257)
T ss_pred Ccccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh--cccCCCC---CC---
Confidence 32211 11347889999999988889999999999999999999999975432221111100 0001100 11
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.++.+++.+||..+|++|||+.++++
T Consensus 225 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 ---NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 22346999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=277.99 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=198.2
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|...+.||+ ++|.||+|.. ++..+++|.+...... ...+.+.+|+.+++.++|+||+++++++...+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 667788999 9999999987 6789999998765432 35778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++++|.+++... ..+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 82 SGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999998653 34778889999999999999999 8999999999999999999999999999988765433
Q ss_pred cccc--ccccCCCCcccchhhhccCC---CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 212 THVT--SHMLTRTKRYLAPEYILTGL---CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 212 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... .....++..|+|||++.... ++.++||||||+++|++++|..||............... ...+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~----- 226 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHKPP----- 226 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCCCC-----
Confidence 2211 11234788999999998766 889999999999999999999998533211111100000 00111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.|.....+..+.+++.+||+.+|++|||+.+++.
T Consensus 227 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 -IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111123456889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=285.08 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=195.8
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||. ++|.||+|.. ++..||+|++..... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667788999 9999999998 688999999876532 23456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+ +++|.+++.... ..+++.++..++.|+++||.||| +.+++|+||||+||+++.++.++++|||.+......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986543 45889999999999999999999 899999999999999999999999999998876543
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhhc-cccc--------cc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVEN-NRLG--------EI 277 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~-~~~~--------~~ 277 (331)
.... .....++..|+|||++... .++.++||||+|+++++|++|.+|+........ .... .... ..
T Consensus 153 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 153 EPRL-YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CCCc-cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCc
Confidence 3211 1113478899999998654 468999999999999999999877632211110 0000 0000 00
Q ss_pred c--cc-ccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 V--DP-IVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~--~~-~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. .. ........+. ..+.+.++.+++.+||+.+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 00 0000000000 0123467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=273.21 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=200.2
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
|...+.||. ++|.||++.. ++..+++|++..... .....+.+|+.+++.++|+||+++++++..++..++++||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 667788999 8999999998 578899999876544 256789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+++|.+++.... ..+++..+..++.+++.||.||| ..+++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 81 GGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred CCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999986542 46899999999999999999999 89999999999999999999999999999887655432
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHH
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (331)
.....++..|+|||.+....++.++||||||+++++|++|..|+............... ..+......
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~------ 221 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN---GPPGLRNPE------ 221 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc---CCCCcCccc------
Confidence 11234788999999998888999999999999999999999998544222211111110 000011111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 293 QQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 293 ~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.++.+++.+||+.||++|||+.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12357999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=302.59 Aligned_cols=245 Identities=20% Similarity=0.347 Sum_probs=199.8
Q ss_pred cCceee-cCcEEEEEEe---CC--ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 59 HQVIAS-EHYKLYKGFL---EN--RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~---~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
.+.||+ .||.|+.|.| .| -.||||.+....-....++|++|+.+|.+|+|||+|+|||+..+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 357999 9999999999 23 36999999876444478899999999999999999999999998 67889999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
.|+|.+.|.... ...|.......++.|||.|+.||. .+++|||||...|+|+...-.+||+|||+.+.+..+..
T Consensus 194 lGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 194 LGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999998732 145777888899999999999999 99999999999999999999999999999998877654
Q ss_pred cc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhccccccccccccccCCCC
Q 020078 213 HV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 213 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.. ....+.-...|-|||.+....++.++|||+|||++|||++ |..||....-.. ..+.. ...+..+..|
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~-------~erLpRPk~c 340 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA-------GERLPRPKYC 340 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc-------cccCCCCCCC
Confidence 43 2223334678999999999999999999999999999999 556763322221 11111 1123344444
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
+ ++++++++.||+.+|++||||..+.+.+
T Consensus 341 s------edIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 341 S------EDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred h------HHHHHHHHHhccCCccccccHHHHHHhH
Confidence 4 5799999999999999999999997544
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=282.19 Aligned_cols=259 Identities=17% Similarity=0.182 Sum_probs=195.3
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|+..+.||. ++|.||+|+. ++..||+|.+...........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778889999 9999999998 688999999876544434567789999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++ +|.+++..... ...+++..+..++.|++.||.||| +.+++||||||+||++++++.++++|||++.......
T Consensus 81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 84 88888765332 135899999999999999999999 8999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-cccc-----ccc-c
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-RLGE-----IVD-P 280 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~~~~-----~~~-~ 280 (331)
... ....++..|+|||++... .++.++||||||+++|++++|+.|+....... ...... .... ... +
T Consensus 155 ~~~--~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 155 NTF--SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccc--ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 211 112368889999998654 57889999999999999999999874222111 000000 0000 000 0
Q ss_pred ccccCCCC-------chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSC-------PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........ ......+.++.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 000123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=281.17 Aligned_cols=250 Identities=17% Similarity=0.277 Sum_probs=201.6
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.+++|+....+|+ ++|.||+|.. ++..+++|.+..... ....+.+|+.++..++|+||+++++++...+..++++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 4667888889999 9999999999 588999999875433 4667889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++.... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 95 EYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred eccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 9999999999997642 36899999999999999999999 8999999999999999999999999999876554
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
..... .....++..|+|||.+....++.++|+||||+++|+|++|+.|+............... . ....
T Consensus 168 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~--------~~~~ 236 (286)
T cd06614 168 KEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-G--------IPPL 236 (286)
T ss_pred cchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-C--------CCCC
Confidence 33211 11233788999999998888999999999999999999999997433222111110000 0 0011
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.....+.++.+++.+||+.+|.+|||+.+++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111124457999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=287.54 Aligned_cols=245 Identities=20% Similarity=0.314 Sum_probs=193.5
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.|...+.||+ ++|.||+|+. ++..+|+|.+..... ......+.+|+.+++.++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677788999 8999999988 678999999864322 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++ |+|.+.+.... .++++.++..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 997 57877775432 45889999999999999999999 89999999999999999999999999999875433
Q ss_pred CCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.. ...+++.|+|||++. .+.++.++||||||+++|+|++|+.|+.............. ...
T Consensus 178 ~~------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----------~~~ 241 (317)
T cd06635 178 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------NES 241 (317)
T ss_pred cc------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh----------ccC
Confidence 22 134788999999974 45688999999999999999999999743322111111000 000
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
........+..+.+++.+||+.+|.+|||+.++++.+
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000113445799999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=284.56 Aligned_cols=262 Identities=16% Similarity=0.136 Sum_probs=193.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCc-----
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMN-HRNILKLIGCCIETEI----- 123 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~----- 123 (331)
++|...+.||. ++|.||+|.. +++.||+|.+...... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999 9999999998 6889999987654322 23457889999999995 6999999999987665
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFS 202 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg 202 (331)
.++||||+++ +|.+++..........+++..+..++.||+.||.||| +.+|+||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 8988886543221246899999999999999999999 899999999999999998 8999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH---hhcc-ccc-c
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH---VENN-RLG-E 276 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~---~~~~-~~~-~ 276 (331)
++..+........ ...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......... .... ... .
T Consensus 157 ~~~~~~~~~~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKSYT--HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCccccC--CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9876533221111 1236788999998865 45789999999999999999999988432222111 1100 000 0
Q ss_pred cccccc-------ccC--CCCc--hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 IVDPIV-------VED--KSCP--EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 ~~~~~~-------~~~--~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... ... .... .....+.++.+++.+||..||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 000 0000 00134567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.37 Aligned_cols=251 Identities=21% Similarity=0.357 Sum_probs=213.4
Q ss_pred ccccCceee-cCcEEEEEEe--CC----ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--EN----RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
....++||+ .||+||+|.+ .+ -+||+|.+......+...+++.|+-+|++|+|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 345678999 9999999999 43 3799999988777777899999999999999999999999998776 77999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
+|+|.|+|.++++... .++..+..+.|+.|||+|+.||| ..+++||||-++|||+.+...+|+.|||+++.+.
T Consensus 777 q~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999997643 56888899999999999999999 9999999999999999999999999999999987
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCCh--hHHHHHHHhhccccccccccccccC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNI--LLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
.+..........-.+.|||-|.+....|+.++|||||||++||++| |..|+. ....+...+..+. .+..+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------RLsqP 922 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------RLSQP 922 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------cCCCC
Confidence 7766555444445788999999999999999999999999999998 777763 2333333333222 24455
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
+-|+. ++.-++.+||..|+..||+|+++...+.++.
T Consensus 923 piCti------DVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 923 PICTI------DVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCccH------HHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 56665 6999999999999999999999999988764
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.16 Aligned_cols=255 Identities=16% Similarity=0.192 Sum_probs=193.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv 127 (331)
++|...+.||. ++|.||+|.. ++..+++|.+...... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788889999 9999999998 5788999998754322 2234677899999999999999999999887 889999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||++ ++|.+++.... ..+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99997 58988886543 35899999999999999999999 899999999999999999999999999998876
Q ss_pred CCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH---hh-------------
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH---VE------------- 270 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~---~~------------- 270 (331)
....... ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 157 GSPLKPY--TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cCCcccc--ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHh
Confidence 5432211 112368889999998754 4688999999999999999999988432211110 00
Q ss_pred -c------cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 271 -N------NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 271 -~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ..........+....... ..++.+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPAL---SLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhcccccc---CCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000000011000 13557899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=284.38 Aligned_cols=258 Identities=19% Similarity=0.182 Sum_probs=194.0
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
+|...+.||+ ++|.||+|.. +++.||+|++...... .....+..|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3666778999 9999999998 6789999998754322 1244677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+ +|+|.+++.... ..+++..+..++.|+++||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 899999986542 25889999999999999999999 999999999999999999999999999998876
Q ss_pred CCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-cc--------
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-RL-------- 274 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~~-------- 274 (331)
........ ...+++.|+|||.+.. ..++.++||||||+++|+|++|.+|+....... ...... ..
T Consensus 153 ~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 153 GSPNRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred cCCCcccc--ccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 54322111 1236788999998854 457899999999999999999977663222111 110000 00
Q ss_pred ccccccccccC-CCCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 275 GEIVDPIVVED-KSCP---EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 275 ~~~~~~~~~~~-~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+...... ...+ .....+.++.+++.+||+.||++|||+.|++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 0000 001235679999999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.61 Aligned_cols=251 Identities=18% Similarity=0.234 Sum_probs=198.3
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~ 128 (331)
+|+..+.+|. ++|.||++.. ++..+|+|.+.... .....+.+..|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677788999 9999999987 77889999886542 33345678899999999999999999998764 34578999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF--RRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||+++++|.+++..... ...++++..++.++.+++.||.|||..+ +.+++|+||+|+||+++.++.++++|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999865321 1246889999999999999999999443 57899999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 284 (331)
........ ....+++.|+|||++....++.++|+||||+++|+|++|..|+..... .......... +
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~---- 228 (265)
T cd08217 160 LGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF-----R---- 228 (265)
T ss_pred ccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-----C----
Confidence 75443211 123488999999999988899999999999999999999999754321 1111111110 0
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+ ...+.++.+++.+||..+|++|||+.++++
T Consensus 229 --~~~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 229 --RIP--YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred --CCc--cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 011 134457999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.69 Aligned_cols=240 Identities=20% Similarity=0.233 Sum_probs=191.2
Q ss_pred eee-cCcEEEEEEeC--CceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFLE--NRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~--~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||. ++|.||+++.. +..+++|.+..... ....+.+.+|+.+++.++||||+++++++.+++..++++||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 567 88999999994 88999999875432 23456789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++... ..++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~---~ 149 (262)
T cd05572 81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---T 149 (262)
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---c
Confidence 9999654 34788999999999999999999 89999999999999999999999999999987654421 1
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH-HHHHhhccccccccccccccCCCCchHHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH-VKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
....++..|+|||.+....++.++|+||||+++|++++|..|+..... ....... +.+. ......|. ..+
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~--~~~~~~~~--~~~ 220 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-----ILKG--NGKLEFPN--YID 220 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-----Hhcc--CCCCCCCc--ccC
Confidence 123478899999999888899999999999999999999999853331 0011100 0000 00111111 224
Q ss_pred HHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 296 QALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 296 ~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
.++.+++.+||..+|++||+ +.|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 57999999999999999999 677664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.09 Aligned_cols=240 Identities=18% Similarity=0.273 Sum_probs=191.3
Q ss_pred cCceee-cCcEEEEEEe--CCceEEEEEeCC---CCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc--cEEEEEe
Q 020078 59 HQVIAS-EHYKLYKGFL--ENRPISVMKFGD---NYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI--PILVFEF 130 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~e~ 130 (331)
..+||+ .|-+||+|.+ +|-.||--.+.- ..+....+.|..|+++|+.|+|||||++|.++.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 467899 6669999999 566666543321 2333456899999999999999999999999998665 6689999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~ 209 (331)
+..|+|..+...- ..+....+..|++||++||.|||+. +.+|||||||-+||+|.. -|.+||+|+|+|+....
T Consensus 125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999765 3477889999999999999999965 789999999999999974 48999999999987754
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh---ccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE---NNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 286 (331)
.... .++|||.|||||+.. ..|+..+||||||++++||+|+.+|+.-.......++ .+.....+..+
T Consensus 199 s~ak----svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV----- 268 (632)
T KOG0584|consen 199 SHAK----SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV----- 268 (632)
T ss_pred cccc----eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc-----
Confidence 3321 156999999999986 7899999999999999999999999865554443332 22222211111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
-.+++++||.+||.. .++|||+.|+|..
T Consensus 269 -------~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 -------KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 124799999999999 9999999999863
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=280.53 Aligned_cols=244 Identities=17% Similarity=0.169 Sum_probs=197.2
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+|...+.||. ++|.||++.. ++..+|+|.+..... ....+.+.+|+.++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4777889999 9999999998 588999999875422 2346788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++... .+++...+..++.|+++||.||| +.+++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999998654 36889999999999999999999 89999999999999999999999999999876644
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... ....++..|+|||.+....++.++|+||||+++|+|++|..|+..... .......... ... .
T Consensus 153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~----~ 220 (258)
T cd05578 153 DTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADV----L 220 (258)
T ss_pred Cccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccc----c
Confidence 3211 123478899999999888899999999999999999999999753321 1111110000 000 1
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTM--VYAA 320 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~--~evl 320 (331)
.+ ...+.++.+++.+||+.||.+||++ +|++
T Consensus 221 ~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YP--ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred Cc--ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11 1234579999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=284.99 Aligned_cols=255 Identities=22% Similarity=0.329 Sum_probs=201.8
Q ss_pred ccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHh--cCCCceeeeEeEEeeCC----ccEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQ--MNHRNILKLIGCCIETE----IPILVF 128 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~ 128 (331)
.....++|+ +||.||||.++++.||||++... ..+.|.+|-.|... ++|+||++++++-.... .++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhccCceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 334567899 99999999999999999998654 56788888887765 57999999999977655 789999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc------CCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI------GFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
||.+.|+|.++|... .++|....+++..+++||+|||+ +...+|+|||||+.|||+.+++++.|+|||
T Consensus 288 ~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999763 58999999999999999999997 346689999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCC-CC-----CcccchhhHHHHHHHHhCCC------------CC-----
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL-CN-----EKTDVFCFGMLLLELLTGRR------------DN----- 259 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~SlG~~l~el~~g~~------------p~----- 259 (331)
+|..+............+||..|||||++.+.. +. ...||||+|.||||+++... ||
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999887665554444467999999999997542 22 36899999999999999653 22
Q ss_pred --hhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 260 --ILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 260 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.....++..+...+.+..+....... ....-+++.++.||..||+.|.||.=|-+.+..+.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h-------~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKH-------AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcC-------ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 23344444444333333222222222 12345899999999999999999998888887765
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=287.98 Aligned_cols=258 Identities=18% Similarity=0.240 Sum_probs=194.5
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET----- 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 121 (331)
...+.|...+.||+ ++|.||+|.. +++.||+|.+.... .......+.+|+.++.+++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35678999999999 9999999998 78899999986542 222456778899999999999999999998644
Q ss_pred -CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
...++||||+. ++|.+.+.. .++...+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence 24689999996 588887743 2778889999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh-------
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE------- 270 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~------- 270 (331)
||++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....
T Consensus 162 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 238 (353)
T cd07850 162 FGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSD 238 (353)
T ss_pred CccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 999986543322 112347889999999999899999999999999999999999874221100 0000
Q ss_pred --------------cccc-------ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 271 --------------NNRL-------GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 271 --------------~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.... ....................+.++.+++.+||+.||++|||+.|++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000000000000000011235578999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=278.84 Aligned_cols=241 Identities=17% Similarity=0.219 Sum_probs=189.1
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||+ ++|+||++.. +++.+|+|.+.... .......+.+|+.++.+++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 567 8999999987 68899999986532 122355678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++..... ..+++..+..++.|++.||.||| ..+++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~--- 151 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--- 151 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---
Confidence 999875432 35889999999999999999999 899999999999999999999999999998765432211
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCCchHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
....++..|+|||++.++.++.++||||||+++|+|++|+.||...... ........ .......+ ...
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~--~~~ 221 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRT--------LEMAVEYP--DKF 221 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcc--------ccccccCC--ccC
Confidence 1234788999999998888999999999999999999999997432210 00010000 00011111 123
Q ss_pred HHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
++++.+++.+||+.||++|| ++.+++.
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 45799999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=288.18 Aligned_cols=261 Identities=17% Similarity=0.164 Sum_probs=194.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----c
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-----I 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~ 123 (331)
.+++|...+.||+ ++|.||+|.. ++..||+|.+...........+.+|+.++.+++||||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999 9999999987 788999999865433335567889999999999999999999876543 4
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++++||++ ++|.+.+.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccc
Confidence 689999997 488887754 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH------HHhhcccc-
Q 020078 204 SEYIPEGETHV-TSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK------KHVENNRL- 274 (331)
Q Consensus 204 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~------~~~~~~~~- 274 (331)
+.......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 87654322111 1122347889999998765 468899999999999999999999873221110 00000000
Q ss_pred --cccccc-------ccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 275 --GEIVDP-------IVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 275 --~~~~~~-------~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.+. ........+. ....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000000000 01234579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=272.33 Aligned_cols=250 Identities=20% Similarity=0.235 Sum_probs=197.6
Q ss_pred HHhcCcccc-Cceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC----
Q 020078 51 IATNNYNGH-QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET---- 121 (331)
Q Consensus 51 ~~~~~~~~~-~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~---- 121 (331)
.+|++|.+. ++||- -.|.|-.+.. +++++|+|.+.+. ....+|+++.-.. .|||||.++++|...
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 356777654 66777 5667777765 8999999998743 4567888877666 499999999998752
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc---CCCceEE
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD---EYNVAKL 198 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl 198 (331)
.-+.+|||.++||.|...+.+.+. ..+++.++..|++||+.|+.||| +.+|.||||||+|+|.. .|..+||
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEe
Confidence 345689999999999999987653 57999999999999999999999 99999999999999996 4457899
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV 278 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 278 (331)
+|||+|+......... +-+.|+.|.|||++-..+|+...|+||+||++|-|++|.+||+...... .. ...-
T Consensus 206 tDfGFAK~t~~~~~L~---TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a--is----pgMk 276 (400)
T KOG0604|consen 206 TDFGFAKETQEPGDLM---TPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA--IS----PGMK 276 (400)
T ss_pred cccccccccCCCcccc---CCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc--CC----hhHH
Confidence 9999998765433221 2347999999999999999999999999999999999999985432210 00 0111
Q ss_pred ccccccC--CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 DPIVVED--KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+..+. ++.|++.+.++++.++|..+|+.+|.+|.|+.++++
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1122233 445667788999999999999999999999999875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.24 Aligned_cols=257 Identities=19% Similarity=0.177 Sum_probs=193.0
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|+..+.||. ++|.||+|.. ++..||+|++...... .....+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456678999 8999999988 7899999998754322 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
+ ++|.+++..... ..+++..+..++.|+++||.||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5 689998865421 35889999999999999999999 8999999999999999999999999999987654332
Q ss_pred ccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh---hc-ccccccc--------
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV---EN-NRLGEIV-------- 278 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~---~~-~~~~~~~-------- 278 (331)
.... ...++..|+|||++.+. .++.++||||||+++|+|++|+.||.......... .. .......
T Consensus 154 ~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 154 RTYT--HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cccC--ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 2111 12368889999988664 57889999999999999999999974322211111 10 0000000
Q ss_pred c---cccccCCCC--chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 D---PIVVEDKSC--PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ~---~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+ ......... ......+.++.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 000123357899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=283.65 Aligned_cols=243 Identities=20% Similarity=0.333 Sum_probs=191.5
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
|...+.||. ++|.||+|+. ++..+++|.+... ........+.+|+.+++.++|+|++++.+++.+.+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 566678999 9999999998 6788999988642 2223456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+. |+|.+.+.... .++++.++..++.+++.||.||| +.+++||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 97 68877775432 45888999999999999999999 899999999999999999999999999998765432
Q ss_pred CccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.. ..++..|+|||++. .+.++.++||||||+++|+|++|..|+............... . .+...
T Consensus 169 ~~------~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~---- 235 (308)
T cd06634 169 NX------FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-E--SPALQ---- 235 (308)
T ss_pred cc------ccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhc-C--CCCcC----
Confidence 21 34788999999975 356788999999999999999999997433221111110000 0 00000
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+..+.+++.+||..+|++||++.+++..
T Consensus 236 ---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred ---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 11344579999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.10 Aligned_cols=249 Identities=19% Similarity=0.203 Sum_probs=210.1
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.-..+|.....||. .|+.|..|+. ++..||+|.+++..-. ...+.+.+|+.+|..|+|||||+++.+......+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 34578899999999 8899999988 8999999999876333 345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+.+|.+++++...+. +....+..+..|+.+|++||| ++.|||||||++|+|++.+.++||+|||++.+
T Consensus 133 V~eya~~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEeccCchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecccccee
Confidence 9999999999999987542 444777888999999999999 99999999999999999999999999999998
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
+...... .+.+|++.|.|||++.+..| .+.+|+||+|++||-|+.|..||. ...+...-+..+.+.
T Consensus 205 ~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD----------G~~lk~Lr~rvl~gk 271 (596)
T KOG0586|consen 205 FDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD----------GQNLKELRPRVLRGK 271 (596)
T ss_pred ecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC----------Ccccccccchheeee
Confidence 8754432 33679999999999988776 578999999999999999999953 333334444455555
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+..|. -++.++.+|+.++|..+|.+|++.+++.+.
T Consensus 272 ~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ecccc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 55444 455689999999999999999999998653
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.57 Aligned_cols=240 Identities=17% Similarity=0.230 Sum_probs=183.4
Q ss_pred ceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHh---cCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 61 VIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQ---MNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~---l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
+||+ +||.||++.. ++..+|+|.+...... .....+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4788 8999999988 6789999988654221 123344555544443 479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999888654 35899999999999999999999 89999999999999999999999999999875533221
Q ss_pred cccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHH-HHHHhhccccccccccccccCCCCch
Q 020078 213 HVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEH-VKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
....|+..|+|||.+.. ..++.++||||||+++|+|++|..||..... .......... ..+...+
T Consensus 153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~~~~- 219 (279)
T cd05633 153 ----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------TVNVELP- 219 (279)
T ss_pred ----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh--------cCCcCCc-
Confidence 11348999999999874 4588999999999999999999999843211 0001110000 0011111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRP-----TMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~~ 322 (331)
...+.++.+++.+||..||++|| |++|+++.
T Consensus 220 -~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 -DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 13455799999999999999999 58888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=281.54 Aligned_cols=260 Identities=19% Similarity=0.201 Sum_probs=190.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc------
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEI------ 123 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 123 (331)
++|.....||+ ++|.||+|.. +++.||+|.+...... .....+.+|+.++++++||||++++++|...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999 9999999998 6889999988654322 223456789999999999999999999887543
Q ss_pred --cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 124 --PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 124 --~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
.++||||+. ++|.+.+.... ..+++.++..++.|+++||.||| +.+++|+||||+||+++.++.++|+||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcC
Confidence 489999997 48888776532 35889999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCcc--ccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhh---ccc
Q 020078 202 SESEYIPEGETH--VTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVE---NNR 273 (331)
Q Consensus 202 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~---~~~ 273 (331)
|++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..|+........ ... ...
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998766433221 111123467889999988654 478899999999999999999988733221110 000 000
Q ss_pred ccccc---------cc-ccccCCCCchHH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 LGEIV---------DP-IVVEDKSCPEKE-----QQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~~~~~---------~~-~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... +. ............ -.+..+.+++.+||..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 00 000000000000 01245789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.96 Aligned_cols=266 Identities=19% Similarity=0.246 Sum_probs=206.7
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------ccEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------IPIL 126 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~~l 126 (331)
..-...+|+ +||.||+|+. .|+.||||.+.........+...+|+++|++|+|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 345678999 9999999997 899999999988766667889999999999999999999999876543 5679
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc--C--CCceEEccCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--E--YNVAKLSDFS 202 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~--~--~~~~kl~Dfg 202 (331)
|||||++|||...+.+..+. ..++..+.+.++.+++.||.||| ..+|+||||||.||++- . .-.-||+|||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999865432 46999999999999999999999 99999999999999993 3 3357999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHHhCCCCChhHH-------HHHHHhhcccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRRDNILLE-------HVKKHVENNRL 274 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~-------~~~~~~~~~~~ 274 (331)
.|+.++++... .+.+||..|.+||++. ++.|+..+|.|||||++|+++||..||.... .++........
T Consensus 170 ~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 99999877632 3367999999999998 4889999999999999999999999983211 11111111111
Q ss_pred cccc--ccccc--------cCCCCchHHHHHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHHHh
Q 020078 275 GEIV--DPIVV--------EDKSCPEKEQQLQALLQLIFECVNESAGDRP--TMVYAAKQLRQMYLS 329 (331)
Q Consensus 275 ~~~~--~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp--s~~evl~~L~~~~~~ 329 (331)
.-.+ .+... -++++.........+...+..+|..+|.+|- .+.+.-..+..|...
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 1000 00011 1112222224445577788889999999999 888888888777654
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=280.77 Aligned_cols=239 Identities=19% Similarity=0.282 Sum_probs=192.1
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
..||+ ++|.||++.. ++..||+|++..... .....+.+|+.+++.++|+||+++++++..++..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46899 9999999988 788999999864432 2566788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++..........
T Consensus 105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~-- 173 (292)
T cd06657 105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR-- 173 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc--
Confidence 987743 24788999999999999999999 8999999999999999999999999999987654332111
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
....++..|+|||.+....++.++|+||+|+++|+|++|..|+....... ....... ........ ..
T Consensus 174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~------~~ 242 (292)
T cd06657 174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPKLKNLH------KV 242 (292)
T ss_pred cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC-----CcccCCcc------cC
Confidence 12347889999999988888999999999999999999999974332211 1111100 11111111 22
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+..+.+++.+||+.+|.+||++.+++.
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 346889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=280.48 Aligned_cols=246 Identities=19% Similarity=0.154 Sum_probs=193.1
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||. ++|.||++.. +++.+++|.+..... ....+.+.+|+.++.+++||||+++++.+...+..++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 466 8899999999 589999999875432 23466788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc---
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH--- 213 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--- 213 (331)
.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9998654 35889999999999999999999 899999999999999999999999999998765433210
Q ss_pred ---ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 214 ---VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 214 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.......++..|+|||......++.++||||||+++|++++|..|+........... . ..+....+.
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~---------~~~~~~~~~ 222 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN-I---------LNGKIEWPE 222 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-H---------hcCCcCCCc
Confidence 111223478889999999888899999999999999999999999743322111100 0 000111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
....+.++.+++.+||+.+|++|||+.++.+.|+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 223 DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 10124579999999999999999999666665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=303.04 Aligned_cols=263 Identities=21% Similarity=0.332 Sum_probs=210.9
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeE
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGC 117 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 117 (331)
++...++....+.+|. .||.|++|... ...||||.+.........+.+..|+.+|..+. |+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3344455555668999 99999999862 45799999988766667889999999999995 9999999999
Q ss_pred EeeCCccEEEEEecCCCChhhhhcCCC---------CCCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCC
Q 020078 118 CIETEIPILVFEFVEYGTLADRICSPH---------GPHLE--PLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~ 186 (331)
|......++|+||+..|+|.+++.... ..... .++....+.++.|||.|+.||+ +.++|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhh
Confidence 999999999999999999999998754 11111 3888999999999999999999 999999999999
Q ss_pred ceEEcCCCceEEccCCCccccCCCCcccccccc-CCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh---
Q 020078 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHML-TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL--- 261 (331)
Q Consensus 187 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~--- 261 (331)
|||+..+..+|++|||+|+.............. .-+..|||||.+....|+.++||||||++|||+++ |..|+..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999976555444322111 12456999999999999999999999999999999 5567643
Q ss_pred HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 262 LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.....+....+.. +..+. .+++++.++|..||+.+|++||++.++.+.++...
T Consensus 528 ~~~l~~~l~~G~r-------~~~P~------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 528 TEELLEFLKEGNR-------MEQPE------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHHHHHHHhcCCC-------CCCCC------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 2333333333332 12222 33457999999999999999999999999998854
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=271.15 Aligned_cols=250 Identities=20% Similarity=0.242 Sum_probs=200.9
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 128 (331)
+|...+.||+ ++|.||+|.. ++..+++|.+..... ....+.+.+|+.++++++||||+++++.+.+. +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667788999 9999999998 588999999875532 23567889999999999999999999999988 8899999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++... ..+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999998754 36889999999999999999999 8999999999999999999999999999988775
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
............++..|+|||.+....++.++||||||+++++|++|..|+.................. ....
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~ 225 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE-------PPEI 225 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC-------CcCC
Confidence 543211112234788999999998888999999999999999999999998543311111111000000 0001
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+ ...+.++.+++.+||..||++||++.+++.
T Consensus 226 ~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 P--EHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred C--cccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1 123457999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=279.77 Aligned_cols=262 Identities=17% Similarity=0.190 Sum_probs=191.8
Q ss_pred ccccCceee-cCcEEEEEEe----CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL----ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPIL 126 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 126 (331)
|...+.||+ ++|.||+|.. .+..+|+|.+.... .......+.+|+.++..++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667788999 9999999998 46899999987642 122346778899999999999999999999988 78999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC----CCceEEccCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE----YNVAKLSDFS 202 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~----~~~~kl~Dfg 202 (331)
||||+++ +|.+.+..........++...+..++.|++.||.||| +.+|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 6777665332222236888999999999999999999 899999999999999999 8999999999
Q ss_pred CccccCCCCc-cccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHH------------HHH
Q 020078 203 ESEYIPEGET-HVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHV------------KKH 268 (331)
Q Consensus 203 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~------------~~~ 268 (331)
++........ ........++..|+|||++.+. .++.++||||||+++++|++|..|+...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9887644332 1122223478899999988764 5789999999999999999999987321110 000
Q ss_pred hhc---c------------ccccccccccccCCC-CchHH------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 269 VEN---N------------RLGEIVDPIVVEDKS-CPEKE------QQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 269 ~~~---~------------~~~~~~~~~~~~~~~-~~~~~------~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.. . ......+........ ..... ..+.++.+++.+||+.||++|||+.|++.
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0 000000000000000 00000 23356899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=282.15 Aligned_cols=252 Identities=17% Similarity=0.204 Sum_probs=186.8
Q ss_pred cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhc
Q 020078 65 EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRIC 141 (331)
Q Consensus 65 ~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 141 (331)
++++||.+.. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+++|+|.+++.
T Consensus 12 ~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~ 91 (328)
T cd08226 12 NLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLK 91 (328)
T ss_pred CceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHH
Confidence 4558999988 78999999987543 22345778899999999999999999999999999999999999999999886
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc-----cc
Q 020078 142 SPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV-----TS 216 (331)
Q Consensus 142 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-----~~ 216 (331)
.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++++||+.+.......... ..
T Consensus 92 ~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (328)
T cd08226 92 TYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFP 165 (328)
T ss_pred hhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccc
Confidence 5421 35788899999999999999999 8999999999999999999999999997643322111100 01
Q ss_pred cccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh---hcccccc---------------
Q 020078 217 HMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV---ENNRLGE--------------- 276 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~--------------- 276 (331)
....++..|+|||++.+. .++.++||||||+++|+|++|+.||.......... .......
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd08226 166 QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKN 245 (328)
T ss_pred ccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhcc
Confidence 112245679999999764 47899999999999999999999984322111110 0000000
Q ss_pred --------ccc---------cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 277 --------IVD---------PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 277 --------~~~---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+.+ .........+....++.++.+|+.+||..||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 246 SQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 0000011122233567789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=282.42 Aligned_cols=259 Identities=18% Similarity=0.184 Sum_probs=193.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~l 126 (331)
.++|...+.||. ++|.||+|.. +++.||+|.+...... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467888999999 9999999998 6899999998654322 1234567899999999999999999998765 45799
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+. ++|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||.+..
T Consensus 86 v~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999997 48888876532 45889999999999999999999 89999999999999999999999999999887
Q ss_pred cCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH--hhcc---cccccc--
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH--VENN---RLGEIV-- 278 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~--~~~~---~~~~~~-- 278 (331)
......... ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... .... ......
T Consensus 158 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 158 YGLPAKPMT--PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cCCccCCCC--cccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 654322111 1225778999999875 45789999999999999999999988432211110 0000 000000
Q ss_pred -------cc-ccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 -------DP-IVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 -------~~-~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ........... ...++++.+++.+||..||++|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000000000 013567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=278.72 Aligned_cols=256 Identities=20% Similarity=0.235 Sum_probs=193.5
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|...+.||. ++|+||+|.. +++.|++|++.............+|+..+.+++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456678999 9999999998 578899999876544323445667999999999 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
+|+|.+++....+ ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 -EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred -CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 7899998876431 35789999999999999999999 8999999999999999999999999999988664432
Q ss_pred ccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc---------------ccc
Q 020078 212 THVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN---------------RLG 275 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~---------------~~~ 275 (331)
... ...++..|+|||++.. ..++.++|+||||+++++|++|+.|+............. ...
T Consensus 154 ~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 154 PYT---DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred CcC---CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhh
Confidence 221 1347889999998854 457899999999999999999998874322211111000 000
Q ss_pred cccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+............ ...+.++.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000000 011357999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=279.78 Aligned_cols=259 Identities=20% Similarity=0.172 Sum_probs=191.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|.....||. ++|.||+|.. +++.+|+|.+..... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46788889999 8999999998 678999998865422 2234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCCCccccC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFSESEYIP 208 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~ 208 (331)
|++ ++|.+++..... ..+++..+..++.||+.||.||| +.+++||||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 588887754321 23577888899999999999999 899999999999999985 5679999999987654
Q ss_pred CCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-ccc-cccc----
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRL-GEIV---- 278 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~-~~~~---- 278 (331)
....... ...+++.|+|||++.+. .++.++||||||+++|+|++|..||...... ...+.. ... ....
T Consensus 155 ~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 155 IPVRTFT--HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred CCccccc--cCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 3322111 12368899999998764 5789999999999999999999998432211 111110 000 0000
Q ss_pred ---cccc--cc-CCCCc--hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 ---DPIV--VE-DKSCP--EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ---~~~~--~~-~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+... .. ..... .....+.++.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00 00000 00123456899999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=278.05 Aligned_cols=256 Identities=19% Similarity=0.198 Sum_probs=195.9
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|...+.||. ++|.||+|.. ++..+++|.+...... .....+.+|+.++++++|+||+++++++.+++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 455677898 9999999988 6888999998754322 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++ +|.+++.... ..+++..+..++.+++.||.||| +.+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 75 8888886533 46889999999999999999999 8999999999999999999999999999987765443
Q ss_pred ccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh---c-cc-----cccccc--
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE---N-NR-----LGEIVD-- 279 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~---~-~~-----~~~~~~-- 279 (331)
... ....++..|+|||.+... .++.++|+||||+++|+|++|+.||........... . .. .....+
T Consensus 153 ~~~--~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPY--THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccc--cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 111 113378889999998876 788999999999999999999988743222211100 0 00 000000
Q ss_pred ----cccccCCCC---chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 ----PIVVEDKSC---PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ----~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
......... ......+.++.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000000 011245678999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=271.13 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=200.2
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||+ ++|.||++.. ++..+++|.+..... +...+.+.+|+.++.+++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667788999 8999999988 678999999876533 23567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998654 45889999999999999999999 999999999999999999999999999999876544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCch
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
... .....++..|+|||......++.++||||+|+++|+|++|..|+............... ..+.. +
T Consensus 153 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~--~----- 220 (254)
T cd06627 153 SKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD---DHPPL--P----- 220 (254)
T ss_pred ccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc---CCCCC--C-----
Confidence 332 12234788999999998778899999999999999999999997543332222211100 00001 0
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.++.+++.+||+.+|++|||+.+++.
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 -EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 123357999999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=278.03 Aligned_cols=251 Identities=18% Similarity=0.230 Sum_probs=192.4
Q ss_pred hcCccccCceee-cCcEEEEEEeC--CceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE--NRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~ 128 (331)
-++|...+.||+ ++|.||+|... +..+|+|.+...........+..|+.++.+.. ||||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 356777889999 89999999994 89999999876544434556777887776665 999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||++ ++|.+++.... ..+++..+..++.+++.||.||| + .+|+||||+|+||++++++.++|+|||++..+
T Consensus 94 e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9985 47777665432 36889999999999999999999 6 58999999999999999999999999998766
Q ss_pred CCCCccccccccCCCCcccchhhhccCC----CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGL----CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
........ ..++..|+|||++.... ++.++||||||+++|+|++|+.||................. .+...
T Consensus 166 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~ 240 (296)
T cd06618 166 VDSKAKTR---SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PPSLP 240 (296)
T ss_pred cCCCcccC---CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CCCCC
Confidence 44322211 23778899999987543 78899999999999999999999854222111111000000 00011
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
... ..+.++.+|+.+||..||++|||+.+++..
T Consensus 241 ~~~------~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 PNE------GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC------CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 233579999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=286.93 Aligned_cols=261 Identities=17% Similarity=0.229 Sum_probs=195.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEee----CCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 124 (331)
.++|...+.||. ++|.||+|.. ++..||+|++..... ......+.+|+.++..++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478888899999 9999999988 789999999875432 2245677889999999999999999998764 3457
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+. |+|.+++... ..+++..+..++.|++.||.||| ..+|+||||||+||+++.++.++|+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 89999996 6898888654 35889999999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCccc--cccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH---hh--cccccc
Q 020078 205 EYIPEGETHV--TSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH---VE--NNRLGE 276 (331)
Q Consensus 205 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~---~~--~~~~~~ 276 (331)
.......... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.||......... .. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 7654332211 1112347889999999865 45889999999999999999999998432211100 00 000000
Q ss_pred ccc-----------cccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 277 IVD-----------PIVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 277 ~~~-----------~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+ .........+. ....+.++.+++.+||+.+|++|||+.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 00000000000 01235679999999999999999999998763
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=273.07 Aligned_cols=242 Identities=19% Similarity=0.147 Sum_probs=186.6
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHH-HHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVF-AAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||. ++|.||+|.. +++.||+|.+..... ......+..|..+ ....+|+||+++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35788 8999999988 678999999865421 1122344555544 4456899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... .++++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-- 151 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccccc--
Confidence 9999998654 35888999999999999999999 8999999999999999999999999999987543311
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCchH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
...++..|+|||.+.+..++.++||||||+++|++++|..|+....... ......... ......
T Consensus 152 ----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~ 217 (260)
T cd05611 152 ----KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN----------WPEEVK 217 (260)
T ss_pred ----cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC----------CCCccc
Confidence 1347889999999988888999999999999999999999984332211 111111100 000000
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
...+.++.+++.+||+.||++|||+.++.+.|+.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 1234579999999999999999988766665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=273.95 Aligned_cols=249 Identities=19% Similarity=0.236 Sum_probs=194.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC----CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--Ccc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY----SENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIP 124 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~ 124 (331)
.+|...+.||+ ++|.||+|.. ++..+|+|.+.... .......+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999 9999999987 68899999875321 122456788999999999999999999998764 357
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++++||+++++|.+++... ..+++.....++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 8999999999999998654 34788889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 205 EYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 205 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
+........ .......++..|+|||++.+..++.++|+||||+++|++++|+.||............... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~---- 227 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQ-P-TK---- 227 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcC-C-CC----
Confidence 765321110 1111234788999999998888899999999999999999999998543322222111000 0 00
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...| ...+.++.+++.+||+ +|..|||+.+++.
T Consensus 228 --~~~p--~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 --PMLP--DGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCC--cccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111 1445679999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.63 Aligned_cols=262 Identities=20% Similarity=0.197 Sum_probs=194.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC----
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE---- 122 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~---- 122 (331)
...++|...+.+|. ++|.||+|.. +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34577888999999 8999999998 678999999875432 223456778999999999999999999987755
Q ss_pred ------ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 123 ------IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 123 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence 78999999986 7777775432 45889999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH---hhc-
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH---VEN- 271 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~---~~~- 271 (331)
||+|||++........... ....++..|+|||++... .++.++||||||+++|+|++|+.|+......... ...
T Consensus 156 kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 156 KLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred EeCcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999887644332111 112357789999988653 5788999999999999999999988433221111 000
Q ss_pred -cccc----cccc--------ccccc-CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 -NRLG----EIVD--------PIVVE-DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 -~~~~----~~~~--------~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.... .... ..... ..........+..+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 00000 0000000023457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=276.21 Aligned_cols=257 Identities=19% Similarity=0.202 Sum_probs=192.5
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPILVFE 129 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e 129 (331)
|...+.||. ++|.||+|.. ++..+|+|.+.... .......+.+|+.+++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455677898 9999999998 57899999998653 222346788999999999999999999999988 78999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++ +|.+++.... ..+++..++.++.|++.||.||| +.+++|+||+|+||++++++.++++|||.+.....
T Consensus 81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 9974 8988886542 36889999999999999999999 89999999999999999999999999999886654
Q ss_pred CCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh---cc---ccccccc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE---NN---RLGEIVD 279 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~---~~---~~~~~~~ 279 (331)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|+....... .... .. ......+
T Consensus 153 ~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 153 RNSADY-TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred CCcccc-cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 432111 11236788999998764 357899999999999999999999974322111 1110 00 0000000
Q ss_pred ----cccccCCCCch-----HHH-HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 ----PIVVEDKSCPE-----KEQ-QLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ----~~~~~~~~~~~-----~~~-~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.........+. ... .+.++.+++.+||..+|++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000 001 1567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=299.74 Aligned_cols=267 Identities=16% Similarity=0.134 Sum_probs=186.1
Q ss_pred HHhcCccccCceee-cCcEEEEEEe---CCceEEEEEe--------------CCC--CCcchhHHHHHHHHHHHhcCCCc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKF--------------GDN--YSENGENFCFNNIVFAAQMNHRN 110 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~--------------~~~--~~~~~~~~~~~E~~~l~~l~h~n 110 (331)
...+.|...+.||+ +||+||++.. .+...+.|.+ .+. ........+.+|+.+|.+++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999 9999999875 2222222211 100 11123456889999999999999
Q ss_pred eeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 111 ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 111 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
||++++++.+.+..++|+|++. ++|.+++...............+..++.|++.||.||| +.+|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence 9999999999999999999985 57877775432111122345667889999999999999 8999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCCh------hHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI------LLEH 264 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~------~~~~ 264 (331)
+.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++. ....
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 999999999999998765433221 122458999999999998899999999999999999999875421 1111
Q ss_pred HHHHhhccc--ccccccc-----------ccccCC-CCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 265 VKKHVENNR--LGEIVDP-----------IVVEDK-SCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 265 ~~~~~~~~~--~~~~~~~-----------~~~~~~-~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
......... ..+..+. ...... ..+. ....+..+.+++.+||+.||++|||+.|++..
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111111000 0000000 000000 0000 00123457889999999999999999999863
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=280.11 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=190.3
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
|...+.||+ ++|.||+|+. ++..+++|.+..... ......+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 455567999 8999999988 788999999864322 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ |+|.+.+.... .++++.++..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 96 57877775432 45889999999999999999999 899999999999999999999999999987643221
Q ss_pred CccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
. ...++..|+|||++. .+.++.++||||||+++|+|++|..|+............... . .+... ..
T Consensus 175 ~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~-~~- 243 (313)
T cd06633 175 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D--SPTLQ-SN- 243 (313)
T ss_pred C------CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-C--CCCCC-cc-
Confidence 1 234788999999984 456888999999999999999999997443222211111000 0 00000 00
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+..+.+++.+||+.+|.+||++.+++..
T Consensus 244 -----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 244 -----EWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 223468999999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.53 Aligned_cols=254 Identities=17% Similarity=0.224 Sum_probs=189.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------ 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 122 (331)
.++|.....||+ ++|.||+|.. ++..||+|++..... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999 9999999987 689999999875432 223456889999999999999999999987643
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++|+||+.. +|..... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg 162 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG 162 (342)
T ss_pred eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence 35899999964 7766552 24788999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhcc------
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVENN------ 272 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~~------ 272 (331)
+++....... ...++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... .......
T Consensus 163 ~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 163 LARHADAEMT-----GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCcCCCCCCC-----CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9876533221 1236888999999876 45889999999999999999999998432211 1111000
Q ss_pred --------ccccccc--cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 273 --------RLGEIVD--PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 273 --------~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....... +..............+.++.+++.+||+.||++|||+.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000000000233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.86 Aligned_cols=260 Identities=23% Similarity=0.279 Sum_probs=193.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC--Ccc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQM-NHRNILKLIGCCIET--EIP 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~--~~~ 124 (331)
..+.|...+.||. ++|.||+|.. ++..+|+|++.... .......+.+|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999 9999999988 67899999886532 222445677899999999 999999999998654 357
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||++ ++|.+++... .+.+..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 99999997 5998888542 4778889999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCcc---ccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-c---
Q 020078 205 EYIPEGETH---VTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-R--- 273 (331)
Q Consensus 205 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~--- 273 (331)
......... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||....... ...... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 866443321 11122347889999998765 457889999999999999999999873211110 000000 0
Q ss_pred ----------cccccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 274 ----------LGEIVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 274 ----------~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.....+. .......+.. ...+.++.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDS-LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhh-cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 0000000000 0134579999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=282.95 Aligned_cols=264 Identities=19% Similarity=0.198 Sum_probs=196.4
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEe
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCI 119 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 119 (331)
....++..++++|.....||+ ++|.||+|.. ++..||+|++..... ....+.+.+|+.++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 344667778899999999999 9999999987 788999999875422 223466888999999999999999999886
Q ss_pred eC------CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC
Q 020078 120 ET------EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193 (331)
Q Consensus 120 ~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 193 (331)
.. +..+++++++ +++|.+++.. ..+++..+..++.|+++||.||| +.+|+||||||+||+++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED 156 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence 43 3357788876 6799887753 34889999999999999999999 8999999999999999999
Q ss_pred CceEEccCCCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHh
Q 020078 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHV 269 (331)
Q Consensus 194 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~ 269 (331)
+.++|+|||++........ ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... ....
T Consensus 157 ~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 157 CELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCEEEeccccccccccccc-----ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999876533221 1347889999999866 46888999999999999999999987322111 1100
Q ss_pred hc-c-cccccccc-----------ccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 270 EN-N-RLGEIVDP-----------IVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 270 ~~-~-~~~~~~~~-----------~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. . ....+... .+...+.... ....++++.+++.+||+.||.+|||+.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0 00000000 0000000000 00124578999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.47 Aligned_cols=260 Identities=20% Similarity=0.227 Sum_probs=196.2
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee-C
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE-T 121 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~ 121 (331)
+++..++++|...+.||. ++|.||++.. +++.+|+|++.... .......+.+|+.++..++||||+++++++.. .
T Consensus 3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 455567889999999999 9999999987 78899999886532 22245678899999999999999999999876 5
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..++++||+ +++|..++.. ..++...+..++.|+++||.||| +.+|+||||+|+||+++.++.++|+||
T Consensus 83 ~~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~df 152 (328)
T cd07856 83 EDIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDF 152 (328)
T ss_pred CcEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence 5788999998 4689888753 24778888899999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH------Hh-----
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK------HV----- 269 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~------~~----- 269 (331)
|.+........ ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..
T Consensus 153 g~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 227 (328)
T cd07856 153 GLARIQDPQMT-----GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227 (328)
T ss_pred ccccccCCCcC-----CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99875432211 1237888999998766 4689999999999999999999998733211100 00
Q ss_pred ------hccccccccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 270 ------ENNRLGEIVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 270 ------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
........+.. .......+.. ...+.++.+++.+||+.+|++|||+.+++..
T Consensus 228 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000 0000011110 0234579999999999999999999998764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.38 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=205.2
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
..++.+.....+||+ -||.||.|.. +|+..|+|-+.-... .+......+|..++..|+|||+|++||+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 445667778899999 8999999998 889999998764322 345778889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
|.||||.+|+|.+++... ...++.....+..|++.|++||| ..+|||||+||.||+++.+|.+|++|||.|.
T Consensus 1311 IFMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccccee
Confidence 999999999999988654 23555666678899999999999 9999999999999999999999999999998
Q ss_pred ccCCCCccc--cccccCCCCcccchhhhccC---CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc
Q 020078 206 YIPEGETHV--TSHMLTRTKRYLAPEYILTG---LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 206 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
.+..+.... ......||+.|||||++.+. ....++||||+|||+.||+||+.||.-.+..+...- .-
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy--------~V 1454 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY--------HV 1454 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh--------HH
Confidence 876553211 12234599999999999753 355789999999999999999999754333332211 11
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.....+..|. ..+.+-.+++.+||..||+.|.++.|+++.
T Consensus 1455 ~~gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hccCCCCCch--hhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1222344444 478889999999999999999999888763
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=274.10 Aligned_cols=239 Identities=17% Similarity=0.224 Sum_probs=183.4
Q ss_pred ceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHH---HHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 61 VIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVF---AAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~---l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
+||+ ++|.||++.. +++.||+|.+...... .....+..|..+ +....||||+.+++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4788 8999999987 6789999998754221 122234444443 444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|+|.+++... ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.++|+|||++..+.....
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999888643 35899999999999999999999 89999999999999999999999999999875533221
Q ss_pred cccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH-HhhccccccccccccccCCCCch
Q 020078 213 HVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK-HVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
....|+..|+|||++..+ .++.++||||+|+++|+|++|+.||........ ...... . ......+.
T Consensus 153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~------~~~~~~~~ 220 (278)
T cd05606 153 ----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--L------TMAVELPD 220 (278)
T ss_pred ----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh--h------ccCCCCCC
Confidence 123489999999999755 588999999999999999999999843311100 000000 0 00111111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..+.++.+++.+||..+|++|| ++.++++
T Consensus 221 --~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2345799999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=270.47 Aligned_cols=248 Identities=21% Similarity=0.281 Sum_probs=200.3
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||. ++|.||++.. ++..+++|.+..... ......+.+|+.+++.++|||++++.+.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4667788999 8999999999 588999999876433 23567788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++..... ....+++..+..++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999876421 1146889999999999999999999 889999999999999999999999999998876544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.. ......+++.|+|||......++.++|+||+|+++++|++|..|+...... ........... + +.
T Consensus 157 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~--~~-- 225 (258)
T cd08215 157 VD--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP-----I--PS-- 225 (258)
T ss_pred cc--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC-----C--CC--
Confidence 31 112234788999999998888999999999999999999999997433211 11111111100 1 11
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.++.+++.+||..+|++|||+.+++.
T Consensus 226 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 ----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23347999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=272.99 Aligned_cols=246 Identities=18% Similarity=0.230 Sum_probs=198.9
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...+.||+ ++|.||++.. +++.+++|.+.... .......+.+|+.++++++|+||+++.+++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677788999 8999999987 67899999987543 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++++|.+++...... ...+++..++.++.+++.||.||| +.+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999988653211 145889999999999999999999 999999999999999999999999999998876544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... ...+++.|+|||.+.+..++.++|+||||+++|++++|+.|+...... ..........
T Consensus 157 ~~~----~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd08530 157 MAK----TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP------------- 219 (256)
T ss_pred Ccc----cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-------------
Confidence 211 133788999999998888999999999999999999999997433221 1111111100
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.....+.++.+++.+||+.+|++|||+.+++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 011144567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=271.11 Aligned_cols=244 Identities=18% Similarity=0.167 Sum_probs=187.1
Q ss_pred HHHHHHhcCccccCce--ee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee
Q 020078 47 GELKIATNNYNGHQVI--AS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE 120 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~i--g~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 120 (331)
.++....++|...+.+ |. +||.||++.. ++..+|+|.+...... . .|+.....+ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-A-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-h-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 3444445566665555 98 8999999987 7788999998654221 1 122222222 69999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEc
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLS 199 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~ 199 (331)
.+..++||||+++|+|.+++... ..+++..+..++.|+++||.||| +.+++||||||+||+++.++ .++++
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999654 36899999999999999999999 89999999999999999988 99999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRLGE 276 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~ 276 (331)
|||++........ ..++..|+|||++....++.++||||||+++|+|++|..||....... .......
T Consensus 153 dfg~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 223 (267)
T PHA03390 153 DYGLCKIIGTPSC------YDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--- 223 (267)
T ss_pred cCccceecCCCcc------CCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---
Confidence 9999876643321 247899999999998889999999999999999999999974221100 0011000
Q ss_pred ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 020078 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-MVYAAK 321 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~evl~ 321 (331)
...... ....++.+.+++.+||+.+|.+||+ ++++++
T Consensus 224 ------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ------QKKLPF--IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ------cccCCc--ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 001111 1134567999999999999999996 588874
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.67 Aligned_cols=248 Identities=19% Similarity=0.225 Sum_probs=199.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 127 (331)
++|...+.||. ++|.||+|.. ++..+|+|.+.... .......+.+|+.++.+++ ||||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999 9999999998 78999999987532 2224567889999999998 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 9999999999999764 36899999999999999999999 899999999999999999999999999998766
Q ss_pred CCCCcc------------------ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh
Q 020078 208 PEGETH------------------VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV 269 (331)
Q Consensus 208 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~ 269 (331)
...... .......++..|+|||+.....++.++||||||++++++++|..|+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 232 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 433211 11222347889999999988889999999999999999999999985443222111
Q ss_pred hccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 020078 270 ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM----VYAAK 321 (331)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~----~evl~ 321 (331)
..... ....+ ...++.+.+++.+||+.+|++|||+ .++++
T Consensus 233 ~~~~~----------~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KILKL----------EYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhc----------CCCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 10000 00111 1234579999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=282.88 Aligned_cols=259 Identities=17% Similarity=0.200 Sum_probs=194.6
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----c
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-----I 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~ 123 (331)
...|...+.||+ ++|.||+|.. ++..||+|.+.... .......+.+|+.++..++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888899999 9999999998 68899999987542 2223556778999999999999999999887542 4
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++|+||+. ++|.+++... ..++...+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 789999996 6898888653 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH------HHhhccc---
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK------KHVENNR--- 273 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~------~~~~~~~--- 273 (331)
+.......... ....++..|+|||++.. ..++.++||||||+++|+|++|+.||....... .......
T Consensus 155 ~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 155 ARTTSEKGDFM--TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccccCCCcccc--cccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 88664432111 12347889999999875 468899999999999999999999884321110 0000000
Q ss_pred cccccccc-------cccCCCC---chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 274 LGEIVDPI-------VVEDKSC---PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 274 ~~~~~~~~-------~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+.+.. ....... ......++++.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000 0000000 0001345678999999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=305.41 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=190.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------ 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 122 (331)
--.+|++..++|+ |||.||+++. +|+.+|||++.-..+........+|+..|++|+|||||+++..+.+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4567888999999 9999999998 999999999987765556778899999999999999999987654310
Q ss_pred --------------------------------------------------------------------------------
Q 020078 123 -------------------------------------------------------------------------------- 122 (331)
Q Consensus 123 -------------------------------------------------------------------------------- 122 (331)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ---------------------------------ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020078 123 ---------------------------------IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAY 169 (331)
Q Consensus 123 ---------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 169 (331)
..||-||||+.-.|.+++....... .....++++++|++||.|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHH
Confidence 0167788888877777765432110 246678899999999999
Q ss_pred hhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC----------------CCccccccccCCCCcccchhhhcc
Q 020078 170 IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE----------------GETHVTSHMLTRTKRYLAPEYILT 233 (331)
Q Consensus 170 LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~----------------~~~~~~~~~~~gt~~y~aPE~~~~ 233 (331)
+| +.+||||||||.||++|++..+||+|||+|+.... +......+..+||.-|+|||++..
T Consensus 713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99 99999999999999999999999999999987320 001112234569999999999975
Q ss_pred C---CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCC
Q 020078 234 G---LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESA 310 (331)
Q Consensus 234 ~---~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP 310 (331)
. .|+.|+||||+|++++||+.- |...+.-.....+.+... ++.+..+. .+..+.-.++|..|++.||
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsMERa~iL~~LR~g~-----iP~~~~f~--~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLYP---FGTSMERASILTNLRKGS-----IPEPADFF--DPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhcc---CCchHHHHHHHHhcccCC-----CCCCcccc--cccchHHHHHHHHHhcCCC
Confidence 4 599999999999999999875 433333222333322222 22221111 1233456799999999999
Q ss_pred CCCCCHHHHHH
Q 020078 311 GDRPTMVYAAK 321 (331)
Q Consensus 311 ~~Rps~~evl~ 321 (331)
++||||.|+|.
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999986
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.19 Aligned_cols=255 Identities=18% Similarity=0.201 Sum_probs=196.9
Q ss_pred CccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCC---cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCcc
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYS---ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIP 124 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 124 (331)
+|...+.||+ ++|.||++.. ++..+|+|.+..... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667788999 9999999875 457899998864321 12345688999999999 599999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++... ..+++..+..++.|+++||.||| +.+++||||+|+||+++.++.++++|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 9999999999999988653 35788899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCC--CCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhcccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDP 280 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~ 280 (331)
..+....... .....++..|+|||.+.+.. .+.++||||||+++|+|++|..|+...... ....... .
T Consensus 153 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~----~--- 224 (288)
T cd05583 153 KEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR----I--- 224 (288)
T ss_pred cccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH----H---
Confidence 7654432211 12234788999999987654 788999999999999999999997421110 0000000 0
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.......+ ...+.++.+++.+||+.||++|||+.++...|+..+.
T Consensus 225 -~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 225 -LKSKPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred -HccCCCCC--cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 00001111 1234578999999999999999999988887766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=275.07 Aligned_cols=256 Identities=13% Similarity=0.065 Sum_probs=179.8
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhH----------HHHHHHHHHHhcCCCceeeeE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGEN----------FCFNNIVFAAQMNHRNILKLI 115 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~h~nIv~l~ 115 (331)
..+.|...+.||+ +||.||+|... +..+|+|...........+ ....+...+..++|+||++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 3467899999999 99999999983 3456666533222110011 112233445567899999999
Q ss_pred eEEeeCC----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc
Q 020078 116 GCCIETE----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191 (331)
Q Consensus 116 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~ 191 (331)
+++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||.||| +.+|+||||||+|||++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVD 160 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEc
Confidence 9876543 23577777643 666665432 23567888999999999999999 89999999999999999
Q ss_pred CCCceEEccCCCccccCCCCcc-----ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH
Q 020078 192 EYNVAKLSDFSESEYIPEGETH-----VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK 266 (331)
Q Consensus 192 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~ 266 (331)
.++.++|+|||+++.+...... .......||+.|+|||+..+..++.++||||||+++|||++|..||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999876432211 11122358999999999998899999999999999999999999985432111
Q ss_pred HHhh---ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 267 KHVE---NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 267 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
.... ......+..... ... ..+.++.+++..||+.+|++||++.++.+.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKRLHEGKI-KIK------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHHhhhhhh-ccC------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1000 000000001101 011 1234799999999999999999999999876
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.38 Aligned_cols=256 Identities=20% Similarity=0.188 Sum_probs=191.5
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhc---CCCceeeeEeEEeeCCc-----
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQM---NHRNILKLIGCCIETEI----- 123 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~~----- 123 (331)
|.....||. ++|.||+|.. ++..+|+|.+...... .....+.+|+.++.++ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456678999 8999999998 5789999998744322 1244566788877766 59999999999998776
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.+++|||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999997 489888865321 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhcccc---ccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVENNRL---GEI 277 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~~~~---~~~ 277 (331)
+.......... ...++..|+|||++.+..++.++|+||||+++|+|++|..|+...... ......... ...
T Consensus 154 ~~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 154 ARIYSFEMALT---SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ceeccCCcccc---cccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 87764432211 123688899999999888999999999999999999999887432211 111110000 000
Q ss_pred c------ccccc-cCCCCc--hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 V------DPIVV-EDKSCP--EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~------~~~~~-~~~~~~--~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ..... .....+ .....+..+.+++.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000 000000 01134577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=263.59 Aligned_cols=243 Identities=19% Similarity=0.247 Sum_probs=190.1
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEecCCCChh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYGTLA 137 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 137 (331)
+|. ..|.|++.+. .+...|||...........+.++..+.++..-. .|.||+.+|+|..+...++.||.|.- -+.
T Consensus 100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~e 178 (391)
T KOG0983|consen 100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAE 178 (391)
T ss_pred hcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHH
Confidence 677 6779999998 679999999987765556777777887776664 89999999999999988999998742 344
Q ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccccc
Q 020078 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217 (331)
Q Consensus 138 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 217 (331)
.++..-. .++++.-+=++...+.+||.||-+ ..+|+|||+||+|||+|+.|++|++|||.+-.+.++..+..
T Consensus 179 kLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr-- 250 (391)
T KOG0983|consen 179 KLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR-- 250 (391)
T ss_pred HHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccccc--
Confidence 4443221 568888888899999999999985 66899999999999999999999999999988766655443
Q ss_pred ccCCCCcccchhhhccC---CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHH
Q 020078 218 MLTRTKRYLAPEYILTG---LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQ 294 (331)
Q Consensus 218 ~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (331)
..|.+.|||||-+.-. .|+..+||||||++|+||.||..||...+........- .+ ..++..+...++
T Consensus 251 -sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv-----ln---~ePP~L~~~~gF 321 (391)
T KOG0983|consen 251 -SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV-----LN---EEPPLLPGHMGF 321 (391)
T ss_pred -ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH-----Hh---cCCCCCCcccCc
Confidence 2389999999998743 68899999999999999999999986533222222110 00 112233333357
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 295 LQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 295 ~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
++.+.+++..||++|+.+||...++++.
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 7889999999999999999999998753
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=280.46 Aligned_cols=259 Identities=16% Similarity=0.172 Sum_probs=194.4
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETE- 122 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~- 122 (331)
++....+.|...+.||+ ++|.||++.. ++..||+|++...... .....+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34456778999999999 9999999987 7889999998654322 23456889999999999999999999987654
Q ss_pred -----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 123 -----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 123 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 348999999 6789888753 35889999999999999999999 89999999999999999999999
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhhc-c
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVEN-N 272 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~-~ 272 (331)
++|||++........ ...+++.|+|||++.. ..++.++|+||||+++|++++|..||........ .... .
T Consensus 159 l~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 159 ILDFGLARQTDSEMT-----GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred EeecccccccccCcc-----ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999876543221 1237889999999876 3588999999999999999999999843221111 0000 0
Q ss_pred ccccccccc------------cccCCC--C-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 273 RLGEIVDPI------------VVEDKS--C-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 273 ~~~~~~~~~------------~~~~~~--~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
......... +..... . ......+.++.+++.+||+.||++|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000 0 000123456899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=265.16 Aligned_cols=264 Identities=17% Similarity=0.227 Sum_probs=205.2
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEe
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCI 119 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~ 119 (331)
-++.|....|+ .++|+ .++.|-.++. ++..+|||++.+.... .+...++|++++.+.+ |+||+.|+.+|+
T Consensus 73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH-sR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH-SRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCch-HHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 34677777765 47899 7778877766 8999999999877443 6888999999999996 999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC---ce
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VA 196 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~ 196 (331)
++...|||||-|.+|+|..+|... ..+++.++..+..+|+.||.||| .++|.||||||+|||..+.. -+
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPv 218 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPV 218 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCce
Confidence 999999999999999999999876 56899999999999999999999 99999999999999997554 37
Q ss_pred EEccCCCccccCCCCc-----cccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH
Q 020078 197 KLSDFSESEYIPEGET-----HVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK 266 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~ 266 (331)
||+||.+...+..... .....+.+|+..|||||+.. --.|+.+.|.|||||+||-|++|.+||...-...
T Consensus 219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d 298 (463)
T KOG0607|consen 219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD 298 (463)
T ss_pred eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence 9999998765432221 11122346888999999875 2358899999999999999999999983211111
Q ss_pred HHhhcccc-----ccccccccccCCCCchH--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 267 KHVENNRL-----GEIVDPIVVEDKSCPEK--EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 267 ~~~~~~~~-----~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+..+.. ..++..+-.+.+.+|+. ...+.+..+|+...|..||.+|.++..++.
T Consensus 299 CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 299 CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11100000 01222233344555543 367889999999999999999999998875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=275.75 Aligned_cols=250 Identities=18% Similarity=0.223 Sum_probs=191.4
Q ss_pred CccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCC---cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCcc
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYS---ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIP 124 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~ 124 (331)
+|...+.||+ ++|.||++.. ++..||+|.+..... ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677788999 9999999986 578899999865321 12346788899999999 599999999999999899
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+++||||+|+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 9999999999999998754 35788899999999999999999 899999999999999999999999999998
Q ss_pred cccCCCCccccccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
......... ......|+..|+|||.+..+ .++.++||||||+++|+|++|..|+......... ..+.....
T Consensus 153 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~~~~~~~~ 225 (290)
T cd05613 153 KEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ------AEISRRIL 225 (290)
T ss_pred eeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH------HHHHHHhh
Confidence 766443221 11123478899999998753 4678999999999999999999997421100000 00000000
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
......+ ...+..+.+++.+||..||++|| ++.+++.
T Consensus 226 ~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 KSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0111111 12345789999999999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=272.55 Aligned_cols=255 Identities=19% Similarity=0.201 Sum_probs=194.7
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|.....||. ++|.||+|+. +++.+|+|.+..... ....+.+.+|+.+++.++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445677898 9999999999 589999999876532 223567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
+ ++|.+++.... ..+++..+..++.+++.||.||| +.+|+||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 8 59999997642 35889999999999999999999 8999999999999999999999999999988765433
Q ss_pred ccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh-----------------ccc
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE-----------------NNR 273 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~-----------------~~~ 273 (331)
.... ...++..|+|||.+... .++.++||||||+++|++++|..|+........... ...
T Consensus 153 ~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 153 RTYT--HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred cccC--ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 2111 12357789999998876 789999999999999999999988843322111100 000
Q ss_pred -cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 -LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
................ ....+.++.+++.+||..||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000000 0022457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=269.31 Aligned_cols=248 Identities=17% Similarity=0.205 Sum_probs=190.5
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCC----CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN----YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
|...+.||+ ++|.||++.. .+..+++|.+... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 667788999 9999999988 3445555554432 12223446778999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++...... ...+++..++.++.|++.||.||| +.+++|+||+|+||+++. +.++|+|||++....
T Consensus 82 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 82 EYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999888642211 146899999999999999999999 899999999999999976 569999999987664
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
..... .....+++.|+|||......++.++|+||||+++|+|++|..|+............. ....+ ..
T Consensus 157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~---~~~~~------~~ 225 (260)
T cd08222 157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV---EGPTP------SL 225 (260)
T ss_pred CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH---cCCCC------CC
Confidence 33221 112347889999999988888999999999999999999999974332221111100 00000 11
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+ ...+.++.+++.+||+.+|++||++.+++.
T Consensus 226 ~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 P--ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred c--chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 144567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=279.45 Aligned_cols=262 Identities=20% Similarity=0.228 Sum_probs=198.6
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----ccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-----IPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~~ 125 (331)
+|.....||. ++|.||+|+. ++..+|+|++..... ....+.+.+|+.+++.++||||+++.+++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3677788999 9999999998 578999999876532 234567889999999999999999999998875 789
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
++|||++ ++|.+++... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999998 5898888653 36889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCcc-ccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhhc-cc-cc---
Q 020078 206 YIPEGETH-VTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVEN-NR-LG--- 275 (331)
Q Consensus 206 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~-~~-~~--- 275 (331)
........ .......++..|+|||++.+. .++.++|+||||+++|+|++|..||........ .... .. ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence 76554311 111123478889999999877 789999999999999999999999843222110 0000 00 00
Q ss_pred ---------cccccccccCCCCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHH
Q 020078 276 ---------EIVDPIVVEDKSCP---EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ--LRQM 326 (331)
Q Consensus 276 ---------~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~--L~~~ 326 (331)
..+.. .......+ .....+.++.+++.+||+.+|++|||+.+++.. ++.+
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 232 KFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 00000 00000000 001235679999999999999999999999874 4443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=282.72 Aligned_cols=256 Identities=19% Similarity=0.249 Sum_probs=194.0
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc---
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI--- 123 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~--- 123 (331)
...++|.....||+ ++|.||+|.. ++..+|+|++..... ......+.+|+.++++++||||+++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999 9999999998 678999999865422 2234667889999999999999999998876654
Q ss_pred ---cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 124 ---PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 124 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.||| +.+|+||||||+||+++.++.++|+|
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcc
Confidence 78999998 5699998864 35889999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccc-cc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNR-LG 275 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~-~~ 275 (331)
||++........ ...++..|+|||.+... .++.++||||||+++|++++|+.||....... ....... ..
T Consensus 162 fg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~ 236 (343)
T cd07851 162 FGLARHTDDEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236 (343)
T ss_pred cccccccccccc-----CCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCC
Confidence 999876643321 12478889999998653 67899999999999999999999874222111 1100000 00
Q ss_pred -ccc------------cccc-ccCCCCc-hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 -EIV------------DPIV-VEDKSCP-EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 -~~~------------~~~~-~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... .... ....... .....+.++.+++.+||+.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000 0000 0000000 00123567999999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=279.83 Aligned_cols=258 Identities=18% Similarity=0.239 Sum_probs=189.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET-------- 121 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 121 (331)
...|...+.||. ++|.||+|.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~-~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ-SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc-hHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 367888899999 9999999988 6789999998655443 567788999999999999999999876654
Q ss_pred ------CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-CCC
Q 020078 122 ------EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYN 194 (331)
Q Consensus 122 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~ 194 (331)
...++||||++ ++|.+++.. ..+++..+..++.|+++||.||| +.+|+||||||+||+++ .++
T Consensus 83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 83 GSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence 34689999997 589888753 24788999999999999999999 89999999999999997 456
Q ss_pred ceEEccCCCccccCCCCccc-cccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH---h
Q 020078 195 VAKLSDFSESEYIPEGETHV-TSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH---V 269 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~---~ 269 (331)
.++++|||.+..+....... ......++..|+|||++.. ..++.++|||||||++|+|++|+.||......... .
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987653321111 1111236888999998764 45788999999999999999999998432211111 1
Q ss_pred hccccc------c---cccccc---ccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 270 ENNRLG------E---IVDPIV---VEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 270 ~~~~~~------~---~~~~~~---~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... . ...... ......+.. ...+.++.+++.+||+.||++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0 000000 000001100 023457899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=273.32 Aligned_cols=261 Identities=17% Similarity=0.181 Sum_probs=191.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETE------ 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 122 (331)
.++|...+.||. ++|.||+|.. +++.+|+|++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999 9999999998 6789999988654322 12346788999999999999999999876543
Q ss_pred --ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 123 --IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 123 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
..++|+||+.. +|...+.... ..+++..+..++.|+++||.||| +.+|+|+||||+||++++++.++|+|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence 35899999975 7777775432 35899999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccc---------cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---H
Q 020078 201 FSESEYIPEGETHV---------TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---K 267 (331)
Q Consensus 201 fg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~ 267 (331)
||++.......... ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... .
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99987654322111 11123467889999988654 57899999999999999999999874221111 1
Q ss_pred Hhh---ccc---------cccccccccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 268 HVE---NNR---------LGEIVDPIVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 268 ~~~---~~~---------~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ... .....+........... .....+++.+++.+||+.||++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 110 000 00000000000000000 0122357899999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=266.61 Aligned_cols=204 Identities=21% Similarity=0.280 Sum_probs=168.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe----C--CceEEEEEeCCCCCcch-hHHHHHHHHHHHhcCCCceeeeEeEEee-CC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL----E--NRPISVMKFGDNYSENG-ENFCFNNIVFAAQMNHRNILKLIGCCIE-TE 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~----~--~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~ 122 (331)
.-..|+....||. .+|.||+|.. + +..+|+|++.......+ .....+|+.+++.|+||||+.|..++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456888888999 8999999966 2 23799999986533323 4577899999999999999999999988 66
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC----CceEE
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY----NVAKL 198 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl 198 (331)
..++++||.+. +|...|+--.....+.++...+..|+.||+.|++||| ++=|+||||||.|||+..+ |.+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence 78999999986 8999887433333367899999999999999999999 8889999999999999766 99999
Q ss_pred ccCCCccccCCCCccc-cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCC
Q 020078 199 SDFSESEYIPEGETHV-TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
+|||+++.+.+.-... ....++-|..|.|||.+++. .|+++.||||.||++.||++..+-|
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF 240 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF 240 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence 9999999886654332 22234568999999999976 5999999999999999999976543
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=276.95 Aligned_cols=259 Identities=15% Similarity=0.162 Sum_probs=190.8
Q ss_pred cCcc-ccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcc-------------hhHHHHHHHHHHHhcCCCceeeeEe
Q 020078 54 NNYN-GHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSEN-------------GENFCFNNIVFAAQMNHRNILKLIG 116 (331)
Q Consensus 54 ~~~~-~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~nIv~l~~ 116 (331)
+.|. ..+.||. ++|.||+|.. .++.||+|.+....... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 3567999 9999999987 68899999986542221 0125779999999999999999999
Q ss_pred EEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 117 CCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
++...+..++||||++ |+|.+++... ..++......++.|++.||.||| +.+++|+||+|+||+++.++.+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence 9999999999999997 6899988653 35888999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCc------------cccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH
Q 020078 197 KLSDFSESEYIPEGET------------HVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE 263 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~ 263 (331)
+|+|||++........ ........++..|+|||++.+. .++.++||||||+++|+|++|+.|+....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999876541110 0011112367889999998754 46899999999999999999999884322
Q ss_pred HHH------HHhhccccc---ccc-----cccccc-CCCC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 264 HVK------KHVENNRLG---EIV-----DPIVVE-DKSC-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 264 ~~~------~~~~~~~~~---~~~-----~~~~~~-~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ......... ... .+.... +... ......+.++.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 211 111000000 000 000000 0000 000122457899999999999999999999985
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=264.35 Aligned_cols=235 Identities=21% Similarity=0.223 Sum_probs=188.4
Q ss_pred eee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 62 IAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 62 ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
||. ++|.||++.. +++.+++|.+...... .....+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 567 8899999998 5789999998765332 2456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccc
Q 020078 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216 (331)
Q Consensus 137 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 216 (331)
.+++... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~ 150 (250)
T cd05123 81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--T 150 (250)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--c
Confidence 9999654 35889999999999999999999 899999999999999999999999999998766443211 1
Q ss_pred cccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHH
Q 020078 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ 296 (331)
Q Consensus 217 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (331)
....++..|+|||.......+.++|+||||+++|++++|..|+........ ..... . .....+. ..+.
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~-----~----~~~~~~~--~~~~ 218 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEKIL-----K----DPLRFPE--FLSP 218 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHh-----c----CCCCCCC--CCCH
Confidence 123478899999999888889999999999999999999999843332111 10000 0 0111111 2235
Q ss_pred HHHHHHHHhccCCCCCCCCHHH
Q 020078 297 ALLQLIFECVNESAGDRPTMVY 318 (331)
Q Consensus 297 ~~~~li~~cl~~dP~~Rps~~e 318 (331)
++.+++.+||..||++|||+.+
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc
Confidence 7899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=272.98 Aligned_cols=258 Identities=19% Similarity=0.186 Sum_probs=187.6
Q ss_pred CccccCceee-cCcEEEEEEe--C--CceEEEEEeCCCCCc-chhHHHHHHHHHHHhc-CCCceeeeEeEEeeC----Cc
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--E--NRPISVMKFGDNYSE-NGENFCFNNIVFAAQM-NHRNILKLIGCCIET----EI 123 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~----~~ 123 (331)
+|...+.||+ ++|.||++.. . +..+|+|++...... ...+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667788999 9999999998 3 668999998754222 2356788999999999 599999999876432 34
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++++||+. ++|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 678888886 6898888653 45889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccc--cccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-ccc-c
Q 020078 204 SEYIPEGETHV--TSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRL-G 275 (331)
Q Consensus 204 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~-~ 275 (331)
+..+....... ......|+..|+|||++.+ ..++.++||||||+++|++++|..||...... ...... +.. .
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 98664432211 1122358899999998865 46889999999999999999999987432110 000000 000 0
Q ss_pred ----ccccc-------ccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 ----EIVDP-------IVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ----~~~~~-------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+..+ ........+.. ...+.++.+++.+||+.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 00000000000 012457999999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=264.34 Aligned_cols=240 Identities=18% Similarity=0.225 Sum_probs=200.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
-++|+-.+++|+ .||.|-.++- .++.+|+|++.+..- .+....-+.|-++|...+||.+..|.-.+..++..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888899999 9999988877 889999999987522 22455677899999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||..+|.|.-++... ..+++.....+...|+.||.||| +.+||+||||.+|+|+|.+|.+||.|||+.+.-
T Consensus 247 MeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999988754 45778888889999999999999 999999999999999999999999999998743
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
-.. ..+..+++|||.|+|||++..+.|...+|.|.+||++|||++|+.||+.-.+. .++..++.++..
T Consensus 319 I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----------kLFeLIl~ed~k 386 (516)
T KOG0690|consen 319 IKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----------KLFELILMEDLK 386 (516)
T ss_pred ccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----------HHHHHHHhhhcc
Confidence 222 12344578999999999999999999999999999999999999997533221 122233444444
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCC
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRP 314 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rp 314 (331)
+|. ..++++..|+...|..||++|.
T Consensus 387 FPr--~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPR--TLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCc--cCCHHHHHHHHHHhhcChHhhc
Confidence 443 5677899999999999999996
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=258.44 Aligned_cols=219 Identities=18% Similarity=0.126 Sum_probs=173.6
Q ss_pred cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcC
Q 020078 65 EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS 142 (331)
Q Consensus 65 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 142 (331)
.++.||+++. +++.+|+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 5 ~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 5 VIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred ccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 4668999988 78899999986542 234555666667899999999999999999999999999999999865
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCC
Q 020078 143 PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222 (331)
Q Consensus 143 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 222 (331)
. ..+++..+..++.|+++||.||| +.+++||||||+||+++.++.++++|||.+........ ...++
T Consensus 79 ~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~ 145 (237)
T cd05576 79 F-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVE 145 (237)
T ss_pred h-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcC
Confidence 4 35889999999999999999999 89999999999999999999999999998765543211 12256
Q ss_pred CcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHH
Q 020078 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302 (331)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (331)
..|+|||.+....++.++||||+|+++|+|++|..|+...... .. .. . ....| ...++.+.+++
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~-----~~--~----~~~~~--~~~~~~~~~li 209 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---IN-----TH--T----TLNIP--EWVSEEARSLL 209 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---cc-----cc--c----ccCCc--ccCCHHHHHHH
Confidence 7799999998888999999999999999999999774221100 00 00 0 00111 12345799999
Q ss_pred HHhccCCCCCCCCHHH
Q 020078 303 FECVNESAGDRPTMVY 318 (331)
Q Consensus 303 ~~cl~~dP~~Rps~~e 318 (331)
.+||+.||++|||+.+
T Consensus 210 ~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 210 QQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHccCCHHHhcCCCc
Confidence 9999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=275.44 Aligned_cols=243 Identities=21% Similarity=0.235 Sum_probs=200.4
Q ss_pred cCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 59 HQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
++++|. -||+||-|+. +|+.||||.+.+- ...+....+.+|+.||.++.||.||.|-..|+..+..+.|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 578999 9999999988 8999999999874 333456788999999999999999999999999999999999995 5
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEccCCCccccCCCC
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a~~~~~~~ 211 (331)
+..+.|.+... ..++...-..++.||+.||.||| .++|+|+||||+|||+.+. ..+||+|||.|+.+.+..
T Consensus 648 DMLEMILSsEk---gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSSEK---GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHhhc---ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 66666654332 34778888889999999999999 9999999999999999644 479999999999986653
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchH
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
. ...++||+.|+|||++.+..|+..-|+||.||++|.-++|..||+........+++..... +...+
T Consensus 722 F---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMy----------Pp~PW 788 (888)
T KOG4236|consen 722 F---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMY----------PPNPW 788 (888)
T ss_pred h---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccccc----------CCCch
Confidence 2 2236799999999999999999999999999999999999999876555544444333211 11113
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+.++++.+||...|+..=.+|-|.+..+.
T Consensus 789 ~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 789 SEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred hhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 367788999999999999999999887654
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=282.41 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=207.7
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee---
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE--- 120 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--- 120 (331)
.+...++-|++..+||. .+|.||+++. +++..|+|+...... ..++...|..+|+.+ .|||++.++|++..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 33445678888899999 6678888876 889999999876543 356677788899888 49999999999975
Q ss_pred --CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 121 --TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
++.+|||||||.+||.-|++....+ ..+.|..+..|++.++.||.+|| ...++|||+|..|||++.++.+||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence 5689999999999999999987653 46889999999999999999999 999999999999999999999999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhccC-----CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-----LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNR 273 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~ 273 (331)
.|||++..+.... ..+.+.+||+.|||||++.-. -|+..+|+||||++..||.-|.+|......+..++.-
T Consensus 165 vDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I-- 240 (953)
T KOG0587|consen 165 VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-- 240 (953)
T ss_pred eeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC--
Confidence 9999998775433 234446799999999999733 4778999999999999999999997555554444421
Q ss_pred cccccccccccCC-CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 LGEIVDPIVVEDK-SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+++ ..--+..+++++.++|..||.+|-.+||++.++++
T Consensus 241 --------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 --------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11221 12223488899999999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=290.90 Aligned_cols=144 Identities=19% Similarity=0.166 Sum_probs=128.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|.....||. +||.||+|.. +++.||+|++..... ......+.+|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 56888899999 9999999999 588999999875322 223467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
||+++|+|.+++... ..+++..++.++.||+.||.||| ..+|+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998653 35788899999999999999999 8899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=237.47 Aligned_cols=257 Identities=15% Similarity=0.186 Sum_probs=195.5
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+|...++||+ .+|+||+|+. +.+.||+|+..-...+ .-....++|+.+|+.++|.|||+++++.-.+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 5667778999 8999999998 7789999998754333 2356789999999999999999999999989999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|.. +|..+..+.+ ..++......++.|+++||.|+| +.++.|||+||+|.||..+|..|++|||+++.+.-.
T Consensus 83 cdq-dlkkyfdsln----g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hhH-HHHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 965 8999998876 35888899999999999999999 999999999999999999999999999999988655
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCC----hhHHHHHHHhhc------cccccccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDN----ILLEHVKKHVEN------NRLGEIVD 279 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~----~~~~~~~~~~~~------~~~~~~~~ 279 (331)
..+... .+-|..|.+|.++.+. .|++..|+||-||++.|+.....|- .........+.. .++..+..
T Consensus 155 vrcysa--evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 VRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred eEeeec--eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 433222 2358899999999876 4899999999999999998755443 122222222221 11111100
Q ss_pred cccccCC-CCc---hHH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 PIVVEDK-SCP---EKE----QQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ~~~~~~~-~~~---~~~----~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..--..+ ..| .+. .....-++|+++.|.-+|.+|.++.++++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 011 111 22334578999999999999999998865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=258.65 Aligned_cols=261 Identities=20% Similarity=0.237 Sum_probs=191.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCC-CCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--------
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGD-NYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET-------- 121 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-------- 121 (331)
..|....+||+ .||+||+|+. .++.||+|+..- +..+.--....+|+.+|..|.|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666778999 8899999988 678889887543 33332345778999999999999999999888642
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
...|+|+.+|+. +|..++.... ..++..++.+++.++..||.|+| ...|+|||+||+|+||+.++.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecc
Confidence 347899999986 8988886542 45888999999999999999999 999999999999999999999999999
Q ss_pred CCccccCCCCccc--cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHH--------------
Q 020078 202 SESEYIPEGETHV--TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEH-------------- 264 (331)
Q Consensus 202 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~-------------- 264 (331)
|+++.+....... .-..++-|..|.+||.+.+. .|+++.|||.-||++.||+++.+.+.....
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9998765443222 11223458999999999865 699999999999999999999886522111
Q ss_pred ---HHHHhhcccccccc--ccccccCCCCch----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 265 ---VKKHVENNRLGEIV--DPIVVEDKSCPE----KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 265 ---~~~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+|+...+-.+.+.+ .|...+..+--. +..-.+++.+|+.+++..||.+||+++++++.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 11111111111111 100000000000 00112368899999999999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=283.57 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=189.2
Q ss_pred CccccCceee-cCc-EEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
-|+..+++|. ..| .||+|...++.||||++... ..+...+|+..|..- .|||||++++.-.+..+.|++.|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4566777887 444 79999999999999998654 355678999999887 5999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---C--CceEEccCCCccc
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---Y--NVAKLSDFSESEY 206 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~--~~~kl~Dfg~a~~ 206 (331)
.. +|.+++... +.......--....+..|+++||++|| +.+||||||||.||||+. + ..++|+|||+++.
T Consensus 586 ~~-sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 586 AC-SLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hh-hHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 86 999999763 111111111334678899999999999 999999999999999976 2 5799999999999
Q ss_pred cCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhC-CCCChhHHHHHHHhhcccccccccccccc
Q 020078 207 IPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG-RRDNILLEHVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (331)
+..+.... ......||.+|+|||++....-+.++||||+||++|+.++| ..||-..-.-...+..+.. +....
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~----~L~~L- 735 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNY----TLVHL- 735 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCcc----ceeee-
Confidence 87766544 23446699999999999988888899999999999999887 6787332222111111110 00000
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. +.. ++ ++.+||.+|++++|..||||.+|+.
T Consensus 736 --~-~~~-d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 736 --E-PLP-DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --c-cCc-hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 111 22 7999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=251.80 Aligned_cols=238 Identities=22% Similarity=0.254 Sum_probs=190.4
Q ss_pred cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcC
Q 020078 65 EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS 142 (331)
Q Consensus 65 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 142 (331)
++|.||+|.. +++.+++|.+.........+.+.+|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 5789999999 46899999988665442367899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCC
Q 020078 143 PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222 (331)
Q Consensus 143 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 222 (331)
.. .+++..+..++.+++.++.||| ..+++|+||+|.||+++.++.++++|||.+........ .....++
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~ 149 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL---LTTFVGT 149 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc---cccccCC
Confidence 42 3788999999999999999999 88999999999999999999999999999887655421 1123478
Q ss_pred CcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHH
Q 020078 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302 (331)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (331)
..|++||......++.++||||||++++++++|..|+............... ........ ....+.++.+++
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~i 221 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGK-----PKPPFPPP---EWKISPEAKDLI 221 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc-----cCCCCccc---cccCCHHHHHHH
Confidence 8999999998888999999999999999999999997542111111111000 00000000 000335799999
Q ss_pred HHhccCCCCCCCCHHHHHH
Q 020078 303 FECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 303 ~~cl~~dP~~Rps~~evl~ 321 (331)
.+||..+|++||++.++++
T Consensus 222 ~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 222 RKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHccCCchhccCHHHHhh
Confidence 9999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=289.47 Aligned_cols=256 Identities=18% Similarity=0.179 Sum_probs=209.5
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
.+++.-.++|.+.++||. .||.|..++. +++.+|.|++.+- .......-|..|-.+|..-+.+-|+.|.-.|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 344455689999999999 9999999988 7889999998763 1122355688899999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..|+||||+|||+|..++... ..++..++..++..|+-||+-|| +.++|||||||+|||+|..|++||+||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccc
Confidence 9999999999999999999765 35899999999999999999999 999999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhc----c-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYIL----T-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE 276 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 276 (331)
|.+-.+..+.. ..+...+|||-|.+||++. + +.|++.+|.||+||++|||+.|..||+...-+.-+-.
T Consensus 220 GsClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~K------ 292 (1317)
T KOG0612|consen 220 GSCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGK------ 292 (1317)
T ss_pred hhHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHH------
Confidence 99877764443 3444567999999999986 3 6799999999999999999999999976665543322
Q ss_pred ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC---HHHHH
Q 020078 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT---MVYAA 320 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps---~~evl 320 (331)
+++. .+.+.+|...+.++++.+||.+.+. +|+.|.. +.++-
T Consensus 293 Im~h--k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 293 IMNH--KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred Hhch--hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 1111 2234455444788899999999775 6778887 66654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=252.40 Aligned_cols=265 Identities=19% Similarity=0.316 Sum_probs=214.9
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEE
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCC 118 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 118 (331)
.++......+....++.+ .||.||.|.| +.+.|.+|.+....++-....++.|..++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 334444556777778888 9999999977 23568888888777766678899999999999999999999998
Q ss_pred ee-CCccEEEEEecCCCChhhhhcCCCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 119 IE-TEIPILVFEFVEYGTLADRICSPHG---PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 119 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
.+ ...++.++.++..|+|..++....+ ...+.++-.+...++.|++.|++||| +.++||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence 75 5678899999999999999983322 22345677788889999999999999 99999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVEN 271 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~ 271 (331)
.+||+|=.+++.+...+.+.....-..+..||+||.+.+..|+..+|||||||+||||+| |+.|+...+ .+..+...
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999998777666554333346889999999999999999999999999999998 777763322 22223333
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
+. .+.+++.||+ ++..+|.-||..+|++|||+.+++..|..+.
T Consensus 514 Gy-------RlaQP~NCPD------eLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 514 GY-------RLAQPFNCPD------ELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred cc-------eecCCCCCcH------HHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 22 3456777776 6999999999999999999999999998765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=270.83 Aligned_cols=237 Identities=20% Similarity=0.196 Sum_probs=186.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++.|.....+|. +|+.|-.+.. ++...++|++.+.. .+..+|+.++... +||||+++.+++.++-..|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 455666666888 6777766666 78899999987652 2244667565555 6999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE-cCCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF-DEYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill-~~~~~~kl~Dfg~a~~~ 207 (331)
|.+.+|-+.+.+... +.....+..|+.+|+.|+.||| .+++|||||||+|||+ ++.++++|+|||.++..
T Consensus 396 e~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred hhccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999888888653 2333777889999999999999 9999999999999999 58899999999999887
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...- .+-+-|..|.|||++....|++.+|+||||++||+|++|+.|+........... .+....+
T Consensus 467 ~~~~-----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~---------~i~~~~~- 531 (612)
T KOG0603|consen 467 ERSC-----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT---------RIQMPKF- 531 (612)
T ss_pred chhh-----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH---------hhcCCcc-
Confidence 6551 112358889999999988999999999999999999999999632221111111 0111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+.++++|+.+||+.||.+||+|.++..
T Consensus 532 ---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 532 ---SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1266778999999999999999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=266.97 Aligned_cols=266 Identities=14% Similarity=0.156 Sum_probs=181.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe------------------CCceEEEEEeCCCCCc-------------chhHHHHHH
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL------------------ENRPISVMKFGDNYSE-------------NGENFCFNN 99 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~------------------~~~~vavK~~~~~~~~-------------~~~~~~~~E 99 (331)
..++|...++||+ +||.||+|.. .++.||||++...... ...+.+..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999 9999999964 3457999998643221 012234457
Q ss_pred HHHHHhcCCCce-----eeeEeEEee--------CCccEEEEEecCCCChhhhhcCCCCC-------------------C
Q 020078 100 IVFAAQMNHRNI-----LKLIGCCIE--------TEIPILVFEFVEYGTLADRICSPHGP-------------------H 147 (331)
Q Consensus 100 ~~~l~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~ 147 (331)
+.++.+++|.++ ++++++|.. ....+|||||+++|+|.+++....+. .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888877654 667777753 34679999999999999998753211 0
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccc
Q 020078 148 LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLA 227 (331)
Q Consensus 148 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 227 (331)
...+++..+..++.|++.||.||| ..+|+||||||+|||++.++.++|+|||++........... ....+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence 123467788999999999999999 89999999999999999999999999999876543322111 11225789999
Q ss_pred hhhhccCC--------------------C--CCcccchhhHHHHHHHHhCCC-CChhHHHHHHHhhcccc-ccccccccc
Q 020078 228 PEYILTGL--------------------C--NEKTDVFCFGMLLLELLTGRR-DNILLEHVKKHVENNRL-GEIVDPIVV 283 (331)
Q Consensus 228 PE~~~~~~--------------------~--~~~~Dv~SlG~~l~el~~g~~-p~~~~~~~~~~~~~~~~-~~~~~~~~~ 283 (331)
||.+.... | ..+.||||+||++++|++|.. |+............... .........
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99886432 1 134799999999999999875 55322222111111000 000000011
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCC---CCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESA---GDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP---~~Rps~~evl~ 321 (331)
.....+.....++...+|+.+||..+| .+|+|+.|+++
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111122222345679999999999876 68999999985
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=270.48 Aligned_cols=238 Identities=17% Similarity=0.194 Sum_probs=197.2
Q ss_pred cccCceee-cCcEEEEEEeCCce--EEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 57 NGHQVIAS-EHYKLYKGFLENRP--ISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~~~~~--vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
....-+|- |||.|=....+++. +|+|.+++. ...+..+....|-++|...+.|.||++|.-|.++...|+.||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 33445788 99999988885544 788887754 22335667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
-+|.|...+..++ .++......++..+++|+.||| +++||+|||||+|.++|.+|-+||.|||+|+.+..+.
T Consensus 503 lGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 503 LGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred cCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999998763 5777888899999999999999 9999999999999999999999999999999987776
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchH
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
.+. +++|||.|.|||.+++...+.++|.||||+++|||++|.+||...+.+.-+..- +.+-.....+
T Consensus 575 KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I----------LkGid~i~~P 641 (732)
T KOG0614|consen 575 KTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI----------LKGIDKIEFP 641 (732)
T ss_pred cee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH----------Hhhhhhhhcc
Confidence 543 377999999999999999999999999999999999999999766555443221 1111111111
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCC
Q 020078 292 EQQLQALLQLIFECVNESAGDRPT 315 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps 315 (331)
......+.+|+++....+|.+|..
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 255567899999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=252.51 Aligned_cols=249 Identities=20% Similarity=0.235 Sum_probs=188.0
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
..||. .||+|+|-.. .|+..|||++......+...+++.|.....+- +.||||++||.+..+.-.|+.||.|. -|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence 45888 8999999877 78999999999877666778888888865554 68999999999999999999999995 46
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 215 (331)
|..+..--.......++++-.-.|....+.||.||-+ ..+|||||+||+|||+|..|.+||+|||.+-.+.++-....
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 6443321000001246677777788888999999986 77999999999999999999999999999876644322111
Q ss_pred ccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh---hccccccccccccccCCCCch
Q 020078 216 SHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV---ENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 216 ~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 290 (331)
-.|...|||||-+... .|+.+|||||||++|+|+.||+.|+..-..+...+ ..+.+ |++..+..+
T Consensus 227 ---daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdp-----p~l~~~~~~-- 296 (361)
T KOG1006|consen 227 ---DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDP-----PILLFDKEC-- 296 (361)
T ss_pred ---ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCC-----CeecCcccc--
Confidence 2388899999998743 58999999999999999999999984333332222 11221 122222111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.+.+..+..++.-||.+|-+.||+..++++.
T Consensus 297 -~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 297 -VHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -cccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1455679999999999999999999998754
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=254.14 Aligned_cols=255 Identities=20% Similarity=0.228 Sum_probs=194.5
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC--CCc----eeeeEeEEeeCC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN--HRN----ILKLIGCCIETE 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~n----Iv~l~~~~~~~~ 122 (331)
.++.|.+...+|+ .||.|-.+.+ .+..||+|++..-. +-.+..+-|+.+|.++. -|+ +|.+.+++.-.+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 3788999999999 9999999988 66889999986532 24677888999999994 233 788889999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC----------
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---------- 192 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---------- 192 (331)
+.|+|+|.+ |.|+.+++...+ ..+++..++..++.|++++++||| +..++|-||||+|||+.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence 999999998 459999997653 367999999999999999999999 999999999999999932
Q ss_pred ----------CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 193 ----------YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 193 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
+..++++|||.|++-....+. .+.|..|.|||++++-.++.++||||+||+|.|+.+|..-|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~-----iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHHST-----IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCcce-----eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 235899999999876554432 45899999999999999999999999999999999998644111
Q ss_pred H-----------------------HHHHHhhcccccccccccccc------CCCCchH------HHHHHHHHHHHHHhcc
Q 020078 263 E-----------------------HVKKHVENNRLGEIVDPIVVE------DKSCPEK------EQQLQALLQLIFECVN 307 (331)
Q Consensus 263 ~-----------------------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~------~~~~~~~~~li~~cl~ 307 (331)
. ...+.+..+.+ ++.+....+ ...-|.. ...-.++.||+.+||.
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rl-dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRL-DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccc-cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 0 01122222211 111111111 0000110 1334569999999999
Q ss_pred CCCCCCCCHHHHHH
Q 020078 308 ESAGDRPTMVYAAK 321 (331)
Q Consensus 308 ~dP~~Rps~~evl~ 321 (331)
.||.+|+|+.|++.
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=271.72 Aligned_cols=262 Identities=16% Similarity=0.154 Sum_probs=167.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--C----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeE------E
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--E----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC------C 118 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~------~ 118 (331)
..++|...+.||+ +||.||+|++ + +..||+|++..... .+.+.+| .+....+.++..+... +
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4678999999999 9999999998 4 68999998764321 1222222 1112222222222211 2
Q ss_pred eeCCccEEEEEecCCCChhhhhcCCCCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC
Q 020078 119 IETEIPILVFEFVEYGTLADRICSPHGPH---------------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI 183 (331)
Q Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdl 183 (331)
......++|+||+++|+|.+++....... ........+..++.|++.||.||| +.+|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcC
Confidence 45667899999999999999886532100 000112345679999999999999 899999999
Q ss_pred CCCceEEcC-CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccC----------------------CCCCcc
Q 020078 184 KLSQILFDE-YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG----------------------LCNEKT 240 (331)
Q Consensus 184 k~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 240 (331)
||+|||++. ++.+||+|||+++.+....... .....+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 5899999999998664433222 2234589999999976432 234567
Q ss_pred cchhhHHHHHHHHhCCCCChhHHHH-HHHhhcccc-----ccccccccccC--CCCchHHHHHHHHHHHHHHhccCCCCC
Q 020078 241 DVFCFGMLLLELLTGRRDNILLEHV-KKHVENNRL-----GEIVDPIVVED--KSCPEKEQQLQALLQLIFECVNESAGD 312 (331)
Q Consensus 241 Dv~SlG~~l~el~~g~~p~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~ 312 (331)
|||||||+||||+++..++...... ...+..... .....+..... ..+...........+|+.+||+.||++
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999999987765322111 111111000 00001100000 000000011224568999999999999
Q ss_pred CCCHHHHHHH
Q 020078 313 RPTMVYAAKQ 322 (331)
Q Consensus 313 Rps~~evl~~ 322 (331)
|||+.++++.
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=256.52 Aligned_cols=240 Identities=19% Similarity=0.246 Sum_probs=196.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+|+-..+||+ +||.|-+|.. +++.+|||++.+..- .++.+--+.|-++|+.. +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45777889999 9999999988 668899999887522 22445556788888776 478999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+.+|+|.-++...+ .+.+..+..++..||-||-||| +++||+||||.+|||+|.+|.+||+|||+.+.-
T Consensus 429 MEyvnGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999998764 3667788889999999999999 999999999999999999999999999998753
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
-... .++.+.+|||.|+|||.+.+.+|+..+|.|||||+||||+.|.+||....... .+ ..++..+..
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF---------~aI~ehnvs 568 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LF---------QAIMEHNVS 568 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HH---------HHHHHccCc
Confidence 2222 34455789999999999999999999999999999999999999985543321 11 112222333
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCC
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPT 315 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps 315 (331)
.|. .++.++.++.+..|.+.|.+|..
T Consensus 569 yPK--slSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 YPK--SLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred Ccc--cccHHHHHHHHHHhhcCCccccC
Confidence 333 67789999999999999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=233.95 Aligned_cols=251 Identities=16% Similarity=0.238 Sum_probs=191.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCC--ccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETE--IPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~~~l 126 (331)
.++|+..+.+|. .+++||.|.. ++++++||.+++. ..+...+|+.+|..|+ ||||++|++...++. .+.|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 467888888999 8889999996 8889999998765 4567899999999997 999999999998754 5679
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCCCcc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESE 205 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~a~ 205 (331)
++||+.+-+...+. +.++...+..++.++++||.|+| +.+|.|||+||.|++||.. -.++|+|+|+|.
T Consensus 113 iFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred HhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHh
Confidence 99999998877665 45777888999999999999999 9999999999999999954 579999999999
Q ss_pred ccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCCh----------------hHHHHHHH
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNI----------------LLEHVKKH 268 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~----------------~~~~~~~~ 268 (331)
+.-.+..... ++.+..|..||.+.. ..|+-.-|+|||||.|..|+..+.||. ........
T Consensus 182 FYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 8866655443 446778899999875 457889999999999999999999981 01111111
Q ss_pred hhcc--ccccccccccccCCC-------CchHHHH-HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 269 VENN--RLGEIVDPIVVEDKS-------CPEKEQQ-LQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 269 ~~~~--~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...- .+...++.++..... .++.... ++++.||+.+.|..|-.+||||+|+..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1100 111111111111100 0111112 368999999999999999999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=250.78 Aligned_cols=263 Identities=21% Similarity=0.265 Sum_probs=201.6
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCC--CCCcc----hhHHHHHHHHHHHhcCCCceeeeEeE
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGD--NYSEN----GENFCFNNIVFAAQMNHRNILKLIGC 117 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~--~~~~~----~~~~~~~E~~~l~~l~h~nIv~l~~~ 117 (331)
.+-....+.|-..+++|. ||+.||++.+ ..+-||||+-.- ++.+. -.+...+|-.|.+.|.||.||++|++
T Consensus 456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 344455667777889999 9999999988 677889987543 33221 23457789999999999999999999
Q ss_pred Ee-eCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---
Q 020078 118 CI-ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY--- 193 (331)
Q Consensus 118 ~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~--- 193 (331)
+. +.+.+|-|.|||++.+|.-++... +.+++.++..|+.||+.||.||.+- ..+|||-||||.|||+.+.
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gtac 609 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTAC 609 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCccc
Confidence 86 567789999999999997777543 4678899999999999999999843 6789999999999999543
Q ss_pred CceEEccCCCccccCCCCcc-----ccccccCCCCcccchhhhccC----CCCCcccchhhHHHHHHHHhCCCCChhHHH
Q 020078 194 NVAKLSDFSESEYIPEGETH-----VTSHMLTRTKRYLAPEYILTG----LCNEKTDVFCFGMLLLELLTGRRDNILLEH 264 (331)
Q Consensus 194 ~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~ 264 (331)
|.+||.|||+++.+.+.... ..+....||..|++||.+.-+ +.+.|+||||.||++|.++.|+.||--...
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 67999999999988655332 123445699999999998754 578899999999999999999999854444
Q ss_pred HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
............. ....+|..+-.+.++.++|.+||++--++|....++..
T Consensus 690 QQdILqeNTIlkA------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 690 QQDILQENTILKA------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHHHhhhchhcc------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 4433333222111 11122333356678999999999999999988877643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=261.85 Aligned_cols=252 Identities=19% Similarity=0.211 Sum_probs=206.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..+.|.....+|. .+|.|||+++ .++..|+|.++-.... ...-..+|+-+++..+|||||.++|.+...+..|+.|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3467888889999 9999999998 8899999998866554 6777889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||.+|+|.+.-+.. .++...++..+++..++||+||| +.+=+|||||..|||+++.+.+|++|||.+..+.
T Consensus 92 EycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhh
Confidence 999999999987765 47899999999999999999999 8999999999999999999999999999987653
Q ss_pred CCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
.. ......+.||+.|||||+.. .+.|...+|||++|++..|+.-..+|......+...+--. ...+++....
T Consensus 164 at--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT--kS~~qpp~lk- 238 (829)
T KOG0576|consen 164 AT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT--KSGFQPPTLK- 238 (829)
T ss_pred hh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh--ccCCCCCccc-
Confidence 32 23344467999999999975 5679999999999999999988888754433333322110 1122222222
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
++..+++.+.++++.||.++|++|||+.-++.
T Consensus 239 ----Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 ----DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ----CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22256667999999999999999999987653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=234.99 Aligned_cols=247 Identities=18% Similarity=0.237 Sum_probs=197.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 126 (331)
-++|....+||. ++..|..++. +++.+|+|.+++. ....+.++.+.|-.+..+- +||.+|-|..++...+..++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467888899999 7779999888 7889999998765 3344678899999998877 59999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
|.||+++|+|.-++..+ ..+++..+..+...|+.||.||| +.+||+||||.+|+|+|..|.+||.|+|..+.
T Consensus 329 vieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999998888765 46999999999999999999999 99999999999999999999999999999875
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh-hccccc-ccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV-ENNRLG-EIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~-~~~~~~-~~~~~~~~~ 284 (331)
--... ..+++++|||.|.|||.+.+..|...+|.|++||+++||+.|+.||.......+.. .+..+. -++...+..
T Consensus 401 ~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 401 GLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred CCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 32222 23445789999999999999999999999999999999999999984433111000 000000 111122222
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPT 315 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 315 (331)
+. ..+..+..+++.-|++||.+|..
T Consensus 479 pr------slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 PR------SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred cc------eeehhhHHHHHHhhcCCcHHhcC
Confidence 21 34456788999999999999963
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=217.96 Aligned_cols=209 Identities=25% Similarity=0.387 Sum_probs=180.4
Q ss_pred eee-cCcEEEEEEeC--CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhh
Q 020078 62 IAS-EHYKLYKGFLE--NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 138 (331)
||+ ++|.||++... ++.+++|.+.........+.+.+|+..+..++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 466 78899999995 899999998866433235789999999999999999999999999889999999999999999
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCCCccccCCCCcccccc
Q 020078 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFSESEYIPEGETHVTSH 217 (331)
Q Consensus 139 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 217 (331)
++.... ..+++..+..++.++++++.+|| ..+++|+||+|.||+++. ++.++++|||.+........ ...
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 986532 35788999999999999999999 889999999999999999 89999999999887654421 111
Q ss_pred ccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHH
Q 020078 218 MLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ 296 (331)
Q Consensus 218 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (331)
...+...|++||..... .++.++|+|++|++++++ .
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~ 188 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------P 188 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------H
Confidence 13378889999999877 788999999999999998 2
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 297 ALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 297 ~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
++.+++..|+..||++||++.++++.
T Consensus 189 ~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 189 ELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 58899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=244.85 Aligned_cols=198 Identities=16% Similarity=0.175 Sum_probs=167.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
-|...+-||- .||+|.+++. +...+|.|.+.+...- ........|-.||+.-..+-||+||-.|.+.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3566677898 8999999977 5567888988765332 234567789999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|++||++..+|... .-|++..+..++..+.+|+.+.| ..+.|||||||+|||||.+|.+||.|||+..-+..
T Consensus 710 YIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred ccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccccee
Confidence 99999999998765 34778888889999999999999 99999999999999999999999999999765532
Q ss_pred CC--------------------------c--------------cccccccCCCCcccchhhhccCCCCCcccchhhHHHH
Q 020078 210 GE--------------------------T--------------HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLL 249 (331)
Q Consensus 210 ~~--------------------------~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l 249 (331)
.. . .......+||+.|+|||++....|+..+|.||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00 0 0112345799999999999999999999999999999
Q ss_pred HHHHhCCCCCh
Q 020078 250 LELLTGRRDNI 260 (331)
Q Consensus 250 ~el~~g~~p~~ 260 (331)
|||+.|++||.
T Consensus 862 ~em~~g~~pf~ 872 (1034)
T KOG0608|consen 862 YEMLVGQPPFL 872 (1034)
T ss_pred HHHhhCCCCcc
Confidence 99999999983
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=226.89 Aligned_cols=252 Identities=20% Similarity=0.248 Sum_probs=182.9
Q ss_pred cCccccCceeecCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------cc
Q 020078 54 NNYNGHQVIASEHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------IP 124 (331)
Q Consensus 54 ~~~~~~~~ig~~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~ 124 (331)
..|.....+|.|...|..+-+ .+++||+|+..... .........+|..++..++|+||++++.++.-.. ..
T Consensus 17 ~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeeecccCCCCceEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 345555666665556666665 78999999987541 1224667889999999999999999999997643 46
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
|+|||+|. ++|.+.+.- .++-.++..+..|+++|+.||| +.+|+||||||+||++..+..+||.|||+|
T Consensus 97 y~v~e~m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHhhh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence 89999996 589888862 2566788899999999999999 999999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH---------------------
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE--------------------- 263 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--------------------- 263 (331)
+.-... ...+. .+.|..|.|||++.+-.|.+.+||||+||++.||++|+.-|....
T Consensus 166 r~e~~~--~~mtp-yVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD--FMMTP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc--cccCc-hhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 754333 11122 347889999999998889999999999999999999986441100
Q ss_pred ----HHHHHhhc------ccccccc-ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 264 ----HVKKHVEN------NRLGEIV-DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 264 ----~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.....+.. ......+ |.........+ .--..-+.+++.+||..||++|.|++++|+
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~--~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS--KLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCC--ccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 11111110 0000000 11000000000 011235889999999999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=227.71 Aligned_cols=257 Identities=17% Similarity=0.247 Sum_probs=190.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----cc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-----IP 124 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-----~~ 124 (331)
.+.+.++-||- .||.||...+ +++.||.|++.+-.. -...+.+.+|+.+|..++|.|++..++...-.. ..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34566788999 9999999998 899999999875422 124567889999999999999999888765433 35
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
|.++|.+. .+|...+.+. +.++...+.-++.||++||.||| +.+|.||||||.|+|+++|..+||+|||++
T Consensus 133 YV~TELmQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccc
Confidence 67888885 4888888764 67888899999999999999999 999999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCCh---------------------hH
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNI---------------------LL 262 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~---------------------~~ 262 (331)
+.....+....+..+ -|-.|.|||.+.+. .|+...||||.||++.|++..+.-|. ..
T Consensus 204 Rvee~d~~~hMTqEV-VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDRLNMTHEV-VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhhhhhHHHH-HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 977655443333333 57889999998764 69999999999999999998776440 11
Q ss_pred HHHHHHhhcccccc---ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 263 EHVKKHVENNRLGE---IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 263 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.+..+..-+.. ..+-...-....+. +-..+..++..+++..||++|.+..+++..
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~--~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPD--DKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCc--ccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11111111111110 00101111111111 334567889999999999999999888754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=214.66 Aligned_cols=196 Identities=16% Similarity=0.213 Sum_probs=157.9
Q ss_pred cccCceee-cCcEE--EEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecC
Q 020078 57 NGHQVIAS-EHYKL--YKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 57 ~~~~~ig~-~~g~V--y~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
....-||. ++|.| |+-..+|...|+|++......+..+..+.|+.+..+. ..|.+|.+||.+.+....|+.||.|.
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 33455888 58854 5555599999999998765555677888899877655 69999999999999999999999996
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
- ||..+-..--..+ ..+++...=+|+..+..||.|||+ ...+||||+||+||||+.+|.+|++|||.+-.+.++..
T Consensus 129 t-Sldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 129 T-SLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 4 7866554321111 357788888999999999999996 67999999999999999999999999999988765433
Q ss_pred cccccccCCCCcccchhhhcc----CCCCCcccchhhHHHHHHHHhCCCCC
Q 020078 213 HVTSHMLTRTKRYLAPEYILT----GLCNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
... ..|...|||||.+.. ..|+.+|||||||+++.||.+++.|+
T Consensus 205 kt~---daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY 252 (282)
T KOG0984|consen 205 KTM---DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPY 252 (282)
T ss_pred HHH---hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccc
Confidence 221 238889999998863 36999999999999999999999996
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=232.44 Aligned_cols=257 Identities=19% Similarity=0.192 Sum_probs=193.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC------CCceeeeEeEEeeCCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN------HRNILKLIGCCIETEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~nIv~l~~~~~~~~~ 123 (331)
-..|......|+ -|++|..|.. .+..||||++.++.. ....=+.|+.+|++|+ --|+++|+-.|...++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 345555666777 7779999988 678999999987643 2455678999999995 3489999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFS 202 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg 202 (331)
+|||+|-+.. +|.+++...+.+ -.|....+..++.|+.-||.+|- ..+|+|.||||+|||+.+. ..+||||||
T Consensus 509 LClVFE~Lsl-NLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 509 LCLVFEPLSL-NLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred eEEEehhhhc-hHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence 9999999864 899999876643 34667788899999999999999 8999999999999999854 578999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCC--hhHHHHHHHhhcc--------
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN--ILLEHVKKHVENN-------- 272 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~--~~~~~~~~~~~~~-------- 272 (331)
.|.+..++...... -+..|.|||.+.+-.|+...|+||.||+||||.||+..| ...+.+..++...
T Consensus 583 SA~~~~eneitPYL----VSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEITPYL----VSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred cccccccccccHHH----HHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 99888766543321 355799999999999999999999999999999999744 1111111111100
Q ss_pred ----ccc------------ccccc---------------------ccccCCCCc-hHHHHHHHHHHHHHHhccCCCCCCC
Q 020078 273 ----RLG------------EIVDP---------------------IVVEDKSCP-EKEQQLQALLQLIFECVNESAGDRP 314 (331)
Q Consensus 273 ----~~~------------~~~~~---------------------~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rp 314 (331)
++. .-.|+ .+......| +......++.+|+.+||..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 000 00000 011111112 2235678899999999999999999
Q ss_pred CHHHHHH
Q 020078 315 TMVYAAK 321 (331)
Q Consensus 315 s~~evl~ 321 (331)
|..++|.
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=256.41 Aligned_cols=196 Identities=14% Similarity=0.172 Sum_probs=141.3
Q ss_pred hcCC-CceeeeEeEE-------eeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 020078 105 QMNH-RNILKLIGCC-------IETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR 176 (331)
Q Consensus 105 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 176 (331)
.++| +||++++++| .+....++++||+ .++|.+++.... ..+++.+++.++.||++||.||| +.
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~ 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAH---SQ 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHH---hC
Confidence 4556 6888888887 2334567788887 569999996532 45899999999999999999999 99
Q ss_pred CeeeCCCCCCceEEcC-------------------CCceEEccCCCccccCCCCc--------------cccccccCCCC
Q 020078 177 PIVFKDIKLSQILFDE-------------------YNVAKLSDFSESEYIPEGET--------------HVTSHMLTRTK 223 (331)
Q Consensus 177 ~ivHrdlk~~Nill~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~ 223 (331)
+|+||||||+|||++. ++.+|++|||+++....... ........||+
T Consensus 100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 9999999999999954 45567777777654321000 00011134788
Q ss_pred cccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHH
Q 020078 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIF 303 (331)
Q Consensus 224 ~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 303 (331)
.|+|||++.+..|+.++|||||||+||||++|..|+............. ...+.. ........+++.
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~ 246 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPPQI---------LLNWPKEASFCL 246 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcChhh---------hhcCHHHHHHHH
Confidence 9999999999999999999999999999999998864332221111110 011100 011234678899
Q ss_pred HhccCCCCCCCCHHHHHH
Q 020078 304 ECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 304 ~cl~~dP~~Rps~~evl~ 321 (331)
+||+++|.+|||+.|++.
T Consensus 247 ~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 247 WLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HhCCCChhhCcChHHHhh
Confidence 999999999999999975
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=233.63 Aligned_cols=195 Identities=22% Similarity=0.237 Sum_probs=165.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--c-----chhHHHHHHHHHHHhcC---CCceeeeEeEEee
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--E-----NGENFCFNNIVFAAQMN---HRNILKLIGCCIE 120 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 120 (331)
.+|...+.+|+ .||.|+.+.+ +...|++|-+.+..- + ...-..--||.||+.|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888899999 9999999999 667888988765421 1 11223556999999997 9999999999999
Q ss_pred CCccEEEEEec-CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEc
Q 020078 121 TEIPILVFEFV-EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199 (331)
Q Consensus 121 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 199 (331)
++.+||+||-. ++-+|.++|.-. +.+++..+..|++|++.|+++|| +.+|||||||-+|+.+|.+|.+||+
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEe
Confidence 99999999986 456899998653 46889999999999999999999 9999999999999999999999999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCC-CcccchhhHHHHHHHHhCCCCCh
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
|||.|.....+.... ++||..|.|||++.+.+|- ..-|||++|++||-++....|++
T Consensus 713 dfgsaa~~ksgpfd~----f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGPFDV----FVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCCcce----eeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998876665433 5699999999999988874 56899999999999998888863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=208.79 Aligned_cols=198 Identities=25% Similarity=0.304 Sum_probs=167.6
Q ss_pred ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
|.....||. +++.||++.. +++.+++|.+.........+.+.+|+..+..++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 345677888 8999999999 4689999998865433246788899999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+++|.+++.... ..+++..+..++.+++.++.+|| ..+++|+|++|.||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999987642 12788999999999999999999 88999999999999999999999999999887755421
Q ss_pred cccccccCCCCcccchhhh-ccCCCCCcccchhhHHHHHHHHhCCCCChh
Q 020078 213 HVTSHMLTRTKRYLAPEYI-LTGLCNEKTDVFCFGMLLLELLTGRRDNIL 261 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~ 261 (331)
. ......++..|++||.+ ....++.++|+||||+++++|++|+.||..
T Consensus 154 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 A-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0 11113477889999998 666788899999999999999999999754
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=222.27 Aligned_cols=197 Identities=21% Similarity=0.268 Sum_probs=164.2
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeC
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIET 121 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 121 (331)
+....+.|...++||+ .|++||++.. .++.||+|.+.... ......+|+++|..+. +.||+++.+++..+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 3445677888999999 9999999987 35789999998665 3456899999999996 89999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEcc
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSD 200 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~D 200 (331)
+...+|+||++.-+..++.. .++...+..+++.+..||.++| .++|||||+||+|+|.+.. +.-.|.|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred CeeEEEecccCccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEe
Confidence 99999999999988888884 4667889999999999999999 9999999999999999854 6789999
Q ss_pred CCCccccCCCC----------------------------------cc--------ccccccCCCCcccchhhhccC-CCC
Q 020078 201 FSESEYIPEGE----------------------------------TH--------VTSHMLTRTKRYLAPEYILTG-LCN 237 (331)
Q Consensus 201 fg~a~~~~~~~----------------------------------~~--------~~~~~~~gt~~y~aPE~~~~~-~~~ 237 (331)
||+|....... .. .....+.||++|.|||++... .-+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99987211000 00 001234689999999999865 467
Q ss_pred CcccchhhHHHHHHHHhCCCCC
Q 020078 238 EKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 238 ~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
+++||||.||+++-+++++.||
T Consensus 257 taiDiws~GVI~Lslls~~~PF 278 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPF 278 (418)
T ss_pred Cccceeeccceeehhhcccccc
Confidence 8999999999999999999998
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=212.84 Aligned_cols=252 Identities=18% Similarity=0.214 Sum_probs=186.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeE-EeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGC-CIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-~~~~~~~~lv 127 (331)
.+.|.+.+.+|+ -||.+-++.. ....+++|.+..... ...+|.+|.+.---|. |.||+.-|++ |...+.+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 467888899999 8999999988 567788888876654 4788999999888885 8999998855 5556777899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc--CCCceEEccCCCcc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--EYNVAKLSDFSESE 205 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfg~a~ 205 (331)
+||+|.|+|..-+.. ..+.+..-.+++.|+++|+.|+| ++++||||||.+||||- +...+||+|||+.+
T Consensus 101 qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 999999999887744 23667777889999999999999 99999999999999993 33589999999987
Q ss_pred ccCCCCccccccccCCCCcccchhhhccC-----CCCCcccchhhHHHHHHHHhCCCCChhHHHH-HHHhhccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTG-----LCNEKTDVFCFGMLLLELLTGRRDNILLEHV-KKHVENNRLGEIVD 279 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~ 279 (331)
........ +..+..|-+||++... ...+.+|+|.||++++.+++|+.|+.-.... .+++.-..+.....
T Consensus 172 k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 172 KVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 54332221 2246678999988632 3568899999999999999999998421110 01111111112222
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
+.++..+. .+++.+..+.++-|..+|++|-...++.+....
T Consensus 247 ~~~P~~F~-----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 PALPKKFN-----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccCchhhc-----ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 22333322 345678899999999999999666666555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=205.16 Aligned_cols=171 Identities=18% Similarity=0.161 Sum_probs=128.3
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++...+ .++++.+++.++.|++.||.||| +.+ ||+|||++.++.+++ ||.+........
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~- 64 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQS- 64 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccccC-
Confidence 68999997543 46999999999999999999999 555 999999999999999 999876644321
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQ 293 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
.||+.|+|||++.+..++.++|||||||++|||++|+.|+............... ...+..... .+....
T Consensus 65 ------~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~ 134 (176)
T smart00750 65 ------RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLN--GMPADDPRD--RSNLES 134 (176)
T ss_pred ------CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHH--HhccCCccc--cccHHH
Confidence 3889999999999999999999999999999999999998543222111111000 000000000 011113
Q ss_pred HHH--HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 294 QLQ--ALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 294 ~~~--~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
... ++.+++.+||..||++|||+.|++..+..+..+.
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 333 6999999999999999999999999998776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=220.63 Aligned_cols=130 Identities=14% Similarity=0.208 Sum_probs=106.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-----C---CceeeeEeEEee--
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-----H---RNILKLIGCCIE-- 120 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~nIv~l~~~~~~-- 120 (331)
..|-..++||. -|++||++.+ ..+-||+|+.+... .-.+..+.||.+|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 55667788999 7889999999 66789999876432 13567788999999884 3 359999999986
Q ss_pred --CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc
Q 020078 121 --TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191 (331)
Q Consensus 121 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~ 191 (331)
+.+.|+|+|+.. -+|..+|..... +.++...+.+|+.||+.||.|||. ..+|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvLG-dnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLG-DNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhh-hHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence 347899999995 488888876544 568899999999999999999997 55999999999999993
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=209.70 Aligned_cols=246 Identities=17% Similarity=0.246 Sum_probs=186.6
Q ss_pred ceee-cCcEEEEEEeCCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhh
Q 020078 61 VIAS-EHYKLYKGFLENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 138 (331)
+|.+ -.|+.|+|++.+..+++|++.-. ......+.|..|.-.|+.+.||||++++|.|.......++..|||.|+|+.
T Consensus 197 kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslyn 276 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYN 276 (448)
T ss_pred hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHH
Confidence 3556 67899999999988888887643 333346789899999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccc
Q 020078 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218 (331)
Q Consensus 139 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 218 (331)
.+++..+ -..+-.++.+++.++++|++|||+. ..-|..--|.+..+++|++.+++|+- +-+++.. ....
T Consensus 277 vlhe~t~---vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsf------qe~g 345 (448)
T KOG0195|consen 277 VLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF------QEVG 345 (448)
T ss_pred HHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeee------eccc
Confidence 9987653 3456788999999999999999952 22333347888999999999888752 2222211 1111
Q ss_pred cCCCCcccchhhhccCCC---CCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHH
Q 020078 219 LTRTKRYLAPEYILTGLC---NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295 (331)
Q Consensus 219 ~~gt~~y~aPE~~~~~~~---~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (331)
+.-.|.||+||.+...+- -..+|+|||.+++|||.|...||.....+....+ +..+......+++.+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------ialeglrv~ippgis 415 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------IALEGLRVHIPPGIS 415 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------hhhccccccCCCCcc
Confidence 235789999999986643 3679999999999999999999854433332221 111122222222566
Q ss_pred HHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 296 QALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 296 ~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.++.+|+.-|.+.||.+||.++.++-.|+++.
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 78999999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=196.89 Aligned_cols=167 Identities=14% Similarity=0.114 Sum_probs=129.0
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe---CCceEEEEEeCCCC----CcchhHHHHHHHHHHHhcCCCceee-eEeEE
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNY----SENGENFCFNNIVFAAQMNHRNILK-LIGCC 118 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~ 118 (331)
.+....++|.....||+ +||+||+|.. ++..+|||++.... .....+.+.+|+.+|.+++|+||++ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34566788999999999 9999999987 46678999876431 1223567899999999999999985 4432
Q ss_pred eeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC-CCCceEEcCCCceE
Q 020078 119 IETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI-KLSQILFDEYNVAK 197 (331)
Q Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~k 197 (331)
+..++||||+++++|.. +.. .. ...++.++++||.||| +.+|+|||| ||+|||++.++.++
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEE
Confidence 45799999999999963 211 11 1457889999999999 999999999 99999999999999
Q ss_pred EccCCCccccCCCCcccc------ccccCCCCcccchhhhcc
Q 020078 198 LSDFSESEYIPEGETHVT------SHMLTRTKRYLAPEYILT 233 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 233 (331)
|+|||+|+.+........ .....+++.|+|||++..
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999987754331111 123457888999998863
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-22 Score=182.89 Aligned_cols=256 Identities=23% Similarity=0.294 Sum_probs=194.9
Q ss_pred ccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcc--hhHHHHHHHHHHHhcCCC-ceeeeEeEEeeCCccEEEEEec
Q 020078 56 YNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSEN--GENFCFNNIVFAAQMNHR-NILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
|.....+|. +|+.||++... ..+++|.+....... ....+.+|+.++..+.|+ +|+++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 455667887 88999999988 888999988765543 477899999999999988 7999999997777789999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCccccCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYIPEG 210 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~~ 210 (331)
.++++.+++...... ..+.......++.+++.++.|+| ..+++|||+||+||+++..+ .++++|||.+......
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999777543211 25788899999999999999999 88999999999999999988 7999999999866544
Q ss_pred Cccc----cccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhHH------HHHHHhhccccccc
Q 020078 211 ETHV----TSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILLE------HVKKHVENNRLGEI 277 (331)
Q Consensus 211 ~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~ 277 (331)
.... ......|+..|+|||.+.. ..++...|+||+|++++++++|..|+.... ............ .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence 3221 1233568999999999987 578899999999999999999999864332 222222211111 0
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
........ .+ ......+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~--~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPS--NP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCcc--cc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 00 1223468899999999999999999877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-25 Score=213.43 Aligned_cols=253 Identities=16% Similarity=0.180 Sum_probs=181.6
Q ss_pred ccCceee-cCcEEEEEEe--CCceEEEEEeC----CCCCcchh-HHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 58 GHQVIAS-EHYKLYKGFL--ENRPISVMKFG----DNYSENGE-NFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~----~~~~~~~~-~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
...++|. .+|.|+.... .....+.|... ........ ..+..|..+-..+.|||++.....+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4566777 5555666655 34444444332 21111111 125557777788999999888877777666666699
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
||++ +|..++.+. ..+....+-.++.|+..|+.|+| +.+|.|||+|++|+++..++.+|++|||.+..+..
T Consensus 402 ~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 999999764 24777888899999999999999 99999999999999999999999999999887654
Q ss_pred CCcc--ccccccCCCCcccchhhhccCCCCC-cccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 210 GETH--VTSHMLTRTKRYLAPEYILTGLCNE-KTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ......+|+..|+|||++....|.+ ..||||.|+++..|.+|+.||.........+..... .+..-....
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~---~~~~~~~~~ 549 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY---SDQRNIFEG 549 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc---ccccccccC
Confidence 4332 3333456999999999999998875 589999999999999999997433322221111010 011111111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
........+.+...++-++|+.||.+|.|+.+|++.
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 222333667789999999999999999999999863
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=187.63 Aligned_cols=212 Identities=24% Similarity=0.367 Sum_probs=158.7
Q ss_pred HHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-eeC
Q 020078 103 AAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPI-VFK 181 (331)
Q Consensus 103 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vHr 181 (331)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.... ..+++.....++++++.||.||| ..+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLH---NSPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHh---cCcceeee
Confidence 357889999999999999999999999999999999997632 56889999999999999999999 5555 999
Q ss_pred CCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCC-------CCCcccchhhHHHHHHHHh
Q 020078 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL-------CNEKTDVFCFGMLLLELLT 254 (331)
Q Consensus 182 dlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Dv~SlG~~l~el~~ 254 (331)
.+++.|+++|.+..+|+.|||+.................-..-|.|||.+.... .+.++||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 999999999999999999999987764311100000011345699999987541 4677999999999999999
Q ss_pred CCCCChhHHH------HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 255 GRRDNILLEH------VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 255 g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...||..... .-..+.. .....+.|.+... ....+++..++.+||..+|..||++..+-..++.+..
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELL------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccCccccccccCChHHHHHHHHh-cCCCCcCcchhhh------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9998733111 1111111 1111122222111 0333469999999999999999999999998877653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-21 Score=175.34 Aligned_cols=257 Identities=16% Similarity=0.141 Sum_probs=190.8
Q ss_pred CccccCceee-cCcEEEEEEeCC---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC----CceeeeEeEE-eeCCccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFLEN---RPISVMKFGDNYSENGENFCFNNIVFAAQMNH----RNILKLIGCC-IETEIPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~~-~~~~~~~ 125 (331)
.|.....||+ +||.||.+.... ..+|+|.-...... ....+..|+.++..+.. +++..+++.. ......+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~-~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGS-KPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccC-CCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 7999999999 999999999833 35777776554333 22267889999998873 5888888888 4677889
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-----CceEEcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-----NVAKLSD 200 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-----~~~kl~D 200 (331)
+||+.+ +.+|.++..... ...++..+++.++.|++.+|.+|| +.+++||||||+|+++... ..+.+.|
T Consensus 98 iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 999998 679999775433 256889999999999999999999 9999999999999999855 4689999
Q ss_pred CCCccccC--CCCc----cc-c-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhh
Q 020078 201 FSESEYIP--EGET----HV-T-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVE 270 (331)
Q Consensus 201 fg~a~~~~--~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~ 270 (331)
||+++... .... .. . .....||..|.++.+..+...+.+.|+||++-++.++..|..||...... ...+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998322 2111 01 1 12345999999999999999999999999999999999999997332211 11111
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.......... .. . ..+.++.++...+-..+...+|....+...|+....
T Consensus 251 ~~~~~~~~~~---~~-~-----~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 251 KDPRKLLTDR---FG-D-----LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred HHhhhhcccc---cc-C-----CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 1111111111 00 1 122357777777777999999999999999877654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=171.87 Aligned_cols=171 Identities=14% Similarity=0.120 Sum_probs=133.3
Q ss_pred HHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcc--hhHH------HHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSEN--GENF------CFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
.+.+.|...+++|. |||.||....++..+|+|.+....... .... +.+|+..+.+++||+|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45788999999999 999999977788899999998654331 1122 57899999999999999998886643
Q ss_pred --------CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC
Q 020078 122 --------EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193 (331)
Q Consensus 122 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 193 (331)
...+++|||++|.+|.+... ++. ....+++.++..+| ..+++|||++|+|++++.+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKN 171 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCC
Confidence 35789999999999977631 222 24569999999999 9999999999999999988
Q ss_pred CceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHH
Q 020078 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLEL 252 (331)
Q Consensus 194 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el 252 (331)
+ ++++|||........... ..+.....|..++|+||||+++..+
T Consensus 172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 8 999999987654322111 1133445567899999999987654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=203.40 Aligned_cols=249 Identities=20% Similarity=0.213 Sum_probs=181.2
Q ss_pred CccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHH--HHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVF--AAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
++.-.+.+|. .|-+|.+|+.+...|+||.+.+....-..+.|.+++.- ...++|||.+++..+-..+.-.|+|=+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 5666678999 88899999997777999999876544455555554443 44568999999988877777788888998
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc--ccCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE--YIPE 209 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~--~~~~ 209 (331)
.+ +|.|.+..+ .-+..-+..-|+.|++.||.-+| ..+|+|||||.+||||+....+.|+||...+ ++++
T Consensus 104 kh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 104 KH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred hh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 75 999999764 34566777889999999999999 9999999999999999999999999998754 3333
Q ss_pred CCccc---cccccCCCCcccchhhhccC----------C-CCCcccchhhHHHHHHHHhC-CCCChhHHHHHHHhhcccc
Q 020078 210 GETHV---TSHMLTRTKRYLAPEYILTG----------L-CNEKTDVFCFGMLLLELLTG-RRDNILLEHVKKHVENNRL 274 (331)
Q Consensus 210 ~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~SlG~~l~el~~g-~~p~~~~~~~~~~~~~~~~ 274 (331)
+.... --.+...-..|.|||-+... . .+++-||||+||++.||++- +++|.+.+-..-...+...
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 32211 00111134469999987642 1 56789999999999999884 6676555543322111111
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
.+. ..+.... ..++.++..|++.||++|.||++.++..
T Consensus 255 ~e~----~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 255 PEQ----LLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred HHH----HHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 111 1111111 1488999999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=162.63 Aligned_cols=138 Identities=13% Similarity=0.116 Sum_probs=105.6
Q ss_pred cCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcc-h-------h-----------------HHHHHHHHHHHhcCCCce
Q 020078 59 HQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSEN-G-------E-----------------NFCFNNIVFAAQMNHRNI 111 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~-------~-----------------~~~~~E~~~l~~l~h~nI 111 (331)
...||+ ++|.||+|.. +|+.||+|.+....... . . ....+|+.++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357899 9999999998 78999999987542210 1 1 122359999999988776
Q ss_pred eeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeCCCCCCceEE
Q 020078 112 LKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYI-HIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 112 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrdlk~~Nill 190 (331)
.....+. . ...++||||++++++....... ..++......++.|++.+|.|+ | +.+|+||||||+|||+
T Consensus 82 ~~p~~~~-~-~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPIL-L-KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEE-e-cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEE
Confidence 4333222 2 2248999999987775543322 3578889999999999999999 7 7899999999999999
Q ss_pred cCCCceEEccCCCcccc
Q 020078 191 DEYNVAKLSDFSESEYI 207 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~ 207 (331)
+ ++.++|+|||+|...
T Consensus 152 ~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 152 H-DGKLYIIDVSQSVEH 167 (190)
T ss_pred E-CCcEEEEEccccccC
Confidence 8 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=163.38 Aligned_cols=260 Identities=16% Similarity=0.162 Sum_probs=196.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 126 (331)
.+.-+|...++||+ +||..+.|+. ++++||||.=.... ..-++.-|....+.|. .+.|...|-+-..+-.-.|
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 45678999999999 9999999988 99999999743322 2345666777777775 6888888877777777889
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-----ceEEccC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-----VAKLSDF 201 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-----~~kl~Df 201 (331)
|+|.. +.||.|++.=++ ..++..++.-+|.|++.-+.|+| .+.+|+|||||+|+||...+ .+.++||
T Consensus 102 VidLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEec
Confidence 99998 789999987655 45889999999999999999999 99999999999999997543 5899999
Q ss_pred CCccccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc
Q 020078 202 SESEYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE 276 (331)
Q Consensus 202 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 276 (331)
|+|+...+..+.. ......||..||+--..++..-+..-|+=|+|.++...+.|..||...+-.....
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~------- 246 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE------- 246 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH-------
Confidence 9999886654321 1233569999999888888888999999999999999999999974433221111
Q ss_pred ccccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 277 IVDPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
-...+-......|.. .+++.++..-+.-.-..+-.+-|..+.+...+..++.
T Consensus 247 kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 247 KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 111111001111111 1455677777777777888889999888877776653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=159.93 Aligned_cols=260 Identities=17% Similarity=0.181 Sum_probs=195.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC-CceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH-RNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv 127 (331)
..++|...+.||. +||.+|.|.. .|+.||+|.=.... ...++..|..+...|++ ..|..+..+..+.....+|
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 3567888999999 9999999988 89999999855432 34567889999999986 5677777888888888999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a 204 (331)
|+.. +.||.+++.-+. ..++..+++-++-|++.-+.|+| ..+.|||||||+|.|..-+ ..+.++|||+|
T Consensus 90 MdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccch
Confidence 9998 789999987554 46888999999999999999999 9999999999999999633 46899999999
Q ss_pred cccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccc
Q 020078 205 EYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVD 279 (331)
Q Consensus 205 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 279 (331)
+...+..+.. ......||..|.+--...+-.-+..-|+=|+|-+|..+-.|..||..........+-....+..-
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 8775543221 22335689899887766555667788999999999999999999865444333332222211111
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
....+. -| .+++.++.-.+.-|-..--++-|....+...+.-+
T Consensus 242 s~~ie~-LC---~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 242 STPIEV-LC---KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCCHHH-Hh---CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 111000 01 14556888899999888888999888776665444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.1e-20 Score=155.73 Aligned_cols=140 Identities=11% Similarity=0.113 Sum_probs=108.4
Q ss_pred cCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcc-h------------------------hHHHHHHHHHHHhcCCCce
Q 020078 59 HQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSEN-G------------------------ENFCFNNIVFAAQMNHRNI 111 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~h~nI 111 (331)
...||+ ++|.||+|.. +|+.||||.+....... . ...+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 357899 9999999998 69999999987652210 0 1234578999999999987
Q ss_pred eeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEE
Q 020078 112 LKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILF 190 (331)
Q Consensus 112 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill 190 (331)
.....+... ..++||||++++++....... ..++......++.+++.++.++| . .+|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEE
Confidence 544433322 248999999987554332221 24667888999999999999999 7 999999999999999
Q ss_pred cCCCceEEccCCCccccCC
Q 020078 191 DEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~ 209 (331)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 78999999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=153.10 Aligned_cols=184 Identities=12% Similarity=-0.000 Sum_probs=136.3
Q ss_pred cccCceee-cCcEEEEEEeCCceEEEEEeCCCCCc---chhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEec
Q 020078 57 NGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSE---NGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.....++. +||+||.+...+.+++.+.+....-- -....+.+|+.+|++|+ |++|++++++ +..+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 34567888 99999988888899998887654321 11235789999999996 5889999886 3468999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC-CCCceEEcCCCceEEccCCCccccCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI-KLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdl-k~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
.+.+|...+.. ....++.+++.+|.++| ..+|+|||| ||+|||++.++.++|+|||++......
T Consensus 81 ~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 81 AGAAMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred cCccHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 98888654311 11346789999999999 999999999 799999999999999999999865443
Q ss_pred Ccc----c-------cccccCCCCcccchhhhccC-CCC-CcccchhhHHHHHHHHhCCCCC
Q 020078 211 ETH----V-------TSHMLTRTKRYLAPEYILTG-LCN-EKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 211 ~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
... . .......++.|++|+....- ..+ ...+.++.|.-+|.++|+..+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 310 0 01122357788888764322 233 3345569999999999999873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.6e-21 Score=179.88 Aligned_cols=223 Identities=18% Similarity=0.167 Sum_probs=172.1
Q ss_pred eee-cCcEEEEEEe-----CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEecCC
Q 020078 62 IAS-EHYKLYKGFL-----ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 62 ig~-~~g~Vy~~~~-----~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+|+ .+|.|+..+. .+.-+|.|.+.+. ...+.......|..++...+ ||.+|++.-.+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 455 5555554332 4555666665543 11112234556788888887 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|...+... ..+.......+...++-+++++| ..+|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 82 g~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 82 GDLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred chhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9998888664 34667777888899999999999 999999999999999999999999999999876444332
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHH
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQ 293 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
+||..|||||.+. .....+|.||||++.+||++|..||.. .-.... +......| ..
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-~~~~~I-------------l~~~~~~p--~~ 209 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-DTMKRI-------------LKAELEMP--RE 209 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-HHHHHH-------------hhhccCCc--hh
Confidence 5899999999987 567889999999999999999999866 111111 11122222 36
Q ss_pred HHHHHHHHHHHhccCCCCCCCCH
Q 020078 294 QLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 294 ~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.+..+.+++..++..+|..|.-.
T Consensus 210 l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 210 LSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhHHHHHHHHHHHhhCHHHHhcc
Confidence 77889999999999999999865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=152.58 Aligned_cols=136 Identities=13% Similarity=0.084 Sum_probs=104.4
Q ss_pred ccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-----CCCceeeeEeEEeeCC---c-cE
Q 020078 56 YNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQM-----NHRNILKLIGCCIETE---I-PI 125 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~---~-~~ 125 (331)
.+....||+ +++.||....+ ...+||++...... ..+.+.+|+.++..+ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~hp~~-~~k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYAHPED-AQRCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEECCCC-cCeEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 445678999 89999962224 33479988654333 456799999999999 5799999999998864 2 33
Q ss_pred EEEEe--cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeeeCCCCCCceEEcC----CCceEE
Q 020078 126 LVFEF--VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAM-AYIHIGFRRPIVFKDIKLSQILFDE----YNVAKL 198 (331)
Q Consensus 126 lv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivHrdlk~~Nill~~----~~~~kl 198 (331)
+|+|| +++|+|.+++... .++.. ..++.+++.++ .||| +.+|+||||||+|||++. +..++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 6689999999542 24433 35678888888 9999 999999999999999974 348999
Q ss_pred ccCCCc
Q 020078 199 SDFSES 204 (331)
Q Consensus 199 ~Dfg~a 204 (331)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.1e-21 Score=173.76 Aligned_cols=172 Identities=23% Similarity=0.345 Sum_probs=120.8
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
|+.|++|...+|.++|...... ..-++...+.++.|++.|+.| ++.+|+|+||.||....+..+||+|||+.
T Consensus 332 yI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 332 YIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred hhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 4667777777777777533211 334566778899999999987 67899999999999999999999999998
Q ss_pred cccCCCCc----cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhC-CCCChhHHHHHHHhhccccccccc
Q 020078 205 EYIPEGET----HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG-RRDNILLEHVKKHVENNRLGEIVD 279 (331)
Q Consensus 205 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~ 279 (331)
.......+ ........||..||+||.+.+..|+.++||||||++|+|+++- ..++..... ...+. ..+++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-~~d~r----~g~ip 478 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-LTDIR----DGIIP 478 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-hhhhh----cCCCC
Confidence 87765541 1122335699999999999999999999999999999999982 222111111 11111 11222
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY 318 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~e 318 (331)
+....++ ++-..|+.+++...|.+||++.+
T Consensus 479 ~~~~~d~---------p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 479 PEFLQDY---------PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hHHhhcC---------cHHHHHHHHhcCCCcccCchHHH
Confidence 1111111 24568999999999999995543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.5e-19 Score=149.15 Aligned_cols=134 Identities=18% Similarity=0.198 Sum_probs=113.0
Q ss_pred Cceee-cCcEEEEEEeCCceEEEEEeCCCCCcc-------hhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 60 QVIAS-EHYKLYKGFLENRPISVMKFGDNYSEN-------GENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+.||+ ++|.||+|...+..+++|......... ....+.+|+.++..++|++|.....++.+.+..+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46888 899999999999999999876432210 1245778999999999999888777777778889999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
++++|.+.+... .. .+..++.+++.+|.++| ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988532 12 77889999999999999 99999999999999999 78899999998764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=158.27 Aligned_cols=195 Identities=19% Similarity=0.228 Sum_probs=138.8
Q ss_pred CCCceeeeEeEEeeC---------------------------CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHH
Q 020078 107 NHRNILKLIGCCIET---------------------------EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159 (331)
Q Consensus 107 ~h~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 159 (331)
+|||||++.++|.+. ...|+||.-.+. +|.+++..++ .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 599999999988762 235899988875 8999997653 445566778
Q ss_pred HHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc--CCC--ceEEccCCCccccCCCC----ccccccccCCCCcccchhhh
Q 020078 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--EYN--VAKLSDFSESEYIPEGE----THVTSHMLTRTKRYLAPEYI 231 (331)
Q Consensus 160 ~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~--~~kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~ 231 (331)
+.|+++|+.||| ..+|.|||+|++|||+. ++. ...++|||.+-.-.... .....-..-|.-.-||||+.
T Consensus 347 laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999 99999999999999993 444 57889999864322110 00011113367778999988
Q ss_pred ccC--C----CCCcccchhhHHHHHHHHhCCCCChhHHHHHH---HhhccccccccccccccCCCCchHHHHHHHHHHHH
Q 020078 232 LTG--L----CNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302 (331)
Q Consensus 232 ~~~--~----~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (331)
... + .-.|+|.|+.|.+.||++....||+....+.- .+.+.++. +.+..+++.+.+++
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP-------------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP-------------ALPSRVPPVARQLV 490 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-------------CCcccCChHHHHHH
Confidence 632 2 12689999999999999999999865222211 11111111 11114445799999
Q ss_pred HHhccCCCCCCCCHHHHHHHHH
Q 020078 303 FECVNESAGDRPTMVYAAKQLR 324 (331)
Q Consensus 303 ~~cl~~dP~~Rps~~evl~~L~ 324 (331)
-..|+.||++|+|..-+.+.|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999887766653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=158.00 Aligned_cols=233 Identities=18% Similarity=0.125 Sum_probs=143.3
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCC-----------CceeeeEeE-
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNH-----------RNILKLIGC- 117 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h-----------~nIv~l~~~- 117 (331)
.+.....||. +++.||.+++ +++.+|+|.+.... .....+.+.+|.-....+.+ .-++++--.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3445678999 9999999999 67999999876432 22346677776654444322 112222111
Q ss_pred -------EeeCC--------ccEEEEEecCCCChhhhhcC---CCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 020078 118 -------CIETE--------IPILVFEFVEYGTLADRICS---PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179 (331)
Q Consensus 118 -------~~~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 179 (331)
..... ..+++|+-+. ++|.+++.. .... ...+....++.+..|+++.+++|| ..+++
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV 167 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLH---SYGLV 167 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence 11111 2256777774 588777642 1110 123444556777799999999999 99999
Q ss_pred eCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccC--------CCCCcccchhhHHHHHH
Q 020078 180 FKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG--------LCNEKTDVFCFGMLLLE 251 (331)
Q Consensus 180 Hrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~SlG~~l~e 251 (331)
|+||+|+|++++.+|.+.|+||+.......... . ...+..|.+||..... .++.+.|.|++|+++|.
T Consensus 168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ecccceeeEEEcCCCCEEEcChHHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999987654422111 1 1246789999987542 47889999999999999
Q ss_pred HHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCC
Q 020078 252 LLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDR 313 (331)
Q Consensus 252 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 313 (331)
+++|..|+...... ...+. . -..|. +.++.+..||..+|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~----------~~~~~-~--f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPE----------ADPEW-D--FSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGG----------STSGG-G--GTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCcc----------ccccc-c--chhcC---CcCHHHHHHHHHHccCCcccC
Confidence 99999996422111 00000 0 01222 455679999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.7e-19 Score=176.04 Aligned_cols=249 Identities=15% Similarity=0.147 Sum_probs=178.8
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC---CCceeeeEeEEeeCC
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN---HRNILKLIGCCIETE 122 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~ 122 (331)
+.+.....|.+.+.+|+ ++|+||.|.. +++.||+|.=.+...- +|.--.+++.+|+ -+-|..+..++.-.+
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW----EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce----eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 44555678899999999 9999999988 8899999987654332 2333344555555 234555555666677
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-------CCCc
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-------EYNV 195 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-------~~~~ 195 (331)
..+||+||.+.|+|.+++... +.+++.-...++.|++.-+.+|| ..+|||+||||+|.||. ...-
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccc
Confidence 788999999999999999733 56888889999999999999999 99999999999999993 2346
Q ss_pred eEEccCCCcccc---CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc
Q 020078 196 AKLSDFSESEYI---PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN 272 (331)
Q Consensus 196 ~kl~Dfg~a~~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~ 272 (331)
++|+|||.+--+ +++. +-...++|-.+..+|+..+..++-.+|.|.|+.+++.|+.|++. . +.++
T Consensus 840 l~lIDfG~siDm~lfp~~~---~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~-------q--~~~g 907 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGT---KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM-------E--VKNG 907 (974)
T ss_pred eEEEecccceeeeEcCCCc---EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH-------H--hcCC
Confidence 899999997533 3331 22224578899999999999999999999999999999999863 1 1111
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.. ..++..+ +-....+. ..++...+|+.|=..=|...++...|+..+.
T Consensus 908 ~~-~~~~~~~----~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 908 SS-WMVKTNF----PRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred cc-eeccccc----hhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 11 1111111 11111122 3455666666555555777787777777653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=145.00 Aligned_cols=131 Identities=18% Similarity=0.214 Sum_probs=107.1
Q ss_pred ceee-cCcEEEEEEeCCceEEEEEeCCCCCc-c------hhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 61 VIAS-EHYKLYKGFLENRPISVMKFGDNYSE-N------GENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~-~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
.||+ ++|.||+|.+++..+++|........ . ....+.+|+.++..++|+++.....++.+.+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3788 89999999999999999986643211 0 13557789999999998876665555666777899999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
+++|.+.+.... . .++.+++.+|.+|| ..+++|+|++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN-----D-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH-----H-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998874321 0 68999999999999 99999999999999999 799999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.9e-18 Score=146.94 Aligned_cols=140 Identities=14% Similarity=0.109 Sum_probs=107.6
Q ss_pred CccccCceee-cCcEEEEEE-e--CCceEEEEEeCCCCCcc-----------------------hhHHHHHHHHHHHhcC
Q 020078 55 NYNGHQVIAS-EHYKLYKGF-L--ENRPISVMKFGDNYSEN-----------------------GENFCFNNIVFAAQMN 107 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~-~--~~~~vavK~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~ 107 (331)
.|.....||+ ++|.||+|. . ++..||+|.+....... ....+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4778889999 999999998 3 88999999987542110 0123568999999997
Q ss_pred CCc--eeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeeCCCC
Q 020078 108 HRN--ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP-IVFKDIK 184 (331)
Q Consensus 108 h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivHrdlk 184 (331)
+.. +.+.+++ ...++||||+++++|....... ..+.......++.|++.++.+|| ..+ ++|||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCC
Confidence 532 3333332 2358999999998887654322 23455567889999999999999 888 9999999
Q ss_pred CCceEEcCCCceEEccCCCcccc
Q 020078 185 LSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 185 ~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|+||+++ ++.++|+|||.+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 789999999988754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-18 Score=164.15 Aligned_cols=138 Identities=15% Similarity=0.186 Sum_probs=113.6
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCC-CCc------chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDN-YSE------NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~-~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
...|...+.||+ ++|.||+|.+.+..+++|+.... ... ...+.+.+|+.++..++|++|+....++.+.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445566789999 99999999997777766654322 111 1135688999999999999999888888777788
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++++|.+++. ....++.+++.+|.+|| +.+++|||+||+|||+ .++.++|+|||++
T Consensus 412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla 474 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG 474 (535)
T ss_pred EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence 99999999999988873 34678999999999999 9999999999999999 5788999999998
Q ss_pred ccc
Q 020078 205 EYI 207 (331)
Q Consensus 205 ~~~ 207 (331)
+..
T Consensus 475 ~~~ 477 (535)
T PRK09605 475 KYS 477 (535)
T ss_pred ccC
Confidence 753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-18 Score=168.11 Aligned_cols=209 Identities=21% Similarity=0.257 Sum_probs=141.6
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..+|+..+.|.- .+|.||..+. ..+.+|. ++++.. .+++. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccc------hhhhc--cccccCCccee-----------------
Confidence 467888888888 8889999977 5778888 443321 11111 22222333333
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+=...+..- .+++. +++.++.||| +.+|+|||+||+|.+|..-|.+|+.|||+++....
T Consensus 136 ----gDc~tllk~~-----g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-----GPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhcccC-----CCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 3444444322 23332 2377899999 99999999999999999999999999999875432
Q ss_pred CCcc-------------ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc
Q 020078 210 GETH-------------VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE 276 (331)
Q Consensus 210 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 276 (331)
.... .....++||+.|.|||++....|...+|.|++|+++||.+-|+.||.... ..+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt----------pee 265 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----------PEE 265 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC----------HHH
Confidence 2111 12334579999999999999999999999999999999999999974321 111
Q ss_pred ccccccccCCCCchH-HHHHHHHHHHHHHhccCCCCCCCCHH
Q 020078 277 IVDPIVVEDKSCPEK-EQQLQALLQLIFECVNESAGDRPTMV 317 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~Rps~~ 317 (331)
++...+.....+|+. ...++++.+++.++|+.+|..|.-..
T Consensus 266 lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 111112111111111 13346899999999999999997433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.8e-17 Score=136.86 Aligned_cols=145 Identities=12% Similarity=0.058 Sum_probs=110.0
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc---------------------chhHHHHHHHHHH
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE---------------------NGENFCFNNIVFA 103 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l 103 (331)
+++......|...+.||+ ++|.||++.. +++.||||.+...... .....+.+|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444444777889999 9999999988 7899999987643210 0112366789999
Q ss_pred HhcCCCc--eeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeC
Q 020078 104 AQMNHRN--ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181 (331)
Q Consensus 104 ~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHr 181 (331)
..+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++| ..+++||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~ 149 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHG 149 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcC
Confidence 9998874 444443 2456899999999998765421 233568899999999999 8999999
Q ss_pred CCCCCceEEcCCCceEEccCCCccccCC
Q 020078 182 DIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 182 dlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
||+|+||+++.++.++|+|||.+..+..
T Consensus 150 Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 150 DLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-15 Score=121.24 Aligned_cols=133 Identities=13% Similarity=0.112 Sum_probs=110.4
Q ss_pred cCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC--CceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 59 HQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH--RNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
.+.+|. +++.||++..++..+++|....... ...+.+|+..+..++| .++.+++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 356788 7889999999888999999765432 4578899999999986 589999999888888999999999877
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
+..+ +......++.++++++.++|.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 80 ~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7543 3456677899999999999943235799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.9e-15 Score=131.04 Aligned_cols=136 Identities=16% Similarity=0.137 Sum_probs=105.0
Q ss_pred cCcee-e-cCcEEEEEEeCCceEEEEEeCCCC------------CcchhHHHHHHHHHHHhcCCCce--eeeEeEEeeCC
Q 020078 59 HQVIA-S-EHYKLYKGFLENRPISVMKFGDNY------------SENGENFCFNNIVFAAQMNHRNI--LKLIGCCIETE 122 (331)
Q Consensus 59 ~~~ig-~-~~g~Vy~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~~ 122 (331)
..++| . |.|+||.....+..+++|.+.... .......+.+|+.++..|+|++| +..+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 45687 4 888999999999999999875321 01123567889999999998875 66666654322
Q ss_pred c----cEEEEEecCC-CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 123 I----PILVFEFVEY-GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 123 ~----~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
. .++|||++++ .+|.+++... .++.. .+.+++.++.+|| +.+|+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence 2 3599999997 6898887532 24433 3578999999999 99999999999999999888999
Q ss_pred EccCCCcccc
Q 020078 198 LSDFSESEYI 207 (331)
Q Consensus 198 l~Dfg~a~~~ 207 (331)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-17 Score=161.44 Aligned_cols=255 Identities=15% Similarity=0.169 Sum_probs=184.9
Q ss_pred cCccccCceee-cCcEEEEEEe---CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 127 (331)
..|....-||+ .++.|-.... ....+|.|.+.... ..........|..+-..+. |+|++.+++...+.+..++.
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34555566888 7777666555 44556666665443 2223445556888888887 99999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEY 206 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~ 206 (331)
++|..+|++.+.+..... ...+......+..|+..++.|+|. ..++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988832211 234455667789999999999995 56899999999999999999 999999999988
Q ss_pred cCC-CCccccccccCC-CCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 207 IPE-GETHVTSHMLTR-TKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ .........
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-----~~~~~~~~~-- 247 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-----RYSSWKSNK-- 247 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-----cceeecccc--
Confidence 776 444444444568 9999999999874 456789999999999999999998643332221 111111111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl 320 (331)
.......+........+++.+++..+|+.|.+..++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 0000111114445688999999999999999988764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.3e-15 Score=125.77 Aligned_cols=136 Identities=15% Similarity=0.158 Sum_probs=95.9
Q ss_pred cCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-chhHHH----------------------HHHHHHHHhcCCCc--e
Q 020078 59 HQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-NGENFC----------------------FNNIVFAAQMNHRN--I 111 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~----------------------~~E~~~l~~l~h~n--I 111 (331)
.+.||+ ++|.||+|.. +++.||||.+...... .....+ ..|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357899 9999999998 5899999988654221 011111 34566666665433 3
Q ss_pred eeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEE
Q 020078 112 LKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILF 190 (331)
Q Consensus 112 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill 190 (331)
.+.+++ ...++||||++++++........ .. ......++.+++.++.++| . .+|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEE
Confidence 334433 24689999999865432211110 01 1566789999999999999 7 899999999999999
Q ss_pred cCCCceEEccCCCccccC
Q 020078 191 DEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~ 208 (331)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.6e-15 Score=131.44 Aligned_cols=204 Identities=17% Similarity=0.237 Sum_probs=139.5
Q ss_pred HHHHhcCCCceeeeEeEEeeC-----CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 020078 101 VFAAQMNHRNILKLIGCCIET-----EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR 175 (331)
Q Consensus 101 ~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 175 (331)
+.|-++-|.|||++..++.+. ....++.||+..|++..+|....... ..+......+|+.||..||.||| +|+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLh-s~~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLH-SCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhh-ccC
Confidence 355677799999999988763 34678999999999999998654322 45667777899999999999999 458
Q ss_pred CCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc--ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHH
Q 020078 176 RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253 (331)
Q Consensus 176 ~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~ 253 (331)
.+|+|+++.-+.|.+..++-+|++.-.-......-... .....-.+-++|.|||+-..-..+.++|||+||....+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 89999999999999999888887643221111110000 0111122678899999877777888999999999999998
Q ss_pred hCCCC-ChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 254 TGRRD-NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 254 ~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+..- ......+.... . +...+.. ... .-=+.++.+|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~~~ee---~----ia~~i~~-len-------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEE---N----IANVIIG-LEN-------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhh---h----hhhheee-ccC-------ccccCcCcccccCCCCCCcchhhhhc
Confidence 87642 21111111000 0 0000000 000 01346899999999999999998864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=6.8e-13 Score=124.76 Aligned_cols=141 Identities=13% Similarity=0.113 Sum_probs=99.6
Q ss_pred cCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcch---------------------------------------hHHHH
Q 020078 59 HQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENG---------------------------------------ENFCF 97 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~---------------------------------------~~~~~ 97 (331)
.+.||. ++|.||+|+. +|+.||||+..++....- .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467899 9999999999 899999999876532100 01355
Q ss_pred HHHHHHHhcC----CCceeeeEeEEee-CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHH-HHHHhh
Q 020078 98 NNIVFAAQMN----HRNILKLIGCCIE-TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN-AMAYIH 171 (331)
Q Consensus 98 ~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH 171 (331)
+|...+.+++ |.+-+.+..++.+ ....+|||||+++++|.+...... .... +..++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH
Confidence 5666666552 3333444444432 345789999999999988764211 1122 2446666665 367888
Q ss_pred cCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 172 IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 172 ~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
..+++|+|++|.||+++.++.++++|||++..++.
T Consensus 275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 88999999999999999999999999999887653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-12 Score=121.97 Aligned_cols=172 Identities=19% Similarity=0.191 Sum_probs=128.7
Q ss_pred EEEE-EEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCC
Q 020078 68 KLYK-GFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPH 144 (331)
Q Consensus 68 ~Vy~-~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 144 (331)
.+|. |.. ++.+|.|........ .......+.++.|+.++||||++++..++.....|||+|-+. -|..++..
T Consensus 26 a~~~~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-- 100 (690)
T KOG1243|consen 26 ALWPDGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-- 100 (690)
T ss_pred ccccccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--
Confidence 4553 444 788899988876655 356678889999999999999999999999999999999873 57667743
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCc
Q 020078 145 GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224 (331)
Q Consensus 145 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 224 (331)
+......-.+.||+.||.|||. +.+++|++|.-..|.++..|..||++|.++........ .......-..
T Consensus 101 ------l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s 170 (690)
T KOG1243|consen 101 ------LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIES 170 (690)
T ss_pred ------hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhc
Confidence 3344555568999999999985 77999999999999999999999999987644322211 0000111223
Q ss_pred ccchhhhccCCCCCcccchhhHHHHHHHHhCC
Q 020078 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256 (331)
Q Consensus 225 y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~ 256 (331)
|..|+.+.... ...|.|-||+++++++.|.
T Consensus 171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 56666543332 3569999999999999993
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=7.4e-12 Score=102.69 Aligned_cols=124 Identities=18% Similarity=0.077 Sum_probs=91.7
Q ss_pred eee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceee-eEeEEeeCCccEEEEEecCCCChhhh
Q 020078 62 IAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILK-LIGCCIETEIPILVFEFVEYGTLADR 139 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lv~e~~~~g~L~~~ 139 (331)
+++ .++.||++...+..+++|....... ....+.+|+.++..+.+.++++ ++.+. ....++||||+++.++.+.
T Consensus 6 l~~G~~~~vy~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 6 LKGGMTNKNYRVEVANKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE 81 (170)
T ss_pred cCCcccCceEEEEECCeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc
Confidence 444 5668999999999999999765432 2335678999999987655543 44443 3346899999999887543
Q ss_pred hcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 140 ICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP-----IVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 140 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
. . . ...++.+++++|..|| ..+ ++|+|++|.||+++ ++.++++||+.+..
T Consensus 82 ~--------~-~----~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D--------F-S----DPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c--------c-c----CHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 1 0 1 1235678999999999 665 59999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.1e-13 Score=123.34 Aligned_cols=245 Identities=18% Similarity=0.153 Sum_probs=175.3
Q ss_pred hcCccccCceee-cCcEEEEEEe---CCceEEEEEeCCCCCcc-hhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNYSEN-GENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 126 (331)
+..|.....||. .|+.|++... ++..+++|.+.+..... +...-+.|+.+...+. |.|++.++..+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 456777778888 8888887765 67889999887664432 2333456777777774 9999998888888888888
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCCCcc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESE 205 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~a~ 205 (331)
--|||.++++...+... ..+....++.+..+++.++.++| .+.++|+|+||+||++..+ +..+++|||++.
T Consensus 344 p~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred chhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence 89999999887766221 34667788899999999999999 9999999999999999886 889999999986
Q ss_pred ccCCCCccccccccCCCCccc--chhhhccCCCCCcccchhhHHHHHHHHhCCCCC-hhHHHHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYL--APEYILTGLCNEKTDVFCFGMLLLELLTGRRDN-ILLEHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
.+.-.... ..+.-.+. +|.......+..++|++|||..+.+.+++.+-- ....+ ..+.....
T Consensus 416 ~~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----------~~i~~~~~ 480 (524)
T KOG0601|consen 416 RLAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----------LTIRSGDT 480 (524)
T ss_pred ccceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCcccccc----------eeeecccc
Confidence 43211111 11233334 555555667889999999999999999987621 11111 11111111
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
... .+....+..+.+.+...+|..||++.++....+-.
T Consensus 481 p~~------~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 481 PNL------PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred cCC------CchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111 12235788899999999999999998877655433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-12 Score=120.95 Aligned_cols=243 Identities=18% Similarity=0.177 Sum_probs=171.5
Q ss_pred ccccCceee---cCcEEEEEEe----CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEE
Q 020078 56 YNGHQVIAS---EHYKLYKGFL----ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 56 ~~~~~~ig~---~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~l 126 (331)
|....-+|. ++|.||.+.. .+..+|+|+-+.... ......-.+|+...++++ |+|.++.+..+++.+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 444455555 5668998877 567899988543322 112334456777777775 9999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN----AMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDF 201 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Df 201 (331)
-+|+|. .+|..+-..... -++....+....+..+ ||.++| ..+++|-|+||.||.+..+ ...++.||
T Consensus 196 qtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCc
Confidence 999985 588777766542 2556666777777777 999999 9999999999999999998 88999999
Q ss_pred CCccccCCCCccccc--ccc-CCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh---HHHHHHHhhccccc
Q 020078 202 SESEYIPEGETHVTS--HML-TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL---LEHVKKHVENNRLG 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~--~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---~~~~~~~~~~~~~~ 275 (331)
|+...+......... ... .|...|++||+. .+.++...|+||+|.+..+..++-.+... ..|. +.+..
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-----~~r~~ 341 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-----QLRQG 341 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-----ccccc
Confidence 998877665422111 111 366779999976 67788999999999999998887654211 1111 00100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. +...+ | ...+.++...+.++++.+|-.|+++..+.+
T Consensus 342 ~-----ip~e~-~---~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 342 Y-----IPLEF-C---EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c-----Cchhh-h---cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 11111 1 022345667999999999999999988764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-10 Score=97.07 Aligned_cols=133 Identities=11% Similarity=0.098 Sum_probs=92.2
Q ss_pred ceee-cCcEEEEEEeC--------CceEEEEEeCCCCC---------------------cchhHHHH----HHHHHHHhc
Q 020078 61 VIAS-EHYKLYKGFLE--------NRPISVMKFGDNYS---------------------ENGENFCF----NNIVFAAQM 106 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~--------~~~vavK~~~~~~~---------------------~~~~~~~~----~E~~~l~~l 106 (331)
.||. .-+.||.|... +..+|+|....... ......+. +|...|.++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566 55689999873 36899998632110 11122333 899999998
Q ss_pred CC--CceeeeEeEEeeCCccEEEEEecCCCChhh-hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeCC
Q 020078 107 NH--RNILKLIGCCIETEIPILVFEFVEYGTLAD-RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYI-HIGFRRPIVFKD 182 (331)
Q Consensus 107 ~h--~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivHrd 182 (331)
.. -++...+++ ...+|||||+.++.+.. .+.. ..++..+...+..+++.+|..+ | ..+|||+|
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD 150 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD 150 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 53 455556654 45679999997644422 1211 1234455677889999999988 8 88999999
Q ss_pred CCCCceEEcCCCceEEccCCCcccc
Q 020078 183 IKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 183 lk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|++.|||++. +.+.++|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 67999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.1e-12 Score=120.53 Aligned_cols=144 Identities=14% Similarity=0.083 Sum_probs=94.0
Q ss_pred CccccCceee-cCcEEEEEEe-C-CceEEEEEeCCCCCcc---------------------------------hh-----
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-E-NRPISVMKFGDNYSEN---------------------------------GE----- 93 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~-~~~vavK~~~~~~~~~---------------------------------~~----- 93 (331)
.|+. ..+|. ++|.||+|+. + |+.||||...++.... -.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 67898 9999999998 4 8999999997652110 00
Q ss_pred -HHHHHHHHHHHhcC----CCceeeeEeEEee-CCccEEEEEecCCCChhhhhcC-CCCCCCCCCCHHHHHHHHHHHHHH
Q 020078 94 -NFCFNNIVFAAQMN----HRNILKLIGCCIE-TEIPILVFEFVEYGTLADRICS-PHGPHLEPLLWRHRLKIAMEIGNA 166 (331)
Q Consensus 94 -~~~~~E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~ 166 (331)
-++.+|+..+.+++ +.+.+.+..++.+ ....+|||||++|+.+.+...- ..+.....+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 12455555555553 4444555555543 3456799999999999774311 111000112222222333333
Q ss_pred HHHhhcCCCCCeeeCCCCCCceEEcCCC----ceEEccCCCccccCC
Q 020078 167 MAYIHIGFRRPIVFKDIKLSQILFDEYN----VAKLSDFSESEYIPE 209 (331)
Q Consensus 167 l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~Dfg~a~~~~~ 209 (331)
. ..+++|+|++|.||+++.++ .++++|||+...++.
T Consensus 277 ----f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 56899999999999999888 999999999887754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.6e-11 Score=120.95 Aligned_cols=246 Identities=17% Similarity=0.120 Sum_probs=160.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+.|.+.+-+.. .++.++.+.- .+...+.|...... .....+....+-.++-.-++|.++...-.+......+|++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 34444444444 5556665544 33333333322111 1111222333333333345566666555555567788999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
+|..+|+|...++.... ....-.......+..++.||| ...++|+|++|.|+++..++..++.||++.....
T Consensus 884 ~~~~~~~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC-----LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred HHhccCCchhhhhcCCC-----cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999876542 222222335566888899999 7779999999999999999999999998433221
Q ss_pred C------C---------------C------c--cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCC
Q 020078 209 E------G---------------E------T--HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 209 ~------~---------------~------~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
. . . . ........+|+.|.+||...+......+|.|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 0 01123346899999999999999999999999999999999999996
Q ss_pred hhHHHHHHHhhccccccccccccccCCCCchHH-HHHHHHHHHHHHhccCCCCCCCCHH
Q 020078 260 ILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE-QQLQALLQLIFECVNESAGDRPTMV 317 (331)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~dP~~Rps~~ 317 (331)
... ....+++.++..+..+|... ..+.++.+++...+..+|.+|..|.
T Consensus 1036 na~----------tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAE----------TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCc----------chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 433 33334444444444443322 4456799999999999999998876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.1e-10 Score=94.79 Aligned_cols=140 Identities=17% Similarity=0.195 Sum_probs=104.9
Q ss_pred ceee-cCcEEEEEEeCC-ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC--CceeeeEeEEeeCC---ccEEEEEecCC
Q 020078 61 VIAS-EHYKLYKGFLEN-RPISVMKFGDNYSENGENFCFNNIVFAAQMNH--RNILKLIGCCIETE---IPILVFEFVEY 133 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~---~~~lv~e~~~~ 133 (331)
.++. ..+.||++...+ ..+++|.............+.+|..++..+++ .++.+++.+..... ..++||||+++
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 3555 566999998854 89999997654332245678899999999976 34566777766542 56899999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG---------------------------------------- 173 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 173 (331)
.++.+.+.. ..++......++.+++++|..||+.
T Consensus 85 ~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 85 RVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 888776532 2366677778888888888888841
Q ss_pred -------------CCCCeeeCCCCCCceEEcC--CCceEEccCCCccc
Q 020078 174 -------------FRRPIVFKDIKLSQILFDE--YNVAKLSDFSESEY 206 (331)
Q Consensus 174 -------------~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~ 206 (331)
....++|+|+.|.||+++. ++.+.++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1245799999999999998 56789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.6e-09 Score=87.72 Aligned_cols=129 Identities=19% Similarity=0.237 Sum_probs=93.0
Q ss_pred eee-cCcEEEEEEeCCceEEEEEeC-CCCCcch------hHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 62 IAS-EHYKLYKGFLENRPISVMKFG-DNYSENG------ENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~~~~vavK~~~-~~~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+++ .-..+|.+.+.|.++++|.=. +..-... ...-.+|+.++.+++--.|..-.=+..+.+...|+|||+++
T Consensus 4 i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G 83 (204)
T COG3642 4 IKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEG 83 (204)
T ss_pred hhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCC
Confidence 445 344788887777777776532 3222111 34566799999988644443333344466677899999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
-.|.+.+... ...++..+..-+.-|| ..+|+|+||.++|+++.... +.++|||++.+
T Consensus 84 ~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 84 ELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred hhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 8888888542 2457788888889999 99999999999999998754 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-09 Score=88.59 Aligned_cols=143 Identities=19% Similarity=0.190 Sum_probs=102.9
Q ss_pred ccCceee-cCcEEEEEEeCCceEEEEE-eCCCCCc------chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 58 GHQVIAS-EHYKLYKGFLENRPISVMK-FGDNYSE------NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~~~~~vavK~-~~~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
...++-+ .-+.|+++.+.|+..+||. +.+.... -......+|++.|.++.--.|..-.-++.+.+.-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3445556 4458999999999988874 4333221 124567789999999875555444445566777789999
Q ss_pred ecCC-CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC---ceEEccCCCcc
Q 020078 130 FVEY-GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLSDFSESE 205 (331)
Q Consensus 130 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfg~a~ 205 (331)
|+++ .++.+++.+... ..........++..|.+.+.-|| ...|||+||..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 9975 478888875432 12222333678999999999999 99999999999999996554 45899999975
Q ss_pred c
Q 020078 206 Y 206 (331)
Q Consensus 206 ~ 206 (331)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.9e-09 Score=94.68 Aligned_cols=141 Identities=10% Similarity=-0.007 Sum_probs=99.8
Q ss_pred Cceee-cCcEEEEEEeCCceEEEEEeCCCCCcchh----------HHHHHHHHHHHhcCCCc--eeeeEeEEee-----C
Q 020078 60 QVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGE----------NFCFNNIVFAAQMNHRN--ILKLIGCCIE-----T 121 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~n--Iv~l~~~~~~-----~ 121 (331)
.++-. ....|++....|+.+.||........... ..+.+|...+.+|...+ +...+++... .
T Consensus 28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 34444 33357788889999999987543211011 14778999888885333 3334444433 2
Q ss_pred CccEEEEEecCCC-ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-------C
Q 020078 122 EIPILVFEFVEYG-TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-------Y 193 (331)
Q Consensus 122 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-------~ 193 (331)
...+||+|++++. +|.+++..... .+.+...+..++.+++..+.-|| ..+|+|+|+++.|||++. +
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCC
Confidence 3468999999875 78888753211 23455677789999999999999 999999999999999975 4
Q ss_pred CceEEccCCCccc
Q 020078 194 NVAKLSDFSESEY 206 (331)
Q Consensus 194 ~~~kl~Dfg~a~~ 206 (331)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-08 Score=92.68 Aligned_cols=215 Identities=14% Similarity=0.136 Sum_probs=147.3
Q ss_pred cEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEe----eCCccEEEEEecCC-CChhhh
Q 020078 67 YKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCI----ETEIPILVFEFVEY-GTLADR 139 (331)
Q Consensus 67 g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~ 139 (331)
.+.|++.. +|..+++|+++..... ....-..-+++.+++.|+|+|++..++. ++...++||+|.|+ ++|.++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred ceeEeeeeccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 37899987 8999999999433222 2222334577899999999999998887 34568899999875 577766
Q ss_pred hcCCCC-C---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 140 ICSPHG-P---------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 140 l~~~~~-~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
-..... . ....+++...|.++.|+..||.++| +.++.-+=|.+.+||++.+.+++++..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 543211 0 1134678899999999999999999 78888899999999999998999998887765544
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
+.... +.. ..+-|.=.||.++..|.+|..-..-.....+. .... +
T Consensus 446 d~~~~----------------le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----~~~~-----I------- 490 (655)
T KOG3741|consen 446 DPTEP----------------LES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS----HLTR-----I------- 490 (655)
T ss_pred CCCcc----------------hhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH----HHHH-----h-------
Confidence 33110 110 12457778999999999996431100000000 0000 0
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+.++.+++.-....++++ -+..+++..
T Consensus 491 -~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 -TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1144567888888888888887 567776655
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=7.1e-09 Score=86.06 Aligned_cols=126 Identities=14% Similarity=0.142 Sum_probs=80.4
Q ss_pred EEEEEEe-CCceEEEEEeCCCCCc-------------------------chhHHHHHHHHHHHhcCCC--ceeeeEeEEe
Q 020078 68 KLYKGFL-ENRPISVMKFGDNYSE-------------------------NGENFCFNNIVFAAQMNHR--NILKLIGCCI 119 (331)
Q Consensus 68 ~Vy~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~ 119 (331)
.||.|.. ++..+|+|........ .......+|...|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998 7889999986432110 0134577899999999755 455565442
Q ss_pred eCCccEEEEEecC--CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 120 ETEIPILVFEFVE--YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAY-IHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 120 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
...|||||++ +..+..+.... +.......++.+++..+.. +| ..+|+|+||.+.|||++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eE
Confidence 3569999998 54443333211 1123345567777775544 57 8999999999999999987 99
Q ss_pred EEccCCCccccC
Q 020078 197 KLSDFSESEYIP 208 (331)
Q Consensus 197 kl~Dfg~a~~~~ 208 (331)
.++|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.5e-08 Score=87.97 Aligned_cols=199 Identities=17% Similarity=0.176 Sum_probs=129.6
Q ss_pred cEEEEEecCCC-ChhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 124 PILVFEFVEYG-TLADRICSPH-GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 124 ~~lv~e~~~~g-~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
.-+.|..+++- -+..+..... +.+..-+.|...+..++.++.+.+-|| ..+.+-+|+.++|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence 44566666542 2333333222 233345789999999999999999999 888899999999999999999999985
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccC-----CCCCcccchhhHHHHHHHHhC-CCCChhHHHH-------HHH
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-----LCNEKTDVFCFGMLLLELLTG-RRDNILLEHV-------KKH 268 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~el~~g-~~p~~~~~~~-------~~~ 268 (331)
..-..-. +.....+ -+|...|.+||.-.-+ .-+...|.|.||+++++++.| +.||..+... ...
T Consensus 162 Dsfqi~~-ng~~~~c--pVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINA-NGTLHLC--PVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeecc-CCceEec--ccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 5433222 2222222 3488999999976522 346789999999999999887 7776221100 000
Q ss_pred hhccccccccc---cccccCCCCchHHHHHHHHHHHHHHhccCC--CCCCCCHHHHHHHHHHHHHh
Q 020078 269 VENNRLGEIVD---PIVVEDKSCPEKEQQLQALLQLIFECVNES--AGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 269 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--P~~Rps~~evl~~L~~~~~~ 329 (331)
+..+......+ .....+...|. .-.++++..|..+|+... |.-|||++..+..|..+.++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111111111 11222223333 245678899999998765 67899999999999887654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.3e-09 Score=103.77 Aligned_cols=150 Identities=19% Similarity=0.231 Sum_probs=99.8
Q ss_pred HHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc-------ccccccCCCCcccchhhhcc
Q 020078 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH-------VTSHMLTRTKRYLAPEYILT 233 (331)
Q Consensus 161 ~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~ 233 (331)
.+++.|+.|+|. +.++||++|.|++|.++.++..|++.|+...-....... ...........|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999995 678999999999999999999999999876543321110 01111224567999999999
Q ss_pred CCCCCcccchhhHHHHHHHHhCCCC-ChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCC
Q 020078 234 GLCNEKTDVFCFGMLLLELLTGRRD-NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD 312 (331)
Q Consensus 234 ~~~~~~~Dv~SlG~~l~el~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~ 312 (331)
...+.++|+||+|+++|-+..|..+ +.........-...... +.... -.....+.++.+=+.+++..++.-
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---~~~~~-----~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---NAGAF-----GYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---ccccc-----cccccCcHHHHHHHHHHhcCCccc
Confidence 8889999999999999999855443 11110000000000000 00000 000245568999999999999999
Q ss_pred CCCHHHHH
Q 020078 313 RPTMVYAA 320 (331)
Q Consensus 313 Rps~~evl 320 (331)
||++.++.
T Consensus 256 rp~~~~l~ 263 (700)
T KOG2137|consen 256 RPTLDLLL 263 (700)
T ss_pred Ccchhhhh
Confidence 99877764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.1e-07 Score=78.92 Aligned_cols=107 Identities=15% Similarity=0.093 Sum_probs=82.0
Q ss_pred hHHHHHHHHHHHhcCCC--ceeeeEeEEeeCC----ccEEEEEecCCC-ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHH
Q 020078 93 ENFCFNNIVFAAQMNHR--NILKLIGCCIETE----IPILVFEFVEYG-TLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165 (331)
Q Consensus 93 ~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 165 (331)
...+.+|...+..|... .+.+.+++.+... ..+||+|++++. +|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 44677888888877533 3445556655532 347999999874 7888886532 2445667889999999
Q ss_pred HHHHhhcCCCCCeeeCCCCCCceEEcCCC---ceEEccCCCcccc
Q 020078 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLSDFSESEYI 207 (331)
Q Consensus 166 ~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfg~a~~~ 207 (331)
.+.-|| ..+|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 130 ~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999999999877 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.57 E-value=8.1e-07 Score=76.50 Aligned_cols=132 Identities=17% Similarity=0.073 Sum_probs=90.2
Q ss_pred cccCceee-cCcEEEEEEe-CCceEEEEEeCCCCC---------------------cchhHHHHHHHHHHHhcCCC--ce
Q 020078 57 NGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYS---------------------ENGENFCFNNIVFAAQMNHR--NI 111 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--nI 111 (331)
..+..||- .-+.||.|.. .|.++|+|.-.-... .-.+....+|...|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34566777 6669999999 699999986321110 01244677899999998644 55
Q ss_pred eeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc
Q 020078 112 LKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191 (331)
Q Consensus 112 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~ 191 (331)
.+-+++ +.-.+||||+.+-.|...= +.....-.++..|++-+.-+- ..+|||+|+.+-||+++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~ 236 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVT 236 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEe
Confidence 555544 4556999999875553322 122233345555555555444 67899999999999999
Q ss_pred CCCceEEccCCCcc
Q 020078 192 EYNVAKLSDFSESE 205 (331)
Q Consensus 192 ~~~~~kl~Dfg~a~ 205 (331)
++|.+.++||-.+.
T Consensus 237 ~dg~~~vIDwPQ~v 250 (304)
T COG0478 237 EDGDIVVIDWPQAV 250 (304)
T ss_pred cCCCEEEEeCcccc
Confidence 99999999996553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.8e-08 Score=93.99 Aligned_cols=178 Identities=15% Similarity=0.061 Sum_probs=126.8
Q ss_pred eee-cCcEEEEEEeCCc-eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc-eeeeEeEEeeCCccEEEEEecCCC-Chh
Q 020078 62 IAS-EHYKLYKGFLENR-PISVMKFGDNYSENGENFCFNNIVFAAQMNHRN-ILKLIGCCIETEIPILVFEFVEYG-TLA 137 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~g-~L~ 137 (331)
.++ ..+++||.+-..+ ....+.+... ....-++++|.+++||| .+..++.+..++..+++++++..| +-.
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 344 5566777665322 2223333221 34556888999999999 777788888888899999999877 333
Q ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcccccc
Q 020078 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217 (331)
Q Consensus 138 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 217 (331)
..+.... ..+...+...+++.-.++++++| +..=+|+| ||+..+ +..+..||+....+.... ...
T Consensus 324 ~~~~~se----~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~ 388 (829)
T KOG0576|consen 324 LEMTVSE----IALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPR 388 (829)
T ss_pred ccCChhh----Hhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc---ccc
Confidence 3222111 23444556667788889999999 55568888 776665 778999999987775543 233
Q ss_pred ccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCCh
Q 020078 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 218 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
+..+++.|+|||+...+.+....|+|++|+--.++.-|.+|..
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3568999999999999999999999999987778888887743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=73.16 Aligned_cols=135 Identities=12% Similarity=0.043 Sum_probs=99.2
Q ss_pred cCcEEEEEEeCCceEEEEEeCCCCC-----cchhHHHHHHHHHHHhcCCCc--eeeeEeEEe-eC----CccEEEEEecC
Q 020078 65 EHYKLYKGFLENRPISVMKFGDNYS-----ENGENFCFNNIVFAAQMNHRN--ILKLIGCCI-ET----EIPILVFEFVE 132 (331)
Q Consensus 65 ~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~-~~----~~~~lv~e~~~ 132 (331)
|-+.|+.-...|..+-+|+-.+... ......|.+|...|.+|..-+ +.+.. ++. .. -..+||+|-++
T Consensus 30 G~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~ 108 (216)
T PRK09902 30 GMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMA 108 (216)
T ss_pred CcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCC
Confidence 6668999888888899998753211 225678999999999986332 33333 322 11 23579999876
Q ss_pred C-CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc--eEEccCCCccc
Q 020078 133 Y-GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV--AKLSDFSESEY 206 (331)
Q Consensus 133 ~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfg~a~~ 206 (331)
+ -+|.+++.... ..+.+...+..+..+++..+.-|| +.++.|+|+-+.||+++.++. +.++||.-++.
T Consensus 109 g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 109 GFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 3 47877764421 134567777899999999999999 999999999999999986666 99999986553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.50 E-value=4.3e-06 Score=69.68 Aligned_cols=105 Identities=19% Similarity=0.230 Sum_probs=82.4
Q ss_pred HHHHHHHHhcCC-CceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 020078 97 FNNIVFAAQMNH-RNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR 175 (331)
Q Consensus 97 ~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 175 (331)
.+|.-++..+++ +++.+++|+|- .++|.||.+.+++...-.... ..-..+|..+.+|+.++++.+.+|+++..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888999986 69999999993 357999998776643210000 00236799999999999999999997655
Q ss_pred CCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 176 RPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 176 ~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
..+.-.|++++|+.+++++.+|++|...+...
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 67888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.9e-06 Score=70.10 Aligned_cols=152 Identities=15% Similarity=0.091 Sum_probs=101.8
Q ss_pred cCHHHHHHHhcCccccCceee-cCc---EEEEEEe-CCceEEEEEeCCCCCcc-----------------------hhHH
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHY---KLYKGFL-ENRPISVMKFGDNYSEN-----------------------GENF 95 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g---~Vy~~~~-~~~~vavK~~~~~~~~~-----------------------~~~~ 95 (331)
.+...+..+.....+....|. +.| .||+|.. ++..+|+|++....... ...+
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 566777777777778888887 777 7999987 78999999975432210 1234
Q ss_pred HHHHHHHHHhcC--CCceeeeEeEEeeCCccEEEEEecCCC-ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 020078 96 CFNNIVFAAQMN--HRNILKLIGCCIETEIPILVFEFVEYG-TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI 172 (331)
Q Consensus 96 ~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 172 (331)
..+|...|.++. +-.+.+-+++. ...|||||+... .-.-.|.. -++.......+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 567888888774 33333444432 245999998643 11122211 122222455666777777766652
Q ss_pred CCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 173 GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 173 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
..++||+||..=|||+. ++.+.++|||-|....
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 47999999999999999 7999999999886554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.2e-05 Score=69.04 Aligned_cols=139 Identities=8% Similarity=0.064 Sum_probs=79.7
Q ss_pred ceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc--eeeeEeEEeeCCccEEEEEecCCCC-h
Q 020078 61 VIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN--ILKLIGCCIETEIPILVFEFVEYGT-L 136 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~-L 136 (331)
.||+ ..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++..+.+...+|||+++|.+ +
T Consensus 8 ~i~~G~t~~~y~~--~~~~~VlR~~~~~~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 8 QTGEGGNGESYTH--KTGKWMLKLYNPGF---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eecCCCCcceeEe--cCCCEEEEeCCCCC---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 4677 55589984 35677788876533 2345688999998886433 4566777777777889999998753 2
Q ss_pred hhhhcC------------------CCCCCCCCCCHHHHH-HHHH----------HHHHH-HHHhhc-CCCCCeeeCCCCC
Q 020078 137 ADRICS------------------PHGPHLEPLLWRHRL-KIAM----------EIGNA-MAYIHI-GFRRPIVFKDIKL 185 (331)
Q Consensus 137 ~~~l~~------------------~~~~~~~~l~~~~~~-~i~~----------~i~~~-l~~LH~-~~~~~ivHrdlk~ 185 (331)
...+.. -+.-........... .+.. .+... ..+|.. .....++|+|+.|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 111110 000000001100000 0000 00010 111111 1134578999999
Q ss_pred CceEEcCCCceEEccCCCcc
Q 020078 186 SQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 186 ~Nill~~~~~~kl~Dfg~a~ 205 (331)
.|+++++++ +.++||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.4e-05 Score=69.49 Aligned_cols=138 Identities=12% Similarity=-0.043 Sum_probs=83.1
Q ss_pred eecCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEecCCCChhhhhc
Q 020078 63 ASEHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYGTLADRIC 141 (331)
Q Consensus 63 g~~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 141 (331)
|+....||+...++..+.+|...... .....+|+.++..+. +--+.+++++...++..++|||+++|.+|.....
T Consensus 9 g~~~~~v~~~~~~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~ 84 (244)
T cd05150 9 GQSGATVYRLDGKNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAALWE 84 (244)
T ss_pred CCCcCeEEEEcCCCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHhhc
Confidence 33556899998877788888875432 235678999888884 3345567777766667889999999877764321
Q ss_pred -------------------CCCCCCCCCCCH--HHHHHH-----------------------HHHHHHHHHHhh-cCCCC
Q 020078 142 -------------------SPHGPHLEPLLW--RHRLKI-----------------------AMEIGNAMAYIH-IGFRR 176 (331)
Q Consensus 142 -------------------~~~~~~~~~l~~--~~~~~i-----------------------~~~i~~~l~~LH-~~~~~ 176 (331)
+..... .++.. ...... ..++...|.-.. .....
T Consensus 85 ~~~~~~~~~~l~~~l~~lH~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 163 (244)
T cd05150 85 ELEPERLVDALAEALRRLHALPVAD-CPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEEDL 163 (244)
T ss_pred ccCHHHHHHHHHHHHHHHhcCCccc-CCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCce
Confidence 110000 01110 000000 011111111100 01145
Q ss_pred CeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 177 PIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 177 ~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
.++|+|+.|.|||++.+....|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 68999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.9e-05 Score=66.60 Aligned_cols=136 Identities=14% Similarity=0.086 Sum_probs=90.1
Q ss_pred HhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHH---------HHHHHHHHHhcC---CCceeeeEeEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENF---------CFNNIVFAAQMN---HRNILKLIGCC 118 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~---------~~~E~~~l~~l~---h~nIv~l~~~~ 118 (331)
..++|...+++-. ....|.+-..++..+++|........ ..+. ..+++..+.+++ -.....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4566776666666 55678888889999999998765332 1111 223344444442 22333333333
Q ss_pred ee-----CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC
Q 020078 119 IE-----TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193 (331)
Q Consensus 119 ~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 193 (331)
+. ....+++|||++|-.|.+... ++. .++..+.+++.-|| ..++.|+|..|.|++++.+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC
Confidence 32 234568999999988866542 222 24466778899999 9999999999999999965
Q ss_pred CceEEccCCCcc
Q 020078 194 NVAKLSDFSESE 205 (331)
Q Consensus 194 ~~~kl~Dfg~a~ 205 (331)
+ ++++||+..+
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 5 8999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.3e-06 Score=77.84 Aligned_cols=140 Identities=16% Similarity=0.087 Sum_probs=89.5
Q ss_pred Cceee-cCcEEEEEEe-CCceEEEEEeCCCCCcc---------------------------------------hhHHHHH
Q 020078 60 QVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSEN---------------------------------------GENFCFN 98 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~---------------------------------------~~~~~~~ 98 (331)
.-++. +-|.||+|++ +|+.||||+..++..+. ..-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45666 8889999999 69999999987653321 0012344
Q ss_pred HHHHHHhcC----CCceeeeEeEEee-CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHH-HHHhhc
Q 020078 99 NIVFAAQMN----HRNILKLIGCCIE-TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA-MAYIHI 172 (331)
Q Consensus 99 E~~~l~~l~----h~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~-l~~LH~ 172 (331)
|...+.+++ ...=+.+-.+|.+ .....|+|||++|-.+.+...-.. ...+. ..++..++++ +..+-
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~---k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDR---KELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCH---HHHHHHHHHHHHHHHH-
Confidence 554444442 2222344444433 455679999999988887742111 12332 2233333332 12222
Q ss_pred CCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 173 GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 173 ~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
..+..|.|..|.||+++.++...+.|||....++.
T Consensus 283 --~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 45899999999999999999999999999877654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.2e-05 Score=77.48 Aligned_cols=75 Identities=9% Similarity=0.115 Sum_probs=51.5
Q ss_pred eee-cCcEEEEEEeCC----ceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCce--eeeEeEEeeC---CccEEEEEe
Q 020078 62 IAS-EHYKLYKGFLEN----RPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNI--LKLIGCCIET---EIPILVFEF 130 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~---~~~~lv~e~ 130 (331)
++. .+..+|.....+ ..+++|+............+.+|..+|..+. |+++ .+++++|.+. ...|+||||
T Consensus 46 l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~ 125 (822)
T PLN02876 46 FGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEY 125 (822)
T ss_pred eCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEe
Confidence 444 344788877643 4677777654332223457889999999995 6665 7778888764 357899999
Q ss_pred cCCCCh
Q 020078 131 VEYGTL 136 (331)
Q Consensus 131 ~~~g~L 136 (331)
+++..+
T Consensus 126 v~G~~~ 131 (822)
T PLN02876 126 LEGRIF 131 (822)
T ss_pred cCCccc
Confidence 987543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.12 E-value=7.8e-06 Score=82.71 Aligned_cols=199 Identities=17% Similarity=0.176 Sum_probs=133.8
Q ss_pred hHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc----EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 020078 93 ENFCFNNIVFAAQMNHRNILKLIGCCIETEIP----ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMA 168 (331)
Q Consensus 93 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 168 (331)
......|+..+..+.|+|++.++.|-...... .+..|+|..-++...+.+- ..++......+..++.+||.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~ 300 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLA 300 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHH
Confidence 34445577788899999999999887654322 2445778777777777654 35778888899999999999
Q ss_pred HhhcCCCCCeeeCCCCCC---ceEEcCCCceEEc--cCCCccccCCCCccccccccCCCCcccchhhhccCCCCC--ccc
Q 020078 169 YIHIGFRRPIVFKDIKLS---QILFDEYNVAKLS--DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNE--KTD 241 (331)
Q Consensus 169 ~LH~~~~~~ivHrdlk~~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~D 241 (331)
|+| .....|.-+..+ +-..+..+....+ ||+.++.+.+...... ...+..+.+||....+.... ..|
T Consensus 301 ~~h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~d 374 (1351)
T KOG1035|consen 301 YLH---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTD 374 (1351)
T ss_pred HHH---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhH
Confidence 999 555555444443 3334455556666 8888776655443222 22456688888887665544 479
Q ss_pred chhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 242 VFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 242 v~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+|.+|..+..+..|..+.......... +.. .+ ..+..+...+|+..++++|+++.+++.
T Consensus 375 L~~lgll~~~~~~~~~i~~~~~~~~~~-------------l~~--~~------~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 375 LWCLGLLLLQLSQGEDISEKSAVPVSL-------------LDV--LS------TSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHHHHHhhhhhcCcccccccchhhh-------------hcc--cc------chhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999999998887652111111111 000 00 114778999999999999999999986
Q ss_pred HH
Q 020078 322 QL 323 (331)
Q Consensus 322 ~L 323 (331)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 53
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.10 E-value=4.5e-05 Score=65.35 Aligned_cols=75 Identities=9% Similarity=0.193 Sum_probs=52.5
Q ss_pred ceeec-CcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC--ceeeeEeEEee---CCccEEEEEecCCC
Q 020078 61 VIASE-HYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR--NILKLIGCCIE---TEIPILVFEFVEYG 134 (331)
Q Consensus 61 ~ig~~-~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~---~~~~~lv~e~~~~g 134 (331)
.++.| .+.||+...++..+++|..... .....+.+|..++..+... .+.+++.++.. ....+++|+++++.
T Consensus 4 ~l~~G~~n~~~~v~~~~~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDDGRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEESSSSEEEEEEETTSEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred cCCCCCeeeEEEEEECCcEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 46664 4489999997789999997654 2466788899998888533 34556654433 33468999999987
Q ss_pred Chhh
Q 020078 135 TLAD 138 (331)
Q Consensus 135 ~L~~ 138 (331)
.+..
T Consensus 81 ~~~~ 84 (239)
T PF01636_consen 81 PLDD 84 (239)
T ss_dssp EHHH
T ss_pred cccc
Confidence 7766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=4.9e-05 Score=72.54 Aligned_cols=142 Identities=13% Similarity=0.045 Sum_probs=87.8
Q ss_pred cCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcch------------------------------------hHHHHHHH
Q 020078 59 HQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENG------------------------------------ENFCFNNI 100 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~------------------------------------~~~~~~E~ 100 (331)
..-||. +.+.||+|+. +|+.||||.-++...... .-+|.+|.
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 356788 9999999999 889999999766533210 01244444
Q ss_pred HHHHh----cCCCc---eeeeEeEEee-CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 020078 101 VFAAQ----MNHRN---ILKLIGCCIE-TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI 172 (331)
Q Consensus 101 ~~l~~----l~h~n---Iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 172 (331)
+...+ +.|-+ =|.+..++.+ .....|+||||+|..+.|.-.-.. ..++... ++..+.++.. +.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----~gi~~~~---i~~~l~~~~~--~q 316 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----RGISPHD---ILNKLVEAYL--EQ 316 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH----cCCCHHH---HHHHHHHHHH--HH
Confidence 44333 34544 1223333332 235679999999987766532111 2344443 3333333321 11
Q ss_pred CCCCCeeeCCCCCCceEEcC----CCceEEccCCCccccCC
Q 020078 173 GFRRPIVFKDIKLSQILFDE----YNVAKLSDFSESEYIPE 209 (331)
Q Consensus 173 ~~~~~ivHrdlk~~Nill~~----~~~~kl~Dfg~a~~~~~ 209 (331)
-...+.+|+|=.|.||++.. ++.+.+-|||+...+..
T Consensus 317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 11456999999999999983 57899999999876644
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.2e-05 Score=60.62 Aligned_cols=128 Identities=8% Similarity=0.040 Sum_probs=89.0
Q ss_pred cccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceee-eEeEEeeCCccEEEEEecCCC
Q 020078 57 NGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILK-LIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~~~~lv~e~~~~g 134 (331)
.....|++ .++.||+|.+.+..+|+|.-.... .+..+..|+++|..+...++-+ +|.+- ..++.|||+.+-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds---~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS---PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc---chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34567899 888999999999999999865443 4678999999999998766654 44442 223569999887
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCC-CCceEEcCCCceEEccCCCccc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIK-LSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk-~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
.|.+..... +-.+ ...+++...-|- ..+|-|+.+. |...++..+..+.|+||..|+.
T Consensus 98 ~L~~~~~~~--------~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG--------DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc--------cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 886655321 2222 334455544445 7788898886 4444444445999999998874
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00039 Score=58.31 Aligned_cols=133 Identities=17% Similarity=0.186 Sum_probs=88.9
Q ss_pred ccCceee-cCcEEEEEEeCCceEEEEEeCCCC---------------CcchhHHHHHHHHHHHhcC------CCceeeeE
Q 020078 58 GHQVIAS-EHYKLYKGFLENRPISVMKFGDNY---------------SENGENFCFNNIVFAAQMN------HRNILKLI 115 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------h~nIv~l~ 115 (331)
....||+ +.-.||.-- .+...+||...... .....++..+|+.....+. +.+|.+++
T Consensus 5 ~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4567888 444676532 45567788876654 1123567788888777766 88899999
Q ss_pred eEEeeCCccEEEEEecCC--C----ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceE
Q 020078 116 GCCIETEIPILVFEFVEY--G----TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL 189 (331)
Q Consensus 116 ~~~~~~~~~~lv~e~~~~--g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nil 189 (331)
|+.+.+--.-+|+|.+.+ | +|.+++... .++. ...+.+.++ ..||- ..+|+.+|++|.||+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIV 150 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEE
Confidence 999998888899998642 3 566666432 3444 333333433 35555 778999999999999
Q ss_pred EcCC---C-ceEEcc-CCCc
Q 020078 190 FDEY---N-VAKLSD-FSES 204 (331)
Q Consensus 190 l~~~---~-~~kl~D-fg~a 204 (331)
+... . .+.|+| ||-.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EEecCCCceEEEEEeCCCCc
Confidence 9533 2 577787 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00057 Score=61.31 Aligned_cols=74 Identities=7% Similarity=-0.011 Sum_probs=52.6
Q ss_pred Cceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC---CceeeeEeEEeeC---CccEEEEEecC
Q 020078 60 QVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH---RNILKLIGCCIET---EIPILVFEFVE 132 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~lv~e~~~ 132 (331)
.-||+ ..+.||.....+..+++|...... ....+.+|...|+.|.- ..+.+++++|... +..+||||+++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 34666 666899987765667777743211 23578899999998853 3577788877643 56899999999
Q ss_pred CCCh
Q 020078 133 YGTL 136 (331)
Q Consensus 133 ~g~L 136 (331)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00046 Score=60.47 Aligned_cols=133 Identities=10% Similarity=-0.037 Sum_probs=73.3
Q ss_pred cEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEecCCCChhhh------
Q 020078 67 YKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEFVEYGTLADR------ 139 (331)
Q Consensus 67 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~~~------ 139 (331)
..+|+...++..+++|........ ..-...+|..++..+....+ .++++... .++||||+++..+...
T Consensus 10 n~~y~~~~~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~~~~~~~ 84 (256)
T TIGR02721 10 NRSWRIEHPGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLDQFVALD 84 (256)
T ss_pred CCeEEEEeCCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccccccCch
Confidence 478888878888888875443222 11245778889988864333 23343332 3689999987665321
Q ss_pred -----------hcCCCCCCCCCCCHH-HHHHHHHHH---------HHHHHHhhc-----CCCCCeeeCCCCCCceEEcCC
Q 020078 140 -----------ICSPHGPHLEPLLWR-HRLKIAMEI---------GNAMAYIHI-----GFRRPIVFKDIKLSQILFDEY 193 (331)
Q Consensus 140 -----------l~~~~~~~~~~l~~~-~~~~i~~~i---------~~~l~~LH~-----~~~~~ivHrdlk~~Nill~~~ 193 (331)
+++..... .++... ....+..++ ..-+..+-. .....++|+|+.|.||+++.+
T Consensus 85 ~~~~la~~l~~lH~~~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~ 163 (256)
T TIGR02721 85 LLLELAALLHQLHSQPRFG-YPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQ 163 (256)
T ss_pred hHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCC
Confidence 11111100 112211 111111111 111111110 113468999999999999987
Q ss_pred CceEEccCCCccc
Q 020078 194 NVAKLSDFSESEY 206 (331)
Q Consensus 194 ~~~kl~Dfg~a~~ 206 (331)
+ +.++||..+..
T Consensus 164 ~-~~lIDwE~a~~ 175 (256)
T TIGR02721 164 G-LKLIDWEYASD 175 (256)
T ss_pred C-CEEEeccccCc
Confidence 7 78999987653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00052 Score=59.34 Aligned_cols=31 Identities=13% Similarity=0.162 Sum_probs=26.3
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
...++|+|+.+.|++++.+...-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 4458999999999999987667899999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00093 Score=55.82 Aligned_cols=125 Identities=20% Similarity=0.223 Sum_probs=88.6
Q ss_pred cCccccCceee-cC-cEEEEEEeCCceEEEEEeCC---C--------CCc---------chhHHHHHHHHHHHhcC---C
Q 020078 54 NNYNGHQVIAS-EH-YKLYKGFLENRPISVMKFGD---N--------YSE---------NGENFCFNNIVFAAQMN---H 108 (331)
Q Consensus 54 ~~~~~~~~ig~-~~-g~Vy~~~~~~~~vavK~~~~---~--------~~~---------~~~~~~~~E~~~l~~l~---h 108 (331)
.+++-...+|. .. |.||++..+|+.+|+|.+.. . ... .-.+.|..|.+...+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 67777888999 77 89999999999999999321 0 000 12346888988888885 4
Q ss_pred Cce--eeeEeEEeeC------------------CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 020078 109 RNI--LKLIGCCIET------------------EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMA 168 (331)
Q Consensus 109 ~nI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 168 (331)
.++ |+.+||..-. ..+.||.||.+... .+... -+.+|.+-+.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------ccchh----HHHHHHHHHH
Confidence 456 8899997432 01246777765533 12222 2466777788
Q ss_pred HhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 169 YIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 169 ~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
.+| ..+|+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 899 999999999999986 5789999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0015 Score=58.49 Aligned_cols=135 Identities=16% Similarity=0.183 Sum_probs=76.7
Q ss_pred cEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc--eeeeEeE------EeeCCccEEEEEecCCCChhh
Q 020078 67 YKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN--ILKLIGC------CIETEIPILVFEFVEYGTLAD 138 (331)
Q Consensus 67 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~~~~g~L~~ 138 (331)
..+|+...++..+++|..... .......|+.++..|.+.. +.+.+.. ....+..+.|++|++|..+..
T Consensus 28 n~~y~v~~~~~~~vLr~~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~ 103 (296)
T cd05153 28 NTNYFVTTDSGRYVLTLFEKV----SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTR 103 (296)
T ss_pred cceEEEEeCCCcEEEEEcCCC----ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCC
Confidence 378988777778999987541 3445667888887774322 3343332 122445679999998866532
Q ss_pred ----h----------hcCC----CCC--CCCCCCHHHHH----------HHHHHHHHHHHHhhc----CCCCCeeeCCCC
Q 020078 139 ----R----------ICSP----HGP--HLEPLLWRHRL----------KIAMEIGNAMAYIHI----GFRRPIVFKDIK 184 (331)
Q Consensus 139 ----~----------l~~~----~~~--~~~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~~~ivHrdlk 184 (331)
. ++.. ... ......|.... .....+...+.++.. .....++|+|+.
T Consensus 104 ~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~ 183 (296)
T cd05153 104 PTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLF 183 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcC
Confidence 0 0100 000 00011111110 011112233344431 113469999999
Q ss_pred CCceEEcCCCceEEccCCCcc
Q 020078 185 LSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 185 ~~Nill~~~~~~kl~Dfg~a~ 205 (331)
|.|++++.+..+.|+||+.+.
T Consensus 184 ~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 184 RDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cccEEEeCCceEEEeehhhhc
Confidence 999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=3.4e-05 Score=80.17 Aligned_cols=196 Identities=9% Similarity=-0.102 Sum_probs=131.0
Q ss_pred ceeecCcEEEEEEe-CC--ceEEEEEeCCCCC----cchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccEEEEEec
Q 020078 61 VIASEHYKLYKGFL-EN--RPISVMKFGDNYS----ENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPILVFEFV 131 (331)
Q Consensus 61 ~ig~~~g~Vy~~~~-~~--~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~ 131 (331)
.+|-+.+.-+++.+ .. .-+.+++...-.- +...+....|...++...|+++...+.=... ....+.+++|+
T Consensus 1234 ~l~i~~~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~ 1313 (2724)
T KOG1826|consen 1234 NLGISNHFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYV 1313 (2724)
T ss_pred eeecccceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHH
Confidence 34557777777777 22 2344444432211 1123445556666667789998877655543 33567899999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--CCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI--GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
..|.+.+.+.+..... .++...-......+...+..-+|. ..+...+|+++|+-|.+|..+..++++++|+.+....
T Consensus 1314 ~~g~~f~iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp 1392 (2724)
T KOG1826|consen 1314 EFGKLFSIIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP 1392 (2724)
T ss_pred HHhHHHHHHHhccccC-CcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc
Confidence 9999999997654321 334333334333443555555553 2244578999999999999999999999999983322
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
... ..+...+++.|++|+....-.++.++|+|+.|+.+|+...|..++
T Consensus 1393 ~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1393 VLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 211 222244788899999888888888899999999999998888775
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.004 Score=56.11 Aligned_cols=158 Identities=14% Similarity=0.153 Sum_probs=84.0
Q ss_pred CHHHHHHHhcCcccc-----CceeecC-cEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc--eeeeEe
Q 020078 45 SAGELKIATNNYNGH-----QVIASEH-YKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN--ILKLIG 116 (331)
Q Consensus 45 ~~~~~~~~~~~~~~~-----~~ig~~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~ 116 (331)
+.+++...-..|... ..++.|. ..+|+...++..+++|....... .+....|+.++..|.... +.+.+.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 334554444444332 2333444 37898877666788887654321 234456677777664222 333333
Q ss_pred EE------eeCCccEEEEEecCCCChhhh--------------hcCCCCC--CC-CC----CCHHHHH------------
Q 020078 117 CC------IETEIPILVFEFVEYGTLADR--------------ICSPHGP--HL-EP----LLWRHRL------------ 157 (331)
Q Consensus 117 ~~------~~~~~~~lv~e~~~~g~L~~~--------------l~~~~~~--~~-~~----l~~~~~~------------ 157 (331)
.. ...+..++++||++|..+... ++..... .. .. -.|....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 21 123456899999987544210 1111000 00 00 0111100
Q ss_pred HHHHHHHHHHHHhhc----CCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 158 KIAMEIGNAMAYIHI----GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 158 ~i~~~i~~~l~~LH~----~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
.....+...+.++.. ....+++|+|+.+.|++++.++...++||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001123334444431 124689999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0037 Score=53.88 Aligned_cols=31 Identities=19% Similarity=0.329 Sum_probs=26.9
Q ss_pred CCCeeeCCCCCCceEEcC-CCceEEccCCCcc
Q 020078 175 RRPIVFKDIKLSQILFDE-YNVAKLSDFSESE 205 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~ 205 (331)
...++|+|+.+.|||++. ++.+.++||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 456899999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0064 Score=55.06 Aligned_cols=31 Identities=19% Similarity=0.330 Sum_probs=26.5
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
..++||+|+.|.||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4579999999999999976666899998764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.012 Score=54.69 Aligned_cols=72 Identities=8% Similarity=-0.063 Sum_probs=47.2
Q ss_pred ceee-cCcEEEEEEeCC--ceEEEEEeCCCCC------cchhHHHHHHHHHHHhcC---CCceeeeEeEEeeCCccEEEE
Q 020078 61 VIAS-EHYKLYKGFLEN--RPISVMKFGDNYS------ENGENFCFNNIVFAAQMN---HRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~--~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.+|. ....||++...+ +.++||.-.+... .-..+.+..|...|..+. ..++.+++.+ +.+..++||
T Consensus 33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVM 110 (401)
T PRK09550 33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVM 110 (401)
T ss_pred EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEE
Confidence 3555 455899999844 4899998542110 113456777888888763 3456677777 345578999
Q ss_pred EecCCC
Q 020078 129 EFVEYG 134 (331)
Q Consensus 129 e~~~~g 134 (331)
||+++.
T Consensus 111 E~L~~~ 116 (401)
T PRK09550 111 EDLSDH 116 (401)
T ss_pred ecCCCc
Confidence 999764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.014 Score=52.49 Aligned_cols=129 Identities=13% Similarity=0.074 Sum_probs=80.8
Q ss_pred EEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC--CceeeeEeEEeeCC--ccEEEEEecCCCChhhhhcCCC
Q 020078 69 LYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH--RNILKLIGCCIETE--IPILVFEFVEYGTLADRICSPH 144 (331)
Q Consensus 69 Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~ 144 (331)
+|....+++++++.+-.............+|..+++.+.- .-+...++.|.++. ..+.||+|+++..+.+.+...
T Consensus 41 t~~~~~~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~- 119 (321)
T COG3173 41 TFRLGDTGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPE- 119 (321)
T ss_pred eEEEecCCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcc-
Confidence 3433344777777722112222345666778888887753 23344678887776 678999999875444333211
Q ss_pred CCCCCCCCHHHHHHHH-HHHHHHHHHhhc---------------------------------------------------
Q 020078 145 GPHLEPLLWRHRLKIA-MEIGNAMAYIHI--------------------------------------------------- 172 (331)
Q Consensus 145 ~~~~~~l~~~~~~~i~-~~i~~~l~~LH~--------------------------------------------------- 172 (331)
... ..++ ..++..|.-||+
T Consensus 120 -------~~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 120 -------SLG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred -------cch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 111 1112 355555555553
Q ss_pred ----CCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 173 ----GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 173 ----~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
.....++|+|+.+.|++++...-+-|.||+++..-
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 12456899999999999998888999999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0055 Score=55.01 Aligned_cols=64 Identities=25% Similarity=0.241 Sum_probs=41.3
Q ss_pred EEEEEEeC--------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEecCCCChh
Q 020078 68 KLYKGFLE--------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEFVEYGTLA 137 (331)
Q Consensus 68 ~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~ 137 (331)
.+|+.... ++.+++|....... ......+|..++..+....+ .++++++.. .+|+||++|..+.
T Consensus 13 ~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~--~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~ 85 (302)
T cd05156 13 AVYKVSLPDEDALSDEPRKVLLRVYGQSVE--LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFIPSRTLT 85 (302)
T ss_pred eeEEEEcCCcccccCCCCeEEEEEecCCCc--ceechHHHHHHHHHHHhCCCCCceEEEeCC----CchhheeCCCcCC
Confidence 78887764 47888888655432 23456788888888853333 345555432 3689999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.006 Score=54.33 Aligned_cols=69 Identities=14% Similarity=0.164 Sum_probs=44.6
Q ss_pred eee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC---CCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 62 IAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN---HRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 62 ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
++. ....+|....+++.+.||.-... ....|..|..-|+.|. .-.+.+.+++....+..+||+||++.+
T Consensus 25 v~GG~i~~a~~~~~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 25 VSGGDINEAYRLDTDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp E--SSSSEEEEEETTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred cCCCChhheEEEECCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 444 44578888878899999986522 4567889999999884 345667888877777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.019 Score=52.61 Aligned_cols=134 Identities=19% Similarity=0.198 Sum_probs=74.6
Q ss_pred cEEEEEEeC------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCcee-eeEeEEeeCCccEEEEEecCCCChhhh
Q 020078 67 YKLYKGFLE------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNIL-KLIGCCIETEIPILVFEFVEYGTLADR 139 (331)
Q Consensus 67 g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~g~L~~~ 139 (331)
..+|+.... ++.+++|...... . ..-.-.+|..++..+...++- ++++.+... .|++|+++.+|...
T Consensus 50 N~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~ 123 (344)
T PLN02236 50 NEVFQIKWPTKEGNLGRKVLVRIYGEGV-E-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAA 123 (344)
T ss_pred ceeEEEEeCCCCCCCCCeEEEEEccCCC-C-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHH
Confidence 378888752 2578888776543 2 222336788888888643333 455554322 58999977665321
Q ss_pred -----------------hcCCCCCCCC-CCCHHHHHHHHHHH-----------------HHHHHHh----hc-CCCCCee
Q 020078 140 -----------------ICSPHGPHLE-PLLWRHRLKIAMEI-----------------GNAMAYI----HI-GFRRPIV 179 (331)
Q Consensus 140 -----------------l~~~~~~~~~-~l~~~~~~~i~~~i-----------------~~~l~~L----H~-~~~~~iv 179 (331)
+++...+... +..+.++..+..++ ...+..| .. .....++
T Consensus 124 ~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~c 203 (344)
T PLN02236 124 DLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFC 203 (344)
T ss_pred HcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEE
Confidence 1111111111 12233333332211 1111111 11 1245789
Q ss_pred eCCCCCCceEEcC-CCceEEccCCCccc
Q 020078 180 FKDIKLSQILFDE-YNVAKLSDFSESEY 206 (331)
Q Consensus 180 Hrdlk~~Nill~~-~~~~kl~Dfg~a~~ 206 (331)
|+|+.+.|||+++ ++.+.++||..+..
T Consensus 204 H~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 204 HNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 9999999999986 47899999987754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.03 Score=49.69 Aligned_cols=31 Identities=29% Similarity=0.419 Sum_probs=25.4
Q ss_pred CCeeeCCCCCCceEEcCCCc-eEEccCCCccc
Q 020078 176 RPIVFKDIKLSQILFDEYNV-AKLSDFSESEY 206 (331)
Q Consensus 176 ~~ivHrdlk~~Nill~~~~~-~kl~Dfg~a~~ 206 (331)
..++|+|+.|.|++++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997554 56999997753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.011 Score=49.90 Aligned_cols=113 Identities=17% Similarity=0.108 Sum_probs=73.0
Q ss_pred EEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCC
Q 020078 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPH 147 (331)
Q Consensus 68 ~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 147 (331)
+.-+|+.+=.+..+|++..-...-...-|.++.++++++. .|++|..- .+..+-++.|+|-....
T Consensus 77 Tl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i----------- 141 (308)
T PF07387_consen 77 TLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI----------- 141 (308)
T ss_pred EEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------
Confidence 3344443334566677665444334556788899999886 47777722 23345578888853221
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 148 LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 148 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.+ ..++..=+++|.-.|++ +.+.+|+|..|+||+-|..|.+||.|=+.
T Consensus 142 ---~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 ---NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred ---ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 11122224567777854 67899999999999999999999999764
|
The function of this family is unknown. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.081 Score=49.33 Aligned_cols=70 Identities=4% Similarity=0.028 Sum_probs=44.5
Q ss_pred eeecCc-EEEEEEeCCceEEEEEeCCCCC---c---chhHHHHHHHHHHHhcC---CCceeeeEeEEeeCCccEEEEEec
Q 020078 62 IASEHY-KLYKGFLENRPISVMKFGDNYS---E---NGENFCFNNIVFAAQMN---HRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 62 ig~~~g-~Vy~~~~~~~~vavK~~~~~~~---~---~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
+|.|.. .||+....+..++||.-..... . .....-..|...|..+. ..++.+++.++. +..+++|||+
T Consensus 40 iggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlvME~L 117 (418)
T PLN02756 40 VGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIGMRYL 117 (418)
T ss_pred cCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEEEeec
Confidence 444333 7999887777899998652211 1 12333444566666553 357788888887 4467899999
Q ss_pred CC
Q 020078 132 EY 133 (331)
Q Consensus 132 ~~ 133 (331)
++
T Consensus 118 ~~ 119 (418)
T PLN02756 118 EP 119 (418)
T ss_pred CC
Confidence 76
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.036 Score=49.82 Aligned_cols=30 Identities=23% Similarity=0.332 Sum_probs=25.7
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
..+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 467899999999999987 668899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.062 Score=45.84 Aligned_cols=66 Identities=14% Similarity=0.102 Sum_probs=47.2
Q ss_pred EEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC---ceeeeEeEEeeCCccEEEEEecCCCChh
Q 020078 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR---NILKLIGCCIETEIPILVFEFVEYGTLA 137 (331)
Q Consensus 68 ~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 137 (331)
..|...+...++.||.-... ....|..|+.-|..|.-. ++.+.+.+-.+....|+|+||.+-|.+.
T Consensus 31 ea~~v~dg~~~~FvK~n~~~----~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 31 EAWRLRDGTDPFFVKCNQRE----QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred ceeEeecCCcceEEEecchh----hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 44555557788888884332 467888999888877544 4555666666778899999999876664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.068 Score=48.96 Aligned_cols=70 Identities=9% Similarity=0.000 Sum_probs=42.5
Q ss_pred eeecCc-EEEEEEeCC--ceEEEEEeCCC------CCcchhHHHHHHHHHHHhcC--CC-ceeeeEeEEeeCCccEEEEE
Q 020078 62 IASEHY-KLYKGFLEN--RPISVMKFGDN------YSENGENFCFNNIVFAAQMN--HR-NILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 62 ig~~~g-~Vy~~~~~~--~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv~e 129 (331)
||.|.. .||++...+ +.|+||.-.+- .-.-..+....|...|.... -| ++.+++.+ +++...+|||
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vME 80 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVME 80 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehHh
Confidence 455443 899999844 57999985421 11223445556777777663 34 44445544 3455668999
Q ss_pred ecCC
Q 020078 130 FVEY 133 (331)
Q Consensus 130 ~~~~ 133 (331)
+++.
T Consensus 81 dL~~ 84 (370)
T TIGR01767 81 DLSH 84 (370)
T ss_pred hCcc
Confidence 9854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.062 Score=49.04 Aligned_cols=133 Identities=14% Similarity=0.159 Sum_probs=83.9
Q ss_pred CcEEEEEEe-CCceEEEEEeCCC--------------------CCc----ch-hHHHHHHHHHHHhcCCCceeeeEeEEe
Q 020078 66 HYKLYKGFL-ENRPISVMKFGDN--------------------YSE----NG-ENFCFNNIVFAAQMNHRNILKLIGCCI 119 (331)
Q Consensus 66 ~g~Vy~~~~-~~~~vavK~~~~~--------------------~~~----~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~ 119 (331)
-..||.+.- +|..+|||+...+ ... +. .-+...|++.|.+|+...|.. ..-..
T Consensus 157 EANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~-PePIl 235 (520)
T KOG2270|consen 157 EANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC-PEPIL 235 (520)
T ss_pred cceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC-CCcee
Confidence 337999988 8889999986422 000 01 234667888898887554322 11111
Q ss_pred eCCccEEEEEecCC-CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 120 ETEIPILVFEFVEY-GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 120 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
-. ...|||+|+.. |--...|.. .+++...+..+-.+++.-+.-|-. ..++||.||.-=|+|+-+ |.+.+
T Consensus 236 Lk-~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Lyhd-G~lyi 305 (520)
T KOG2270|consen 236 LK-NHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLYHD-GKLYI 305 (520)
T ss_pred ee-cceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheEEC-CEEEE
Confidence 11 13589999852 111222211 245555666676777777766653 568999999999998865 88999
Q ss_pred ccCCCccccCC
Q 020078 199 SDFSESEYIPE 209 (331)
Q Consensus 199 ~Dfg~a~~~~~ 209 (331)
+|.+.+.....
T Consensus 306 IDVSQSVE~DH 316 (520)
T KOG2270|consen 306 IDVSQSVEHDH 316 (520)
T ss_pred EEccccccCCC
Confidence 99987765433
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.026 Score=47.85 Aligned_cols=31 Identities=26% Similarity=0.385 Sum_probs=21.7
Q ss_pred CCeeeCCCCCCceEE-cCCCceEEccCCCccc
Q 020078 176 RPIVFKDIKLSQILF-DEYNVAKLSDFSESEY 206 (331)
Q Consensus 176 ~~ivHrdlk~~Nill-~~~~~~kl~Dfg~a~~ 206 (331)
..++|+|+.|.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 467899999999999 8889999999987653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.007 Score=57.19 Aligned_cols=50 Identities=16% Similarity=0.210 Sum_probs=38.3
Q ss_pred hHHHHHHHHHHHhcCCCceeeeEeEEeeC-CccEEEEEecCCCChhhhhcCC
Q 020078 93 ENFCFNNIVFAAQMNHRNILKLIGCCIET-EIPILVFEFVEYGTLADRICSP 143 (331)
Q Consensus 93 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~ 143 (331)
..+.+....+++.+.|+|....+++.... ....+|+|++. -||.+.+...
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~ 76 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTG 76 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhc
Confidence 34556677889999999999988887653 34678999995 5898888653
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.75 E-value=0.13 Score=46.82 Aligned_cols=133 Identities=18% Similarity=0.221 Sum_probs=71.6
Q ss_pred EEEEEEeCC-----ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEecCCCChhh---
Q 020078 68 KLYKGFLEN-----RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEFVEYGTLAD--- 138 (331)
Q Consensus 68 ~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~~--- 138 (331)
.+|+....+ ..++++....... ..-.-.+|..++..+..-++ .++++++. +. +|.+|+++..|..
T Consensus 29 ~~~~v~~~~~~~~~~~~v~Ri~g~~t~--~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~l~~~~l 102 (330)
T PLN02421 29 LLLKVSVKEENGNEVSVTVRLFGPNTD--YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINARTLTPSDM 102 (330)
T ss_pred eEEEEEecCCCCCCceEEEEEecCCcC--eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCCCChHHC
Confidence 688876533 2788887765422 22334578888888864444 34555552 21 5889987655421
Q ss_pred --------------hhcCCCCCCC-CCCCHHHHHHHHHHHH----------------------HHHH----Hhhc-CCCC
Q 020078 139 --------------RICSPHGPHL-EPLLWRHRLKIAMEIG----------------------NAMA----YIHI-GFRR 176 (331)
Q Consensus 139 --------------~l~~~~~~~~-~~l~~~~~~~i~~~i~----------------------~~l~----~LH~-~~~~ 176 (331)
.+++...+.. .+-.+..+..+..++. .-+. ++.. ....
T Consensus 103 ~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~~~~~~~ 182 (330)
T PLN02421 103 RKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITDSLKAPV 182 (330)
T ss_pred CCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhccCCCCe
Confidence 1111111110 1112333322222211 1111 1110 1123
Q ss_pred CeeeCCCCCCceEEcC-CCceEEccCCCccc
Q 020078 177 PIVFKDIKLSQILFDE-YNVAKLSDFSESEY 206 (331)
Q Consensus 177 ~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~ 206 (331)
-.+|.|+-+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999974 57899999987653
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.034 Score=50.55 Aligned_cols=54 Identities=19% Similarity=0.197 Sum_probs=46.5
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 151 LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 151 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
-.+.+...++.+.+.-++-+.. ..+.-|||+.-.||||+ +|++.|+||-+++.-
T Consensus 318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 4678889999988887777764 56889999999999999 899999999999843
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.024 Score=50.85 Aligned_cols=130 Identities=13% Similarity=0.050 Sum_probs=80.6
Q ss_pred ccccCceee-cCcEEEEEEe-CCceEEEEEeCCC-----------------CCc----chhHHHHHHHHHHHhcC-CCc-
Q 020078 56 YNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDN-----------------YSE----NGENFCFNNIVFAAQMN-HRN- 110 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~-----------------~~~----~~~~~~~~E~~~l~~l~-h~n- 110 (331)
++.++.||- .-+.||.+.. +|.+.++|.-.-. ... -++-...+|...|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 344566666 5558999999 6888888752110 000 11234567888888885 322
Q ss_pred eeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 111 ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 111 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+.+.+ +.+.-++|||++.+-.|...-+- ....++..-+.++. --|- ..++||+|..-=||++
T Consensus 174 VPkpi----D~~RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~~I---v~la---~~GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 174 VPKPI----DHNRHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMGLI---VRLA---NHGLIHGDFNEFNIMV 235 (465)
T ss_pred CCCcc----cccceeeHHHhhcccceeeeeec--------CChHHHHHHHHHHH---HHHH---HcCceecccchheeEE
Confidence 22222 33456789999887666543321 12223222222222 2233 6799999999999999
Q ss_pred cCCCceEEccCCC
Q 020078 191 DEYNVAKLSDFSE 203 (331)
Q Consensus 191 ~~~~~~kl~Dfg~ 203 (331)
++++.++++||-.
T Consensus 236 ~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQ 248 (465)
T ss_pred ecCCCEEEeechH
Confidence 9999999999954
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.083 Score=49.03 Aligned_cols=71 Identities=15% Similarity=0.061 Sum_probs=43.9
Q ss_pred ceeecCc-EEEEEEeC--CceEEEEEeCCC--CC---cchhHHHHHHHHHHHhcC--CC-ceeeeEeEEeeCCccEEEEE
Q 020078 61 VIASEHY-KLYKGFLE--NRPISVMKFGDN--YS---ENGENFCFNNIVFAAQMN--HR-NILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 61 ~ig~~~g-~Vy~~~~~--~~~vavK~~~~~--~~---~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~~~~~~~~~lv~e 129 (331)
.||.|.. .||++... ++.|+||.-.+- .. .-..+....|...|+... -| ++.+++.+ +++...+|||
T Consensus 36 eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vME 113 (409)
T PRK12396 36 EIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVME 113 (409)
T ss_pred EcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHHH
Confidence 3555443 89999974 678999975421 11 123456667778887664 34 45556555 3444568999
Q ss_pred ecCC
Q 020078 130 FVEY 133 (331)
Q Consensus 130 ~~~~ 133 (331)
+++.
T Consensus 114 dL~~ 117 (409)
T PRK12396 114 DLSD 117 (409)
T ss_pred hCcc
Confidence 8854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.69 Score=48.76 Aligned_cols=32 Identities=22% Similarity=0.283 Sum_probs=26.2
Q ss_pred CCCeeeCCCCCCceEEcCCC--ce-EEccCCCccc
Q 020078 175 RRPIVFKDIKLSQILFDEYN--VA-KLSDFSESEY 206 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~--~~-kl~Dfg~a~~ 206 (331)
...+||+|+.+.|||++.+. .+ -|+|||.+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 45799999999999999775 44 5999998653
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.094 Score=47.27 Aligned_cols=31 Identities=26% Similarity=0.458 Sum_probs=27.7
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
..+++|+|+.+.|+|++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4579999999999999999899999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.37 Score=40.98 Aligned_cols=129 Identities=9% Similarity=0.057 Sum_probs=84.4
Q ss_pred eeecCcEEEEEEeCCceEE-EEEeCCCCCcchhHHHHHHHHHHHhcCCC--ceeeeEeEEeeCCccEEEEEecCCCChhh
Q 020078 62 IASEHYKLYKGFLENRPIS-VMKFGDNYSENGENFCFNNIVFAAQMNHR--NILKLIGCCIETEIPILVFEFVEYGTLAD 138 (331)
Q Consensus 62 ig~~~g~Vy~~~~~~~~va-vK~~~~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 138 (331)
.|++.+.||.-....+..+ +|+-... ....+.+|...++=+.-. -+..+.++..+.+.-||+|+-+++-++..
T Consensus 28 ~geS~~~v~rl~a~~r~g~~~k~~~~~----~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~ 103 (266)
T COG3231 28 EGESGAGVFRLFADSRPGLYLKIASSG----PAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASH 103 (266)
T ss_pred ccCCCCeEEEEeccCCCceEEEEecCc----chhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccc
Confidence 3446668888666444433 3443222 356788898888755321 22334455556788899999999877643
Q ss_pred hhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 020078 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG--------------------------------------------- 173 (331)
Q Consensus 139 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------- 173 (331)
.-. .++.. +.+--++++|..||..
T Consensus 104 ~~~--------~~~p~---r~v~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~ 172 (266)
T COG3231 104 PRY--------ALDPK---RAVPLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELF 172 (266)
T ss_pred hhh--------cCCHH---HHHHHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHH
Confidence 221 13332 3456688889999950
Q ss_pred ----------CCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 174 ----------FRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 174 ----------~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
.+.-+.|+|=+.-|++++.+...-.+|+|..-
T Consensus 173 d~L~~~rp~~edLVv~HGDACLPN~i~d~~rf~GfIDlGrlG 214 (266)
T COG3231 173 DELEARRPAVEDLVVTHGDACLPNFILDGWRFSGFIDLGRLG 214 (266)
T ss_pred HHHHhcCCchhhceeecCcccCcceEecCCceEEeeecCccc
Confidence 13457899999999999998888889988654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.81 Score=41.63 Aligned_cols=135 Identities=16% Similarity=0.211 Sum_probs=73.4
Q ss_pred EEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc------eeeeEeEEee--CC--ccEEEEEecCCCChh
Q 020078 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN------ILKLIGCCIE--TE--IPILVFEFVEYGTLA 137 (331)
Q Consensus 68 ~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~--~~--~~~lv~e~~~~g~L~ 137 (331)
.+|.....+..+++|...... ...+..-|+..|.-|.-.. +..+=|-... .. ..+-+++|++|..+.
T Consensus 40 ~~f~~~~~~g~~iLki~~~~~---~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~ 116 (331)
T COG2334 40 SNFRVQTEDGRYILKIYRPGW---TRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRPLE 116 (331)
T ss_pred ceEEEEecCCCeEEEEecCCC---CHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcCcC
Confidence 799999877777888877652 3445555666666553111 1111111111 22 566789999987776
Q ss_pred h-h--------------hcC--CCCC--C---CCCCCHHH-------------HHHHHHHHHHHHHHhhc-----CCCCC
Q 020078 138 D-R--------------ICS--PHGP--H---LEPLLWRH-------------RLKIAMEIGNAMAYIHI-----GFRRP 177 (331)
Q Consensus 138 ~-~--------------l~~--~~~~--~---~~~l~~~~-------------~~~i~~~i~~~l~~LH~-----~~~~~ 177 (331)
. . |+. .+.+ . .....|.. ......++...+..+.. -...+
T Consensus 117 ~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~ 196 (331)
T COG2334 117 RDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPALG 196 (331)
T ss_pred CCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCccc
Confidence 3 1 010 1100 0 01122320 01122333333333332 11333
Q ss_pred --eeeCCCCCCceEEcCCCc-eEEccCCCcc
Q 020078 178 --IVFKDIKLSQILFDEYNV-AKLSDFSESE 205 (331)
Q Consensus 178 --ivHrdlk~~Nill~~~~~-~kl~Dfg~a~ 205 (331)
+||+|+.|.||+++.+.. +.++||+-+.
T Consensus 197 ~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 197 DQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998874 8999999754
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.18 E-value=1.8 Score=45.63 Aligned_cols=95 Identities=7% Similarity=0.084 Sum_probs=51.7
Q ss_pred CccccCHHHHHHHh-cCccccCce---eecCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-------CC
Q 020078 40 PIRSFSAGELKIAT-NNYNGHQVI---ASEHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQM-------NH 108 (331)
Q Consensus 40 ~~~~~~~~~~~~~~-~~~~~~~~i---g~~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-------~h 108 (331)
+...++..++...- ..|.....+ +.+.-.+|+...++..+++|+....... .....|...+..| .-
T Consensus 13 ~~p~ls~~~~~~ll~~~ygl~~~~~~L~s~~d~nf~v~t~~~~yVLKi~~~~~~~---~~l~~e~~~l~hL~~~~~glpv 89 (972)
T PRK06149 13 PAPDVSEAQAERILAEHYGLSGTLTELGSQQDRNFRVDSDGGRFVLKICHAAYAA---VELEAQHAALRHLAEREPALRV 89 (972)
T ss_pred CCCCCCHHHHHHHHHHhcCCceEEEecCCcCcceEEEEecCCcEEEEeCCccCCh---HHHHHHHHHHHHHHhhCCCCCC
Confidence 44557778876655 567654223 3222268888776678899887654322 3344455555444 23
Q ss_pred CceeeeE-e----EEe--eCCccEEEEEecCCCChh
Q 020078 109 RNILKLI-G----CCI--ETEIPILVFEFVEYGTLA 137 (331)
Q Consensus 109 ~nIv~l~-~----~~~--~~~~~~lv~e~~~~g~L~ 137 (331)
|.+++-. | ... .....+-+++|++|..+.
T Consensus 90 p~pi~t~~G~~~~~~~~~g~~~~vrL~~~l~G~~~~ 125 (972)
T PRK06149 90 PVVIPALDGEELLTLDVRGQGLRVRLLDYLPGQPLT 125 (972)
T ss_pred ceeeECCCCCeEEEEecCCceEEEEEEEecCCcccc
Confidence 3444321 1 111 112356789999875553
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.17 E-value=3.4 Score=37.55 Aligned_cols=94 Identities=10% Similarity=0.082 Sum_probs=50.4
Q ss_pred CccccCHHHHHHHhcCc--ccc---CceeecCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC--ce
Q 020078 40 PIRSFSAGELKIATNNY--NGH---QVIASEHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR--NI 111 (331)
Q Consensus 40 ~~~~~~~~~~~~~~~~~--~~~---~~ig~~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--nI 111 (331)
+...++.+.+..+-..+ ... ..++.....||.... ++..+++|....... .......|+..+..|... .+
T Consensus 7 ~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~~~gipv 84 (325)
T PRK11768 7 PFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELAEAEIPV 84 (325)
T ss_pred CCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHHHCCCCC
Confidence 44456666655544333 211 122334447999887 466788887653321 345566777777766321 12
Q ss_pred eee---Ee--EEeeCCccEEEEEecCCCC
Q 020078 112 LKL---IG--CCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 112 v~l---~~--~~~~~~~~~lv~e~~~~g~ 135 (331)
+.. -| ...-++..+.++++++|..
T Consensus 85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 221 11 1222445678899987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 331 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-27 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-23 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-22 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-20 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-20 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-20 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 6e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-09 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 9e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-07 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-06 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-06 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-05 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-05 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-05 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-05 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-05 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-04 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-04 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-04 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 203 bits (520), Expect = 8e-64
Identities = 91/296 (30%), Positives = 154/296 (52%), Gaps = 33/296 (11%)
Query: 41 IRSFSAGELKIATNNYNGHQVIASEHY-KLYKGFLEN-RPISVMKFGDNYSENGEN-FCF 97
++ FS EL++A++N++ ++ + K+YKG L + ++V + + ++ GE F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQ- 75
Query: 98 NNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG--PHLEPLLWRH 155
+ + HRN+L+L G C+ +LV+ ++ G++A + PL W
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCL---RERPESQPPLDWPK 132
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
R +IA+ +AY+H I+ +D+K + IL DE A + DF ++ + +THVT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 216 SHMLTR---TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR-----------DNIL 261
T T ++APEY+ TG +EKTDVF +G++LLEL+TG+R D +L
Sbjct: 193 ----TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVML 248
Query: 262 LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ-ALLQLIFECVNESAGDRPTM 316
L+ VK ++ +L +VD + + E EQ +Q ALL C S +RP M
Sbjct: 249 LDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL-----CTQSSPMERPKM 299
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 8e-63
Identities = 80/292 (27%), Positives = 134/292 (45%), Gaps = 32/292 (10%)
Query: 42 RSFSAGELKIATNNYNGHQVIASEHY-KLYKGFLEN-RPISVMKFGDNYSENGENFCFNN 99
+L+ ATNN++ +I + K+YKG L + +++ K S G
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVAL-KRRTPESSQGIEEFETE 85
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG--PHLEPLLWRHRL 157
I + H +++ LIG C E IL+++++E G L + +G + W RL
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL---YGSDLPTMSMSWEQRL 142
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG-ETHVTS 216
+I + + Y+H I+ +D+K IL DE V K++DF S+ E +TH++
Sbjct: 143 EICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS- 198
Query: 217 HMLTR---TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---------DNILLEH 264
T T Y+ PEY + G EK+DV+ FG++L E+L R L E
Sbjct: 199 ---TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255
Query: 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+ N +L +IVDP + + + L+ +C+ S+ DRP+M
Sbjct: 256 AVESHNNGQLEQIVDPNLADKIR----PESLRKFGDTAVKCLALSSEDRPSM 303
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 6e-62
Identities = 79/298 (26%), Positives = 135/298 (45%), Gaps = 39/298 (13%)
Query: 42 RSFSAGELKIATNNYNGHQVIASEHY-------KLYKGFLENRPISVMKFGDNYSENGEN 94
SFS ELK TNN++ + + +YKG++ N ++V K E
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 95 ----FCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP 150
F I A+ H N+++L+G + + LV+ ++ G+L DR+ G P
Sbjct: 73 LKQQF-DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPP 129
Query: 151 LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210
L W R KIA N + ++H + +DIK + IL DE AK+SDF + +
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 211 E-THVTSHMLTR---TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR-------DN 259
T +T +R T Y+APE L G K+D++ FG++LLE++TG
Sbjct: 187 AQTVMT----SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 260 ILLEHVKK-HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+LL+ ++ E + + +D + ++A+ + +C++E RP +
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKM---NDADSTS--VEAMYSVASQCLHEKKNKRPDI 294
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-46
Identities = 65/312 (20%), Positives = 122/312 (39%), Gaps = 38/312 (12%)
Query: 44 FSAGELKIATNNYNGHQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCF-NNIV 101
L + +V A + ++K L N ++V F ++ +++ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIF---PIQDKQSWQNEYEVY 70
Query: 102 FAAQMNHRNILKLIGCCIETEIP----ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRL 157
M H NIL+ IG L+ F E G+L+D + + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELC 124
Query: 158 KIAMEIGNAMAYIH-------IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210
IA + +AY+H G + I +DIK +L A ++DF + G
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 211 ETHVTSHMLTRTKRYLAPEYILTGL-----CNEKTDVFCFGMLLLELLTGRR--DNILLE 263
++ +H T+RY+APE + + + D++ G++L EL + D + E
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 264 HV---KKHVENNRLGEIVDPIVVEDKSCPE------KEQQLQALLQLIFECVNESAGDRP 314
++ ++ + + E + +VV K P K + L + I EC + A R
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
Query: 315 TMVYAAKQLRQM 326
+ +++ QM
Sbjct: 305 SAGCVGERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 5e-44
Identities = 67/326 (20%), Positives = 125/326 (38%), Gaps = 49/326 (15%)
Query: 44 FSAGELKIATNNYNGHQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFC-FNNIV 101
+A E + +N ++I Y +YKG L+ RP++V F N +NF NI
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---SFANRQNFINEKNIY 59
Query: 102 FAAQMNHRNILKLIGCCIETEIPI-----LVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
M H NI + I LV E+ G+L + L W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSS 113
Query: 157 LKIAMEIGNAMAYIH------IGFRRPIVFKDIKLSQILFDEYNVAKLSDF------SES 204
++A + +AY+H ++ I +D+ +L +SDF + +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 205 EYIPEGETHVTSHMLTRTKRYLAPEYI-------LTGLCNEKTDVFCFGMLLLELLTGRR 257
+ GE + T RY+APE + ++ D++ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 258 DNILLEHVKKH-------VENNRLGEIVDPIVVEDK-------SCPEKEQQLQALLQLIF 303
D E V ++ V N+ E + +V +K + E +++L + I
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 304 ECVNESAGDRPTMVYAAKQLRQMYLS 329
+C ++ A R T A +++ ++ +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMI 319
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-34
Identities = 55/268 (20%), Positives = 108/268 (40%), Gaps = 38/268 (14%)
Query: 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127
+ K + +++ + + F + +++NH NI+KL G C+ LV
Sbjct: 23 VVCKAKWRAKDVAIKQI--ESESERKAFI-VELRQLSRVNHPNIVKLYGACLNP--VCLV 77
Query: 128 FEFVEYGTLADRICSPHGPHLEPLL-WRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
E+ E G+L + + HG P H + ++ +AY+H + ++ +D+K
Sbjct: 78 MEYAEGGSLYNVL---HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 187 QILFDE-YNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRYLAPEYILTGLCNEKTDVF 243
+L V K+ DF + + +HM + ++APE +EK DVF
Sbjct: 135 NLLLVAGGTVLKICDFGTA-------CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVF 187
Query: 244 CFGMLLLELLTGRR-----DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQAL 298
+G++L E++T R+ + R P+ K+ P+ +
Sbjct: 188 SWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-----PL---IKNLPK------PI 233
Query: 299 LQLIFECVNESAGDRPTMVYAAKQLRQM 326
L+ C ++ RP+M K + +
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-33
Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 26/270 (9%)
Query: 68 KLYKGFLENRP--ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125
+++ + ++ D ++E F + ++ H NI+ +G +
Sbjct: 52 TVHRAEWHGSDVAVKILMEQDFHAERVNEFL-REVAIMKRLRHPNIVLFMGAVTQPPNLS 110
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
+V E++ G+L + E L R RL +A ++ M Y+H PIV +++K
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKS 167
Query: 186 SQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCF 245
+L D+ K+ DF S + T ++S T ++APE + NEK+DV+ F
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 246 GMLLLELLTGRR--DNILLEHVKKHV--ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQL 301
G++L EL T ++ N+ V V + RL I ++ + +
Sbjct: 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCKRL-----EI---PRNLNP------QVAAI 271
Query: 302 IFECVNESAGDRPTMVYAAKQLRQMYLSAV 331
I C RP+ LR + SAV
Sbjct: 272 IEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 51/282 (18%)
Query: 68 KLYKGFLENRPISV----MKFGDNYSENGENFCFNN----IVFAAQMNHRNILKLIGCCI 119
++KG L V + GD+ E F + + +NH NI+KL G
Sbjct: 34 LVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM- 92
Query: 120 ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179
P +V EFV G L R+ P+ W +L++ ++I + Y+ PIV
Sbjct: 93 -HNPPRMVMEFVPCGDLYHRL---LDKA-HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIV 146
Query: 180 FKDIKLSQILFDEYN-----VAKLSDFSESEYIPEGETHVTSHMLTR---TKRYLAPEYI 231
+D++ I + AK++DF G + + H ++ +++APE I
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADF--------GLSQQSVHSVSGLLGNFQWMAPETI 198
Query: 232 LT--GLCNEKTDVFCFGMLLLELLTGRR-----DNILLEHVKKHVENNRLGEIVDPIVVE 284
EK D + F M+L +LTG ++ + E I P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI--P---- 252
Query: 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ CP + L +I C + RP Y K+L ++
Sbjct: 253 -EDCPPR------LRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 54/299 (18%), Positives = 114/299 (38%), Gaps = 40/299 (13%)
Query: 59 HQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFA-AQMNHRNILKLIG 116
+ I + ++++G ++V F S ++ ++ + H NIL I
Sbjct: 47 QESIGKGRFGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 117 CCIETEIPI----LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIH- 171
+ LV ++ E+G+L D + + + +K+A+ + +A++H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 172 ----IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRY 225
+ I +D+K IL + ++D + + R TKRY
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 226 LAPEYILTGLCN-------EKTDVFCFGMLLLELLTGRRDNILLEHVKK----HVENNRL 274
+APE +L N ++ D++ G++ E+ + E + V ++
Sbjct: 218 MAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276
Query: 275 GEIVDPIVVEDKSCPE------KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
E + +V E K P + L+ + +++ EC + R T + K L Q+
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-32
Identities = 67/275 (24%), Positives = 108/275 (39%), Gaps = 41/275 (14%)
Query: 68 KLYKGFLENRPISVMKF----GDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123
K+Y+ F ++V ++ S+ EN A + H NI+ L G C++
Sbjct: 22 KVYRAFWIGDEVAVKAARHDPDEDISQTIENVR-QEAKLFAMLKHPNIIALRGVCLKEPN 80
Query: 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI 183
LV EF G L + + + + A++I M Y+H PI+ +D+
Sbjct: 81 LCLVMEFARGGPLNRVL------SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134
Query: 184 KLSQILFDEY--------NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL 235
K S IL + + K++DF + T S ++APE I +
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSA--AGAYAWMAPEVIRASM 190
Query: 236 CNEKTDVFCFGMLLLELLTGRR--DNILLEHVKKHV--ENNRLGEIVDPIVVEDKSCPEK 291
++ +DV+ +G+LL ELLTG I V V L PI +CPE
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL-----PI---PSTCPE- 241
Query: 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+L+ +C N RP+ QL +
Sbjct: 242 -----PFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 57/288 (19%), Positives = 110/288 (38%), Gaps = 39/288 (13%)
Query: 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFA-AQMNHRNILKLIGCCIETEIPI- 125
+++ G ++V F ++ ++ ++ M H NIL I I+
Sbjct: 52 EVWMGKWRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108
Query: 126 ---LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIH-----IGFRRP 177
L+ ++ E G+L D + L + LK+A + + ++H +
Sbjct: 109 QLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA 162
Query: 178 IVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRYLAPEYILTGL 235
I +D+K IL + ++D + V TR TKRY+ PE +L
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDES 221
Query: 236 CN-------EKTDVFCFGMLLLELLTGRRDNILLEHVK----KHVENNRLGEIVDPIVVE 284
N D++ FG++L E+ ++E + V ++ E + IV
Sbjct: 222 LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCI 281
Query: 285 DK------SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
K + ++ L+ + +L+ EC + R T + K L +M
Sbjct: 282 KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 59/296 (19%), Positives = 120/296 (40%), Gaps = 38/296 (12%)
Query: 60 QVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFA-AQMNHRNILKLIGC 117
+ + Y ++++G + ++V F S + +++ ++ + H NIL I
Sbjct: 14 ECVGKGRYGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 118 CIETEIPI----LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIH-- 171
+ + L+ + E G+L D + L L L+I + I + +A++H
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 172 ---IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRYL 226
+ I +D+K IL + ++D + + + R TKRY+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 227 APE------YILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK----KHVENNRLGE 276
APE + ++ D++ FG++L E+ N ++E K V N+ E
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 277 IVDPIVVEDKSCPE------KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ +V D+ P + L +L +L+ EC ++ R T + K L ++
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 53/279 (18%), Positives = 95/279 (34%), Gaps = 36/279 (12%)
Query: 59 HQVIASEHY-KLYKGFLENRPISV--MKFGDNYSENGENFCFNNIVFAAQMNHRNILKLI 115
+ H +L+KG + I V +K D + +F +H N+L ++
Sbjct: 15 LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFN-EECPRLRIFSHPNVLPVL 73
Query: 116 GCCIETEIPIL--VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG 173
G C P + ++ YG+L + + H + +K A+++ MA++H
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARGMAFLH-T 129
Query: 174 FRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL- 232
I + ++ DE A++S M ++APE +
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKF-----SFQSPGRMYA--PAWVAPEALQK 182
Query: 233 --TGLCNEKTDVFCFGMLLLELLTGR---RDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287
D++ F +LL EL+T D +E K I P
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI--P-----PG 235
Query: 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ +L+ C+NE RP L +M
Sbjct: 236 ISP------HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 53/277 (19%), Positives = 98/277 (35%), Gaps = 33/277 (11%)
Query: 68 KLYKGFLENRPISV-MKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126
+ K + MK + E + + + H N+LK IG + +
Sbjct: 25 QAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNF 84
Query: 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
+ E+++ GTL I S W R+ A +I + MAY+H I+ +D+
Sbjct: 85 ITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSH 137
Query: 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR------------TKRYLAPEYILTG 234
L E ++DF + + + +T + ++APE I
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 235 LCNEKTDVFCFGMLLLELLTGRR--DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292
+EK DVF FG++L E++ + L + + + P +CP
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP-----PNCPP-- 250
Query: 293 QQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
+ + C + RP+ V L + +
Sbjct: 251 ----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-30
Identities = 47/228 (20%), Positives = 98/228 (42%), Gaps = 23/228 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H NIL +G ++ I V ++ E +L + H + + IA +
Sbjct: 76 KTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHL---HASE-TKFEMKKLIDIARQTA 130
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
M Y+H + I+ +D+K + I E N K+ DF + L+ +
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 225 YLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGR---RDNILLEHVKKHVENNRLGEIV 278
++APE I + + ++DV+ FG++L EL+TG+ + + + + V L +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247
Query: 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ +CP+ + +L+ EC+ + +RP+ ++ ++
Sbjct: 248 SKV---RSNCPK------RMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 47/274 (17%), Positives = 90/274 (32%), Gaps = 36/274 (13%)
Query: 68 KLYKGFLENR-PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126
++Y G I ++ + + + F ++ Q H N++ +G C+ +
Sbjct: 48 QVYHGRWHGEVAIRLIDIERDNEDQLKAFK-REVMAYRQTRHENVVLFMGACMSPPHLAI 106
Query: 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
+ + TL + L +IA EI M Y+H + I+ KD+K
Sbjct: 107 ITSLCKGRTLYSVV---RDAK-IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSK 159
Query: 187 QILFDEYNVAKLSDF---SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL-------- 235
+ +D V ++DF S S + G + +LAPE I
Sbjct: 160 NVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 236 -CNEKTDVFCFGMLLLELLTGRR--DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKE 292
++ +DVF G + EL E + + + +
Sbjct: 219 PFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS------QIGMGK-- 270
Query: 293 QQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ ++ C +RPT L ++
Sbjct: 271 ----EISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q +H NI++LIG C + + PI +V E V+ G + + G L + L++ +
Sbjct: 168 QYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGDFLTFLRT-EGARLRV---KTLLQMVGDA 222
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
M Y+ + + +D+ L E NV K+SDF S +G + +
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENNRLGEIVDP 280
++ APE + G + ++DV+ FG+LL E + G N+ + ++ VE G +
Sbjct: 280 KWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK---GGRLPC 336
Query: 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ CP+ A+ +L+ +C G RP+ ++L+ +
Sbjct: 337 ----PELCPD------AVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++ H N+++L+G C P ++ EF+ YG L D + + + L +A +I
Sbjct: 272 EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSA---VVLLYMATQI 327
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+AM Y+ ++ + +++ L E ++ K++DF S + G+T+
Sbjct: 328 SSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPI 383
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGEIVD 279
++ APE + + K+DV+ FG+LL E+ T G I L V + +E + R+
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER--- 440
Query: 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P + CPE + +L+ C + DRP+ + M+
Sbjct: 441 P-----EGCPE------KVYELMRACWQWNPSDRPSFAEIHQAFETMF 477
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 28/228 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++ H +++L +E PI +V E++ G+L D + G +L + +A +I
Sbjct: 318 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL---PQLVDMAAQI 372
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ MAY+ R V +D++ + IL E V K++DF + I + E K
Sbjct: 373 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 429
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGEIVD 279
+ APE L G K+DV+ FG+LL EL T GR ++ V VE R+
Sbjct: 430 -WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--- 485
Query: 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P CPE +L L+ +C + +RPT Y L +
Sbjct: 486 P-----PECPE------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
Q+ H N+++L+G +E + + +V E++ G+L D R + L LK ++
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSL 296
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--SESEYIPEGETHVTSHML 219
++ AM Y+ V +D+ +L E NVAK+SDF ++ +
Sbjct: 297 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-------- 345
Query: 220 TRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN- 272
K ++ APE + + K+DV+ FG+LL E+ + GR I L+ V VE
Sbjct: 346 --GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 403
Query: 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
++ P CP A+ ++ C + A RPT + +QL +
Sbjct: 404 KMDA---P-----DGCPP------AVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 28/228 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++ H +++L +E PI +V E++ G+L D + G +L + +A +I
Sbjct: 235 KLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL---PQLVDMAAQI 289
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ MAY+ R V +D++ + IL E V K++DF + I + E K
Sbjct: 290 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 346
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGEIVD 279
+ APE L G K+DV+ FG+LL EL T GR ++ V VE R+
Sbjct: 347 -WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC--- 402
Query: 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P CPE +L L+ +C + +RPT Y L +
Sbjct: 403 P-----PECPE------SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 7e-18
Identities = 48/243 (19%), Positives = 86/243 (35%), Gaps = 50/243 (20%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAME 162
+ NH+NI++ IG +++ ++ E + G L R P L L +A +
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 163 IGNAMAY------IHIGFRRPIVFKDIKLSQIL---FDEYNVAKLSDFSESEYIPEGETH 213
I Y IH +DI L VAK+ DF + I +
Sbjct: 149 IACGCQYLEENHFIH---------RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 214 VTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLE 263
+++ PE + G+ KTD + FG+LL E+ + + + +LE
Sbjct: 200 RKG---GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256
Query: 264 HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
V R+ + CP + +++ +C DRP +++
Sbjct: 257 FVT---SGGRMDPPKN--------CPG------PVYRIMTQCWQHQPEDRPNFAIILERI 299
Query: 324 RQM 326
Sbjct: 300 EYC 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 50/243 (20%), Positives = 88/243 (36%), Gaps = 50/243 (20%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAME 162
+ NH+NI++ IG +++ ++ E + G L R P L L +A +
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 163 IGNAMAY------IHIGFRRPIVFKDIKLSQIL---FDEYNVAKLSDFSESEYIPEGETH 213
I Y IH +DI L VAK+ DF + I +
Sbjct: 190 IACGCQYLEENHFIH---------RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 214 VTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLE 263
+++ PE + G+ KTD + FG+LL E+ + + + +LE
Sbjct: 241 RKG---GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297
Query: 264 HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
V R+ P K+CP + +++ +C DRP +++
Sbjct: 298 FVT---SGGRMDP---P-----KNCPG------PVYRIMTQCWQHQPEDRPNFAIILERI 340
Query: 324 RQM 326
Sbjct: 341 EYC 343
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 49/237 (20%), Positives = 98/237 (41%), Gaps = 38/237 (16%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPH---GPHLEPLLWRHRLKI 159
+ N ++++L+G + + +++ E + G L R P P L P +++
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + MAY++ V +D+ + E K+ DF + I E + +
Sbjct: 144 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG--- 197
Query: 220 TRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHVKKHV 269
+ R+++PE + G+ +DV+ FG++L E+ T G + +L V
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 254
Query: 270 ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
E L + P +CP+ L +L+ C + RP+ + +++
Sbjct: 255 EGGLLDK---P-----DNCPDM------LFELMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 49/246 (19%), Positives = 97/246 (39%), Gaps = 53/246 (21%)
Query: 105 QMNHRNILKLIGCCIETE-----IPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRL 157
+H N+++L+G CIE P+++ F++YG L L + L
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL-QTLL 150
Query: 158 KIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211
K ++I M Y +H +D+ + + ++DF S+ I G+
Sbjct: 151 KFMVDIALGMEYLSNRNFLH---------RDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
Query: 212 THVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GR-----RDNILL 262
+ K +++A E + + K+DV+ FG+ + E+ T G N
Sbjct: 202 YYRQG---RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--- 255
Query: 263 EHVKKHVEN-NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321
+ ++ + +RL + P + C ++ L ++++ C DRPT
Sbjct: 256 HEMYDYLLHGHRLKQ---P-----EDCLDE------LYEIMYSCWRTDPLDRPTFSVLRL 301
Query: 322 QLRQMY 327
QL ++
Sbjct: 302 QLEKLL 307
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 50/239 (20%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 105 QMNHRNILKLIGCCIETEIPIL-VFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
+H N+L L+G C+ +E L V ++++G L + R + + P ++ L + +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDL-----IGFGL 199
Query: 162 EIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
++ M + +H +D+ + DE K++DF + + + E
Sbjct: 200 QVAKGMKFLASKKFVH---------RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 216 SHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHV 269
H T K +++A E + T K+DV+ FG+LL EL+T G ++ + ++
Sbjct: 251 -HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 270 EN-NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
RL + P + CP+ L +++ +C + A RP+ ++ ++
Sbjct: 310 LQGRRLLQ---P-----EYCPD------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 48/250 (19%), Positives = 93/250 (37%), Gaps = 55/250 (22%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPH--------GPHLEPLLW 153
+ H++I++ G C E ++VFE++ +G L R P PL
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 154 RHRLKIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207
L +A ++ M Y +H +D+ L + V K+ DF S I
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVH---------RDLATRNCLVGQGLVVKIGDFGMSRDI 208
Query: 208 PEGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRR 257
+ + + RT R++ PE IL ++DV+ FG++L E+ T
Sbjct: 209 YSTDYY---RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 258 DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMV 317
+ ++ + + L P ++CP + + ++ C R ++
Sbjct: 266 NTEAIDCIT---QGRELER---P-----RACPPE------VYAIMRGCWQREPQQRHSIK 308
Query: 318 YAAKQLRQMY 327
+L+ +
Sbjct: 309 DVHARLQALA 318
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H ++KL T+ PI ++ EF+ G+L D + S G + + +I
Sbjct: 239 TLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL---PKLIDFSAQI 293
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MA+I +R + +D++ + IL V K++DF + I + E K
Sbjct: 294 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----AK 346
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGE 276
++ APE I G K+DV+ FG+LL+E++T GR + V + +E R+
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
P ++CPE L ++ C +RPT Y L Y +
Sbjct: 407 ---P-----ENCPE------ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-17
Identities = 48/240 (20%), Positives = 101/240 (42%), Gaps = 48/240 (20%)
Query: 105 QMNHRNILKLIGCCIETEIPIL-VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+H N+L L+G C+ +E L V ++++G L + I + + + + +++
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTV---KDLIGFGLQV 137
Query: 164 GNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
M Y +H +D+ + DE K++DF + + + E + +
Sbjct: 138 AKGMKYLASKKFVH---------RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHN 188
Query: 218 MLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR-----DNILLEHVKKH 268
T K +++A E + T K+DV+ FG+LL EL+T G + + +
Sbjct: 189 K-TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVY 244
Query: 269 VEN-NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ RL + P + CP+ L +++ +C + A RP+ ++ ++
Sbjct: 245 LLQGRRLLQ---P-----EYCPD------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 27/163 (16%)
Query: 102 FAAQMNHRNILKLI-----GCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
F A++ H +I+++ + +V E+V +L + L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEA 184
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG-ETHVT 215
+ +EI A++Y+H +V+ D+K I+ E + KL D G + +
Sbjct: 185 IAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDL--------GAVSRIN 232
Query: 216 SH-MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
S L T + APE I+ TD++ G L L
Sbjct: 233 SFGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 45/247 (18%), Positives = 94/247 (38%), Gaps = 54/247 (21%)
Query: 105 QMNHRNILKLIGCCIETE------IPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHR 156
+ +H ++ KL+G + + IP+++ F+++G L L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL-QTL 139
Query: 157 LKIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210
++ ++I M Y IH +D+ + E ++DF S I G
Sbjct: 140 VRFMVDIACGMEYLSSRNFIH---------RDLAARNCMLAEDMTVCVADFGLSRKIYSG 190
Query: 211 ETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNI 260
+ + +K ++LA E + L +DV+ FG+ + E++T G +
Sbjct: 191 DYYRQG---CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
Query: 261 LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320
+ ++ NRL + P C E+ + L+++C + RP+
Sbjct: 248 IYNYLI---GGNRLKQ---P-----PECMEE------VYDLMYQCWSADPKQRPSFTCLR 290
Query: 321 KQLRQMY 327
+L +
Sbjct: 291 MELENIL 297
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 45/232 (19%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
A +++ ++ +L+G C + L+ + + +G L D + H ++ ++ L ++
Sbjct: 72 ASVDNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVRE-HKDNIGS---QYLLNWCVQ 125
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I M Y+ R +V +D+ +L K++DF ++ + E +
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA---EGG 179
Query: 223 K---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NRLG 275
K +++A E IL + ++DV+ +G+ + EL+T G + D I + +E RL
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ P C + ++ +C A RP + +M
Sbjct: 240 Q---P-----PICTI------DVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 48/177 (27%), Positives = 83/177 (46%), Gaps = 30/177 (16%)
Query: 103 AAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
++Q++H+NI+ +I E + LV E++E TL++ I HGP L + +
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGP----LSVDTAINFTNQ 119
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG------ETHVT- 215
I + + + H IV +DIK IL D K+ DF G ET +T
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDF--------GIAKALSETSLTQ 168
Query: 216 SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR----DN---ILLEHV 265
++ + T +Y +PE +E TD++ G++L E+L G + I ++H+
Sbjct: 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-16
Identities = 47/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 103 AAQMNHRNILKL--IGC--CIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLK 158
AA +NH I+ + G +P +V E+V+ TL D + GP + + ++
Sbjct: 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGP----MTPKRAIE 120
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT-SH 217
+ + A+ + H + I+ +D+K + I+ N K+ DF + I + VT +
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR----DN---ILLEHVKKHVE 270
+ T +YL+PE + ++DV+ G +L E+LTG D+ + +HV++
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI 237
Query: 271 -----NNRLGEIVDPIV 282
+ L +D +V
Sbjct: 238 PPSARHEGLSADLDAVV 254
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 48/240 (20%), Positives = 99/240 (41%), Gaps = 31/240 (12%)
Query: 104 AQMNHRNILKLIGCCIET-EIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
+ H NI+K G C + L+ E++ YG+L D + H ++ L+
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDH---IKLLQYTS 121
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I M Y+ + + +D+ IL + N K+ DF ++ +P+ +
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK--EP 176
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEI 277
+ + APE + + +DV+ FG++L EL T + + + N++ G++
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 278 VDPIVVED----------KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ ++E CP+ + ++ EC N + RP+ A ++ Q+
Sbjct: 237 IVFHLIELLKNNGRLPRPDGCPD------EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-16
Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 34/233 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPIL-VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q+ H+ +++L T+ PI + E++E G+L D + +P G L L +A +I
Sbjct: 64 QLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQI 118
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MA+I R + +D++ + IL + K++DF + I + E K
Sbjct: 119 AEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG----AK 171
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGE 276
++ APE I G K+DV+ FG+LL E++T GR + V +++E R+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
P +CPE L QL+ C E DRPT Y L + +
Sbjct: 232 ---P-----DNCPE------ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 20/161 (12%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
H ++L E I L E +L + E +W
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW----GY 162
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+ A+A++H + +V D+K + I KL DF + +
Sbjct: 163 LRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLL-------VELGTAGA 212
Query: 220 TRTK----RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+ RY+APE +L G DVF G+ +LE+
Sbjct: 213 GEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 49/245 (20%), Positives = 93/245 (37%), Gaps = 44/245 (17%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHR----- 156
+ H +I+K G C + + I+VFE++++G L R P L R
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 157 ----LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212
L IA +I + M Y+ + V +D+ L + K+ DF S + +
Sbjct: 132 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 213 HVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILL 262
+ + T R++ PE I+ ++DV+ FG++L E+ T + ++
Sbjct: 189 Y---RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 263 EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322
E + + L P + CP++ + ++ C R + K
Sbjct: 246 ECIT---QGRVLER---P-----RVCPKE------VYDVMLGCWQREPQQRLNIKEIYKI 288
Query: 323 LRQMY 327
L +
Sbjct: 289 LHALG 293
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 40/236 (16%)
Query: 105 QMNHRNILKLIGCCIETE-IPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
+NH N+L LIG + E +P ++ ++ +G L R + P ++ L + +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDL-----ISFGL 131
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
++ M Y+ + V +D+ + DE K++DF + I + E + +
Sbjct: 132 QVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE-YYSVQQHRH 187
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR-----DNILLEHVKKHVEN- 271
+ ++ A E + T K+DV+ FG+LL ELLT G D + +
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQG 244
Query: 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
RL + P + CP+ +L Q++ +C RPT ++ Q+
Sbjct: 245 RRLPQ---P-----EYCPD------SLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 48/240 (20%), Positives = 100/240 (41%), Gaps = 31/240 (12%)
Query: 104 AQMNHRNILKLIGCCIET-EIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
+ H NI+K G C + L+ E++ YG+L D + H ++ L+
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK-HKERIDH---IKLLQYTS 152
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I M Y+ + + +D+ IL + N K+ DF ++ +P+ + +
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK--EP 207
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEI 277
+ + APE + + +DV+ FG++L EL T + + + N++ G++
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 278 VDPIVVED----------KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ ++E CP+ + ++ EC N + RP+ A ++ Q+
Sbjct: 268 IVFHLIELLKNNGRLPRPDGCPD------EIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 44/235 (18%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
Q+ H N+++L+G +E + + +V E++ G+L D R + L LK ++
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSL 124
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--SESEYIPEGETHVTSHML 219
++ AM Y+ V +D+ +L E NVAK+SDF ++ +
Sbjct: 125 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------- 171
Query: 220 TRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN- 272
K ++ APE + + K+DV+ FG+LL E+ + GR I L+ V VE
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 231
Query: 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
++ P CP A+ +++ C + A RP+ + +QL +
Sbjct: 232 KMDA---P-----DGCPP------AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
++ H N+++L+G C P ++ EF+ YG L D R C+ L L +A
Sbjct: 65 EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMAT 118
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I +AM Y+ ++ + +D+ L E ++ K++DF S + +
Sbjct: 119 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG---- 171
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NRL 274
K ++ APE + + K+DV+ FG+LL E+ T G I L V + +E R+
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 231
Query: 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P + CPE + +L+ C + DRP+ + M+
Sbjct: 232 ER---P-----EGCPE------KVYELMRACWQWNPSDRPSFAEIHQAFETMF 270
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 48/241 (19%), Positives = 95/241 (39%), Gaps = 34/241 (14%)
Query: 104 AQMNHRNILKLIGCCIET-EIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
++ I+K G + LV E++ G L D + H L+ L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-HRARLDA---SRLLLYSS 134
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I M Y+ R V +D+ IL + K++DF ++ +P + +
Sbjct: 135 QICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR--EP 189
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR----DNILLEHVKKHVENNR 273
+ + APE + + + ++DV+ FG++L EL T + L + +
Sbjct: 190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA 249
Query: 274 LGEIVDPIVVED-------KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
L +++ ++E+ +CP + +L+ C S DRP+ QL +
Sbjct: 250 LSRLLE--LLEEGQRLPAPPACPA------EVHELMKLCWAPSPQDRPSFSALGPQLDML 301
Query: 327 Y 327
+
Sbjct: 302 W 302
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 47/231 (20%), Positives = 97/231 (41%), Gaps = 34/231 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
++H +I++L+G C + LV +++ G+L D + G LL L ++
Sbjct: 70 GSLDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL----LNWGVQ 123
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I M Y+ +V +++ +L + +++DF ++ +P + + +
Sbjct: 124 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY---SEA 177
Query: 223 K---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLG 275
K +++A E I G ++DV+ +G+ + EL+T G + L V +E RL
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ P + C + ++ +C RPT A + +M
Sbjct: 238 Q---P-----QICTI------DVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-16
Identities = 55/235 (23%), Positives = 107/235 (45%), Gaps = 34/235 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+++H +++L G C+E PI LV EF+E+G L+D + + G L L + +++
Sbjct: 59 KLSHPKLVQLYGVCLEQA-PICLVTEFMEHGCLSDYLRTQRGLFAAETL----LGMCLDV 113
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
MAY+ ++ +D+ L E V K+SDF + ++ + + ++ TK
Sbjct: 114 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG----TK 166
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGE 276
++ +PE + K+DV+ FG+L+ E+ + G+ +N V + + RL +
Sbjct: 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 226
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSAV 331
P + + Q++ C E DRP +QL ++ S +
Sbjct: 227 ---P-----RLAST------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 50/239 (20%), Positives = 95/239 (39%), Gaps = 32/239 (13%)
Query: 104 AQMNHRNILKLIGCCIETEI-PI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
+ H NI+K G C E I L+ EF+ G+L + + + + + +LK A+
Sbjct: 78 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINL---KQQLKYAV 133
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I M Y+ R V +D+ +L + + K+ DF ++ I + + T
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK--DD 188
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEI 277
+ APE ++ +DV+ FG+ L ELLT D+ + K + G++
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH-GQM 247
Query: 278 VDPIVVED----------KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+V +CP+ + QL+ +C +R + + +
Sbjct: 248 TVTRLVNTLKEGKRLPCPPNCPD------EVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-16
Identities = 54/265 (20%), Positives = 91/265 (34%), Gaps = 37/265 (13%)
Query: 81 VMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP----ILVFEFVEYGTL 136
+K + + NH NIL+L+ C+ L+ F + GTL
Sbjct: 58 ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 137 ADRI--CSPHGPHL-EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193
+ I G L E + + + I + IH + +D+K + IL +
Sbjct: 118 WNEIERLKDKGNFLTEDQIL----WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDE 170
Query: 194 NVAKLSDF-SESEYIPEGETHVTSHMLTR------TKRYLAPEYILT---GLCNEKTDVF 243
L D S ++ E + L T Y APE + +E+TDV+
Sbjct: 171 GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230
Query: 244 CFGMLLLELLTGRRDNILLEHVKKH--VENNRLGEIVDPIVVEDKSCPEKEQQLQALLQL 301
G +L ++ G + + G+ V V S P+ + AL QL
Sbjct: 231 SLGCVLYAMMFG-----------EGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQL 279
Query: 302 IFECVNESAGDRPTMVYAAKQLRQM 326
+ + RP + QL +
Sbjct: 280 LNSMMTVDPHQRPHIPLLLSQLEAL 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-16
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 19/160 (11%)
Query: 106 MNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM--- 161
+ + L G I + +++E++E ++ + +++
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCII 157
Query: 162 -EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+ N+ +YIH + I +D+K S IL D+ KLSDF ESEY+ + +
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK------G 209
Query: 221 R--TKRYLAPEYILTGLC--NEKTDVFCFGMLLLELLTGR 256
T ++ PE+ K D++ G+ L +
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-16
Identities = 49/240 (20%), Positives = 96/240 (40%), Gaps = 45/240 (18%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
Q+++ I++LIG C + LV E G L + + + ++ +
Sbjct: 65 HQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFL-VGKREEIPVS---NVAELLHQ 118
Query: 163 IGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ M Y +H +D+ +L + AK+SDF S+ + +++ T+
Sbjct: 119 VSMGMKYLEEKNFVH---------RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169
Query: 217 HMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVE 270
+ K ++ APE I + ++DV+ +G+ + E L+ G++ + V +E
Sbjct: 170 R--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
Query: 271 NN-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
R+ P CP L L+ +C DRP + +++R Y S
Sbjct: 228 QGKRMEC---P-----PECPP------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 48/248 (19%), Positives = 96/248 (38%), Gaps = 56/248 (22%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHL---------EPLLWRH 155
H+NI+ L+G C + ++ E+ G L + R P G E + ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-------SESEYIP 208
+ ++ M Y+ + + +D+ +L E NV K++DF + Y
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 209 EGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDN 259
V +++APE + + ++DV+ FG+L+ E+ T G
Sbjct: 262 TTNGRLPV---------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 260 ILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYA 319
L + +K E +R+ + P +C + L ++ +C + RPT
Sbjct: 313 ELFKLLK---EGHRMDK---P-----ANCTNE------LYMMMRDCWHAVPSQRPTFKQL 355
Query: 320 AKQLRQMY 327
+ L ++
Sbjct: 356 VEDLDRIL 363
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 55/239 (23%), Positives = 91/239 (38%), Gaps = 32/239 (13%)
Query: 104 AQMNHRNILKLIGCCIET-EIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
+ H +I+K GCC + + LV E+V G+L D + H L L L A
Sbjct: 88 RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQL-----LLFAQ 141
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I MAY+H + + +D+ +L D + K+ DF ++ +PEG +
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR--ED 196
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEI 277
+ APE + +DV+ FG+ L ELLT + + +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256
Query: 278 VDPIV--VED-------KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
V + +E CP + L+ C A RPT L+ ++
Sbjct: 257 VLRLTELLERGERLPRPDKCPA------EVYHLMKNCWETEASFRPTFENLIPILKTVH 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-15
Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 49/249 (19%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-------------LVFEFVEYGTLADRICSPHGPHLEP 150
A +NH+ +++ +E + + E+ E GTL D I S +
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 151 LLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF--------- 201
WR + +I A++YIH + I+ +D+K I DE K+ DF
Sbjct: 117 EYWR----LFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 202 -SESEYIPEGETHVTSHMLTR--TKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRR 257
+ + + ++ + T Y+A E + TG NEK D++ G++ E++
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS 229
Query: 258 DNILLEHVKKHVENNRLGEIV-DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+ ++ K + R I P ++K EK+ +I ++ RP
Sbjct: 230 TGMERVNILKKL---RSVSIEFPPDFDDNKMKVEKK--------IIRLLIDHDPNKRPG- 277
Query: 317 VYAAKQLRQ 325
A+ L
Sbjct: 278 ---ARTLLN 283
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 32/230 (13%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H ++K G C + +V E++ G L + + S HG LEP L++ ++
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-HGKGLEP---SQLLEMCYDVC 114
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK- 223
MA++ + +D+ L D K+SDF + Y+ + + + TK
Sbjct: 115 EGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG----TKF 167
Query: 224 --RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGEI 277
++ APE + K+DV+ FG+L+ E+ + G+ D V V RL
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR- 226
Query: 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P + + Q+++ C +E RPT + +
Sbjct: 227 --P-----HLASD------TIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 48/248 (19%), Positives = 96/248 (38%), Gaps = 56/248 (22%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHL---------EPLLWRH 155
H+NI+ L+G C + ++ E+ G L + R P G E + ++
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-------SESEYIP 208
+ ++ M Y+ + + +D+ +L E NV K++DF + Y
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 215
Query: 209 EGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDN 259
V +++APE + + ++DV+ FG+L+ E+ T G
Sbjct: 216 TTNGRLPV---------KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 260 ILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYA 319
L + +K E +R+ + P +C + L ++ +C + RPT
Sbjct: 267 ELFKLLK---EGHRMDK---P-----ANCTNE------LYMMMRDCWHAVPSQRPTFKQL 309
Query: 320 AKQLRQMY 327
+ L ++
Sbjct: 310 VEDLDRIL 317
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 48/240 (20%), Positives = 96/240 (40%), Gaps = 45/240 (18%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
Q+++ I++LIG C + LV E G L + + + ++ +
Sbjct: 391 HQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVG-KREEIPVS---NVAELLHQ 444
Query: 163 IGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ M Y +H +++ +L + AK+SDF S+ + +++ T+
Sbjct: 445 VSMGMKYLEEKNFVH---------RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495
Query: 217 HMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVE 270
+ K ++ APE I + ++DV+ +G+ + E L+ G++ + V +E
Sbjct: 496 R--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
Query: 271 NN-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
R+ P CP L L+ +C DRP + +++R Y S
Sbjct: 554 QGKRMEC---P-----PECPP------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 45/232 (19%), Positives = 96/232 (41%), Gaps = 34/232 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
A +++ ++ +L+G C + L+ + + +G L D + H ++ ++ L ++
Sbjct: 72 ASVDNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVRE-HKDNIGS---QYLLNWCVQ 125
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I M Y+ R +V +D+ +L K++DF ++ + E +
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA---EGG 179
Query: 223 K---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NRLG 275
K +++A E IL + ++DV+ +G+ + EL+T G + D I + +E RL
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ P C + ++ +C A RP + +M
Sbjct: 240 Q---P-----PICTI------DVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 47/246 (19%), Positives = 96/246 (39%), Gaps = 50/246 (20%)
Query: 107 NHRNILKLIGCCIETEIPILV-FEFVEYGTLAD--RICSPHG---------PHLEPLLWR 154
+H N++ L+G C + P++V EF ++G L+ R + + L
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
H + + ++ M ++ R + +D+ IL E NV K+ DF + I + +V
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 215 TSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEH 264
+ +++APE I + ++DV+ FG+LL E+ + G + + E
Sbjct: 206 RK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EE 259
Query: 265 VKKHVEN-NRLGEIVDPIVVEDK--SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321
+ ++ R+ + + Q + +C + RPT +
Sbjct: 260 FCRRLKEGTRM----------RAPDYTTPE------MYQTMLDCWHGEPSQRPTFSELVE 303
Query: 322 QLRQMY 327
L +
Sbjct: 304 HLGNLL 309
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-15
Identities = 33/162 (20%), Positives = 56/162 (34%), Gaps = 23/162 (14%)
Query: 103 AAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
A ++ +++ + + + LA + GP L P + I +
Sbjct: 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGP-LAP---PRAVAIVRQ 142
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG------ETHVTS 216
IG+A+ H +D+K IL + A L DF G + +T
Sbjct: 143 IGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDF--------GIASATTDEKLTQ 191
Query: 217 H-MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T Y+APE + D++ +L E LTG
Sbjct: 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 53/242 (21%), Positives = 96/242 (39%), Gaps = 46/242 (19%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
Q+++ I+++IG C LV E E G L + H++ ++ +++ +
Sbjct: 73 QQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL--QQNRHVKD---KNIIELVHQ 125
Query: 163 IGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ M Y +H +D+ +L + AK+SDF S+ + E + +
Sbjct: 126 VSMGMKYLEESNFVH---------RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 176
Query: 217 HMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVE 270
T K ++ APE I + K+DV+ FG+L+ E + G++ + V +E
Sbjct: 177 Q--THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234
Query: 271 NN-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
R+G P CP + L+ C +RP +LR Y
Sbjct: 235 KGERMGC---P-----AGCPR------EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
Query: 330 AV 331
V
Sbjct: 281 VV 282
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 51/244 (20%), Positives = 100/244 (40%), Gaps = 48/244 (19%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHL---------EPLLWRH 155
H+NI+ L+G C + ++ E+ G L + + P G E L +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
+ A ++ M Y+ + + +D+ +L E NV K++DF + I + +
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 216 SHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNILLEHV 265
+ T + +++APE + + ++DV+ FG+LL E+ T G L + +
Sbjct: 250 T---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 266 KKHVENNRLGEIVDPIVVEDK--SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323
K E +R+ DK +C + L ++ +C + RPT + L
Sbjct: 307 K---EGHRM----------DKPSNCTNE------LYMMMRDCWHAVPSQRPTFKQLVEDL 347
Query: 324 RQMY 327
++
Sbjct: 348 DRIV 351
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-15
Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 35/231 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q +H +I+KLIG TE P+ ++ E G L + L+ + A ++
Sbjct: 72 QFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQV-RKYSLDL---ASLILYAYQL 125
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
A+AY+ + V +DI +L + KL DF S Y+ + + S K
Sbjct: 126 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK----GK 178
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN-NRLGE 276
+++APE I +DV+ FG+ + E+L G + + V +EN RL
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 238
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P +CP L L+ +C RP QL +
Sbjct: 239 ---P-----PNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-15
Identities = 48/248 (19%), Positives = 92/248 (37%), Gaps = 50/248 (20%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHR----- 156
A++ H N++ L+G + + ++F + +G L + + SPH R
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 157 ----LKIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206
+ + +I M Y +H KD+ +L + K+SD
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVH---------KDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 207 IPEGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNI 260
+ + + + R++APE I+ G + +D++ +G++L E+ + G +
Sbjct: 178 VYAADYYKLL---GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 261 LLEHVKKHVEN-NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYA 319
+ V + + N L P CP + L+ EC NE RP
Sbjct: 235 SNQDVVEMIRNRQVLPC---P-----DDCPA------WVYALMIECWNEFPSRRPRFKDI 280
Query: 320 AKQLRQMY 327
+LR
Sbjct: 281 HSRLRAWG 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-15
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 27/228 (11%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
Q +H +I+KLIG TE P+ ++ E G L + L+ + A +
Sbjct: 446 RQFDHPHIVKLIGVI--TENPVWIIMELCTLGELRSFLQV-RKFSLDLA---SLILYAYQ 499
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ A+AY+ + V +DI +L + KL DF S Y+ + + S
Sbjct: 500 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENNRLGEIVD 279
K ++APE I +DV+ FG+ + E+L G + + V +EN GE +
Sbjct: 557 K-WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GERLP 612
Query: 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+CP L L+ +C RP QL +
Sbjct: 613 M----PPNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 7e-15
Identities = 47/239 (19%), Positives = 97/239 (40%), Gaps = 50/239 (20%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
++H +++L G C + PI ++ E++ G L + R + + L++
Sbjct: 75 NLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLR---EMRHRFQT---QQLLEMCK 127
Query: 162 EIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
++ AM Y +H +D+ L ++ V K+SDF S Y+ + E +
Sbjct: 128 DVCEAMEYLESKQFLH---------RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 216 SHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHV 269
+K R+ PE ++ + K+D++ FG+L+ E+ + G+ + +H+
Sbjct: 179 VG----SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
Query: 270 ENN-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
RL P E + +++ C +E A +RPT + +
Sbjct: 235 AQGLRLYR---P-----HLASE------KVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 49/233 (21%), Positives = 93/233 (39%), Gaps = 34/233 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
++HRN+++L G P+ +V E G+L DR+ G L L + A++
Sbjct: 76 HSLDHRNLIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTL----SRYAVQ 129
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ M Y+ + + +D+ +L ++ K+ DF +P+ + H
Sbjct: 130 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ--EHR 184
Query: 223 K---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN--RL 274
K + APE + T + +D + FG+ L E+ T G+ + + ++ RL
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P + CP+ + ++ +C DRPT V L +
Sbjct: 245 PR---P-----EDCPQ------DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-15
Identities = 60/259 (23%), Positives = 105/259 (40%), Gaps = 64/259 (24%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHG---------------- 145
A+ ++ NI+KL+G C + L+FE++ YG L + R SPH
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 146 -PHLEPLLWRHRLKIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
P PL +L IA ++ MAY +H +D+ L E V K+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH---------RDLATRNCLVGENMVVKI 215
Query: 199 SDFSESEYIPEGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT- 254
+DF S I + + R++ PE I ++DV+ +G++L E+ +
Sbjct: 216 ADFGLSRNIYSADYYK---ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 255 ------GRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNE 308
G ++ +V+ + N L P ++CP + L L+ C ++
Sbjct: 273 GLQPYYGMAHEEVIYYVR---DGNILAC---P-----ENCPLE------LYNLMRLCWSK 315
Query: 309 SAGDRPTMVYAAKQLRQMY 327
DRP+ + L++M
Sbjct: 316 LPADRPSFCSIHRILQRMC 334
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 32/232 (13%)
Query: 104 AQMNHRNILKLIGCCIETEIPIL-VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
Q +H NI++L G + V E++E G+L + + G L + +
Sbjct: 105 GQFDHPNIIRLEGVVTRGR-LAMIVTEYMENGSLDTFLRTHDGQFTIMQL----VGMLRG 159
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+G M Y+ V +D+ +L D V K+SDF S + + ++ T
Sbjct: 160 VGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGG 214
Query: 223 K---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLG 275
K R+ APE I + +DV+ FG+++ E+L G R N+ V VE RL
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P CP AL QL+ +C ++ RP L +
Sbjct: 275 A---P-----MGCPH------ALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-14
Identities = 39/155 (25%), Positives = 64/155 (41%), Gaps = 10/155 (6%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL-EPLLWRHRLKIAME 162
A M H NI++ E +V ++ E G L RI + G E + ++
Sbjct: 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQ 133
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
I A+ ++H R I+ +DIK I + +L DF + + + T
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
YL+PE N K+D++ G +L EL T +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 47/237 (19%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++H +I+KLIG E P ++ E YG L + + L+ L + +++I
Sbjct: 69 NLDHPHIVKLIGII--EEEPTWIIMELYPYGELGHYLER-NKNSLKVL---TLVLYSLQI 122
Query: 164 GNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
AMAY +H +DI + IL KL DF S YI + + + S
Sbjct: 123 CKAMAYLESINCVH---------RDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 218 MLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVEN 271
T+ ++++PE I +DV+ F + + E+L+ G++ + + V +E
Sbjct: 174 ----TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK 229
Query: 272 N-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
RL + P CP L L+ C + DRP L +Y
Sbjct: 230 GDRLPK---P-----DLCPP------VLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 33/221 (14%), Positives = 64/221 (28%), Gaps = 25/221 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+K + +LV E YGTL + I + + + AM +
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF-----------DEYNVAKLSDFSESEYIPEGETH 213
+ +H I+ DIK + D L D +S +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 214 VTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGR--------RDNILLEH 264
T + E +L+ N + D F + +L G +
Sbjct: 240 TIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298
Query: 265 VKKHVENNRLGEIVDPIV-VEDKSCPEKEQQLQALLQLIFE 304
++ + E ++ + D L+ L+ +F+
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 30/231 (12%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q +H NI++L G +++ ++V E++E G+L + L + + I
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL----VGMLRGI 156
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ M Y+ V +D+ IL + V K+SDF + + ++ K
Sbjct: 157 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGK 211
Query: 224 ---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RLGE 276
R+ +PE I +DV+ +G++L E+++ G R + + V K V+ RL
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP 271
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P CP AL QL+ +C + +RP L ++
Sbjct: 272 ---P-----MDCPA------ALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 49/244 (20%), Positives = 93/244 (38%), Gaps = 51/244 (20%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHL-------EPLLWRHRL 157
H NI+ L+G C +++ E+ YG L + R S R L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-------SESEYIPEG 210
+ ++ MA++ + + +D+ +L +VAK+ DF ++S YI +G
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 224
Query: 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNI-LL 262
L +++APE I + ++DV+ +G+LL E+ + G N
Sbjct: 225 NA-----RL--PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277
Query: 263 EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322
+ VK + ++ + P P+ + ++ C RPT
Sbjct: 278 KLVK---DGYQMAQ---P-----AFAPKN------IYSIMQACWALEPTHRPTFQQICSF 320
Query: 323 LRQM 326
L++
Sbjct: 321 LQEQ 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 55/325 (16%), Positives = 103/325 (31%), Gaps = 47/325 (14%)
Query: 6 RKTKNQEKVDKKTFLRNG-----KILLEKLIISCDGKRNPIRSFSAGELKIATNNYNGHQ 60
K + K+ L N K++ E ++ +R F+A
Sbjct: 27 NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86
Query: 61 VIASEHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE 120
I + S + + I + +N + +
Sbjct: 87 EIWLKDESTDWPLS--------------SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 121 TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVF 180
+ + L D + LE L I ++I A+ ++H + ++
Sbjct: 133 KVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMH 187
Query: 181 KDIKLSQILFDEYNVAKLSDF-------SESEYIPEGETHVTSHMLTR---TKRYLAPEY 230
+D+K S I F +V K+ DF + E T TK Y++PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 231 ILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPE 290
I + K D+F G++L ELL + + V N + P++ K E
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKF-----PLLFTQKYPQE 302
Query: 291 KEQQLQALLQLIFECVNESAGDRPT 315
++ + ++ S +RP
Sbjct: 303 H--------MMVQDMLSPSPTERPE 319
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 51/250 (20%), Positives = 91/250 (36%), Gaps = 65/250 (26%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHL---------EPLLWRH 155
+H NI+ L+G C L E+ +G L D R L +
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 156 RLKIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF----SESE 205
L A ++ M Y IH +D+ IL E VAK++DF +
Sbjct: 144 LLHFAADVARGMDYLSQKQFIH---------RDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 206 YIPEGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRD--N 259
Y+ + T + R++A E + + +DV+ +G+LL E+++ G
Sbjct: 195 YVKK----------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
Query: 260 ILLEHVKKHVEN-NRLGEIVDPIVVEDK--SCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+ + + + RL +K +C + + L+ +C E +RP+
Sbjct: 245 MTCAELYEKLPQGYRL----------EKPLNCDD------EVYDLMRQCWREKPYERPSF 288
Query: 317 VYAAKQLRQM 326
L +M
Sbjct: 289 AQILVSLNRM 298
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 7e-14
Identities = 22/184 (11%), Positives = 59/184 (32%), Gaps = 25/184 (13%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEF-VEYGTLADRI--CSPHGPHLEPLLWRHRLKIAME 162
+ ++++ + + F + L H + L+ RL++ ++
Sbjct: 160 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 219
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ +A +H +V ++ I+ D+ L+ F + +G + V+
Sbjct: 220 VIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGASAVSPI----G 270
Query: 223 KRYLAPEYI----------LTGLCNEKTDVFCFGMLLLELLTGR---RDNILLEHVKKHV 269
+ + PE L D + G+ + + D+ L +
Sbjct: 271 RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIF 330
Query: 270 ENNR 273
+ +
Sbjct: 331 RSCK 334
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 33/157 (21%), Positives = 58/157 (36%), Gaps = 16/157 (10%)
Query: 105 QMNHRNILKLIGCCIETEIP----ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIA 160
+ H NI++ T +LV E + GTL ++ + R
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT-YLKRFK-VMKIKVLR---SWC 135
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYIPEGETHVTSHML 219
+I + ++H PI+ +D+K I K+ D + + +
Sbjct: 136 RQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAV 190
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T ++APE +E DV+ FGM +LE+ T
Sbjct: 191 IGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-14
Identities = 53/233 (22%), Positives = 92/233 (39%), Gaps = 34/233 (14%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAM 161
Q +H NI++L G + + +++ E++E G L R L + +
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVL---QLVGMLR 154
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
I M Y+ V +D+ IL + V K+SDF S + + ++ +
Sbjct: 155 GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--ATYTTSG 209
Query: 222 TK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRR--DNILLEHVKKHVENN-RL 274
K R+ APE I +DV+ FG+++ E++T G R + V K + + RL
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269
Query: 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
P CP A+ QL+ +C + RP L ++
Sbjct: 270 PT---P-----MDCPS------AIYQLMMQCWQQERARRPKFADIVSILDKLI 308
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 43/234 (18%), Positives = 79/234 (33%), Gaps = 40/234 (17%)
Query: 104 AQMNHRNILKLIGCCIETEIPI------------LVFEFVEYGTLADRICSPHGPHLEPL 151
A++ H I++ +E + + L D +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE- 116
Query: 152 LWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF-------SES 204
L I ++I A+ ++H + ++ +D+K S I F +V K+ DF +
Sbjct: 117 -RSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 205 EYIPEGETHVTSHMLTR---TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL 261
E T TK Y++PE I + K D+F G++L ELL +
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQME 232
Query: 262 LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315
V N + P Q+ ++ + ++ S +RP
Sbjct: 233 RVRTLTDVRNLKFP-------------PLFTQKYPCEYVMVQDMLSPSPMERPE 273
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 43/247 (17%), Positives = 86/247 (34%), Gaps = 51/247 (20%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHG-----------PHLEPLLW 153
NH NI+ L+G C +++ E+ YG L + R L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
L + ++ MA++ + + +D+ IL + K+ DF + I +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 214 VTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRDNI-LL 262
V + +++APE I + ++DV+ +G+ L EL + G +
Sbjct: 202 VVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 263 EHVKKHVENNRLGEIVDPIVVEDK--SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320
+ +K E R+ P + + ++ C + RPT
Sbjct: 259 KMIK---EGFRM----------LSPEHAPAE------MYDIMKTCWDADPLKRPTFKQIV 299
Query: 321 KQLRQMY 327
+ + +
Sbjct: 300 QLIEKQI 306
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 27/171 (15%)
Query: 104 AQMNHRNILKLIGCCIETEIPI----------------LVFEFVEYGTLADRICSPHGPH 147
A+++H NI+ GC + + EF + GTL I G
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 148 L-EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206
L + L ++ +I + YIH + ++ +D+K S I + K+ DF
Sbjct: 119 LDKVLAL----ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171
Query: 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+ S T RY++PE I + ++ D++ G++L ELL
Sbjct: 172 LKNDGKRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRI--CSPHGPHL-EPLLWRHRLKIA 160
Q+NH N++K IE +V E + G L+ I + E +W K
Sbjct: 87 KQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW----KYF 142
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+++ +A+ ++H R ++ +DIK + + V KL D + T S L
Sbjct: 143 VQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LV 197
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T Y++PE I N K+D++ G LL E+ +
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 18/155 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H NIL++ I L+ EF G L + HG E R + E+
Sbjct: 70 HLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL-QKHGRFDEQ---RSATFME-EL 123
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR-- 221
+A+ Y H R ++ +DIK +L K++DF S + P T
Sbjct: 124 ADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR------TMCG 174
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T YL PE I +EK D++C G+L E L G
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 57/263 (21%), Positives = 97/263 (36%), Gaps = 76/263 (28%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHG----------------- 145
Q+NH +++KL G C + +L+ E+ +YG+L R G
Sbjct: 82 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 146 PHLEPLLWRHRLKIAMEIGNAMAY------IHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199
P L + A +I M Y +H R D+ IL E K+S
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMKLVH---R------DLAARNILVAEGRKMKIS 192
Query: 200 DF-------SESEYIPEGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLL 250
DF E Y+ + V +++A E + + ++DV+ FG+LL
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPV---------KWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 251 ELLT-------GRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIF 303
E++T G L +K +R+ P +C E+ + +L+
Sbjct: 244 EIVTLGGNPYPGIPPERLFNLLK---TGHRMER---P-----DNCSEE------MYRLML 286
Query: 304 ECVNESAGDRPTMVYAAKQLRQM 326
+C + RP +K L +M
Sbjct: 287 QCWKQEPDKRPVFADISKDLEKM 309
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 40/153 (26%), Positives = 64/153 (41%), Gaps = 14/153 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H NIL+L G + L+ E+ GT+ + E E+
Sbjct: 65 HLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFDEQ----RTATYITEL 118
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
NA++Y H + ++ +DIK +L K++DF S + P L T
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTD---LCGTL 171
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
YL PE I + +EK D++ G+L E L G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 20/165 (12%), Positives = 54/165 (32%), Gaps = 23/165 (13%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEF-VEYGTLADRICS--PHGPHLEPLLWRHRLKIAME 162
+ ++++ + + F + L H + L+ RL++ ++
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ +A +H +V ++ I+ D+ L+ F + +G V+S +
Sbjct: 215 VIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGARVVSSV----S 265
Query: 223 KRYLAPEYILTGLC-----------NEKTDVFCFGMLLLELLTGR 256
+ + PE D + G+++ +
Sbjct: 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 44/244 (18%), Positives = 80/244 (32%), Gaps = 44/244 (18%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRI--CSPHGPHL-EPLLWRHR 156
A H ++++ E + ++ E+ G+LAD I + E L
Sbjct: 62 YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK--- 118
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET---- 212
+ +++G + YIH +V DIK S I ++ + E
Sbjct: 119 -DLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 213 -----HVTSHMLTRTK----RYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILL 262
HVT + + R+LA E + K D+F + ++
Sbjct: 175 IGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA------- 227
Query: 263 EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQL-QALLQLIFECVNESAGDRPTMVYAAK 321
+ + N G+ I P Q L Q +L+ ++ RP+ A
Sbjct: 228 ----EPLPRN--GDQWHEIR--QGRLPRIPQVLSQEFTELLKVMIHPDPERRPS----AM 275
Query: 322 QLRQ 325
L +
Sbjct: 276 ALVK 279
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 7e-13
Identities = 38/153 (24%), Positives = 61/153 (39%), Gaps = 13/153 (8%)
Query: 106 MNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H +IL+L E + LV E G + + + P E +I
Sbjct: 68 LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII---- 122
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI-PEGETHVTSHMLTRTK 223
M Y+H I+ +D+ LS +L K++DF + + E H T L T
Sbjct: 123 TGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---LCGTP 176
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y++PE ++DV+ G + LL GR
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 15/155 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q++H NI+KL + LV E G L D I S E +I ++
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSE----VDAARIIRQVL 136
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ + Y+H + IV +D+K +L + ++ DF S + +
Sbjct: 137 SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KIG 190
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE +L G +EK DV+ G++L LL+G
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 12/158 (7%)
Query: 104 AQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
A ++ I+ L G E + E +E G+L + G E L +
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQMGCLPEDRA----LYYLGQA 159
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSESEYIPE---GETHVTSHML 219
+ Y+H R I+ D+K +L + A L DF + + G++ +T +
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T+ ++APE ++ C+ K D++ ++L +L G
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++H NI+KL + LV E + G L D I E I ++
Sbjct: 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNE----VDAAVIIKQVL 146
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ + Y+H + IV +D+K +L ++ + K+ DF S +
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLG 200
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T Y+APE +L +EK DV+ G++L LL G
Sbjct: 201 TAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 13/161 (8%)
Query: 104 AQMNHRNILKLIGCCIETEIPIL--VFEFVEYGTLADRI--CSPHGPHL-EPLLWRHRLK 158
++ H NI++ I+ L V E+ E G LA I + +L E + R
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR---- 115
Query: 159 IAMEIGNAMAYIH--IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ ++ A+ H ++ +D+K + + D KL DF + + + +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT 175
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T Y++PE + NEK+D++ G LL EL
Sbjct: 176 --FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-12
Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 14/154 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H++++ G E + +V E +L + EP +I
Sbjct: 97 SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARY----YLRQI 150
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI-PEGETHVTSHMLTRT 222
Y+H R ++ +D+KL + +E K+ DF + + +GE L T
Sbjct: 151 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGT 204
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y+APE + + + DV+ G ++ LL G+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 33/154 (21%), Positives = 62/154 (40%), Gaps = 14/154 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H++++ G E + +V E +L + EP +I
Sbjct: 71 SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARY----YLRQI 124
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI-PEGETHVTSHMLTRT 222
Y+H R ++ +D+KL + +E K+ DF + + +GE L T
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGT 178
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y+APE + + + DV+ G ++ LL G+
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 30/174 (17%), Positives = 64/174 (36%), Gaps = 30/174 (17%)
Query: 107 NHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHR--LKIAMEI 163
+H N+++ C T+ + + E L D + S + L + + + +I
Sbjct: 67 DHPNVIRYY-CSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFD-------------EYNVAKLSDFSESEYIPEG 210
+ +A++H I+ +D+K IL E +SDF + + G
Sbjct: 125 ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 211 ETHVTSHMLTR--TKRYLAPEYILTGL-------CNEKTDVFCFGMLLLELLTG 255
++ +++ T + APE + D+F G + +L+
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 6e-12
Identities = 36/165 (21%), Positives = 65/165 (39%), Gaps = 23/165 (13%)
Query: 105 QMNHRNILKLIGCCIETE-------IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRL 157
++NH N++ + +P+L E+ E G L + + L
Sbjct: 68 KLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIR 124
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLSDFSESEYIPEGETHV 214
+ +I +A+ Y+H I+ +D+K I+ + K+ D ++ + +GE
Sbjct: 125 TLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-- 179
Query: 215 TSHMLTR--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T +YLAPE + D + FG L E +TG R
Sbjct: 180 ---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 15/156 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H NI+KL ++ +V E G L D I E +I ++
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSE----HDAARIIKQVF 131
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ + Y+H + IV +D+K IL ++ K+ DF S +
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T Y+APE +L G +EK DV+ G++L LL+G
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP 220
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 44/249 (17%), Positives = 88/249 (35%), Gaps = 52/249 (20%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHR-------- 156
+H NI+ L+G C + L+FE+ YG L + R E +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 157 --------LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208
L A ++ M ++ + V +D+ +L V K+ DF + I
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 209 EGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT-------GRRD 258
+V + +++APE + G+ K+DV+ +G+LL E+ + G
Sbjct: 224 SDSNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280
Query: 259 NI-LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMV 317
+ + ++ ++ + P E+ + ++ C + RP+
Sbjct: 281 DANFYKLIQ---NGFKMDQ---P-----FYATEE------IYIIMQSCWAFDSRKRPSFP 323
Query: 318 YAAKQLRQM 326
L
Sbjct: 324 NLTSFLGCQ 332
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 44/243 (18%), Positives = 93/243 (38%), Gaps = 52/243 (21%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRLKIAME 162
+++H++++ G C+ + ILV EFV++G+L + + + L +L++A +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINIL---WKLEVAKQ 121
Query: 163 IGNAMAY------IH--IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
+ AM + IH + + ++ ++ KLSD S + +
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDI-- 176
Query: 215 TSHMLTRTK---RYLAPEYILTGLC-NEKTDVFCFGMLLLELLT-GRR--DNILLEHVKK 267
+ ++ PE I N TD + FG L E+ + G + + + +
Sbjct: 177 -------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229
Query: 268 HVENN-RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
E+ +L P+ + L LI C++ RP+ + L +
Sbjct: 230 FYEDRHQL------------PAPKAAE----LANLINNCMDYEPDHRPSFRAIIRDLNSL 273
Query: 327 YLS 329
+
Sbjct: 274 FTP 276
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 14/158 (8%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGP--HLEPLLWRHRLKIAME 162
+ H+NI++ +G E + E V G+L+ + S GP E + +
Sbjct: 75 HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI----GFYTKQ 130
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYIPEGETHVTSHMLTR 221
I + Y+H IV +DIK +L + Y+ V K+SDF S+ + + T
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTG 185
Query: 222 TKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGRR 257
T +Y+APE I G + D++ G ++E+ TG+
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 32/160 (20%), Positives = 62/160 (38%), Gaps = 21/160 (13%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
H N+++ + + + E TL + + HL + + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG----LEPITLLQQTTSG 130
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYN-----VAKLSDFSESEYIPEGETHVTSHMLTR 221
+A++H IV +D+K IL N A +SDF + + G H S
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-HSFSRRSGV 186
Query: 222 --TKRYLAPEYILTGLCN----EKTDVFCFGMLLLELLTG 255
T+ ++APE +L+ C D+F G + +++
Sbjct: 187 PGTEGWIAPE-MLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 11/156 (7%), Positives = 33/156 (21%), Gaps = 15/156 (9%)
Query: 107 NHRNILKLIGCCIETEIP--ILVFEFVEYGTLADRI--CSPHGPHLEPLLWRHRLKIAME 162
+ +L + + +L+ L + +
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQ 202
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ A + + +V + L D S + +
Sbjct: 203 LIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVP 254
Query: 223 KRYLAPEYILTGLC--NEKTDVFCFGMLLLELLTGR 256
Y E++ + + G+ + +
Sbjct: 255 VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 15/156 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++H NI+KL + + LV EF E G L ++I + E I +I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDE----CDAANIMKQIL 156
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ + Y+H + IV +DIK IL + K+ DF S + +
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL---G 210
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
T Y+APE +L NEK DV+ G+++ LL G
Sbjct: 211 TAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 24/167 (14%)
Query: 105 QMNHRNILKLIGCCIETEIP---ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
++NH+NI+KL E +L+ EF G+L + P + L L +
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLR 119
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSH 217
++ M ++ IV ++IK I+ D +V KL+DF + + + E V+ +
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 218 MLTRTKRYLAPEYILTGLC--------NEKTDVFCFGMLLLELLTGR 256
T+ YL P+ + D++ G+ TG
Sbjct: 177 ---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 36/169 (21%), Positives = 66/169 (39%), Gaps = 28/169 (16%)
Query: 105 QMNHRNILKLIGCCIETE---IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
++NH+NI+KL E +L+ EF G+L + P + L L +
Sbjct: 63 KLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPS--NAYGLPESEFLIVLR 119
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSH 217
++ M ++ IV ++IK I+ D +V KL+DF + + + E
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-----Q 171
Query: 218 MLTR--TKRYLAPEYILTGLC--------NEKTDVFCFGMLLLELLTGR 256
++ T+ YL P+ + D++ G+ TG
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 32/163 (19%), Positives = 54/163 (33%), Gaps = 21/163 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q + I++L I + +V E L + +
Sbjct: 84 QQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWER----KSYWKNML 137
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
A+ IH + IV D+K + L + + KL DF + + T V T
Sbjct: 138 EAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 225 YLAPEYIL-----------TGLCNEKTDVFCFGMLLLELLTGR 256
Y+ PE I + K+DV+ G +L + G+
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 17/155 (10%), Positives = 42/155 (27%), Gaps = 39/155 (25%)
Query: 103 AAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
++++ + +++ ++V E++ G+L + + P ++
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-------GAIRAMQS 137
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ A H R + S++ L+
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP--------------------- 173
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+ N + D+ G L LL R
Sbjct: 174 -ATMPDA-------NPQDDIRGIGASLYALLVNRW 200
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 50/275 (18%), Positives = 90/275 (32%), Gaps = 54/275 (19%)
Query: 81 VMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIP-------ILVFEFVE 132
+K + E + F ++ H NI++ + L+ +
Sbjct: 57 ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC 116
Query: 133 YGTLADRI--CSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190
G L + + GP + LKI + A+ ++H + PI+ +D+K+ +L
Sbjct: 117 KGQLVEFLKKMESRGPLSCDTV----LKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLL 171
Query: 191 DEYNVAKLSDF-------------SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC- 236
KL DF ++ E +T + T Y PE I
Sbjct: 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT---TPMYRTPEIIDLYSNF 228
Query: 237 --NEKTDVFCFGMLLLELLTGR---RDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEK 291
EK D++ G +L L + D L IV S P
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----------------IVNGKYSIPPH 271
Query: 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ Q LI + + +R ++ QL+++
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 32/163 (19%), Positives = 54/163 (33%), Gaps = 21/163 (12%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q + I++L I + +V E L + +
Sbjct: 65 QQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWER----KSYWKNML 118
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
A+ IH + IV D+K + L + + KL DF + + T V T
Sbjct: 119 EAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 225 YLAPEYIL-----------TGLCNEKTDVFCFGMLLLELLTGR 256
Y+ PE I + K+DV+ G +L + G+
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 106 MNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+NH NI+KL IETE + L+ E+ G + D + + HG E +I
Sbjct: 71 LNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVA-HGRMKEK----EARSKFRQIV 124
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
+A+ Y H ++ IV +D+K +L D K++DF S G
Sbjct: 125 SAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF---CGAPP 178
Query: 225 YLAPEYILTGLCNE--KTDVFCFGMLLLELLTGR 256
Y APE + G + + DV+ G++L L++G
Sbjct: 179 YAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 28/162 (17%)
Query: 106 MNHRNILKL---IGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
++H N++KL + E + +VFE V G + + P E + +
Sbjct: 93 LDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPT--LKPLSEDQARFY----FQD 145
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ + Y+H + I+ +DIK S +L E K++DF S S L
Sbjct: 146 LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVS------NEFKGSDALLSN 196
Query: 223 K----RYLAPEYILTGLCNE----KTDVFCFGMLLLELLTGR 256
++APE L+ DV+ G+ L + G+
Sbjct: 197 TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 41/175 (23%), Positives = 75/175 (42%), Gaps = 27/175 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++H NI++L E I LV E G L +R+ E +I ++
Sbjct: 62 SLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVH-KRVFRE----SDAARIMKDV 115
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+A+AY H + + +D+K LF + KL DF + G+ M T
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-----MRT 167
Query: 221 R--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
+ T Y++P+ +L GL + D + G+++ LL G D+ ++ +++
Sbjct: 168 KVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 40/166 (24%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 106 MNHRNILKLIG-----------CCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLW 153
+N R +L L+ T + + + + G L + S HG E
Sbjct: 237 LNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEA--- 292
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
R A EI + ++H R +V++D+K + IL DE+ ++SD + + + H
Sbjct: 293 DMRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 214 VTSHMLTR--TKRYLAPEYILTGLCNEKT-DVFCFGMLLLELLTGR 256
T Y+APE + G+ + + D F G +L +LL G
Sbjct: 349 ------ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 25/174 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++H NI+KL ++ +V E G L D I E +I ++
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSE----HDAARIIKQVF 131
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ + Y+H + IV +D+K IL ++ K+ DF S + M R
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-----MKDR 183
Query: 222 --TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR------DNILLEHVKK 267
T Y+APE +L G +EK DV+ G++L LL+G + +L+ V+
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 24/160 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++NH I+K+ + E +V E +E G L D++ + E ++
Sbjct: 196 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG-NKRLKE----ATCKLYFYQML 249
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
A+ Y+H I+ +D+K +L +E + K++DF S+ + E M T
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-----MRTL 301
Query: 222 --TKRYLAPEYILTGLC----NEKTDVFCFGMLLLELLTG 255
T YLAPE +L + N D + G++L L+G
Sbjct: 302 CGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 30/161 (18%), Positives = 52/161 (32%), Gaps = 21/161 (13%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
+ I++L I + +V E L + + A
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWER----KSYWKNMLEA 167
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYL 226
+ IH + IV D+K + L + + KL DF + + T V Y+
Sbjct: 168 VHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 227 APEYIL-----------TGLCNEKTDVFCFGMLLLELLTGR 256
PE I + K+DV+ G +L + G+
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 43/178 (24%), Positives = 72/178 (40%), Gaps = 29/178 (16%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICS---PHGPHLEPLLWRHRLKIA 160
++H NI+K+ E + +V E E G L +RI S E + ++
Sbjct: 76 SLDHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSE----GYVAELM 130
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSH 217
++ NA+AY H + +V KD+K ILF ++ K+ DF +E E
Sbjct: 131 KQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH----- 182
Query: 218 MLTR--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR------DNILLEHVKK 267
T Y+APE + K D++ G+++ LLTG + +
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
E+ A+ Y+ + I+ +D+K IL DE+ ++DF+ + +P T +
Sbjct: 123 ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAG 176
Query: 222 TKRYLAPEYILTGLC---NEKTDVFCFGMLLLELLTGRR 257
TK Y+APE + + D + G+ ELL GRR
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 31/153 (20%), Positives = 63/153 (41%), Gaps = 12/153 (7%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H ++ L + ++++EF+ G L +++ H E ++ ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE----DEAVEYMRQVC 265
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF--DEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ ++H V D+K I+F N KL DF + ++ ++ + T T
Sbjct: 266 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGT 319
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+ APE TD++ G+L LL+G
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 3e-08
Identities = 46/212 (21%), Positives = 69/212 (32%), Gaps = 54/212 (25%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRL------ 157
+++H NI +L E E I LV E G L D++
Sbjct: 84 KLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 158 -----------------------------KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188
I +I +A+ Y+H + I +DIK
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENF 199
Query: 189 LF--DEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRYLAPEYILTGLC---NEKTD 241
LF ++ KL DF S+ + M T+ T ++APE +L K D
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCD 258
Query: 242 VFCFGMLLLELLTGRR------DNILLEHVKK 267
+ G+LL LL G D + V
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLN 290
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 24/160 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++NH I+K+ + E +V E +E G L D++ + E ++
Sbjct: 71 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG-NKRLKE----ATCKLYFYQML 124
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
A+ Y+H I+ +D+K +L +E + K++DF S+ + E M T
Sbjct: 125 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-----MRTL 176
Query: 222 --TKRYLAPEYILTGLC----NEKTDVFCFGMLLLELLTG 255
T YLAPE +L + N D + G++L L+G
Sbjct: 177 CGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 107 NHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
H +I+ LI E+ + LVF+ + G L D + E + I +
Sbjct: 158 GHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTE-KVALSE----KETRSIMRSLLE 211
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TK 223
A++++H IV +D+K IL D+ +LSDF S ++ GE + T
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-----LRELCGTP 263
Query: 224 RYLAPEYILTGLC-------NEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
YLAPE IL ++ D++ G++L LL G RR ++L + +
Sbjct: 264 GYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 5e-08
Identities = 42/175 (24%), Positives = 71/175 (40%), Gaps = 29/175 (16%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAM 167
H NI++L LVF+ ++ G L D + E + KI + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSE----KETRKIMRALLEVI 137
Query: 168 AYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRY 225
+H + IV +D+K IL D+ KL+DF S + GE + T Y
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-----LREVCGTPSY 189
Query: 226 LAPEYILTGLC-------NEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
LAPE I+ ++ D++ G+++ LL G R+ ++L +
Sbjct: 190 LAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 5e-08
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A EI + +H R IV++D+K IL D++ ++SD + ++PEG+T
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IK--- 343
Query: 220 TR--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
R T Y+APE + D + G LL E++ G+
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 38/175 (21%), Positives = 61/175 (34%), Gaps = 35/175 (20%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL-EPLLWRHRLK 158
+ + NH NI+ I +V F+ YG+ D IC+ + E
Sbjct: 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA------- 129
Query: 159 IAM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVT 215
IA + A+ YIH V + +K S IL LS + +
Sbjct: 130 IAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN-------LSMI 179
Query: 216 SHMLTRTKRY------------LAPEYILTGLC--NEKTDVFCFGMLLLELLTGR 256
SH + + L+PE + L + K+D++ G+ EL G
Sbjct: 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 1e-07
Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 107 NHRNILKLIGCCI-ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
N I+ G + EI I E ++ G+L D++ G E +L K+++ +
Sbjct: 89 NSPYIVGFYGAFYSDGEISI-CMEHMDGGSL-DQVLKKAGRIPEQIL----GKVSIAVIK 142
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG--ETHVTSHMLTRTK 223
+ Y+ + I+ +D+K S IL + KL DF S + + + V T+
Sbjct: 143 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG------TR 194
Query: 224 RYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
Y++PE + + ++D++ G+ L+E+ GR
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 39/200 (19%), Positives = 76/200 (38%), Gaps = 34/200 (17%)
Query: 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197
+ +P + + L H + + ++ M ++ R + +D+ IL E NV K
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 233
Query: 198 LSDFSESEYIPEGETHVTSHMLTRTK---RYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
+ DF + I + +V + +++APE I + ++DV+ FG+LL E+ +
Sbjct: 234 ICDFGLARDIYKDPDYVRK---GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
Query: 255 -GRR-------DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECV 306
G D +K E R+ P + + Q + +C
Sbjct: 291 LGASPYPGVKIDEEFCRRLK---EGTRMRA---P-----DYTTPE------MYQTMLDCW 333
Query: 307 NESAGDRPTMVYAAKQLRQM 326
+ RPT + L +
Sbjct: 334 HGEPSQRPTFSELVEHLGNL 353
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 21/97 (21%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
EI +A+ Y+H + I+ +D+K IL +E +++DF ++ + ++
Sbjct: 136 TAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T +Y++PE + + +D++ G ++ +L+ G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 44/219 (20%)
Query: 47 GELKIATNNYNGHQV---IASEHYKLYKGFLEN---RPISVMKFGDNYSENGENFCFNNI 100
G++KI + GH+V I + K+ + R I +K
Sbjct: 25 GKVKIGEHQLTGHKVAVKILNRQ-KIRSLDVVGKIKREIQNLK----------------- 66
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
H +I+KL I T +V E+V G L D IC HG E ++
Sbjct: 67 ----LFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICK-HGRVEE----MEARRL 116
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+I +A+ Y H R +V +D+K +L D + AK++DF S + +GE TS
Sbjct: 117 FQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--- 170
Query: 220 TRTKRYLAPEYILTGLCNE--KTDVFCFGMLLLELLTGR 256
+ Y APE +++G + D++ G++L LL G
Sbjct: 171 CGSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 38/154 (24%), Positives = 58/154 (37%), Gaps = 17/154 (11%)
Query: 107 NHRNILKLIGCCIETEIPI-LVFEFVEYGT-LADRICSPHGPHLEPLLWRHRLKIAMEIG 164
H +++L+ ET+ LV E L D I GP E ++
Sbjct: 96 GHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGP----SRCFFGQVV 149
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
A+ + H R +V +DIK IL D AKL DF + + T+
Sbjct: 150 AAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDG----TR 202
Query: 224 RYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGR 256
Y PE+I V+ G+LL +++ G
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 35/163 (21%), Positives = 68/163 (41%), Gaps = 21/163 (12%)
Query: 106 MNHRNILKLIGC--------CIETEIPI-LVFEFVEYGTL---ADRICSPHGPHLEPLLW 153
M + IL + ET+ + LV + G + + + EP
Sbjct: 233 MVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP--- 289
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
R A +I + + ++H +R I+++D+K +L D+ ++SD + + G+T
Sbjct: 290 RAIFYTA-QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT- 344
Query: 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+ T ++APE +L + D F G+ L E++ R
Sbjct: 345 -KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 41/176 (23%), Positives = 72/176 (40%), Gaps = 28/176 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++ H NI++L I+ E LVF+ V G L + I + + E +I
Sbjct: 84 KLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDIVA-REFYSE----ADASHCIQQI 137
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
++AY H IV +++K +L + KL+DF + + + E
Sbjct: 138 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-----WHG 189
Query: 221 R--TKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
T YL+PE +L ++ D++ G++L LL G + L +K
Sbjct: 190 FAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 47 GELKIATNNYNGHQV---IASEHYKLYKGFLEN--RPISVMKFGDNYSENGENFCFNNIV 101
G++K+ + GH+V I + + R I +K
Sbjct: 30 GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKL----------------- 72
Query: 102 FAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIA 160
H +I+KL I T I +V E+V G L D IC +G L+ R +
Sbjct: 73 ----FRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICK-NGR-LDEKESRRLFQ-- 123
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+I + + Y H R +V +D+K +L D + AK++DF S + +GE TS
Sbjct: 124 -QILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS---C 176
Query: 221 RTKRYLAPEYILTGLCNE--KTDVFCFGMLLLELLTGR 256
+ Y APE +++G + D++ G++L LL G
Sbjct: 177 GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 8e-07
Identities = 36/169 (21%), Positives = 64/169 (37%), Gaps = 31/169 (18%)
Query: 98 NNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRL 157
I Q + +++K G + +V E+ G+++D I + E
Sbjct: 73 KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED------- 125
Query: 158 KIAM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
+IA + Y+H + +DIK IL + AKL+DF + + +
Sbjct: 126 EIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD----- 177
Query: 215 TSHMLTRTKR--------YLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T KR ++APE I N D++ G+ +E+ G
Sbjct: 178 -----TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 48/224 (21%), Positives = 77/224 (34%), Gaps = 53/224 (23%)
Query: 47 GELKIATNNYNGHQV---------IASEHYKLYKGFLENRPISVMKFGDNYSENGENFCF 97
GE+++A N V + + I + K
Sbjct: 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINK-------------- 60
Query: 98 NNIVFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
+NH N++K G L E+ G L DRI P EP
Sbjct: 61 -------MLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIE-PDIGMPEP----DA 107
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ ++ + Y+H I +DIK +L DE + K+SDF +
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RE 161
Query: 217 HMLTR---TKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGR 256
+L + T Y+APE + + E DV+ G++L +L G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 17/143 (11%)
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
HRN+L+LI E + LVFE + G++ I E + ++ +
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK-RRHFNE----LEASVVVQDVAS 122
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHV---TSHML 219
A+ ++H + I +D+K IL ++ + K+ DF I T +L
Sbjct: 123 ALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 220 TR--TKRYLAPEYILTGLCNEKT 240
T + Y+APE ++ E +
Sbjct: 180 TPCGSAEYMAPE-VVEAFSEEAS 201
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 35/138 (25%), Positives = 57/138 (41%), Gaps = 17/138 (12%)
Query: 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185
LV ++ G L + E R +A E+ A+ +H + V +DIK
Sbjct: 151 LVMDYYVGGDLLTLLSKFEDRLPEE---MARFYLA-EMVIAIDSVH---QLHYVHRDIKP 203
Query: 186 SQILFDEYNVAKLSDFSES-EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKT---- 240
IL D +L+DF + + +G V S + T Y++PE IL + K
Sbjct: 204 DNILMDMNGHIRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPE-ILQAMEGGKGRYGP 260
Query: 241 --DVFCFGMLLLELLTGR 256
D + G+ + E+L G
Sbjct: 261 ECDWWSLGVCMYEMLYGE 278
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 36/230 (15%), Positives = 79/230 (34%), Gaps = 58/230 (25%)
Query: 47 GELKIATNNYNGHQV----IASEHYKLYKGFLEN--RPISVMKFGDNYSENGENFCFNNI 100
G++K ++ + + + + N + I +++
Sbjct: 19 GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR----------------- 61
Query: 101 VFAAQMNHRNILKL---IGCCIETEIPILVFEFVEYGT--LADRICSPHGPHLEPLLWRH 155
++ H+N+++L + + ++ +V E+ G + D +
Sbjct: 62 ----RLRHKNVIQLVDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVP------------EK 104
Query: 156 RLKIAM------EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209
R + ++ + + Y+H + IV KDIK +L K+S +E +
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161
Query: 210 GETHVTSHMLTRTKRYLAPEYILTGLCN---EKTDVFCFGMLLLELLTGR 256
T + + PE I GL K D++ G+ L + TG
Sbjct: 162 FAADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 26/175 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H NI++L E LVF+ V G L + I + + E +I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSE----ADASHCIQQIL 115
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
++AY H IV +++K +L + KL+DF + + + E
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-----WHGF 167
Query: 222 --TKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
T YL+PE +L ++ D++ G++L LL G + L +K
Sbjct: 168 AGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 12/153 (7%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q++H ++ L + +L+ EF+ G L DRI + E + +
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE----AEVINYMRQAC 159
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF--DEYNVAKLSDFSESEYIPEGETHVTSHMLTRT 222
+ ++H IV DIK I+ + + K+ DF + + E T T
Sbjct: 160 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTAT 213
Query: 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+ APE + TD++ G+L LL+G
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 27/167 (16%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
FN +V H N++++ + E ++ EF++ G L D + E
Sbjct: 90 FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QVRLNEE----QI 143
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ + A+AY+H + ++ +DIK IL KLSDF I +
Sbjct: 144 ATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK------- 193
Query: 217 HMLTRTKR--------YLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
KR ++APE I L + D++ G++++E++ G
Sbjct: 194 ---DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 18/173 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H +I++L+ ++ + +VFEF++ L I +I
Sbjct: 82 MLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQI 139
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
A+ Y H I+ +D+K +L + KL F + + E
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RV 194
Query: 221 RTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRR-----DNILLEHVKK 267
T ++APE ++ + DV+ G++L LL+G L E + K
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 48/224 (21%), Positives = 77/224 (34%), Gaps = 53/224 (23%)
Query: 47 GELKIATNNYNGHQV---------IASEHYKLYKGFLENRPISVMKFGDNYSENGENFCF 97
GE+++A N V + + I + K
Sbjct: 21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK------KEICINK-------------- 60
Query: 98 NNIVFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
+NH N++K G L E+ G L DRI P EP
Sbjct: 61 -------MLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIE-PDIGMPEP----DA 107
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ ++ + Y+H I +DIK +L DE + K+SDF +
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN---RE 161
Query: 217 HMLTR---TKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGR 256
+L + T Y+APE + + E DV+ G++L +L G
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 34/156 (21%), Positives = 58/156 (37%), Gaps = 17/156 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H N++ L IL+ E V G L D + E + +I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTE----EEATEFLKQIL 124
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
N + Y+H I D+K I+ K+ DF + I G +
Sbjct: 125 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IF 178
Query: 221 RTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG 255
T ++APE I+ + D++ G++ LL+G
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 33/167 (19%), Positives = 65/167 (38%), Gaps = 27/167 (16%)
Query: 97 FNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
N I+ + + NI+ + + + +V E++ G+L D + E
Sbjct: 65 INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG----QI 118
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ E A+ ++H ++ +DIK IL KL+DF I
Sbjct: 119 AAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------- 168
Query: 217 HMLTRTKR--------YLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
++KR ++APE + K D++ G++ +E++ G
Sbjct: 169 ---EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 15/155 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
++ H NI+ L +L+ E V G L D + E + +I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTE----DEATQFLKQIL 118
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+ + Y+H + I D+K I+ KL DF + I G +
Sbjct: 119 DGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IF 172
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T ++APE + + D++ G++ LL+G
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 29/98 (29%), Positives = 50/98 (51%), Gaps = 6/98 (6%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
EI +A+ Y+H + +V++D+KL ++ D+ K++DF E I +G T T
Sbjct: 254 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--- 308
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T YLAPE + D + G+++ E++ GR
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 25/175 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+++H NI+KL ET I LV E V G L DRI G + E R +I
Sbjct: 104 RLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVE-KGYYSE----RDAADAVKQI 157
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
A+AY+H IV +D+K +L+ K++DF S+ + T +
Sbjct: 158 LEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VC 211
Query: 221 RTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG-------RRDNILLEHVKK 267
T Y APE IL G + D++ G++ LL G R D + +
Sbjct: 212 GTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILN 265
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 33/155 (21%), Positives = 58/155 (37%), Gaps = 15/155 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q+ H N++ L +L+ E V G L D + E +I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSE----EEATSFIKQIL 125
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+ + Y+H + I D+K I+ KL DF + I +G +
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179
Query: 221 RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T ++APE + + D++ G++ LL+G
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 35/161 (21%), Positives = 67/161 (41%), Gaps = 25/161 (15%)
Query: 106 MNHRNILKLIGCCIETEIPI-----LVFEFVEYGTLADRICS-PHGPHLEPLLWRHRLKI 159
+I+ ++ E ++ E +E G L RI E R +I
Sbjct: 79 SGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE----REAAEI 133
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTS 216
+IG A+ ++H I +D+K +L+ ++ V KL+DF ++ +
Sbjct: 134 MRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----- 185
Query: 217 HMLTR--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+ T T Y+APE + ++ D++ G+++ LL G
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 42/167 (25%), Positives = 66/167 (39%), Gaps = 27/167 (16%)
Query: 101 VFAAQMNHRNILKLIGCCI-ETEIPILVFEFVEY--GTLADRICSPHGPHLEPLLWRHRL 157
V + I++ G I T++ I + E GP E +L
Sbjct: 76 VVLKSHDCPYIVQCFGTFITNTDVFIAM----ELMGTCAEKLKKRMQGPIPERIL----G 127
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
K+ + I A+ Y+ + ++ +D+K S IL DE KL DF S + V
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL------VDDK 179
Query: 218 MLTR---TKRYLAPEYILTGLCNE-----KTDVFCFGMLLLELLTGR 256
R Y+APE I + + DV+ G+ L+EL TG+
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 8e-06
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 17/155 (10%)
Query: 106 MNHRNILKLIGCCIETEIPI-LVFEF-VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
+ H NI+K++ E + LV E L I H EPL I ++
Sbjct: 86 VEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPL----ASYIFRQL 139
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+A+ Y+ + I+ +DIK I+ E KL DF + Y+ G+ T T
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTI 193
Query: 224 RYLAPEYILTGLCNE--KTDVFCFGMLLLELLTGR 256
Y APE +L G + +++ G+ L L+
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 19/155 (12%)
Query: 107 NHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
H NI+KL ++ LV E + G L +RI E I ++ +
Sbjct: 64 GHPNIVKLHEVF-HDQLHTFLVMELLNGGELFERIKK-KKHFSE----TEASYIMRKLVS 117
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR- 221
A++++H +V +D+K +LF ++ K+ DF + P + T
Sbjct: 118 AVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD----NQPLKTPC 170
Query: 222 -TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T Y APE + +E D++ G++L +L+G
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 28/106 (26%), Positives = 41/106 (38%), Gaps = 15/106 (14%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
EI A+ +H R V +DIK IL D +L+DF + +G V S +
Sbjct: 168 LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT--VRSLV 222
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVF--------CFGMLLLELLTGR 256
T YL+PE IL + G+ E+ G+
Sbjct: 223 AVGTPDYLSPE-ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 35/156 (22%), Positives = 59/156 (37%), Gaps = 17/156 (10%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q+ H NI+ L +L+ E V G L D + E +I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSE----EEATSFIKQIL 125
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+ + Y+H + I D+K I+ KL DF + I +G +
Sbjct: 126 DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IF 179
Query: 221 RTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG 255
T ++APE I+ + D++ G++ LL+G
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/101 (23%), Positives = 42/101 (41%), Gaps = 8/101 (7%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
E+ A+ IH + +D+K +L D+ KL+DF + + V
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTA 229
Query: 220 TRTKRYLAPEYILT----GLCNEKTDVFCFGMLLLELLTGR 256
T Y++PE + + G + D + G+ L E+L G
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
Q++H N+++L E++ I LV E+V+ G L DRI E + +I
Sbjct: 142 QLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTE----LDTILFMKQI 196
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF--DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ ++H + I+ D+K IL + K+ DF + E +
Sbjct: 197 CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-----LKVN 248
Query: 222 --TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
T +LAPE + + TD++ G++ LL+G
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 53/223 (23%)
Query: 47 GELKIATNNYNGHQV---IASEHYKLYKGFLEN---RPISVMKFGDNYSENGENFCFNNI 100
G++K+AT+ +V S L K + R IS +K
Sbjct: 23 GKVKLATHYKTQQKVALKFISRQ-LLKKSDMHMRVEREISYLKL---------------- 65
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
+ H +I+KL I T I +V E+ G L D I E +
Sbjct: 66 -----LRHPHIIKLYDV-ITTPTDIVMVIEYAG-GELFDYIVE-KKRMTEDE----GRRF 113
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS--- 216
+I A+ Y H R IV +D+K +L D+ K++DF S + +G TS
Sbjct: 114 FQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGS 170
Query: 217 -HMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGR 256
+ Y APE ++ G + DV+ G++L +L GR
Sbjct: 171 PN-------YAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 25/175 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H NI++L E L+F+ V G L + I + + E +I
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSE----ADASHCIQQIL 120
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
A+ + H + +V +++K +L + KL+DF + + +
Sbjct: 121 EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ----QAWFGF 173
Query: 222 --TKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
T YL+PE +L + D++ G++L LL G + L + +K
Sbjct: 174 AGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 38/168 (22%), Positives = 70/168 (41%), Gaps = 18/168 (10%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD--RICSPHGPHLEPLLWRHRL 157
I +Q +H NI+ + + LV + + G++ D + G H +L
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL--DES 121
Query: 158 KIAM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
IA E+ + Y+H + + +D+K IL E +++DF S ++
Sbjct: 122 TIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL--ATGGD 176
Query: 215 TSHMLTR-----TKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGR 256
+ R T ++APE + + K D++ FG+ +EL TG
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 1e-05
Identities = 51/330 (15%), Positives = 105/330 (31%), Gaps = 70/330 (21%)
Query: 4 FLRKTKNQEKVDKKTFLRNGKILLEKLI-ISCDGKRNPIRSFSAGELKIATNNYNGHQVI 62
+ ++E++D ++ +L + ++ F L+I NY +
Sbjct: 41 MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRI---NYK---FL 94
Query: 63 ASEHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN---HRNILKLIGCCI 119
S ++ Y E + +N VFA + N + LKL +
Sbjct: 95 MSP--------IKTEQRQPSMMTRMYIEQRDRLYNDNQVFA-KYNVSRLQPYLKLRQALL 145
Query: 120 E--TEIPILVFEFVEYG-------TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYI 170
E +L+ G +A +C + K+ ++ + ++
Sbjct: 146 ELRPAKNVLI-----DGVLGSGKTWVALDVCLSY-------------KVQCKMDFKIFWL 187
Query: 171 HIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRY---- 225
++ L ++L+ + N SD S + + L ++K Y
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 226 LAPEYILTGLCNEKT-DVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284
L +L + N K + F +L L T R K V + I ++
Sbjct: 248 L----VLLNVQNAKAWNAFNLSCKIL-LTT--RF--------KQVTDFLSAATTTHISLD 292
Query: 285 DKSCPEKEQQLQALLQLIFECVNESAGDRP 314
S ++++LL ++ D P
Sbjct: 293 HHSMTLTPDEVKSLLLK---YLDCRPQDLP 319
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 14/154 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL-EPLLWRHRLKIAMEI 163
HRNIL L E +++FEF+ + +RI + L E R + ++
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNE----REIVSYVHQV 111
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF--DEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
A+ ++H I DI+ I++ + K+ +F ++ + G+ L
Sbjct: 112 CEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFT 165
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
Y APE + + TD++ G L+ LL+G
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 39/166 (23%), Positives = 67/166 (40%), Gaps = 25/166 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPI--------LVFEFVEYGTLADRICSPHGPHLEPLLWRHR 156
+ H N++ LI C P LVF+F E+ LA + +
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS----EI 126
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF----SESEYIPEGET 212
++ + N + YIH R I+ +D+K + +L V KL+DF + S
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKT--DVFCFGMLLLELLTGR 256
T+ ++T Y PE +L G + D++ G ++ E+ T
Sbjct: 184 RYTNRVVTL--WYRPPE-LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I +Q + + K G ++ ++ E++ G+ D + GP E +I
Sbjct: 71 ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDET-------QI 121
Query: 160 AM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
A EI + Y+H + +DIK + +L E+ KL+DF + +T
Sbjct: 122 ATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA-------GQLTD 171
Query: 217 HMLTR-----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+ R T ++APE I + K D++ G+ +EL G
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 35/160 (21%), Positives = 65/160 (40%), Gaps = 24/160 (15%)
Query: 107 NHRNILKLIGCCIETEIPI-----LVFEFVEYGTLADRICS-PHGPHLEPLLWRHRLKIA 160
+I++++ E +V E ++ G L RI E R +I
Sbjct: 113 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIM 167
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSH 217
IG A+ Y+H I +D+K +L+ + KL+DF ++ +
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS----- 219
Query: 218 MLTR--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+ T T Y+APE + ++ D++ G+++ LL G
Sbjct: 220 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 24/97 (24%), Positives = 46/97 (47%), Gaps = 8/97 (8%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A +I Y+H ++++D+K +L D+ +++DF ++ + + L
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTL 198
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T LAPE IL+ N+ D + G+L+ E+ G
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 22/162 (13%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
VF NH ++ L C +TE + V E+V G L + E R
Sbjct: 62 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEE---HARFYS 116
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI A+ Y+H R I+++D+KL +L D KL+D+ E + G+T
Sbjct: 117 A-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------ 166
Query: 219 LTR----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T T Y+APE + D + G+L+ E++ GR
Sbjct: 167 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 22/162 (13%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
VF NH ++ L C +TE + V E+V G L + E R
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEE---HARFYS 159
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI A+ Y+H R I+++D+KL +L D KL+D+ E + G+T
Sbjct: 160 A-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT------ 209
Query: 219 LTR----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T T Y+APE + D + G+L+ E++ GR
Sbjct: 210 -TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 50/163 (30%), Positives = 72/163 (44%), Gaps = 24/163 (14%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
+ + NH + +L CC +T + V EFV G L I E R R
Sbjct: 76 ILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEA---RARFYA 130
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI +A+ ++H + I+++D+KL +L D KL+DF E I G T
Sbjct: 131 A-EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT------ 180
Query: 219 LTR----TKRYLAPEYILTGLCNEKT-DVFCFGMLLLELLTGR 256
T T Y+APE IL + D + G+LL E+L G
Sbjct: 181 -TATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 35/153 (22%), Positives = 55/153 (35%), Gaps = 16/153 (10%)
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHL-EPLLWRHRLKIAMEIGNA 166
++ L T IL+ E+ G + + E +++ +I
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE----NDVIRLIKQILEG 143
Query: 167 MAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
+ Y+H + IV D+K IL K+ DF S I + T
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTP 197
Query: 224 RYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG 255
YLAPE IL TD++ G++ LLT
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 15/102 (14%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
EI +A+ Y+H R +V++DIKL ++ D+ K++DF E I +G T
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT------ 161
Query: 219 LTR----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+ T YLAPE + D + G+++ E++ GR
Sbjct: 162 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 27/162 (16%)
Query: 107 NHRNILKLIGCCI-ETEIPILVFEFVEY--GTLAD---RICSPHGPHLEPLLWRHRLKIA 160
+ + G E ++ I + E +L ++ E +L KIA
Sbjct: 64 DCPFTVTFYGALFREGDVWICM----ELMDTSLDKFYKQVIDKGQTIPEDIL----GKIA 115
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+ I A+ ++H ++ +D+K S +L + K+ DF S G
Sbjct: 116 VSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVAKDI 168
Query: 221 R--TKRYLAPEYILTGLC----NEKTDVFCFGMLLLELLTGR 256
K Y+APE I L + K+D++ G+ ++EL R
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 24/163 (14%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
V A + +L C +T + V E+V G L I G EP
Sbjct: 394 VLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEP---HAVFYA 448
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI + ++ + I+++D+KL ++ D K++DF E I +G T
Sbjct: 449 A-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT------ 498
Query: 219 LTR----TKRYLAPEYILTGLCNEKT-DVFCFGMLLLELLTGR 256
T+ T Y+APE I+ K+ D + FG+LL E+L G+
Sbjct: 499 -TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 4e-05
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 27/175 (15%)
Query: 105 QMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEI 163
++ H NI+ L E+ LV + V G L DRI G + E + + ++
Sbjct: 62 KIKHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILE-RGVYTE----KDASLVIQQV 115
Query: 164 GNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGETHVTSHMLT 220
+A+ Y+H IV +D+K +L+ +E + ++DF S+ G M T
Sbjct: 116 LSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI------MST 166
Query: 221 R--TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG------RRDNILLEHVKK 267
T Y+APE + ++ D + G++ LL G ++ L E +K+
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 4e-05
Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 22/162 (13%)
Query: 101 VFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
V + H + + C +T+ + V E++ G L I R
Sbjct: 70 VLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLS---RATFYA 124
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI + ++H + IV++D+KL IL D+ K++DF E +
Sbjct: 125 A-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK------ 174
Query: 219 LTR----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T T Y+APE +L N D + FG+LL E+L G+
Sbjct: 175 -TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 6e-05
Identities = 36/156 (23%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
H NI+ L + + +V E ++ G L D+I E R + I
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSE----REASAVLFTITKT 128
Query: 167 MAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSESEYIPEGETHVTSHMLTR- 221
+ Y+H + +V +D+K S IL+ ++ DF ++ + ++T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN----GLLMTPC 181
Query: 222 -TKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTG 255
T ++APE +L + D++ G+LL +LTG
Sbjct: 182 YTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 7e-05
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 23/183 (12%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
I M + S + F ++ H N ++ GC + LV E+ G+ +D
Sbjct: 84 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD 142
Query: 139 RICSPHGPHLEPLLWRHRLKIAM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195
+ P E +IA +AY+H ++ +D+K IL E +
Sbjct: 143 LLEVHKKPLQEV-------EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGL 192
Query: 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC---NEKTDVFCFGMLLLEL 252
KL DF + + + V T ++APE IL + K DV+ G+ +EL
Sbjct: 193 VKLGDFGSASIMAPANSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
Query: 253 LTG 255
Sbjct: 247 AER 249
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 33/102 (32%), Positives = 45/102 (44%), Gaps = 15/102 (14%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI +A+ Y+H IV++D+K IL D L+DF E I T
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST------ 195
Query: 219 LTR----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T T YLAPE + + D +C G +L E+L G
Sbjct: 196 -TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 34/172 (19%), Positives = 66/172 (38%), Gaps = 36/172 (20%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I A +H I+KL+G ++ EF G + + EP +I
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QI 119
Query: 160 AM---EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
+ ++ A+ ++H + I+ +D+K +L +L+DF S +
Sbjct: 120 QVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK------- 169
Query: 217 HMLTRTKR--------YLAPEYILTGLC-----NEKTDVFCFGMLLLELLTG 255
T KR ++APE ++ + K D++ G+ L+E+
Sbjct: 170 ---TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 31/103 (30%), Positives = 52/103 (50%), Gaps = 17/103 (16%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHM 218
A EI + ++ + I+++D+KL ++ D K++DF E I +G T
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT------ 177
Query: 219 LTR----TKRYLAPEYILTGLCNEKT-DVFCFGMLLLELLTGR 256
T+ T Y+APE I+ K+ D + FG+LL E+L G+
Sbjct: 178 -TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 42.5 bits (101), Expect = 9e-05
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 17/101 (16%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHMLT 220
E+ A+ ++H I+++D+K IL DE KL+DF S E I +
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-------A 183
Query: 221 R----TKRYLAPEYILTGLCNEKT-DVFCFGMLLLELLTGR 256
T Y+APE ++ + ++ D + FG+L+ E+LTG
Sbjct: 184 YSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 23/100 (23%), Positives = 41/100 (41%), Gaps = 9/100 (9%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEY---GTLADRICSPHGPHLEPLLWRHRLKIAM 161
++ H NI++L LVFEF++ + R LE L +
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK---YFQW 115
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201
++ +A+ H I+ +D+K +L ++ KL DF
Sbjct: 116 QLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDF 152
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.1 bits (100), Expect = 1e-04
Identities = 28/100 (28%), Positives = 48/100 (48%), Gaps = 15/100 (15%)
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES-EYIPEGETHVTSHMLT 220
EI A+ ++H ++ I+++D+K I+ + KL+DF E I +G T
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV-------T 178
Query: 221 R----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE ++ N D + G L+ ++LTG
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 15/106 (14%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSH 217
KI + A+ ++ I+ +DIK S IL D KL DF S + V S
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSI 180
Query: 218 MLTR---TKRYLAPEYILTGLCNE----KTDVFCFGMLLLELLTGR 256
TR + Y+APE I + ++DV+ G+ L EL TGR
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 16/155 (10%)
Query: 106 MNHRNILKLIGCCIETEIPI-LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+ H NI++ I T + ++ E+ G L +RIC+ G E ++
Sbjct: 73 LRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERICN-AGRFSED----EARFFFQQLL 126
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA--KLSDFSESEYIPEGETHVTSHMLTRT 222
+ ++Y H I +D+KL L D K+ DF S+ ++ T
Sbjct: 127 SGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 180
Query: 223 KRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGR 256
Y+APE +L + DV+ G+ L +L G
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 32/163 (19%), Positives = 64/163 (39%), Gaps = 20/163 (12%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIP------ILVFEFVEYGTLADRICSPHGPHLEPLLW 153
+V +NH+NI+ L+ + LV E ++ + L
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD--------ANLCQVIQMELDH 163
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
+ ++ + ++H I+ +D+K S I+ K+ DF +
Sbjct: 164 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFM 219
Query: 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+T +++TR Y APE IL E D++ G ++ E++ +
Sbjct: 220 MTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 4e-04
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 8/97 (8%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q+ H N++ L+ C + + LVFEFV++ T+ D + L+ + + K +I
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLEL-FPNGLDYQVVQ---KYLFQII 134
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201
N + + H I+ +DIK IL + V KL DF
Sbjct: 135 NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDF 168
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 40.2 bits (95), Expect = 5e-04
Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A E+ A+ Y+H + I+++D+K IL D+ K++DF ++Y+P+ ++ L
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTL 163
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
T Y+APE + T N+ D + FG+L+ E+L G
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 7e-04
Identities = 25/105 (23%), Positives = 47/105 (44%), Gaps = 13/105 (12%)
Query: 158 KIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA------KLSDFSESEYIPEGE 211
+I+ ++ + Y+H I+ DIK +L + + K++D + + E
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-- 190
Query: 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
H T+ + TR Y +PE +L D++ L+ EL+TG
Sbjct: 191 -HYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 25/103 (24%), Positives = 40/103 (38%), Gaps = 14/103 (13%)
Query: 105 QMNHRNILKLIGCCIETEIPI-----LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
H N+++L+ C + LVFE V+ L + P L +K
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA----ETIKD 124
Query: 160 AM-EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201
M + + ++H IV +D+K IL KL+DF
Sbjct: 125 LMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADF 164
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 17/104 (16%)
Query: 107 NHRNILKLIGCCIETEIPI-----LVFEFVEYGTLADRICS-PHGPHLEPLLWRHRLKIA 160
+I++++ E +V E ++ G L RI E R +I
Sbjct: 69 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE----REASEIM 123
Query: 161 MEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDF 201
IG A+ Y+H I +D+K +L+ + KL+DF
Sbjct: 124 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 164
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.8 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.38 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.75 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.69 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.33 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.98 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.91 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.9 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.79 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.59 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.04 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.25 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.17 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.45 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.73 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-61 Score=427.00 Aligned_cols=259 Identities=20% Similarity=0.320 Sum_probs=212.3
Q ss_pred cCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++|...+.||+ +||+||+|++ ++..||||++.... ....+.|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 56777889999 9999999986 35789999997543 335778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 126 LVFEFVEYGTLADRICSPH--------GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
+|||||++|+|.+++...+ +.....+++.+++.++.||++||.||| +++||||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 122356999999999999999999999 89999999999999999999999
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccc
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRL 274 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~ 274 (331)
|+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.... .....+..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~ 248 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 248 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999987655443333333458999999999999999999999999999999998 899984322 22222222211
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
...+. .+++++.+|+.+||+.||++||||.|++..|+++...
T Consensus 249 -------~~~p~------~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 249 -------LQRPR------TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp -------CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCc------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11122 2345799999999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=425.93 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=208.8
Q ss_pred ccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
+...+.||+ +||+||+|.+ +++.||||++.........+.|.+|+.++++++|||||+++|+|.+++..++|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 444567999 9999999987 35789999998765555678899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 128 FEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
||||++|+|.++|...... ....+++.+++.++.||++||.||| +.+||||||||+|||+++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCE
Confidence 9999999999999653211 1245899999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~ 273 (331)
||+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||+| |..||.... .+...+..+.
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~ 264 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ 264 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999987654433333334568999999999999999999999999999999998 899984322 2222222221
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
. ...+. ++++++.+|+.+||+.||++||||.||++.|+.+.
T Consensus 265 ~-------~~~p~------~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 265 V-------LPCPD------DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp C-------CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred C-------CCCcc------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 11122 33457999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-59 Score=419.62 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=202.9
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.+++...+.||+ +||+||+|++.+ .||||.+.... .....+.|.+|+.+|++++|||||+++|+|.+ +..+|||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 356677788999 999999999865 59999987543 33456789999999999999999999999865 568999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++.... ..+++.++..|+.||++||.||| +.+||||||||+|||+++++++||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999997643 46999999999999999999999 899999999999999999999999999999876544
Q ss_pred CccccccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhH---HHHHHHhhccccccccccccc-
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILL---EHVKKHVENNRLGEIVDPIVV- 283 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~- 283 (331)
.........+||+.|||||++.. +.|+.++|||||||+||||+||+.||... ............ .+...
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~----~p~~~~ 261 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----SPDLSK 261 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC----CCCSTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----CCCccc
Confidence 33333334569999999999963 46899999999999999999999998532 222222222111 11111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
... ++++++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 262 ~~~------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 262 LYK------NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp SCT------TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred ccc------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111 334579999999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-60 Score=426.29 Aligned_cols=259 Identities=18% Similarity=0.271 Sum_probs=204.1
Q ss_pred cCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+|...+.||+ +||.||+|++ ++..||||++.... ....+.|.+|+.+|++++|||||+++|+|.+++..+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 45666788999 9999999986 36789999997543 335778999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 126 LVFEFVEYGTLADRICSPHGP----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
||||||++|+|.+++...... ...++++.+++.|+.||++||.||| +.+||||||||+|||++.++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence 999999999999999764311 1246899999999999999999999 899999999999999999999
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENN 272 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~ 272 (331)
+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |+.||.... .....+..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g 276 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999987755443333333569999999999999999999999999999999999 899984322 222222221
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.. ...+. .+++++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 277 ~~-------~~~p~------~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 RE-------LERPR------ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CC-------CCCCT------TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC-------CCCcc------cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11 11122 2345799999999999999999999999999998753
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-59 Score=423.81 Aligned_cols=271 Identities=17% Similarity=0.325 Sum_probs=221.6
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC-Cceeee
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNH-RNILKL 114 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l 114 (331)
+...+++...++|...+.||+ +||+||+|.+. ++.||||.+.........+.|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 445666667788999999999 99999999872 257999999877666567789999999999975 999999
Q ss_pred EeEEeeC-CccEEEEEecCCCChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 020078 115 IGCCIET-EIPILVFEFVEYGTLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKD 182 (331)
Q Consensus 115 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrd 182 (331)
+|+|.+. +..++|||||++|+|.++|..... .....+++.++..++.||++||.||| +++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence 9999764 568999999999999999975321 01245899999999999999999999 89999999
Q ss_pred CCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh
Q 020078 183 IKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL 261 (331)
Q Consensus 183 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~ 261 (331)
|||+|||+++++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765554444444568999999999999999999999999999999998 8999843
Q ss_pred H---HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 262 L---EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 262 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
. .........+.... .+. .+++++.+|+.+||+.||++||||.|+++.|+++.++.
T Consensus 291 ~~~~~~~~~~i~~g~~~~-------~p~------~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDEEFCRRLKEGTRMR-------APD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSHHHHHHHHHTCCCC-------CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHHHHHHHHHcCCCCC-------CCc------cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 2 22222232221111 111 23457999999999999999999999999999988654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=412.43 Aligned_cols=245 Identities=15% Similarity=0.205 Sum_probs=208.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||+||+|+. +++.||+|.+.+.. .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999 9999999998 78999999997532 1224678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|.+++... ..+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 999999999999764 46899999999999999999999 8999999999999999999999999999999876
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.........+.+||+.|||||++.+..|+.++||||+||++|+|++|+.||...+. ...... ..++
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------~~~~ 251 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------------KLEY 251 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------HTCC
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------cCCC
Confidence 54443444456799999999999999999999999999999999999999843222 111111 1122
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl 320 (331)
..|. ..++++.+|+.+||+.||++|||+.|++
T Consensus 252 ~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPE--KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCc--ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2222 3456799999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=416.46 Aligned_cols=247 Identities=21% Similarity=0.231 Sum_probs=201.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|...+.||+ +||+||+|+. +++.||||++.... .....+.+.+|+.+|++|+|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57899999999 9999999998 78999999997653 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
||++|+|.+++....+ ..+++.++..|+.||+.||.||| +.+||||||||+|||++.++.+||+|||+|+.+..
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999975432 35788999999999999999999 89999999999999999999999999999987643
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 287 (331)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... .........
T Consensus 178 ~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~------------ 243 (350)
T 4b9d_A 178 TVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP------------ 243 (350)
T ss_dssp HHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------------
T ss_pred Ccc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC------------
Confidence 221 2223569999999999999999999999999999999999999984322211 111111110
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.+..+++++.+|+.+||+.||++|||+.|+++
T Consensus 244 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 244 -PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 001134457999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=411.56 Aligned_cols=245 Identities=18% Similarity=0.270 Sum_probs=205.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..|...+.||+ +||.||+|+. +++.||||++...... ..+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 45888899999 9999999998 7899999999754333 467789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++.. ..+++.++..++.||+.||.||| +.+||||||||+|||++.++.+||+|||+|+.+...
T Consensus 153 ~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 153 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 999999999864 35899999999999999999999 899999999999999999999999999999877544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... ....+||+.|||||++....|+.++|||||||++|||++|+.||....... ..+..... +..
T Consensus 224 ~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-----------~~~ 290 (346)
T 4fih_A 224 VPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-----------PRL 290 (346)
T ss_dssp SCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-----------CCC
T ss_pred CCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----------CCC
Confidence 322 223569999999999999999999999999999999999999985432221 11111110 011
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111245568999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=403.86 Aligned_cols=261 Identities=19% Similarity=0.271 Sum_probs=198.2
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC----ccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE----IPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~ 128 (331)
..|...+.||+ +||+||+|+++|+.||||++..... ....+..|+..+.+++|||||+++|+|.+++ ..||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE--RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch--hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 34667788999 9999999999999999999865421 1222334666667899999999999998764 468999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG-----FRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
|||++|+|.+++.. .++++..+..++.|+++||.|||+. ...+||||||||+|||++.++++||+|||+
T Consensus 81 Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp ECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 99999999999965 3589999999999999999999932 123999999999999999999999999999
Q ss_pred ccccCCCCccc--cccccCCCCcccchhhhccC------CCCCcccchhhHHHHHHHHhCCCCChh--------------
Q 020078 204 SEYIPEGETHV--TSHMLTRTKRYLAPEYILTG------LCNEKTDVFCFGMLLLELLTGRRDNIL-------------- 261 (331)
Q Consensus 204 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~el~~g~~p~~~-------------- 261 (331)
|+......... .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~ 234 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence 98775543322 22235699999999999754 467899999999999999999765411
Q ss_pred ---HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 262 ---LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 262 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
........... ..++.++... ...+.+..+.+|+.+||+.||++||||.||++.|+++..+
T Consensus 235 ~~~~~~~~~~~~~~----~~rp~~p~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 235 DPSVEEMRKVVCEQ----KLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTS----CCCCCCCGGG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHHhcc----cCCCCCCccc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111111111 1112111111 1114566899999999999999999999999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-57 Score=408.44 Aligned_cols=251 Identities=18% Similarity=0.181 Sum_probs=202.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||+ +||.||+|+. +++.||||++..... ..+|+.+|+.++|||||++++++.+++..||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45677788999 9999999998 789999999975422 24799999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCccccCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYIPE 209 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~~~~ 209 (331)
|++|+|.+++... ..+++.++..++.||+.||.||| +.+||||||||+|||++.++ .+||+|||+|+.+..
T Consensus 132 ~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999754 36999999999999999999999 99999999999999999987 599999999998754
Q ss_pred CCcc---ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 210 GETH---VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ...+...+...+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~----------~~~~~~~i~~~~~ 273 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF----------RGPLCLKIASEPP 273 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC----------CSCCHHHHHHSCC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC----------HHHHHHHHHcCCC
Confidence 3221 12334569999999999999999999999999999999999999984211 0111111111110
Q ss_pred CC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 287 SC-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 287 ~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.. ..+..+++++.+|+.+||+.||++|||+.|+++.|.....
T Consensus 274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 00 0011345679999999999999999999999999987664
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=398.44 Aligned_cols=240 Identities=17% Similarity=0.264 Sum_probs=193.7
Q ss_pred cccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee----CCccEEEE
Q 020078 57 NGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEIPILVF 128 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 128 (331)
.....||+ +||+||+|.+ ++..||+|++.... .....+.|.+|+.+|++|+|||||++++++.+ ++..|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999 9999999998 68899999987543 33356789999999999999999999999876 34578999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEcC-CCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFDE-YNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~~-~~~~kl~Dfg~a~ 205 (331)
|||++|+|.+++... ..+++..+..++.||+.||.||| +.+ ||||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 999999999999754 46899999999999999999999 776 999999999999984 7999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH---HHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE---HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 282 (331)
...... ..+.+||+.|||||++. +.|+.++|||||||++|||++|+.||.... ........... +
T Consensus 181 ~~~~~~----~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~-----~-- 248 (290)
T 3fpq_A 181 LKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-----P-- 248 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-----C--
T ss_pred eCCCCc----cCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC-----C--
Confidence 653322 22356999999999885 569999999999999999999999984322 12222211111 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 249 -----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011123347999999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=393.98 Aligned_cols=242 Identities=20% Similarity=0.245 Sum_probs=190.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||+||+|+. +++.||+|.+.+... ......+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999 9999999998 789999999975432 223567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||| +|+|.+++... ..+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 68999999764 46999999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 285 (331)
..... .+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.||..... ........ .
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~------------~ 228 (275)
T 3hyh_A 164 DGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG------------V 228 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------C
T ss_pred CCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------C
Confidence 43321 23569999999999988776 5799999999999999999999843221 11111111 1
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~p~--~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 229 YTLPK--FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CCCCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCC--CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 34457999999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-55 Score=407.14 Aligned_cols=245 Identities=18% Similarity=0.281 Sum_probs=205.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
..|...+.||+ +||.||+|+. +++.||||++...... ..+.+.+|+.+|+.++|||||++++++.+++..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46888899999 9999999998 7899999999765433 567799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++.. ..+++.++..++.||+.||.||| +++||||||||+|||++.++.+||+|||+|+.+...
T Consensus 230 ~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 230 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 999999999864 35899999999999999999999 899999999999999999999999999999877544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||....... ..+.... .+.....
T Consensus 301 ~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-----~~~~~~~--- 370 (423)
T 4fie_A 301 VPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-----PPRLKNL--- 370 (423)
T ss_dssp CCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-----CCCCSCT---
T ss_pred Ccc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----CCCCccc---
Confidence 322 223569999999999999999999999999999999999999984432221 1221111 1111111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+++++.+|+.+||+.||++|||+.|+++
T Consensus 371 ---~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 ---HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp ---TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 134457999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=389.03 Aligned_cols=250 Identities=18% Similarity=0.262 Sum_probs=191.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc-------
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI------- 123 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------- 123 (331)
.+|...+.||+ +||.||+|+. +++.||||++.....+...+.+.+|+.+|++|+|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35888899999 9999999998 7899999999765555456789999999999999999999999986553
Q ss_pred -----cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 124 -----PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 124 -----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
.|+|||||++|+|.+++..... .....+..++.++.||++||.||| +++|+||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence 5899999999999999976432 134567778899999999999999 899999999999999999999999
Q ss_pred ccCCCccccCCCCccc----------cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH
Q 020078 199 SDFSESEYIPEGETHV----------TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH 268 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~ 268 (331)
+|||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.........
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 9999998775432211 1223469999999999999999999999999999999996 66433222221
Q ss_pred hhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 269 VENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ... ..+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~---------~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LTDVR---------NLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHH---------TTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHh---------cCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11100 001 11222345567889999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=398.88 Aligned_cols=239 Identities=18% Similarity=0.189 Sum_probs=191.8
Q ss_pred cCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
++|...+.||+ +||+||+|+. .++.||+|.+.+.. .......+.+|+.+|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 56999999999 9999999986 35789999987542 22234578899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
|||||++|+|.+++... ..+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999764 46899999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 284 (331)
...... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...+.. ...... .
T Consensus 176 ~~~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~------------~ 241 (304)
T 3ubd_A 176 SIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK------------A 241 (304)
T ss_dssp -----C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------C
T ss_pred ccCCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc------------C
Confidence 544332 222356999999999999999999999999999999999999998532221 111111 1
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
....|. ..++++.+|+.+||+.||++|||+
T Consensus 242 ~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 KLGMPQ--FLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCC--cCCHHHHHHHHHHcccCHHHCCCC
Confidence 111121 345679999999999999999996
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=380.64 Aligned_cols=259 Identities=16% Similarity=0.220 Sum_probs=198.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC------Cc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIET------EI 123 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 123 (331)
+.|...+.||+ +||.||+|+. +|+.||||++..... ....+.+.+|+.+|+.|+|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 56888999999 9999999998 789999999976533 23456788999999999999999999998643 56
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.|+|||||+ |+|.+++... ..+++..+..++.||+.||.||| +.+||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence 799999996 7899999764 46999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-cccc-
Q 020078 204 SEYIPEGET--HVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRLG- 275 (331)
Q Consensus 204 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~~- 275 (331)
|+.+..... .....+.+||+.|+|||++.+. .|+.++||||+||++|||++|+.||...... ...... ....
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 987644321 1123345799999999998875 5689999999999999999999998432211 111110 0000
Q ss_pred ccccc-----------ccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDP-----------IVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~-----------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ........+.. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000 00000011110 023467999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=374.53 Aligned_cols=195 Identities=16% Similarity=0.228 Sum_probs=168.5
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEI 123 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 123 (331)
...+.|...+.||+ +||+||+|+. +++.||+|.+.... ....+.+|+.+|..+ +|||||++++++.+++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 45678999999999 9999999975 36789999987643 345688999999998 69999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFS 202 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg 202 (331)
.|+|||||++|+|.+++ ..+++.++..++.|++.||.||| +.+|+||||||+|||++.+ +.+||+|||
T Consensus 95 ~~lvmE~~~g~~L~~~~--------~~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL--------NSLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEECCCCCCHHHHH--------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeCCCcccHHHHH--------cCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999998 34889999999999999999999 9999999999999999877 799999999
Q ss_pred CccccCCCCcc--------------------------ccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhC
Q 020078 203 ESEYIPEGETH--------------------------VTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTG 255 (331)
Q Consensus 203 ~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g 255 (331)
+|+........ ......+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 99865433211 011234699999999999875 489999999999999999999
Q ss_pred CCCC
Q 020078 256 RRDN 259 (331)
Q Consensus 256 ~~p~ 259 (331)
+.||
T Consensus 244 ~~Pf 247 (361)
T 4f9c_A 244 RYPF 247 (361)
T ss_dssp CSSS
T ss_pred CCCC
Confidence 9998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=386.49 Aligned_cols=248 Identities=15% Similarity=0.175 Sum_probs=206.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ +||.||+|+. +++.||+|.+..... ...+.+.+|+.+|+.|+|||||++++++.+++..|+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~-~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch-hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 367999999999 9999999998 789999999876432 256788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC--CceEEccCCCcccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY--NVAKLSDFSESEYI 207 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfg~a~~~ 207 (331)
||++|+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 235 ~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 235 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred ecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999996543 35899999999999999999999 8999999999999999854 89999999999987
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 285 (331)
...... ...+||+.|+|||++.+..|+.++||||+||++|+|++|..||....... ..+..... .
T Consensus 308 ~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~----------~ 374 (573)
T 3uto_A 308 DPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------N 374 (573)
T ss_dssp CTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----------C
T ss_pred cCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC----------C
Confidence 654332 22469999999999999999999999999999999999999985332221 11111111 0
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.....++++.+||.+||+.||++|||+.|+++
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111244567999999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=358.77 Aligned_cols=280 Identities=30% Similarity=0.517 Sum_probs=226.5
Q ss_pred CccccCHHHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeE
Q 020078 40 PIRSFSAGELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGC 117 (331)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~ 117 (331)
..+.++..++...+++|...+.||+ +||.||+|.. ++..||+|++...........+.+|+.++..++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 4567899999999999999999999 9999999988 7889999999876544445578999999999999999999999
Q ss_pred EeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
+.+.+..++||||+++|+|.+++...... ..++++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTT-CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999765322 24589999999999999999999932222999999999999999999999
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH-----------HHH
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE-----------HVK 266 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~-----------~~~ 266 (331)
|+|||++........... ....||+.|+|||++..+.++.++||||||+++|+|++|+.||.... +..
T Consensus 175 l~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 999999987754433222 22448999999999999999999999999999999999999984322 111
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
............+...... .....+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGN----YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTS----CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHhhchhhhhhcChhhccc----cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 1222222223333322222 223677899999999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=356.57 Aligned_cols=276 Identities=28% Similarity=0.463 Sum_probs=224.8
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
++..++...+++|...+.||+ +||.||+|+. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS-HHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH-HHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 444556678899999999999 9999999998 6899999998765433 677899999999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCC-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCC-ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999754321 235899999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh---------HHHHHHHhhcc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL---------LEHVKKHVENN 272 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---------~~~~~~~~~~~ 272 (331)
|++................||+.|+|||++.++.++.++||||||+++|+|++|+.||.. ..+........
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 999865443322222234489999999999999999999999999999999999998731 22222222333
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.....+++..... .....+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 264 ~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 264 QLEQIVDPNLADK----IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCSSSSSSCTTC----SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHhcChhhccc----cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 3333333333221 223677889999999999999999999999999998763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-50 Score=386.31 Aligned_cols=245 Identities=17% Similarity=0.216 Sum_probs=196.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHH---HHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNN---IVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++|...++||+ +||.||+|+. +++.||+|.+.+... ......+.+| +.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 57899999999 9999999998 789999999864311 1122334444 56667789999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+|||||++|+|.+++... ..+++..+..++.||+.||.||| +.+||||||||+|||++.+|.+||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999764 35899999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
.+..... .+.+||+.|||||++.. ..|+.++|+|||||++|||++|..||..... ..... ..+.
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~---------~~i~ 407 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RMTL 407 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH---------HHHH
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---------Hhhc
Confidence 7754432 23569999999999975 4799999999999999999999999843210 00111 0111
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
......|. .+++++.+|+.+||+.||++|++ +.||++
T Consensus 408 ~~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 TMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HCCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11122222 34568999999999999999998 577653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=344.13 Aligned_cols=280 Identities=28% Similarity=0.457 Sum_probs=224.5
Q ss_pred CCccccCHHHHHHHhcCcccc------Cceee-cCcEEEEEEeCCceEEEEEeCCCC---CcchhHHHHHHHHHHHhcCC
Q 020078 39 NPIRSFSAGELKIATNNYNGH------QVIAS-EHYKLYKGFLENRPISVMKFGDNY---SENGENFCFNNIVFAAQMNH 108 (331)
Q Consensus 39 ~~~~~~~~~~~~~~~~~~~~~------~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h 108 (331)
.....|++.++..++++|+.. +.||+ ++|.||+|..++..||+|++.... .....+.+.+|+.++++++|
T Consensus 10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 355779999999999999988 88999 999999999999999999987542 22346789999999999999
Q ss_pred CceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 109 RNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 109 ~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
|||+++++++.+.+..++||||+++|+|.+++..... ..++++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Ni 164 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANI 164 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHE
Confidence 9999999999999999999999999999999875322 146899999999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH-----
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE----- 263 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----- 263 (331)
+++.++.++|+|||++................||+.|+|||.+. +.++.++||||||+++|+|++|..||....
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 99999999999999998765443332233345899999999875 468899999999999999999999973211
Q ss_pred -HHHHHhhcc--ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 264 -HVKKHVENN--RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 264 -~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
......... .....+++.+. ......+..+.+++.+||+.||++|||+.++++.|+++..|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKMN-----DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSCS-----CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHHHhhhhhhhhhhhcccccc-----ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 111111110 11111121111 11225677899999999999999999999999999998654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=351.76 Aligned_cols=260 Identities=23% Similarity=0.279 Sum_probs=207.2
Q ss_pred HhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc----cEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI----PIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~~l 126 (331)
..++|...+.||+ +||.||+|+..++.||||++.... .....+.+|+.++.+++||||+++++++.+... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD--KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEECCCEEEEEEeecCc--hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999 999999999999999999986542 234456679999999999999999999998654 589
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC----------CeeeCCCCCCceEEcCCCce
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR----------PIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivHrdlk~~Nill~~~~~~ 196 (331)
||||+++|+|.+++.. ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+
T Consensus 100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence 9999999999999965 34899999999999999999999 88 99999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccC-----CCCCcccchhhHHHHHHHHhCCCCChh----------
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-----LCNEKTDVFCFGMLLLELLTGRRDNIL---------- 261 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~el~~g~~p~~~---------- 261 (331)
||+|||+++...............||+.|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999877654433333334589999999999763 466789999999999999999988731
Q ss_pred --------HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 262 --------LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 262 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
................+.... .....+.++.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYW-------QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGG-------GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccc-------cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111111111111000 1114566799999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=351.45 Aligned_cols=266 Identities=21% Similarity=0.276 Sum_probs=205.3
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++.....+|...+.||+ +||.||+|+.++..||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 33445678899999999 9999999999999999999876543 334568899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEcCCCceEEccCCC
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
+||||+++|+|.+++..... ...+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.+||+|||+
T Consensus 111 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999976421 124889999999999999999999 888 99999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............... .....
T Consensus 186 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~----~~~~~ 259 (309)
T 3p86_A 186 SRLKASTFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFK----CKRLE 259 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHS----CCCCC
T ss_pred Ccccccccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----CCCCC
Confidence 976543321 122245899999999999999999999999999999999999998543222111110000 00000
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
.+. ..++++.+|+.+||+.||++|||+.++++.|+.+..+.
T Consensus 260 ~~~------~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 260 IPR------NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111 23457999999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=361.48 Aligned_cols=260 Identities=21% Similarity=0.342 Sum_probs=212.1
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
....++|...+.||+ +||.||+|.+ ++..||+|.+.........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 334567888899999 9999999999 6889999998766544456789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 190 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~ 262 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262 (377)
T ss_dssp EEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCcee
Confidence 999999999999997532 35889999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
..............+++.|+|||++..+.++.++||||||+++|||++ |..||.... ........... ..
T Consensus 263 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-------~~ 335 (377)
T 3cbl_A 263 EADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-------LP 335 (377)
T ss_dssp CTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-------CC
T ss_pred cCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------CC
Confidence 544322211112225678999999999999999999999999999998 998884322 22222221111 11
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+..+ ++++.+|+.+||+.||++|||+.++++.|+++...
T Consensus 336 ~~~~~------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELC------PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11223 34699999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=354.43 Aligned_cols=260 Identities=17% Similarity=0.313 Sum_probs=211.0
Q ss_pred hcCccccCceee-cCcEEEEEEe---------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL---------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
.++|...+.||+ +||.||+|.. ++..||+|.+.........+.+.+|+.++..+ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357788889999 9999999986 23469999998765555677899999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+..++||||+++|+|.+++...... ....+++..++.++.||+.||.||| +.+|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence 9999999999999999999754321 1135889999999999999999999 8999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKK 267 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~ 267 (331)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987655433322233447889999999999999999999999999999999 998874321 1111
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
....... ...+. ..+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 317 ~~~~~~~-------~~~~~------~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 317 LLKEGHR-------MDKPA------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHTTCC-------CCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCC-------CCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 01111 233479999999999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=348.05 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=208.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--C---CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--E---NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.+.|...+.||+ +||.||+|.+ + +..||||.+.........+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 356778899999 9999999998 2 345999999876665567789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.++|+|||+++.
T Consensus 128 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999996543 45899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccccccccccc
Q 020078 207 IPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 207 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
........ ......+|+.|+|||++....++.++||||||+++|+|++ |..||..... .......... .
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-------~ 273 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYR-------L 273 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-------C
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCC-------C
Confidence 75443221 1222336778999999998999999999999999999999 9999843221 1111211110 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..+. ..+.++.+|+.+||..||++|||+.++++.|+.+..+
T Consensus 274 ~~~~------~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 PAPM------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCC------CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1111 2335799999999999999999999999999998754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=336.33 Aligned_cols=256 Identities=20% Similarity=0.337 Sum_probs=210.1
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.++|...+.||+ +||.||+|.. +++.||+|++..... ..+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc--CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 467888899999 9999999999 788899999976543 356799999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 87 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999997643 45889999999999999999999 899999999999999999999999999999866443
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... .....+|+.|+|||++....++.++||||||+++|+|++ |..||...... ......... ...+.
T Consensus 160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~- 230 (269)
T 4hcu_A 160 QYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------LYKPR- 230 (269)
T ss_dssp HHHS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------CCCCT-
T ss_pred cccc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc-------CCCCC-
Confidence 2211 112336788999999999999999999999999999999 89997432221 111111100 00111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhcC
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSAV 331 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 331 (331)
..+.++.+++.+||+.||++|||+.++++.|+++.++++
T Consensus 231 -----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~gl 269 (269)
T 4hcu_A 231 -----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269 (269)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -----cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHccC
Confidence 223479999999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=356.59 Aligned_cols=270 Identities=17% Similarity=0.334 Sum_probs=218.1
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeee
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKL 114 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l 114 (331)
+...++....++|...+.||+ +||.||+|++ +++.||||.+.........+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 455667777899999999999 9999999984 44789999998765555667899999999999 78999999
Q ss_pred EeEEeeCCc-cEEEEEecCCCChhhhhcCCCCCC----------------------------------------------
Q 020078 115 IGCCIETEI-PILVFEFVEYGTLADRICSPHGPH---------------------------------------------- 147 (331)
Q Consensus 115 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~---------------------------------------------- 147 (331)
++++.+.+. .++||||+++|+|.+++.......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 899999999999999997643210
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCc
Q 020078 148 ---------------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 148 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
...+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999 89999999999999999999999999999987655443
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH---HHHHHHhhccccccccccccccCCCC
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL---EHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||... .............. .+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------~~~-- 319 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-------APD-- 319 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC-------CCT--
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC-------CCC--
Confidence 333333457899999999999999999999999999999998 99998432 12222222111110 011
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..++++.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 320 ----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 320 ----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 2334799999999999999999999999999998865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=344.97 Aligned_cols=257 Identities=20% Similarity=0.305 Sum_probs=206.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 356888899999 9999999998 68899999986543 3367789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 88 YIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp CCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 999999999997643 46899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCccc------------cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccc
Q 020078 210 GETHV------------TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEI 277 (331)
Q Consensus 210 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 277 (331)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..|+...... .......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~-----~~~~~~~ 235 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR-----TMDFGLN 235 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB-----CTTSSBC
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh-----HHHHhhh
Confidence 33211 011345899999999999999999999999999999999999885311000 0000000
Q ss_pred ccccc--ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 278 VDPIV--VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 278 ~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..... ..+..+ ++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 VRGFLDRYCPPNC------PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHHHTCCTTC------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccccCCCCC------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000 001122 2369999999999999999999999999998874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=339.79 Aligned_cols=245 Identities=16% Similarity=0.285 Sum_probs=204.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ +||.||+|.. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 467999999999 9999999987 7899999998755433 46778899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999965 34889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh---hccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV---ENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 286 (331)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.......... ..... . .
T Consensus 169 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~-----~---- 236 (297)
T 3fxz_A 169 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-E-----L---- 236 (297)
T ss_dssp TTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-C-----C----
T ss_pred cccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-C-----C----
Confidence 4332 222459999999999999999999999999999999999999984332222111 11110 0 0
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. +...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SC--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC--ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01 1134457999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.06 Aligned_cols=245 Identities=19% Similarity=0.228 Sum_probs=203.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
..++|...+.||+ +||.||+|.. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568999999999 9999999998 88999999987643 333466788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 9999999999999654 35889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCC-CcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 284 (331)
...... ...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||..... ........
T Consensus 165 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------ 229 (328)
T 3fe3_A 165 TVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG------------ 229 (328)
T ss_dssp SSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred CCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 544322 224599999999999888765 789999999999999999999843221 11111111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 KYRIPF--YMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCCCT--TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCC--CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111 23457999999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=351.86 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=198.4
Q ss_pred hcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
..+|...+.||+ +||.||+|+. .+..||+|.+.........+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357888999999 9999999987 3567999999876555567789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++.+++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 124 v~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 999999999999997643 46899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccccccccccc
Q 020078 207 IPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 207 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
........ ......+++.|+|||++....++.++||||||+++|||++ |+.||..... .......... .
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~-------~ 269 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------L 269 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE-------C
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------C
Confidence 65433211 1111235778999999999999999999999999999998 9999843221 1111111110 1
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..+.++.+|+.+||+.||++|||+.++++.|+++..
T Consensus 270 ~~~~------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 270 PPPM------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CCCT------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCc------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 1111 233479999999999999999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=335.75 Aligned_cols=256 Identities=19% Similarity=0.276 Sum_probs=209.9
Q ss_pred ccCHHHHHHHhcC----------ccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC
Q 020078 43 SFSAGELKIATNN----------YNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR 109 (331)
Q Consensus 43 ~~~~~~~~~~~~~----------~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 109 (331)
.++..++..+++. |.....||+ +||.||+|+. +++.||||.+...... ..+.+.+|+.+++.++||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCC
Confidence 4778888877764 566678999 9999999998 6899999998765433 567889999999999999
Q ss_pred ceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceE
Q 020078 110 NILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL 189 (331)
Q Consensus 110 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nil 189 (331)
||+++++++...+..++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEE
Confidence 999999999999999999999999999998864 35899999999999999999999 899999999999999
Q ss_pred EcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--H
Q 020078 190 FDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--K 267 (331)
Q Consensus 190 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~ 267 (331)
++.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999876543222 122459999999999999999999999999999999999999984322211 1
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... .+.... ....++++.+++.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~-----~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRDSP-----PPKLKN------SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHSS-----CCCCTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCC-----CCCcCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 111111 1133457999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=332.17 Aligned_cols=256 Identities=17% Similarity=0.272 Sum_probs=208.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..++|...+.||+ +||.||+|.. ++..||+|.+..... ..+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM--SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC--cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 3567888999999 9999999998 566899999976533 35678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 999999999997542 45899999999999999999999 89999999999999999999999999999987655
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
....... ...+|+.|+|||++....++.++||||||+++|+|++ |+.||................. ...+.
T Consensus 157 ~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~-- 228 (268)
T 3sxs_A 157 DQYVSSV-GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR-----LYRPH-- 228 (268)
T ss_dssp TCEEECC-SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-----CCCCT--
T ss_pred hhhhccc-CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC-----CCCCC--
Confidence 4432222 2336778999999998899999999999999999999 9999843322221111111000 00111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..++++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 229 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 ----LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ----cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 123469999999999999999999999999998764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=342.45 Aligned_cols=249 Identities=18% Similarity=0.176 Sum_probs=204.5
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
..+.|...+.||+ +||.||+++. ++..||+|.+...... ...+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4577999999999 9999999998 6899999998764332 135678999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC----ceEEc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN----VAKLS 199 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~ 199 (331)
.++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 99999999999999999654 46899999999999999999999 89999999999999998777 79999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEI 277 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~ 277 (331)
|||++......... ....||+.|+|||++....++.++||||||+++|+|++|..||....... ........
T Consensus 162 DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~--- 235 (361)
T 2yab_A 162 DFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY--- 235 (361)
T ss_dssp CCSSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC---
T ss_pred ecCCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC---
Confidence 99999877554322 22459999999999998899999999999999999999999984322211 11111110
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+..+.+...++++.+|+.+||..||++|||+.|+++
T Consensus 236 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 -------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0010111134567999999999999999999999974
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=338.77 Aligned_cols=269 Identities=19% Similarity=0.277 Sum_probs=204.8
Q ss_pred hcCccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 123 (331)
.+.|...+.||+ +||.||+|++ +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 467888899999 9999999984 67899999987543 2356789999999999999999999999865 356
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred eEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 899999999999999997643 35899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccc-cccc----
Q 020078 204 SEYIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNR-LGEI---- 277 (331)
Q Consensus 204 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~---- 277 (331)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++|..|+.............. ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 98765443221 12223467789999999999999999999999999999999988744332211111100 0000
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
....+......+.+..+++++.+|+.+||+.||++|||+.|+++.|+++..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0000000001111113445799999999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=342.73 Aligned_cols=249 Identities=20% Similarity=0.222 Sum_probs=200.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367889999999 9999999988 6889999998765444345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++..+..
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999754 45899999999999999999999 89999999999999999999999999999987644
Q ss_pred CCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhccccccccccccccC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 285 (331)
...........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ........
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~------------ 225 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK------------ 225 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTC------------
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccc------------
Confidence 333222233569999999999987765 77899999999999999999998422111 11111100
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000111134457899999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=332.67 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=201.7
Q ss_pred HhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHh--cCCCceeeeEeEEeeC----Ccc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQ--MNHRNILKLIGCCIET----EIP 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~~----~~~ 124 (331)
..++|...+.||+ +||.||+|+.+++.||+|++... ....+.+|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 3568999999999 99999999999999999998653 34566777777776 7999999999997653 357
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeCCCCCCceEEcCCCceEEc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF-----RRPIVFKDIKLSQILFDEYNVAKLS 199 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrdlk~~Nill~~~~~~kl~ 199 (331)
++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. +.+|+||||||+|||++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 899999999999999954 35899999999999999999999421 5689999999999999999999999
Q ss_pred cCCCccccCCCCccc--cccccCCCCcccchhhhccC------CCCCcccchhhHHHHHHHHhC----------CCCChh
Q 020078 200 DFSESEYIPEGETHV--TSHMLTRTKRYLAPEYILTG------LCNEKTDVFCFGMLLLELLTG----------RRDNIL 261 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~el~~g----------~~p~~~ 261 (331)
|||+++......... ......||+.|+|||++... .++.++||||||+++|||++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765443321 12224589999999999876 455799999999999999999 777622
Q ss_pred H-------HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 262 L-------EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 262 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
. ............ .+... ........+.++.+|+.+||+.||++|||+.++++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQ----RPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCC----CCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHhccCC----CCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 111111111111 11111 0001125677899999999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=355.78 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=207.0
Q ss_pred HhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-ccEEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE-IPILVFE 129 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e 129 (331)
..++|...+.||+ +||.||+|.+.+..||||.+.... ..+.|.+|+.++++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888899999 999999999999999999997653 4578999999999999999999999988765 6899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 268 ~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp CCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999976431 34789999999999999999999 89999999999999999999999999999985533
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ..+++.|+|||++....++.++||||||+++|||++ |+.||.... ........+.. ...+.
T Consensus 342 ~~~~-----~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~-------~~~p~ 409 (450)
T 1k9a_A 342 TQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDAPD 409 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC-------CCCCT
T ss_pred cccC-----CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------CCCCC
Confidence 2211 237889999999999999999999999999999998 999974221 11111111110 11112
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
.+++++.+|+.+||+.||++|||+.++++.|+.+....
T Consensus 410 ------~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 410 ------GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 23457999999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=345.59 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=212.5
Q ss_pred HHHhcCccccCceee-cCcEEEEEEeCC-------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFLEN-------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
....++|...+.||+ +||.||+|...+ ..||+|.+.........+.+.+|+.++.+++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345678999999999 999999999843 789999998765555577899999999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGP-------------------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKD 182 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrd 182 (331)
+..++||||+++|+|.+++...... ....+++.+++.++.||+.||.||| +.+|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 9999999999999999999753211 1146899999999999999999999 89999999
Q ss_pred CCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh
Q 020078 183 IKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL 261 (331)
Q Consensus 183 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~ 261 (331)
|||+||+++.++.+||+|||++................+|+.|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986643322222223447889999999999999999999999999999999 9999843
Q ss_pred HHH--HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 262 LEH--VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 262 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
... ........... ..+. ..+.++.+|+.+||+.||++|||+.++++.|+++..
T Consensus 280 ~~~~~~~~~~~~~~~~-------~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEEVIYYVRDGNIL-------ACPE------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHHHHHHHHTTCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHHHHHHHhCCCcC-------CCCC------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 222 11222211111 1111 233479999999999999999999999999998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.53 Aligned_cols=263 Identities=17% Similarity=0.296 Sum_probs=214.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
...+.|...+.||+ +||.||+|... +..||+|++...........+.+|+.++.++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578888999999 99999999862 2579999998776655678899999999999 8999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
+.+..++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceE
Confidence 999999999999999999999764321 1135899999999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHH
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHV 265 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~ 265 (331)
|++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999987655433222333447889999999999999999999999999999999 99987432 222
Q ss_pred HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 266 KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
........... .+. ..+.++.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 303 ~~~~~~~~~~~-------~~~------~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 303 FKLLKEGHRMD-------KPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHHHTTCCCC-------CCS------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCC-------CCc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22222211111 111 2234799999999999999999999999999998743
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=344.59 Aligned_cols=255 Identities=18% Similarity=0.341 Sum_probs=199.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.++|...+.||+ +||.||+|++ +++ +||+|.+.........+.+.+|+.++++++||||++++++|.+++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 467888999999 9999999997 444 368888765554446778999999999999999999999998765 77
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 9999999999999997643 46899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 282 (331)
...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.... ........... .
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~-------~ 238 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------L 238 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------C
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC-------C
Confidence 7755544333333447889999999999999999999999999999999 999974211 11111111110 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..+.++.+++.+||+.||++|||+.++++.|+.+..
T Consensus 239 ~~~~------~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 PQPP------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCT------TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCc------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111 233479999999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=346.08 Aligned_cols=263 Identities=19% Similarity=0.320 Sum_probs=208.9
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE 120 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 120 (331)
....++|...+.||+ +||.||+|.. .+..||+|.+.........+.+.+|+.++.++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 345678899999999 9999999996 34579999998655444677899999999999 89999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCC------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPH------------------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKD 182 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrd 182 (331)
.+..++||||+++|+|.+++....... ...+++..++.++.|++.||.||| +.+|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCC
Confidence 999999999999999999997643210 124789999999999999999999 89999999
Q ss_pred CCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh
Q 020078 183 IKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL 261 (331)
Q Consensus 183 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~ 261 (331)
|||+||+++.++.++|+|||++................+|+.|+|||++.++.++.++||||||+++|+|++ |..||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987654433323333447889999999999999999999999999999998 9999743
Q ss_pred HH---HHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 262 LE---HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 262 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.. ........... ...+. ..++++.+|+.+||..||++|||+.++++.|+.+..
T Consensus 278 ~~~~~~~~~~~~~~~~-------~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFK-------MDQPF------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCSHHHHHHHHTTCC-------CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcHHHHHHHHhcCCC-------CCCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 21 22222221110 01111 223479999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=340.40 Aligned_cols=264 Identities=16% Similarity=0.279 Sum_probs=214.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
...+.|...+.||+ +||.||+|.. ++..||+|.+.........+.+.+|+.++.++ +||||+++++++.+.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 44578889999999 9999999985 45789999998765554578899999999999 899999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGP-------------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
+..++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence 9999999999999999999754321 1125899999999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH---HH
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL---EH 264 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~---~~ 264 (331)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ..
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999987765543333333447889999999999999999999999999999999 99887432 11
Q ss_pred HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
.......... . ..+. ..+.++.+|+.+||+.||++|||+.|+++.|+++..+.
T Consensus 257 ~~~~~~~~~~-----~--~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 FYKMIKEGFR-----M--LSPE------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHTCC-----C--CCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHhccCCC-----C--CCcc------cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1122211110 0 0011 23347999999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=338.67 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=213.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
...++|...+.||+ +||.||+|.. ++..||+|.+.........+.+.+|+.++++++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34577888999999 9999999986 237899999987655556788999999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGP-------------------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI 183 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdl 183 (331)
..++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence 999999999999999999754321 1134889999999999999999999 899999999
Q ss_pred CCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH
Q 020078 184 KLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL 262 (331)
Q Consensus 184 k~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~ 262 (331)
||+||+++.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987755443333333447889999999999999999999999999999999 99987422
Q ss_pred H--HHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 263 E--HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 263 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. ............ ..+. ..++++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 257 ~~~~~~~~~~~~~~~-------~~~~------~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPERLFNLLKTGHRM-------ERPD------NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGGHHHHHHTTCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHhhcCCcC-------CCCc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 1 111111111110 0111 2335799999999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=351.50 Aligned_cols=260 Identities=19% Similarity=0.290 Sum_probs=208.9
Q ss_pred hcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++|...+.||+ +||.||+|.+ ++..||||++...........+.+|+.++.+++||||+++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467888899999 9999999995 45689999997665555667899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC---ceEEc
Q 020078 125 ILVFEFVEYGTLADRICSPHGP--HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLS 199 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~ 199 (331)
++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999754321 1235889999999999999999999 89999999999999999554 59999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGE 276 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~ 276 (331)
|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..... ..........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-- 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-- 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999976533222222223447899999999999999999999999999999998 9999843222 1122221111
Q ss_pred ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+. ..+.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 305 -----~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 305 -----MDPPK------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp -----CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCc------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 01111 233469999999999999999999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=336.61 Aligned_cols=251 Identities=19% Similarity=0.262 Sum_probs=202.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI------ 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------ 123 (331)
.++|...+.||+ +||.||+|+. +++.||||++.........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 456888999999 9999999998 7899999999765555467889999999999999999999999876542
Q ss_pred ---------------------------------------------------cEEEEEecCCCChhhhhcCCCCCCCCCCC
Q 020078 124 ---------------------------------------------------PILVFEFVEYGTLADRICSPHGPHLEPLL 152 (331)
Q Consensus 124 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~ 152 (331)
.++||||+++|+|.+++..... .....
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence 7899999999999999976532 23456
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc----------ccccccCCC
Q 020078 153 WRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH----------VTSHMLTRT 222 (331)
Q Consensus 153 ~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt 222 (331)
+..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........ .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 7788999999999999999 899999999999999999999999999999877554211 112224589
Q ss_pred CcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHH
Q 020078 223 KRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLI 302 (331)
Q Consensus 223 ~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (331)
+.|+|||++.+..++.++||||||+++|+|++|..|+.............. ........++++.+|+
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK-------------FPLLFTQKYPQEHMMV 306 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTC-------------CCHHHHHHCHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccC-------------CCcccccCChhHHHHH
Confidence 999999999999999999999999999999999888543333222222111 1111224556789999
Q ss_pred HHhccCCCCCCCCHHHHHH
Q 020078 303 FECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 303 ~~cl~~dP~~Rps~~evl~ 321 (331)
.+||+.||++|||+.|+++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHH
T ss_pred HHHccCCCCcCCCHHHHhh
Confidence 9999999999999999986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=335.57 Aligned_cols=260 Identities=21% Similarity=0.237 Sum_probs=204.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|...+.||+ +||.||+|.. ++..||+|.+..... ....+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467899999999 9999999997 788999999865432 23457889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... .++++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999754 35899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||............... ...........
T Consensus 162 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~- 238 (294)
T 4eqm_A 162 SETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SVPNVTTDVRK- 238 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CCCCHHHHSCT-
T ss_pred ccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cCCCcchhccc-
Confidence 4433221 22245899999999999999999999999999999999999998543322211111000 00000000011
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRP-TMVYAAKQLRQMYL 328 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~ 328 (331)
..++.+.+++.+||..||++|| ++.++.+.|+++..
T Consensus 239 -----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 239 -----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 2335799999999999999999 99999999987653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=331.48 Aligned_cols=250 Identities=19% Similarity=0.239 Sum_probs=204.2
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--CccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~ 128 (331)
.++|...+.||+ ++|.||+|++++..||+|.+.... .....+.+.+|+.++.+++||||+++++++.+. +..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 356888899999 999999999999999999998653 333466899999999999999999999999887 7789999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.++++|||++..
T Consensus 89 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp ECCTTCBHHHHHHSCSS---CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred cccCCCcHHHHHhhccc---CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999976432 35899999999999999999999 778 99999999999999999999998888654
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCC---cccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNE---KTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRLGEIVDP 280 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~ 280 (331)
..... ..||+.|+|||++.+..++. ++||||||+++|+|++|+.||....... ........ +
T Consensus 163 ~~~~~-------~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~ 230 (271)
T 3kmu_A 163 FQSPG-------RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR-----P 230 (271)
T ss_dssp TSCTT-------CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC-----C
T ss_pred ecccC-------ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC-----C
Confidence 32221 34899999999998765554 7999999999999999999984322211 11111111 1
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.. +. ..++++.+++.+||+.||++|||+.++++.|+++..
T Consensus 231 ~~--~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 231 TI--PP------GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CC--CT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CC--CC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 11 233479999999999999999999999999998864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=332.19 Aligned_cols=265 Identities=17% Similarity=0.211 Sum_probs=209.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC--ccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE--IPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv 127 (331)
.+.|...+.||+ +||.||+|.. +++.||+|.+.........+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467888999999 9999999999 589999999986544445678889999999999999999999998765 67899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE----cCCCceEEccCCC
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSE 203 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfg~ 203 (331)
|||+++|+|.+++...... ..+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999764321 23899999999999999999999 8999999999999999 7888899999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhc--------cCCCCCcccchhhHHHHHHHHhCCCCChh-------HHHHHHH
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYIL--------TGLCNEKTDVFCFGMLLLELLTGRRDNIL-------LEHVKKH 268 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~~l~el~~g~~p~~~-------~~~~~~~ 268 (331)
++......... ...||+.|+|||++. ...++.++||||||+++|+|++|+.||.. .......
T Consensus 163 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 239 (319)
T 4euu_A 163 ARELEDDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (319)
T ss_dssp CEECCTTCCBC---CCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred ceecCCCCcee---ecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence 98775543322 245899999999986 46789999999999999999999999831 1111111
Q ss_pred hhcccccccccc-------cc----ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 269 VENNRLGEIVDP-------IV----VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 269 ~~~~~~~~~~~~-------~~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
... ........ .. .-+..+......+..+.+++.+||+.||++|||+.|+++..+.-
T Consensus 240 ~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHH-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcC-CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111 11110000 00 01111222347788899999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=332.77 Aligned_cols=257 Identities=19% Similarity=0.277 Sum_probs=197.3
Q ss_pred HHhcCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
...+.|...+.||+ +||.||+|... +..||+|.+.........+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 34567888999999 99999999882 34699999876655555778999999999999999999999985 5578
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EEEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred EEEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccc
Confidence 89999999999999997542 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~ 281 (331)
+......... .....+|+.|+|||++....++.++||||||+++|+|++ |..||.... ...........
T Consensus 164 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~------- 235 (281)
T 1mp8_A 164 RYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER------- 235 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------
T ss_pred cccCcccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC-------
Confidence 8765433221 112336788999999998999999999999999999996 888874221 11111111110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
...+. ..++++.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 236 ~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 LPMPP------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00111 2335799999999999999999999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.22 Aligned_cols=247 Identities=17% Similarity=0.209 Sum_probs=203.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ +||.||+|.. +++.+|+|.+.... .....+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467889999999 9999999998 68899999986442 245678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC--CCceEEccCCCcccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE--YNVAKLSDFSESEYI 207 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~~ 207 (331)
|+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++...
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred eCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999996542 35899999999999999999999 899999999999999987 789999999999877
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 285 (331)
....... ...||+.|+|||++.+..++.++||||||+++|+|++|..||...... ......... .
T Consensus 155 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------~ 221 (321)
T 1tki_A 155 KPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------T 221 (321)
T ss_dssp CTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC----------C
T ss_pred CCCCccc---cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC----------C
Confidence 5543322 234899999999999888999999999999999999999998432211 111111110 0
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.....+.++.+|+.+||..||++|||+.|+++
T Consensus 222 ~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000011134567999999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=341.17 Aligned_cols=251 Identities=20% Similarity=0.238 Sum_probs=205.3
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
...++|...+.||+ +||.||+|.. ++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44678999999999 9999999998 68899999997653 33346778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~ 203 (331)
||||+++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 99999999999998754 45889999999999999999999 8999999999999999865 4599999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 281 (331)
+......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..........
T Consensus 178 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~------- 247 (362)
T 2bdw_A 178 AIEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY------- 247 (362)
T ss_dssp CBCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-------
T ss_pred ceEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-------
Confidence 9876543321 224599999999999988999999999999999999999999843222 1111111111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+.....++++.+|+.+||+.||++|||+.++++.
T Consensus 248 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 ---DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111112345679999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=339.23 Aligned_cols=254 Identities=19% Similarity=0.337 Sum_probs=203.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCce----EEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRP----ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.++|...+.||+ +||.||+|.+ ++.. ||+|.+...........+.+|+.++.+++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 356888899999 9999999998 4444 88888765544445677889999999999999999999986 45688
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccc
Confidence 9999999999999997642 35888999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 282 (331)
...............+|+.|+|||++..+.++.++||||||+++|+|++ |..||.... ........... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~ 236 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------L 236 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-------C
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------C
Confidence 8765543333333457889999999999999999999999999999999 999974321 11111211111 1
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
..+..++ .++.+++.+||..||++|||+.++++.|+++.
T Consensus 237 ~~~~~~~------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 AQPQICT------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCCTTBC------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCcCc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111122 35889999999999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=335.10 Aligned_cols=249 Identities=17% Similarity=0.166 Sum_probs=202.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
..+.|...+.||+ +||.||+|.. ++..||+|.+...... ...+.+.+|+.++..++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456888999999 9999999998 6889999998754322 135779999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC----ceEEc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN----VAKLS 199 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~ 199 (331)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 99999999999999999653 46899999999999999999999 89999999999999999887 89999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEI 277 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~ 277 (331)
|||++......... ....||+.|+|||++....++.++||||||+++|+|++|..||...... .........
T Consensus 161 Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~--- 234 (326)
T 2y0a_A 161 DFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--- 234 (326)
T ss_dssp CCTTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC---
T ss_pred ECCCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC---
Confidence 99999876543321 1245899999999999889999999999999999999999998432211 111111110
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 -------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000001123457999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=330.14 Aligned_cols=256 Identities=16% Similarity=0.321 Sum_probs=207.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
...++|...+.||+ +||.||+|.. ++..||+|.+..... ..+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC--CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 44567888899999 9999999998 667899999976533 3567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 99 EYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp CCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred eccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 9999999999997632 45899999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHH--HHHhhccccccccccccccC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV--KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 285 (331)
....... ....+|+.|+|||++....++.++||||||+++|+|++ |+.||...... ......... ...+
T Consensus 172 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 243 (283)
T 3gen_A 172 DDEYTSS-VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------LYRP 243 (283)
T ss_dssp CHHHHST-TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-------CCCC
T ss_pred ccccccc-cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC-------CCCC
Confidence 4322111 12336788999999998999999999999999999998 99998432221 111111110 0011
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. ..++++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 244 ~------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 H------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp T------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1 1234699999999999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=348.74 Aligned_cols=251 Identities=18% Similarity=0.191 Sum_probs=204.0
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
...+.|...+.||+ +||.||+|.. +++.+|+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35677999999999 9999999988 789999999876533 2345678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc---CCCceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD---EYNVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~ 203 (331)
||||+++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999764 45899999999999999999999 89999999999999998 467899999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 281 (331)
+.......... ....||+.|+|||++....++.++|||||||++|+|++|..||..... ...........
T Consensus 160 a~~~~~~~~~~--~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~------ 231 (444)
T 3soa_A 160 AIEVEGEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYD------ 231 (444)
T ss_dssp CBCCCTTCCBC--CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC------
T ss_pred eEEecCCCcee--ecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCC------
Confidence 98765443221 224599999999999988999999999999999999999999843222 11122111110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 ----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011111134457999999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=341.88 Aligned_cols=244 Identities=16% Similarity=0.202 Sum_probs=201.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+++. +++.||+|.+.+.. .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999 9999999998 68999999986531 1224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999998653 35889999999999999999999 8999999999999999999999999999998643
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........ ..
T Consensus 157 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------~~ 222 (337)
T 1o6l_A 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------EI 222 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------CC
T ss_pred cCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------------CC
Confidence 3222 12234589999999999998999999999999999999999999843221 11111111 11
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..|. ..++++.+|+.+||+.||++|| ++.|+++
T Consensus 223 ~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1111 2345799999999999999999 8888865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=358.17 Aligned_cols=259 Identities=20% Similarity=0.338 Sum_probs=210.0
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++....++|...+.||+ +||.||+|.+ .+..||||.+..... ..+.|.+|+.++++++|||||++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 444556678888899999 9999999999 578899999976432 4778999999999999999999999987 5678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++....+ ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred EEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 999999999999999975321 25788999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~ 281 (331)
+......... .....+|+.|+|||++..+.++.++||||||+++|||++ |+.||.... ...........
T Consensus 332 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------- 403 (454)
T 1qcf_A 332 RVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------- 403 (454)
T ss_dssp GGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCC-------
T ss_pred eEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 8764432111 112336788999999999999999999999999999999 999984322 11122211110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+. .+++++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 404 ~~~~~------~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 404 MPRPE------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCC------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 11122 233479999999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=330.64 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=193.6
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCc---chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSE---NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.++|...+.||+ +||.||+|.+.+..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 357888999999 99999999999999999998754322 23567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---eeeCCCCCCceEEcC--------CCceE
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP---IVFKDIKLSQILFDE--------YNVAK 197 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---ivHrdlk~~Nill~~--------~~~~k 197 (331)
||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+||+++. ++.++
T Consensus 86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999998853 45889999999999999999999 666 999999999999986 67899
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh--hccccc
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV--ENNRLG 275 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~ 275 (331)
|+|||++......... ...||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... ......
T Consensus 157 l~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (271)
T 3dtc_A 157 ITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC
T ss_pred EccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC
Confidence 9999999866443322 1348999999999999999999999999999999999999985433222111 111100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
...+. ..++++.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 ------LPIPS------TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCCc------ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00111 2334799999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=331.04 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=203.1
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc--CCCceeeeEeEEeeC---
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQM--NHRNILKLIGCCIET--- 121 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l~~~~~~~--- 121 (331)
.-....+.|...+.||+ +||.||+|+..++.||+|.+... ....+.+|..++..+ +||||+++++++.+.
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 33455678999999999 99999999999999999998643 334555666666554 899999999999987
Q ss_pred -CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC--------CeeeCCCCCCceEEcC
Q 020078 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR--------PIVFKDIKLSQILFDE 192 (331)
Q Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivHrdlk~~Nill~~ 192 (331)
...++||||+++|+|.+++.. ..+++..++.++.|++.||.||| .. +|+||||||+|||++.
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECC
Confidence 678999999999999999965 35889999999999999999999 77 9999999999999999
Q ss_pred CCceEEccCCCccccCCCCccc--cccccCCCCcccchhhhccCCCCCc------ccchhhHHHHHHHHhC---------
Q 020078 193 YNVAKLSDFSESEYIPEGETHV--TSHMLTRTKRYLAPEYILTGLCNEK------TDVFCFGMLLLELLTG--------- 255 (331)
Q Consensus 193 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~~l~el~~g--------- 255 (331)
++.+||+|||++.......... ......||+.|+|||++....++.. +||||||+++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997764433221 1223458999999999987766665 9999999999999999
Q ss_pred -CCCChh-------HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 256 -RRDNIL-------LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 256 -~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
..|+.. ............. .+.... .......++++.+|+.+||+.||++|||+.++++.|+++.
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDMREIVCIKKL----RPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCchhhhHHHHhhhcc----Cccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 555421 1111111111111 111100 0011267788999999999999999999999999999998
Q ss_pred Hh
Q 020078 328 LS 329 (331)
Q Consensus 328 ~~ 329 (331)
.+
T Consensus 331 ~~ 332 (337)
T 3mdy_A 331 ES 332 (337)
T ss_dssp HT
T ss_pred hh
Confidence 65
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=326.13 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=209.1
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.++|...+.||+ ++|.||+|.. ++..||+|.+..... ..+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB--CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 457888899999 9999999998 778999999976543 346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999997543 35889999999999999999999 899999999999999999999999999999866432
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
... ......+++.|+|||++....++.++||||||+++|+|++ |+.||..... .......... ...+.
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~-------~~~~~- 228 (267)
T 3t9t_A 158 QYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------LYKPR- 228 (267)
T ss_dssp HHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------CCCCT-
T ss_pred ccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-------CCCCc-
Confidence 211 1112336788999999998999999999999999999999 8988743221 1111111110 00111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhcC
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSAV 331 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 331 (331)
..+.++.+++.+||+.||++|||+.++++.|+++..+++
T Consensus 229 -----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~l 267 (267)
T 3t9t_A 229 -----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267 (267)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred -----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 123469999999999999999999999999999988764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=333.17 Aligned_cols=268 Identities=19% Similarity=0.237 Sum_probs=206.6
Q ss_pred hcCccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--Cc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET--EI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~~ 123 (331)
...|...+.||+ +||.||+|++ +++.||+|.+.........+.+.+|+.++..++||||+++++++.+. +.
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 345788899999 9999999983 67899999998665554678899999999999999999999999876 66
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccc
Confidence 899999999999999995432 45899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc----cc
Q 020078 204 SEYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE----IV 278 (331)
Q Consensus 204 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~~ 278 (331)
+......... .......+|..|+|||++.+..++.++||||||+++|+|++|..|+................. ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 9877554332 122234578889999999999999999999999999999999988633222111111000000 00
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
...+......+.+...++++.+|+.+||+.||++|||+.++++.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000000011111134457999999999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=330.06 Aligned_cols=260 Identities=20% Similarity=0.302 Sum_probs=196.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
...+.|...+.||+ +||.||+|+..+ .+|+|.+..... ....+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 44678999999999 999999998755 599999875533 33467899999999999999999999976 455689999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 99 QWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 9999999999996543 46899999999999999999999 8999999999999999999999999999997654
Q ss_pred CCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChh---HHHHHHHhhcccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNIL---LEHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~ 282 (331)
............||+.|+|||++. ...++.++||||||+++|+|++|+.||.. ...................
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 249 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK-- 249 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS--
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh--
Confidence 332222222345899999999987 56788899999999999999999999843 2222222222211111000
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
... .+++++.+|+.+||+.||++|||+.++++.|+++..
T Consensus 250 -~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 -VRS------NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -ccc------cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011 233579999999999999999999999999998753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=358.86 Aligned_cols=256 Identities=18% Similarity=0.323 Sum_probs=209.2
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
....+|...+.||+ +||.||+|.+ .+..||||.+..... ..+.|.+|+.+|++++|||||+++++|.+.+..++|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 34566778889999 9999999999 478999999876533 467899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 295 ~E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999975432 45889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 284 (331)
........ ....+++.|+|||++..+.++.++||||||+++|||++ |..||.... .......... ....
T Consensus 369 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-------~~~~ 440 (495)
T 1opk_A 369 TGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------RMER 440 (495)
T ss_dssp TTCCEECC-TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------CCCC
T ss_pred cCCceeec-CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------CCCC
Confidence 54332221 12336788999999999999999999999999999999 888874221 1111111111 0111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
+. .++.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 441 ~~------~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 441 PE------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CC------CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 12 233479999999999999999999999999988753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=338.55 Aligned_cols=270 Identities=17% Similarity=0.334 Sum_probs=216.7
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeee
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKL 114 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l 114 (331)
+...++....++|...+.||+ +||.||+|.+ +++.||+|.+.........+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 444556666789999999999 9999999984 45789999998766555667899999999999 69999999
Q ss_pred EeEEeeCC-ccEEEEEecCCCChhhhhcCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 020078 115 IGCCIETE-IPILVFEFVEYGTLADRICSPHGPH-----------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKD 182 (331)
Q Consensus 115 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrd 182 (331)
++++...+ ..++||||+++|+|.+++....... ...+++..++.++.|++.||.||| +.+|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence 99988755 4899999999999999997643210 123789999999999999999999 89999999
Q ss_pred CCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh
Q 020078 183 IKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL 261 (331)
Q Consensus 183 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~ 261 (331)
|||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655443333333447889999999999999999999999999999998 9998743
Q ss_pred H---HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 262 L---EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 262 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. ............. ..+. ..++++.+++.+||+.||++|||+.|+++.|+.+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~-------~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRM-------RAPD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSHHHHHHHHHTCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccC-------CCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 2 1122222111110 0011 2234699999999999999999999999999998865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=336.97 Aligned_cols=264 Identities=16% Similarity=0.297 Sum_probs=194.4
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCc---eEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENR---PISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~---~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
....++|...+.||+ +||.||+|.. ++. .||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 345678999999999 9999999998 232 79999987653 3335778999999999999999999999998876
Q ss_pred cc------EEEEEecCCCChhhhhcCCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 123 IP------ILVFEFVEYGTLADRICSPHG-PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 123 ~~------~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
.. ++||||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence 55 899999999999999864321 11135899999999999999999999 899999999999999999999
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENN 272 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~ 272 (331)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||..... ........
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 99999999987654433222222346788999999999999999999999999999999 8888743211 11111111
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.. ...+. ..+.++.+|+.+||+.||++|||+.++++.|+++...
T Consensus 256 ~~-------~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 256 NR-------LKQPP------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp CC-------CCCCT------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-------CCCCC------ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 10 11111 2335799999999999999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=335.52 Aligned_cols=261 Identities=17% Similarity=0.309 Sum_probs=211.8
Q ss_pred HhcCccccCceee-cCcEEEEEEe---------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL---------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE 120 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~ 120 (331)
..++|...+.||+ +||.||+|.. ++..||+|.+.........+.+.+|+.++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578889999999 9999999986 34679999998766555677899999999999 89999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceE
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPH-----------LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL 189 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nil 189 (331)
.+..++||||+++|+|.+++....... ...+++..++.++.|++.||.||| +.+|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence 999999999999999999997643211 134889999999999999999999 899999999999999
Q ss_pred EcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHH
Q 020078 190 FDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVK 266 (331)
Q Consensus 190 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~ 266 (331)
++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ...
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999987755443322223347889999999998899999999999999999999 999884322 222
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
......... ..+. ..+.++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 270 ~~~~~~~~~-------~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 270 KLLKEGHRM-------DKPA------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHTCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-------CCCc------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 222211110 0111 223469999999999999999999999999999874
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=333.01 Aligned_cols=246 Identities=17% Similarity=0.240 Sum_probs=194.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-------------------------chhHHHHHHHHHHH
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-------------------------NGENFCFNNIVFAA 104 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~ 104 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+...... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 467999999999 9999999988 7889999998654211 12467899999999
Q ss_pred hcCCCceeeeEeEEee--CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCC
Q 020078 105 QMNHRNILKLIGCCIE--TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKD 182 (331)
Q Consensus 105 ~l~h~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrd 182 (331)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||.||| +.+|+|||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 162 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD 162 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 9999999999999987 5578999999999999886533 46899999999999999999999 88999999
Q ss_pred CCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCC---CCCcccchhhHHHHHHHHhCCCCC
Q 020078 183 IKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL---CNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 183 lk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
|||+|||++.++.+||+|||++.......... ....||+.|+|||++.... ++.++||||||+++|+|++|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99999999999999999999998765443221 2245899999999987654 477899999999999999999998
Q ss_pred hhHHHH--HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 260 ILLEHV--KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 260 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... ......... ...... ..++++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~------~~~~~~------~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQAL------EFPDQP------DIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSHHHHHHHHHHCCC------CCCSSS------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccHHHHHHHHhcccC------CCCCcc------ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 432211 111111110 001111 23346999999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=340.20 Aligned_cols=244 Identities=19% Similarity=0.228 Sum_probs=200.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+.|...+.||+ +||.||+|.. +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57889999999 9999999998 788999999864311 113457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+ +|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 68999988754 45899999999999999999999 8899999999999999999999999999998765
Q ss_pred CCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
..... ...+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.. ................
T Consensus 160 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~----------~~~~~~~~~i~~~~~~ 226 (336)
T 3h4j_B 160 DGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD----------EFIPNLFKKVNSCVYV 226 (336)
T ss_dssp TSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC----------SSSTTCBCCCCSSCCC
T ss_pred CCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC----------ccHHHHHHHHHcCCCC
Confidence 44322 22459999999999987776 6899999999999999999999742 1222222222222222
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 227 ~p~--~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 227 MPD--FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCT--TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred Ccc--cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 222 34567999999999999999999999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=340.37 Aligned_cols=265 Identities=17% Similarity=0.286 Sum_probs=212.1
Q ss_pred HHHHhcCccccCceee-cCcEEEEEEe--CC-----ceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGFL--EN-----RPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
+....++|...+.||+ +||.||+|.. .+ ..||+|.+.........+.+.+|+.++.++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4445678999999999 9999999998 22 379999998765555677899999999999 8999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHG---------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+.+..++||||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEE
Confidence 99999999999999999999864210 00135789999999999999999999 8999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH---HHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL---EHVK 266 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~---~~~~ 266 (331)
+.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999986644433222223346889999999999999999999999999999998 88887431 1112
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
........ ...+.. .+.++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 278 ~~~~~~~~-------~~~~~~------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 278 KLVKDGYQ-------MAQPAF------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHTCC-------CCCCTT------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCC-------CCCCCC------CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 22211111 001111 234699999999999999999999999999988653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=331.69 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=196.3
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecC
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVE 132 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 132 (331)
++|...+.||+ +||.||+|...++.||+|.+... ...+.+.+|+.++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56788899999 99999999999999999998643 25678999999999999999999999987 45899999999
Q ss_pred CCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc-eEEccCCCccccCCCC
Q 020078 133 YGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV-AKLSDFSESEYIPEGE 211 (331)
Q Consensus 133 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-~kl~Dfg~a~~~~~~~ 211 (331)
+|+|.+++..... ...+++..++.++.|+++||.|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~ 160 (307)
T 2eva_A 83 GGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM 160 (307)
T ss_dssp TCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence 9999999976431 134788999999999999999999321189999999999999998876 7999999987654322
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH----HHHHHhhccccccccccccccCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE----HVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
. ...||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ............. . ..
T Consensus 161 ~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~--~~- 227 (307)
T 2eva_A 161 T-----NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP-----L--IK- 227 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC-----C--BT-
T ss_pred c-----cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC-----c--cc-
Confidence 1 1348999999999998899999999999999999999999984211 1111111111000 0 11
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 228 -----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 228 -----NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred -----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 233469999999999999999999999999998864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=355.55 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=204.1
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
..+....++|...+.||+ +||.||+|.+ .+..||||.+..... ..+.|.+|+.++++++||||+++++++.+ +..
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 334455677888899999 9999999999 456799999876542 35789999999999999999999999976 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++....+ ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence 999999999999999964211 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~ 281 (331)
+.......... ....+++.|+|||++..+.++.++||||||+++|||++ |+.||.... ...........
T Consensus 328 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------- 399 (452)
T 1fmk_A 328 RLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------- 399 (452)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred eecCCCceecc-cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 87654322211 12336788999999999999999999999999999999 899984322 22222221111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+. .+++++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 400 ~~~~~------~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 400 MPCPP------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11112 233479999999999999999999999999998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=329.41 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=202.8
Q ss_pred CccccCceee-cCcEEEEEEe--CCc---eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc-EEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENR---PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP-ILV 127 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-~lv 127 (331)
.|...+.||+ +||.||+|.+ ++. .+|+|.+.........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3555688999 9999999987 322 69999998765555678899999999999999999999999876655 899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++..
T Consensus 102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999999999997643 45889999999999999999999 889999999999999999999999999999865
Q ss_pred CCCCcc--ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH---HHHHHHhhcccccccccccc
Q 020078 208 PEGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL---EHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 208 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~ 282 (331)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+... ............ .
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-------~ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR-------L 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-------C
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-------C
Confidence 443211 1112234788999999999989999999999999999999966653211 111111111110 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..+. ..+.++.+++.+||+.||++|||+.++++.|+++..+
T Consensus 248 ~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 248 PQPE------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCc------cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 2334799999999999999999999999999998754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=339.21 Aligned_cols=249 Identities=18% Similarity=0.194 Sum_probs=203.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..+.|...+.||+ +||.||+|.. +++.+|+|.+...... ....+.+|+.++..++||||+++++++.+.+..++||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh-hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 3567999999999 9999999998 6889999998754322 4567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC--CCceEEccCCCccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE--YNVAKLSDFSESEY 206 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~ 206 (331)
||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. .+.+||+|||++..
T Consensus 128 E~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 128 EFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp ECCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 9999999999987543 35899999999999999999999 899999999999999974 47899999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 284 (331)
........ ...||+.|+|||++....++.++|||||||++|+|++|..||....... ........ ..+...
T Consensus 201 ~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~--~~~~~~-- 273 (387)
T 1kob_A 201 LNPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW--EFDEDA-- 273 (387)
T ss_dssp CCTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC--CCCSST--
T ss_pred cCCCccee---eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCccc--
Confidence 75443221 2348999999999998899999999999999999999999985432211 11111111 001000
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....++++.+|+.+||+.||++|||+.|+++
T Consensus 274 ------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 ------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0133457999999999999999999999986
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=328.83 Aligned_cols=261 Identities=17% Similarity=0.169 Sum_probs=198.9
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
...+.|...+.||+ +||.||+|.. +++.||+|++...... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 34578999999999 9999999999 7899999998754322 2457788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||++ |+|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 98 FEFME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EECCS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EcCCC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99998 48888886543 45889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChh------HHHHHHHhhccccccccc-
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNIL------LEHVKKHVENNRLGEIVD- 279 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~------~~~~~~~~~~~~~~~~~~- 279 (331)
........ ...+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.. ..................
T Consensus 170 ~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 170 GIPVRSYT--HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp TSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred CCCccccc--CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 53322211 2348999999999876 5689999999999999999999999832 111111111111000000
Q ss_pred -----------cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 -----------PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 -----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...............++++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000000000123457899999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=334.47 Aligned_cols=241 Identities=18% Similarity=0.281 Sum_probs=200.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+++. +++.||+|.+.+.. .....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56888999999 9999999998 78999999987532 1124567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999754 45889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 286 (331)
... ...+||+.|+|||++.+..++.++||||||+++|+|++|..||....... ...... ..
T Consensus 158 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~------------~~ 220 (318)
T 1fot_A 158 DVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA------------EL 220 (318)
T ss_dssp SCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC------------CC
T ss_pred Ccc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------CC
Confidence 322 22459999999999999999999999999999999999999984322211 111111 11
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
..|. ..+.++.+|+.+||+.||++|| ++.++++
T Consensus 221 ~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1111 2345799999999999999999 8888864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.86 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=201.2
Q ss_pred hcCccccCceee-cCcEEEEEEeC--C----ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE--N----RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
...|...+.||+ +||.||+|... + ..||+|.+...........+.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 345666789999 99999999872 2 3599999987655555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999997543 45899999999999999999999 8899999999999999999999999999998
Q ss_pred ccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccc
Q 020078 206 YIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 206 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~ 281 (331)
......... ......+|+.|+|||++....++.++||||||+++|+|++ |+.||.... ...........
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~------- 268 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------- 268 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc-------
Confidence 765432211 1112236788999999998999999999999999999999 999984322 11122211110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+. ..+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 269 ~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 269 LPTPM------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp CCCCT------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCcc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111 233469999999999999999999999999998864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=330.88 Aligned_cols=251 Identities=19% Similarity=0.292 Sum_probs=199.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CC-------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--EN-------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
.++|...+.||+ +||.||+|.. ++ ..||+|.+...... ..+.+.+|+.++.+++||||+++++++.+++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN-YSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG-GHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 457888899999 9999999988 33 46999998654332 5678999999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc-------
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV------- 195 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~------- 195 (331)
..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence 9999999999999999997642 34889999999999999999999 899999999999999998887
Q ss_pred -eEEccCCCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCC-ChhHHHHHHHhhcc
Q 020078 196 -AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRD-NILLEHVKKHVENN 272 (331)
Q Consensus 196 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p-~~~~~~~~~~~~~~ 272 (331)
++|+|||++....... ...+|+.|+|||++.+ ..++.++||||||+++|+|++|..| +.............
T Consensus 159 ~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~ 232 (289)
T 4fvq_A 159 FIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232 (289)
T ss_dssp EEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred eeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh
Confidence 9999999987553221 1237889999999987 6789999999999999999996554 32211111111000
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
.... . +... +.++.+|+.+||+.||++|||+.++++.|+++..+.
T Consensus 233 ~~~~-----~--~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 233 DRHQ-----L--PAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp TTCC-----C--CCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred ccCC-----C--CCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0000 0 1111 125889999999999999999999999999887543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=326.73 Aligned_cols=248 Identities=24% Similarity=0.376 Sum_probs=198.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcch------hHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENG------ENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
.++|...+.||+ +||.||+|+. +++.||+|.+........ .+.+.+|+.++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 477889999999 9999999998 788999999875433211 267899999999999999999999986554
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEcCCCc-----e
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFDEYNV-----A 196 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~-----~ 196 (331)
++||||+++|+|.+.+.... ..+++..++.++.|++.||.||| +.+ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 79999999999999887643 46899999999999999999999 888 999999999999987776 9
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhc--cCCCCCcccchhhHHHHHHHHhCCCCChhHH----HHHHHhh
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL--TGLCNEKTDVFCFGMLLLELLTGRRDNILLE----HVKKHVE 270 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----~~~~~~~ 270 (331)
||+|||+++...... ....||+.|+|||++. ...++.++||||||+++|+|++|+.||.... .......
T Consensus 169 kl~Dfg~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 169 KVADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp EECCCTTCBCCSSCE-----ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred EeCCCCccccccccc-----cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 999999997543321 1245899999999984 4567899999999999999999999984211 1111111
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
.... .+.. +. ..++++.+++.+||+.||++|||+.++++.|+++
T Consensus 244 ~~~~----~~~~--~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGL----RPTI--PE------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCC----CCCC--CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCC----CCCC--Cc------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1111 0111 11 2335799999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=343.80 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=196.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 126 (331)
.++|...++||+ +||.||+|+. +++.||+|.+.+... ....+.+.+|..++.++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467899999999 9999999998 678999999876422 22456788999999887 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|..++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999998754 45899999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... .....+...+.....
T Consensus 203 ~~~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 203 GLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-NTEDYLFQVILEKQI 279 (396)
T ss_dssp CCCTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------CCHHHHHHHHHHCCC
T ss_pred cccCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-hhHHHHHHHHhcccc
Confidence 332221 22335699999999999999999999999999999999999999842210000000 000000000111111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
..|. ..+.++.+|+.+||+.||++||++
T Consensus 280 ~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 RIPR--SLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCT--TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCC--cCCHHHHHHHHHHhcCCHhHcCCC
Confidence 2221 344579999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=342.87 Aligned_cols=241 Identities=20% Similarity=0.248 Sum_probs=194.8
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 125 (331)
..++|...+.||+ +||.||+|+. +++.||+|.+.+.. .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999 9999999998 68899999987531 122456788999999988 6999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999754 45899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 283 (331)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......
T Consensus 173 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------------ 238 (353)
T 3txo_A 173 EGICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------------ 238 (353)
T ss_dssp CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred ecccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc------------
Confidence 5433222 222356999999999999888999999999999999999999998432221 111111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.....|. ..+.++.+|+.+||+.||++||++
T Consensus 239 ~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 239 DEVVYPT--WLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCC--CCCHHHHHHHHHHhhhCHHHccCC
Confidence 1111111 234579999999999999999998
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=324.79 Aligned_cols=258 Identities=14% Similarity=0.134 Sum_probs=207.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
..++|...+.||+ ++|.||+|.. +++.||+|.+.... ..+.+.+|+.++..+ +|+||+++++++.+....++|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC---ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 3567999999999 9999999996 88999999986543 345688999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc-----eEEccCC
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV-----AKLSDFS 202 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfg 202 (331)
|||+ +|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. ++|+|||
T Consensus 85 ~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 899999997543 35899999999999999999999 999999999999999987765 9999999
Q ss_pred CccccCCCCcc-----ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH-----HHHHHHhhcc
Q 020078 203 ESEYIPEGETH-----VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL-----EHVKKHVENN 272 (331)
Q Consensus 203 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~-----~~~~~~~~~~ 272 (331)
++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 99877544321 1123345899999999999889999999999999999999999998431 1111111100
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.... +...... ..++++.+|+.+||+.||++|||+.++++.|+++...
T Consensus 237 ~~~~---~~~~~~~------~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 237 KQST---PLRELCA------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp HHHS---CHHHHTT------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCc---cHHHHHh------hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 0000 0000001 2235799999999999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=336.68 Aligned_cols=254 Identities=16% Similarity=0.137 Sum_probs=202.1
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC----CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN----YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
..+.|...+.||+ +||.||+|.. +++.||+|.+... ......+.+.+|+.++..++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467899999999 9999999988 6899999998632 1112357799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc---eEEccC
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV---AKLSDF 201 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Df 201 (331)
++||||+++|+|.+.+...... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 9999999999998887643211 135889999999999999999999 899999999999999986654 999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH-HHHhhcccccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV-KKHVENNRLGEIVDP 280 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 280 (331)
|++......... .....||+.|+|||++....++.++|||||||++|+|++|..||...... ..........
T Consensus 178 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~----- 250 (351)
T 3c0i_A 178 GVAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYK----- 250 (351)
T ss_dssp TTCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCC-----
T ss_pred cceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCC-----
Confidence 999877543321 22245999999999999889999999999999999999999998543221 1111111100
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.........+.++.+|+.+||+.||++|||+.|+++
T Consensus 251 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 -----MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp -----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000001133457999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=335.38 Aligned_cols=255 Identities=17% Similarity=0.326 Sum_probs=199.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCce----EEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRP----ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.++|...+.||+ +||.||+|.+ +++. ||+|.+.........+.+.+|+.++.+++||||+++++++..++ .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999 9999999998 4444 57788766555556788999999999999999999999998765 78
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+|+||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 9999999999999997643 45889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 282 (331)
...............+|+.|+|||++.+..++.++||||||+++|+|++ |..||.... ........... .
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-------~ 238 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------L 238 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-------C
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------C
Confidence 7654433333223346889999999999999999999999999999999 999974311 11111111110 1
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..+.++.+|+.+||+.||++|||+.|+++.|+++..
T Consensus 239 ~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 PQPP------ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCc------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 233479999999999999999999999999998863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.47 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=203.4
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
..++|...+.||+ ++|.||+|.+. +..||+|.+.........+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 4567889999999 99999999872 2359999988765555678899999999999999999999998754 568
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 9999999999999996532 45889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~~~~~~~~~~~~~~~~~~ 282 (331)
......... .....+|+.|+|||++....++.++||||||+++|+|++ |+.||... ............ .
T Consensus 162 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-------~ 233 (281)
T 3cc6_A 162 YIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-------L 233 (281)
T ss_dssp CC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-------C
T ss_pred ccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-------C
Confidence 765433221 122337889999999998999999999999999999998 99997321 111111111110 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..++.+.+++.+||..||++|||+.|+++.|+++..
T Consensus 234 ~~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 234 PKPD------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1111 223469999999999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=326.13 Aligned_cols=255 Identities=18% Similarity=0.307 Sum_probs=207.2
Q ss_pred cCccccC-ceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQ-VIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~-~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|.... .||+ +||.||+|.+ .+..||+|.+.........+.+.+|+.++.+++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455544 8999 9999999986 56789999998765555678899999999999999999999999 55678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 99999999999996543 46899999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 208 PEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 208 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
....... ......+|+.|+|||++....++.++||||||+++|+|++ |+.||.... ............ .
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~-------~ 233 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------E 233 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------C
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC-------C
Confidence 5443221 1222346889999999998899999999999999999998 999984321 111122111110 1
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+. ..++++.+++.+||+.||++|||+.++++.|++++.+
T Consensus 234 ~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 234 CPP------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp CCT------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC------CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 2335799999999999999999999999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=333.27 Aligned_cols=255 Identities=16% Similarity=0.171 Sum_probs=206.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+.... ..+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS---RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC---SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 567999999999 9999999996 78999999986543 234688999999999 8999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc-----eEEccCCC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV-----AKLSDFSE 203 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~-----~kl~Dfg~ 203 (331)
||+ +|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 999 899999997542 46899999999999999999999 899999999999999998887 99999999
Q ss_pred ccccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH-----HHHHHHhhccc
Q 020078 204 SEYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL-----EHVKKHVENNR 273 (331)
Q Consensus 204 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~-----~~~~~~~~~~~ 273 (331)
++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||... ...........
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 98765433211 122356999999999999999999999999999999999999998431 11111110000
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
... +.-.... ..+ ++.+++..||+.||.+||++.++.+.|+++..
T Consensus 237 ~~~---~~~~~~~------~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 237 RAT---PIEVLCE------NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp HHS---CHHHHTT------TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccC---CHHHHhc------cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 000 0000000 122 79999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=331.05 Aligned_cols=268 Identities=20% Similarity=0.278 Sum_probs=209.1
Q ss_pred hcCc-cccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC--C
Q 020078 53 TNNY-NGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET--E 122 (331)
Q Consensus 53 ~~~~-~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~--~ 122 (331)
.+.| ...+.||+ +||.||++.+ +++.||+|++.........+.+.+|+.++++++||||+++++++.+. .
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3444 88899999 9999998865 67889999998765555677899999999999999999999999984 5
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg 179 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFG 179 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred eEEEEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcc
Confidence 678999999999999999653 4889999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccc----c
Q 020078 203 ESEYIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE----I 277 (331)
Q Consensus 203 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~----~ 277 (331)
++.......... ......+|..|+|||++.+..++.++||||||+++|+|++|..|+................. .
T Consensus 180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR 259 (318)
T ss_dssp GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH
T ss_pred ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH
Confidence 998776543321 22224478889999999998999999999999999999999999854332211110000000 0
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
....+......+.+...+.++.+|+.+||+.||++|||+.|+++.|+.+.++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 0000000000111113345799999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=339.32 Aligned_cols=268 Identities=19% Similarity=0.304 Sum_probs=215.4
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeE
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLI 115 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~ 115 (331)
+..+++....++|...+.||+ +||.||+|... +..||+|.+...........+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556677789999999999 99999999863 5789999998765555567899999999999999999999
Q ss_pred eEEeeCCccEEEEEecCCCChhhhhcCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 116 GCCIETEIPILVFEFVEYGTLADRICSPH-----GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+++.+.+..++||||+++|+|.+++.... ......+++..++.++.|++.||.||| +.+|+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence 99999999999999999999999986421 011135789999999999999999999 8999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKK 267 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~ 267 (331)
+.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..|+.... ....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 9999999999999986644333222223346889999999999999999999999999999999 888874322 1122
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
........ ..+. ..+.++.+|+.+||+.||++|||+.|+++.|+++.
T Consensus 252 ~~~~~~~~-------~~~~------~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 252 FVMEGGLL-------DKPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHTTCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHcCCcC-------CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 22211110 1111 23346999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=328.24 Aligned_cols=258 Identities=19% Similarity=0.328 Sum_probs=211.6
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
....++|...+.||+ ++|.||+|.. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 345678899999999 9999999999 588999999875432 46789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 87 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp EEECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred EEEcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 9999999999999976432 45899999999999999999999 88999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
.......... ...+|+.|+|||++....++.++||||||+++|+|++ |..||.... ........... ..
T Consensus 161 ~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~-------~~ 232 (288)
T 3kfa_A 161 MTGDTYTAHA-GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------ME 232 (288)
T ss_dssp SCSSSSEEET-TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-------CC
T ss_pred ccCCcccccc-CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCC-------CC
Confidence 6544332222 2336788999999999999999999999999999999 888873211 11111111100 01
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+. ..++++.+|+.+||..||++|||+.++++.|+.+..+
T Consensus 233 ~~~------~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 233 RPE------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC------CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 111 2335799999999999999999999999999988753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=336.71 Aligned_cols=247 Identities=19% Similarity=0.215 Sum_probs=187.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
...+.|...+.||+ +||.||+|+. +++.||+|.+.... ..+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 35677999999999 9999999999 57889999987543 345688999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CCceEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YNVAKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Dfg~a 204 (331)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 9999999999999754 45899999999999999999999 899999999999999975 889999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~ 281 (331)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........... .
T Consensus 199 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-~---- 270 (349)
T 2w4o_A 199 KIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-F---- 270 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-C----
T ss_pred cccCcccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-c----
Confidence 86643321 1224589999999999988999999999999999999999999843221 11111111110 0
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 271 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 -----ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111133457999999999999999999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=326.32 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=207.1
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
...+.|...+.||+ ++|.||+|.. .+..||+|.+..... ..+.+.+|+.++.+++||||+++++++.+ +..++||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 44577888999999 9999999998 566899999876533 36789999999999999999999999874 4688999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++....+ ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 87 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp ECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999964311 25889999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccccC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 285 (331)
....... ....+++.|+|||++..+.++.++||||||+++|+|++ |+.||..... .......... ...+
T Consensus 161 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 232 (279)
T 1qpc_A 161 DNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-------MVRP 232 (279)
T ss_dssp SSCEECC-TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------CCCC
T ss_pred Ccccccc-cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccC-------CCCc
Confidence 5432222 12336788999999998899999999999999999999 8888743221 1111111110 0111
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. ..+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 233 ~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 233 D------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp T------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c------cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1 2234799999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=357.74 Aligned_cols=248 Identities=18% Similarity=0.315 Sum_probs=199.0
Q ss_pred ceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 61 VIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
.||+ +||.||+|.+ ++..||||.+.........+.+.+|+.+|++++|||||+++++|.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6899 9999999987 3457999999876555567889999999999999999999999976 56899999999999
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccc-
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV- 214 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~- 214 (331)
|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999996543 46899999999999999999999 8999999999999999999999999999998765433221
Q ss_pred cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCCchH
Q 020078 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSCPEK 291 (331)
Q Consensus 215 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (331)
......+|+.|+|||++..+.++.++||||||+++|||++ |+.||.... .....+..... +..+.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-------~~~p~----- 562 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-------MECPP----- 562 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-------CCCCT-----
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------CCCCC-----
Confidence 1112235689999999999999999999999999999998 999984321 12222222111 11112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 292 ~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.++.++.+|+.+||+.||++|||+.++++.|+.++.+
T Consensus 563 -~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 563 -ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp -TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 2334799999999999999999999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=326.16 Aligned_cols=269 Identities=19% Similarity=0.290 Sum_probs=210.7
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHh--cCCCceeeeEeEEee
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQ--MNHRNILKLIGCCIE 120 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~~~ 120 (331)
....--....+.|...+.||+ +||.||+|+.+++.||+|.+... ....+.+|+.++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 333334556788999999999 99999999999999999998643 45678889999887 789999999999988
Q ss_pred CC----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeCCCCCCceEEc
Q 020078 121 TE----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF-----RRPIVFKDIKLSQILFD 191 (331)
Q Consensus 121 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivHrdlk~~Nill~ 191 (331)
.+ ..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. +.+|+||||||+||+++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 76 78999999999999999965 35889999999999999999999321 46899999999999999
Q ss_pred CCCceEEccCCCccccCCCCccc--cccccCCCCcccchhhhccC------CCCCcccchhhHHHHHHHHhC--------
Q 020078 192 EYNVAKLSDFSESEYIPEGETHV--TSHMLTRTKRYLAPEYILTG------LCNEKTDVFCFGMLLLELLTG-------- 255 (331)
Q Consensus 192 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~el~~g-------- 255 (331)
.++.+||+|||++.......... ......||+.|+|||++... .++.++||||||+++|+|++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999998765443221 12234589999999999765 234689999999999999999
Q ss_pred --CCCChhH-------HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 256 --RRDNILL-------EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 256 --~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
..||... ............ .+.+... + .....+..+.+|+.+||+.||++|||+.++++.|+++
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~--~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNR--W-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGG--G-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHHHHHHh----CCCCccc--c-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 6676321 122222211111 1111110 0 1125667899999999999999999999999999999
Q ss_pred HHh
Q 020078 327 YLS 329 (331)
Q Consensus 327 ~~~ 329 (331)
..+
T Consensus 335 ~~~ 337 (342)
T 1b6c_B 335 SQQ 337 (342)
T ss_dssp HHT
T ss_pred HHH
Confidence 864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=338.21 Aligned_cols=242 Identities=15% Similarity=0.194 Sum_probs=201.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ +||.||+++. +++.||+|.+.... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367889999999 9999999998 68999999986532 112456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 120 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence 9999999999999754 35889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 285 (331)
.... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .........
T Consensus 192 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------------ 254 (350)
T 1rdq_E 192 KGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK------------ 254 (350)
T ss_dssp SSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred cCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC------------
Confidence 4432 124589999999999999999999999999999999999999843221 111111111
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
...|. ..+.++.+|+.+||+.||++||+ +.++++
T Consensus 255 ~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 255 VRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11111 23457999999999999999998 777764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=339.25 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=200.6
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCc
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEI 123 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 123 (331)
....++|...+.||+ +||.||+|+. +++.||+|.+.... .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999 9999999998 68899999987532 122456788899999887 89999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChh
Confidence 99999999999999999754 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 281 (331)
++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ........
T Consensus 165 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--------- 233 (345)
T 1xjd_A 165 CKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--------- 233 (345)
T ss_dssp CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred hhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC---------
Confidence 986433222 12235699999999999998999999999999999999999999843222 11111111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMV-YAA 320 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-evl 320 (331)
....|. ..+.++.+|+.+||+.||++||++. +++
T Consensus 234 ---~~~~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 ---NPFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111111 2345799999999999999999997 554
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=321.96 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=205.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--------
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-------- 120 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 120 (331)
..++|...+.||+ ++|.||+|.. +++.||+|.+.... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567899999999 9999999998 68999999987542 457799999999999999999999865
Q ss_pred --------CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC
Q 020078 121 --------TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE 192 (331)
Q Consensus 121 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~ 192 (331)
....++||||+++|+|.+++....+ ..+++..++.++.|++.||.||| +.+|+||||||+||+++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence 3447899999999999999965321 45889999999999999999999 899999999999999999
Q ss_pred CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc
Q 020078 193 YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN 272 (331)
Q Consensus 193 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~ 272 (331)
++.++|+|||++.......... ...||+.|+|||++.+..++.++||||||+++|+|++|..|+.............
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 234 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234 (284)
T ss_dssp TTEEEECCCTTCEESSCCSCCC---CCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTT
T ss_pred CCCEEECcchhheecccccccc---ccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcc
Confidence 9999999999998765543221 2348999999999998899999999999999999999999875444333322221
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
. +. . ..+.++.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 235 ~--------~~--~------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 I--------IS--D------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp C--------CC--T------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred c--------cc--c------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 1 11 1 122368999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=336.66 Aligned_cols=243 Identities=19% Similarity=0.189 Sum_probs=194.2
Q ss_pred ccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 58 GHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 58 ~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
..+.||+ +||.||+|.. ++..||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3567999 9999999998 688999999876433 25678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE--cCCCceEEccCCCccccCCCCc
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF--DEYNVAKLSDFSESEYIPEGET 212 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill--~~~~~~kl~Dfg~a~~~~~~~~ 212 (331)
+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 172 ELFDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 9999886532 45889999999999999999999 8999999999999999 5678999999999987654432
Q ss_pred cccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCCCCch
Q 020078 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDKSCPE 290 (331)
Q Consensus 213 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
.. ...||+.|+|||++....++.++|||||||++|+|++|+.||....... ......... . ....
T Consensus 245 ~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~-~---------~~~~ 311 (373)
T 2x4f_A 245 LK---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWD-L---------EDEE 311 (373)
T ss_dssp CC---CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC-S---------CSGG
T ss_pred cc---cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-C---------Chhh
Confidence 21 2358999999999998899999999999999999999999984322211 111111110 0 0001
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 291 KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 291 ~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....++++.+|+.+||+.||++|||+.|+++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1133457999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=326.63 Aligned_cols=256 Identities=18% Similarity=0.295 Sum_probs=201.8
Q ss_pred cCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee-CCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-TEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~l 126 (331)
..|...+.||+ +||.||+|... ...+|+|.+.........+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 45777899999 99999999872 125899998876555567789999999999999999999999654 567899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++..
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999997543 45789999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCcc--ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCC-CCChhHHH--HHHHhhccccccccccc
Q 020078 207 IPEGETH--VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-RDNILLEH--VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 207 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~-~p~~~~~~--~~~~~~~~~~~~~~~~~ 281 (331)
....... .......+|+.|+|||.+.+..++.++||||||+++|+|++|. +|+..... ..........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~------- 250 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR------- 250 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------
T ss_pred ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------
Confidence 6443221 1122234778899999999999999999999999999999954 45421111 1111111110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
...+. ..+.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus 251 ~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 251 LLQPE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCc------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01111 2234699999999999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=339.43 Aligned_cols=268 Identities=17% Similarity=0.193 Sum_probs=211.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC--ccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE--IPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~~~lv 127 (331)
.+.|...+.||+ +||.||+|+. +++.||+|.+.........+.+.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467888999999 9999999999 589999999986544445678889999999999999999999998765 67999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE----cCCCceEEccCCC
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAKLSDFSE 203 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~kl~Dfg~ 203 (331)
|||+++|+|.+++...... ..+++..++.++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999754221 23899999999999999999999 8999999999999999 7888899999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhcc--------CCCCCcccchhhHHHHHHHHhCCCCChh-------HHHHHHH
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILT--------GLCNEKTDVFCFGMLLLELLTGRRDNIL-------LEHVKKH 268 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~~l~el~~g~~p~~~-------~~~~~~~ 268 (331)
++........ ....||+.|+|||++.. ..++.++||||||+++|+|++|+.||.. .......
T Consensus 163 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 163 ARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp CEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred ceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 9876543321 22458999999999875 5678899999999999999999999832 1112222
Q ss_pred hhcccccccccc-----------ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 269 VENNRLGEIVDP-----------IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 269 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.. ......+.. .-..+..+......+..+.+++.+||+.||++|||+.++++.++.+...
T Consensus 240 ~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 240 IT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred hc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 21 111111000 0011112222347788899999999999999999999999999988753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=348.26 Aligned_cols=257 Identities=16% Similarity=0.146 Sum_probs=204.9
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
.++...+++|...++||+ +||.||+|+. +++.||+|++.+.. .......+.+|+.++..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 344455689999999999 9999999998 57899999986521 111344588999999999999999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999997642 45899999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNR 273 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~ 273 (331)
|+++........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||....... .......
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 999876544332 222346999999999997 4678999999999999999999999984322211 1111000
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAK 321 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~ 321 (331)
... .+.... ..++++.+|+.+||..+|++ ||++.|+++
T Consensus 299 ~~~-----~p~~~~-----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 RFQ-----FPTQVT-----DVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HCC-----CCSSCC-----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccc-----CCcccc-----cCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000 000000 23457999999999998888 999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=329.64 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=199.5
Q ss_pred HhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC-CccEEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET-EIPILVFE 129 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e 129 (331)
..++|...+.||+ ++|.||+|...++.||+|.+.... ..+.+.+|+.++.+++||||+++++++.+. +..++|||
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred ChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 3567889999999 999999999999999999987543 457799999999999999999999997654 47899999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 96 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999965321 23788999999999999999999 89999999999999999999999999999876543
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.... ..+++.|+|||.+....++.++||||||+++|+|++ |+.||.... ........... ...+.
T Consensus 170 ~~~~-----~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 237 (278)
T 1byg_A 170 TQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDAPD 237 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-------CCCCT
T ss_pred cccC-----CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-------CCCcc
Confidence 3221 237889999999999999999999999999999998 999874321 11111111100 00111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
..++++.+++.+||+.||++|||+.++++.|+++....
T Consensus 238 ------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 238 ------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 23357999999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=327.70 Aligned_cols=244 Identities=16% Similarity=0.120 Sum_probs=194.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ +||+||+|+. +++.||||++...... .....+..|+..+.++ +||||++++++|.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367899999999 9999999999 6899999998764332 2344566677666665 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+ +|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 136 ~e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 679999887543 45899999999999999999999 889999999999999999999999999998876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ....||+.|+|||++.+ .++.++||||||+++|||++|..|+........... ... .+.
T Consensus 208 ~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~-~~~----~~~------ 272 (311)
T 3p1a_A 208 GTAGAG---EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ-GYL----PPE------ 272 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTT-TCC----CHH------
T ss_pred ccCCCC---cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhc-cCC----Ccc------
Confidence 443221 22458999999998864 799999999999999999999776544333222211 110 010
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.....++++.+|+.+||+.||++|||+.|+++
T Consensus 273 --~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 --FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11123457999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=327.95 Aligned_cols=263 Identities=19% Similarity=0.339 Sum_probs=197.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
...+.|...+.||+ +||.||+|.. .+..||+|.+.... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 45678888999999 9999999987 23479999987543 33346789999999999999999999999987653
Q ss_pred -----cEEEEEecCCCChhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 124 -----PILVFEFVEYGTLADRICSPH-GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 124 -----~~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
.++||||+++|+|.+++.... ......+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence 489999999999999985321 111256899999999999999999999 89999999999999999999999
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccc
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRL 274 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~ 274 (331)
|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ..........
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence 999999987654432222223347889999999999999999999999999999999 8888732111 1111111110
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
...+. ..+.++.+++.+||..||++|||+.++++.|+++..+
T Consensus 268 -------~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 268 -------LKQPE------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp -------CCCBT------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCc------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00111 2335799999999999999999999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=327.10 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=204.3
Q ss_pred HhcCccccC-ceee-cCcEEEEEEe----CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 52 ATNNYNGHQ-VIAS-EHYKLYKGFL----ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 52 ~~~~~~~~~-~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
..+.|.... .||+ +||.||+|.+ .+..||+|.+..... ....+.+.+|+.++..++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677666 8999 9999999965 457899999976533 22367899999999999999999999999 56678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 93 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 9999999999999999764 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCcccc-ccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhcccccccccc
Q 020078 205 EYIPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDP 280 (331)
Q Consensus 205 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~ 280 (331)
........... .....+++.|+|||++....++.++||||||+++|+|++ |..||..... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----- 239 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM----- 239 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-----
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence 87755433221 122336788999999998889999999999999999999 9999843222 12222211110
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..+. ..+.++.+++.+||+.||++|||+.++++.|++++.+
T Consensus 240 --~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 240 --GCPA------GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp --CCCT------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0111 2334799999999999999999999999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=339.20 Aligned_cols=254 Identities=19% Similarity=0.341 Sum_probs=192.9
Q ss_pred ccccCceee-cCcEEEEEEe--CC---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee-CCccEEEE
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--EN---RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-TEIPILVF 128 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~ 128 (331)
|...+.||+ +||.||+|.+ ++ ..||+|.+.........+.+.+|+.++++++||||++++++|.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 455678999 9999999987 22 35899998765555567889999999999999999999999765 45789999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 171 e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp ECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred ECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999997643 45788999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCccc--cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccccc
Q 020078 209 EGETHV--TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 209 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
...... ......+|+.|+|||++....++.++||||||+++|||++ |.+||..... .......... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-------~~ 316 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LL 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-------CC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-------CC
Confidence 332211 1122346788999999999999999999999999999999 5666532110 1111111110 11
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+..+ +.++.+++.+||+.||++|||+.|+++.|+++..+
T Consensus 317 ~p~~~------~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 317 QPEYC------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CCTTC------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11222 34699999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=326.38 Aligned_cols=249 Identities=18% Similarity=0.180 Sum_probs=203.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
..+.|...+.||+ +||.||+|.. ++..||+|.+...... ...+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467888999999 9999999998 6889999998754322 135779999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC----ceEEc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN----VAKLS 199 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~ 199 (331)
.++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .++|+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 99999999999999999754 45889999999999999999999 89999999999999999887 79999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEI 277 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~ 277 (331)
|||++......... ....||+.|+|||++....++.++||||||+++|+|++|..||...... ......... .
T Consensus 162 Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--~ 236 (321)
T 2a2a_A 162 DFGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSY--D 236 (321)
T ss_dssp CCTTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC--C
T ss_pred cCccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc--c
Confidence 99999876544322 1234899999999999889999999999999999999999998432221 111111110 0
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.++.. ....+..+.+|+.+||..||++|||+.|+++
T Consensus 237 ~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 237 FDEEF--------FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCHHH--------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cChhh--------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 0123457999999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.00 Aligned_cols=251 Identities=18% Similarity=0.205 Sum_probs=191.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ +||.||+++. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467999999999 9999999999 788999999976433 34678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc--eEEccCCCcccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV--AKLSDFSESEYI 207 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Dfg~a~~~ 207 (331)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++. +||+|||+++..
T Consensus 97 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 97 YASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred eCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 99999999998654 35899999999999999999999 899999999999999987765 999999998744
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCc-ccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEK-TDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
..... .....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.......... ..+........
T Consensus 169 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~~~~~~~~~~~ 239 (361)
T 3uc3_A 169 VLHSQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR------KTIQRILSVKY 239 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH------HHHHHHHTTCC
T ss_pred cccCC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH------HHHHHHhcCCC
Confidence 32221 112358999999999988887665 899999999999999999985322100000 00000000111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.....++++.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111233579999999999999999999999863
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=330.34 Aligned_cols=258 Identities=21% Similarity=0.317 Sum_probs=196.6
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHH--HHhcCCCceeeeEeEEee-----CCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVF--AAQMNHRNILKLIGCCIE-----TEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~~~~-----~~~~ 124 (331)
.++|...+.||+ +||.||+|+.+++.||+|++... ....+..|..+ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 467889999999 99999999999999999998643 33445555555 445899999999986653 2356
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC---------CeeeCCCCCCceEEcCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR---------PIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivHrdlk~~Nill~~~~~ 195 (331)
++||||+++|+|.+++... ..++..+..++.|++.||.||| +. +|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred EEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCc
Confidence 8999999999999999653 3588999999999999999999 77 9999999999999999999
Q ss_pred eEEccCCCccccCCCCc------cccccccCCCCcccchhhhcc-------CCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 196 AKLSDFSESEYIPEGET------HVTSHMLTRTKRYLAPEYILT-------GLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
+||+|||+++.+..... ........||+.|+|||++.+ ..++.++||||||+++|||++|..|+...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999987654321 111223458999999999976 35667899999999999999997764211
Q ss_pred --------------------HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 263 --------------------EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 263 --------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
............ .+... ..++.....++++.+|+.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFP--EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCC--TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCC--cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 111111111111 11111 1111122566789999999999999999999999999
Q ss_pred HHHHHHh
Q 020078 323 LRQMYLS 329 (331)
Q Consensus 323 L~~~~~~ 329 (331)
|+++...
T Consensus 313 L~~ll~~ 319 (336)
T 3g2f_A 313 MAELMMI 319 (336)
T ss_dssp HHHHHHC
T ss_pred HHHHHHH
Confidence 9998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=331.02 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=203.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCce--EEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRP--ISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|...+.||+ +||.||+|+. ++.. +|+|.+.........+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999 9999999988 5654 4999887654444667899999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 128 FEFVEYGTLADRICSPHG-----------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
|||+++|+|.+++..... .....+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence 999999999999976420 11246899999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~ 273 (331)
||+|||+++....... .....+++.|+|||++....++.++||||||+++|+|++ |..||....... .......
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence 9999999874322211 111336889999999998889999999999999999998 999984432211 1111110
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. ...+. ..+.++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 259 ~-------~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 259 R-------LEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp C-------CCCCT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C-------CCCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 01111 2334799999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=346.36 Aligned_cols=244 Identities=21% Similarity=0.238 Sum_probs=201.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ +||.||+|+. +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367888999999 9999999998 789999999865321 12356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999999999654 45899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHH--HHHHHhhcccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLE--HVKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 284 (331)
...... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ..........
T Consensus 167 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------- 232 (476)
T 2y94_A 167 SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI----------- 232 (476)
T ss_dssp CTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-----------
T ss_pred cccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-----------
Confidence 544322 22459999999999988765 689999999999999999999984321 1111111111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 233 -~~~p~--~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 233 -FYTPQ--YLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp -CCCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -cCCCc--cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 11111 23347999999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=347.50 Aligned_cols=254 Identities=16% Similarity=0.206 Sum_probs=203.3
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
++....++|...+.||+ +||.||+|+. +++.||+|.+.+.. .....+.+.+|+.++..++|||||++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 33445678999999999 9999999998 67899999986421 1113456889999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..|+||||+++|+|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccc
Confidence 99999999999999999864 24889999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCC----CCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcccccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL----CNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGE 276 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~ 276 (331)
+++........ .....+||+.|+|||++.... ++.++|||||||++|||++|+.||....... ........
T Consensus 214 ~a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-- 290 (410)
T 3v8s_A 214 TCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-- 290 (410)
T ss_dssp TCEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--
T ss_pred eeEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--
Confidence 99876544321 222356999999999998655 8899999999999999999999984322211 11111000
Q ss_pred ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 020078 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD--RPTMVYAAK 321 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--Rps~~evl~ 321 (331)
....|.....+.++.+|+.+||+.+|.+ ||++.|+++
T Consensus 291 --------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 --------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp --------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred --------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0011111123457999999999999988 999999875
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=324.56 Aligned_cols=258 Identities=15% Similarity=0.176 Sum_probs=197.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|...+.||+ +||+||+|.. +++.||+|++..... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 46888899999 9999999998 688999999875433 2345788899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++ +|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9985 6666665433 46899999999999999999999 89999999999999999999999999999987643
Q ss_pred CCccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChh----HHHHHHHhh---ccccccc---c
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNIL----LEHVKKHVE---NNRLGEI---V 278 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~----~~~~~~~~~---~~~~~~~---~ 278 (331)
..... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..|+.. ......... ....... .
T Consensus 154 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccccc--cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 32221 2234899999999998765 89999999999999999999888521 111111111 0000000 0
Q ss_pred ---c----cccc-cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 ---D----PIVV-EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ---~----~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+ +... ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0000 00000000134457999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.34 Aligned_cols=258 Identities=17% Similarity=0.196 Sum_probs=196.4
Q ss_pred cCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ +||.||+|.. +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46888899999 9999999998 6889999998754322 2356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 985 9999887643 45889999999999999999999 899999999999999999999999999999876433
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhh---ccccc--------
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVE---NNRLG-------- 275 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~---~~~~~-------- 275 (331)
.... ....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||...... ..... .....
T Consensus 154 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 VRKY--THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cccc--ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 2211 123489999999999754 5899999999999999999999998432211 11111 00000
Q ss_pred cccccccccCCCCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDPIVVEDKSCP---EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...++........+ .....++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00011000000000 00123457899999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.81 Aligned_cols=239 Identities=20% Similarity=0.276 Sum_probs=197.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|...+.||+ +||.||+++. +++.||+|.+..... ....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999 9999999998 688999999976532 23456788999999988 899999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999998753 35899999999999999999999 899999999999999999999999999999864
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH-----------HHHHHHhhcccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL-----------EHVKKHVENNRLGE 276 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~-----------~~~~~~~~~~~~~~ 276 (331)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||... .........
T Consensus 161 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~----- 233 (345)
T 3a8x_A 161 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE----- 233 (345)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-----
T ss_pred cCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-----
Confidence 32221 122356999999999999989999999999999999999999998431 111111111
Q ss_pred ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.....|. ..+.++.+|+.+||+.||++||++
T Consensus 234 -------~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 234 -------KQIRIPR--SLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred -------CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1111111 334579999999999999999996
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=321.38 Aligned_cols=249 Identities=20% Similarity=0.219 Sum_probs=202.6
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ ++|.||+|.. +++.||+|.+.........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 456888899999 9999999998 6889999998765444456789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||.+.....
T Consensus 86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 99999999998653 46889999999999999999999 89999999999999999999999999999986643
Q ss_pred CCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhccccccccccccccC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 285 (331)
...........||+.|+|||++....+ +.++||||||+++|+|++|..||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------- 226 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----------- 226 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-----------
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-----------
Confidence 332222233458999999999987665 7789999999999999999999843211 1111111000
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00001133457999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=330.88 Aligned_cols=242 Identities=19% Similarity=0.214 Sum_probs=201.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-------chhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-------NGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
..+.|...+.||+ +||.||+|+. +++.||+|.+...... .....+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578899999999 9999999987 7889999998765321 1345678899999999999999999999999
Q ss_pred CccEEEEEecCCC-ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 122 EIPILVFEFVEYG-TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 122 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
+..++||||+..| +|.+++... ..+++..+..++.|++.||.||| ..+|+||||||+|||++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEee
Confidence 9999999999777 999998764 35899999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVD 279 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 279 (331)
||++.......... ...||+.|+|||++.+..+ +.++||||||+++|+|++|..||.... ....
T Consensus 174 fg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------------~~~~ 238 (335)
T 3dls_A 174 FGSAAYLERGKLFY---TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------------ETVE 238 (335)
T ss_dssp CTTCEECCTTCCBC---EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------------GGTT
T ss_pred cccceECCCCCcee---ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------------HHHh
Confidence 99998775543322 2458999999999988776 789999999999999999999974311 1111
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.....+.. .++++.+|+.+||+.||++|||+.++++.
T Consensus 239 ~~~~~~~~------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYL------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSC------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCcc------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111222 23479999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=336.44 Aligned_cols=262 Identities=13% Similarity=0.101 Sum_probs=200.5
Q ss_pred HhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcc----------hhHHHHHHHHHHHhcCCCceee
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSEN----------GENFCFNNIVFAAQMNHRNILK 113 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~ 113 (331)
.+++|...+.||+ +||.||+|.+. ++.||+|.+....... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4568999999999 99999999882 4789999986543210 0122334555667788999999
Q ss_pred eEeEEeeC----CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceE
Q 020078 114 LIGCCIET----EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQIL 189 (331)
Q Consensus 114 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nil 189 (331)
+++++... ...++||||+ +|+|.+++.... ..+++..++.++.||+.||.||| +.+|+||||||+|||
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL 184 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence 99999875 4479999999 999999997643 46899999999999999999999 899999999999999
Q ss_pred Ec--CCCceEEccCCCccccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 190 FD--EYNVAKLSDFSESEYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 190 l~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 88999999999998764332111 112345999999999999889999999999999999999999998532
Q ss_pred HH-------HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 263 EH-------VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 263 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.. ..... .......+++.+.. ..+ +.++.+++..||..||++|||+.++++.|+++...
T Consensus 265 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~------~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 265 LKDPKYVRDSKIRY-RENIASLMDKCFPA-ANA------PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp TTCHHHHHHHHHHH-HHCHHHHHHHHSCT-TCC------CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHh-hhhHHHHHHHhccc-ccC------HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 10 01000 01111222222111 122 34799999999999999999999999999988753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=327.24 Aligned_cols=263 Identities=17% Similarity=0.230 Sum_probs=189.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ +||.||+|.. +++.||+|.+.........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888899999 9999999988 6889999998765544456788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 130 FVEYGTLADRICSPH-GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|++ |+|.+++.... ......+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999886432 111245889999999999999999999 8999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhc-ccccc-------
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVEN-NRLGE------- 276 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~-~~~~~------- 276 (331)
...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ....... .....
T Consensus 160 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNTF--SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCCC--CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcccC--CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 332211 123489999999999764 689999999999999999999999843221 1111110 00000
Q ss_pred ---ccccccccCCCCch--------HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 ---IVDPIVVEDKSCPE--------KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 ---~~~~~~~~~~~~~~--------~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.......... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000000000 0023357999999999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.27 Aligned_cols=243 Identities=17% Similarity=0.238 Sum_probs=198.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ +||.||++.. +++.||+|.+.... .....+.+.+|+.++..++|||||++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999 9999999998 67889999986432 122456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp ECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999999999764 45899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhH-----HHHHHHhhccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILL-----EHVKKHVENNRLGEIVD 279 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~-----~~~~~~~~~~~~~~~~~ 279 (331)
...... ....||+.|+|||++.. ..++.++|||||||++|+|++|+.||... ..........
T Consensus 166 ~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------- 235 (384)
T 4fr4_A 166 PRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------- 235 (384)
T ss_dssp CTTCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-------
T ss_pred cCCCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-------
Confidence 543322 22559999999999974 35899999999999999999999998421 1111111110
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-MVYAA 320 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~evl 320 (331)
....|. .++.++.+|+.+||+.||++||+ +.+++
T Consensus 236 -----~~~~p~--~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 236 -----VVTYPS--AWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp -----CCCCCT--TSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred -----ccCCCC--cCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 111111 23457999999999999999998 66654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=321.22 Aligned_cols=245 Identities=19% Similarity=0.225 Sum_probs=201.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..+.|...+.||+ +||.||+|.. ++..+|+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 4567899999999 9999999998 5678999998765443 5678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 205 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++.
T Consensus 86 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 86 ELCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp ECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 999999999988654 45889999999999999999999 8999999999999999 788999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 283 (331)
........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||...... .......
T Consensus 158 ~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 222 (277)
T 3f3z_A 158 RFKPGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG----------- 222 (277)
T ss_dssp ECCTTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred eccCccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-----------
Confidence 76543322 12358999999998854 5899999999999999999999998432221 1111111
Q ss_pred cCCCCchH--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEK--EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+.. ...++++.+|+.+||+.||++|||+.++++
T Consensus 223 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 -TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 123457999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=330.76 Aligned_cols=258 Identities=13% Similarity=0.122 Sum_probs=206.1
Q ss_pred HHHHhcCccccCceee-cCcEEEEEE-----e--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC---CCceeeeEeE
Q 020078 49 LKIATNNYNGHQVIAS-EHYKLYKGF-----L--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN---HRNILKLIGC 117 (331)
Q Consensus 49 ~~~~~~~~~~~~~ig~-~~g~Vy~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~ 117 (331)
+....+.|...+.||+ +||.||+|. . .++.||+|.+... ....+.+|+.++..++ |+||+.++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 3345677888999999 999999994 2 7889999998754 3557888999998887 9999999999
Q ss_pred EeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-----
Q 020078 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE----- 192 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~----- 192 (331)
+...+..++||||+++|+|.+++..........+++..++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCc
Confidence 999999999999999999999997422212256999999999999999999999 899999999999999998
Q ss_pred ------CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH
Q 020078 193 ------YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK 266 (331)
Q Consensus 193 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~ 266 (331)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-- 290 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-- 290 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET--
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC--
Confidence 899999999999765432222223335699999999999999999999999999999999999999632110
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHh
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDR-PTMVYAAKQLRQMYLS 329 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-ps~~evl~~L~~~~~~ 329 (331)
....+..... ... ..+.+.+++..||+.+|.+| |++.++.+.|+++...
T Consensus 291 -------~~~~~~~~~~-~~~------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 291 -------GECKPEGLFR-RLP------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------TEEEECSCCT-TCS------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------Cceeechhcc-ccC------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0001111111 111 13468899999999999999 5788888888887643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=349.13 Aligned_cols=245 Identities=15% Similarity=0.182 Sum_probs=192.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+... ........+.+|+.++..++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467888999999 9999999998 7889999998753 2222456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
|||+++|+|.+++... ..+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+|||+++.
T Consensus 227 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~ 298 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 298 (446)
T ss_dssp ECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred EeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence 9999999999998654 45899999999999999999999 7 8999999999999999999999999999986
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 284 (331)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ........
T Consensus 299 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 364 (446)
T 4ejn_A 299 GIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------ 364 (446)
T ss_dssp TCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred ccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC------------
Confidence 4333221 2235699999999999999999999999999999999999999843222 11111111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
....|. ..++++.+|+.+||+.||++|| |+.|+++
T Consensus 365 ~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 111111 2335799999999999999999 9999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.53 Aligned_cols=268 Identities=18% Similarity=0.195 Sum_probs=207.4
Q ss_pred hcCccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~ 123 (331)
.+.|...+.||+ +||.||+|++ ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 467888899999 9999999984 678899999876532 256779999999999999999999999874 456
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccc
Confidence 889999999999999997532 35899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcc-cccc---cc
Q 020078 204 SEYIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN-RLGE---IV 278 (331)
Q Consensus 204 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~-~~~~---~~ 278 (331)
+.......... ......+|+.|+|||++.+..++.++||||||+++|+|++|..|+............. .... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 98775443322 2222447888999999999999999999999999999999999975433221111000 0000 00
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+......+.+...++++.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00000000011111344579999999999999999999999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=318.69 Aligned_cols=249 Identities=20% Similarity=0.231 Sum_probs=203.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
..++|...+.||+ ++|.||+|.. ++..||+|.+.... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 4578999999999 9999999988 68899999987543 333467788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc---eEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV---AKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg~a 204 (331)
|||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. ++|+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999888654 45889999999999999999999 899999999999999986655 999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhcccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIV 282 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 282 (331)
......... ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ..........
T Consensus 156 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~------- 225 (284)
T 3kk8_A 156 IEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD------- 225 (284)
T ss_dssp EECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-------
T ss_pred EEcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhcccc-------
Confidence 776544322 1245899999999999999999999999999999999999998432221 1111111110
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000111133457999999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=335.98 Aligned_cols=263 Identities=18% Similarity=0.215 Sum_probs=199.2
Q ss_pred hcCccccCceeec---CcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIASE---HYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~~---~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.+.|...+.||+| +|.||+|+. +++.||+|++..... ....+.+.+|+.+++.++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 5679999999986 679999999 689999999976533 2345678889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999975422 35889999999999999999999 89999999999999999999999999998765
Q ss_pred cCCCCc-----cccccccCCCCcccchhhhcc--CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhh--ccccccc
Q 020078 207 IPEGET-----HVTSHMLTRTKRYLAPEYILT--GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVE--NNRLGEI 277 (331)
Q Consensus 207 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~--~~~~~~~ 277 (331)
...... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.||........... .......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 432211 111122358999999999987 5789999999999999999999999832111000000 0000000
Q ss_pred ccc--------------------------------ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDP--------------------------------IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~--------------------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+. ........+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 00000011122244567999999999999999999999975
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=330.46 Aligned_cols=245 Identities=17% Similarity=0.204 Sum_probs=190.3
Q ss_pred hcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCC---cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYS---ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
.++|...+.||+ +||.||+++. +++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 467999999999 9999999986 678999999976421 2235568899999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999998653 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPI 281 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 281 (331)
++....... ......||+.|+|||++....++.++||||||+++|+|++|+.||...... ........
T Consensus 168 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------- 237 (327)
T 3a62_A 168 CKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------- 237 (327)
T ss_dssp C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------
T ss_pred ccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------
Confidence 876433222 122245899999999999889999999999999999999999998432211 11111111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
...|. ..+.++.+|+.+||+.||++|| ++.|+++
T Consensus 238 ----~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ----LNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ----CCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ----CCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111 2335799999999999999999 6667754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=335.76 Aligned_cols=241 Identities=18% Similarity=0.241 Sum_probs=197.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 125 (331)
..++|...+.||+ +||.||+|+. +++.||+|.+.... .....+.+.+|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999 9999999999 56889999987542 122456788999999988 7999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~ 169 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence 999999999999999754 35889999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .......
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------------ 235 (353)
T 2i0e_A 170 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------------ 235 (353)
T ss_dssp CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred ccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------
Confidence 6432221 22235699999999999999999999999999999999999999843221 1111111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.....|. ..+.++.+|+.+||+.||++||++
T Consensus 236 ~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 236 HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp CCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111111 344579999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=330.38 Aligned_cols=261 Identities=19% Similarity=0.161 Sum_probs=201.4
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC----CcchhHHHHHHHHHHHhcCCCceeeeEeEEe
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY----SENGENFCFNNIVFAAQMNHRNILKLIGCCI 119 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 119 (331)
+++....+.|...+.||+ +||.||+|.. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 345677888999999999 9999999998 67889999986431 2335678999999999999999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCCCC-----------------------------------CCCCCCHHHHHHHHHHHH
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPHGP-----------------------------------HLEPLLWRHRLKIAMEIG 164 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~ 164 (331)
+.+..++||||+++|+|.+++...... ....+++..+..++.|++
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 999999999999999999988521000 001235677888999999
Q ss_pred HHHHHhhcCCCCCeeeCCCCCCceEEcCCC--ceEEccCCCccccCCCCcc--ccccccCCCCcccchhhhcc--CCCCC
Q 020078 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYN--VAKLSDFSESEYIPEGETH--VTSHMLTRTKRYLAPEYILT--GLCNE 238 (331)
Q Consensus 165 ~~l~~LH~~~~~~ivHrdlk~~Nill~~~~--~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~ 238 (331)
.||.||| +.+|+||||||+||+++.++ .+||+|||++..+...... .......||+.|+|||++.. ..++.
T Consensus 179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999 88999999999999998776 8999999999865432211 11223458999999999975 67899
Q ss_pred cccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC
Q 020078 239 KTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT 315 (331)
Q Consensus 239 ~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps 315 (331)
++||||||+++|+|++|+.||....... ........ ...+.....++++.+|+.+||+.||++|||
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-----------FENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----------TTSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-----------cCCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999984322221 11111100 011111134457999999999999999999
Q ss_pred HHHHHH
Q 020078 316 MVYAAK 321 (331)
Q Consensus 316 ~~evl~ 321 (331)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=334.65 Aligned_cols=243 Identities=20% Similarity=0.339 Sum_probs=197.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
...|...+.||+ +||.||+|+. +++.||+|++...... ...+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 345888899999 9999999997 7899999998754322 2346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||++ |+|.+++.... .++++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++...
T Consensus 133 ~e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99997 68888875432 46899999999999999999999 889999999999999999999999999999766
Q ss_pred CCCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRLGEIVDPI 281 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~ 281 (331)
.... ...||+.|+|||++. .+.++.++||||||+++|||++|+.||....... ....... +.
T Consensus 205 ~~~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------~~ 272 (348)
T 1u5q_A 205 APAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------PA 272 (348)
T ss_dssp SSBC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------CC
T ss_pred CCCC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC------CC
Confidence 4322 235899999999985 5678999999999999999999999984322211 1111111 10
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. .. ..+..+.+|+.+||+.||++|||+.++++.
T Consensus 273 ~~-~~------~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 273 LQ-SG------HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CC-CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CC-CC------CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11 11 223469999999999999999999999753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=331.29 Aligned_cols=261 Identities=19% Similarity=0.282 Sum_probs=206.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
..++|...+.||+ +||.||+|++ ++..||+|.+...........+.+|+.++.+++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3578999999999 9999999984 4568999999766555567789999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CCceEE
Q 020078 124 PILVFEFVEYGTLADRICSPHGP--HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YNVAKL 198 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl 198 (331)
.++||||+++|+|.+++...... ....+++..++.++.|++.||.||| +.+|+||||||+||+++. +..++|
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999764321 1135889999999999999999999 899999999999999984 456999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLG 275 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~ 275 (331)
+|||++................+|+.|+|||++....++.++||||||+++|+|++ |..||..... ...........
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM 264 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCC
Confidence 99999876543332222222347899999999999999999999999999999998 8888743221 11222211110
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..+..+.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 265 -------~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 265 -------DPPK------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCC------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 0111 223469999999999999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=322.21 Aligned_cols=248 Identities=17% Similarity=0.263 Sum_probs=181.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ ++|.||+|.. +++.||+|.+..... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 457888999999 9999999997 788999999864321 11346789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... .++++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 99999999999997643 46899999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
....... ....||+.|+|||.+....++.++||||||+++|+|++|+.||.... ..............
T Consensus 163 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----------~~~~~~~~~~~~~~ 230 (278)
T 3cok_A 163 KMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT----------VKNTLNKVVLADYE 230 (278)
T ss_dssp C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS----------CC-----CCSSCCC
T ss_pred cCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh----------HHHHHHHHhhcccC
Confidence 4332211 12348999999999998889999999999999999999999974211 11111111111111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+. ..+.++.+|+.+||+.||++|||+.++++
T Consensus 231 ~~~--~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPS--FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCT--TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccc--ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111 23457999999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=328.30 Aligned_cols=269 Identities=19% Similarity=0.282 Sum_probs=207.8
Q ss_pred hcCccccCceee-cCcEEEEEEe------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC--c
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL------ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE--I 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~--~ 123 (331)
.+.|...+.||+ ++|.||++++ +++.||+|++..... ...+.+.+|+.++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 456888899999 9999999984 678999999976533 35678999999999999999999999987654 6
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 899999999999999997643 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH-HHHhhccccccc----
Q 020078 204 SEYIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV-KKHVENNRLGEI---- 277 (331)
Q Consensus 204 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~~~---- 277 (331)
+.......... ......++..|+|||++.+..++.++||||||+++|+|++|..|+...... ............
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 98775543321 112234677899999999888999999999999999999999987433211 111111000000
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
+...+......+.+...+.++.+|+.+||+.||++|||+.|+++.|+++...
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000000011113345799999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=329.06 Aligned_cols=259 Identities=18% Similarity=0.253 Sum_probs=196.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc--
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP-- 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~-- 124 (331)
..+.|...+.||+ +||.||+|+. +++.||+|.+...... .....+.+|+.++.+++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3577999999999 9999999997 7889999999765332 2356788999999999999999999999876654
Q ss_pred --EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 125 --ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 125 --~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg 161 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFG 161 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCS
T ss_pred ccEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999999754 35899999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccc
Q 020078 203 ESEYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 203 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 281 (331)
++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................. .+
T Consensus 162 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~- 239 (311)
T 3ork_A 162 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI-PP- 239 (311)
T ss_dssp CC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC-CH-
T ss_pred CcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCC-Cc-
Confidence 99876543322 1222345899999999999999999999999999999999999998433222111110000000 00
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA-KQLRQM 326 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl-~~L~~~ 326 (331)
..... ..+.++.+++.+||+.||++||++.+++ ..|.++
T Consensus 240 ~~~~~------~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 240 SARHE------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp HHHST------TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccC------CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00001 2345799999999999999999766554 445544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=331.92 Aligned_cols=246 Identities=21% Similarity=0.205 Sum_probs=179.0
Q ss_pred cCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEecCCC
Q 020078 59 HQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g 134 (331)
.+.||+ +||.||+|.. +++.||+|.+... ....+.+|+.++..+. ||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999 9999999998 6889999998643 4567889999999997 999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC---ceEEccCCCccccCCCC
Q 020078 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLSDFSESEYIPEGE 211 (331)
Q Consensus 135 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---~~kl~Dfg~a~~~~~~~ 211 (331)
+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++......
T Consensus 92 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 92 ELFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp BHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 999999764 46899999999999999999999 89999999999999997665 89999999998765433
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC--Cc
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS--CP 289 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 289 (331)
.... ...||+.|+|||++....++.++||||||+++|+|++|..||......... ............+... .+
T Consensus 164 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~i~~~~~~~~~~ 238 (325)
T 3kn6_A 164 QPLK--TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC---TSAVEIMKKIKKGDFSFEGE 238 (325)
T ss_dssp ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C---CCHHHHHHHHTTTCCCCCSH
T ss_pred Cccc--ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc---ccHHHHHHHHHcCCCCCCcc
Confidence 2221 234899999999999999999999999999999999999998543221000 0000011111111111 11
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.....++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 22245678999999999999999999998863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=322.36 Aligned_cols=250 Identities=20% Similarity=0.208 Sum_probs=196.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ +||.||++.. ++..+|+|.+.........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 457888999999 9999999998 6889999999876555467889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCCccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEY 206 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~~ 206 (331)
|+++|+|.+.+...... ...+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++..
T Consensus 101 ~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 101 TCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred eCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 99999999988542110 145889999999999999999999 8999999999999999 4567899999999986
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 284 (331)
....... ....||+.|+|||++. +.++.++||||||+++|+|++|+.||..... ............ ...
T Consensus 177 ~~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~ 247 (285)
T 3is5_A 177 FKSDEHS---TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY-----AVE 247 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-----CC-
T ss_pred cCCcccC---cCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc-----ccc
Confidence 6443221 1244899999999875 5689999999999999999999999843221 111111111000 000
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~------~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CR------PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -C------CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cC------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 12346899999999999999999999985
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=343.61 Aligned_cols=258 Identities=17% Similarity=0.164 Sum_probs=204.0
Q ss_pred HHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEee
Q 020078 46 AGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIE 120 (331)
Q Consensus 46 ~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 120 (331)
+.++....++|...+.||+ +||.||+++. +++.||+|++.+.. .....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455556789999999999 9999999998 68999999986531 11234568899999999999999999999999
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999997532 35889999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhc-------cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-------TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVEN 271 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~ 271 (331)
||+++........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||....... .....
T Consensus 206 FGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 284 (412)
T 2vd5_A 206 FGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284 (412)
T ss_dssp CTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred chhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 9999876544322 222346999999999997 3568999999999999999999999984332211 11111
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDR---PTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---ps~~evl~ 321 (331)
... ....+.. ....++++.+|+.+||. +|++| |++.|+++
T Consensus 285 ~~~-~~~~p~~--------~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKE-HLSLPLV--------DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHH-HCCCC------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccc-CcCCCcc--------ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 0000000 01234579999999999 99998 58888764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=356.90 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=208.5
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
..+....+.|...+.||+ +||.||+|.+ .+..||||++..... ..+.|.+|+.+|++++||||+++++++.+ +..
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 344455677888899999 9999999999 457799999976542 35789999999999999999999999976 678
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++....+ ..+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred eEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 999999999999999964211 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~ 281 (331)
+........ ......++..|+|||++..+.++.++||||||+++|||++ |+.||.... .....+.....
T Consensus 411 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------- 482 (535)
T 2h8h_A 411 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------- 482 (535)
T ss_dssp TTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred eecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 876432211 1112336788999999999999999999999999999999 898884322 22222221111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
+..+. .++.++.+||.+||+.||++|||+.++++.|+.+..
T Consensus 483 ~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 483 MPCPP------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11112 233479999999999999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=320.48 Aligned_cols=256 Identities=18% Similarity=0.212 Sum_probs=195.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|...+.||+ ++|.||+|.. +++.||+|++...... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57888999999 9999999998 5899999998765433 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999998887654 45899999999999999999999 89999999999999999999999999999987654
Q ss_pred CCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH-----------------hhc
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH-----------------VEN 271 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~-----------------~~~ 271 (331)
..... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......... +..
T Consensus 155 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 155 PSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred ccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 33221 12348999999999976 56899999999999999999999998332211110 000
Q ss_pred cccccccccccccCCC-CchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKS-CPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....... ....... .+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 233 NQYFSGV--KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CGGGTTC--CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccC--cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000000 0000 123457999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.78 Aligned_cols=262 Identities=19% Similarity=0.227 Sum_probs=190.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCC--c
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMN-HRNILKLIGCCIETE--I 123 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~--~ 123 (331)
...+.|...+.||+ +||.||+|.. +++.||+|++.... .......+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999 9999999988 78999999987542 2334667889999999997 999999999998654 6
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.|+||||++ |+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 799999997 689998865 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCc-------------------cccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHH
Q 020078 204 SEYIPEGET-------------------HVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLE 263 (331)
Q Consensus 204 a~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~ 263 (331)
++.+..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 986643110 111223469999999999986 578999999999999999999999983322
Q ss_pred HHH---HHhhcccccc--cc----cc----------------ccccCCCCchH----------HHHHHHHHHHHHHhccC
Q 020078 264 HVK---KHVENNRLGE--IV----DP----------------IVVEDKSCPEK----------EQQLQALLQLIFECVNE 308 (331)
Q Consensus 264 ~~~---~~~~~~~~~~--~~----~~----------------~~~~~~~~~~~----------~~~~~~~~~li~~cl~~ 308 (331)
... .......... .+ .+ .......++.. ...++++.+|+.+||+.
T Consensus 236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 111 1110000000 00 00 00000000000 02245799999999999
Q ss_pred CCCCCCCHHHHHHH
Q 020078 309 SAGDRPTMVYAAKQ 322 (331)
Q Consensus 309 dP~~Rps~~evl~~ 322 (331)
||++|||+.|+++.
T Consensus 316 dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 316 NPNKRISANDALKH 329 (388)
T ss_dssp SGGGSCCHHHHTTS
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=322.79 Aligned_cols=259 Identities=22% Similarity=0.322 Sum_probs=198.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ ++|.||+|.. ++..||+|++.... .......+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 457889999999 9999999997 78999999997532 233467889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQ-KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhccc-ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 9999999999988642110 145889999999999999999999 899999999999999999999999999998866
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH----HHHHHhhccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE----HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~ 283 (331)
...... .....|++.|+|||++....++.++||||||+++|+|++|..||.... ............. ..
T Consensus 187 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~ 259 (310)
T 2wqm_A 187 SSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-----LP 259 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-----CC
T ss_pred cCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-----Cc
Confidence 443221 112348999999999999999999999999999999999999984322 1111111111110 00
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.. ..+.++.+|+.+||+.||++|||+.++++.|+++...
T Consensus 260 -~~------~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 260 -SD------HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp -TT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cc------ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 01 2334799999999999999999999999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=334.87 Aligned_cols=206 Identities=20% Similarity=0.210 Sum_probs=178.8
Q ss_pred ccccCHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-----CCcee
Q 020078 41 IRSFSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-----HRNIL 112 (331)
Q Consensus 41 ~~~~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~nIv 112 (331)
...+++.+.....+.|...+.||+ +||.||+|+. +++.||+|.+... ......+..|+.++..++ ||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 334555666677889999999999 9999999998 7889999998642 224567788999999997 99999
Q ss_pred eeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC
Q 020078 113 KLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE 192 (331)
Q Consensus 113 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~ 192 (331)
++++++...+..++||||+ +|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDD 172 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcc
Confidence 9999999999999999999 8899999975432 35889999999999999999999 899999999999999975
Q ss_pred -------------------------CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHH
Q 020078 193 -------------------------YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGM 247 (331)
Q Consensus 193 -------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ 247 (331)
++.+||+|||++........ ...||+.|+|||++.+..++.++|||||||
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC-----SCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc-----CccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 78999999999986544322 245899999999999999999999999999
Q ss_pred HHHHHHhCCCCCh
Q 020078 248 LLLELLTGRRDNI 260 (331)
Q Consensus 248 ~l~el~~g~~p~~ 260 (331)
++|+|++|+.||.
T Consensus 248 il~ell~g~~pf~ 260 (360)
T 3llt_A 248 VLAELYTGSLLFR 260 (360)
T ss_dssp HHHHHHHSSCSCC
T ss_pred HHHHHHHCCCCCC
Confidence 9999999999983
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=321.83 Aligned_cols=257 Identities=16% Similarity=0.130 Sum_probs=198.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.-++|...+.||+ +||.||+|.. +++.||+|.+...... ...+.+.+|+.++.+++||||+++++++.+++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3478999999999 9999999998 6889999998754322 234778899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++..
T Consensus 112 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~ 183 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASA 183 (309)
T ss_dssp EEECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred EEEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence 99999999999999753 35889999999999999999999 89999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 284 (331)
........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ....... ..+ ...
T Consensus 184 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~-~~~ 257 (309)
T 2h34_A 184 TTDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI----PRP-STV 257 (309)
T ss_dssp --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCC----CCG-GGT
T ss_pred cccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCC----CCc-ccc
Confidence 65432221 112348999999999998899999999999999999999999985433221 1111110 000 011
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRP-TMVYAAKQLRQMYL 328 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~ 328 (331)
.. ..+.++.+++.+||+.||++|| |+.++++.|++...
T Consensus 258 ~~------~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 258 RP------GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp ST------TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred CC------CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 11 2234699999999999999999 99999999987653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=323.44 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=193.8
Q ss_pred hcCccc-cCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNG-HQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~-~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|.. .++||+ +||.||+|.. +++.||+|.+...... ..+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 355666 478999 9999999987 7899999999765432 567889999999985 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc---eEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV---AKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~Dfg~a 204 (331)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||+|||++
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 9999999999999754 45889999999999999999999 889999999999999998775 999999998
Q ss_pred cccCCCCcc-----ccccccCCCCcccchhhhcc-----CCCCCcccchhhHHHHHHHHhCCCCChhH------------
Q 020078 205 EYIPEGETH-----VTSHMLTRTKRYLAPEYILT-----GLCNEKTDVFCFGMLLLELLTGRRDNILL------------ 262 (331)
Q Consensus 205 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~el~~g~~p~~~~------------ 262 (331)
......... .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 765432211 11122358999999999875 56889999999999999999999998431
Q ss_pred -----HHHHHHhhccccccccccccccCCCCchH--HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 263 -----EHVKKHVENNRLGEIVDPIVVEDKSCPEK--EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 263 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.......... ....+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 242 CPACQNMLFESIQEG------------KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CHHHHHHHHHHHHHC------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred chhHHHHHHHHHhcc------------CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111111111 1111111 123457999999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.76 Aligned_cols=247 Identities=17% Similarity=0.201 Sum_probs=192.8
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCC--CceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNH--RNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|...+.||+ +||.||++.. +++.||+|++..... ....+.+.+|+.++..++| |||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 466889999999 9999999988 778899999875433 3345788999999999986 9999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|| +.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 99 5678999999764 46889999999999999999999 89999999999999997 578999999999877
Q ss_pred CCCCccccccccCCCCcccchhhhcc-----------CCCCCcccchhhHHHHHHHHhCCCCChhH----HHHHHHhhcc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILT-----------GLCNEKTDVFCFGMLLLELLTGRRDNILL----EHVKKHVENN 272 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~----~~~~~~~~~~ 272 (331)
.............||+.|+|||++.. ..++.++||||||+++|+|++|+.||... ..........
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 55443333333569999999999865 67899999999999999999999998431 1111111100
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. ...+. ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~-------~~~~~------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 HE-------IEFPD------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SC-------CCCCC------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-------cCCcc------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 00 00011 112368999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=315.54 Aligned_cols=254 Identities=17% Similarity=0.192 Sum_probs=202.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++|...+.||+ +||.||++.. +++.||+|.+...... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 456888999999 9999999999 6889999998754221 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC----ceEEcc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN----VAKLSD 200 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~D 200 (331)
++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++ .++|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999653 46899999999999999999999 89999999999999998877 899999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhcccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIV 278 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~ 278 (331)
||++......... ....+|+.|+|||++....++.++||||||+++|+|++|..||....... ........ ..
T Consensus 156 fg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~ 230 (283)
T 3bhy_A 156 FGIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNY--DF 230 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--CC
T ss_pred cccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhccc--CC
Confidence 9999876443321 12348999999999998899999999999999999999999984322211 11111110 00
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK--QLRQMY 327 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~--~L~~~~ 327 (331)
+. ......+..+.+|+.+||..||++|||+.++++ .++.+.
T Consensus 231 ~~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 231 DE--------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CH--------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred cc--------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 00 000123457999999999999999999999997 355554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=321.22 Aligned_cols=246 Identities=20% Similarity=0.307 Sum_probs=204.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ ++|.||+|.. +++.||+|.+.........+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 456888999999 9999999987 6889999999766555567889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 9999999999854 35889999999999999999999 89999999999999999999999999999987654
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--HhhccccccccccccccCCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 287 (331)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|..|+........ ....... +... .
T Consensus 172 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~--~- 241 (303)
T 3a7i_A 172 TQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-----PTLE--G- 241 (303)
T ss_dssp TBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----CCCC--S-
T ss_pred cccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-----CCCc--c-
Confidence 3221 1224589999999999999999999999999999999999999843322211 1111111 0111 1
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+.++.+|+.+||+.||++|||+.++++.
T Consensus 242 -----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 -----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -----ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 223469999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=320.47 Aligned_cols=261 Identities=17% Similarity=0.180 Sum_probs=196.3
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC----cchhHHHHHHHHHHHhcC---CCceeeeEeEEee
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS----ENGENFCFNNIVFAAQMN---HRNILKLIGCCIE 120 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~ 120 (331)
..++.|...+.||+ +||+||+|+. +++.||+|.+..... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34678999999999 9999999997 788999999864321 112356778888887775 9999999999987
Q ss_pred CC-----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 121 TE-----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 121 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
.. ..++||||+. |+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCC
Confidence 65 4789999997 699999976532 34899999999999999999999 899999999999999999999
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhcc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVENN 272 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~~ 272 (331)
+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ........
T Consensus 159 ~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 235 (308)
T 3g33_A 159 VKLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 235 (308)
T ss_dssp EEECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999876543322 124589999999999999999999999999999999999999833221 11111110
Q ss_pred ---cccccc------ccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 273 ---RLGEIV------DPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 273 ---~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... ..........+.. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000000 0000000000000 023457999999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=321.31 Aligned_cols=261 Identities=18% Similarity=0.196 Sum_probs=199.3
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEE-eeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCC-IETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~l 126 (331)
...+.|...+.||+ +||.||+|+. +++.||+|.+.... ....+.+|+.++..++|++++..++++ .+.+..++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 34678999999999 9999999996 78899999865443 234688999999999988877776666 56677899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~ 203 (331)
||||+ +|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 99999 899999987433 45899999999999999999999 8999999999999999 7889999999999
Q ss_pred ccccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccc
Q 020078 204 SEYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIV 278 (331)
Q Consensus 204 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 278 (331)
+.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ......
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~ 227 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-------TKRQKY 227 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-------SSSSHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchh-------hhhhhh
Confidence 98765543211 122345899999999999999999999999999999999999997321000 000000
Q ss_pred ccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 279 DPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 279 ~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..........+.. ...++++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 228 ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 0000000000000 02245799999999999999999999999999998753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=353.81 Aligned_cols=248 Identities=20% Similarity=0.302 Sum_probs=198.5
Q ss_pred Cceee-cCcEEEEEEe----CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL----ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||.||+|.+ .+..||||++..... ....+.+.+|+.++.+++|||||+++++|.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 46999 9999999976 457899999976432 2346789999999999999999999999964 457899999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 9999999654 45889999999999999999999 899999999999999999999999999999877544322
Q ss_pred c-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCCc
Q 020078 214 V-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
. ......+|+.|+|||++....++.++||||||+++|||++ |+.||.... ............ ..+.
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~-------~~p~--- 595 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-------GCPA--- 595 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------CCCT---
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------CCCC---
Confidence 1 1122336788999999999999999999999999999998 999984322 222222222111 1111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.++.++.+|+.+||+.||++|||+.++++.|++++.+
T Consensus 596 ---~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 596 ---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2335799999999999999999999999999998765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=337.87 Aligned_cols=255 Identities=17% Similarity=0.204 Sum_probs=192.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------ 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 122 (331)
.+.|...+.||+ +||.||+|.. +++.||+|++.... .....+.+.+|+.+++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467888999999 9999999988 78999999997542 2334677889999999999999999999997654
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..|+||||+++ +|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 45999999976 5767663 24889999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhc-ccc----
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVEN-NRL---- 274 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~-~~~---- 274 (331)
+++....... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ..... +..
T Consensus 210 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 210 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286 (464)
T ss_dssp CC-----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeeecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987644322 122458999999999999999999999999999999999999984322111 11000 000
Q ss_pred ------------------cccccccc-c---cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 275 ------------------GEIVDPIV-V---EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 275 ------------------~~~~~~~~-~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.....+.. . .+.........++++.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000 0 00001111123678999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=321.79 Aligned_cols=244 Identities=19% Similarity=0.279 Sum_probs=198.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ ++|.||+|.. ++..||+|.+..... ......+.+|+.++..++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467889999999 9999999998 667899999864321 11356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999998654 35889999999999999999999 999999999999999999999999999998655
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 285 (331)
..... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||....... .......
T Consensus 160 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 223 (279)
T 3fdn_A 160 PSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------ 223 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC------------
T ss_pred Ccccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC------------
Confidence 43322 12348999999999998899999999999999999999999984322211 1111110
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+. ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 224 ~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 FTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCCT--TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCC--cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01111 223469999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=332.84 Aligned_cols=247 Identities=17% Similarity=0.196 Sum_probs=193.4
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcC--CCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMN--HRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~lv 127 (331)
...|...+.||+ +||.||++.. .++.||||.+.... .....+.+.+|+.++..++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 345889999999 9999999998 68889999987543 3335678999999999997 59999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|| +.+|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++.+
T Consensus 135 ~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred Ee-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99 5678999999764 35888899999999999999999 99999999999999996 589999999999877
Q ss_pred CCCCccccccccCCCCcccchhhhcc-----------CCCCCcccchhhHHHHHHHHhCCCCChhH----HHHHHHhhcc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILT-----------GLCNEKTDVFCFGMLLLELLTGRRDNILL----EHVKKHVENN 272 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~----~~~~~~~~~~ 272 (331)
.............||+.|+|||++.. ..++.++|||||||++|+|++|+.||... ..........
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 54433322333569999999999865 36889999999999999999999998432 1111111100
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. ...+.. .+.++.+|+.+||+.||++|||+.|+++.
T Consensus 285 ~~-------~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 HE-------IEFPDI------PEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SC-------CCCCCC------SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-------CCCCcc------chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 00 000111 12469999999999999999999999753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=341.49 Aligned_cols=248 Identities=22% Similarity=0.231 Sum_probs=200.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc------------chhHHHHHHHHHHHhcCCCceeeeEe
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE------------NGENFCFNNIVFAAQMNHRNILKLIG 116 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~nIv~l~~ 116 (331)
..+.|...+.||+ +||+||+|.. ++..||+|.+...... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 5678999999999 9999999998 6789999998754321 24567899999999999999999999
Q ss_pred EEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC--
Q 020078 117 CCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-- 194 (331)
Q Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-- 194 (331)
++.+.+..++|||||++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999988654 45899999999999999999999 89999999999999998775
Q ss_pred -ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhc
Q 020078 195 -VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVEN 271 (331)
Q Consensus 195 -~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~ 271 (331)
.+||+|||++......... ....||+.|+|||++. +.++.++||||+||++|+|++|..||..... .......
T Consensus 186 ~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp SSEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 6999999999876544322 2245999999999986 5699999999999999999999999843222 1112211
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ....+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus 262 ~~~----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 262 GKY----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCC----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 0011111234567999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.96 Aligned_cols=245 Identities=18% Similarity=0.226 Sum_probs=197.3
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
..++|...+.||+ +||.||++.. +++.||+|.+..... ...+|+.++.++ +||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 4567999999999 9999999998 688999999975432 345788888888 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC----CceEEccCCC
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY----NVAKLSDFSE 203 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~ 203 (331)
|||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+.++ +.+||+|||+
T Consensus 95 ~E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 95 TELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp ECCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 9999999999999764 45899999999999999999999 8999999999999998533 3599999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh-----HHHHHHHhhcccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL-----LEHVKKHVENNRLGEIV 278 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~-----~~~~~~~~~~~~~~~~~ 278 (331)
++......... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.. ..............
T Consensus 167 a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~--- 241 (342)
T 2qr7_A 167 AKQLRAENGLL--MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS--- 241 (342)
T ss_dssp CEECBCTTCCB--CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC---
T ss_pred cccCcCCCCce--eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc---
Confidence 98765443221 224589999999999888899999999999999999999999842 12222222211110
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.... .+...+.++.+|+.+||+.||++|||+.++++
T Consensus 242 ---~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGG----YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCST----TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000 01134457999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=336.41 Aligned_cols=243 Identities=19% Similarity=0.218 Sum_probs=189.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHH-HHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVF-AAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.++|...+.||+ +||.||+|+. ++..||+|.+.+... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999 9999999998 678899999976432 2234566777776 567899999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999998753 35888999999999999999999 89999999999999999999999999999986
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 284 (331)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ........
T Consensus 189 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~------------ 254 (373)
T 2r5t_A 189 NIEHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK------------ 254 (373)
T ss_dssp GBCCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS------------
T ss_pred cccCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc------------
Confidence 433222 12235699999999999999999999999999999999999999843221 11111111
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYA 319 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~ev 319 (331)
....+. ..+.++.+|+.+||+.||++||++.+.
T Consensus 255 ~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 255 PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp CCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred ccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 111111 233479999999999999999998643
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=323.79 Aligned_cols=261 Identities=16% Similarity=0.165 Sum_probs=204.0
Q ss_pred cCHHHHHHHhcCcccc-Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcC-CCceeeeEeE
Q 020078 44 FSAGELKIATNNYNGH-QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMN-HRNILKLIGC 117 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~-~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~ 117 (331)
..+.......+.|... +.||+ +||.||+|.. +++.||+|.+..... ......+.+|+.++..+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 4444555666777766 88999 9999999998 689999999876432 334678999999999995 6999999999
Q ss_pred EeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CC
Q 020078 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YN 194 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~ 194 (331)
+.+.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. ++
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELA---EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence 9999999999999999999999865322 46899999999999999999999 899999999999999997 78
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRL 274 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 274 (331)
.+||+|||++......... ....||+.|+|||++....++.++||||||+++|+|++|+.||...............
T Consensus 172 ~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred cEEEeeCccccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 9999999999876543221 1245899999999999999999999999999999999999998433222211110000
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. . ...+.....+..+.+|+.+||+.||++|||+.++++
T Consensus 249 ~~--~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 249 NV--D------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CC--C------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--c------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 0 000001133457999999999999999999999975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=341.94 Aligned_cols=248 Identities=21% Similarity=0.238 Sum_probs=203.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
..+.|...+.||+ +||.||+|+. +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567888999999 9999999998 789999999865432 2356789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~ 203 (331)
||||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 99999999999999764 45899999999999999999999 8999999999999999 4678999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPI 281 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 281 (331)
+.......... ...||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ...+.....
T Consensus 176 a~~~~~~~~~~---~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~------- 244 (484)
T 3nyv_A 176 STHFEASKKMK---DKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY------- 244 (484)
T ss_dssp HHHBCCCCSHH---HHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC-------
T ss_pred eEEcccccccc---cCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCC-------
Confidence 98775543322 2348999999999865 6999999999999999999999998432221 111211111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus 245 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 245 ---TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 1111222245568999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=328.26 Aligned_cols=258 Identities=16% Similarity=0.170 Sum_probs=191.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ +||.||+|.. +++.||+|.+...........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46888899999 9999999998 68899999997654433344566899999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 97 58999887643 45889999999999999999999 899999999999999999999999999998765433
Q ss_pred CccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-c-ccccccccccc-
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-N-RLGEIVDPIVV- 283 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~-~~~~~~~~~~~- 283 (331)
.... ....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ...... . ...........
T Consensus 154 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 TKTY--DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred cccc--ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 2211 12348999999999876 56899999999999999999999998332211 111110 0 00000000000
Q ss_pred ------------cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 ------------EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...........++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000123457899999999999999999999976
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=340.63 Aligned_cols=248 Identities=20% Similarity=0.228 Sum_probs=197.1
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
..+.|...+.||+ +||.||+|+. ++..||+|.+.... .......+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3456888999999 9999999998 68899999987543 223467889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~a 204 (331)
||||++|+|.+.+... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.. +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988654 45889999999999999999999 8999999999999999764 55999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
......... ....||+.|+|||++. +.++.++||||+||++|+|++|..||..... ..........
T Consensus 187 ~~~~~~~~~---~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 254 (494)
T 3lij_A 187 AVFENQKKM---KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY-------- 254 (494)
T ss_dssp EECBTTBCB---CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------
T ss_pred eECCCCccc---cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 876543321 2245999999999875 5799999999999999999999999843222 1122211111
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus 255 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 255 --TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp --CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0111111234467999999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=334.22 Aligned_cols=258 Identities=15% Similarity=0.200 Sum_probs=202.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.++|...+.||+ +||.||+|.. ++..||+|.+.........+.+.+|+.++..++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467889999999 9999999999 5889999999876555557789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|+++|+|.+++... ..+++..+..++.+++.||.||| +. +|+||||||+||+++.++.++|+|||++....
T Consensus 112 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999754 35889999999999999999999 75 89999999999999999999999999987553
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhc---cc----------
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVEN---NR---------- 273 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~---~~---------- 273 (331)
... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ..... ..
T Consensus 184 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3eqc_A 184 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259 (360)
T ss_dssp HHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred ccc----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence 221 112358999999999999999999999999999999999999983211110 00000 00
Q ss_pred -----------------cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 274 -----------------LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 274 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.....+...............+.++.+|+.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000000000000001234579999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=340.66 Aligned_cols=249 Identities=20% Similarity=0.236 Sum_probs=201.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
..+.|...+.||+ +||.||+|+. +++.||+|.+.... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4467999999999 9999999998 68899999986431 122467889999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc---CCCceEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD---EYNVAKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a 204 (331)
|||+++|+|.+.+... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999988654 45899999999999999999999 89999999999999995 4567999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 282 (331)
+........ ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..........
T Consensus 172 ~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-------- 239 (486)
T 3mwu_A 172 TCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY-------- 239 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC--------
T ss_pred eECCCCCcc---CCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------
Confidence 876543321 22459999999999864 699999999999999999999999843222 1111111111
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+.+...++++.+|+.+||+.||++|||+.++++.
T Consensus 240 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 --AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112222445689999999999999999999999873
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=333.30 Aligned_cols=244 Identities=18% Similarity=0.263 Sum_probs=187.5
Q ss_pred cCcccc-Cceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHh-cCCCceeeeEeEEee----CCcc
Q 020078 54 NNYNGH-QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQ-MNHRNILKLIGCCIE----TEIP 124 (331)
Q Consensus 54 ~~~~~~-~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~nIv~l~~~~~~----~~~~ 124 (331)
++|... ++||. +||.||++.. +++.||+|.+.. ...+.+|+.++.+ .+||||+++++++.. .+..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 455554 68999 9999999998 688999999853 2457788988754 589999999999876 5568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CCceEEccC
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YNVAKLSDF 201 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~Df 201 (331)
|+||||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++. ++.+||+||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEec
Confidence 999999999999999976432 35899999999999999999999 899999999999999997 789999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH------HHHHhhccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH------VKKHVENNRLG 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~ 275 (331)
|+++........ ...+||+.|+|||++....++.++|||||||++|+|++|..||..... ..........
T Consensus 209 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~- 284 (400)
T 1nxk_A 209 GFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY- 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-
T ss_pred ccccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-
Confidence 999866433221 224589999999999989999999999999999999999999742210 0111111100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
....+.....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 285 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 ---------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00011111345679999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=319.75 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=202.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEE-eeCCccEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCC-IETEIPILV 127 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~-~~~~~~~lv 127 (331)
..++|...+.||+ ++|.||+|+. +++.||+|.+.... ..+.+.+|+.++..++|++++..++++ .+.+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS---SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc---chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 3578999999999 9999999996 78999999986543 234688999999999998877766665 556678999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCCc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSES 204 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a 204 (331)
|||+ +|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 9999 899999997432 46899999999999999999999 8999999999999999 48899999999999
Q ss_pred cccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH-----HHHHhhcccc
Q 020078 205 EYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH-----VKKHVENNRL 274 (331)
Q Consensus 205 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~ 274 (331)
.......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 8765543211 12234589999999999998999999999999999999999999742100 0000000000
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
. .+...... ..++++.+++.+||+.||++|||+.++++.|+++..+
T Consensus 236 ~---~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 236 S---TPIEVLCK------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp H---SCHHHHTT------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred C---CchHHHHh------hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 0 00000001 2235799999999999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=334.99 Aligned_cols=243 Identities=12% Similarity=0.060 Sum_probs=188.0
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC--CCcchhHHHHHHH---HHHHhcCCCceeeeE-------eE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN--YSENGENFCFNNI---VFAAQMNHRNILKLI-------GC 117 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~h~nIv~l~-------~~ 117 (331)
.+.|...+.||+ +||.||+|+. +++.||||.+... ......+.+.+|+ .+++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 356777899999 9999999997 6899999998743 2223567889999 455566899999998 66
Q ss_pred EeeCC-----------------ccEEEEEecCCCChhhhhcCCCCCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 020078 118 CIETE-----------------IPILVFEFVEYGTLADRICSPHGPH--LEPLLWRHRLKIAMEIGNAMAYIHIGFRRPI 178 (331)
Q Consensus 118 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 178 (331)
+.+.+ ..++||||+ +|+|.+++....... ...+++..++.++.||+.||.||| +.+|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 65543 278999999 589999997532100 123456888899999999999999 8999
Q ss_pred eeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccC-----------CCCCcccchhhHH
Q 020078 179 VFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-----------LCNEKTDVFCFGM 247 (331)
Q Consensus 179 vHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~ 247 (331)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++... .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999864321 122447 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 248 LLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 248 ~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
++|+|++|+.||..... .............+ ++++.+|+.+||+.||++|||+.|+++
T Consensus 302 il~elltg~~Pf~~~~~----------~~~~~~~~~~~~~~------~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAA----------LGGSEWIFRSCKNI------PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC----------------CCSGGGGSSCCCC------CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccc----------ccchhhhhhhccCC------CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999743221 11111122222222 346999999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.81 Aligned_cols=198 Identities=19% Similarity=0.272 Sum_probs=165.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----C
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET-----E 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~ 122 (331)
+.++|...+.||+ +||.||+|+. +++.||||++...... ...+.+.+|+.+|+.++||||+++++++... +
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 4578999999999 9999999998 6789999999765332 3456889999999999999999999999876 5
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..|+||||+. |+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 6899999986 6999999764 45899999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCcc--------------------ccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHHhCCCC
Q 020078 203 ESEYIPEGETH--------------------VTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRRD 258 (331)
Q Consensus 203 ~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~~g~~p 258 (331)
+++........ ......+||+.|+|||++. ...++.++|||||||++|||++|..|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 251 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTT
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccc
Confidence 99876543211 1123356899999999864 55699999999999999999985443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=315.43 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=194.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.|....+||+ +||.||+|.. ++..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH-HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3445568999 9999999998 6789999998765432 5678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEccCCCccccCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~Dfg~a~~~~~~ 210 (331)
++|+|.+++....+ ...+++..+..++.|++.||.||| +.+|+||||||+||+++. ++.++|+|||++......
T Consensus 102 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 102 PGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp SEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred CCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 99999999975432 134678899999999999999999 899999999999999987 899999999999876443
Q ss_pred CccccccccCCCCcccchhhhccCC--CCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
... .....||+.|+|||++..+. ++.++||||||+++|+|++|+.||................. ..+.+ +.
T Consensus 177 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~--~~-- 249 (295)
T 2clq_A 177 NPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK-VHPEI--PE-- 249 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-CCCCC--CT--
T ss_pred CCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-ccccc--cc--
Confidence 221 12245899999999997654 88999999999999999999999853221111110000000 00111 11
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.++.+|+.+||+.||++|||+.+++.
T Consensus 250 ----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 ----SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 23357999999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=351.28 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=204.9
Q ss_pred HHhcCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
...+.|...+.||+ +||.||+|.+. +..||+|.+.........+.+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34567888899999 99999999882 35699999876655545678999999999999999999999985 4568
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence 99999999999999997542 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHH--HHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEH--VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 281 (331)
+.......... ....+|+.|+|||++....++.++||||||+++|||++ |..||..... ...........
T Consensus 539 ~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~------ 611 (656)
T 2j0j_A 539 RYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------ 611 (656)
T ss_dssp CSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC------
T ss_pred eecCCCcceec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 87654432221 22346789999999999999999999999999999997 8889843221 11111111110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
..+. ..++++.+|+.+||+.||++|||+.++++.|+++...
T Consensus 612 -~~~~------~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 -PMPP------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp -CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCc------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 1111 2334799999999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=332.12 Aligned_cols=249 Identities=19% Similarity=0.230 Sum_probs=189.8
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-------CcchhHHHHHHHHHHHhcCCCceeeeEeEEee
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-------SENGENFCFNNIVFAAQMNHRNILKLIGCCIE 120 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 120 (331)
...+.|...+.||+ +||.||+|.. +++.||+|.+.... .......+.+|+.+|++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45688999999999 9999999998 67899999986532 11123468899999999999999999999864
Q ss_pred CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceE
Q 020078 121 TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAK 197 (331)
Q Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~k 197 (331)
+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.+ +.+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEE
Confidence 4578999999999999988654 46899999999999999999999 8899999999999999754 4599
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHH---HHHHHhhc
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLE---HVKKHVEN 271 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~---~~~~~~~~ 271 (331)
|+|||+++....... .....||+.|+|||++. ...++.++||||||+++|+|++|..||.... ........
T Consensus 283 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 283 ITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred EeecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 999999987654322 12245899999999985 3578899999999999999999999973211 01111111
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ..........++++.+|+.+||+.||++|||+.|+++
T Consensus 360 ~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKY----------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCC----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC----------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 100 0000011133567999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=333.01 Aligned_cols=194 Identities=20% Similarity=0.297 Sum_probs=155.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----Cc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET-----EI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 123 (331)
.+.|...+.||+ +||.||+|+. +++.||||++...... ...+.+.+|+.+|..++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999 9999999987 7899999999764332 3457789999999999999999999999543 46
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.|+||||+. |+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 899999985 7999998754 45899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCcc-------------------------ccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHHhC
Q 020078 204 SEYIPEGETH-------------------------VTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTG 255 (331)
Q Consensus 204 a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~~g 255 (331)
++........ ......+||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 9876432110 0112345899999999874 56799999999999999999993
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=317.85 Aligned_cols=247 Identities=18% Similarity=0.223 Sum_probs=199.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..+.|...+.||+ ++|.||+++. +++.||+|.+...... ..+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 3467888999999 9999999998 6899999998754332 3467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 205 (331)
||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++ +.++.++|+|||++.
T Consensus 86 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 86 QLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 999999999988654 35889999999999999999999 8999999999999999 788999999999987
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ........... .
T Consensus 158 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~-~------ 226 (304)
T 2jam_A 158 MEQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE-F------ 226 (304)
T ss_dssp CCCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC-C------
T ss_pred ecCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-C------
Confidence 6543221 113489999999999988999999999999999999999999843221 11112111110 0
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.....+.++.+++.+||..||++|||+.|+++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 ---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111133457999999999999999999999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=318.18 Aligned_cols=243 Identities=19% Similarity=0.239 Sum_probs=200.4
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...+.||+ ++|.||+|.. ++..||+|.+..... ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367888999999 9999999998 578899999864321 11356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 9999999999998754 35889999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 285 (331)
..... ....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ....... ...+
T Consensus 165 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------~~~~ 232 (284)
T 2vgo_A 165 PSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--------LKFP 232 (284)
T ss_dssp SSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------CCCC
T ss_pred ccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccc--------cCCC
Confidence 43322 12458999999999999899999999999999999999999984322211 1111111 0001
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ..+.++.+++.+||+.||++|||+.++++
T Consensus 233 ~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 P------FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp T------TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C------cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1 23347999999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.58 Aligned_cols=255 Identities=19% Similarity=0.209 Sum_probs=192.8
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE----- 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 122 (331)
..+.|...+.||+ +||.||+|.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 3577999999999 9999999998 789999999865432 234567889999999999999999999998763
Q ss_pred -ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 123 -IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 123 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEee
Confidence 359999999 7899999865 35889999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-cccc-
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRLG- 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~~- 275 (331)
|+++....... ...+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ...... +...
T Consensus 173 g~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~ 247 (367)
T 1cm8_A 173 GLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 247 (367)
T ss_dssp TTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecccccccccC-----cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99987643322 2348999999999987 67999999999999999999999998432211 111100 0000
Q ss_pred cccc--------------cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVD--------------PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.... +..............++++.+|+.+||..||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000 000000000000123457999999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=323.82 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=201.8
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-------chhHHHHHHHHHHHhc-CCCceeeeEeEE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-------NGENFCFNNIVFAAQM-NHRNILKLIGCC 118 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~ 118 (331)
....++|...+.||. ++|.||+|+. +++.||||.+...... ...+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567888899999 9999999998 6899999998754321 1245678999999999 799999999999
Q ss_pred eeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 119 IETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
...+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999998653 45899999999999999999999 889999999999999999999999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhcc------CCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhh
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT------GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVE 270 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~ 270 (331)
+|||++..+...... ....||+.|+|||++.. ..++.++||||||+++|+|++|..||...... .....
T Consensus 242 ~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 242 SDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred EecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 999999877544322 22458999999999863 35889999999999999999999998432211 11111
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.... ....+.....+.++.+|+.+||+.||++|||+.++++
T Consensus 319 ~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 319 EGQY----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HTCC----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hCCC----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 0011111123457999999999999999999999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=324.73 Aligned_cols=260 Identities=16% Similarity=0.162 Sum_probs=191.1
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
...++|...+.||+ +||.||+|.. +++.||+|++...... .....+.+|+.++++++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999 9999999987 7899999998754332 235677899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE-----cCCCceEEccC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF-----DEYNVAKLSDF 201 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill-----~~~~~~kl~Df 201 (331)
||||++ |+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+ +.++.+||+||
T Consensus 111 v~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 999998 5999999764 35889999999999999999999 8999999999999999 45566999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccc-ccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNR-LGE 276 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~-~~~ 276 (331)
|++.......... ....+|+.|+|||++.+. .++.++|||||||++|+|++|..||....... ....... ...
T Consensus 182 g~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 182 GLARAFGIPIRQF--THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred CCccccCCccccc--CCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 9998764332221 123479999999999874 48999999999999999999999984322211 1111100 000
Q ss_pred -ccc---------cccccCCCCch----HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 277 -IVD---------PIVVEDKSCPE----KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 277 -~~~---------~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ........... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 00000000000 0013467999999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=326.34 Aligned_cols=262 Identities=16% Similarity=0.134 Sum_probs=196.2
Q ss_pred hcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCCCcc----------hhHHHHHHHHHHHhcCCCceeeeEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNYSEN----------GENFCFNNIVFAAQMNHRNILKLIG 116 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv~l~~ 116 (331)
.++|...+.||+ +||.||+|.. .+..+|+|......... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467889999999 9999999998 45789999987653220 1234667888999999999999999
Q ss_pred EEee----CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC
Q 020078 117 CCIE----TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE 192 (331)
Q Consensus 117 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~ 192 (331)
++.+ ....++||||+ +|+|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+|||++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence 9988 67889999999 89999999754 36899999999999999999999 889999999999999998
Q ss_pred CC--ceEEccCCCccccCCCCcc-----ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH--H
Q 020078 193 YN--VAKLSDFSESEYIPEGETH-----VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL--E 263 (331)
Q Consensus 193 ~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~--~ 263 (331)
++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||... .
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 77 9999999999876432211 1112345899999999999889999999999999999999999998321 1
Q ss_pred HH-HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 264 HV-KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 264 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.. .............+....... ....+.++.+++.+||+.||++|||+.++++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PVAVQTAKTNLLDELPQSVLKWAP----SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHHTTTHHHHHHSC----TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cHHHHHHHHhhcccccHHHHhhcc----ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 00 000100000010000000000 0022347999999999999999999999999997643
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=329.14 Aligned_cols=257 Identities=13% Similarity=0.144 Sum_probs=201.8
Q ss_pred hcCccccCceee-cCcEEEEEEeC----------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceee--------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE----------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILK-------- 113 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~-------- 113 (331)
.++|...+.||+ +||.||+|... ++.||+|.+... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 468999999999 99999999982 689999998643 46889999999999999998
Q ss_pred -------eEeEEee-CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 020078 114 -------LIGCCIE-TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185 (331)
Q Consensus 114 -------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~ 185 (331)
+++++.. ++..++||||+ +|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp 187 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK---HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA 187 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence 6777776 67789999999 8999999975421 46899999999999999999999 88999999999
Q ss_pred CceEEcCCC--ceEEccCCCccccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCC
Q 020078 186 SQILFDEYN--VAKLSDFSESEYIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRD 258 (331)
Q Consensus 186 ~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p 258 (331)
+|||++.++ .++|+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999988 99999999998764332111 11223589999999999988999999999999999999999999
Q ss_pred ChhHH----HHHHHhh--ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 259 NILLE----HVKKHVE--NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 259 ~~~~~----~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
|.... ....... ........+.... . ...++++.+|+.+||+.||++|||+.++++.|+++..+
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 337 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDKPGPFVGPCGH-W------IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD 337 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHSCCCEECTTSC-E------ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccCCcCHHHHHHHHHhccCChhhhhhhccc-c------CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence 85432 1111110 0111111111000 0 01234799999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=345.94 Aligned_cols=246 Identities=20% Similarity=0.253 Sum_probs=202.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.++|...++||+ +||.||+|+. +++.||+|++.... .......+.+|+.+|..++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 466888999999 9999999998 78999999986531 112356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999976432 35899999999999999999999 899999999999999999999999999999877
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH------HHHHHHhhccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL------EHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~ 281 (331)
....... ..+||+.|+|||++.+..++.++|||||||++|||++|..||... ..........
T Consensus 337 ~~~~~~~---~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--------- 404 (576)
T 2acx_A 337 PEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--------- 404 (576)
T ss_dssp CTTCCEE---CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC---------
T ss_pred ccCcccc---ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc---------
Confidence 5543221 245999999999999889999999999999999999999998432 1111111111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
+...+. ..++++.+|+.+||+.||++|| ++.|+++
T Consensus 405 ---~~~~p~--~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 ---PEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ---CCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ---cccCCc--cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111111 3445799999999999999999 6788764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=318.68 Aligned_cols=246 Identities=16% Similarity=0.215 Sum_probs=202.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|...+.||+ +||.||++.. +++.+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467888999999 9999999999 57889999987542 223467788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988653 35889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--HhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 285 (331)
...... .....||+.|+|||++....++.++||||||+++|+|++|+.||........ ......
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 231 (294)
T 2rku_A 166 EYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE------------ 231 (294)
T ss_dssp CSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC------------
T ss_pred ccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc------------
Confidence 433221 1224589999999999988899999999999999999999999843322111 111110
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
...+. ..+.++.+++.+||+.||++|||+.++++.
T Consensus 232 ~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 YSIPK--HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCCCT--TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCCcc--ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01111 223469999999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=319.70 Aligned_cols=251 Identities=14% Similarity=0.195 Sum_probs=195.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEee--CCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIE--TEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~--~~~~~l 126 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+... ..+.+.+|+.++.+++ ||||+++++++.+ ....++
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 367888999999 9999999987 7889999998743 3567899999999997 9999999999998 567899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCcc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESE 205 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~ 205 (331)
||||+++++|.+++ ..++...+..++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHH--------HhCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999988 34888999999999999999999 89999999999999999776 89999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhH----HH------------HHHH
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILL----EH------------VKKH 268 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~----~~------------~~~~ 268 (331)
......... ...+|+.|+|||++.. ..++.++||||||+++|+|++|+.||... .. ....
T Consensus 180 ~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 180 FYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp ECCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred EcCCCCccc---cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 765443221 2358999999999987 67899999999999999999999998210 00 0000
Q ss_pred hhccccc--ccc--------ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 269 VENNRLG--EIV--------DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 269 ~~~~~~~--~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....... ... ......-.........++++.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 000 0000000000001124568999999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=322.14 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=195.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.+.|...+.||+ ++|.||+|+. +++.||+|++...... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 356888899999 9999999998 5889999998655433 23566889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++....
T Consensus 104 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 999999998876543 35899999999999999999999 8999999999999999999999999999998664
Q ss_pred CCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH-----------------hh
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH-----------------VE 270 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~-----------------~~ 270 (331)
...... ....||+.|+|||++.+. .++.++||||||+++|+|++|+.||......... +.
T Consensus 176 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 176 APGEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred CCcccc--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 432221 123489999999999865 6899999999999999999999998332211110 00
Q ss_pred c-cccccccccccccCCCC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 271 N-NRLGEIVDPIVVEDKSC-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 271 ~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ........+........ ......++++.+|+.+||+.||++|||+.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00001111111100000 000123467999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.35 Aligned_cols=256 Identities=18% Similarity=0.317 Sum_probs=196.9
Q ss_pred hcCccccCceee-cCcEEEEEEe---CCc--eEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL---ENR--PISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~---~~~--~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.++|...+.||+ ++|.||+|.+ ++. .||+|.+.... .....+.+.+|+.++.+++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467889999999 9999999986 222 58999887542 2335678999999999999999999999998765 8
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 89999999999999997532 35889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHH--HHhhcccccccccc
Q 020078 205 EYIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVK--KHVENNRLGEIVDP 280 (331)
Q Consensus 205 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~--~~~~~~~~~~~~~~ 280 (331)
.......... ......+|+.|+|||++....++.++||||||+++|+|++ |..||....... ........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------ 242 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE------ 242 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC------
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCC------
Confidence 8775543321 2222347888999999998889999999999999999999 999984322211 11111100
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...... ..+.++.+++.+||+.||++|||+.++++.|+++..
T Consensus 243 ~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 243 RLPRPE------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCCCCc------CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 001111 233579999999999999999999999999998764
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=313.02 Aligned_cols=246 Identities=17% Similarity=0.233 Sum_probs=198.8
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~l 126 (331)
.+++|...+.||+ ++|.||+|.. +++.||+|.+..... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567889999999 9999999999 689999999876432 33567888999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC--------------
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-------------- 192 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-------------- 192 (331)
||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+|+||||||+||+++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 9999999999999975311 0135889999999999999999999 899999999999999984
Q ss_pred -----CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH
Q 020078 193 -----YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK 266 (331)
Q Consensus 193 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~ 266 (331)
...++|+|||.+........ ..||+.|+|||++... .++.++||||||+++|+|++|.+++.......
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 238 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH 238 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH
T ss_pred cccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH
Confidence 44799999999987654332 2389999999999866 56789999999999999999998764333322
Q ss_pred HHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 267 KHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ...... . +. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~-~~~~~~-----~--~~------~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 239 EIR-QGRLPR-----I--PQ------VLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHH-TTCCCC-----C--SS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-cCCCCC-----C--Cc------ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 222 111111 1 11 22347999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.75 Aligned_cols=262 Identities=21% Similarity=0.226 Sum_probs=193.3
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE----NGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
....+.|...+.||+ +||.||+|.. +++.||+|.+...... ...+.+.+|+.++..++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 345678999999999 9999999998 6889999998753221 12357889999999999999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++||||+++ +|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG 157 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence 99999999985 8988886543 45788899999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhc-cc--cc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVEN-NR--LG 275 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~-~~--~~ 275 (331)
+++......... ....+|+.|+|||++.+. .++.++||||||+++|+|++|..||..... ....+.. .. ..
T Consensus 158 ~a~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 158 LAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235 (346)
T ss_dssp GGSTTTSCCCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceeccCCcccC--CcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChh
Confidence 998764432211 124589999999999754 588999999999999999999998743221 1111111 00 00
Q ss_pred ccc------ccccccC-CCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIV------DPIVVED-KSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~------~~~~~~~-~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... +...... ...+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 0000000 000100 123457999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=313.26 Aligned_cols=245 Identities=17% Similarity=0.242 Sum_probs=193.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee----CCccEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEIPIL 126 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~l 126 (331)
.|.....||+ +||.||+|.. ++..||+|.+.... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3666778999 9999999998 67789999987543 33356788999999999999999999999876 345789
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEc-CCCceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFD-EYNVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~-~~~~~kl~Dfg~ 203 (331)
||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+ |+||||||+||+++ .++.++|+|||+
T Consensus 107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 99999999999999753 45889999999999999999999 777 99999999999998 789999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
+......... ...||+.|+|||++. +.++.++||||||+++|+|++|+.||............... . ..+.
T Consensus 179 ~~~~~~~~~~----~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~-~~~~-- 249 (290)
T 1t4h_A 179 ATLKRASFAK----AVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-G-VKPA-- 249 (290)
T ss_dssp GGGCCTTSBE----ESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-T-CCCG--
T ss_pred cccccccccc----cccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-c-CCcc--
Confidence 9765433221 234899999999875 56999999999999999999999998432221111111000 0 0000
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 250 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000122346999999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=317.12 Aligned_cols=250 Identities=17% Similarity=0.226 Sum_probs=198.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
...+.|...+.||+ ++|.||+|.. +++.||+|.+.... ..+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 34577999999999 9999999998 58899999987543 356789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+|+||||+||+++.++.++|+|||++...
T Consensus 103 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 103 MEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99999999999986322 46899999999999999999999 899999999999999999999999999999776
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... .....||+.|+|||++....++.++||||||+++|+|++|..||............... ..+...
T Consensus 176 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~---- 246 (314)
T 3com_A 176 TDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN---PPPTFR---- 246 (314)
T ss_dssp BTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---CCCCCS----
T ss_pred hhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC---CCcccC----
Confidence 443221 12245899999999999889999999999999999999999998543222211110000 000000
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+ ...+.++.+|+.+||+.||++|||+.++++
T Consensus 247 ~~--~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 KP--ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SG--GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Cc--ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01 123457999999999999999999999975
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=324.77 Aligned_cols=245 Identities=16% Similarity=0.214 Sum_probs=202.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|...+.||+ +||.||++.. +++.+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467888999999 9999999998 57889999987542 223467788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999988653 35889999999999999999999 899999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 285 (331)
...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 192 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------- 258 (335)
T 2owb_A 192 EYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY----------- 258 (335)
T ss_dssp CSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----------
T ss_pred ccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCC-----------
Confidence 433221 122458999999999998889999999999999999999999984322111 11111110
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+. ..+.++.+|+.+||+.||++|||+.|+++
T Consensus 259 -~~~~--~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 -SIPK--HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -CCCT--TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -CCCc--cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111 22346899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=342.35 Aligned_cols=243 Identities=16% Similarity=0.226 Sum_probs=199.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...++||+ +||.||+|+. +++.||+|++..... ....+.+.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56788889999 9999999998 689999999865321 123567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++...... ...+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus 265 E~~~gg~L~~~l~~~~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp CCCTTCBHHHHHHTSSTT-SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeccCCCHHHHHHHhhcc-cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999998754321 246899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH------HHHHHHhhcccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL------EHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~ 282 (331)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||... .........
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----------- 407 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----------- 407 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-----------
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-----------
Confidence 44322 22245999999999999989999999999999999999999998432 111111111
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.....|. ..+.++.+|+.+||+.||++||++
T Consensus 408 -~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 408 -QAVTYPD--KFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp -CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred -cccCCCc--ccCHHHHHHHHHhccCCHhHCCCC
Confidence 1111111 334579999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=322.07 Aligned_cols=256 Identities=18% Similarity=0.220 Sum_probs=191.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------ 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------ 122 (331)
.+.|...+.||+ +||.||+|.. +++.||+|++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 467999999999 9999999988 788999999876432 234567889999999999999999999998765
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++||||++ |+|.+.+.. .+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence 5799999997 578888842 4888999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcccc-----
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRL----- 274 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~----- 274 (331)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ........
T Consensus 173 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 173 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249 (371)
T ss_dssp C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHH
T ss_pred cccccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9986643321 112458999999999999899999999999999999999999984322211 11110000
Q ss_pred ---------------cc----cc---ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 275 ---------------GE----IV---DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 275 ---------------~~----~~---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
.. .. .+....+.........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00 00 00000011111122446789999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.39 Aligned_cols=265 Identities=18% Similarity=0.263 Sum_probs=185.5
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
....++|...+.||+ ++|.||+|.. +++.||+|.+.........+.+.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 344678999999999 9999999987 7889999998765444456788899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCC---CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSP---HGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
||||+++|+|.+++... .......+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999988631 1111245899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCcc---ccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH--Hhhccccccc
Q 020078 204 SEYIPEGETH---VTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK--HVENNRLGEI 277 (331)
Q Consensus 204 a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~ 277 (331)
+......... .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||........ ..........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 247 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence 8766433211 11222458999999999875 5689999999999999999999999843211111 0111111111
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... .... ... ...+.++.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~-~~~~-~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETG-VQDK-EML--KKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-------CCC--CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccc-cccc-hhh--hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000 0000 000 022347999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.30 Aligned_cols=266 Identities=17% Similarity=0.180 Sum_probs=196.4
Q ss_pred CHHHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcc----------hhHHHHHHHHHHHhcCCCcee
Q 020078 45 SAGELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSEN----------GENFCFNNIVFAAQMNHRNIL 112 (331)
Q Consensus 45 ~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~nIv 112 (331)
...++....+.|...+.||+ +||.||+|.. ++..||+|++....... ..+.+.+|+.++.+++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 35677888999999999999 9999999988 78899999986543221 136789999999999999999
Q ss_pred eeEeEEeeC-----CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCc
Q 020078 113 KLIGCCIET-----EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQ 187 (331)
Q Consensus 113 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~N 187 (331)
++++++... ...++||||++ |+|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~N 164 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGN 164 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHH
Confidence 999998653 34689999998 68888887543 46899999999999999999999 8899999999999
Q ss_pred eEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHH---
Q 020078 188 ILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLE--- 263 (331)
Q Consensus 188 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--- 263 (331)
|+++.++.+||+|||++......... ....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||....
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999999999999754433221 12348999999999876 678999999999999999999999983321
Q ss_pred HHHHHhhc---cc-----------cccccccccccCCCCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 264 HVKKHVEN---NR-----------LGEIVDPIVVEDKSCP---EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 264 ~~~~~~~~---~~-----------~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........ .. ................ .....++.+.+|+.+||+.||++|||+.|+++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111100 00 0000000000000000 00122457999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=315.70 Aligned_cols=252 Identities=18% Similarity=0.261 Sum_probs=199.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~l 126 (331)
.++|...+.||+ ++|.||++.. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999 9999999998 68899999987653 33356788999999999999999999998864 567899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeCCCCCCceEEcCCCceEEccC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP-----IVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
||||+++|+|.+++..... ....+++..++.++.|++.||.||| +.+ |+||||||+||+++.++.++|+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999875321 1135899999999999999999999 666 999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVD 279 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 279 (331)
|++.......... ....||+.|+|||++....++.++||||||+++|+|++|..||..... ............
T Consensus 161 g~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--- 235 (279)
T 2w5a_A 161 GLARILNHDTSFA--KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR--- 235 (279)
T ss_dssp CHHHHC---CHHH--HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---
T ss_pred chheeeccccccc--cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---
Confidence 9998765433211 123489999999999988999999999999999999999999843221 112222211111
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQL 323 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L 323 (331)
+ +. ..+.++.+++.+||+.||++|||+.|+++.+
T Consensus 236 --~--~~------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 236 --I--PY------RYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp --C--CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred --C--Cc------ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 1 11 2334799999999999999999999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=322.60 Aligned_cols=261 Identities=18% Similarity=0.208 Sum_probs=197.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC-------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET------- 121 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------- 121 (331)
.+.|...+.||+ +||.||+|+. +++.||+|++...... .....+.+|+.++..++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 357889999999 9999999998 7889999998654332 2356788999999999999999999999874
Q ss_pred -CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEcc
Q 020078 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200 (331)
Q Consensus 122 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~D 200 (331)
+..++||||+++ +|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred CceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 457899999985 7878776543 45899999999999999999999 89999999999999999999999999
Q ss_pred CCCccccCCCCcc--ccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhc--cc
Q 020078 201 FSESEYIPEGETH--VTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVEN--NR 273 (331)
Q Consensus 201 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~--~~ 273 (331)
||+++.+...... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....... ..... ..
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9999876532211 12223458999999999876 458999999999999999999999984322111 11100 00
Q ss_pred c-ccccccc----------cccCCCCchHHH-----HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 L-GEIVDPI----------VVEDKSCPEKEQ-----QLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~-~~~~~~~----------~~~~~~~~~~~~-----~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ....... ............ .++++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0 0000000 000000001001 1356899999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=320.35 Aligned_cols=259 Identities=19% Similarity=0.188 Sum_probs=202.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee----CCcc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEIP 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~ 124 (331)
..++|...+.||+ +||.||++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3568999999999 9999999997 78999999886543 2356788999999999999999999999973 3467
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 8999999999999988752111 146899999999999999999999 889999999999999999999999999998
Q ss_pred cccCCCCccc-------cccccCCCCcccchhhhccCC---CCCcccchhhHHHHHHHHhCCCCChhHHHH----HHHhh
Q 020078 205 EYIPEGETHV-------TSHMLTRTKRYLAPEYILTGL---CNEKTDVFCFGMLLLELLTGRRDNILLEHV----KKHVE 270 (331)
Q Consensus 205 ~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~----~~~~~ 270 (331)
.......... ......||+.|+|||++.... ++.++||||||+++|+|++|+.||...... .....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 7653211100 011234799999999987543 689999999999999999999998532211 00111
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
. . ....... ..+.++.+|+.+||+.||++|||+.++++.|+.+..
T Consensus 262 ~-~------~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 262 N-Q------LSIPQSP------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp C-C--------CCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred c-c------CCCCccc------cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0 0 0011111 233579999999999999999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=327.23 Aligned_cols=266 Identities=17% Similarity=0.181 Sum_probs=201.3
Q ss_pred HHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC
Q 020078 46 AGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122 (331)
Q Consensus 46 ~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 122 (331)
.+++....+.|...+.||+ +||.||+|.. ++..||+|++.........+.+.+|+.++.+++||||+++++++....
T Consensus 19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 3444455678999999999 9999999988 788999999986555545678999999999999999999999997653
Q ss_pred -----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 123 -----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 123 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
..++||||++ |+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+|
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ccccceEEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEE
Confidence 5789999997 599998865 35889999999999999999999 89999999999999999999999
Q ss_pred EccCCCccccCCCCccc-cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH------HHHHHh
Q 020078 198 LSDFSESEYIPEGETHV-TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE------HVKKHV 269 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~------~~~~~~ 269 (331)
|+|||++.......... ......||+.|+|||++..+ .++.++||||||+++|+|++|+.||.... ......
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 248 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 248 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh
Confidence 99999998764332211 12234589999999987654 58999999999999999999999983211 111000
Q ss_pred hccccc---cccc-------cccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 270 ENNRLG---EIVD-------PIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 270 ~~~~~~---~~~~-------~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... ...+ .........+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 249 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000 000000000000 023457999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=325.35 Aligned_cols=256 Identities=21% Similarity=0.289 Sum_probs=197.8
Q ss_pred cCHHHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEe
Q 020078 44 FSAGELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCI 119 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~ 119 (331)
++..++....+.|...+.||+ +||.||+|+. +++.||+|.+..... ..+.+.+|+.++.++ +||||+++++++.
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 444455567789999999999 9999999998 788999999865432 457889999999999 7999999999998
Q ss_pred e------CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC
Q 020078 120 E------TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY 193 (331)
Q Consensus 120 ~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~ 193 (331)
. .+..++||||+++|+|.+++....+ ..+++..+..++.|++.||.||| +.+|+||||||+||+++.+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 165 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTEN 165 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTT
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCC
Confidence 7 4578999999999999999975421 35889999999999999999999 8899999999999999999
Q ss_pred CceEEccCCCccccCCCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH
Q 020078 194 NVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH 268 (331)
Q Consensus 194 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~ 268 (331)
+.++|+|||++......... .....||+.|+|||++. ...++.++||||||+++|+|++|..||.........
T Consensus 166 ~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 243 (326)
T 2x7f_A 166 AEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL 243 (326)
T ss_dssp CCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred CCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH
Confidence 99999999998766433211 12234899999999987 567899999999999999999999998443222211
Q ss_pred h--hccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 269 V--ENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 269 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ..... +... .. ..+.++.+|+.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~-----~~~~-~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 FLIPRNPA-----PRLK-SK------KWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHHHSCC-----CCCS-CS------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhcCcc-----ccCC-cc------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1 11111 0010 11 22347999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=321.34 Aligned_cols=259 Identities=18% Similarity=0.243 Sum_probs=188.3
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEee-----
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIE----- 120 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~----- 120 (331)
.....+|...+.||+ +||.||+|.. +++.||+|++..... ...+.+.+|+.++.++. ||||+++++++..
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 344568999999999 9999999998 789999999865432 25678899999999996 9999999999953
Q ss_pred ---CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEcCCCc
Q 020078 121 ---TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~~~~~ 195 (331)
....++||||+. |+|.+++...... ..+++..++.++.|++.||.||| ..+ |+||||||+|||++.++.
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSC
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCC
Confidence 334789999996 7999988642111 35899999999999999999999 788 999999999999999999
Q ss_pred eEEccCCCccccCCCCccc----------cccccCCCCcccchhhh---ccCCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 196 AKLSDFSESEYIPEGETHV----------TSHMLTRTKRYLAPEYI---LTGLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
+||+|||++.......... ......||+.|+|||++ ....++.++||||||+++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 9999999998765432211 11124489999999998 4667889999999999999999999997533
Q ss_pred HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 263 EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
........ .. . ...... .+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 257 ~~~~~~~~--~~----~--~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 257 AKLRIVNG--KY----S--IPPHDT------QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp -----------C----C--CCTTCC------SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHhhcC--cc----c--CCcccc------cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22111000 00 0 011111 123588999999999999999999999999988753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=350.97 Aligned_cols=241 Identities=18% Similarity=0.237 Sum_probs=199.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~ 125 (331)
..++|...++||+ +||.||+|+. +++.||+|++.... .....+.+..|..++..+ +||||+.+++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3467999999999 9999999998 67889999987531 122456788999999988 6999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 419 lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999754 35899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
....... .....+||+.|+|||++....|+.++||||||+++|||++|..||..... ....+. .
T Consensus 491 ~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~------------~ 556 (674)
T 3pfq_A 491 ENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------------E 556 (674)
T ss_dssp ECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------S
T ss_pred ccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH------------h
Confidence 6433322 22335699999999999999999999999999999999999999853322 111111 1
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
.....|. ..+.++.+|+.+||+.||++||++
T Consensus 557 ~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 557 HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCCCCc--cCCHHHHHHHHHHccCCHHHCCCC
Confidence 1112221 345679999999999999999998
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=329.10 Aligned_cols=247 Identities=17% Similarity=0.221 Sum_probs=197.9
Q ss_pred hcCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCC---CcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY---SENGENFCFNNIVFAAQM-NHRNILKLIGCCIETE 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~ 122 (331)
.++|...+.||+ +||.||+++. +++.||+|.+.... .....+.+.+|+.++..+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999 9999999987 67899999987532 112356678899999999 6999999999999999
Q ss_pred ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 123 IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence 999999999999999999754 35889999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhH------HHHHHHhhcccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILL------EHVKKHVENNRL 274 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~------~~~~~~~~~~~~ 274 (331)
+++........ ......||+.|+|||++.++ .++.++||||||+++|+|++|+.||... .........
T Consensus 205 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--- 280 (355)
T 1vzo_A 205 LSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--- 280 (355)
T ss_dssp EEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH---
T ss_pred CCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc---
Confidence 99866433222 12224599999999999853 4789999999999999999999997421 111111110
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAKQ 322 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~~ 322 (331)
.....+. ..+..+.+|+.+||..||++|| |+.|+++.
T Consensus 281 ---------~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 281 ---------SEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp ---------CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---------cCCCCCc--ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 0111111 2345799999999999999999 89998764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=314.68 Aligned_cols=245 Identities=21% Similarity=0.235 Sum_probs=193.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|...+.||+ ++|.||+|.. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467889999999 9999999998 68999999986532 112356788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999654 35889999999999999999999 889999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhcccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVE 284 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 284 (331)
...... ....+|+.|+|||.+.+..+ +.++||||||+++|+|++|..||..... .......... ..
T Consensus 162 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~ 230 (276)
T 2h6d_A 162 SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF--------YI 230 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CC
T ss_pred CCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--------cC
Confidence 543221 12348999999999987765 6899999999999999999999843221 1111111110 00
Q ss_pred CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 285 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
+. ..+.++.+++.+||+.||++|||+.++++.
T Consensus 231 ~~------~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PE------YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ch------hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 223469999999999999999999999873
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=324.00 Aligned_cols=255 Identities=19% Similarity=0.226 Sum_probs=182.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC------
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIET------ 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------ 121 (331)
..+.|...+.||+ +||.||+|.. +++.||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999 9999999987 789999999876432 23456788999999999999999999998754
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
...++|+||+ +++|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-
T ss_pred CeEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeec
Confidence 5579999999 6899888854 35899999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-ccc-c
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRL-G 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~-~ 275 (331)
|+++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...... +.. .
T Consensus 177 G~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 177 GLARHTADEMT-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccccccccCC-----CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99986543321 2348999999999986 67899999999999999999999998432211 111100 000 0
Q ss_pred ccccc-----------ccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVDP-----------IVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~~-----------~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... .+......+.. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000 00000000000 022457999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=315.24 Aligned_cols=249 Identities=15% Similarity=0.196 Sum_probs=195.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..+.|...+.||+ ++|.||+|.. ++..||+|.+...... ..+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 4577889999999 9999999999 5889999998765433 5678999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+++||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 9999999999886532 45899999999999999999999 8999999999999999999999999999875331
Q ss_pred CCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh--hccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV--ENNRLGEIVDPI 281 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~ 281 (331)
... .......||+.|+|||++. ...++.++||||||+++|+|++|..|+.......... ...... .
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~ 241 (302)
T 2j7t_A 169 KTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-----T 241 (302)
T ss_dssp HHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-----C
T ss_pred ccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-----c
Confidence 110 0111234899999999984 5678899999999999999999999985432221111 111110 0
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... +...+.++.+++.+||+.||++|||+.++++
T Consensus 242 ~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LLT------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CSS------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCC------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001 1133457999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=313.81 Aligned_cols=250 Identities=16% Similarity=0.146 Sum_probs=195.5
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC---CcchhHHHHHHHHHHHhcCCCceeeeEeEEe--eCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY---SENGENFCFNNIVFAAQMNHRNILKLIGCCI--ETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~--~~~~ 123 (331)
..++|...+.||+ +||.||++.. ++..||+|.+.... .......+.+|+.++.+++||||+++++++. +.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3468999999999 9999999998 67899999987532 1224678999999999999999999999984 4557
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+++| |.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 7677654322 46889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCC--CCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGL--CNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVD 279 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 279 (331)
+................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~----- 230 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----- 230 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-----
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-----
Confidence 98765433222233345899999999987643 47799999999999999999999843221 1111111110
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
..+. ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 231 ---~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ---AIPG------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCCS------SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCCC------ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111 223469999999999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.11 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=201.4
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--------cchhHHHHHHHHHHHhcC-CCceeeeEeEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--------ENGENFCFNNIVFAAQMN-HRNILKLIGCC 118 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~ 118 (331)
...++|...+.||+ ++|.||+|.. +++.||+|.+..... ....+.+.+|+.++.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999 9999999998 678999999875431 112467889999999996 99999999999
Q ss_pred eeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEE
Q 020078 119 IETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198 (331)
Q Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl 198 (331)
.+.+..++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 165 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKL 165 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEE
Confidence 9999999999999999999999753 46899999999999999999999 899999999999999999999999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhc------cCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhh
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL------TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVE 270 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~ 270 (331)
+|||++......... ....+++.|+|||++. ...++.++||||||+++|+|++|..||...... .....
T Consensus 166 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 166 TDFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ecccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 999999876543322 1234899999999985 456889999999999999999999998432211 11111
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ...+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 SGNYQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HTCCC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCcc----------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11110 011111134457999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.99 Aligned_cols=258 Identities=18% Similarity=0.240 Sum_probs=201.3
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcc----------------hhHHHHHHHHHHHhcCCCceeeeE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSEN----------------GENFCFNNIVFAAQMNHRNILKLI 115 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~nIv~l~ 115 (331)
.++|...+.||+ ++|.||+|..+++.||+|.+....... ..+.+.+|+.++.+++||||++++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 468999999999 999999999999999999987532110 117899999999999999999999
Q ss_pred eEEeeCCccEEEEEecCCCChhhh------hcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC-CCeeeCCCCCCce
Q 020078 116 GCCIETEIPILVFEFVEYGTLADR------ICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFR-RPIVFKDIKLSQI 188 (331)
Q Consensus 116 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivHrdlk~~Ni 188 (331)
+++.+.+..++||||+++|+|.++ +.... ...+++..+..++.|++.||.||| + .+|+||||||+||
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI 183 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence 999999999999999999999998 54321 256899999999999999999999 7 9999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccC-CCCC-cccchhhHHHHHHHHhCCCCChhH---H
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNE-KTDVFCFGMLLLELLTGRRDNILL---E 263 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~~l~el~~g~~p~~~~---~ 263 (331)
+++.++.++|+|||.+....... .....||+.|+|||++.+. .++. ++||||||+++|+|++|..||... .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 99999999999999998764431 1224589999999999877 6666 999999999999999999998432 2
Q ss_pred HHHHHhhccccccccc------cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 264 HVKKHVENNRLGEIVD------PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 264 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...............+ +...... .......+.++.+|+.+||+.||++|||+.|+++
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKS-TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHHhccCcCCccchhhhhcccccccc-ccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222222211110000 0000000 0000133457999999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=331.71 Aligned_cols=253 Identities=8% Similarity=-0.028 Sum_probs=179.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHHHHHHHhc--CCCceeeeE-------eEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNNIVFAAQM--NHRNILKLI-------GCC 118 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l--~h~nIv~l~-------~~~ 118 (331)
...|...+.||+ +||.||+|.+ +++.||+|++..... ....+.+.+|+.++..| +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 445888999999 9999999997 788999999987543 23456677886555555 699988755 444
Q ss_pred eeCC-----------------ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCC
Q 020078 119 IETE-----------------IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHR------LKIAMEIGNAMAYIHIGFR 175 (331)
Q Consensus 119 ~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~ 175 (331)
.... ..++||||++ |+|.+++.... ..+.+..+ ..++.||+.||.||| +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~ 212 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ---S 212 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH---H
Confidence 4332 3799999999 89999997542 22344455 677899999999999 8
Q ss_pred CCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhcc--CCCCCcccchhhHHHHHHHH
Q 020078 176 RPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT--GLCNEKTDVFCFGMLLLELL 253 (331)
Q Consensus 176 ~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~el~ 253 (331)
.+|+||||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 9999999999999999999999999999986643221 1237799999999987 67999999999999999999
Q ss_pred hCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 254 TGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 254 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+|+.||....... ...................+.....++++.+|+.+||+.||++|||+.++++
T Consensus 288 tg~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGI---KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTC---TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCccc---ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999974321100 0000000000001111111211134567999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.63 Aligned_cols=254 Identities=17% Similarity=0.205 Sum_probs=193.4
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc---
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP--- 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~--- 124 (331)
..+.|...+.||+ +||.||+|.. +++.||+|++...... .....+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578889999999 9999999988 7899999999765332 2357888999999999999999999999887655
Q ss_pred ---EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 125 ---ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 125 ---~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
++||||+. |+|.+.+. ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECST
T ss_pred eeEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEec
Confidence 99999997 68988773 34889999999999999999999 889999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccc-c-c
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNR-L-G 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~-~-~ 275 (331)
|+++....... ...||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....... ....... . .
T Consensus 189 g~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 189 GLARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp TCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CcccccccCcC-----CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99986543322 2348999999999987 678999999999999999999999984322111 1110000 0 0
Q ss_pred cccc-----------cccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 EIVD-----------PIVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ~~~~-----------~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.... ..+........ ....++++.+|+.+||+.||++|||+.|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000 00000000000 0023467999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=315.34 Aligned_cols=248 Identities=19% Similarity=0.228 Sum_probs=193.0
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-------cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-------ENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
..+.|...+.||+ +||.||+|.. +++.||+|.+..... ......+.+|+.++.+++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999 9999999998 678999999875421 11245688999999999999999999998765
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc---eEE
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV---AKL 198 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl 198 (331)
+ .++||||+++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++. +||
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred c-eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence 5 89999999999999988654 46889999999999999999999 899999999999999987654 999
Q ss_pred ccCCCccccCCCCccccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhcc
Q 020078 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVENN 272 (331)
Q Consensus 199 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~~ 272 (331)
+|||++......... ....||+.|+|||++. ...++.++||||||+++|+|++|..||..... ........
T Consensus 159 ~Dfg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 159 TDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp CCCTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred ccCccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 999999876443211 1234899999999974 45789999999999999999999999742110 11111111
Q ss_pred ccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... .........+.++.+|+.+||+.||++|||+.++++
T Consensus 236 ~~~----------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KYN----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CCC----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc----------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 100 000000123457999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=327.54 Aligned_cols=194 Identities=20% Similarity=0.239 Sum_probs=168.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc------CCCceeeeEeEEeeCCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM------NHRNILKLIGCCIETEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~nIv~l~~~~~~~~~ 123 (331)
...|...+.||+ +||.||+|.. +++.||||.+... ......+.+|+.++..+ +|+||+++++++...+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456888999999 9999999988 6789999999753 22456788899998887 57799999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc--eEEccC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV--AKLSDF 201 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~--~kl~Df 201 (331)
.++||||+. |+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++. +||+||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred EEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 999999996 699998876432 35899999999999999999999 889999999999999999887 999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCCh
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
|++........ ...||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 247 G~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 247 GSSCYEHQRVY-----TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp TTCEETTCCCC-----SSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccceecCCccc-----ccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 99976543322 2458999999999999999999999999999999999999983
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=316.88 Aligned_cols=261 Identities=17% Similarity=0.216 Sum_probs=200.9
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
.+.....++|...+.||+ ++|.||+|...+ .+|+|.+..... ....+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 444455688999999999 999999999865 599999875422 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++ ++.++|+|||++
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred EEEeecccCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 99999999999999997542 35888999999999999999999 89999999999999998 689999999998
Q ss_pred cccCCCCc---cccccccCCCCcccchhhhcc---------CCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhh
Q 020078 205 EYIPEGET---HVTSHMLTRTKRYLAPEYILT---------GLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVE 270 (331)
Q Consensus 205 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~ 270 (331)
........ ........||+.|+|||++.. ..++.++||||||+++|+|++|+.||..... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 76532211 111222348899999999874 3578899999999999999999999843221 111111
Q ss_pred ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 271 NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.... +... ...++ .++.+++.+||+.||++|||+.++++.|+++..
T Consensus 257 ~~~~-----~~~~-~~~~~------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 257 TGMK-----PNLS-QIGMG------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp TTCC-----CCCC-CSSCC------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred cCCC-----CCCC-cCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111 1111 11122 359999999999999999999999999988764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=310.39 Aligned_cols=248 Identities=16% Similarity=0.214 Sum_probs=183.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhH-HHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGEN-FCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.++|...+.||+ +||.||+|.. +++.||+|++.......... .+..+...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467889999999 9999999998 78999999997654433333 3444555678889999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||++ |+|.+++...... ...+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9997 5887776531110 146899999999999999999999 77 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhh----ccCCCCCcccchhhHHHHHHHHhCCCCChh----HHHHHHHhhccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYI----LTGLCNEKTDVFCFGMLLLELLTGRRDNIL----LEHVKKHVENNRLGEIVD 279 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~----~~~~~~~~~~~~~~~~~~ 279 (331)
....... ...||+.|+|||++ ....++.++||||||+++|+|++|+.||.. ............. .
T Consensus 161 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~--- 233 (290)
T 3fme_A 161 VDDVAKD---IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP-Q--- 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC-C---
T ss_pred ccccccc---ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC-C---
Confidence 5433221 13489999999996 455789999999999999999999999842 1111111111110 0
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. .. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 234 --~~-~~------~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 --LP-AD------KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --CC-TT------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --cc-cc------cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 01 23457999999999999999999999987
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=321.75 Aligned_cols=260 Identities=16% Similarity=0.134 Sum_probs=197.9
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----Cc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET-----EI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 123 (331)
..++|...+.||+ +||.||+|.. +++.||+|.+...........+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 4578999999999 9999999998 58899999997655444567788999999999999999999998764 56
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.++||||+. |+|.+++.. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+
T Consensus 89 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 899999997 699998865 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccc--------cccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhhc
Q 020078 204 SEYIPEGETHV--------TSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVEN 271 (331)
Q Consensus 204 a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~ 271 (331)
+.......... ......||+.|+|||++.. ..++.++||||||+++|+|++|+.||........ ....
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 98765432111 1122358999999998865 6789999999999999999999999843221111 1100
Q ss_pred -cccc--ccc----cc-------ccccCCCCch---HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 -NRLG--EIV----DP-------IVVEDKSCPE---KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 -~~~~--~~~----~~-------~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+... ... .. .+......+. ....++++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000 000 00 0000000000 0133457999999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=325.11 Aligned_cols=259 Identities=17% Similarity=0.193 Sum_probs=190.8
Q ss_pred HHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET----- 121 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~----- 121 (331)
....+.|...+.||+ +||.||+|.. +++.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 456778999999999 9999999988 789999999865422 234799999999999999999998543
Q ss_pred ---------------------------------CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 020078 122 ---------------------------------EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMA 168 (331)
Q Consensus 122 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~ 168 (331)
...++||||++ |+|.+.+...... ...+++..+..++.|++.||.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence 23789999998 5877776531111 146899999999999999999
Q ss_pred HhhcCCCCCeeeCCCCCCceEEc-CCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhH
Q 020078 169 YIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFG 246 (331)
Q Consensus 169 ~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG 246 (331)
||| +.+|+||||||+|||++ .++.+||+|||+++......... ...+|+.|+|||++.+. .++.++||||+|
T Consensus 156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSV---AYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCC---CCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCc---CcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 999 99999999999999998 68899999999998764443222 23489999999998865 489999999999
Q ss_pred HHHHHHHhCCCCChhHHHH---HHHhhc-------------cccccccccccccCC-CCchHHHHHHHHHHHHHHhccCC
Q 020078 247 MLLLELLTGRRDNILLEHV---KKHVEN-------------NRLGEIVDPIVVEDK-SCPEKEQQLQALLQLIFECVNES 309 (331)
Q Consensus 247 ~~l~el~~g~~p~~~~~~~---~~~~~~-------------~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~d 309 (331)
|++|+|++|+.||...... ...... .......-+...... ....+...++++.+|+.+||+.|
T Consensus 230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999998432211 111110 000000000000000 00000023457999999999999
Q ss_pred CCCCCCHHHHHH
Q 020078 310 AGDRPTMVYAAK 321 (331)
Q Consensus 310 P~~Rps~~evl~ 321 (331)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.28 Aligned_cols=256 Identities=17% Similarity=0.236 Sum_probs=202.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC-CceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH-RNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~ 128 (331)
.+.|...+.||+ +||.||+|.. +++.||||.+.... ....+.+|+.++..++| ++|..+..++.+.+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC---SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc---ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 578999999999 9999999997 68999999876543 23468899999999987 55666667777788889999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE---cCCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill---~~~~~~kl~Dfg~a~ 205 (331)
||+ +|+|.+++.... ..+++..++.++.||+.||.||| ..+|+||||||+|||+ +.++.+||+|||+++
T Consensus 83 e~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred ECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 999 899999997433 46899999999999999999999 8999999999999999 688999999999998
Q ss_pred ccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH-----HHHHHhhccccc
Q 020078 206 YIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE-----HVKKHVENNRLG 275 (331)
Q Consensus 206 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~-----~~~~~~~~~~~~ 275 (331)
......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 775543221 1223569999999999999999999999999999999999999983211 111111110100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+.. +. . .++.++.+|+..||+.||++||++.++++.|+.+..
T Consensus 235 ~~~~~-l~--~------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 235 TSIEA-LC--R------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SCHHH-HH--T------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHH-Hh--c------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 00000 00 1 223579999999999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=317.38 Aligned_cols=256 Identities=17% Similarity=0.206 Sum_probs=178.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHH-HHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIV-FAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+...........+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467888999999 9999999998 589999999976654444556666766 677789999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||+++ +|.+++..........+++..+..++.|++.||.||| .. +|+||||||+||+++.++.+||+|||++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 8877775311111146889999999999999999999 77 9999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhh----ccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYI----LTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (331)
....... ...||+.|+|||++ ....++.++||||||+++|+|++|+.||................. .+.+.
T Consensus 177 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~ 251 (327)
T 3aln_A 177 VDSIAKT---RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD--PPQLS 251 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC--CCCCC
T ss_pred ccccccc---cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC--CCCCC
Confidence 4432211 12489999999998 456789999999999999999999999854322211111100000 00011
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
... ....+.++.+|+.+||+.||++|||+.++++
T Consensus 252 ~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 252 NSE----EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCS----SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred Ccc----cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000 0123357999999999999999999999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.12 Aligned_cols=251 Identities=18% Similarity=0.281 Sum_probs=190.3
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--------
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-------- 120 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-------- 120 (331)
..++|...+.||+ +||.||+|+. +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3567888999999 9999999997 7889999998543 2246788999999999999999999999865
Q ss_pred -----CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc
Q 020078 121 -----TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195 (331)
Q Consensus 121 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~ 195 (331)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCC
Confidence 345789999999999999997532 45788999999999999999999 889999999999999999999
Q ss_pred eEEccCCCccccCCCCc------------cccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 196 AKLSDFSESEYIPEGET------------HVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
++|+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|+++..+....
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~~~~~~ 234 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccCCchhH
Confidence 99999999986643210 0111224589999999999754 6899999999999999999833322111
Q ss_pred HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 263 EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
............ . .... .+ ...+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~--~----~~~~--~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSI--E----FPPD--FD--DNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTC--C----CCTT--CC--TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcccccc--c----cCcc--cc--ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111110 0 0001 11 123346899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.35 Aligned_cols=249 Identities=20% Similarity=0.231 Sum_probs=200.2
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
...+.|...+.||+ ++|.||+|.. +++.||+|.+.... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34567999999999 9999999998 68899999986542 23356789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC---CceEEccCCC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY---NVAKLSDFSE 203 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~---~~~kl~Dfg~ 203 (331)
||||+++++|.+.+... ..+++..++.++.|++.||.||| ..+|+||||||+||+++.+ +.+||+|||+
T Consensus 99 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 99999999999988653 35889999999999999999999 8999999999999999754 4799999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPI 281 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 281 (331)
+.......... ...+|+.|+|||.+.+ .++.++||||||+++|+|++|..||..... ...........
T Consensus 171 ~~~~~~~~~~~---~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 240 (287)
T 2wei_A 171 STCFQQNTKMK---DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA------ 240 (287)
T ss_dssp GGTBCCCSSCS---CHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC------
T ss_pred ceeecCCCccc---cccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC------
Confidence 88665433221 1237889999998864 589999999999999999999999843221 11112111110
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.....+.++.+++.+||+.||++|||+.|+++
T Consensus 241 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 011111133457999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=323.44 Aligned_cols=256 Identities=19% Similarity=0.212 Sum_probs=188.7
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc------c
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI------P 124 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~------~ 124 (331)
...|...+.||+ +||.||+|+. .+..+|+|++..... ...+|+.+++.++||||+++++++..... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 456889999999 9999999999 666799998865432 23379999999999999999999976443 7
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-CCCceEEccCCC
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSE 203 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~~kl~Dfg~ 203 (331)
++||||++++ +...+..... ....+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.+||+|||+
T Consensus 114 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 114 NLVLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 8999999875 4343321100 0146889999999999999999999 89999999999999999 789999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhcc-c-----
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENN-R----- 273 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~-~----- 273 (331)
++......... ...||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... ...... .
T Consensus 189 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 189 AKILIAGEPNV---SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CEECCTTCCCC---SSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccCCCCCc---ccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 98764443221 23589999999998765 58999999999999999999999984322111 111100 0
Q ss_pred ----cccccccccccCCCCchH----HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 ----LGEIVDPIVVEDKSCPEK----EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ----~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...............+.. ...++++.+|+.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000000000100 023457999999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=313.34 Aligned_cols=252 Identities=16% Similarity=0.199 Sum_probs=192.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc-----
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIETEI----- 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----- 123 (331)
.+.|.....||+ +||.||+|.. +++.||+|.+...... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467889999999 9999999998 6899999999765332 235678899999999999999999999987654
Q ss_pred -cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 124 -PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 124 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
.++||||++ |+|.+++. ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 68988773 24889999999999999999999 8999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-ccc-c-
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRL-G- 275 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~-~- 275 (331)
++........ ...+|+.|+|||++.. ..++.++||||||+++|+|++|+.||...... ...... +.. .
T Consensus 172 ~~~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 172 LARHADAEMT-----GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred cccCCCCCcc-----ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9976543221 2348999999999886 67899999999999999999999998432211 111100 000 0
Q ss_pred ---c-----------ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 276 ---E-----------IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 276 ---~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ........... ......++++.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000000000 000133457999999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=315.63 Aligned_cols=257 Identities=16% Similarity=0.195 Sum_probs=196.2
Q ss_pred ccCHHHHHHHhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcC--CCceeeeEeE
Q 020078 43 SFSAGELKIATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMN--HRNILKLIGC 117 (331)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~ 117 (331)
.+.+..+....+.|...+.||+ +||.||++.. +++.||+|.+.... .....+.+.+|+.++.+++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3444555566788999999999 9999999998 78889999987543 2335678899999999997 5999999999
Q ss_pred EeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
+.+.+..++||| +.+|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+||++++ +.+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~k 166 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLK 166 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEE
Confidence 999999999999 5678999999764 46889999999999999999999 899999999999999975 8999
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhcc-----------CCCCCcccchhhHHHHHHHHhCCCCChhHH---
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT-----------GLCNEKTDVFCFGMLLLELLTGRRDNILLE--- 263 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--- 263 (331)
|+|||++................||+.|+|||++.. ..++.++||||||+++|+|++|+.||....
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 999999987654433222233458999999999875 468889999999999999999999984321
Q ss_pred -HHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 264 -HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 264 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
........... ...+..+ +.++.+++.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~-------~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 SKLHAIIDPNHE-------IEFPDIP------EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHCTTSC-------CCCCCCS------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcccc-------cCCcccc------hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111110000 0001111 2469999999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=312.40 Aligned_cols=255 Identities=20% Similarity=0.205 Sum_probs=198.3
Q ss_pred HhcCccccCceee-cCcEEEEEEe---CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc------eeeeEeEEeeC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN------ILKLIGCCIET 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~ 121 (331)
..+.|...+.||+ +||.||+|.. +++.||+|.+.... ...+.+.+|+.++..++|+| |+++++++.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3468999999999 9999999987 67899999986532 24677889999999987665 99999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---------
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE--------- 192 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~--------- 192 (331)
+..++||||+ +++|.+++..... .++++..+..++.|++.||.||| +.+|+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 7899999976432 35889999999999999999999 899999999999999987
Q ss_pred ----------CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 193 ----------YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 193 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
++.+||+|||++........ ...||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 237 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHHS-----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCCC-----SSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCceEeeCcccccCccccc-----cccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 66899999999986543322 234899999999999889999999999999999999999998322
Q ss_pred HHHH--HHhhc---ccccc---------ccc--------------------cccccCCCCchHHHHHHHHHHHHHHhccC
Q 020078 263 EHVK--KHVEN---NRLGE---------IVD--------------------PIVVEDKSCPEKEQQLQALLQLIFECVNE 308 (331)
Q Consensus 263 ~~~~--~~~~~---~~~~~---------~~~--------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 308 (331)
.... ..... ..... ... ......... ....++++.+|+.+||+.
T Consensus 238 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 238 DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS--QDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSC--CSHHHHHHHHHHHHHTCS
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhccc--chhhHHHHHHHHHHHhCc
Confidence 1111 00000 00000 000 000000000 114567899999999999
Q ss_pred CCCCCCCHHHHHHH
Q 020078 309 SAGDRPTMVYAAKQ 322 (331)
Q Consensus 309 dP~~Rps~~evl~~ 322 (331)
||++|||+.|+++.
T Consensus 316 dP~~Rpt~~ell~h 329 (339)
T 1z57_A 316 DPAKRITLREALKH 329 (339)
T ss_dssp STTTSCCHHHHTTS
T ss_pred CcccccCHHHHhcC
Confidence 99999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.04 Aligned_cols=253 Identities=15% Similarity=0.217 Sum_probs=195.6
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC--------CCceeeeEeEEe--
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN--------HRNILKLIGCCI-- 119 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~nIv~l~~~~~-- 119 (331)
.+.|...+.||+ +||.||+|+. +++.||+|.+... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 578999999999 9999999987 6889999998743 224677889999999996 788999999988
Q ss_pred --eCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCC--
Q 020078 120 --ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYN-- 194 (331)
Q Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~-- 194 (331)
.....++||||+ +|+|.+.+..... ..+++..+..++.||+.||.||| +. +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence 455789999999 4567666654321 45899999999999999999999 77 999999999999999775
Q ss_pred -----------------------------------------------ceEEccCCCccccCCCCccccccccCCCCcccc
Q 020078 195 -----------------------------------------------VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLA 227 (331)
Q Consensus 195 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 227 (331)
.+||+|||++........ ...||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~-----~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSC-----SCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCc-----cCCCCCcccC
Confidence 799999999987643322 1348999999
Q ss_pred hhhhccCCCCCcccchhhHHHHHHHHhCCCCChh---------HHHHHHHhhc-ccc-----------cccccc------
Q 020078 228 PEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL---------LEHVKKHVEN-NRL-----------GEIVDP------ 280 (331)
Q Consensus 228 PE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---------~~~~~~~~~~-~~~-----------~~~~~~------ 280 (331)
||++.+..++.++|||||||++|+|++|+.||.. .......... +.. ...+..
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 9999999999999999999999999999999831 1111111100 000 000000
Q ss_pred -----------ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 -----------IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 -----------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+...... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEW--SQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCC--CHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhccc--chhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000111 2356778999999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=326.30 Aligned_cols=255 Identities=21% Similarity=0.214 Sum_probs=188.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC------cc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE------IP 124 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~------~~ 124 (331)
..|...+.||+ +||.||+|+. +++.||||++.... ..+.+|+.+++.++|||||++++++.... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 46888999999 9999999999 68999999986532 22347999999999999999999986422 25
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-CceEEccCCC
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-NVAKLSDFSE 203 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-~~~kl~Dfg~ 203 (331)
++||||+++ +|.+.+..... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 789999985 66665542110 0146899999999999999999999 9999999999999999955 6789999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhc--------
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVEN-------- 271 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~-------- 271 (331)
++.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .......
T Consensus 204 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCTTCCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhcccCCCce---eeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 98764433221 24589999999999765 789999999999999999999999843221 1111110
Q ss_pred -----cccccccccccccCCCC-chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 -----NRLGEIVDPIVVEDKSC-PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 -----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........+.+...... ......+.++.+|+.+||..||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000111000000 000023457999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=313.26 Aligned_cols=251 Identities=19% Similarity=0.211 Sum_probs=172.3
Q ss_pred HhcCccc-cCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee----CCc
Q 020078 52 ATNNYNG-HQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEI 123 (331)
Q Consensus 52 ~~~~~~~-~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~ 123 (331)
..++|.. .++||+ +||.||+|.. +++.||+|.+... ..........+..++||||+++++++.. ...
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 5678887 457999 9999999998 6899999998643 1222223334667799999999999986 445
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CCceEEcc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YNVAKLSD 200 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 200 (331)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. ++.+||+|
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 7899999999999999976532 46899999999999999999999 899999999999999976 45699999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
||++......... ...+|+.|+|||++....++.++||||||+++|+|++|..||.............. .+...
T Consensus 175 fg~~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~ 248 (336)
T 3fhr_A 175 FGFAKETTQNALQ----TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--RIRLG 248 (336)
T ss_dssp CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred cccceeccccccc----cCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--hhhcc
Confidence 9999866433221 23489999999999888899999999999999999999999854332111000000 00000
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ....+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 249 ~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QY--GFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc--ccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 0011111134457999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.95 Aligned_cols=261 Identities=16% Similarity=0.175 Sum_probs=197.2
Q ss_pred HHhcCccccCceee-cCcEEEEEEe---CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhc---CCCceeeeEeEEe---
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQM---NHRNILKLIGCCI--- 119 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~--- 119 (331)
...+.|...+.||+ +||.||+|.. +++.||+|.+...... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 35678999999999 9999999987 4678999998653222 2344677888888777 8999999999987
Q ss_pred --eCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 120 --ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.++
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEE
Confidence 4567899999998 699999875432 34889999999999999999999 89999999999999999999999
Q ss_pred EccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhccc-
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVENNR- 273 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~~~- 273 (331)
|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........
T Consensus 161 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 161 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999987654322 122245899999999999999999999999999999999999998432211 11111000
Q ss_pred --ccccc------cccccc---CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 --LGEIV------DPIVVE---DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 --~~~~~------~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... ...... ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 000000 0000000123457999999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=309.53 Aligned_cols=257 Identities=18% Similarity=0.232 Sum_probs=189.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEe----------
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCI---------- 119 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~---------- 119 (331)
.+.|...+.||+ ++|.||+|.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 467888999999 9999999999 58999999987543 235678899999999999999999999874
Q ss_pred ----eCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-CCC
Q 020078 120 ----ETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYN 194 (331)
Q Consensus 120 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~ 194 (331)
+.+..++||||++ |+|.+++.. .++++..+..++.|++.||.||| +.+|+||||||+||+++ .++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence 3456789999998 699999854 35889999999999999999999 89999999999999997 567
Q ss_pred ceEEccCCCccccCCCCcc-ccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHh
Q 020078 195 VAKLSDFSESEYIPEGETH-VTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHV 269 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~ 269 (331)
.+||+|||++......... .......+|..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ....
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999876432211 11122347899999998875 67899999999999999999999998432211 1111
Q ss_pred hccccc---------ccc----ccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 270 ENNRLG---------EIV----DPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 270 ~~~~~~---------~~~----~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...... ..+ ......+ ..+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEP-HKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSC-CCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCC-CCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 100000 000 0000000 00000 023457999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=322.99 Aligned_cols=253 Identities=15% Similarity=0.216 Sum_probs=184.8
Q ss_pred cCccccCceee-cCcEEEEE-EeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKG-FLENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...++||+ +||+||.+ ..+++.||||++... ..+.+.+|+.++.++ +|||||++++++.+.+..++||||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~ 90 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL 90 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence 44556788999 99998654 448999999998653 345678999999886 899999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC-------------Cc
Q 020078 131 VEYGTLADRICSPHGPHL--EPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY-------------NV 195 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~-------------~~ 195 (331)
|. |+|.+++........ ....+..++.++.||+.||.||| +.+|+||||||+|||++.+ +.
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 96 699999976432111 11123345789999999999999 8999999999999999754 48
Q ss_pred eEEccCCCccccCCCCccc--cccccCCCCcccchhhhcc-------CCCCCcccchhhHHHHHHHHh-CCCCChhHHHH
Q 020078 196 AKLSDFSESEYIPEGETHV--TSHMLTRTKRYLAPEYILT-------GLCNEKTDVFCFGMLLLELLT-GRRDNILLEHV 265 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~ 265 (331)
+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 9999999998775543221 1223459999999999975 568999999999999999999 89897432111
Q ss_pred HHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 266 KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
......... . ............+.++.+|+.+||+.||++|||+.++++
T Consensus 247 ~~~i~~~~~----~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ESNIIRGIF----S---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHTCC----C---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCC----C---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111110 0 001111112367788999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=309.02 Aligned_cols=267 Identities=15% Similarity=0.118 Sum_probs=187.4
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
.+.....++|...+.||+ +||.||+|.. ++..||+|++..... ....+.+++..+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 455667789999999999 9999999998 688999999865432 34567788889999999999999999976443
Q ss_pred -------cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCc
Q 020078 124 -------PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNV 195 (331)
Q Consensus 124 -------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~ 195 (331)
.++||||+++ +|...+..... ....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTE
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCc
Confidence 7899999986 55444432100 014588899999999999999999932 578999999999999996 899
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN 271 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~ 271 (331)
+||+|||++.......... ...||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ......
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEPNV---AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTSCCC---STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCCcc---cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 9999999998765443222 234899999999987654 899999999999999999999998332111 111100
Q ss_pred c-cc-c--------cccccccccCCCCchH-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 N-RL-G--------EIVDPIVVEDKSCPEK-------EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~-~~-~--------~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. .. . ...+.........+.. ...+.++.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00 0 0000000000000000 013568999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=309.65 Aligned_cols=245 Identities=18% Similarity=0.227 Sum_probs=191.1
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhc----CCCceeee
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQM----NHRNILKL 114 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~h~nIv~l 114 (331)
.+.....++|...+.||+ +||.||+|.. +++.||+|.+...... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 344566788999999999 9999999988 7889999998755322 1234567899999999 89999999
Q ss_pred EeEEeeCCccEEEEEe-cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-C
Q 020078 115 IGCCIETEIPILVFEF-VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-E 192 (331)
Q Consensus 115 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~ 192 (331)
++++.+.+..++|+|| +++++|.+++... ..+++..++.++.|++.||.||| +.+|+||||||+||+++ .
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLR 175 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCC
Confidence 9999999999999999 7899999999754 35899999999999999999999 88999999999999999 8
Q ss_pred CCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCC-CcccchhhHHHHHHHHhCCCCChhHHHHHHHhhc
Q 020078 193 YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCN-EKTDVFCFGMLLLELLTGRRDNILLEHVKKHVEN 271 (331)
Q Consensus 193 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~ 271 (331)
++.++|+|||++......... ...||+.|+|||++....+. .++||||||+++|+|++|+.||.........
T Consensus 176 ~~~~kl~dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--- 248 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEPYT----DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEA--- 248 (312)
T ss_dssp TTEEEECCCSSCEECCSSCBC----CCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHT---
T ss_pred CCeEEEEEcchhhhcccCccc----ccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhh---
Confidence 899999999999876543321 23489999999999877664 5899999999999999999998654332211
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ...+. ..+.++.+++.+||+.||++|||+.|+++
T Consensus 249 -~--------~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 -E--------LHFPA------HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -C--------CCCCT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -c--------cCCcc------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00011 23346999999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=318.73 Aligned_cols=253 Identities=17% Similarity=0.205 Sum_probs=195.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-----------CCceeeeEeEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-----------HRNILKLIGCC 118 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~ 118 (331)
.+.|...+.||+ +||.||+|+. +++.||+|.+.... ...+.+.+|+.++.+++ ||||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 467999999999 9999999997 78999999987432 24567889999999886 89999999999
Q ss_pred eeCC----ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEc--
Q 020078 119 IETE----IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFD-- 191 (331)
Q Consensus 119 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~-- 191 (331)
...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||.||| +. +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEecc
Confidence 8754 678999999 8899999875432 35889999999999999999999 77 999999999999994
Q ss_pred ----CCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH----
Q 020078 192 ----EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE---- 263 (331)
Q Consensus 192 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~---- 263 (331)
..+.+||+|||++........ ...||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CCCcCcceEEEcccccccccCCCCC-----CCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 445899999999987644322 1348999999999999999999999999999999999999985322
Q ss_pred -----HHHHHhhc-cccc-----------------cccc-----------cccccCCCCchHHHHHHHHHHHHHHhccCC
Q 020078 264 -----HVKKHVEN-NRLG-----------------EIVD-----------PIVVEDKSCPEKEQQLQALLQLIFECVNES 309 (331)
Q Consensus 264 -----~~~~~~~~-~~~~-----------------~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 309 (331)
........ +... .... .........+ ...+.++.+|+.+||+.|
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSS
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccC
Confidence 11111100 0000 0000 0001111122 367788999999999999
Q ss_pred CCCCCCHHHHHH
Q 020078 310 AGDRPTMVYAAK 321 (331)
Q Consensus 310 P~~Rps~~evl~ 321 (331)
|++|||+.|+++
T Consensus 322 P~~Rpt~~ell~ 333 (373)
T 1q8y_A 322 PRKRADAGGLVN 333 (373)
T ss_dssp TTTCBCHHHHHT
T ss_pred ccccCCHHHHhh
Confidence 999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=312.68 Aligned_cols=198 Identities=19% Similarity=0.209 Sum_probs=168.6
Q ss_pred HHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CC-----ceeeeEeEEeeC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HR-----NILKLIGCCIET 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----nIv~l~~~~~~~ 121 (331)
...++|...+.||+ +||.||+|.. +++.||||.+.... .....+.+|+.++..++ |+ +|+++++++...
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 44678999999999 9999999988 67899999997432 23567788999998885 55 499999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc--CCCceEEc
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--EYNVAKLS 199 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~ 199 (331)
+..++||||++ |+|.+++..... ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999996 599999976432 3588999999999999999999931 36899999999999994 57889999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCCh
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
|||++........ ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 204 DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~ 259 (382)
T 2vx3_A 204 DFGSSCQLGQRIY-----QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFS 259 (382)
T ss_dssp CCTTCEETTCCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eccCceecccccc-----cccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999987644322 2358999999999999999999999999999999999999984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=313.72 Aligned_cols=244 Identities=19% Similarity=0.251 Sum_probs=199.3
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcc-----hhHHHHHHHHHHHhcC--CCceeeeEeE
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSEN-----GENFCFNNIVFAAQMN--HRNILKLIGC 117 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~nIv~l~~~ 117 (331)
+.....+.|...+.||+ +||.||+|+. +++.||+|.+....... ....+.+|+.++.+++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34456778999999999 9999999988 78899999987543221 2356778999999996 5999999999
Q ss_pred EeeCCccEEEEEecCC-CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc-CCCc
Q 020078 118 CIETEIPILVFEFVEY-GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYNV 195 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~-~~~~ 195 (331)
+.+.+..++|||++.. ++|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999975 8999998753 45889999999999999999999 89999999999999999 7899
Q ss_pred eEEccCCCccccCCCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccc
Q 020078 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRL 274 (331)
Q Consensus 196 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~ 274 (331)
+||+|||++......... ...||+.|+|||++....+ +.++||||||+++|+|++|+.||......... .
T Consensus 189 ~kL~Dfg~~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~----~- 259 (320)
T 3a99_A 189 LKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----Q- 259 (320)
T ss_dssp EEECCCTTCEECCSSCBC----CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC----C-
T ss_pred EEEeeCcccccccccccc----CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcc----c-
Confidence 999999999876543221 2348999999999987765 67899999999999999999998654332111 0
Q ss_pred ccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 275 GEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+.. .++++.+|+.+||+.||++|||+.|+++
T Consensus 260 -------~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 -------VFFRQR------VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------CCCSSC------CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------cccccc------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112 2346999999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=317.81 Aligned_cols=200 Identities=17% Similarity=0.209 Sum_probs=152.8
Q ss_pred cCccc-cCceee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccE
Q 020078 54 NNYNG-HQVIAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPI 125 (331)
Q Consensus 54 ~~~~~-~~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~ 125 (331)
+.|.. .++||+ +||.||+|+. ++..||+|++.... ....+.+|+.+|+.++||||+++++++.. ....+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS---CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC---CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 44554 558999 9999999996 46789999987543 24568899999999999999999999965 66789
Q ss_pred EEEEecCCCChhhhhcCCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE----cCCCceE
Q 020078 126 LVFEFVEYGTLADRICSPH----GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF----DEYNVAK 197 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill----~~~~~~k 197 (331)
+||||++ |+|.+++.... ......+++..+..++.||+.||.||| +.+|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999997 58888775211 111135899999999999999999999 8999999999999999 7778999
Q ss_pred EccCCCccccCCCCcc-ccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCCh
Q 020078 198 LSDFSESEYIPEGETH-VTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNI 260 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~ 260 (331)
|+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 9999999876543221 122234589999999999874 58999999999999999999999983
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=323.77 Aligned_cols=248 Identities=17% Similarity=0.220 Sum_probs=185.4
Q ss_pred HhcCccccCceee-cCcE-EEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYK-LYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
....|...++||+ +||+ ||++..+++.||||++.... ...+.+|+.+|..+ +|||||++++++.+.+..++||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT----EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 3457889999999 9997 56666699999999997542 33467899999999 7999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-----CCceEEccCCC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-----YNVAKLSDFSE 203 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfg~ 203 (331)
|||+ |+|.+++..... ......+..++.||+.||.||| +.+|+||||||+|||++. ...++|+|||+
T Consensus 98 E~~~-g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDF----AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp ECCS-EEHHHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred ECCC-CCHHHHHHhcCC----CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 9996 699999976542 2333456789999999999999 899999999999999953 34688999999
Q ss_pred ccccCCCCcc-ccccccCCCCcccchhhhc---cCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHH-Hhhccccccc
Q 020078 204 SEYIPEGETH-VTSHMLTRTKRYLAPEYIL---TGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKK-HVENNRLGEI 277 (331)
Q Consensus 204 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~-~~~~~~~~~~ 277 (331)
++........ .......||+.|+|||++. ...++.++|||||||++|+|++ |..||........ ........
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-- 247 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL-- 247 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC--
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc--
Confidence 9877544321 1223355999999999997 4567889999999999999999 8888732211111 11110000
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+ ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 -------~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 -------DCLHP-EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -------TTSCT-TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------cccCc-cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00001 1144567899999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=308.17 Aligned_cols=256 Identities=16% Similarity=0.171 Sum_probs=195.6
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CC-ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc------eeeeEeEEeeC
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--EN-RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN------ILKLIGCCIET 121 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~l~~~~~~~ 121 (331)
..+.|...+.||+ +||.||+|.. ++ ..||+|.+... ....+.+.+|+.++..++|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 3578999999999 9999999998 34 68999998643 224677889999999998766 99999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE-----------
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF----------- 190 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill----------- 190 (331)
+..++||||+ +|+|.+.+..... ..+++..+..++.||+.||.||| +.+|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 5677777765321 45899999999999999999999 9999999999999999
Q ss_pred --------cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH
Q 020078 191 --------DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL 262 (331)
Q Consensus 191 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~ 262 (331)
+.++.+||+|||+++....... ...||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHHT-----TIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCCC-----SSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccccCCCcEEEeecCcccccccccc-----CCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 5678999999999986543322 235899999999999999999999999999999999999998432
Q ss_pred HHHH--HHhhc---cccccc----------cccccccCC-----------------CCchHHHHHHHHHHHHHHhccCCC
Q 020078 263 EHVK--KHVEN---NRLGEI----------VDPIVVEDK-----------------SCPEKEQQLQALLQLIFECVNESA 310 (331)
Q Consensus 263 ~~~~--~~~~~---~~~~~~----------~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~cl~~dP 310 (331)
.... ..... ...... .......+. ........+.++.+|+.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1111 00000 000000 000000000 000011345689999999999999
Q ss_pred CCCCCHHHHHH
Q 020078 311 GDRPTMVYAAK 321 (331)
Q Consensus 311 ~~Rps~~evl~ 321 (331)
++|||+.|+++
T Consensus 323 ~~Rpt~~e~l~ 333 (355)
T 2eu9_A 323 AQRITLAEALL 333 (355)
T ss_dssp TTSCCHHHHTT
T ss_pred hhCcCHHHHhc
Confidence 99999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=332.22 Aligned_cols=268 Identities=16% Similarity=0.169 Sum_probs=201.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee------CCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE------TEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~------~~~ 123 (331)
.+.|...+.||. +||.||+|.. +++.||+|.+.........+.+.+|+.++.+++||||+++++++.. ++.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 367999999999 9999999998 7899999998876555567789999999999999999999999865 667
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCc---eEEcc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV---AKLSD 200 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~---~kl~D 200 (331)
.++||||+++|+|.+++...... ..+++..+..++.+++.||.||| +.+|+||||||+||+++.++. ++|+|
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred EEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 89999999999999999764321 35788899999999999999999 899999999999999996654 99999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh----hcccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV----ENNRLGE 276 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~----~~~~~~~ 276 (331)
||++......... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.......... .......
T Consensus 168 FG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~ 244 (676)
T 3qa8_A 168 LGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244 (676)
T ss_dssp CCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------C
T ss_pred ccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhh
Confidence 9999876544322 22458999999999998999999999999999999999999984321111100 0000000
Q ss_pred cccccccc--------CCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHHHHHH
Q 020078 277 IVDPIVVE--------DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVY-----AAKQLRQMYL 328 (331)
Q Consensus 277 ~~~~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~e-----vl~~L~~~~~ 328 (331)
.......+ +.........++++.+++.+||..||++|||+.+ ..+.++.+..
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 00000000 0011111246778999999999999999999988 4566666553
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=303.60 Aligned_cols=247 Identities=19% Similarity=0.240 Sum_probs=178.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhH-HHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGEN-FCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~-~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.++|...+.||+ +||.||+|.. +++.||+|.+.......... .+..+..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888899999 9999999998 68999999997654433333 3444555788889999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||+ ++.+..+..... ..+++..+..++.|++.||.||| +. +|+||||||+||+++.++.+||+|||++...
T Consensus 104 e~~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 445555443222 45889999999999999999999 75 9999999999999999999999999998766
Q ss_pred CCCCccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHH---HHHHHhhccccccccc
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLE---HVKKHVENNRLGEIVD 279 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~ 279 (331)
....... ...+|+.|+|||++. ...++.++||||||+++|+|++|+.||.... ...........
T Consensus 176 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 247 (318)
T 2dyl_A 176 VDDKAKD---RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP----- 247 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC-----
T ss_pred cCCcccc---ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC-----
Confidence 4432211 234899999999994 4568899999999999999999999984311 11111111111
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+...... ..+.++.+|+.+||+.||++|||+.++++
T Consensus 248 ~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 PLLPGHM------GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCCCSSS------CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCccC------CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111111 22346999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=328.16 Aligned_cols=240 Identities=20% Similarity=0.244 Sum_probs=194.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe---CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc----
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL---ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI---- 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 123 (331)
..+.|...+.||+ +||.||+|.+ +++.||||.+...........+.+|+.++.+++||||+++++++.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999 9999999987 5789999998765444456788999999999999999999999998766
Q ss_pred -cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCC
Q 020078 124 -PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFS 202 (331)
Q Consensus 124 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg 202 (331)
.|+||||+++++|.+++.. .+++.+++.++.||+.||.||| +.+|+||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecc
Confidence 6999999999999887642 5899999999999999999999 8999999999999999985 89999999
Q ss_pred CccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccccc
Q 020078 203 ESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 203 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 282 (331)
+++..... ....||+.|+|||++.++. +.++||||||+++|+|++|..|+.. ..... +
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~----------~~~~~-----~ 284 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG----------RYVDG-----L 284 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT----------EECSS-----C
T ss_pred cchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc----------ccccc-----c
Confidence 99876543 1245999999999987654 8899999999999999999887531 00000 0
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-MVYAAKQLRQMY 327 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-~~evl~~L~~~~ 327 (331)
. ...+ ....++.+.+|+.+||+.||++||+ +.++...|..+.
T Consensus 285 ~--~~~~-~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 285 P--EDDP-VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp C--TTCH-HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c--cccc-ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0 0111 1244567999999999999999995 666666676654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=288.45 Aligned_cols=229 Identities=10% Similarity=0.034 Sum_probs=181.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
.+.|...+.||+ +||.||+|.. +++.||+|.+...... ...+.+.+|+.++.+++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999 9999999999 5899999999865432 2357899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||+++++|.+++... ....++..++.|++.||.||| +.+|+||||||+|||++.++.++|++++
T Consensus 110 ~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999998431 345578889999999999999 8999999999999999999999998443
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
|++ .++.++||||||+++|+|++|+.||...... ...............
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~~~ 223 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR-------SGLAPAERDTAGQPI 223 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC-------CCSEECCBCTTSCBC
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc-------hhhHHHHHHhccCCC
Confidence 333 2678999999999999999999996421110 000000011111111
Q ss_pred Cch--HHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 288 CPE--KEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 288 ~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+. ....++++.+|+.+||+.||++| |+.|+++.|+++..
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 110 01345679999999999999999 99999999998764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=288.78 Aligned_cols=227 Identities=17% Similarity=0.241 Sum_probs=177.9
Q ss_pred hcCcccc-Cceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHH-HhcCCCceeeeEeEEee----CCc
Q 020078 53 TNNYNGH-QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFA-AQMNHRNILKLIGCCIE----TEI 123 (331)
Q Consensus 53 ~~~~~~~-~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~----~~~ 123 (331)
.++|... ++||+ +||.||++.. +++.||+|.+.. ...+.+|+.++ +.++||||+++++++.. ...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 4556665 78999 9999999998 788999999853 34677899888 55689999999999987 667
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CCceEEcc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YNVAKLSD 200 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 200 (331)
.++||||+++|+|.+++..... ..+++..++.++.|++.||.||| +.+|+||||||+||+++. ++.++|+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence 8999999999999999976432 36899999999999999999999 899999999999999998 78999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
||++.... ...++.++||||||+++|+|++|..||.......... .....
T Consensus 164 fg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~------~~~~~ 213 (299)
T 3m2w_A 164 FGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP------GMKTR 213 (299)
T ss_dssp CTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C------CSCCS
T ss_pred cccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH------HHHHH
Confidence 99986432 2346789999999999999999999985433221110 01111
Q ss_pred ccccCCCCch--HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVEDKSCPE--KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........+. ....++++.+|+.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 214 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111112221 1234568999999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=297.02 Aligned_cols=243 Identities=9% Similarity=0.076 Sum_probs=186.5
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCC-------CcchhHHHHHHHHHHHhcC---------CCceeeeE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNY-------SENGENFCFNNIVFAAQMN---------HRNILKLI 115 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------h~nIv~l~ 115 (331)
.++|...+.||+ +||.||+|+.+++.||+|++.... .....+.+.+|+.+++.++ |||||++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 456888899999 999999999999999999997543 2223578999999999886 66666666
Q ss_pred eEE-----------------ee-------------CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHH
Q 020078 116 GCC-----------------IE-------------TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165 (331)
Q Consensus 116 ~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 165 (331)
+++ .+ .+..++||||+++|++.+.+.. ..+++..+..++.||+.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHH
Confidence 553 32 6788999999999987777743 34789999999999999
Q ss_pred HHHHhhcCCCCCeeeCCCCCCceEEcCCC--------------------ceEEccCCCccccCCCCccccccccCCCCcc
Q 020078 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYN--------------------VAKLSDFSESEYIPEGETHVTSHMLTRTKRY 225 (331)
Q Consensus 166 ~l~~LH~~~~~~ivHrdlk~~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 225 (331)
||.|||+ +.+|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 173 aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 9999993 36899999999999999887 8999999999876532 13499999
Q ss_pred cchhhhccCCCCCcccchhhHHH-HHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHH
Q 020078 226 LAPEYILTGLCNEKTDVFCFGML-LLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFE 304 (331)
Q Consensus 226 ~aPE~~~~~~~~~~~Dv~SlG~~-l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 304 (331)
+|||++.+.. +.++||||++++ .+++++|..||....+.......... . .........+.....++++.+|+.+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK-Q---MTFKTKCNTPAMKQIKRKIQEFHRT 318 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHH-T---CCCSSCCCSHHHHHHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhh-h---hccCcccchhhhhhcCHHHHHHHHH
Confidence 9999997655 889999998776 77899999998554332211111000 0 0011112223344788899999999
Q ss_pred hccCCCCCCCCHHHHH
Q 020078 305 CVNESAGDRPTMVYAA 320 (331)
Q Consensus 305 cl~~dP~~Rps~~evl 320 (331)
||+.| |+.|++
T Consensus 319 ~L~~d-----sa~e~l 329 (336)
T 2vuw_A 319 MLNFS-----SATDLL 329 (336)
T ss_dssp GGGSS-----SHHHHH
T ss_pred HhccC-----CHHHHH
Confidence 99977 999887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=303.07 Aligned_cols=242 Identities=13% Similarity=0.075 Sum_probs=178.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCC-Ccee---------------
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNH-RNIL--------------- 112 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~nIv--------------- 112 (331)
..|...++||+ +||.||+|.+ +++.||||++...... ...+.+.+|+.++..++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45777889999 9999999998 6899999998743222 236789999999999987 3211
Q ss_pred ee------EeEEee-----CCccEEEEEecCCCChhhhhcCCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 020078 113 KL------IGCCIE-----TEIPILVFEFVEYGTLADRICSPH--GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179 (331)
Q Consensus 113 ~l------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 179 (331)
.+ ..++.. ....+++|+++ +|+|.+++.... ......+++..++.++.|+++||.||| +.+|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 11 111111 12345666655 679999884110 001145788899999999999999999 89999
Q ss_pred eCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhh----------ccCCCCCcccchhhHHHH
Q 020078 180 FKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYI----------LTGLCNEKTDVFCFGMLL 249 (331)
Q Consensus 180 Hrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlG~~l 249 (331)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 9999999999999999999999998765432 222447 999999999 445688899999999999
Q ss_pred HHHHhCCCCChhHHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 250 LELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 250 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
|+|++|+.||.... ...............| +++.+|+.+||+.||++|||+.++++
T Consensus 308 ~elltg~~Pf~~~~----------~~~~~~~~~~~~~~~~------~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDA----------ALGGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTG----------GGSCSGGGGSSCCCCC------HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcc----------hhhhHHHHHhhcccCC------HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999974321 1222233333222333 46999999999999999999888754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-33 Score=268.27 Aligned_cols=169 Identities=14% Similarity=0.056 Sum_probs=126.2
Q ss_pred CCceEEEEEeCCCCC---------cchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCC
Q 020078 75 ENRPISVMKFGDNYS---------ENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPH 144 (331)
Q Consensus 75 ~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 144 (331)
.|+.+++|.+..... +...+.|.+|+.+|+++ .|+||+++++++++++..||||||++||+|.+++...
T Consensus 258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~- 336 (569)
T 4azs_A 258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG- 336 (569)
T ss_dssp ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT-
T ss_pred ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC-
Confidence 688999999865421 12356799999999999 6999999999999999999999999999999999765
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCc
Q 020078 145 GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224 (331)
Q Consensus 145 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 224 (331)
.+++.. +|+.||+.||.|+| +.+||||||||+|||++.++.+||+|||+|+......... .+.+||+.
T Consensus 337 ----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~--~t~vGTp~ 404 (569)
T 4azs_A 337 ----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP--TNLVQSFF 404 (569)
T ss_dssp ----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS--HHHHHHHH
T ss_pred ----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc--cCceechh
Confidence 345553 48899999999999 9999999999999999999999999999998775543322 22459999
Q ss_pred ccchhhhccCCCCCcccchhhHHHHHHHHhCCC
Q 020078 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257 (331)
Q Consensus 225 y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~ 257 (331)
|+|||++. +.+..++|+||+|++++++.++..
T Consensus 405 YmAPE~l~-g~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 405 VFVNELFA-ENKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHHHC------------------CCCCTTHH
T ss_pred hccHHHhC-CCCCCcccccccccchhhhccccc
Confidence 99999985 456778999999998887766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=240.90 Aligned_cols=185 Identities=12% Similarity=0.102 Sum_probs=146.4
Q ss_pred cccCceee-cCcEEEEEEeCCceEEEEEeCCCCCc-c------hhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 57 NGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSE-N------GENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~-~------~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
...+.||+ +||.||+|...+..+++|+....... . ..+.+.+|+.++++++||||+++..++...+..++||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 34568999 99999999889999999987653221 1 1345889999999999999997766777788889999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+++|+|.+++.. +..++.|+++||.||| +.+|+||||||+|||++. .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999853 3578999999999999 899999999999999999 99999999999875
Q ss_pred CCCccc-----cccccCCCCcccchhhhcc--CCCCCcccchhhHHHHHHHHhCCCCC
Q 020078 209 EGETHV-----TSHMLTRTKRYLAPEYILT--GLCNEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 209 ~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
...... ......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532211 1223569999999999986 56888999999998888777766553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=191.92 Aligned_cols=146 Identities=12% Similarity=0.028 Sum_probs=117.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-----------------chhHHHHHHHHHHHhcCCCcee
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-----------------NGENFCFNNIVFAAQMNHRNIL 112 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv 112 (331)
....|...+.||+ ++|.||+|.. +++.||+|.+...... .....+.+|+.++.+++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 3445566689999 9999999999 6889999998643211 13457889999999999 5 7
Q ss_pred eeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC
Q 020078 113 KLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE 192 (331)
Q Consensus 113 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~ 192 (331)
++++++.. +..++||||+++|+|.+ +.. .....++.|++.||.||| +.+|+||||||+|||++
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~- 227 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS- 227 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence 77776544 56799999999999988 421 123469999999999999 89999999999999999
Q ss_pred CCceEEccCCCccccCCCCccccccccCCCCcccchhhhc
Q 020078 193 YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL 232 (331)
Q Consensus 193 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 232 (331)
++.++|+|||++. .+..++|||++.
T Consensus 228 ~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 9999999999986 344578999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.6e-19 Score=157.54 Aligned_cols=136 Identities=13% Similarity=0.093 Sum_probs=103.7
Q ss_pred ccccCceee-cCcEEEEEEe--CCce--EEEEEeCCCCCc-----------------------chhHHHHHHHHHHHhcC
Q 020078 56 YNGHQVIAS-EHYKLYKGFL--ENRP--ISVMKFGDNYSE-----------------------NGENFCFNNIVFAAQMN 107 (331)
Q Consensus 56 ~~~~~~ig~-~~g~Vy~~~~--~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 107 (331)
|.....||+ ++|.||+|.. +|+. ||||.+...... .....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 567788999 9999999998 8888 999987543111 01136889999999998
Q ss_pred CCce--eeeEeEEeeCCccEEEEEecCC-C----ChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 020078 108 HRNI--LKLIGCCIETEIPILVFEFVEY-G----TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVF 180 (331)
Q Consensus 108 h~nI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 180 (331)
|+++ ...+++ +..++||||+.+ | +|.+.... .++..+..++.|++.||.|||. ..+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEe
Confidence 8764 333332 357899999942 4 66655422 2234567899999999999994 468999
Q ss_pred CCCCCCceEEcCCCceEEccCCCcccc
Q 020078 181 KDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 181 rdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-17 Score=149.07 Aligned_cols=138 Identities=7% Similarity=0.037 Sum_probs=97.3
Q ss_pred cCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-------------chhHH--------HHHHHHHHHhcCCCc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-------------NGENF--------CFNNIVFAAQMNHRN 110 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-------------~~~~~--------~~~E~~~l~~l~h~n 110 (331)
.-|.....||. ++|.||+|.. +|+.||||.+...... ..... ..+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 34888899999 9999999998 8899999987532110 00111 234566666664433
Q ss_pred eeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 111 ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 111 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+.. ...+. .+..+|||||+++++|..+... .....++.|++.+|.+|| ..+||||||||.|||+
T Consensus 175 v~v-p~p~~-~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPV-PEPIA-QSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLA---KHGLIHGDFNEFNILI 238 (397)
T ss_dssp CSC-CCEEE-EETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred CCC-Ceeee-ccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence 321 11111 1234799999999888765421 123467899999999999 8899999999999999
Q ss_pred cCCC----------ceEEccCCCcccc
Q 020078 191 DEYN----------VAKLSDFSESEYI 207 (331)
Q Consensus 191 ~~~~----------~~kl~Dfg~a~~~ 207 (331)
++++ .+.|+||+-+...
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred eCCCCcccccccccceEEEEeCCcccC
Confidence 8776 3899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=6.9e-13 Score=115.40 Aligned_cols=145 Identities=13% Similarity=0.036 Sum_probs=110.9
Q ss_pred HHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEE
Q 020078 50 KIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 50 ~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv 127 (331)
...-.+|......+. +.+.||+....+..+++|........ ....+.+|+.++..+. +..+.++++++.+.+..|+|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 334456766666666 66789999888899999998753221 3446889999999995 67788899999888889999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF--------------------------------- 174 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 174 (331)
|||++|.+|.+.+... .....++.+++.+|..||.-.
T Consensus 89 ~e~i~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EECCSSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEecCCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999998764211 122467889999999999510
Q ss_pred -----------------------CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 -----------------------RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 -----------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
...++|+|++|.|||++.+..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0458999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=4.8e-11 Score=103.19 Aligned_cols=134 Identities=12% Similarity=0.010 Sum_probs=96.7
Q ss_pred CccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc--eeeeEeEEeeCCccEEEEEe
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN--ILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~ 130 (331)
++....+.+. ..+.||+... ++..+++|..... ....+.+|+.++..+.+.+ +.+++++...++..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 4444333334 4469999977 4678999997653 2356889999999986544 45588888877788999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF------------------------------------ 174 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 174 (331)
+++.+|. ... ... ..++.+++..|..||...
T Consensus 97 i~G~~l~--~~~--------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 97 VPGQDLL--SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp CSSEETT--TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred cCCcccC--cCc--------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 9998883 311 111 256778888888888421
Q ss_pred -------------------CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 -------------------RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 -------------------~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999887667799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=9.2e-11 Score=106.77 Aligned_cols=140 Identities=14% Similarity=0.124 Sum_probs=103.9
Q ss_pred Cceee-cCcEEEEEEeCCceEEEEEeC--CCCCcchhHHHHHHHHHHHhcC--CCceeeeEeEEeeC---CccEEEEEec
Q 020078 60 QVIAS-EHYKLYKGFLENRPISVMKFG--DNYSENGENFCFNNIVFAAQMN--HRNILKLIGCCIET---EIPILVFEFV 131 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~e~~ 131 (331)
..++. .+..||+....+..+++|+.. ..........+.+|..++..|. +..+.++++++.+. ...++||||+
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 34555 556899998888889998876 4322223567889999999997 45678889988876 3478999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF------------------------------------- 174 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 174 (331)
++..+.+... ..++..++..++.+++..|..||...
T Consensus 124 ~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 124 SGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred CCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9887754221 34677888899999999999999520
Q ss_pred ------------------CCCeeeCCCCCCceEEcCCCc--eEEccCCCccc
Q 020078 175 ------------------RRPIVFKDIKLSQILFDEYNV--AKLSDFSESEY 206 (331)
Q Consensus 175 ------------------~~~ivHrdlk~~Nill~~~~~--~kl~Dfg~a~~ 206 (331)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999987653 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.8e-09 Score=94.65 Aligned_cols=183 Identities=14% Similarity=0.168 Sum_probs=114.8
Q ss_pred ceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCc--eeeeEeEEeeCC---ccEEEEEecCC
Q 020078 61 VIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRN--ILKLIGCCIETE---IPILVFEFVEY 133 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lv~e~~~~ 133 (331)
.++. ....||+.. ..+++|..... .....+.+|..+|..+. +.. +...+......+ ..|+|||+++|
T Consensus 27 ~~~~G~~n~v~~v~---~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN---RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST---TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC---CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 4555 444777753 67888886432 24567889999999884 333 334444443333 34789999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG---------------------------------------- 173 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 173 (331)
.+|.+... ..++..++..++.+++..|..||..
T Consensus 101 ~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 88865332 2366677777888888888888841
Q ss_pred ---------------CCCCeeeCCCCCCceEEcC--CCceEEccCCCccccCCCCccccccccCCCCcccchhhhc----
Q 020078 174 ---------------FRRPIVFKDIKLSQILFDE--YNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL---- 232 (331)
Q Consensus 174 ---------------~~~~ivHrdlk~~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---- 232 (331)
....++|+|++|.||+++. ...+.++||+.+..-.... ..... . ....-.+|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~-~-~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISL-M-EDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTT-C-CTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHH-H-hhccccCHHHHHHHHH
Confidence 0135799999999999998 5568899999876542211 10000 0 000002222211
Q ss_pred -cCCC---------CCcccchhhHHHHHHHHhCCCCC
Q 020078 233 -TGLC---------NEKTDVFCFGMLLLELLTGRRDN 259 (331)
Q Consensus 233 -~~~~---------~~~~Dv~SlG~~l~el~~g~~p~ 259 (331)
++.. ..-.+.|++|.++|.+.+|..++
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0111 11257899999999999999764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.4e-07 Score=80.39 Aligned_cols=128 Identities=10% Similarity=0.023 Sum_probs=92.4
Q ss_pred cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEecCCCChhhhhc
Q 020078 65 EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYGTLADRIC 141 (331)
Q Consensus 65 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 141 (331)
+...||+... .+..+++|.-... ....+.+|...|+.|. +--+.++++++.+.+..++|||++++.++.+...
T Consensus 37 S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 37 SGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp SSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHH
T ss_pred cCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccccc
Confidence 4457998766 4567888885432 3557888999999885 3336678888888899999999999888766553
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-------------------------------------------------
Q 020078 142 SPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI------------------------------------------------- 172 (331)
Q Consensus 142 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------------- 172 (331)
.. ......++.+++..|.-||.
T Consensus 113 ~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 183 (272)
T 4gkh_A 113 EY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEM 183 (272)
T ss_dssp HC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHH
T ss_pred CC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHH
Confidence 21 11223456667777777773
Q ss_pred ------CCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 173 ------GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 173 ------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
.....++|+|+.+.|||++..+.+-|+||+.+.
T Consensus 184 ~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 184 HKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 002247999999999999987777899998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=3.5e-06 Score=74.68 Aligned_cols=133 Identities=11% Similarity=0.067 Sum_probs=88.7
Q ss_pred ceeecCc-EEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC---ceeeeEeEEe-eCCccEEEEEecCCCC
Q 020078 61 VIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR---NILKLIGCCI-ETEIPILVFEFVEYGT 135 (331)
Q Consensus 61 ~ig~~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~g~ 135 (331)
.++.|.. .||.. +..+++|.... ......+.+|..+|..|.+. .+.+.+.++. ..+..++||||++|.+
T Consensus 26 ~l~~G~~n~v~~v---g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV---NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE---TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE---CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 3455444 78887 67888888532 12456788999999999753 2445566654 3445789999999988
Q ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 020078 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG------------------------------------------ 173 (331)
Q Consensus 136 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 173 (331)
+.+... ..++..+...++.+++..|.-||..
T Consensus 100 l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 866321 1234445555555555555555531
Q ss_pred ---------------CCCCeeeCCCCCCceEEcC---CCc-eEEccCCCccc
Q 020078 174 ---------------FRRPIVFKDIKLSQILFDE---YNV-AKLSDFSESEY 206 (331)
Q Consensus 174 ---------------~~~~ivHrdlk~~Nill~~---~~~-~kl~Dfg~a~~ 206 (331)
....++|+|+.|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1335699999999999987 344 58999997754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.5e-06 Score=74.34 Aligned_cols=76 Identities=5% Similarity=-0.095 Sum_probs=50.1
Q ss_pred eecC-cEEEEEEeC--------CceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCC---CceeeeEeEEeeC---CccE
Q 020078 63 ASEH-YKLYKGFLE--------NRPISVMKFGDNY--SENGENFCFNNIVFAAQMNH---RNILKLIGCCIET---EIPI 125 (331)
Q Consensus 63 g~~~-g~Vy~~~~~--------~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~---~~~~ 125 (331)
+.|. ..+|..... +..+++|...... .......+.+|+.++..|.. ..+.++++++.+. ...+
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 4433 478887664 6778888764432 01012567889998888852 3466778877665 3568
Q ss_pred EEEEecCCCChhh
Q 020078 126 LVFEFVEYGTLAD 138 (331)
Q Consensus 126 lv~e~~~~g~L~~ 138 (331)
+||||+++..+.+
T Consensus 110 ~v~e~l~G~~l~~ 122 (357)
T 3ats_A 110 FLMDYVEGVVPPD 122 (357)
T ss_dssp EEEECCCCBCCCB
T ss_pred EEEEecCCCChhh
Confidence 9999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00015 Score=66.47 Aligned_cols=73 Identities=10% Similarity=0.021 Sum_probs=46.3
Q ss_pred Cceee-cCcEEEEEEe--CCceEEEEEeCCCCC------cchhHHHHHHHHHHHhcCC--Cce-eeeEeEEeeCCccEEE
Q 020078 60 QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS------ENGENFCFNNIVFAAQMNH--RNI-LKLIGCCIETEIPILV 127 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~nI-v~l~~~~~~~~~~~lv 127 (331)
..+|. ..+.||++.. .++.+++|....... ....+.+..|..++..+.. |.. .+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 35666 5669999965 567899998653211 1124556789999988742 443 345544 45567899
Q ss_pred EEecCCC
Q 020078 128 FEFVEYG 134 (331)
Q Consensus 128 ~e~~~~g 134 (331)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00021 Score=62.36 Aligned_cols=77 Identities=13% Similarity=0.172 Sum_probs=51.2
Q ss_pred CccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC---ceeeeEeEEeeCCccEEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR---NILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.....+|. ....||+... +|+.+++|+....... ....|..|...|+.|.-. -+.+.+++ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3444455677 5559999998 7889999986544322 345788999999988532 23344443 23478999
Q ss_pred ecCCCCh
Q 020078 130 FVEYGTL 136 (331)
Q Consensus 130 ~~~~g~L 136 (331)
|++.+..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9876543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.75 E-value=0.00028 Score=62.87 Aligned_cols=31 Identities=13% Similarity=0.153 Sum_probs=27.9
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
...++|+|+.+.|||++.++.+.++||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999877889999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00036 Score=61.80 Aligned_cols=72 Identities=13% Similarity=-0.020 Sum_probs=55.8
Q ss_pred ceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC---CCceeeeEeEEeeCCccEEEEEecCCCCh
Q 020078 61 VIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN---HRNILKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 61 ~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
.++. ....+|+...++..+++|..... ....+..|...|+.|. ...+.+.++++...+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLINDEVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEESSSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEECCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3555 44589999888888999986532 3567889999998884 35677888888877889999999998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00065 Score=56.30 Aligned_cols=99 Identities=12% Similarity=0.115 Sum_probs=63.0
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
-||.+.|...+ .++++.++|.++.|.+.+|.-+-. ...-..+=..|..|++..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------
Confidence 37889998766 689999999999999999876620 11111233446889999989887764 1110
Q ss_pred ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh
Q 020078 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254 (331)
Q Consensus 214 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~ 254 (331)
.....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0223466887652 334567779999999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0016 Score=60.11 Aligned_cols=32 Identities=13% Similarity=0.210 Sum_probs=28.2
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
...++|+|++|.|||++.++ +.++||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 67899999999999998776 999999987653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0027 Score=57.68 Aligned_cols=135 Identities=18% Similarity=0.165 Sum_probs=78.7
Q ss_pred CcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCccEEEEEecCCCC
Q 020078 66 HYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 66 ~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
...+|+.... +..+++++..... .......+|..+++.|. +.-..++++.+.+ .+||||+++.+
T Consensus 63 TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~ 136 (379)
T 3feg_A 63 SNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRP 136 (379)
T ss_dssp -CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEE
T ss_pred cccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCcc
Confidence 3467888763 3678888853321 23556678999998885 3223456666543 28999998765
Q ss_pred hhhh-----------------hcCCCCCCCCCC--CHHHHHHHHHHHHH-------------------HHHHhh----c-
Q 020078 136 LADR-----------------ICSPHGPHLEPL--LWRHRLKIAMEIGN-------------------AMAYIH----I- 172 (331)
Q Consensus 136 L~~~-----------------l~~~~~~~~~~l--~~~~~~~i~~~i~~-------------------~l~~LH----~- 172 (331)
|..- ++...-...... .+.++.++..++.. .+..|. .
T Consensus 137 l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~ 216 (379)
T 3feg_A 137 LKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLEST 216 (379)
T ss_dssp CCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTS
T ss_pred CChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhc
Confidence 5321 111111001111 24555555444322 122222 1
Q ss_pred CCCCCeeeCCCCCCceEEcCC----CceEEccCCCccc
Q 020078 173 GFRRPIVFKDIKLSQILFDEY----NVAKLSDFSESEY 206 (331)
Q Consensus 173 ~~~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~a~~ 206 (331)
.....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 217 ~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 217 PSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred CCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 123468999999999999876 6899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0055 Score=53.59 Aligned_cols=70 Identities=9% Similarity=0.040 Sum_probs=40.3
Q ss_pred cCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEec-CCCC
Q 020078 59 HQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEFV-EYGT 135 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~g~ 135 (331)
...++. ....+|+. ..+++|....... ......+|..++..+....+ .++++++ .+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~--~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTE--EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcc--ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 344555 33488888 6788888765321 12234568887777742222 3455543 33457899999 5544
Q ss_pred h
Q 020078 136 L 136 (331)
Q Consensus 136 L 136 (331)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.98 E-value=0.03 Score=49.34 Aligned_cols=163 Identities=13% Similarity=0.061 Sum_probs=85.3
Q ss_pred CccccCHHHHHHHhcCcccc-----CceeecCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCC--ce
Q 020078 40 PIRSFSAGELKIATNNYNGH-----QVIASEHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR--NI 111 (331)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~-----~~ig~~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~--nI 111 (331)
+...++.+++...-..|... ..++.....||+... +|+.+++|....... ....+..|..++..|... .+
T Consensus 7 ~~~~l~~~~i~~~l~~~g~~~~~~~~~l~g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 7 TFQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCCHHHHHHHHHHcCCCCCceEEeecCcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCee
Confidence 34445666665544444221 223323348998876 456899999864321 245666788888777422 23
Q ss_pred eeeEeE-----EeeCCccEEEEEecCCCChhh----h----------hcC----CCCCCCCCCCHHHH------------
Q 020078 112 LKLIGC-----CIETEIPILVFEFVEYGTLAD----R----------ICS----PHGPHLEPLLWRHR------------ 156 (331)
Q Consensus 112 v~l~~~-----~~~~~~~~lv~e~~~~g~L~~----~----------l~~----~~~~~~~~l~~~~~------------ 156 (331)
.+++.. ....+..+++|+|+++..+.. . ++. ........+.+...
T Consensus 85 p~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 164 (328)
T 1zyl_A 85 AAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDAT 164 (328)
T ss_dssp CCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCS
T ss_pred cceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcC
Confidence 344432 112345578999998754321 0 110 00000011222111
Q ss_pred ----------HHHHHHHHHHHHHhhc-CCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 157 ----------LKIAMEIGNAMAYIHI-GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 157 ----------~~i~~~i~~~l~~LH~-~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
...+..++..+.-+-. .....++|+|+.+.|||++ + .+.++||+.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 165 LIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111122222221110 1145689999999999999 4 899999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.059 Score=47.24 Aligned_cols=159 Identities=13% Similarity=0.116 Sum_probs=84.5
Q ss_pred cCHHHHHHHhcCccccC-----ceeecC-cEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCc--eeeeE
Q 020078 44 FSAGELKIATNNYNGHQ-----VIASEH-YKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN--ILKLI 115 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~-----~ig~~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~ 115 (331)
++.+++...-..|.... .++.|. ..+|+...++..+++|...... ....+..|+.++..|.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 55666666655565422 222332 3789988866689999887532 2234556777777664212 22232
Q ss_pred eE------EeeCCccEEEEEecCCCChhh--------------hhcCC----CCCCCCCC---CHHHHHH----------
Q 020078 116 GC------CIETEIPILVFEFVEYGTLAD--------------RICSP----HGPHLEPL---LWRHRLK---------- 158 (331)
Q Consensus 116 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~~~~~l---~~~~~~~---------- 158 (331)
.. ....+..+++++|+++..+.. .++.. ........ .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999998765421 01110 00000001 1221100
Q ss_pred --HHHHHHHHHHHhhc----CCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 159 --IAMEIGNAMAYIHI----GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 159 --i~~~i~~~l~~LH~----~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+...+...+..+.. .....++|+|+.+.|||++.+..+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113334444432 113478999999999999987666899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0037 Score=55.51 Aligned_cols=33 Identities=15% Similarity=0.219 Sum_probs=28.1
Q ss_pred CCCeeeCCCCCCceEEcCC----CceEEccCCCcccc
Q 020078 175 RRPIVFKDIKLSQILFDEY----NVAKLSDFSESEYI 207 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~----~~~kl~Dfg~a~~~ 207 (331)
...++|+|+.+.|||++.+ ..+.++||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4579999999999999874 67899999987654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.019 Score=53.42 Aligned_cols=64 Identities=14% Similarity=-0.022 Sum_probs=42.3
Q ss_pred cEEEEEEeCC--ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEecCCCCh
Q 020078 67 YKLYKGFLEN--RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEFVEYGTL 136 (331)
Q Consensus 67 g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g~L 136 (331)
..+|+....+ ..+++|+...... ..-.-.+|..++..|...++ .++++.+. + .+||||+++.+|
T Consensus 122 N~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 122 NILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred eEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 3799998865 7888888754321 12223589999999875555 45677662 2 369999987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.006 Score=56.39 Aligned_cols=64 Identities=16% Similarity=0.129 Sum_probs=41.4
Q ss_pred CcEEEEEEeC---------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEecCCCC
Q 020078 66 HYKLYKGFLE---------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEFVEYGT 135 (331)
Q Consensus 66 ~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g~ 135 (331)
...||+.... +..+++|+..... ..+.+.+|..++..|...++ .++++.+.+ .+|+||+++.+
T Consensus 86 tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~ 158 (429)
T 1nw1_A 86 SNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP 158 (429)
T ss_dssp TEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred ccceEEEEeCCCccccCCCCceEEEEEeCCCC---cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence 3489999874 4678888874321 12455679999888853333 556666532 38999998644
Q ss_pred h
Q 020078 136 L 136 (331)
Q Consensus 136 L 136 (331)
|
T Consensus 159 l 159 (429)
T 1nw1_A 159 L 159 (429)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0072 Score=54.51 Aligned_cols=31 Identities=19% Similarity=0.273 Sum_probs=25.2
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
...++|+|+.+.|||++.+. +.++||..+..
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 34689999999999998655 89999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.59 E-value=0.13 Score=45.58 Aligned_cols=32 Identities=16% Similarity=0.266 Sum_probs=27.9
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
...++|+|+.+.||+++.++.+.++||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45789999999999999878899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.04 E-value=0.099 Score=48.09 Aligned_cols=31 Identities=16% Similarity=0.266 Sum_probs=26.6
Q ss_pred CCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 175 RRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 175 ~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
...++|+|+.+.|++ +.++.+.++||..+..
T Consensus 261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 346899999999999 7788999999988764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.25 E-value=0.14 Score=46.56 Aligned_cols=30 Identities=30% Similarity=0.371 Sum_probs=25.0
Q ss_pred CeeeCCCCCCceEE------cCCCceEEccCCCccc
Q 020078 177 PIVFKDIKLSQILF------DEYNVAKLSDFSESEY 206 (331)
Q Consensus 177 ~ivHrdlk~~Nill------~~~~~~kl~Dfg~a~~ 206 (331)
.++|+|+.+.|||+ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999988764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.17 E-value=0.096 Score=48.77 Aligned_cols=57 Identities=12% Similarity=-0.002 Sum_probs=16.2
Q ss_pred cCcEEEEEEeCC--ceEEE------EEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC
Q 020078 65 EHYKLYKGFLEN--RPISV------MKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121 (331)
Q Consensus 65 ~~g~Vy~~~~~~--~~vav------K~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 121 (331)
|||.||+|.+.+ .+||+ |...... .......+.+|..++..++|||+++.+++....
T Consensus 151 GfG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~~ 216 (463)
T 3cxl_A 151 GYTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVHT 216 (463)
T ss_dssp SBCCC---------CCBGGGC-----------------------------------CBCCCEEEEC
T ss_pred CchhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEee
Confidence 699999999943 57888 6655432 222455788899999999999999998887653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.45 E-value=2.6 Score=34.69 Aligned_cols=83 Identities=7% Similarity=-0.047 Sum_probs=56.3
Q ss_pred CCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhcCCCCCeeeCCCCC
Q 020078 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMA-YIHIGFRRPIVFKDIKL 185 (331)
Q Consensus 107 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivHrdlk~ 185 (331)
.||+. -...-.+++...+.++--+++.=...+ ..++...+++++..|+.-.. +++ .-+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 57777 333335566655555554333323334 34778889999988887655 444 446778899
Q ss_pred CceEEcCCCceEEccCCCc
Q 020078 186 SQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 186 ~Nill~~~~~~kl~Dfg~a 204 (331)
+|+++|.++.+++.-.|+-
T Consensus 113 ~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGEEECTTCCEEESCCEET
T ss_pred ceEEEeCCCcEEEEEcCCc
Confidence 9999999999999977754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.73 E-value=2.2 Score=35.03 Aligned_cols=84 Identities=5% Similarity=-0.072 Sum_probs=57.2
Q ss_pred CCCceeeeEeEEeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCC
Q 020078 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186 (331)
Q Consensus 107 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~ 186 (331)
.||+.+.. .+-.+.+.. ...|-...+...+-.- +.++...++.++..|+.-..+++ .-+|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v--~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSF--QIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEE--EEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred cCCcccce-EEEEcccEE--EEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 57888866 455556654 4444333323222211 45778899999999988776555 2367789999
Q ss_pred ceEEcCCCceEEccCCCc
Q 020078 187 QILFDEYNVAKLSDFSES 204 (331)
Q Consensus 187 Nill~~~~~~kl~Dfg~a 204 (331)
|++++.++.+++.--|+.
T Consensus 109 NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GEEECTTSCEEESCCEET
T ss_pred eEEEcCCCCEEEEEccCc
Confidence 999999999999977754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 331 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-36 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-34 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-33 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-32 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-32 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-32 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-31 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-31 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-30 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-30 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-29 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-28 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-28 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-27 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-25 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-24 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-23 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-23 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-22 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-21 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-20 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-20 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-16 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-16 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-15 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-13 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-13 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-41
Identities = 54/284 (19%), Positives = 108/284 (38%), Gaps = 26/284 (9%)
Query: 51 IATNNYNGHQVIASEHY-KLYKGFLENR-PISVMKFGDNYSENGENFCFNNIVFAAQMNH 108
I Q I S + +YKG + ++ + + F N + + H
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAF-KNEVGVLRKTRH 63
Query: 109 RNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMA 168
NIL +G ++ +V ++ E +L + + IA + M
Sbjct: 64 VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMD 118
Query: 169 YIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAP 228
Y+H + I+ +D+K + I E K+ DF + L+ + ++AP
Sbjct: 119 YLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 229 EYILT---GLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIV 282
E I + ++DV+ FG++L EL+TG+ + + + V L + +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV- 234
Query: 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+CP+ A+ +L+ EC+ + +RP + +
Sbjct: 235 --RSNCPK------AMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 63/284 (22%), Positives = 116/284 (40%), Gaps = 28/284 (9%)
Query: 51 IATNNYNGHQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHR 109
+ + + + + +++ G+ +K S + + F Q+ H+
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAF-LAEANLMKQLQHQ 68
Query: 110 NILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAY 169
+++L + I ++ E++E G+L D + +P G L L +A +I MA+
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLT---INKLLDMAAQIAEGMAF 124
Query: 170 IHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPE 229
I R + +D++ + IL + K++DF + I + E ++ APE
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPE 180
Query: 230 YILTGLCNEKTDVFCFGMLLLELLTGRR----DNILLEHVKKHVENNRLGEIVDPIVVED 285
I G K+DV+ FG+LL E++T R E ++ R+ V
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM--------VRP 232
Query: 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
+CPE+ L QL+ C E DRPT Y L + +
Sbjct: 233 DNCPEE------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-36
Identities = 58/263 (22%), Positives = 110/263 (41%), Gaps = 31/263 (11%)
Query: 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI-L 126
+ G ++V ++ + + F Q+ H N+++L+G +E + + +
Sbjct: 22 DVMLGDYRGNKVAVKCIKNDATA--QAF-LAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78
Query: 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
V E++ G+L D + L LK ++++ AM Y+ V +D+
Sbjct: 79 VTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAAR 132
Query: 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFG 246
+L E NVAK+SDF ++ + ++ APE + + K+DV+ FG
Sbjct: 133 NVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFSTKSDVWSFG 187
Query: 247 MLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIF 303
+LL E+ + R I L+ V VE + D CP A+ +++
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD-------GCPP------AVYEVMK 234
Query: 304 ECVNESAGDRPTMVYAAKQLRQM 326
C + A RP+ + +QL +
Sbjct: 235 NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 7e-36
Identities = 54/306 (17%), Positives = 109/306 (35%), Gaps = 39/306 (12%)
Query: 41 IRSFSAGELKIATNNYNGHQVIASEHYKL------------YKGFL-----ENRPISVMK 83
I F+ + A + + I K+ G L +++
Sbjct: 4 IDPFTFEDPNEAVREF--AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT 61
Query: 84 FGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSP 143
Y+E + Q +H N++ L G ++ +++ EF+E G+L +
Sbjct: 62 LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121
Query: 144 HGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203
G + + I M Y+ V +D+ IL + V K+SDF
Sbjct: 122 DGQF----TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 204 SEYIPEGETHVTSHMLT---RTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI 260
S ++ + + T R+ APE I +DV+ +G+++ E+++
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG---- 230
Query: 261 LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320
++ + ++++ + +D P AL QL+ +C + RP
Sbjct: 231 -----ERPYWDMTNQDVIN-AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 321 KQLRQM 326
L +M
Sbjct: 285 NTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-36
Identities = 56/275 (20%), Positives = 116/275 (42%), Gaps = 22/275 (8%)
Query: 54 NNYNGHQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNIL 112
+ Q I S + ++ G+ N+ +K + + E+F +++H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDF-IEEAEVMMKLSHPKLV 63
Query: 113 KLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI 172
+L G C+E LVFEF+E+G L+D + + G L + +++ MAY+
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF----AAETLLGMCLDVCEGMAYLE- 118
Query: 173 GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL 232
++ +D+ L E V K+SDF + ++ + + ++ ++ +PE
Sbjct: 119 --EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF-PVKWASPEVFS 175
Query: 233 TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLG-EIVDPIVVEDKSCPEK 291
+ K+DV+ FG+L+ E+ + + + VE+ G + P +
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP-----RLASTH 230
Query: 292 EQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ Q++ C E DRP +QL ++
Sbjct: 231 ------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 6e-35
Identities = 43/277 (15%), Positives = 104/277 (37%), Gaps = 26/277 (9%)
Query: 54 NNYNGHQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNIL 112
+ + + + + + G + +K S + + F ++H ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEF-IEEAKVMMNLSHEKLV 62
Query: 113 KLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI 172
+L G C + ++ E++ G L + + + L++ ++ AM Y+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLE- 117
Query: 173 GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL 232
+ + +D+ L ++ V K+SDF S Y+ + E + R+ PE ++
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF-PVRWSPPEVLM 174
Query: 233 TGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289
+ K+D++ FG+L+ E+ + + + +H+
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------PHLAS 227
Query: 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
EK + +++ C +E A +RPT + +
Sbjct: 228 EK------VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-34
Identities = 47/270 (17%), Positives = 103/270 (38%), Gaps = 29/270 (10%)
Query: 68 KLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123
+ +G + +++ + Q+++ I++LIG C +
Sbjct: 24 SVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL 83
Query: 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDI 183
+LV E G L + + + ++ ++ M Y+ + V +D+
Sbjct: 84 -MLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLE---EKNFVHRDL 135
Query: 184 KLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR-TKRYLAPEYILTGLCNEKTDV 242
+L + AK+SDF S+ + +++ T+ + ++ APE I + ++DV
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195
Query: 243 FCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALL 299
+ +G+ + E L+ + + V +E + E CP + L
Sbjct: 196 WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-------PPECPPE------LY 242
Query: 300 QLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
L+ +C DRP + +++R Y S
Sbjct: 243 ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 124 bits (311), Expect = 7e-34
Identities = 59/291 (20%), Positives = 119/291 (40%), Gaps = 26/291 (8%)
Query: 42 RSFSAGELKIATNNYNGHQVIASEHY-KLYKGFLENRPISV-MKFGDNYSENGENFCFNN 99
S + + ++ + + Y ++Y+G + ++V +K + E F
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-LKE 63
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
++ H N+++L+G C ++ EF+ YG L D + + + L +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVS---AVVLLYM 120
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
A +I +AM Y+ ++ + +D+ L E ++ K++DF S + +
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
Query: 220 TRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGE 276
++ APE + + K+DV+ FG+LL E+ T I L V + +E + E
Sbjct: 178 FPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ CPEK + +L+ C + DRP+ + M+
Sbjct: 237 R-------PEGCPEK------VYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-33
Identities = 31/212 (14%), Positives = 81/212 (38%), Gaps = 14/212 (6%)
Query: 49 LKIATNNYNGHQVIASEHY-KLYKGFLE--NRPISVMKFGDNYSENGENFCFNNIVFAAQ 105
+++ +++ + + + ++K + ++ N + +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 106 MNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
N I+ G + E ++ G+L + + + K+++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIK 115
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRY 225
+ Y+ + I+ +D+K S IL + KL DF S + + + T+ Y
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSY 169
Query: 226 LAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
++PE + + ++D++ G+ L+E+ GR
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-33
Identities = 62/306 (20%), Positives = 119/306 (38%), Gaps = 40/306 (13%)
Query: 48 ELKIATNNYNGHQVIASEHY-KLYKGFL-------ENRPISVMKFGDNYSENGENFCFNN 99
L+ NN + I + ++++ ++V + S + +
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICS----------------- 142
A+ ++ NI+KL+G C + L+FE++ YG L + + S
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 143 --PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSD 200
P PL +L IA ++ MAY+ R V +D+ L E V K++D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNI 260
F S I + + R++ PE I ++DV+ +G++L E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 261 LLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAA 320
++ + R G I+ ++CP + L L+ C ++ DRP+
Sbjct: 244 YGMAHEEVIYYVRDGNILAC----PENCPLE------LYNLMRLCWSKLPADRPSFCSIH 293
Query: 321 KQLRQM 326
+ L++M
Sbjct: 294 RILQRM 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-33
Identities = 49/289 (16%), Positives = 106/289 (36%), Gaps = 41/289 (14%)
Query: 68 KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI-- 125
++++G ++V F + E F I + H NIL I +
Sbjct: 18 EVWRGKWRGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75
Query: 126 --LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF-----RRPI 178
LV ++ E+G+L D + + + +K+A+ + +A++H+ + I
Sbjct: 76 LWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129
Query: 179 VFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRYLAPEYILTGL- 235
+D+K IL + ++D + + R TKRY+APE + +
Sbjct: 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 189
Query: 236 -----CNEKTDVFCFGMLLLELLTGR-------------RDNILLEHVKKHVENNRLGEI 277
++ D++ G++ E+ D + + + + +
Sbjct: 190 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 249
Query: 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ P + E L+ + +++ EC + R T + K L Q+
Sbjct: 250 LRPNIPNRWQSCE---ALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-33
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 26/291 (8%)
Query: 43 SFSAGELKIATNNYNGHQVIASEHY-KLYKGFLENRPISVMKFGDNYSENGENFCFNNIV 101
+ +I + + + +++ G +K + + E F
Sbjct: 6 GLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAF-LQEAQ 64
Query: 102 FAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
++ H +++L E I I V E++ G+L D + G +L + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAA 120
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR 221
+I + MAY+ R V +D++ + IL E V K++DF + I + E
Sbjct: 121 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF- 176
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIV 278
++ APE L G K+DV+ FG+LL EL T R ++ V VE
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC- 235
Query: 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329
CPE L L+ +C + +RPT Y L + S
Sbjct: 236 ------PPECPES------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 6e-33
Identities = 52/274 (18%), Positives = 101/274 (36%), Gaps = 33/274 (12%)
Query: 68 KLYKGFLENRP------ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET 121
+ KG+ + + + ++K N + Q+++ I+++IG C E
Sbjct: 22 TVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL-LAEANVMQQLDNPYIVRMIGIC-EA 79
Query: 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181
E +LV E E G L + + ++ +++ ++ M Y+ V +
Sbjct: 80 ESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE---ESNFVHR 131
Query: 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKT 240
D+ +L + AK+SDF S+ + E + ++ APE I + K+
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 241 DVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQA 297
DV+ FG+L+ E + + + V +E CP +
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-------PAGCPRE------ 238
Query: 298 LLQLIFECVNESAGDRPTMVYAAKQLRQMYLSAV 331
+ L+ C +RP +LR Y V
Sbjct: 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-32
Identities = 48/272 (17%), Positives = 108/272 (39%), Gaps = 33/272 (12%)
Query: 68 KLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE 122
+Y G L + +V + + +H N+L L+G C+ +E
Sbjct: 42 CVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE 101
Query: 123 -IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFK 181
P++V ++++G L + I + + + +++ M ++ + V +
Sbjct: 102 GSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLA---SKKFVHR 154
Query: 182 DIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTR--TKRYLAPEYILTGLCNEK 239
D+ + DE K++DF + + + E + +++A E + T K
Sbjct: 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214
Query: 240 TDVFCFGMLLLELLTGRR----DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQL 295
+DV+ FG+LL EL+T D + ++ RL ++ + CP+
Sbjct: 215 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--------LQPEYCPDP---- 262
Query: 296 QALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
L +++ +C + A RP+ ++ ++
Sbjct: 263 --LYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 50/253 (19%), Positives = 96/253 (37%), Gaps = 22/253 (8%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
+ +K + + ++HRN+++L G + + +V E G+L D
Sbjct: 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLD 99
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
R+ G L + A+++ M Y+ + + +D+ +L ++ K+
Sbjct: 100 RLRKHQGH----FLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKI 152
Query: 199 SDFSESEYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
DF +P+ + H V + APE + T + +D + FG+ L E+ T +
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 258 DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMV 317
+ +I+ I E + P E Q + ++ +C DRPT
Sbjct: 213 EPW---------IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF- 262
Query: 318 YAAKQLRQMYLSA 330
LR L A
Sbjct: 263 ---VALRDFLLEA 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-32
Identities = 54/285 (18%), Positives = 106/285 (37%), Gaps = 25/285 (8%)
Query: 50 KIATNNYNGHQVIASEHY-KLYKGFLEN------RPISVMKFGDNYSENGENFCFNNIVF 102
+I + +VI + + ++YKG L+ P+++ Y+E
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 103 AAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAME 162
Q +H NI++L G + + +++ E++E G L + G + +
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRG 118
Query: 163 IGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV-TSHMLTR 221
I M Y+ V +D+ IL + V K+SDF S + + T+
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 222 TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPI 281
R+ APE I +DV+ FG+++ E++T + ++
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----------A 225
Query: 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ + P A+ QL+ +C + RP L ++
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 3e-32
Identities = 44/270 (16%), Positives = 93/270 (34%), Gaps = 35/270 (12%)
Query: 76 NRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILVFEFVEYG 134
+ ++V + + + + Q+ +H NI+ L+G C + L+FE+ YG
Sbjct: 67 SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126
Query: 135 TLADRICSPHGPHLE------------------PLLWRHRLKIAMEIGNAMAYIHIGFRR 176
L + + S E L + L A ++ M ++ +
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FK 183
Query: 177 PIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC 236
V +D+ +L V K+ DF + I +V +++APE + G+
Sbjct: 184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
Query: 237 NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ 296
K+DV+ +G+LL E+ + + ++ + +
Sbjct: 244 TIKSDVWSYGILLWEIFSLGV---------NPYPGIPVDANFYKLIQNGFKMDQPFYATE 294
Query: 297 ALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ ++ C + RP+ L
Sbjct: 295 EIYIIMQSCWAFDSRKRPSF----PNLTSF 320
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-32
Identities = 39/233 (16%), Positives = 81/233 (34%), Gaps = 25/233 (10%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLE-------------PLLW 153
NH NI+ L+G C +++ E+ YG L + + + L
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213
L + ++ MA++ + + +D+ IL + K+ DF + I +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 214 VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNR 273
V +++APE I + ++DV+ +G+ L EL +
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS---------SPYPGMP 252
Query: 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ ++ E E + ++ C + RPT + + +
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 5e-32
Identities = 42/244 (17%), Positives = 87/244 (35%), Gaps = 23/244 (9%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE--IPILVFEFVEYGTL 136
+ +G + + + ++ H NI++ I+ +V E+ E G L
Sbjct: 34 WKELDYGSMTEAEKQML-VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 92
Query: 137 ADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIH--IGFRRPIVFKDIKLSQILFDEYN 194
A I + L L++ ++ A+ H ++ +D+K + + D
Sbjct: 93 ASVITK-GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151
Query: 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
KL DF + + + + + T Y++PE + NEK+D++ G LL EL
Sbjct: 152 NVKLGDFGLARILNHDTSFAKAFVGTP--YYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 209
Query: 255 GRR--DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD 312
+ + + + I + L ++I +N
Sbjct: 210 LMPPFTAFSQKELAGKIREGKFRRI-------PYRYSD------ELNEIITRMLNLKDYH 256
Query: 313 RPTM 316
RP++
Sbjct: 257 RPSV 260
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 7e-32
Identities = 52/290 (17%), Positives = 107/290 (36%), Gaps = 33/290 (11%)
Query: 54 NNYNGHQVIASEHY-KLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-N 107
N+ VI ++ ++ K + ++ + + S++ + ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 108 HRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEP-----------LLWRHR 156
H NI+ L+G C L E+ +G L D + +P L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 157 LKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTS 216
L A ++ M Y+ ++ + +D+ IL E VAK++DF S E +V
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 217 HMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE 276
M R++A E + + +DV+ +G+LL E+++ + E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 238
Query: 277 IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+ + + + L+ +C E +RP+ L +M
Sbjct: 239 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-31
Identities = 50/238 (21%), Positives = 87/238 (36%), Gaps = 24/238 (10%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
+ V+ E+ + + + H NIL+L G + L+ E+ GT+
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
+ + E+ NA++Y H + ++ +DIK +L K+
Sbjct: 96 ELQKLS-----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKI 147
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRD 258
+DF S + P L T YL PE I + +EK D++ G+L E L G+
Sbjct: 148 ADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP- 202
Query: 259 NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
E N E I + + P+ + LI + + RP +
Sbjct: 203 ---------PFEANTYQETYKRISRVEFTFPDFVT--EGARDLISRLLKHNPSQRPML 249
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 115 bits (290), Expect = 9e-31
Identities = 47/244 (19%), Positives = 84/244 (34%), Gaps = 33/244 (13%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
I M + S + F ++ H N ++ GC + LV E+
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
H +PL + +AY+H ++ +D+K IL E + KL
Sbjct: 105 LEV-----HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKL 156
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTG 255
DF + + + V T ++APE IL G + K DV+ G+ +EL
Sbjct: 157 GDFGSASIMAPANSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210
Query: 256 RR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD 312
+ + + + +N + ++ E + C+ + D
Sbjct: 211 KPPLFNMNAMSALYHIAQN-------ESPALQSGHWSE------YFRNFVDSCLQKIPQD 257
Query: 313 RPTM 316
RPT
Sbjct: 258 RPTS 261
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 51/267 (19%), Positives = 93/267 (34%), Gaps = 21/267 (7%)
Query: 54 NNYNGHQVIASEHY-KLYKGFLE--NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRN 110
+++ Q + Y ++ ++V + + I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 111 ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYI 170
++K G E I L E+ G L DRI G + + ++ + Y+
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 119
Query: 171 HIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEY 230
H I +DIK +L DE + K+SDF + + + T Y+APE
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 231 ILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCP 289
+ E DV+ G++L +L G + + + + K
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP---WKKID 233
Query: 290 EKEQQLQALLQLIFECVNESAGDRPTM 316
A L L+ + + E+ R T+
Sbjct: 234 S------APLALLHKILVENPSARITI 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-30
Identities = 49/258 (18%), Positives = 90/258 (34%), Gaps = 30/258 (11%)
Query: 68 KLYKGFLENRPISV-MKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126
K+YK + + K D SE I A +H NI+KL+ +
Sbjct: 27 KVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI 86
Query: 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
+ EF G + + PL + + +A+ Y+H I+ +D+K
Sbjct: 87 LIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAG 139
Query: 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC-----NEKTD 241
ILF KL+DF S S + T ++APE ++ + K D
Sbjct: 140 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP--YWMAPEVVMCETSKDRPYDYKAD 197
Query: 242 VFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQAL 298
V+ G+ L+E+ + + + K ++ P + +
Sbjct: 198 VWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP------PTLAQPSRWSS------NF 245
Query: 299 LQLIFECVNESAGDRPTM 316
+ +C+ ++ R T
Sbjct: 246 KDFLKKCLEKNVDARWTT 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-30
Identities = 53/282 (18%), Positives = 97/282 (34%), Gaps = 25/282 (8%)
Query: 51 IATNNYNGHQVIASEHY-KLYKGFL-----ENRPISVMKFGDNYSENGENFCFNNIVFAA 104
I + I + +++G +++ + S++ +
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
Q +H +I+KLIG E + I + E G L + L + A ++
Sbjct: 64 QFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVRKYS----LDLASLILYAYQLS 118
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
A+AY+ + V +DI +L + KL DF S Y+ + + S +
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIK 174
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284
++APE I +DV+ FG+ + E+L + GE +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---- 230
Query: 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
+CP L L+ +C RP QL +
Sbjct: 231 PPNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 3e-30
Identities = 42/255 (16%), Positives = 101/255 (39%), Gaps = 18/255 (7%)
Query: 72 GFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131
G P+++ + + S + A +++ ++ +L+G C+ + + ++ + +
Sbjct: 34 GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLM 92
Query: 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD 191
+G L D + ++ L ++I M Y+ R +V +D+ +L
Sbjct: 93 PFGCLLDYVREHKDNIG----SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVK 145
Query: 192 EYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLE 251
K++DF ++ + E + +++A E IL + ++DV+ +G+ + E
Sbjct: 146 TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 205
Query: 252 LLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAG 311
L+T K + EI I+ + + P+ + ++ +C A
Sbjct: 206 LMTFGS---------KPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMVKCWMIDAD 255
Query: 312 DRPTMVYAAKQLRQM 326
RP + +M
Sbjct: 256 SRPKFRELIIEFSKM 270
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 9e-30
Identities = 46/255 (18%), Positives = 101/255 (39%), Gaps = 30/255 (11%)
Query: 86 DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG 145
D ++ + + H+NI+ L+G C + ++ E+ G L + + +
Sbjct: 56 DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115
Query: 146 PHLE-----------PLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194
P LE L + + A ++ M Y+ + + +D+ +L E N
Sbjct: 116 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDN 172
Query: 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
V K++DF + I + + + +++APE + + ++DV+ FG+LL E+ T
Sbjct: 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
Query: 255 GRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAG 311
+ +E + K ++ + +C + L ++ +C +
Sbjct: 233 LGGSPYPGVPVEELFKLLKEGHRMDK-------PSNCTNE------LYMMMRDCWHAVPS 279
Query: 312 DRPTMVYAAKQLRQM 326
RPT + L ++
Sbjct: 280 QRPTFKQLVEDLDRI 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 36/238 (15%), Positives = 84/238 (35%), Gaps = 26/238 (10%)
Query: 82 MKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRIC 141
++ + + + N I+ + + NI+ + + + +V E++ G+L D +
Sbjct: 50 IRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109
Query: 142 SPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201
+ E A+ ++H ++ +DIK IL KL+DF
Sbjct: 110 ETCMD------EGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160
Query: 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---D 258
I ++ ++ + T ++APE + K D++ G++ +E++ G +
Sbjct: 161 GFCAQITPEQSKRSTMVGTP--YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 259 NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
L + N P + + + C++ R +
Sbjct: 219 ENPLRALYLIATNGT------PELQNPEKLSA------IFRDFLNRCLDMDVEKRGSA 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 53/295 (17%), Positives = 113/295 (38%), Gaps = 32/295 (10%)
Query: 48 ELKIATNNYNGHQVIASEHY-KLYKGFL-------ENRPISVMKFGDNYSENGENFCFNN 99
E ++A + + + +Y+G +++ + S N
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG-----PHLEPLLWR 154
+ N ++++L+G + + +++ E + G L + S P L P
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 155 HRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHV 214
+++A EI + MAY++ V +D+ + E K+ DF + I E + +
Sbjct: 134 KMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 215 TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVEN 271
R+++PE + G+ +DV+ FG++L E+ T + E V + V
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
Query: 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326
L + D +CP+ L +L+ C + RP+ + +++
Sbjct: 251 GGLLDKPD-------NCPDM------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 6e-29
Identities = 50/260 (19%), Positives = 103/260 (39%), Gaps = 25/260 (9%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI-LVFEFVEYGTLA 137
+ ++K G +SE+ + +H N++ L+G C + P+ ++ EF ++G L+
Sbjct: 48 VKMLKEGATHSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 106
Query: 138 DRICS-----------PHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLS 186
+ S P + + L H + + ++ M ++ R + +D+
Sbjct: 107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAAR 163
Query: 187 QILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFG 246
IL E NV K+ DF + I + +V +++APE I + ++DV+ FG
Sbjct: 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 223
Query: 247 MLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECV 306
+LL E+ + ++ E + E + + Q + +C
Sbjct: 224 VLLWEIFSLGA---------SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 274
Query: 307 NESAGDRPTMVYAAKQLRQM 326
+ RPT + L +
Sbjct: 275 HGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 109 bits (273), Expect = 5e-28
Identities = 36/208 (17%), Positives = 82/208 (39%), Gaps = 14/208 (6%)
Query: 54 NNYNGHQVIASEHY-KLYKGF-LENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI 111
++Y+ H+ + + + +++ KF E+ + I + + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 112 LKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIH 171
+ L + ++++EF+ G L +++ H + ++ ++ + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMH 141
Query: 172 IGFRRPIVFKDIKLSQILF--DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPE 229
V D+K I+F N KL DF + ++ ++ + T T + APE
Sbjct: 142 ---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPE 195
Query: 230 YILTGLCNEKTDVFCFGMLLLELLTGRR 257
TD++ G+L LL+G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 7e-28
Identities = 31/179 (17%), Positives = 72/179 (40%), Gaps = 8/179 (4%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
I +++ EN + ++++H +KL + E + + G L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
I + EI +A+ Y+H + I+ +D+K IL +E ++
Sbjct: 98 YIR-----KIGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 149
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+DF ++ + ++ T +Y++PE + + +D++ G ++ +L+ G
Sbjct: 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-27
Identities = 43/260 (16%), Positives = 88/260 (33%), Gaps = 34/260 (13%)
Query: 68 KLYKGFLE--NRPISVMKFGDNYSENGENFCFNN-IVFAAQMNHRNILKLIGCCIET--- 121
+YKG ++ + D E F + H NI++ T
Sbjct: 24 TVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 83
Query: 122 -EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVF 180
+ +LV E + GTL + + + +I + ++H PI+
Sbjct: 84 KKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIH 137
Query: 181 KDIKLSQILF-DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEK 239
+D+K I K+ D + + T ++APE +E
Sbjct: 138 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYEEKY-DES 192
Query: 240 TDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQ 296
DV+ FGM +LE+ T + + + V + D + + +
Sbjct: 193 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE----------- 241
Query: 297 ALLQLIFECVNESAGDRPTM 316
+ ++I C+ ++ +R ++
Sbjct: 242 -VKEIIEGCIRQNKDERYSI 260
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 102 bits (256), Expect = 1e-25
Identities = 46/238 (19%), Positives = 83/238 (34%), Gaps = 20/238 (8%)
Query: 81 VMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRI 140
V KF + + N I Q++H ++ L + +L+ EF+ G L DRI
Sbjct: 58 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI 117
Query: 141 CSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN--VAKL 198
+ + + + + ++H IV DIK I+ + K+
Sbjct: 118 AAEDY----KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKI 170
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRD 258
DF + + E + T T + APE + TD++ G+L LL+G
Sbjct: 171 IDFGLATKLNPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS- 226
Query: 259 NILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
E + ++N + + PE I + + R T+
Sbjct: 227 PFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE-------AKDFIKNLLQKEPRKRLTV 277
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 98.7 bits (245), Expect = 1e-24
Identities = 47/255 (18%), Positives = 101/255 (39%), Gaps = 30/255 (11%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETE----IPILVFEFVEYG 134
+ V++ + AA +NH I+ + +P +V E+V+
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 135 TLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194
TL D + P+ + +++ + A+ + H + I+ +D+K + I+ N
Sbjct: 97 TLRDIVH-----TEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATN 148
Query: 195 VAKLSDFSESEYIPEGETHVT-SHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELL 253
K+ DF + I + VT + + T +YL+PE + ++DV+ G +L E+L
Sbjct: 149 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208
Query: 254 TGRR---DNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESA 310
TG + + +HV + + P + L ++ + + ++
Sbjct: 209 TGEPPFTGDSPVSVAYQHVREDPI-----PPSARHEGLSA------DLDAVVLKALAKNP 257
Query: 311 GDRPTMVYAAKQLRQ 325
+R A ++R
Sbjct: 258 ENRYQ---TAAEMRA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 8e-24
Identities = 43/219 (19%), Positives = 80/219 (36%), Gaps = 20/219 (9%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
I HRNIL L E +++FEF+ + +RI + L R +
Sbjct: 52 ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSY 107
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--EYNVAKLSDFSESEYIPEGETHVTSH 217
++ A+ ++H I DI+ I++ + K+ +F ++ + G+
Sbjct: 108 VHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEI 277
Y APE + + TD++ G L+ LL+G L E ++ +EN E
Sbjct: 165 T---APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN-PFLAETNQQIIENIMNAEY 220
Query: 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+ E + + + + R T
Sbjct: 221 TFDEEAFKEISIE-------AMDFVDRLLVKERKSRMTA 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 3e-23
Identities = 48/230 (20%), Positives = 82/230 (35%), Gaps = 22/230 (9%)
Query: 93 ENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLL 152
E V + H + + E V E++ G L I S H
Sbjct: 47 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFD 101
Query: 153 WRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGET 212
A EI + ++H + IV++D+KL IL D+ K++DF + G+
Sbjct: 102 LSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158
Query: 213 HVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENN 272
+ T Y+APE +L N D + FG+LL E+L G+
Sbjct: 159 KTNTFC--GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS----------PFHGQ 206
Query: 273 RLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322
E+ I +++ P + + L+ + R + +Q
Sbjct: 207 DEEELFHSIRMDNPFYPRWLE--KEAKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 3e-23
Identities = 43/221 (19%), Positives = 81/221 (36%), Gaps = 26/221 (11%)
Query: 106 MNHRNILKLIGCC----IETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAM 161
+I++++ + ++V E ++ G L RI + R +I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMK 118
Query: 162 EIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---VAKLSDFSESEYIPEGETHVTSHM 218
IG A+ Y+H I +D+K +L+ + KL+DF ++ + T
Sbjct: 119 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR---DNILLEHVKKHVENNRLG 275
T Y+APE + ++ D++ G+++ LL G N L R+G
Sbjct: 176 ---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232
Query: 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+ P + E + LI + R T+
Sbjct: 233 QYEFPNPEWSEVSEE-------VKMLIRNLLKTEPTQRMTI 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 95.6 bits (237), Expect = 6e-23
Identities = 45/282 (15%), Positives = 100/282 (35%), Gaps = 31/282 (10%)
Query: 54 NNYNGHQVIASEHY-KLYKGFLENRP----ISVMKFGDNYSENGENFCFNNIVFAAQM-- 106
N+++ H++I + ++Y + + + + GE N + + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 107 -NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGN 165
+ I+ + + + + + G L + A EI
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIIL 118
Query: 166 AMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRY 225
+ ++H R +V++D+K + IL DE+ ++SD + + + H T Y
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGY 171
Query: 226 LAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284
+APE + G+ + D F G +L +LL G + KH + + +
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--- 228
Query: 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYA-AKQLRQ 325
S L L+ + R + A+++++
Sbjct: 229 PDSFSP------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 94.4 bits (234), Expect = 9e-23
Identities = 37/179 (20%), Positives = 77/179 (43%), Gaps = 13/179 (7%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
+ V+K + + + + H I+++ G + + ++ +++E G L
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
+ A E+ A+ Y+H + I+++D+K IL D+ K+
Sbjct: 94 LLRKSQRFP-----NPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 145
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+DF ++Y+P+ + Y+APE + T N+ D + FG+L+ E+L G
Sbjct: 146 TDFGFAKYVPDVTYTLCGT-----PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 92.8 bits (230), Expect = 3e-22
Identities = 43/244 (17%), Positives = 79/244 (32%), Gaps = 22/244 (9%)
Query: 76 NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGT 135
+ +++ E E N I ++ H NI+ L L+ + V G
Sbjct: 34 QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE 93
Query: 136 LADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNV 195
L DRI R ++ ++ +A+ Y+H K L DE +
Sbjct: 94 LFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSK 148
Query: 196 AKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG 255
+SDF S+ G T T Y+APE + ++ D + G++ LL G
Sbjct: 149 IMISDFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 205
Query: 256 R---RDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGD 312
D + ++ ++ + + + I + +
Sbjct: 206 YPPFYDENDAKLFEQILKAE-----YEFDSPYWDDISD------SAKDFIRHLMEKDPEK 254
Query: 313 RPTM 316
R T
Sbjct: 255 RFTC 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 91.4 bits (226), Expect = 8e-22
Identities = 38/244 (15%), Positives = 76/244 (31%), Gaps = 25/244 (10%)
Query: 97 FNNIVFAAQMNHRNILKLIG-CCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRH 155
M + I C E + ++V E + +
Sbjct: 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKT 104
Query: 156 RLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF---DEYNVAKLSDFSESEYIPEGET 212
L +A ++ + + YIH + + +D+K L + N+ + DF ++ + T
Sbjct: 105 VLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161
Query: 213 HVTSHMLTR-----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR--DNILLEHV 265
H T RY + L + + D+ G +L+ G +
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 266 KKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325
++ E ++ PI V K P + C + D+P Y + R
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPS------EFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
Query: 326 MYLS 329
++
Sbjct: 276 LFHR 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 90.1 bits (223), Expect = 2e-21
Identities = 46/219 (21%), Positives = 79/219 (36%), Gaps = 31/219 (14%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
H NI++L LVF+ ++ G L D + L + KI +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEV 122
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYL 226
+ +H + IV +D+K IL D+ KL+DF S + GE + T YL
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGTPSYL 176
Query: 227 APEYILTGLC------NEKTDVFCFGMLLLELLTGR---RDNILLEHVKKHVENNRLGEI 277
APE I + ++ D++ G+++ LL G + ++ + N
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY---- 232
Query: 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
PE + + L+ + R T
Sbjct: 233 -------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 5e-21
Identities = 42/242 (17%), Positives = 78/242 (32%), Gaps = 23/242 (9%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
I + + + ++ H N++ L IL+ E V G L D
Sbjct: 43 IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA-- 196
+ E L + +I N + Y+H I D+K I+ + NV
Sbjct: 103 FLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 154
Query: 197 --KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT 254
K+ DF + I G + T ++APE + + D++ G++ LL+
Sbjct: 155 RIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 255 GRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP 314
G L + ++ + N + I + + R
Sbjct: 212 GAS-PFLGDTKQETLANVSAVNYEFEDEYFSNTSAL-------AKDFIRRLLVKDPKKRM 263
Query: 315 TM 316
T+
Sbjct: 264 TI 265
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 4e-20
Identities = 37/176 (21%), Positives = 66/176 (37%), Gaps = 11/176 (6%)
Query: 82 MKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRIC 141
+ + I +++H NI+ L+ LVF+F+E
Sbjct: 33 LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD 92
Query: 142 SPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201
+ H + + Y+H + I+ +D+K + +L DE V KL+DF
Sbjct: 93 NSLVLT-----PSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 144
Query: 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGR 256
++ T ++TR Y APE + + D++ G +L ELL
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRW--YRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 86.0 bits (212), Expect = 6e-20
Identities = 33/233 (14%), Positives = 68/233 (29%), Gaps = 26/233 (11%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
I + E +LV + + + A ++
Sbjct: 59 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLAR 113
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEY-----NVAKLSDFSESEYIPEGETHVTSHMLTR 221
+ IH + +V++DIK L N+ + DF ++ + T +
Sbjct: 114 VQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 222 -----TKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGE 276
T RY++ L + + D+ G + + L G L+ + R+GE
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230
Query: 277 IVDPIVVED--KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327
+ + PE + + N + P Y ++
Sbjct: 231 KKQSTPLRELCAGFPE------EFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 8e-19
Identities = 36/213 (16%), Positives = 76/213 (35%), Gaps = 15/213 (7%)
Query: 50 KIATNNYNGHQVIASEHY-KLYKGFLENRP----ISVMKFGDNYSENGENFCFNNIVFAA 104
K+ N+++ +++ + K+ + + +++ +++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
H + L + V E+ G L + EI
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIV 115
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKR 224
+A+ Y+H R +V++DIKL ++ D+ K++DF + T T
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPE 170
Query: 225 YLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
YLAPE + D + G+++ E++ GR
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 9e-19
Identities = 40/166 (24%), Positives = 68/166 (40%), Gaps = 16/166 (9%)
Query: 100 IVFAAQMNHRNILKLIGCCIETEIP------ILVFEFVEYGTLADRICSPHGPHLEPLLW 153
+ +++H NI++L + LV ++V R+ + + L
Sbjct: 64 LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPV 121
Query: 154 RHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGET 212
+ ++ ++AYIH I +DIK +L D + V KL DF ++ + GE
Sbjct: 122 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 213 HVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRR 257
+V+ Y APE I DV+ G +L ELL G+
Sbjct: 179 NVSYICSRY---YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.8 bits (201), Expect = 2e-18
Identities = 36/233 (15%), Positives = 73/233 (31%), Gaps = 30/233 (12%)
Query: 104 AQMNHRNILKLIGCCIETEIP-----ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLK 158
H N+++L C + LVFE V+ P +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKD 120
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHM 218
+ ++ + ++H +V +D+K IL KL+DF +
Sbjct: 121 MMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TS 174
Query: 219 LTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR------DNILLEHVKKHVENN 272
+ T Y APE +L D++ G + E+ + D L + +
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234
Query: 273 RLGEIVDPIVVEDKSCPEKEQQL---------QALLQLIFECVNESAGDRPTM 316
+ + + ++ K Q + L+ +C+ + R +
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 9e-18
Identities = 36/173 (20%), Positives = 65/173 (37%), Gaps = 10/173 (5%)
Query: 86 DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG 145
D +E + I ++NH NI+KL+ LVFEF+ S
Sbjct: 38 DTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT 97
Query: 146 PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205
+ ++ +A+ H ++ +D+K +L + KL+DF +
Sbjct: 98 G----IPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150
Query: 206 YIPEGETHVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRR 257
T ++T Y APE +L + D++ G + E++T R
Sbjct: 151 AFGVPVRTYTHEVVTL--WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 3e-17
Identities = 39/214 (18%), Positives = 68/214 (31%), Gaps = 31/214 (14%)
Query: 105 QMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIG 164
+++L+ + +L+ E E + G L ++
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVL 120
Query: 165 NAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGETHVTSHMLTRTK 223
A+ + H ++ +DIK IL D KL DF + + T+
Sbjct: 121 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 173
Query: 224 RYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIV 282
Y PE+I V+ G+LL +++ G E++ EI+ V
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI----------PFEHDE--EIIRGQV 221
Query: 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTM 316
+ LI C+ DRPT
Sbjct: 222 FFRQRVSS------ECQHLIRWCLALRPSDRPTF 249
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 4e-17
Identities = 38/219 (17%), Positives = 71/219 (32%), Gaps = 18/219 (8%)
Query: 47 GELKIATNNYNGHQVIASEHY-KLYKGFLE--NRPISVMKFGDNYSENGENFCFNNIVFA 103
G++ Y I Y + + +++ K + I
Sbjct: 1 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60
Query: 104 AQMNHRNILKLIGCC----IETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKI 159
+ H NI+ + IE + + + L + + L H
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYF 114
Query: 160 AMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHML 219
+I + YIH ++ +D+K S +L + K+ DF + H
Sbjct: 115 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 220 TRTKR-YLAPEYILTGLC-NEKTDVFCFGMLLLELLTGR 256
R Y APE +L + D++ G +L E+L+ R
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 75.3 bits (184), Expect = 4e-16
Identities = 39/207 (18%), Positives = 75/207 (36%), Gaps = 14/207 (6%)
Query: 54 NNYNGHQVIASEHY-KLYKGFLENRPISVMKF--GDNYSENGENFCFNNIVFAAQMNHRN 110
Y+G + I Y +YK +K + E + I ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 111 ILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYI 170
I+KL + +LVFE ++ L +++ N +AY
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYC 116
Query: 171 HIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEY 230
H R ++ +D+K +L + K++DF + G T Y AP+
Sbjct: 117 H---DRRVLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDV 171
Query: 231 IL-TGLCNEKTDVFCFGMLLLELLTGR 256
++ + + D++ G + E++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 8e-16
Identities = 36/183 (19%), Positives = 62/183 (33%), Gaps = 19/183 (10%)
Query: 86 DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI--------LVFEFVEYGTLA 137
+N E I + H N++ LI C P LVF+F E+
Sbjct: 46 ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG 105
Query: 138 DRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197
L ++ + N + + R I+ +D+K + +L V K
Sbjct: 106 LLSN-----VLVKFTLSEIKRVMQMLLNGL---YYIHRNKILHRDMKAANVLITRDGVLK 157
Query: 198 LSDFSESEYIPEGETHVTSHMLTR--TKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLT 254
L+DF + + + R T Y PE +L D++ G ++ E+ T
Sbjct: 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217
Query: 255 GRR 257
Sbjct: 218 RSP 220
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 74.8 bits (183), Expect = 9e-16
Identities = 31/179 (17%), Positives = 65/179 (36%), Gaps = 13/179 (7%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
+ ++ N +N ++KL + +V E+V G +
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
+ + H A +I Y+H ++++D+K +L D+ ++
Sbjct: 131 HLR-----RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
+DF ++ + + LAPE IL+ N+ D + G+L+ E+ G
Sbjct: 183 TDFGFAKRVKGRTWTLCGTP-----EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 1e-15
Identities = 27/172 (15%), Positives = 57/172 (33%), Gaps = 9/172 (5%)
Query: 86 DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG 145
D+ E + I ++ H+NI++L + LVFEF +
Sbjct: 38 DDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD 97
Query: 146 PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205
++ + + H R ++ +D+K +L + KL++F +
Sbjct: 98 LD-----PEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
Query: 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR 257
++ ++T L + D++ G + EL R
Sbjct: 150 AFGIPVRCYSAEVVTLW-YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 67.9 bits (165), Expect = 2e-13
Identities = 29/161 (18%), Positives = 62/161 (38%), Gaps = 18/161 (11%)
Query: 101 VFAAQMNHRNILKLIGCCIE--TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLK 158
+ NI+ L + + P LVFE V + L
Sbjct: 82 ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ--------LYQTLTDYDIRF 133
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD-EYNVAKLSDFSESEYIPEGETHVTSH 217
EI A+ Y H I+ +D+K ++ D E+ +L D+ +E+ G+ + +
Sbjct: 134 YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---N 187
Query: 218 MLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRR 257
+ ++ + PE ++ + + D++ G +L ++ +
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 3e-13
Identities = 44/222 (19%), Positives = 78/222 (35%), Gaps = 20/222 (9%)
Query: 107 NHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNA 166
++ L L+ +++ G L + EI A
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLA 141
Query: 167 MAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYL 226
+ ++H + I+++DIKL IL D L+DF S+ ET Y+
Sbjct: 142 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI-EYM 197
Query: 227 APEYILTGL--CNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVE 284
AP+ + G ++ D + G+L+ ELLTG E N EI I+
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS------PFTVDGEKNSQAEISRRILKS 251
Query: 285 DKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYA-AKQLRQ 325
+ P++ LI + + R A ++++
Sbjct: 252 EPPYPQEMS--ALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 3e-13
Identities = 35/172 (20%), Positives = 68/172 (39%), Gaps = 10/172 (5%)
Query: 86 DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHG 145
SE + + M H N++ L+ E +F
Sbjct: 54 PFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM 113
Query: 146 PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205
H E L + ++ + YIH I+ +D+K + +E K+ DF +
Sbjct: 114 KH-EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 169
Query: 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGR 256
+ ++ +T +++TR Y APE IL + + D++ G ++ E++TG+
Sbjct: 170 ---QADSEMTGYVVTR--WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 64.3 bits (155), Expect = 3e-12
Identities = 27/159 (16%), Positives = 55/159 (34%), Gaps = 3/159 (1%)
Query: 99 NIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLK 158
+ M +ILKL+ + V + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 159 IAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEYIPEGETHVTSH 217
I+ ++ + Y+H R I+ DIK +L + + L ++
Sbjct: 130 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 218 MLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
+T+ Y +PE +L D++ L+ EL+TG
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.0 bits (139), Expect = 4e-10
Identities = 35/179 (19%), Positives = 66/179 (36%), Gaps = 11/179 (6%)
Query: 79 ISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEYGTLAD 138
+ + + + + + M H N++ L+ + L
Sbjct: 48 VKKLSRPFQSIIHAKRT-YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG 106
Query: 139 RICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKL 198
+ + + L H + +I + YIH I+ +D+K S + +E K+
Sbjct: 107 ADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162
Query: 199 SDFSESEYIPEGETHVTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGR 256
DF + + T T+ Y APE +L N+ D++ G ++ ELLTGR
Sbjct: 163 LDFGLARH-----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (131), Expect = 4e-09
Identities = 30/177 (16%), Positives = 61/177 (34%), Gaps = 20/177 (11%)
Query: 86 DNYSENGENFCFNNIVFAAQMNHRNILKLIGCCI------ETEIPILVFEFVEYGTLADR 139
++ + +V +NH+NI+ L+ E + LV E ++
Sbjct: 53 PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 112
Query: 140 ICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199
+ ++ + ++H I+ +D+K S I+ K+
Sbjct: 113 QMELD--------HERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR 256
DF + T+ Y APE IL E D++ G ++ E++ +
Sbjct: 162 DFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.28 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.37 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.62 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-58 Score=403.98 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=204.3
Q ss_pred hcCccccCceee-cCcEEEEEEeCCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.++|...+.||+ +||+||+|++.+ .||||.+... ......+.|.+|+.+|.+++|||||+++|++.+ +..++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 467888999999 999999998765 5999998754 333467889999999999999999999999865 467999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++.... ..+++..+..++.||++||.||| +++||||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 85 CEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999997643 45899999999999999999999 899999999999999999999999999999877554
Q ss_pred CccccccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhH---HHHHHHhhccccccccccccc-
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILL---EHVKKHVENNRLGEIVDPIVV- 283 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~- 283 (331)
..........||+.|+|||++.. +.|+.++|||||||++|||++|+.||... ............ .+...
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~----~p~~~~ 233 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL----SPDLSK 233 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC----CCCGGG
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC----CCcchh
Confidence 43333344569999999999864 45899999999999999999999998432 222222222211 11111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+. .+++++.+|+.+||+.||++||||.|+++.|+.+..+
T Consensus 234 ~~~------~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 234 VRS------NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp SCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccc------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111 2334799999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-58 Score=402.69 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=200.8
Q ss_pred cCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
++|...+.||+ +||.||+|++ ++..||||++..... ..+.|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46788889999 9999999999 678899999876433 3578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999987643 46889999999999999999999 8999999999999999999999999999998775543
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCC-CCChh--HHHHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-RDNIL--LEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~-~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.... ....||+.|+|||++..+.|+.++|||||||++|||+++. +|+.. ............. ...+.
T Consensus 156 ~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~-------~~~p~-- 225 (263)
T d1sm2a_ 156 YTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------LYKPR-- 225 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-------CCCCT--
T ss_pred ceee-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-------CCCcc--
Confidence 3222 2235899999999999999999999999999999999954 44421 1122222222111 01111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
..++++.+|+.+||+.||++||||+|+++.|+++.++|
T Consensus 226 ----~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~esg 263 (263)
T d1sm2a_ 226 ----LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263 (263)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhCC
Confidence 22347999999999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-57 Score=405.55 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=197.7
Q ss_pred CccccCceee-cCcEEEEEEe--CCc---eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENR---PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~---~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
.|...++||+ +||+||+|.+ +++ .||||.+.........+.|.+|+.+|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 3455678999 9999999998 332 588999877666656788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|.+++.... ..+++.+++.++.||++||.||| +.+|+||||||+|||++.++++||+|||+++.+.
T Consensus 107 Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp ECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999887643 46899999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCccc---cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhcccccccccccc
Q 020078 209 EGETHV---TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 209 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 282 (331)
...... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||.... .....+..+.. .
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-------~ 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-------L 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------C
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-------C
Confidence 543221 1112347899999999999999999999999999999998 899984322 22222221111 1
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
..+. ..++++.+|+.+||+.||++||||.|+++.|+++..
T Consensus 253 ~~~~------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 PPPM------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCT------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCc------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1112 334579999999999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=398.60 Aligned_cols=248 Identities=20% Similarity=0.221 Sum_probs=202.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
++|...+.||+ +||+||+|+. +++.||+|.+.........+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 56888999999 9999999998 68999999997654444567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++... ..+++.++..++.||++||.||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 ~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999754 46999999999999999999999 899999999999999999999999999999987554
Q ss_pred CccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhccccccccccccccCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 286 (331)
.........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~------------ 224 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------------ 224 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT------------
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC------------
Confidence 43333344569999999999988776 57899999999999999999998332111 111111000
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111134567999999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=400.33 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=208.1
Q ss_pred HhcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
..++|...+.||+ +||.||+|.+ ++..||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 3467888899999 9999999999 567899999975433 45789999999999999999999998865 56789999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+++|+|.+++....+ .++++..++.++.||++||.||| +.+|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 88 y~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccC
Confidence 9999999998765321 35899999999999999999999 89999999999999999999999999999998765
Q ss_pred CCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh---HHHHHHHhhccccccccccccccCC
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL---LEHVKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
....... ...||+.|+|||++..+.++.++|||||||++|||+||..|+.. ............. + ..+.
T Consensus 162 ~~~~~~~-~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-----~--~~p~ 233 (272)
T d1qpca_ 162 NEYTARE-GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-----M--VRPD 233 (272)
T ss_dssp SCEECCT-TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----C--CCCT
T ss_pred Ccccccc-ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----C--CCcc
Confidence 5433222 23489999999999999999999999999999999997655422 1112222221111 0 1111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
.+++++.+|+.+||+.||++||||+|+++.|+.+..++
T Consensus 234 ------~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 23347999999999999999999999999999988763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.8e-58 Score=405.21 Aligned_cols=259 Identities=19% Similarity=0.321 Sum_probs=212.7
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCcc
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIP 124 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~ 124 (331)
+++...++|...+.||+ +||+||+|++ +++.||||++..... ..+.|.+|+.+|++++|||||+++|+|.+++..
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 34444567888899999 9999999998 688999999875433 467899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
++|||||++|+|.+++..... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred EEEeecccCcchHHHhhhccc---cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccce
Confidence 999999999999999865432 46899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh---HHHHHHHhhccccccccccc
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL---LEHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~ 281 (331)
+............ ..||+.|+|||++.++.|+.++|||||||++|||++|..|+.. .............
T Consensus 163 ~~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~------- 234 (287)
T d1opja_ 163 RLMTGDTYTAHAG-AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------- 234 (287)
T ss_dssp TTCCSSSSEEETT-EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC-------
T ss_pred eecCCCCceeecc-ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC-------
Confidence 9876544333222 3378999999999999999999999999999999997776522 2222222222111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+. .+++++.+|+.+||+.||++|||+.|+++.|+.+.+
T Consensus 235 ~~~~~------~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 235 MERPE------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCc------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11111 334579999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=394.21 Aligned_cols=254 Identities=18% Similarity=0.306 Sum_probs=208.0
Q ss_pred cCccccCc-eee-cCcEEEEEEe----CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQV-IAS-EHYKLYKGFL----ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~-ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|....+ ||+ +||.||+|.+ ++..||||.+.........+.|.+|+.+|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45555564 999 9999999976 3447999999876665567889999999999999999999999965 467899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||||++|+|.+++.... ..+++.++..++.|+++||.||| +++|+||||||+|||++.++.+||+|||+++.+
T Consensus 87 mE~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 99999999999886543 46899999999999999999999 899999999999999999999999999999987
Q ss_pred CCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 208 PEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 208 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
....... ......||+.|+|||++..+.++.++|||||||++|||+| |+.||.... .....+..+... .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-------~ 232 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------E 232 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC-------C
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------C
Confidence 6544322 2233458999999999999999999999999999999998 899984322 222222222111 1
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+. .+++++.+|+.+||+.||++||||.+|++.|+.++.
T Consensus 233 ~p~------~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 CPP------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp CCT------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC------cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111 334579999999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=392.48 Aligned_cols=256 Identities=21% Similarity=0.319 Sum_probs=202.8
Q ss_pred hcCccccCceee-cCcEEEEEEeC--C----ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE--N----RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
.+.|+..++||+ +||.||+|.+. + ..||||++...........|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 356888999999 99999999882 2 3699999987666656678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+|||||.+|++.+.+.... ..+++.++..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhh
Confidence 9999999999998886543 46899999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh---HHHHHHHhhccccccccccc
Q 020078 206 YIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL---LEHVKKHVENNRLGEIVDPI 281 (331)
Q Consensus 206 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~ 281 (331)
......... ......||+.|+|||++.++.++.++|||||||++|||++|..|+.. .......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------- 231 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR------- 231 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-------
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-------
Confidence 775543221 22224589999999999999999999999999999999997665422 2222222222111
Q ss_pred cccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 282 VVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
...+. ..+.++.+|+.+||+.||++||||.||++.|+++..
T Consensus 232 ~~~~~------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 LPTPM------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCCCT------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCch------hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 233479999999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=390.61 Aligned_cols=242 Identities=19% Similarity=0.288 Sum_probs=203.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+|+. +++.||+|.+.+.. .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888899999 9999999998 68899999986432 1224567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999754 46899999999999999999999 8999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 286 (331)
..... ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... ........ .+
T Consensus 158 ~~~~~----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------~~ 221 (263)
T d2j4za1 158 SSRRT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------EF 221 (263)
T ss_dssp CCCCE----ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------CC
T ss_pred CCccc----ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------CC
Confidence 44322 24599999999999999999999999999999999999999853322 11111111 11
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~p~--~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPD--FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1111 23457999999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=390.55 Aligned_cols=244 Identities=16% Similarity=0.285 Sum_probs=204.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||+ +||+||+|+. +++.||+|++...... ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 46999999999 9999999997 7899999998755433 467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++.. ..+++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 99 ~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred cCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 999999998864 35899999999999999999999 899999999999999999999999999999877544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---HhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 287 (331)
... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ...... +.
T Consensus 170 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~------------~~ 235 (293)
T d1yhwa1 170 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT------------PE 235 (293)
T ss_dssp TCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS------------CC
T ss_pred ccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC------------CC
Confidence 322 2234599999999999999999999999999999999999999843322221 111111 01
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111134567999999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=389.30 Aligned_cols=248 Identities=20% Similarity=0.307 Sum_probs=200.0
Q ss_pred Cceee-cCcEEEEEEe----CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEecCC
Q 020078 60 QVIAS-EHYKLYKGFL----ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFVEY 133 (331)
Q Consensus 60 ~~ig~-~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 133 (331)
+.||+ +||+||+|.+ .++.||||++..... ....+.|.+|+.+|++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999 9999999986 236799999975432 3346789999999999999999999999965 457899999999
Q ss_pred CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCCcc
Q 020078 134 GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGETH 213 (331)
Q Consensus 134 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 213 (331)
|+|.+++... ..+++.+++.++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++.+......
T Consensus 92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999998764 46999999999999999999999 899999999999999999999999999999877554433
Q ss_pred c-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHHHHHhhccccccccccccccCCCCc
Q 020078 214 V-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHVKKHVENNRLGEIVDPIVVEDKSCP 289 (331)
Q Consensus 214 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (331)
. ......||+.|+|||++.++.++.++|||||||++|||++ |+.||... ......+..+.. ...+.
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~-------~~~p~--- 233 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER-------MGCPA--- 233 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------CCCCT---
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC-------CCCCc---
Confidence 2 2233458999999999999999999999999999999998 89998432 222222222211 11111
Q ss_pred hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 290 EKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 290 ~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+++++.+|+.+||+.||++|||+.+|++.|+.++.+
T Consensus 234 ---~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 234 ---GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ---TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 2345799999999999999999999999999887643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=399.14 Aligned_cols=257 Identities=20% Similarity=0.327 Sum_probs=205.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CC-----ceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--EN-----RPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~ 123 (331)
.++|...+.||+ +||+||+|++ .+ ..||+|.+...........+.+|+.++.++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 357888899999 9999999987 22 269999987665555677899999999998 89999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGP------------------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~ 185 (331)
.++|||||++|+|.+++...... ....+++..++.++.||++||.||| +.+|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence 99999999999999999764321 1135889999999999999999999 89999999999
Q ss_pred CceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--
Q 020078 186 SQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL-- 262 (331)
Q Consensus 186 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~-- 262 (331)
+|||++.++.+||+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||++ |+.||...
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987755544333333458999999999999999999999999999999998 89998432
Q ss_pred -HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 263 -EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
............ ...+. ..++++.+|+.+||+.||++||||+||++.|..
T Consensus 273 ~~~~~~~~~~~~~-------~~~p~------~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DANFYKLIQNGFK-------MDQPF------YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHHHHHHHHTTCC-------CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCC-------CCCCC------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 222222222111 11111 234579999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=382.49 Aligned_cols=249 Identities=16% Similarity=0.329 Sum_probs=207.6
Q ss_pred cCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
++|...+.||+ +||+||+|++ ++..||||.+..... ..+.|.+|+.++++++|||||+++|+|.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57888899999 9999999999 667899999876543 3578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++.... ..+++..++.++.|+++||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 82 ANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999976653 46889999999999999999999 8999999999999999999999999999998765543
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.... ....||+.|+|||.+.+..++.++||||||+++|||+| |+.||.... .....+..... ...+.
T Consensus 155 ~~~~-~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~-------~~~p~-- 224 (258)
T d1k2pa_ 155 YTSS-VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------LYRPH-- 224 (258)
T ss_dssp CCCC-CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC-------CCCCT--
T ss_pred ceee-cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC-------CCCcc--
Confidence 3222 22448999999999999999999999999999999998 788884322 22222222111 11111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQ 325 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~ 325 (331)
..++++.+|+.+||+.||++||||.|+++.|..
T Consensus 225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 233479999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=389.26 Aligned_cols=247 Identities=17% Similarity=0.223 Sum_probs=202.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||+ +||+||+|+. ++..||+|++..... ...+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS-GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 46888889999 9999999998 788999999876533 3678899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
|++|+|.+++.... .++++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 91 ~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 91 CAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 99999999876533 46899999999999999999999 899999999999999999999999999999765322
Q ss_pred CccccccccCCCCcccchhhhc-----cCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccc
Q 020078 211 ETHVTSHMLTRTKRYLAPEYIL-----TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVV 283 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 283 (331)
. .......||+.|+|||++. ...|+.++|||||||++|||++|+.||....... ........
T Consensus 164 ~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~--------- 232 (288)
T d2jfla1 164 I--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--------- 232 (288)
T ss_dssp H--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC---------
T ss_pred c--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------
Confidence 1 1222356999999999984 4568999999999999999999999984322111 11111110
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+..+.+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 --PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111244568999999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=392.94 Aligned_cols=246 Identities=15% Similarity=0.205 Sum_probs=202.1
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||+||+|+. +++.||||.+.... .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999 9999999998 68899999986432 1224567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+|+.+.
T Consensus 88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence 999999999988754 46899999999999999999999 8999999999999999999999999999999876
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 286 (331)
............||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... ..... ...
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------------~~~ 227 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------------LEY 227 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT------------TCC
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc------------CCC
Confidence 5443333334569999999999999999999999999999999999999985332211 11111 111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..|. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1111 34457999999999999999999999754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=397.38 Aligned_cols=262 Identities=15% Similarity=0.218 Sum_probs=206.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..++|...+.||+ +||+||+|+. +++.||+|++.........+.+.+|+.+|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999 9999999998 689999999976655556778999999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRR-PIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
|||++|+|.+++... ..+++..+..++.|++.||.||| +. +|+||||||+|||++.++.+||+|||+|+..
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 999999999999754 35899999999999999999999 64 8999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHh---hccccc-------
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHV---ENNRLG------- 275 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~---~~~~~~------- 275 (331)
.... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... ... ......
T Consensus 156 ~~~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (322)
T d1s9ja_ 156 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231 (322)
T ss_dssp HHHT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred CCCc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence 4322 123569999999999999999999999999999999999999983211000 000 000000
Q ss_pred --------------------cccccccccC-CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHH
Q 020078 276 --------------------EIVDPIVVED-KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK--QLRQM 326 (331)
Q Consensus 276 --------------------~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~--~L~~~ 326 (331)
+..+...... +..+. ...+.++.+|+.+||+.||++||||.|+++ .+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS-GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------------CCCCHHHHHHHHHTSCCCCCCB-TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccchhHHHHHhhhhccCCccCcc-ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000000000 00111 023457999999999999999999999987 35443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=388.78 Aligned_cols=252 Identities=17% Similarity=0.241 Sum_probs=191.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee--CCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE--TEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--~~~~~lv 127 (331)
++|+..+.||+ +||+||+|+. +++.||+|.+.... .+...+.+.+|+.++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888999999 9999999998 68899999997653 33346778999999999999999999999975 4567999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGF--RRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
||||++|+|.+++...... ...+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999988642111 146899999999999999999999421 2359999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
.+...... .....||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ............ +
T Consensus 163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-----~- 234 (269)
T d2java1 163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-----I- 234 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-----C-
T ss_pred ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-----C-
Confidence 87544322 2234599999999999999999999999999999999999999843222 222222221111 0
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 235 -~~------~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -PY------RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Cc------ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 23457999999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=386.02 Aligned_cols=249 Identities=19% Similarity=0.220 Sum_probs=189.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
+.+.|...+.||+ +||+||+|+. +++.||||.+...........+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3466899999999 9999999998 688999999976654444567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc---CCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD---EYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a~ 205 (331)
|||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||+. .++.+||+|||+|+
T Consensus 87 E~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred eccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999764 46999999999999999999999 89999999999999994 57899999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 283 (331)
........ ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... ..........
T Consensus 159 ~~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--------- 226 (307)
T d1a06a_ 159 MEDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--------- 226 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC---------
T ss_pred EccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC---------
Confidence 76544322 224599999999999999999999999999999999999999843221 1111211111
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111111134567999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-55 Score=388.72 Aligned_cols=242 Identities=19% Similarity=0.288 Sum_probs=198.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
..|+..+.||+ +||+||+|+. +++.||||++...... ...+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34888899999 9999999997 7889999998765432 23567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|..++... .++++.++..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 999999987666543 46899999999999999999999 8999999999999999999999999999998654
Q ss_pred CCCccccccccCCCCcccchhhhcc---CCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHh--hccccccccccccc
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILT---GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHV--ENNRLGEIVDPIVV 283 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~ 283 (331)
... ...||+.|+|||++.+ +.|+.++|||||||++|||++|..||.......... ....... ..
T Consensus 167 ~~~------~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~-----~~ 235 (309)
T d1u5ra_ 167 PAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-----LQ 235 (309)
T ss_dssp SBC------CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----CS
T ss_pred CCC------ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC-----CC
Confidence 332 2459999999999863 468999999999999999999999984332222111 1111100 00
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 236 -~~------~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 -SG------HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CT------TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CC------CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 23457999999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=378.89 Aligned_cols=240 Identities=17% Similarity=0.251 Sum_probs=193.0
Q ss_pred cccCceee-cCcEEEEEEe--CCceEEEEEeCCCC-CcchhHHHHHHHHHHHhcCCCceeeeEeEEee----CCccEEEE
Q 020078 57 NGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY-SENGENFCFNNIVFAAQMNHRNILKLIGCCIE----TEIPILVF 128 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~ 128 (331)
.....||+ +||+||+|++ ++..||+|.+.... .....+.+.+|+.+|++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999 9999999998 67899999987643 33456789999999999999999999999876 34578999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeCCCCCCceEEc-CCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRP--IVFKDIKLSQILFD-EYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivHrdlk~~Nill~-~~~~~kl~Dfg~a~ 205 (331)
|||++|+|.+++... ..+++..+..++.||++||.||| +.+ |+||||||+|||++ .++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 999999999999754 46899999999999999999999 776 99999999999996 57899999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH---HHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH---VKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 282 (331)
....... ....||+.|+|||++. +.++.++|||||||++|||++|+.||..... ...........
T Consensus 164 ~~~~~~~----~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~------- 231 (270)
T d1t4ha_ 164 LKRASFA----KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------- 231 (270)
T ss_dssp GCCTTSB----EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------
T ss_pred eccCCcc----CCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-------
Confidence 6543322 2346999999999885 4699999999999999999999999843221 11222111110
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+...++++.+|+.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 -----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111123457999999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-55 Score=390.04 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=214.0
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEE
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCC 118 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~ 118 (331)
.+++...++|+..+.||+ +||+||+|++. +..||||++.........+.|.+|+.+|++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 344445678999999999 99999999873 3689999998766655677899999999999999999999999
Q ss_pred eeCCccEEEEEecCCCChhhhhcCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 020078 119 IETEIPILVFEFVEYGTLADRICSPHG-------------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIV 179 (331)
Q Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 179 (331)
.+.+..+++|||+++|+|.+++..... .....+++..++.++.|++.||+||| +.+||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeE
Confidence 999999999999999999999864321 11235889999999999999999999 89999
Q ss_pred eCCCCCCceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCC-CC
Q 020078 180 FKDIKLSQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-RD 258 (331)
Q Consensus 180 Hrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~-~p 258 (331)
||||||+|||+|.++.+||+|||+|+...............||+.|+|||.+....|+.++|||||||++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 99999999999999999999999998765544333333455889999999999999999999999999999999996 45
Q ss_pred ChhHH--HHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 259 NILLE--HVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 259 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
|.... .....+....... .+. ..++++.+|+.+||+.||++||||.||++.|++|.
T Consensus 243 ~~~~~~~e~~~~v~~~~~~~-------~p~------~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMAHEEVIYYVRDGNILA-------CPE------NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSCHHHHHHHHHTTCCCC-------CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCHHHHHHHHHcCCCCC-------CCc------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 53222 2222222221111 111 33357999999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=382.27 Aligned_cols=255 Identities=19% Similarity=0.266 Sum_probs=197.6
Q ss_pred hcCccccCceee-cCcEEEEEEeC-----CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE-----NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.++|...+.||+ +||.||+|++. +..||||.+.........+.|.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 457888899999 99999999872 24588998876655556778999999999999999999999996 467899
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
||||+++|+|.+++.... .++++..++.++.||++||.||| +.+|+||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999876543 46899999999999999999999 89999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~ 283 (331)
+........ ....||+.|+|||++..+.++.++|||||||++|||++ |.+|+.... .....+...... .
T Consensus 158 ~~~~~~~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-------~ 229 (273)
T d1mp8a_ 158 MEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-------P 229 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------C
T ss_pred ccCCcceec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------C
Confidence 654433222 22448999999999999999999999999999999998 888874321 111112211110 1
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.+. .+++++.+|+.+||+.||++|||+.|+++.|+++.+.
T Consensus 230 ~~~------~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 230 MPP------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC------CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 3345799999999999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-55 Score=380.08 Aligned_cols=251 Identities=23% Similarity=0.315 Sum_probs=198.7
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEee-CCccEEEEEec
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIE-TEIPILVFEFV 131 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 131 (331)
++|...+.||+ +||.||+|++.+..||||++.+.. ..+.|.+|+.++++++|||||+++|+|.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677788999 999999999999999999996542 45789999999999999999999999965 45689999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++..... ..+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCC
Confidence 99999999965321 35899999999999999999999 8999999999999999999999999999998764432
Q ss_pred ccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHH--HHHHHhhccccccccccccccCCCC
Q 020078 212 THVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLE--HVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.. ..+|+.|+|||++.++.++.++||||||+++|||++ |+.|+.... .....+.+..... . +.
T Consensus 158 ~~-----~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~-----~--~~-- 223 (262)
T d1byga_ 158 DT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-----A--PD-- 223 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-----C--CT--
T ss_pred cc-----ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----C--Cc--
Confidence 22 237889999999999999999999999999999998 677763211 1111121111111 1 11
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhcC
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSAV 331 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~~ 331 (331)
..++++.+|+.+||..||++||||.++++.|+++++..|
T Consensus 224 ----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~~~ 262 (262)
T d1byga_ 224 ----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262 (262)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhCCC
Confidence 233579999999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=386.67 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=199.9
Q ss_pred hcCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
.++|...+.||+ +||.||+|++ ++..||||++..... ..+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 467889999999 9999999999 667899999875433 45789999999999999999999999865 567899999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+++|+|..++..... ..+++.+++.++.||+.||.||| ..+|+||||||+|||++.++++||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999988865321 35899999999999999999999 889999999999999999999999999999876544
Q ss_pred CccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhH---HHHHHHhhccccccccccccccCCC
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILL---EHVKKHVENNRLGEIVDPIVVEDKS 287 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (331)
...... ...||+.|+|||++..+.++.++||||||+++|||++|..|+... ............ ...+.
T Consensus 167 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~-------~~~~~- 237 (285)
T d1fmka3 167 EYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------MPCPP- 237 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-------CCCCT-
T ss_pred Cceeec-cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-------CCCCc-
Confidence 332222 234899999999999999999999999999999999977665221 111222211111 01111
Q ss_pred CchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 288 CPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 288 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+++++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 238 -----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 238 -----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 334579999999999999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.8e-53 Score=384.19 Aligned_cols=248 Identities=15% Similarity=0.172 Sum_probs=205.1
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
-++|...+.||+ +||.||+|+. +|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE-SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH-HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch-hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999 9999999998 689999999976543 256788999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc--CCCceEEccCCCcccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--EYNVAKLSDFSESEYI 207 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfg~a~~~ 207 (331)
||++|+|.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+++.+
T Consensus 104 ~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 104 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999986543 35899999999999999999999 89999999999999996 4578999999999887
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHH--HHHHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEH--VKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 285 (331)
....... ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||..... .......... .
T Consensus 177 ~~~~~~~---~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----------~ 243 (350)
T d1koaa2 177 DPKQSVK---VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------N 243 (350)
T ss_dssp CTTSCEE---EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------C
T ss_pred ccccccc---eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------C
Confidence 5544322 24599999999999999999999999999999999999999843221 1111111111 0
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.........++++.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111134567999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-54 Score=384.79 Aligned_cols=253 Identities=18% Similarity=0.347 Sum_probs=201.5
Q ss_pred cCccccCceee-cCcEEEEEEe--CCc----eEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENR----PISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~l 126 (331)
.+|...++||+ +||+||+|.+ +++ +||+|++.........+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35889999999 9999999988 343 68999987665555678899999999999999999999999865 4678
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccc
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEY 206 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~ 206 (331)
++||+++|+|.+.+.... ..+++..++.++.||++||.||| +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 899999999999887643 56899999999999999999999 89999999999999999999999999999998
Q ss_pred cCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhH--HHHHHHhhccccccccccccc
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILL--EHVKKHVENNRLGEIVDPIVV 283 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~ 283 (331)
..............||+.|+|||++.++.|+.++|||||||++|||+| |..||... .........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-------~~ 233 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------LP 233 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-------CC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------CC
Confidence 765554444334458999999999999999999999999999999998 77786321 111222221111 11
Q ss_pred cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 020078 284 EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMY 327 (331)
Q Consensus 284 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~ 327 (331)
.+. .+++++.+|+.+||+.||++|||+.|++..|+++.
T Consensus 234 ~p~------~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 234 QPP------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CCT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCc------ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111 33457999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=384.61 Aligned_cols=267 Identities=17% Similarity=0.314 Sum_probs=204.0
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeE
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGC 117 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~ 117 (331)
.+++...++|...+.||+ +||.||+|.+ +++.||||++.........+.+.+|..++.++ +|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 444444577999999999 9999999987 23579999998766555677888899888887 58999999999
Q ss_pred EeeC-CccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCC
Q 020078 118 CIET-EIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKL 185 (331)
Q Consensus 118 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~ 185 (331)
+.+. +..++|||||++|+|.+++...... ....+++.+++.++.||++||.||| +.+|+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCc
Confidence 8765 4689999999999999999753210 1135889999999999999999999 89999999999
Q ss_pred CceEEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCC-CCChhH--
Q 020078 186 SQILFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-RDNILL-- 262 (331)
Q Consensus 186 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~-~p~~~~-- 262 (331)
+|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++|. .||...
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998765554444444456999999999999999999999999999999999975 465321
Q ss_pred -HHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHh
Q 020078 263 -EHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLS 329 (331)
Q Consensus 263 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~ 329 (331)
.........+.... .+. ..++++.+|+.+||+.||++||||.|+++.|+++.++
T Consensus 243 ~~~~~~~~~~~~~~~-------~~~------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 DEEFCRRLKEGTRMR-------APD------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp SHHHHHHHHHTCCCC-------CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCC-------CCc------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 12222222221111 111 2335799999999999999999999999999998765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-53 Score=374.35 Aligned_cols=249 Identities=17% Similarity=0.160 Sum_probs=204.7
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-----cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-----ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI 123 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 123 (331)
+.+.|...+.||+ +||+||+|+. +++.||||.+.+... ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 3467999999999 9999999998 689999999865322 1235789999999999999999999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC----ceEEc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN----VAKLS 199 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~----~~kl~ 199 (331)
.|+|||||++|+|.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEec
Confidence 99999999999999999754 46999999999999999999999 89999999999999998776 59999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEI 277 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~ 277 (331)
|||+|.......... ...||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........
T Consensus 160 DfG~a~~~~~~~~~~---~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--- 233 (293)
T d1jksa_ 160 DFGLAHKIDFGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY--- 233 (293)
T ss_dssp CCTTCEECTTSCBCS---CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---
T ss_pred chhhhhhcCCCcccc---ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC---
Confidence 999998875543322 245899999999999999999999999999999999999998532221 111111110
Q ss_pred cccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 VDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 234 -------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 -------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011111134567999999999999999999999985
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.1e-53 Score=382.67 Aligned_cols=248 Identities=18% Similarity=0.189 Sum_probs=205.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
.+.|...+.||+ +||.||+|+. +++.||||.+...... ....+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 457999999999 9999999998 7899999998765332 45678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc--CCCceEEccCCCcccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD--EYNVAKLSDFSESEYI 207 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~--~~~~~kl~Dfg~a~~~ 207 (331)
||++|+|.+.+.... .++++.++..++.||+.||.||| +.+|+||||||+|||++ .++.+||+|||+|+.+
T Consensus 107 ~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 107 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence 999999999886543 46899999999999999999999 89999999999999998 6789999999999987
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 285 (331)
....... ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||....... .........
T Consensus 180 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---------- 246 (352)
T d1koba_ 180 NPDEIVK---VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE---------- 246 (352)
T ss_dssp CTTSCEE---EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC----------
T ss_pred CCCCcee---eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence 6543322 2458999999999999999999999999999999999999985422221 111111110
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
+..+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011134457999999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=377.54 Aligned_cols=252 Identities=18% Similarity=0.311 Sum_probs=203.7
Q ss_pred cCceee-cCcEEEEEEe-C-C---ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC-CccEEEEEec
Q 020078 59 HQVIAS-EHYKLYKGFL-E-N---RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET-EIPILVFEFV 131 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~-~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~ 131 (331)
.++||+ +||+||+|++ . + ..||||++.........+.|.+|+.+|++++|||||+++|+|.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 467999 9999999998 2 1 258999997655555678899999999999999999999998764 5789999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|+|.+++.... ..+++..++.++.|++.||.||| +.+|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999987653 45778899999999999999999 8999999999999999999999999999998775543
Q ss_pred ccc--cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhccccccccccccccCC
Q 020078 212 THV--TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 212 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 286 (331)
... ......||+.|+|||++..+.++.++||||||+++|||++|..|+....... ..+..+.. ...+.
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~-------~~~p~ 257 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LLQPE 257 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC-------CCCCT
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-------CCCcc
Confidence 221 1222458999999999999999999999999999999999888764322211 11111111 11111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHhc
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYLSA 330 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~~~ 330 (331)
..++++.+|+.+||+.||++||||.||++.|++++.+.
T Consensus 258 ------~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 258 ------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ------cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 22347999999999999999999999999999998763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=378.57 Aligned_cols=256 Identities=19% Similarity=0.290 Sum_probs=203.0
Q ss_pred cCccccCceee-cCcEEEEEEe--CCc--eEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENR--PISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|...+.||+ +||.||+|.+ ++. .||||++.........+.|.+|+.+|.++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56778889999 9999999998 444 57888886655554677899999999999 799999999999999999999
Q ss_pred EEecCCCChhhhhcCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCce
Q 020078 128 FEFVEYGTLADRICSPH-----------GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVA 196 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~ 196 (331)
|||+++|+|.+++.... ......+++..++.++.||+.||.||| +.+|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence 99999999999997542 111256899999999999999999999 8999999999999999999999
Q ss_pred EEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCC-CChhHH--HHHHHhhccc
Q 020078 197 KLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRR-DNILLE--HVKKHVENNR 273 (331)
Q Consensus 197 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~-p~~~~~--~~~~~~~~~~ 273 (331)
||+|||+++........ ....||..|+|||.+..+.++.++|||||||++|||++|.. |+.... .....+..+.
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 99999999765433221 12348999999999999999999999999999999999765 553222 2112222111
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
. ...+. .+++++.+|+.+||+.||++||||.||++.|+++.+
T Consensus 244 ~-------~~~~~------~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 244 R-------LEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp C-------CCCCT------TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------CCCCc------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1 01111 334579999999999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=381.52 Aligned_cols=244 Identities=16% Similarity=0.201 Sum_probs=203.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+|+. +++.||+|++.+.. .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 56889999999 9999999998 78999999987542 1224677899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999998764 45889999999999999999999 9999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVEDK 286 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 286 (331)
..... ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ..... ....
T Consensus 157 ~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------------~~~~ 222 (337)
T d1o6la_ 157 SDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------------MEEI 222 (337)
T ss_dssp CTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------HCCC
T ss_pred cCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh------------cCCC
Confidence 43322 22356999999999999999999999999999999999999998433221 11111 1111
Q ss_pred CCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 287 SCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 287 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
..|. ..++++.+|+.+||+.||++||+ +.|+++
T Consensus 223 ~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 RFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2221 34567999999999999999995 777765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=373.97 Aligned_cols=260 Identities=18% Similarity=0.304 Sum_probs=210.0
Q ss_pred hcCccccCceee-cCcEEEEEEeC--C-------ceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFLE--N-------RPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~~--~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
.+.|...+.||+ +||.||+|+.. + ..||||++...........+.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 467888899999 99999999871 1 369999998776665678899999999998 799999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEE
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGP-----------HLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILF 190 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill 190 (331)
+..++|||||++|+|.+++...... ....+++.+++.++.||+.||.||| +.+||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence 9999999999999999999765321 1245899999999999999999999 9999999999999999
Q ss_pred cCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChh--HHHHHH
Q 020078 191 DEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNIL--LEHVKK 267 (331)
Q Consensus 191 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~--~~~~~~ 267 (331)
+.++.+||+|||+++...............+|+.|+|||++.++.|+.++||||||+++|||++ |..||.. ......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999987765544433444568999999999999999999999999999999998 6777732 222222
Q ss_pred HhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 268 HVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+....... .+. .+++++.+|+.+||+.||++||||.||++.|+++..
T Consensus 249 ~i~~~~~~~-------~p~------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 LLKEGHRMD-------KPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHTTCCCC-------CCS------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCCCCC-------CCc------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 222221111 111 233579999999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=377.08 Aligned_cols=262 Identities=16% Similarity=0.254 Sum_probs=212.7
Q ss_pred HHhcCccccCceee-cCcEEEEEEe-------CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEeeC
Q 020078 51 IATNNYNGHQVIAS-EHYKLYKGFL-------ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIET 121 (331)
Q Consensus 51 ~~~~~~~~~~~ig~-~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~ 121 (331)
...+.|...+.||+ +||.||+|++ ++..||||++...........|.+|+.++..+ +|||||+++|+|.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34567888899999 9999999986 34589999998766555677899999999999 699999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCce
Q 020078 122 EIPILVFEFVEYGTLADRICSPHG-------------PHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQI 188 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Ni 188 (331)
+..++|||||++|+|.+++..... .....+++..+..++.||++||.||| +.+|+||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence 999999999999999999875321 11235889999999999999999999 89999999999999
Q ss_pred EEcCCCceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhC-CCCChh---HHH
Q 020078 189 LFDEYNVAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTG-RRDNIL---LEH 264 (331)
Q Consensus 189 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g-~~p~~~---~~~ 264 (331)
+++.++.++++|||+++...............||+.|+|||++..+.++.++|||||||++|||+++ .+|+.. ...
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999987665544444445689999999999999999999999999999999995 444422 122
Q ss_pred HHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 265 VKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
........... ..+. ..++++.+|+.+||+.||++||||.|+++.|+++..
T Consensus 257 ~~~~i~~~~~~-------~~~~------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 FYKMIKEGFRM-------LSPE------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHHHTCCC-------CCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCC-------CCcc------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 22222221110 1111 233579999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-52 Score=376.32 Aligned_cols=243 Identities=18% Similarity=0.270 Sum_probs=201.7
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||+||+|+. +++.||||++.... .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46888999999 9999999998 68999999986532 1224678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
|||++|+|..++... ..++...+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999988765 45788899999999999999999 9999999999999999999999999999998875
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.... ..+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.......... .+.......
T Consensus 156 ~~~~-----~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------~i~~~~~~~ 220 (316)
T d1fota_ 156 DVTY-----TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE----------KILNAELRF 220 (316)
T ss_dssp SCBC-----CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------HHHHCCCCC
T ss_pred cccc-----cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH----------HHHcCCCCC
Confidence 4332 2459999999999999899999999999999999999999984322211110 001111111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
|. ..++++.+++.+||..||++|| |+.++++
T Consensus 221 p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 221 PP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 11 3345799999999999999996 8988875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-52 Score=366.40 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=202.7
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc----
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--NGENFCFNNIVFAAQMNHRNILKLIGCCIETEI---- 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---- 123 (331)
.+.|...+.||+ +||.||+|+. +++.||||.+...... ...+.+.+|+.+++.++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999 9999999997 7899999999765332 345679999999999999999999999987553
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.|+|||||++|+|.+++... .++++.++..++.||+.||.||| +.+|+||||||+|||++.++..+++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence 78999999999999988654 46899999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHH---Hhhccccccccc
Q 020078 204 SEYIPEGETH-VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKK---HVENNRLGEIVD 279 (331)
Q Consensus 204 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~ 279 (331)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~----~ 233 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPI----P 233 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCC----C
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCC----C
Confidence 8765433221 223335699999999999988999999999999999999999999854322221 1111110 0
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRP-TMVYAAKQLRQMYL 328 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp-s~~evl~~L~~~~~ 328 (331)
+ ..... ..++++.+++.+||+.||++|| |+.+++..|.+++.
T Consensus 234 ~-~~~~~------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 234 P-SARHE------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp G-GGTSS------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred C-chhcc------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 0 01111 2345799999999999999999 89999999998763
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-53 Score=372.79 Aligned_cols=252 Identities=18% Similarity=0.321 Sum_probs=195.7
Q ss_pred cCccccCceee-cCcEEEEEEeC---C--ceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLE---N--RPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~---~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++|...+.||+ +||.||+|++. + ..||||.+.... .....+.|.+|+.+|++++|||||+++|+|.++ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 56888889999 99999999872 2 368999887542 233467899999999999999999999999764 678
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+||||+++|++.+.+.... ..+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence 9999999999998887543 46899999999999999999999 8999999999999999999999999999999
Q ss_pred ccCCCCccc-cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHh-CCCCChhHHHHHH--Hh-hcccccccccc
Q 020078 206 YIPEGETHV-TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLT-GRRDNILLEHVKK--HV-ENNRLGEIVDP 280 (331)
Q Consensus 206 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~-g~~p~~~~~~~~~--~~-~~~~~~~~~~~ 280 (331)
.+....... ......||..|+|||++.+..++.++||||||+++|||++ |+.||........ .+ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~------ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------ 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC------
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC------
Confidence 876554332 2223447889999999999999999999999999999998 8999843332221 11 11110
Q ss_pred ccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 020078 281 IVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQM 326 (331)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~ 326 (331)
...+. ..+.++.+|+.+||+.||++||||.|+++.|++.
T Consensus 234 -~~~~~------~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 -LPRPE------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -CCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCcc------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01111 3345799999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-52 Score=370.40 Aligned_cols=258 Identities=19% Similarity=0.302 Sum_probs=197.8
Q ss_pred cCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHH--HHHHHHhcCCCceeeeEeEEeeCC----ccEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFN--NIVFAAQMNHRNILKLIGCCIETE----IPIL 126 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~--E~~~l~~l~h~nIv~l~~~~~~~~----~~~l 126 (331)
..|...+.||+ +||.||+|+++|+.||||++... ....+.+ |+..+.+++|||||+++|+|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 34566778999 99999999999999999998643 2334444 455556789999999999998754 4689
Q ss_pred EEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 127 VFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIG-----FRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 127 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
|||||++|+|.+++.+ .+++|.+++.++.|++.||.|||+. ..++|+||||||+|||++.++.+||+||
T Consensus 79 v~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 9999999999999975 3589999999999999999999942 1369999999999999999999999999
Q ss_pred CCccccCCCCccc--cccccCCCCcccchhhhccCC------CCCcccchhhHHHHHHHHhCCCCChh------------
Q 020078 202 SESEYIPEGETHV--TSHMLTRTKRYLAPEYILTGL------CNEKTDVFCFGMLLLELLTGRRDNIL------------ 261 (331)
Q Consensus 202 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlG~~l~el~~g~~p~~~------------ 261 (331)
|+++......... ......||+.|+|||++.... ++.++|||||||++|||+||..|+..
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 9998775543322 233456999999999987542 67799999999999999999876511
Q ss_pred -----HHHHHHHhhccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 262 -----LEHVKKHVENNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 262 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
............ .++.+... .........+.+|+.+||+.||++||||.||++.|+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~----~~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 233 PSDPSVEEMRKVVCEQK----LRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CSSCCHHHHHHHHTTSC----CCCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHhccc----cCCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111111111111 11111111 1111455679999999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=375.65 Aligned_cols=265 Identities=19% Similarity=0.295 Sum_probs=214.1
Q ss_pred HHHHHhcCccccCceee-cCcEEEEEEeC-------CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEe
Q 020078 48 ELKIATNNYNGHQVIAS-EHYKLYKGFLE-------NRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCI 119 (331)
Q Consensus 48 ~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 119 (331)
+++...++|...+.||+ +||+||+|.+. +..||||++...........|.+|+.++++++|||||+++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34444577888899999 89999999873 46899999987665556678999999999999999999999999
Q ss_pred eCCccEEEEEecCCCChhhhhcCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC
Q 020078 120 ETEIPILVFEFVEYGTLADRICSPH-----GPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN 194 (331)
Q Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~ 194 (331)
..+..++||||+++|+|.+++.... ......+++..+..++.|+++||.||| +.+|+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence 9999999999999999999886421 112245789999999999999999999 89999999999999999999
Q ss_pred ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCC-CCChhH--HHHHHHhhc
Q 020078 195 VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGR-RDNILL--EHVKKHVEN 271 (331)
Q Consensus 195 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~-~p~~~~--~~~~~~~~~ 271 (331)
++||+|||+++.+.............||+.|+|||.+.++.++.++||||||+++|||++|. .|+... .........
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999998775554444444445899999999999999999999999999999999986 555322 122222222
Q ss_pred cccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 272 NRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.... ..+. .+++.+.+|+.+||+.||++|||+.+|++.|++..+
T Consensus 251 ~~~~-------~~p~------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 251 GGLL-------DKPD------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCC-------CCcc------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1111 1111 233479999999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-51 Score=360.82 Aligned_cols=247 Identities=20% Similarity=0.248 Sum_probs=202.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc--------chhHHHHHHHHHHHhcC-CCceeeeEeEEeeC
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE--------NGENFCFNNIVFAAQMN-HRNILKLIGCCIET 121 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~ 121 (331)
++|...+.||+ +||+||+|+. +++.||||++...... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999 9999999998 7899999998754321 12346889999999997 99999999999999
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..|+|||||++|+|.+++... .++++.++..++.||+.||.||| ..+|+||||||+|||++.++.+||+||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999754 46899999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhcc------CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhccc
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILT------GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVENNR 273 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~~~ 273 (331)
|+++.+...... ....||+.|+|||.+.. ..++.++||||+||++|+|++|+.||....... .......
T Consensus 155 G~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 155 GFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp TTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred hheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 999887554322 22459999999999863 357889999999999999999999984432221 1121111
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ...+.....++++.+|+.+||+.||++|||+.||++
T Consensus 232 ~~----------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 232 YQ----------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CC----------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CC----------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 10 111111245568999999999999999999999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=370.36 Aligned_cols=245 Identities=18% Similarity=0.226 Sum_probs=202.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
-+.|...+.||+ +||+||+|.. +++.||+|.+..... ....+.+|+.+|+.++|||||++++++.+++..|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357888999999 9999999998 688999999976432 34568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCC--CceEEccCCCcccc
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEY--NVAKLSDFSESEYI 207 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~--~~~kl~Dfg~a~~~ 207 (331)
||++|+|.+++.... ..+++.++..++.||+.||.||| +.+|+||||||+|||++.+ ..+||+|||+++..
T Consensus 82 ~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999997643 35899999999999999999999 8999999999999999854 58999999999876
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH--HHHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV--KKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 285 (331)
....... ...+|+.|+|||.+.+..|+.++||||+||++|+|++|..||...... ...... ..
T Consensus 155 ~~~~~~~---~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~------------~~ 219 (321)
T d1tkia_ 155 KPGDNFR---LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN------------AE 219 (321)
T ss_dssp CTTCEEE---EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------------TC
T ss_pred ccCCccc---ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------CC
Confidence 5443322 234899999999999999999999999999999999999998432221 111111 11
Q ss_pred CCCch--HHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 286 KSCPE--KEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 286 ~~~~~--~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...+. ....++++.+|+.+||..||++|||+.|+++
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 1134567999999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.9e-52 Score=375.66 Aligned_cols=243 Identities=16% Similarity=0.188 Sum_probs=202.3
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~ 128 (331)
++|...+.||+ +||.||+|+. +++.||||.+.... .....+.+.+|+.+|+.++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999 9999999998 68999999986431 1224567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIP 208 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~ 208 (331)
||+.+|+|.+++... ..+++..+..++.||+.||.||| +.+||||||||+|||++.++.+||+|||+|+.+.
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999998754 35899999999999999999999 8999999999999999999999999999998775
Q ss_pred CCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccccccccCCCC
Q 020078 209 EGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDPIVVEDKSC 288 (331)
Q Consensus 209 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (331)
.... ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||........... +.......
T Consensus 193 ~~~~-----~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~----------i~~~~~~~ 257 (350)
T d1rdqe_ 193 GRTW-----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----------IVSGKVRF 257 (350)
T ss_dssp SCBC-----CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----------HHHCCCCC
T ss_pred cccc-----cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH----------HhcCCCCC
Confidence 4322 24599999999999999999999999999999999999999854322111110 01111111
Q ss_pred chHHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 020078 289 PEKEQQLQALLQLIFECVNESAGDRP-----TMVYAAK 321 (331)
Q Consensus 289 ~~~~~~~~~~~~li~~cl~~dP~~Rp-----s~~evl~ 321 (331)
|. ..++++.+|+.+||+.||++|+ |+.++++
T Consensus 258 p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 PS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred Cc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11 3445799999999999999994 8999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=372.15 Aligned_cols=243 Identities=19% Similarity=0.264 Sum_probs=199.9
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCC--CcchhHHHHHHHHHHH-hcCCCceeeeEeEEeeCCccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNY--SENGENFCFNNIVFAA-QMNHRNILKLIGCCIETEIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~lv 127 (331)
++|...+.||+ +||+||+|+. +++.||||++.+.. .....+.+.+|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999 9999999999 78999999997532 1224566777777765 68999999999999999999999
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYI 207 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~ 207 (331)
||||++|+|.+++... ..+++.++..++.||+.||.||| +.+|+||||||+|||+++++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 9999999999999754 45889999999999999999999 899999999999999999999999999999866
Q ss_pred CCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHH--HHHHHhhccccccccccccccC
Q 020078 208 PEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLE--HVKKHVENNRLGEIVDPIVVED 285 (331)
Q Consensus 208 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 285 (331)
...... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... ......... .
T Consensus 154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------~ 219 (320)
T d1xjda_ 154 MLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------N 219 (320)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------C
T ss_pred cccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------C
Confidence 443322 222459999999999999999999999999999999999999984322 222222111 1
Q ss_pred CCCchHHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 020078 286 KSCPEKEQQLQALLQLIFECVNESAGDRPTMV-YAA 320 (331)
Q Consensus 286 ~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~-evl 320 (331)
+..|. ..++++.+|+.+||+.||++|||+. +++
T Consensus 220 ~~~p~--~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 220 PFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCc--cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 11111 3345799999999999999999995 664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-51 Score=367.24 Aligned_cols=248 Identities=18% Similarity=0.240 Sum_probs=197.8
Q ss_pred hcCcccc-Cceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhc-CCCceeeeEeEEee----CCc
Q 020078 53 TNNYNGH-QVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQM-NHRNILKLIGCCIE----TEI 123 (331)
Q Consensus 53 ~~~~~~~-~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~----~~~ 123 (331)
.++|... ++||+ +||.||+|+. +++.||||++.. ...+.+|+.++.++ +|||||++++++.+ ++.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 4678765 57999 9999999998 789999999853 34677899987655 89999999999876 356
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC---CCceEEcc
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE---YNVAKLSD 200 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~---~~~~kl~D 200 (331)
.|+|||||++|+|.+++..... ..+++.++..++.||+.||.||| +.+|+||||||+|||++. .+.+||+|
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred EEEEEECCCCCcHHHHHHhcCC---CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence 8999999999999999976432 46899999999999999999999 899999999999999985 46799999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhcccccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVDP 280 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 280 (331)
||+|+......... ...||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ...+...
T Consensus 158 FG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~------~~~~~~~ 228 (335)
T d2ozaa1 158 FGFAKETTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------SPGMKTR 228 (335)
T ss_dssp CTTCEECCCCCCCC---CCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C
T ss_pred cceeeeccCCCccc---cccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH------HHHHHHH
Confidence 99998775543322 24599999999999988999999999999999999999999843211000 0001111
Q ss_pred ccccC--CCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 IVVED--KSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 ~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..... .+.+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11112 222333456788999999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-51 Score=373.78 Aligned_cols=245 Identities=17% Similarity=0.231 Sum_probs=194.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC--cchhHHHHHH---HHHHHhcCCCceeeeEeEEeeCCccE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS--ENGENFCFNN---IVFAAQMNHRNILKLIGCCIETEIPI 125 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E---~~~l~~l~h~nIv~l~~~~~~~~~~~ 125 (331)
++|...+.||+ +||.||+|+. +++.||+|.+.+... ......+.+| +.+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999 9999999998 689999999864311 1122334444 66677778999999999999999999
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
+|||||++|+|.+++... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999754 45789999999999999999999 9999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH--HHHHHhhcccccccccccc
Q 020078 206 YIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE--HVKKHVENNRLGEIVDPIV 282 (331)
Q Consensus 206 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 282 (331)
.+...... ...||+.|+|||++..+ .|+.++|||||||++|||++|+.||.... ........ ..
T Consensus 156 ~~~~~~~~----~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---------~~ 222 (364)
T d1omwa3 156 DFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---------TL 222 (364)
T ss_dssp ECSSSCCC----SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---------SS
T ss_pred ecCCCccc----ccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------cc
Confidence 77554322 24599999999999754 68999999999999999999999984211 00011110 01
Q ss_pred ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 283 VEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
......+. ..++++.+||.+||+.||++||| |.|+++
T Consensus 223 ~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 TMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCCCCCCS--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cCCCCCCC--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111111 34457999999999999999999 677764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-51 Score=361.88 Aligned_cols=253 Identities=20% Similarity=0.192 Sum_probs=191.2
Q ss_pred cCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc----chhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEec
Q 020078 59 HQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE----NGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEFV 131 (331)
Q Consensus 59 ~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 131 (331)
.++||+ +||+||+|+. +++.||||++...... ...+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999 8999999998 7899999998654322 12457889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCCC
Q 020078 132 EYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEGE 211 (331)
Q Consensus 132 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~~ 211 (331)
++|++..+.... ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 988776655432 45888899999999999999999 8999999999999999999999999999998765443
Q ss_pred ccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh---cccccccccc----
Q 020078 212 THVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE---NNRLGEIVDP---- 280 (331)
Q Consensus 212 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~---~~~~~~~~~~---- 280 (331)
... ...+||+.|+|||++..+ .|+.++|||||||++|||++|..||....... .... ........+.
T Consensus 155 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 155 RAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 222 224589999999998755 57999999999999999999999984322211 1111 0000000000
Q ss_pred --c-cccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 281 --I-VVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 281 --~-~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. .......+.. ...++++.+|+.+||+.||++||||.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 0000011110 023467999999999999999999999985
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=357.49 Aligned_cols=260 Identities=18% Similarity=0.176 Sum_probs=196.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
++|...+.||+ +||+||+|+. +++.||+|++..... +...+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57889999999 8999999998 689999999965432 2246789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
|+.++ +.+++..... ..+++..+..++.|++.||.||| +.+||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~~-~~~~~~~~~~---~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASAL---TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSEE-HHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCCc-hhhhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence 99764 4454433221 46899999999999999999999 89999999999999999999999999999987754
Q ss_pred CCccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhc-ccccccccccc--
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVEN-NRLGEIVDPIV-- 282 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~-~~~~~~~~~~~-- 282 (331)
..... ....||+.|+|||++.... ++.++||||+||++|+|++|+.||....... ..... ....+...+..
T Consensus 155 ~~~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 155 PVRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CSBCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred Ccccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 43322 2245999999999987765 5789999999999999999999984322111 11110 01111000000
Q ss_pred --------ccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 283 --------VEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 283 --------~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
......+.. ...++++.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000 1234679999999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=354.96 Aligned_cols=239 Identities=19% Similarity=0.250 Sum_probs=195.8
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-----chhHHHHHHHHHHHhcC--CCceeeeEeEEeeCC
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-----NGENFCFNNIVFAAQMN--HRNILKLIGCCIETE 122 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~ 122 (331)
.+.|...+.||+ +||.||+|+. +++.||||++...... .....+.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357889999999 9999999998 7899999998754221 12345779999999997 899999999999999
Q ss_pred ccEEEEEecCC-CChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-CCceEEcc
Q 020078 123 IPILVFEFVEY-GTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-YNVAKLSD 200 (331)
Q Consensus 123 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-~~~~kl~D 200 (331)
..++||||+.+ +++.+++... ..+++..+..++.|++.||.||| +.+|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECc
Confidence 99999999975 6777777653 46899999999999999999999 899999999999999985 47999999
Q ss_pred CCCccccCCCCccccccccCCCCcccchhhhccCCC-CCcccchhhHHHHHHHHhCCCCChhHHHHHHHhhccccccccc
Q 020078 201 FSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLC-NEKTDVFCFGMLLLELLTGRRDNILLEHVKKHVENNRLGEIVD 279 (331)
Q Consensus 201 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 279 (331)
||+|+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... .
T Consensus 155 FG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~----~------ 220 (273)
T d1xwsa_ 155 FGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG----Q------ 220 (273)
T ss_dssp CTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHC----C------
T ss_pred cccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhc----c------
Confidence 999987644322 22459999999999987765 56789999999999999999998654432211 0
Q ss_pred cccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 280 PIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..-+. ..++++.+|+.+||+.||++|||+.|+++
T Consensus 221 --~~~~~------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 --VFFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --CCCSS------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cCCCC------CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01111 23357999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=353.19 Aligned_cols=259 Identities=16% Similarity=0.175 Sum_probs=193.9
Q ss_pred hcCccccCceee-cCcEEEEEEe--C-CceEEEEEeCCCCC-cchhHHHHHHHHHHHhc---CCCceeeeEeEEee----
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--E-NRPISVMKFGDNYS-ENGENFCFNNIVFAAQM---NHRNILKLIGCCIE---- 120 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~-~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~---- 120 (331)
.+.|...+.||+ +||+||+|+. + ++.||||++..... ......+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999 9999999997 3 56799999865422 22345677888887766 79999999999864
Q ss_pred -CCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEc
Q 020078 121 -TEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLS 199 (331)
Q Consensus 121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~ 199 (331)
....+++|||+.+|++........ ..+++..+..++.|++.||.||| +.+|+||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence 245789999999877755444332 46889999999999999999999 8999999999999999999999999
Q ss_pred cCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc---cc
Q 020078 200 DFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN---NR 273 (331)
Q Consensus 200 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~---~~ 273 (331)
|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||...... ...... ..
T Consensus 159 dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 159 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235 (305)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred chhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCc
Confidence 999987653322 223356999999999999999999999999999999999999998432211 111110 00
Q ss_pred cccc------cccccccCCCC---chHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 274 LGEI------VDPIVVEDKSC---PEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 274 ~~~~------~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.... ........... ......++++.+|+.+||+.||++||||.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00000000000 000133457999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-49 Score=349.56 Aligned_cols=258 Identities=17% Similarity=0.183 Sum_probs=196.6
Q ss_pred cCccccCceee-cCcEEEEEEe-CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEEe
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 130 (331)
+.|...+.||+ +||+||+|+. +++.||||++..... +...+.+.+|+.+|++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 46888899999 9999999998 789999999976432 23467899999999999999999999999999999999999
Q ss_pred cCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCCC
Q 020078 131 VEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPEG 210 (331)
Q Consensus 131 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~~ 210 (331)
+.++.+..+.... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9887776665443 46999999999999999999999 899999999999999999999999999999876543
Q ss_pred CccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhh---ccccccc------
Q 020078 211 ETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVE---NNRLGEI------ 277 (331)
Q Consensus 211 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~---~~~~~~~------ 277 (331)
... .....+++.|+|||.+... .++.++|||||||++|||++|+.||...... ..... .......
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 VRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 321 2223489999999999755 5689999999999999999999998432111 11110 0000000
Q ss_pred --cccccccCCCCc---hHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 --VDPIVVEDKSCP---EKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 --~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
...........+ .....++++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 00133467999999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=349.98 Aligned_cols=262 Identities=16% Similarity=0.156 Sum_probs=197.2
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCc----c
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIETEI----P 124 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~----~ 124 (331)
++..|...+.||+ +||+||+|+. +++.||||++.........+.+.+|+.+|++++||||+++++++..... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 3456888999999 9999999988 7899999999765555456789999999999999999999999976542 3
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCc
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSES 204 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a 204 (331)
+++++|+.+|+|.+++.. ..+++..+..++.|++.||.||| +.+||||||||+|||++.++.+||+|||++
T Consensus 86 ~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 566677889999999964 35899999999999999999999 899999999999999999999999999999
Q ss_pred cccCCCCcc-ccccccCCCCcccchhhhc-cCCCCCcccchhhHHHHHHHHhCCCCChhHHHH---HHHhhc-cccc-cc
Q 020078 205 EYIPEGETH-VTSHMLTRTKRYLAPEYIL-TGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV---KKHVEN-NRLG-EI 277 (331)
Q Consensus 205 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~---~~~~~~-~~~~-~~ 277 (331)
+........ .......||+.|+|||++. ...++.++||||+||++|+|++|+.||...... ...... .... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 876443222 1223355899999999985 456789999999999999999999998322111 000000 0000 00
Q ss_pred c-----------ccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 278 V-----------DPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 278 ~-----------~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
. ..........+.. ...+.++.+|+.+||+.||++||||.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000011110 1234579999999999999999999999863
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=341.85 Aligned_cols=260 Identities=18% Similarity=0.182 Sum_probs=192.4
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCC-CCcchhHHHHHHHHHHHhcCCCceeeeEeEEee--------C
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDN-YSENGENFCFNNIVFAAQMNHRNILKLIGCCIE--------T 121 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~--------~ 121 (331)
++|...+.||+ +||+||+|+. +++.||||++... ..+.....+.+|+.+|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67888999999 8999999998 7899999998654 223346778999999999999999999999865 3
Q ss_pred CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 122 EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
+..++||||+.++.+....... ..++...+..++.|++.||.||| +.+|+||||||+|||++.++.+|++||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeec
Confidence 4578999999887665444332 45888999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccc--cccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHH--HHhhc--ccc
Q 020078 202 SESEYIPEGETHV--TSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVK--KHVEN--NRL 274 (331)
Q Consensus 202 g~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~--~~~~~--~~~ 274 (331)
|+++.+....... ......||+.|+|||++... .++.++||||+||++|||++|+.||....... ..... ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998765433221 22234589999999998765 68999999999999999999999984222111 11100 000
Q ss_pred -ccccccc----------cccCCCCchHH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 275 -GEIVDPI----------VVEDKSCPEKE-----QQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 275 -~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
....... .......+... ..++++.+|+.+||+.||++||||.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000 00001111111 12456889999999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=347.89 Aligned_cols=254 Identities=21% Similarity=0.207 Sum_probs=187.6
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeeeEeEEeeC------CccE
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKLIGCCIET------EIPI 125 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~~~ 125 (331)
.|...++||+ +||+||+|+. +++.||||++..... ...+|+.+|++++|||||++++++... ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5888899999 9999999999 789999999875432 234799999999999999999998653 2368
Q ss_pred EEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCc
Q 020078 126 LVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSES 204 (331)
Q Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a 204 (331)
+|||||++|.+..+..... ....+++.++..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++
T Consensus 96 lv~Ey~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEECCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEeccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence 9999998764433322110 1146899999999999999999999 99999999999999999775 8999999999
Q ss_pred cccCCCCccccccccCCCCcccchhhhcc-CCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhh----------
Q 020078 205 EYIPEGETHVTSHMLTRTKRYLAPEYILT-GLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVE---------- 270 (331)
Q Consensus 205 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~---------- 270 (331)
+.+....... ...||+.|+|||.+.. ..++.++||||+||++|||++|+.||....... ....
T Consensus 171 ~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGEPNV---SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTSCCC---SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhccCCcccc---cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhh
Confidence 8775443322 2458999999999875 468999999999999999999999983222111 1100
Q ss_pred ----ccccccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 271 ----NNRLGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 271 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..............+.........++++.+|+.+||+.||++||||.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000000000123457999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=345.44 Aligned_cols=256 Identities=19% Similarity=0.202 Sum_probs=191.8
Q ss_pred HhcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCC-----
Q 020078 52 ATNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETE----- 122 (331)
Q Consensus 52 ~~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~----- 122 (331)
..+.|...+.||+ +||+||+|.. +++.||||++..... ....+.+.+|+.+|++++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 3567888899999 9999999998 689999999976433 334668899999999999999999999998755
Q ss_pred -ccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccC
Q 020078 123 -IPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDF 201 (331)
Q Consensus 123 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Df 201 (331)
..|+||||+ +++|..++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|++||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ceEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccc
Confidence 469999999 4577777643 35999999999999999999999 899999999999999999999999999
Q ss_pred CCccccCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH---hhc-ccc-c
Q 020078 202 SESEYIPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH---VEN-NRL-G 275 (331)
Q Consensus 202 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~---~~~-~~~-~ 275 (331)
|+|+....... ...||+.|+|||++.+. .++.++||||+||++|+|++|+.||......... ... ... .
T Consensus 166 g~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 166 GLARQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp TTCEECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cceeccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 99987654332 24589999999998764 5689999999999999999999998332111110 000 000 0
Q ss_pred ccc--------------ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 020078 276 EIV--------------DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQ 322 (331)
Q Consensus 276 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~ 322 (331)
... .+..............++++.+|+.+||..||++||||.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00000000000001234578999999999999999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-47 Score=336.60 Aligned_cols=259 Identities=19% Similarity=0.198 Sum_probs=196.5
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCceeee-EeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNILKL-IGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l-~~~~~~~~~~~lv~ 128 (331)
.+.|...+.||+ +||.||+|++ +++.||||.+.... ....+.+|+.+++.++|+|+|.. .++..+++..++||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT---TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc---cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 356999999999 9999999998 68899999876543 23468899999999987776555 55556777888999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEc---CCCceEEccCCCcc
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFD---EYNVAKLSDFSESE 205 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~---~~~~~kl~Dfg~a~ 205 (331)
||+. |+|.+.+.... ..+++..+..++.|++.||.||| +.+|+||||||+|||++ .+..++++|||+|+
T Consensus 83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp ECCC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEcC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 9995 56766665433 46899999999999999999999 89999999999999986 44579999999999
Q ss_pred ccCCCCccc-----cccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHHHH--hhcccccccc
Q 020078 206 YIPEGETHV-----TSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVKKH--VENNRLGEIV 278 (331)
Q Consensus 206 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~ 278 (331)
.+....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 876543221 223356999999999999889999999999999999999999998321111000 0000000000
Q ss_pred ccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 279 DPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.+.-.... .+++++.+++..||+.||++||++.++.+.|+++..
T Consensus 235 ~~~~~~~~------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 235 TPIEVLCK------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp SCHHHHTT------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred CChhHhcc------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 00000011 233579999999999999999999999999988764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=338.31 Aligned_cols=250 Identities=15% Similarity=0.208 Sum_probs=193.8
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeC--CccEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIET--EIPILV 127 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv 127 (331)
++|...+.||+ +||+||+|+. +++.||||++... ..+.+.+|+.+|..++ ||||+++++++... ...++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 57999999999 9999999998 7899999998654 3567889999999996 99999999999854 468899
Q ss_pred EEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC-ceEEccCCCccc
Q 020078 128 FEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN-VAKLSDFSESEY 206 (331)
Q Consensus 128 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~-~~kl~Dfg~a~~ 206 (331)
||||++|+|.... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+|+.
T Consensus 111 ~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 111 FEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence 9999999997764 45889999999999999999999 99999999999999998655 699999999987
Q ss_pred cCCCCccccccccCCCCcccchhhhccC-CCCCcccchhhHHHHHHHHhCCCCChhHH----H---H---------HHHh
Q 020078 207 IPEGETHVTSHMLTRTKRYLAPEYILTG-LCNEKTDVFCFGMLLLELLTGRRDNILLE----H---V---------KKHV 269 (331)
Q Consensus 207 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~el~~g~~p~~~~~----~---~---------~~~~ 269 (331)
........ ...+|+.|+|||.+.+. .++.++||||+||++|++++|+.||.... . . ....
T Consensus 180 ~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCCCC---SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ccCCCccc---ccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 75543322 24589999999998865 47999999999999999999999982110 0 0 0000
Q ss_pred hc--ccccccccccc--------ccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 270 EN--NRLGEIVDPIV--------VEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 270 ~~--~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
.. ........... ......+.....++++.+|+.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000000000 001111111244568999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=336.21 Aligned_cols=258 Identities=14% Similarity=0.148 Sum_probs=200.2
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeCCccEEEEE
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e 129 (331)
+.|...+.||+ +||+||+|+. +++.||||++..... ......+.+|+.+|+.++|||||++++++.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 46888899999 9999999998 788999999865432 3356789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCCccccCC
Q 020078 130 FVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESEYIPE 209 (331)
Q Consensus 130 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~~~~~ 209 (331)
++.+++|..++... ..+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+|++|||.++....
T Consensus 82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 99999988877654 46889999999999999999999 89999999999999999999999999999987755
Q ss_pred CCccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChh----HHHHHH---Hhhccccccc----
Q 020078 210 GETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNIL----LEHVKK---HVENNRLGEI---- 277 (331)
Q Consensus 210 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~----~~~~~~---~~~~~~~~~~---- 277 (331)
...... ...+++.|+|||.+.... ++.++||||+||++|||++|+.|+.. ...... ..........
T Consensus 154 ~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 154 PVRCYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCSCCC--SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccce--eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 433222 134788899999988665 68999999999999999999998621 111111 1110000000
Q ss_pred ------cccccc-cCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 ------VDPIVV-EDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ------~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
..+... ...........++++.+|+.+||+.||++||||.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00000011134567999999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.5e-46 Score=330.27 Aligned_cols=256 Identities=13% Similarity=0.114 Sum_probs=203.2
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC-CceeeeEeEEeeCCccEEEE
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH-RNILKLIGCCIETEIPILVF 128 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~ 128 (331)
.++|...+.||+ +||+||+|+. +++.||||.+.... ....+.+|++++..|+| +||+.+++++.++...++||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS---DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT---TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc---CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 467999999999 9999999998 68999999875543 23467889999999975 89999999999999999999
Q ss_pred EecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcC-----CCceEEccCCC
Q 020078 129 EFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDE-----YNVAKLSDFSE 203 (331)
Q Consensus 129 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~-----~~~~kl~Dfg~ 203 (331)
||+ +|+|.+++.... ..++..++..++.|++.||.||| +.+|+||||||+|||++. .+.++|+|||+
T Consensus 81 e~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred Eec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccce
Confidence 999 689999887643 46889999999999999999999 999999999999999974 56899999999
Q ss_pred ccccCCCCcc-----ccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChh-----HHHHHHHhhccc
Q 020078 204 SEYIPEGETH-----VTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNIL-----LEHVKKHVENNR 273 (331)
Q Consensus 204 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~-----~~~~~~~~~~~~ 273 (331)
|+........ .......||+.|+|||++.+..++.++||||||+++|||++|+.||.. ............
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~ 232 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 232 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence 9877543221 122335699999999999999999999999999999999999999831 111111111100
Q ss_pred cccccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 020078 274 LGEIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAKQLRQMYL 328 (331)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~~L~~~~~ 328 (331)
.... ...+ .. .+++++.+++..|++.+|++||++..+.+.|+++..
T Consensus 233 ~~~~-~~~l--~~------~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 233 QSTP-LREL--CA------GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHSC-HHHH--TT------TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCC-hHHh--cC------CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0000 0000 11 223479999999999999999999999999888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=339.15 Aligned_cols=253 Identities=17% Similarity=0.193 Sum_probs=188.6
Q ss_pred cCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCC-cchhHHHHHHHHHHHhcCCCceeeeEeEEeeC------Cc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYS-ENGENFCFNNIVFAAQMNHRNILKLIGCCIET------EI 123 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~------~~ 123 (331)
+.|...++||+ +||+||+|++ +++.||||++..... ......+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888999999 9999999998 689999999976533 33456788999999999999999999999643 56
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.|+|||||.++.+ +.+. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.++++|||+
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchHHH-Hhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence 7999999976544 5553 35889999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHHH---H-------------
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHVK---K------------- 267 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~------------- 267 (331)
++........ ....+|+.|+|||++.+..+++++||||+||++++|++|+.||....... .
T Consensus 166 ~~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 8766443322 22458999999999999999999999999999999999999983211110 0
Q ss_pred ---------Hhhccccc-c-----ccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 268 ---------HVENNRLG-E-----IVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 268 ---------~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
........ . .... .............++++.+|+.+||..||++||||+|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPD-SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCG-GGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCcccccccccccccc-ccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0 0000 0111122233356788999999999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-47 Score=339.33 Aligned_cols=245 Identities=18% Similarity=0.219 Sum_probs=196.6
Q ss_pred cCccccCceee-cCcEEEEEEe-----CCceEEEEEeCCCC---CcchhHHHHHHHHHHHhcCC-CceeeeEeEEeeCCc
Q 020078 54 NNYNGHQVIAS-EHYKLYKGFL-----ENRPISVMKFGDNY---SENGENFCFNNIVFAAQMNH-RNILKLIGCCIETEI 123 (331)
Q Consensus 54 ~~~~~~~~ig~-~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~~~~~~ 123 (331)
++|...+.||+ +||+||+|+. +|+.||||.+.... .....+.+.+|+.++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999 9999999986 46889999987542 12245678899999999976 899999999999999
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.+++|||+.+|+|.+++... ..++...+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999998765 35678889999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccC--CCCCcccchhhHHHHHHHHhCCCCChhHH------HHHHHhhccccc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTG--LCNEKTDVFCFGMLLLELLTGRRDNILLE------HVKKHVENNRLG 275 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~ 275 (331)
++.+....... .....|++.|+|||.+... .++.++|||||||+||+|++|+.||.... .........
T Consensus 176 a~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--- 251 (322)
T d1vzoa_ 176 SKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--- 251 (322)
T ss_dssp EEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC---
T ss_pred hhhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC---
Confidence 98765433322 2234589999999999754 46889999999999999999999983221 111111100
Q ss_pred cccccccccCCCCchHHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 020078 276 EIVDPIVVEDKSCPEKEQQLQALLQLIFECVNESAGDRPT-----MVYAAK 321 (331)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps-----~~evl~ 321 (331)
....| ...++++.+|+.+||.+||++||| ++|+++
T Consensus 252 ---------~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---------EPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---------CCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---------CCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11111 134457999999999999999995 788875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=338.57 Aligned_cols=255 Identities=18% Similarity=0.221 Sum_probs=191.3
Q ss_pred hcCccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCc-chhHHHHHHHHHHHhcCCCceeeeEeEEeeC-----Cc
Q 020078 53 TNNYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSE-NGENFCFNNIVFAAQMNHRNILKLIGCCIET-----EI 123 (331)
Q Consensus 53 ~~~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~-----~~ 123 (331)
++.|...+.||+ +||+||+|+. +++.||||++...... ...+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 567999999999 9999999997 7899999999765332 3456788999999999999999999998643 23
Q ss_pred cEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceEEccCCC
Q 020078 124 PILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAKLSDFSE 203 (331)
Q Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~ 203 (331)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence 4677888889999999854 35999999999999999999999 89999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCcccchhhhccCC-CCCcccchhhHHHHHHHHhCCCCChhHHHHH---HHhhc-cccc-cc
Q 020078 204 SEYIPEGETHVTSHMLTRTKRYLAPEYILTGL-CNEKTDVFCFGMLLLELLTGRRDNILLEHVK---KHVEN-NRLG-EI 277 (331)
Q Consensus 204 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~~---~~~~~-~~~~-~~ 277 (331)
+....... ....||+.|+|||...+.. ++.++|||||||++|+|++|+.||....... ..... .... ..
T Consensus 168 a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 87553221 2245899999999977654 6889999999999999999999983221111 00000 0000 00
Q ss_pred c-----------ccccccCCCCchH---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 020078 278 V-----------DPIVVEDKSCPEK---EQQLQALLQLIFECVNESAGDRPTMVYAAK 321 (331)
Q Consensus 278 ~-----------~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~Rps~~evl~ 321 (331)
. ..........+.. ...++++.+|+.+||..||++||||.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 0 0000000000000 023457999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-40 Score=299.75 Aligned_cols=256 Identities=15% Similarity=0.137 Sum_probs=184.6
Q ss_pred CccccCceee-cCcEEEEEEe--CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-----------CCceeeeEeEEee
Q 020078 55 NYNGHQVIAS-EHYKLYKGFL--ENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-----------HRNILKLIGCCIE 120 (331)
Q Consensus 55 ~~~~~~~ig~-~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~nIv~l~~~~~~ 120 (331)
.|...+.||+ +||+||+|+. +++.||||++.... ...+.+.+|+.+++.++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3888999999 8999999998 78999999997542 13467788999988775 5789999988865
Q ss_pred C--CccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCC----
Q 020078 121 T--EIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYN---- 194 (331)
Q Consensus 121 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~---- 194 (331)
. ...+++++++..+.......... ....++...+..++.||+.||.|||+ ..+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 3 45567777765544333222111 11467889999999999999999993 37899999999999998655
Q ss_pred --ceEEccCCCccccCCCCccccccccCCCCcccchhhhccCCCCCcccchhhHHHHHHHHhCCCCChhHHHH-------
Q 020078 195 --VAKLSDFSESEYIPEGETHVTSHMLTRTKRYLAPEYILTGLCNEKTDVFCFGMLLLELLTGRRDNILLEHV------- 265 (331)
Q Consensus 195 --~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el~~g~~p~~~~~~~------- 265 (331)
.++++|||.+........ ...||+.|+|||++....++.++||||+||++++|++|+.||......
T Consensus 168 ~~~~kl~dfg~s~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHYT-----NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBCCC-----SCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccccc-----cccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 389999999886543322 245999999999999999999999999999999999999998422110
Q ss_pred --HHHhhc-cc----------c-ccccc-----cccccCC----------CCchHHHHHHHHHHHHHHhccCCCCCCCCH
Q 020078 266 --KKHVEN-NR----------L-GEIVD-----PIVVEDK----------SCPEKEQQLQALLQLIFECVNESAGDRPTM 316 (331)
Q Consensus 266 --~~~~~~-~~----------~-~~~~~-----~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~ 316 (331)
...... +. . ....+ ..+.... ........++++.+|+.+||+.||.+||||
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000000 00 0 00000 0000000 011123667889999999999999999999
Q ss_pred HHHHH
Q 020078 317 VYAAK 321 (331)
Q Consensus 317 ~evl~ 321 (331)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=5.7e-24 Score=175.45 Aligned_cols=159 Identities=13% Similarity=0.055 Sum_probs=116.6
Q ss_pred cccCceee-cCcEEEEEEe-CCceEEEEEeCCCCCc-----------------chhHHHHHHHHHHHhcCCCceeeeEeE
Q 020078 57 NGHQVIAS-EHYKLYKGFL-ENRPISVMKFGDNYSE-----------------NGENFCFNNIVFAAQMNHRNILKLIGC 117 (331)
Q Consensus 57 ~~~~~ig~-~~g~Vy~~~~-~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h~nIv~l~~~ 117 (331)
..++.||+ +||+||+|+. +|+.||||.+...... .......+|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45678999 9999999998 8899999987532110 012345568889999999999988766
Q ss_pred EeeCCccEEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeCCCCCCceEEcCCCceE
Q 020078 118 CIETEIPILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHIGFRRPIVFKDIKLSQILFDEYNVAK 197 (331)
Q Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivHrdlk~~Nill~~~~~~k 197 (331)
. ..+++|||++++.+.++ +......++.|++.++.||| ..+|+||||||+|||++++ .++
T Consensus 83 ~----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEE
T ss_pred c----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEE
Confidence 3 34799999987665432 22334678999999999999 8999999999999999965 589
Q ss_pred EccCCCccccCCCCccccccccCCCCcccc------hhhhccCCCCCcccchhhH
Q 020078 198 LSDFSESEYIPEGETHVTSHMLTRTKRYLA------PEYILTGLCNEKTDVFCFG 246 (331)
Q Consensus 198 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~SlG 246 (331)
|+|||+|......... .|.. .+. ....|+.++|+||..
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~ 186 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAI 186 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHH
Confidence 9999999765433221 1111 111 235678899999975
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.79 E-value=2.4e-08 Score=84.25 Aligned_cols=148 Identities=14% Similarity=0.047 Sum_probs=102.0
Q ss_pred HHHHHHhcCccccCceee-cCcEEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcC-CCceeeeEeEEeeCCcc
Q 020078 47 GELKIATNNYNGHQVIAS-EHYKLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMN-HRNILKLIGCCIETEIP 124 (331)
Q Consensus 47 ~~~~~~~~~~~~~~~ig~-~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~ 124 (331)
.++...-..|......+. +...||+...++..+++|+....... ....+.+|...+..+. +--+.+++.+..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 455555566655444433 44589998888888999987654332 3446778888888775 33356677888888889
Q ss_pred EEEEEecCCCChhhhhcCCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc--------------------------------
Q 020078 125 ILVFEFVEYGTLADRICSPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI-------------------------------- 172 (331)
Q Consensus 125 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------- 172 (331)
++||+++++.++.+..... .. ...++.++++.+.-||.
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEeccccccccccccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999988876654221 11 23345566666666663
Q ss_pred ------------------------CCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 173 ------------------------GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 173 ------------------------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
.....++|+|+.|.|||++++..+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 012237899999999999987777899998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.28 E-value=2.6e-06 Score=70.94 Aligned_cols=124 Identities=12% Similarity=0.018 Sum_probs=81.9
Q ss_pred cCcEEEEEEeC-CceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC--CceeeeEeEEeeCCccEEEEEecCCCChhhhhc
Q 020078 65 EHYKLYKGFLE-NRPISVMKFGDNYSENGENFCFNNIVFAAQMNH--RNILKLIGCCIETEIPILVFEFVEYGTLADRIC 141 (331)
Q Consensus 65 ~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 141 (331)
+...||+...+ +..+++|...... ...+..|...+..+.. -.+.+++++..+++..++||+++++-++.+..
T Consensus 23 s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~~- 97 (255)
T d1nd4a_ 23 SDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSSH- 97 (255)
T ss_dssp SSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTSC-
T ss_pred cCCeEEEEEeCCCCEEEEEeCCccC----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccccc-
Confidence 44589998884 5567778765442 3356778888877743 33566788888888899999999876654321
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-------------------------------------------------
Q 020078 142 SPHGPHLEPLLWRHRLKIAMEIGNAMAYIHI------------------------------------------------- 172 (331)
Q Consensus 142 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------------- 172 (331)
... ...+.+++..|.-||+
T Consensus 98 ---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 98 ---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred ---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 111 1123344444444442
Q ss_pred ------CCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 173 ------GFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 173 ------~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
.....++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 012247999999999999987777899998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.37 E-value=0.00063 Score=60.06 Aligned_cols=72 Identities=10% Similarity=0.010 Sum_probs=43.3
Q ss_pred eeec-CcEEEEEEe--CCceEEEEEeCCC------CCcchhHHHHHHHHHHHhcC-C--CceeeeEeEEeeCCccEEEEE
Q 020078 62 IASE-HYKLYKGFL--ENRPISVMKFGDN------YSENGENFCFNNIVFAAQMN-H--RNILKLIGCCIETEIPILVFE 129 (331)
Q Consensus 62 ig~~-~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv~e 129 (331)
||.| ...||+... .++.+++|.-... ......+....|...|..+. + ..+.+++.+ +++..++|||
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE 111 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVME 111 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEEC
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEe
Confidence 4553 348999887 4668999975431 11112344567888887663 2 345555554 4556789999
Q ss_pred ecCCCC
Q 020078 130 FVEYGT 135 (331)
Q Consensus 130 ~~~~g~ 135 (331)
++++..
T Consensus 112 ~L~~~~ 117 (392)
T d2pula1 112 DLSHLK 117 (392)
T ss_dssp CCTTSE
T ss_pred ccCCcc
Confidence 997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.0023 Score=54.65 Aligned_cols=65 Identities=14% Similarity=0.090 Sum_probs=42.4
Q ss_pred EEEEEEe-CCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-----eee--EeEEeeCCccEEEEEecCCC
Q 020078 68 KLYKGFL-ENRPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-----LKL--IGCCIETEIPILVFEFVEYG 134 (331)
Q Consensus 68 ~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l--~~~~~~~~~~~lv~e~~~~g 134 (331)
.||+... +|..+++|....+.. ..+++..|...+..|....| +.. -.........+.++++++|.
T Consensus 37 ~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 37 RVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp EEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred eeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 7999998 778899999866532 35667788888887742222 111 11223345667889998764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.03 E-value=0.007 Score=51.11 Aligned_cols=159 Identities=11% Similarity=0.012 Sum_probs=82.5
Q ss_pred cCHHHHHHHhcCccccCceee---cCc---EEEEEEeCCceEEEEEeCCCCCcchhHHHHHHHHHHHhcCC-----Ccee
Q 020078 44 FSAGELKIATNNYNGHQVIAS---EHY---KLYKGFLENRPISVMKFGDNYSENGENFCFNNIVFAAQMNH-----RNIL 112 (331)
Q Consensus 44 ~~~~~~~~~~~~~~~~~~ig~---~~g---~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-----~nIv 112 (331)
++.+|+...-..|..+.+..- ..| +.|....++..+++|+...... .+....|+.++..|.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~---~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCC---HHHHHHHHHHHHhhhhccccccccc
Confidence 567888888888977655442 233 6899988888899999865422 2344456666665532 2222
Q ss_pred eeE-e--EEeeCCccEEEEEecCCCChhhh--------------hc----CCCCCCCCCCCHHH----------------
Q 020078 113 KLI-G--CCIETEIPILVFEFVEYGTLADR--------------IC----SPHGPHLEPLLWRH---------------- 155 (331)
Q Consensus 113 ~l~-~--~~~~~~~~~lv~e~~~~g~L~~~--------------l~----~~~~~~~~~l~~~~---------------- 155 (331)
... | +..-......++.+..+...... ++ ..............
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 01112334556666654322110 00 00000000001000
Q ss_pred --HHHHHHHHHHHHHHhh-cCCCCCeeeCCCCCCceEEcCCCceEEccCCCcc
Q 020078 156 --RLKIAMEIGNAMAYIH-IGFRRPIVFKDIKLSQILFDEYNVAKLSDFSESE 205 (331)
Q Consensus 156 --~~~i~~~i~~~l~~LH-~~~~~~ivHrdlk~~Nill~~~~~~kl~Dfg~a~ 205 (331)
....+..+...+.-.+ .....++||+|+.+.|++++.+...-++||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222 1225679999999999999998888999999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.62 E-value=0.006 Score=53.47 Aligned_cols=68 Identities=16% Similarity=0.141 Sum_probs=41.8
Q ss_pred eeecCc-EEEEEEeCC---------ceEEEEEeCCCCCcchhHHHHHHHHHHHhcCCCce-eeeEeEEeeCCccEEEEEe
Q 020078 62 IASEHY-KLYKGFLEN---------RPISVMKFGDNYSENGENFCFNNIVFAAQMNHRNI-LKLIGCCIETEIPILVFEF 130 (331)
Q Consensus 62 ig~~~g-~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~ 130 (331)
++.|.. .+|+....+ +.|.++.... .. ......+|..+++.+.-.++ .++++++.+ .+|+||
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 433333 899988632 3466666542 22 23455689999988853344 467777642 589999
Q ss_pred cCCCCh
Q 020078 131 VEYGTL 136 (331)
Q Consensus 131 ~~~g~L 136 (331)
+++.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 986544
|